<SEC-DOCUMENT>0000784199-22-000189.txt : 20221104
<SEC-HEADER>0000784199-22-000189.hdr.sgml : 20221104
<ACCEPTANCE-DATETIME>20221104145628
ACCESSION NUMBER:		0000784199-22-000189
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		82
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221104
DATE AS OF CHANGE:		20221104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARTIVION, INC.
		CENTRAL INDEX KEY:			0000784199
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				592417093
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13165
		FILM NUMBER:		221361956

	BUSINESS ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
		BUSINESS PHONE:		7704193355

	MAIL ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CRYOLIFE INC
		DATE OF NAME CHANGE:	19940526
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>aort-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:e6891988-c797-4972-93bc-9ac5fa18c933,g:19ec5362-98a4-465a-8335-497bfcde1bb2,d:167b7825c15e480eba61f77e008c32de--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:aort="http://www.cryolife.com/20220930" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>aort-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80L2ZyYWc6ODExNjkwMWUxYzRkNGZkZWFkNDQ4YjJlY2U3OTEzNjcvdGFibGU6ZmExY2MwOWFlZmQ5NGNlN2I2YjU3OWFjNTllOGQzNGQvdGFibGVyYW5nZTpmYTFjYzA5YWVmZDk0Y2U3YjZiNTc5YWM1OWU4ZDM0ZF8yLTEtMS0xLTIxMTYx_2cff90ab-ea6c-4b74-9310-62ec00e76d8f">0000784199</ix:nonNumeric><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80L2ZyYWc6ODExNjkwMWUxYzRkNGZkZWFkNDQ4YjJlY2U3OTEzNjcvdGFibGU6ZmExY2MwOWFlZmQ5NGNlN2I2YjU3OWFjNTllOGQzNGQvdGFibGVyYW5nZTpmYTFjYzA5YWVmZDk0Y2U3YjZiNTc5YWM1OWU4ZDM0ZF8zLTEtMS0xLTIxMTYx_b0668ee6-11aa-4532-85f1-f9c5e6aed26c">12-31</ix:nonNumeric><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80L2ZyYWc6ODExNjkwMWUxYzRkNGZkZWFkNDQ4YjJlY2U3OTEzNjcvdGFibGU6ZmExY2MwOWFlZmQ5NGNlN2I2YjU3OWFjNTllOGQzNGQvdGFibGVyYW5nZTpmYTFjYzA5YWVmZDk0Y2U3YjZiNTc5YWM1OWU4ZDM0ZF80LTEtMS0xLTIxMTYx_77e3fd2a-56ab-4bc9-a29d-6c21c01ae456">2022</ix:nonNumeric><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80L2ZyYWc6ODExNjkwMWUxYzRkNGZkZWFkNDQ4YjJlY2U3OTEzNjcvdGFibGU6ZmExY2MwOWFlZmQ5NGNlN2I2YjU3OWFjNTllOGQzNGQvdGFibGVyYW5nZTpmYTFjYzA5YWVmZDk0Y2U3YjZiNTc5YWM1OWU4ZDM0ZF81LTEtMS0xLTIxMTYx_08029443-fddd-4943-bc16-42ea1491f087">Q3</ix:nonNumeric><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80L2ZyYWc6ODExNjkwMWUxYzRkNGZkZWFkNDQ4YjJlY2U3OTEzNjcvdGFibGU6ZmExY2MwOWFlZmQ5NGNlN2I2YjU3OWFjNTllOGQzNGQvdGFibGVyYW5nZTpmYTFjYzA5YWVmZDk0Y2U3YjZiNTc5YWM1OWU4ZDM0ZF82LTEtMS0xLTIxMTYx_16b83211-d462-4af7-af96-99c7ce495b68">false</ix:nonNumeric><ix:nonNumeric contextRef="i97c1b95c6b7a4740b6c54cca5ae8f0df_D20200101-20201231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNS0wLTEtMS0yMTE2MS90ZXh0cmVnaW9uOjMwNzdjZjk4YTE0NDQ2YjliOTkyNjljODNlZGM0MTNjXzI2_24621f48-2c6f-4533-bf80-a0d0ebc54e1b">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonNumeric contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyNA_232befca-efbd-4242-931d-c2e23c341abe">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyNA_bf517df5-2808-40a4-b74d-94a6a829e5d0">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i5b95d5c7e8924fa28d703d9a61c60819_D20210602-20210602" name="aort:DebtInstrumentExtensionPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81NS9mcmFnOmY2MTAxNWI0ZTQ0ZDQ3ODJiOWM1MWZjYTY5NTNjMDc5L3RhYmxlOmNlNDM2OTIxNWQxYzQwNTA5MGY0YmIzZTg3MmY4NDNkL3RhYmxlcmFuZ2U6Y2U0MzY5MjE1ZDFjNDA1MDkwZjRiYjNlODcyZjg0M2RfMi0xLTEtMS0yMTE2MQ_35bc507a-e490-4c1f-8939-29fd7800fefe">2.5</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i0f3ad67fb29042d3a507e43f558ecda8_D20200618-20200618" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81NS9mcmFnOmY2MTAxNWI0ZTQ0ZDQ3ODJiOWM1MWZjYTY5NTNjMDc5L3RhYmxlOmNlNDM2OTIxNWQxYzQwNTA5MGY0YmIzZTg3MmY4NDNkL3RhYmxlcmFuZ2U6Y2U0MzY5MjE1ZDFjNDA1MDkwZjRiYjNlODcyZjg0M2RfMy0xLTEtMS0yMTE2MQ_513538b0-a70f-4926-94f1-4dbb8523eadb">0.0426203</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="aort-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb29878d56724102860bc5a9cb2fa5cc_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="idc916650fa81469598a7b03003c27168_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:ProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i9f5bc0203be146e5bb0bd8b45cbdb2b7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:ProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e5a4f6af84f4ddeae300f7b08e9e59d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:ProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd7debfcacac4069a398cab44625bd73_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:ProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i640c303a0a1c4e72a4879aa8b98e0402_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:PreservationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i377e56bf409a455ba20de5d37520ea48_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:PreservationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84212de5e3c34a078a34d879bfeeb394_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:PreservationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8faff0cacc944396b07783c2a5b064e3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:PreservationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92a6652f436d43be99bd75c32c0406d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02c95f38d9b543ae84f37d41d8baa157_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfb7570230e54f50941fc14b31243894_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f32d331c65a4d77abae1c29bfd76fad_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75cedf86a43b46479cf2b7e2e4ffa5b6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2327fb17357843d49351125df49690ce_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i500babc0c996435a9c7bf3de79597910_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5517182634564914ba321ae01406e558_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0173bc1ef6e4cd89e057d607f1488e3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie53b06b7fc644641930b5fae9767bb47_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27b4dd9bf4a1461f8c3787382c8bdc2c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d654e08061c4d2eb225d927a13203b2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4351c2916a14e6583947067dccfd48f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb24e4445f234f45bd7b3b6d182b317a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ebbddb2f6f04869aef50eed79a94a0a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c92a5fd903b49a588c3ceab6bf0fd71_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcf07ce8eeae433881f120218ee9a339_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i855b2caffaf74a64b3f2ef74285e23ad_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i707205b1c07e4c1988ca5ff5d74d4a17_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee6c1445ceaf40bbb5e5f10623f14612_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i017ca17a602e45219dab10ea1da5ec48_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d546f3304f74a65ad65e63d5f35549c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3556d5d3a27c416a831f28c2fa395382_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5632806a31294031ba676bcf8ede366e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebd5d3ab6b5148ef93bef9493a895975_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic31b11b9e24042e291cfae22df2c5210_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9e49d8b70744e2291a48074042aac1d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd29210f343141e18bac0fa033368edb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6cad2dbd6f2405aa20050ef52e24d72_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc8bf90a94e84b16b4e0133d5e3511c8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i382d3d021f0e4fc5926b820bd792e570_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8fc748ed8cc4d6197311f7f5b70f8b9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d640434e1ec4e1f8bc779369e3c30fc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1171158da9d64ea3bb3f8187eeb9bb6a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c9e6fcb6b5041a28fcbb938004e223e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37d952f703594debb99cbb034f182acc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i280bd3e07c864a7c9aaa759e2c9d499a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e85ab3998944bb3b78d14636d55e58c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a36f4d7f25b4eeaa95f908a94d5a7d0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5259bc5ea2d48cfb9c3d8a509a38485_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i874eb09dd9e04c1193c970174fefa74c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6421cdadddcd4de2b8a922abe34ec4d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34648a7bb99f40b581988c47181998e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie76736e9a34845c0be39eb23bee21d1d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3ea81c295134d2a950a870df83c0fc8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39b0402fe99e4b81b9cc8baa58b16782_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib830edf09033428cbcfce9cd0d56ccd3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfcc2e11a6ef41a4bf0b9fc74a0437c7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97c1b95c6b7a4740b6c54cca5ae8f0df_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88ff77f1faa34bb5a9274393c266a3c5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c206091bc204dc2a0b88d27cd64ac1c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia34aaa5e1fdf43c6976074120b87cf65_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bb844b6a956440a8c40b76f8ef5e9ad_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93965fb5672a40aaa73943e5e32c7968_I20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:ArtivionInc.AndStarchMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7419f77f0164d6e8bbfd14061a58dc8_I20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6db073c52b794f6f9307cf9c09aa6840_I20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:StarchMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i474797d7697b4b30bbed0e1b1e4c0c1f_D20210728-20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:ArtivionInc.AndStarchMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8c37cb40b344c3fba9bdc98b545a5de_D20210728-20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:StarchMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e2e38f130ed4105acb2e32af2c464db_I20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:ArtivionInc.AndStarchMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">aort:PmaApprovalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieec45bdddc8041219cabad03cec97440_I20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">aort:PmaApprovalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:StarchMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i377d4fb97be743429e52f8c0cf18419e_I20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">aort:BaxterAchievementOfWorldwideSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:ArtivionInc.AndStarchMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic721009275b44299b76bee3aab313494_I20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">aort:BaxterAchievementOfWorldwideSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:StarchMedicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea42e8fd134e416a8ca4bf1b048423f4_I20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">aort:TransferOfPerclotManufacturingEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c6ab9a4a9c64f29a055949f7555bfee_D20210728-20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i950e76f991cb4fe09eff1721971650dd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec9b82a7f6604a2bbbe148b7d4abe182_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bf831653ca749c6acafb610a2e28758_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e42ab1c54464099a18768bdfff45114_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8204321837cc4faeaa2f049f14c3892b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6561a8259c80412f9d65d166fc210a1a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7196597c5deb49e1bb184bfb4947a913_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dc99e11cae64b9ea4455cb43369f79c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab3c1df5f3a046efb727e88f49e41f79_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic70a37d9dc5d47ff92c7cf4a36a1f693_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedfc3424257043348e41663c5bdc6fd2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7748b61019a4fd4a51f83204e8a357b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f304425672d48179954b9c1f45b94c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81cb3cd3d95849408779cbf36a73bfc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6525e7731ff74ad0828ab59973e96ed9_I20200902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i0da58d4628e84024a2ac81e40f54f818_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id93794b724d14804926854714e119380_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i260c7a4a20d1487d8c43eb7ccdbcf577_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a6f190d5fa245329e12192250fb7f35_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7832872936b4b9fb5d8ab87dfa734ae_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8491b725aa2a46399318dc2aa090e37e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie18a5ff4b2e4444f818e82a116bbe4cf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47ea06876fd54ecdab5ff8648c2c9200_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic210a1a5c32344f8a0d5bb24192cd622_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92f2162a5f2c42d99bb26f8349f42660_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5f9cb6f422b426ea46da0e9c04c8488_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bf438e13a654ecf8c83a67427ed9c00_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedf397d3ddca43f3bc7c0be07a26764c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i415a7398d0b44f30b0c2ac4c3cd52d77_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d1dafbd2f6f4fe292ea508a5b6aae73_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9458b6ce90844216a730adfd5f9304f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bc1a93076b240cdb83aca83562c898c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33d83b59bd714eed96ac088c627a3bb4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f7ee96a23d84973bb23f2b986cd0caa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc1a239494bc4d77b7d869dfb120b17b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fb32fabff8742a98b5467dff62122bf_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida30868564d148eca610e7d10cfd5e6f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideb42e83c22b42c3bb0af7e0655023df_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5927140a3ae44b469c4565ca6f2dc116_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d32d2810d144a3f896cf0d85612aeb7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92c5d5cd7490482d80b5d6c02da7f08d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf210313db394b1ba95827556680cf9d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1ef7a095c054e5bb5088a9e425e637d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d4aa5c197a74658b6b130f04486afd2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffdb325d037c49f5ad546b5419a0a089_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib74a27dcdc9b4dd6af46f79ebbdf834b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d72e53f0f1a452eb2f9cac1876bdd95_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5835fa7529b2441f8256f2039dcd4977_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ec8b963122c48c1bc141284ae59b0cd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1319adccede54d05b8a215934cf0b015_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e3f166e92e3409b8d455325985327e8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b943d5080d34bec84109493c800df5f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia15d0aa664ea4a7f97d1948f098fd347_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30ad3a0d685c4b1fa5f05ae3aeeb8d54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie597e010fff64cb687fea5326f697ce7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90c63eb879c049d8a922a2011f7756e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8267638c5c76419694cfdd6148d710ec_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0452204939dc44418b4b735573daceb1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b5b7de541014928a789871dab61c5b8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1155d3f6605345d9bf6e5eff5b2ff517_D20210106-20210106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-06</xbrli:startDate><xbrli:endDate>2021-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98cd2d841a0d40e39000ad02cbe23dfe_I20210106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91ff9b76a1ca40d280c764ffb11b5962_D20210601-20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i704c126d4e494f8d8caab84f162c9d5f_I20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48b9bbe85c68425d911ee0c362147e39_I20171201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if48526739d454c7aa0ead75443f922f1_I20171201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib252a536e8c2403f88b1f7002f4ad93d_I20171201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a9e96716e2d43fc8cb58b6a571003ac_I20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd8fae709fff4c1da4933fc5331a3616_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i308d3c512f144d22ba8f06fad96609aa_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaea6f089ed074e359ce7c3f017e6b10b_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3079296817f64fe0829aa2166586dc63_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c4d08f8fa5d4fa69f8b6d4049e4bb52_D20210601-20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d9fad1b5e5f409ab72291a10865c569_D20210601-20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ee1e8077bf9471fbd587c9b736b28e0_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5eabbbcdab349c69c7b71952f9f1c67_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ea6eb948294472ab4381af301387075_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18723f9aeb154e06b9755af8e0a35dc0_I20200618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f3ad67fb29042d3a507e43f558ecda8_D20200618-20200618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-18</xbrli:startDate><xbrli:endDate>2020-06-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57c5164417a34d7cad7bfcdca48c018d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc66c0e69857453e9e2dfc50dbf9e1be_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i027b214348ca447cb2405a448216447e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaad6e3991c64789be68b008759c87e6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbe178457b16413291bbf12b116f4451_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaf43f6c29284708b18275267e3af457_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb55cd7b1c67424e83334b51ddeeed75_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>aort:day</xbrli:measure></xbrli:unit><xbrli:context id="i3162fd9f3aad4da4b4a6c31ca14cc416_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee01dabe643e479586ec04799b683ba4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceAfterJuly52023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33db3b1cd5a744adaf668932b3d7a752_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifda76d72993449d1998f915ef6c42d12_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacc74ff3ae064710b11fbf91c5b4da32_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb17620c310648b8a165d09b227c1a9d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2917e811dec840bfa296f07c2b87727d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6c541e6344348c7932037179bc9a6a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d9322af829e4028a7955119f8529d4f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8d8863bba6645fab208cbec4e5af0c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b95d5c7e8924fa28d703d9a61c60819_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19857ac737a849ee839c3f22bc8089c2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:DomesticHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11915924fe704fb89347da42e1ef2eb2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:DomesticHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia809a613bd144fa0a274104dcd26acb1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:DomesticHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i899343d6cb944a4681fdbfcdbd5d1ca8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:DomesticHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id714b6b2b6a64790a42d603abb8e18f3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68e49df3a3c64e688b8a31a561b96ed9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa5de9333d824fe48fda6782f64fdc3c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4668dfae4f444b93ac2d0b184ad2f75e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c79bfd4d6346bb876c81a81a51573a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i281a6ea681e94b3b8da636232186b497_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48e4181561d94c5fbb84354840056db1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1599f4e6f31b49738062fad1654aec04_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9704cb4285d424bbc6f7b1dfef34dc5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:CardiogenesisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i342b33ea32d64961aa1bcb645535ae46_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:CardiogenesisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42999e55d750436abb4dc19f0fde883f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:CardiogenesisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fdd33ca91264d388735248eee07f5b7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:CardiogenesisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee66ca91fc234b09b3c2d8a46621d0df_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15ccab14e00e482fa8cc9b73fec811d4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cfd4278c4d54da3ad77a6c6aa2631c6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2743263dde35403486ed30d48ff92d6f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41e84a48d560438c8c1d2cd5b2e60304_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fb88599f3ba47168b057695501cbbcf_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i461739b4f0b94d58b483520fd7eacf68_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i014313fc131f48999cd3c9dec9fb977c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42eac7fb937149b19cdc9f258f5ac32e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b553a2641f34d9fbc27aa2ae76e41e4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89e0d9a60d324513b3fdf16f71bc2d39_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i381fc1148e2b43d8bbc80cf38962e6a1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i298934a6b2a54c778e6398d092865235_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9c2d41d46d24d208d34d8d8f2b436e1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6984cade7c05443d9b12c962524d654d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i354fb63b18a2436c9633c0f1845308b2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4a80aa36fc046ebb86b318c4afa0f59_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if109928fc6f647eab134f6bf056db23a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb0051e154454d23a5b025f8cdd2f9a0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibba44be2c273425fa97ea9bf1feae546_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>aort:segment</xbrli:measure></xbrli:unit><xbrli:context id="i9cc67891184f42aca2e8fcb53d876e27_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ed6e56bac6643c2b13e09943b8594b7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b620f0bebe540458a2e554bbc88fa32_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7ee257b1f5e474fa73da9aed693faf2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7dd6b35f20045999c192f8de847c482_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1220aed07ca14aa8abe0c90027bf1bd1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:PreservationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc4c0fa38f304458a49eead228b1f066_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:PreservationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9732a2ada58456da4367d2ad51237e4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:PreservationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae2dfd5024fd4d04a7f0acbdbbea5062_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:PreservationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie06e2f5450764fcd97b8a391bba3cd2d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:AorticStentGraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c63bff320e64af081a5cce353c3a62f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:AorticStentGraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifae4dce6ca1b41baa6d2d313ffead3fa_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:AorticStentGraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie049d9169eb74ff0b2390aefc7f182e5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:AorticStentGraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3c197a3565b4c02b9d51132c7d4c1b9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:SurgicalSealantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82adeb266a2341f1901704b9be13d09a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:SurgicalSealantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7616c3cb7c904ae6b62508a5b0cc36f6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:SurgicalSealantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i487be8addd144d008e7c5a14b09cc518_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:SurgicalSealantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3211f9da72d54b2cab2ccedbc087d2ba_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OnXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96b0754bb93c43ceb3c6ef24d7d19ba5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OnXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if29b95e231c94833a32e361d0662e465_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OnXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a377880ef554ca480923257a9fe5357_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OnXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib053fe4e77a849b7bafcb527494112c2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4b2d900fb184620875c7570364d036e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf398fc9c82649119889d264cbda9dbf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7aeb442b84a4ce49062b5e2c520b373_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i167b7825c15e480eba61f77e008c32de_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">UNITED STATES</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:110%">FORM <ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQ5_27469eae-f607-47c7-be8c-ab80cf683fdb">10-Q</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQw_29b11602-f724-475a-a49c-12eb4f221d25">x</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">For the quarterly period ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTA_03c31933-4c2f-480e-91fe-94af6ec10c2e">September 30, 2022</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">OR</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQx_3f9d451d-aca2-4c4d-91aa-328e50699d17">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">For the transition period from ________________ to ________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Commission file number: <ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQ0_68d78eda-1dda-4f47-a410-ffaf58468f85">1-13165</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:110%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTUw_2b001071-e4a4-4a74-897f-783ea35e30ce">ARTIVION, INC.</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:110%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6MjRmNTJmOWU4MzlmNDY2Yjk2NzRjNTc1YWI5ZjIxMGUvdGFibGVyYW5nZToyNGY1MmY5ZTgzOWY0NjZiOTY3NGM1NzVhYjlmMjEwZV8wLTAtMS0xLTIxMTYx_ecd7ab0a-ff04-4ad4-ba1a-9117273e7557">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6MjRmNTJmOWU4MzlmNDY2Yjk2NzRjNTc1YWI5ZjIxMGUvdGFibGVyYW5nZToyNGY1MmY5ZTgzOWY0NjZiOTY3NGM1NzVhYjlmMjEwZV8wLTItMS0xLTIxMTYx_f894781c-8705-4a99-abdc-e3f892d3a645">59-2417093</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(State or other jurisdiction of <br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6MjRmNTJmOWU4MzlmNDY2Yjk2NzRjNTc1YWI5ZjIxMGUvdGFibGVyYW5nZToyNGY1MmY5ZTgzOWY0NjZiOTY3NGM1NzVhYjlmMjEwZV8zLTAtMS0xLTIxMTYxL3RleHRyZWdpb246ZmQ3YTgxMzc1ZWNjNGYxMjgyNzBkOGVhZDVhZTY0ZmJfNA_d1ceecf3-e3f8-4b62-9933-8ed68fd753ac">1655 Roberts Boulevard, NW</ix:nonNumeric>, <ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6MjRmNTJmOWU4MzlmNDY2Yjk2NzRjNTc1YWI5ZjIxMGUvdGFibGVyYW5nZToyNGY1MmY5ZTgzOWY0NjZiOTY3NGM1NzVhYjlmMjEwZV8zLTAtMS0xLTIxMTYxL3RleHRyZWdpb246ZmQ3YTgxMzc1ZWNjNGYxMjgyNzBkOGVhZDVhZTY0ZmJfOA_f9847c56-0ba7-4335-a660-0554b1f6e742">Kennesaw</ix:nonNumeric>, <ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6MjRmNTJmOWU4MzlmNDY2Yjk2NzRjNTc1YWI5ZjIxMGUvdGFibGVyYW5nZToyNGY1MmY5ZTgzOWY0NjZiOTY3NGM1NzVhYjlmMjEwZV8zLTAtMS0xLTIxMTYxL3RleHRyZWdpb246ZmQ3YTgxMzc1ZWNjNGYxMjgyNzBkOGVhZDVhZTY0ZmJfMTI_781f19ff-cdfb-48b3-ab24-657393f38ccf">Georgia</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6MjRmNTJmOWU4MzlmNDY2Yjk2NzRjNTc1YWI5ZjIxMGUvdGFibGVyYW5nZToyNGY1MmY5ZTgzOWY0NjZiOTY3NGM1NzVhYjlmMjEwZV8zLTItMS0xLTIxMTYx_2b11c1eb-0192-4dfb-8d52-cac83bf6cb15">30144</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(Zip Code)</span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">(<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQ3_572e01bb-60f1-460b-9e2f-f539a086d1ab">770</ix:nonNumeric>) <ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTUx_fa14f197-a476-4fae-a560-e3e25ad45f39">419-3355</ix:nonNumeric> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:31.676%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.813%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6YTAwMzA1MzU3MWQ3NDQ3NTk1NjlkOTY0NTNmYmUxYmIvdGFibGVyYW5nZTphMDAzMDUzNTcxZDc0NDc1OTU2OWQ5NjQ1M2ZiZTFiYl8xLTAtMS0xLTIxMTYx_df3e90fb-e9e5-49e5-98cc-870628d94c4e">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6YTAwMzA1MzU3MWQ3NDQ3NTk1NjlkOTY0NTNmYmUxYmIvdGFibGVyYW5nZTphMDAzMDUzNTcxZDc0NDc1OTU2OWQ5NjQ1M2ZiZTFiYl8xLTEtMS0xLTIxMTYx_49efddd7-54c6-4680-bd2c-de2f28e7c9b1">AORT</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6YTAwMzA1MzU3MWQ3NDQ3NTk1NjlkOTY0NTNmYmUxYmIvdGFibGVyYW5nZTphMDAzMDUzNTcxZDc0NDc1OTU2OWQ5NjQ1M2ZiZTFiYl8xLTItMS0xLTIxMTYx_d6258974-6455-4561-9c41-fed10195262d">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQ1_6f8f989f-65ee-459b-9036-e316acc4230f">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%">o</span></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQ2_03d0b2ad-106c-4ab4-a6c3-8437867616f0">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%">o</span></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6OTM1YTRiNTg0MDliNGI2ODg0NjEzNzdkZDNhYmU2ZmYvdGFibGVyYW5nZTo5MzVhNGI1ODQwOWI0YjY4ODQ2MTM3N2RkM2FiZTZmZl8wLTEtMS0xLTIxMTYxL3RleHRyZWdpb246Y2E1YTY1NDA5OWRhNGZiNjgxMzVhMzQ5ODY2MWVkMGZfNA_c4fa696e-e82e-4899-9f03-eb899d2fb70e">Large Accelerated Filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%">o</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-accelerated Filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6OTM1YTRiNTg0MDliNGI2ODg0NjEzNzdkZDNhYmU2ZmYvdGFibGVyYW5nZTo5MzVhNGI1ODQwOWI0YjY4ODQ2MTM3N2RkM2FiZTZmZl8xLTQtMS0xLTIxMTYx_65c3863a-ba70-4bb8-b65e-b600777fa048">o</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6OTM1YTRiNTg0MDliNGI2ODg0NjEzNzdkZDNhYmU2ZmYvdGFibGVyYW5nZTo5MzVhNGI1ODQwOWI0YjY4ODQ2MTM3N2RkM2FiZTZmZl8yLTQtMS0xLTIxMTYx_11c9cf51-a35d-42ec-926d-3ff5c1f099a7">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"> </span></div></td></tr></table></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%">o</span></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQz_d47ac3b6-5a62-4f93-9e41-eec06542333e">x</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at October&#160;28, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock, $0.01 par value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb29878d56724102860bc5a9cb2fa5cc_I20221028" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6NzQ5OTEyYjI2YjI1NDQxYzljNWM1NWI2NTI4N2E3ODAvdGFibGVyYW5nZTo3NDk5MTJiMjZiMjU0NDFjOWM1YzU1YjY1Mjg3YTc4MF8xLTItMS0xLTIxMTYx_75eeceac-5c9a-4448-b27b-9acbba629ec3">40,329,481</ix:nonFraction></span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.961%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_10">Part I &#8211; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_13">Item 1. Financial Statements.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_13">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_16">Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_16">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_19">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_19">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_22">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_22">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_25">Condensed Consolidated Statements of Shareholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_25">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_28">Notes to Condensed Consolidated Financial Statements </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_28">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_76">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_76">24</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_124">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_124">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_127">Item 4. Controls and Procedures.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_127">37</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_130">Part II - OTHER INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_130">38</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_133">Item 1. Legal Proceedings.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_133">38</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_136">Item 1A. Risk Factors.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_136">38</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_139">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_139">53</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_142">Item 3. Defaults Upon Senior Securities.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_142">53</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_145">Item 4. Mine Safety Disclosures.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_145">53</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_148">Item 5. Other Information.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_148">53</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_151">Item 6. Exhibits.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_151">54</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_154">Signatures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i167b7825c15e480eba61f77e008c32de_154">55</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2</span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I &#8211; FINANCIAL INFORMATION</span></div><div id="i167b7825c15e480eba61f77e008c32de_13"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements.</span></div><div id="i167b7825c15e480eba61f77e008c32de_16"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artivion, Inc. and Subsidiaries </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Thousands, Except Per Share Data</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc916650fa81469598a7b03003c27168_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMy0xLTEtMS0yMTE2MQ_3c1f293f-ecdd-4f87-b662-088146bc9c93">55,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5bc0203be146e5bb0bd8b45cbdb2b7_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMy0zLTEtMS0yMTE2MQ_c8a3f703-29a1-459a-bc9a-f1c322321267">53,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5a4f6af84f4ddeae300f7b08e9e59d_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMy01LTEtMS0yMTE2MQ_932eb3f2-5218-454e-aaf4-34ebb40c0f51">171,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd7debfcacac4069a398cab44625bd73_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMy03LTEtMS0yMTE2MQ_0ff88507-1ecb-4bd2-a269-a2b2068931ae">162,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640c303a0a1c4e72a4879aa8b98e0402_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNC0xLTEtMS0yMTE2MQ_339d641d-3fbc-4554-8b9c-c580168a824c">21,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377e56bf409a455ba20de5d37520ea48_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNC0zLTEtMS0yMTE2MQ_3f20046a-4909-4e9a-a681-9e2ff78fd054">19,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84212de5e3c34a078a34d879bfeeb394_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNC01LTEtMS0yMTE2MQ_6d77c7ec-73a4-4620-ae94-e55e37ea989b">62,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8faff0cacc944396b07783c2a5b064e3_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNC03LTEtMS0yMTE2MQ_eb91ad88-b7e5-4587-97fd-ad0ac034c872">56,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNS0xLTEtMS0yMTE2MQ_c56cd9df-6e3f-4214-a487-3597fa33fd5d">76,838</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNS0zLTEtMS0yMTE2MQ_76090371-d563-47e3-9e9b-5e5987fde21a">72,207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNS01LTEtMS0yMTE2MQ_88f8a241-41e8-4ed9-b9ff-9189d3d80dee">234,391</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNS03LTEtMS0yMTE2MQ_e26f9ed2-b166-429f-9bce-f4a491f39b26">219,442</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of products and preservation services:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc916650fa81469598a7b03003c27168_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOC0xLTEtMS0yMTE2MQ_a69c7160-d95a-4ca5-b517-be2387d75d0c">17,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5bc0203be146e5bb0bd8b45cbdb2b7_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOC0zLTEtMS0yMTE2MQ_6896480b-1804-4011-9389-3c73350a107e">15,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5a4f6af84f4ddeae300f7b08e9e59d_D20220101-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOC01LTEtMS0yMTE2MQ_a3699f22-54f7-431a-9644-82637d01aa51">53,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd7debfcacac4069a398cab44625bd73_D20210101-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOC03LTEtMS0yMTE2MQ_624ba31a-ed84-4d23-b90d-7a45da319069">46,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preservation services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640c303a0a1c4e72a4879aa8b98e0402_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOS0xLTEtMS0yMTE2MQ_5bfd864a-7d2c-4f36-a05e-f56960ced595">10,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377e56bf409a455ba20de5d37520ea48_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOS0zLTEtMS0yMTE2MQ_ff75c5ae-a130-42d0-a348-bfb34a4f959c">8,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84212de5e3c34a078a34d879bfeeb394_D20220101-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOS01LTEtMS0yMTE2MQ_c9c98c1a-d55c-4843-bb27-88e79bb70ec4">29,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8faff0cacc944396b07783c2a5b064e3_D20210101-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOS03LTEtMS0yMTE2MQ_f1c9e7d0-9e50-400b-9b9d-85b42501a28b">26,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cost of products and preservation services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTAtMS0xLTEtMjExNjE_0aa98858-3b8f-4a74-a9b2-e0ebaab0b146">28,094</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTAtMy0xLTEtMjExNjE_277cd9c5-1115-4285-86c7-674f601bd762">24,418</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTAtNS0xLTEtMjExNjE_ad648e95-c12e-45f2-9b27-6cbec0d899f0">82,756</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTAtNy0xLTEtMjExNjE_1fb40e9e-0415-4515-a57f-b2c2fbba201a">73,302</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTItMS0xLTEtMjExNjE_2dd1c888-4144-489b-a223-6f6ccbcee785">48,744</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTItMy0xLTEtMjExNjE_81639731-1284-4be0-8a07-40d710dcff3c">47,789</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTItNS0xLTEtMjExNjE_879e11ea-db91-41db-a0a9-e559fc903fdc">151,635</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTItNy0xLTEtMjExNjE_4c589487-d066-4e5a-8eeb-bffd9819a8c1">146,140</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative, and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTUtMS0xLTEtMjExNjE_18d70a33-aaf4-466d-a51f-c995d8f3c01e">41,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTUtMy0xLTEtMjExNjE_acd0e3b3-11e1-4730-b35b-c47934ea8c09">39,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTUtNS0xLTEtMjExNjE_1c2633c1-2b90-429d-9117-c6365867d41c">118,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTUtNy0xLTEtMjExNjE_2bf4a713-9aba-4f5b-82c5-5e5ea0ed6ef1">118,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTYtMS0xLTEtMjExNjE_adf6639e-6451-4c9b-826d-bcd6ee04e6f3">11,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTYtMy0xLTEtMjExNjE_41cc0ed2-3e77-4439-9471-b7da04c04184">9,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTYtNS0xLTEtMjExNjE_3bb5e75c-e4c8-4028-aaf5-6911840cad7b">30,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTYtNy0xLTEtMjExNjE_4790496b-0c98-4468-bd86-6dbf0923d7f1">26,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTctMS0xLTEtMjExNjE_e4944da6-6ffb-41d2-b48f-f383ab8b0a28">52,850</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTctMy0xLTEtMjExNjE_9ae9bb8c-6271-469a-8fc2-54babc0ea5a0">49,025</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTctNS0xLTEtMjExNjE_3e33c9c3-463f-457d-8b4a-1671eb7edb08">149,564</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTctNy0xLTEtMjExNjE_65f162de-410f-4f5e-af3c-729e9624e2e0">144,607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from sale of non-financial assets </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTgtMS0xLTEtMjE0MDM_8d23c34e-a3b2-4fa7-8820-f287aac0fe76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTgtMy0xLTEtMjE0MDM_a9941443-2ac8-41f0-8c56-1448f6a70101">15,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTgtNS0xLTEtMjE0MDM_6b8e73bc-8025-4b88-8ed2-d8ccf156b0ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTgtNy0xLTEtMjE0MDM_c84c1bdc-6d73-4b66-ae4d-58d7ef7d2729">15,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTktMS0xLTEtMjExNjE_531946e5-4df7-4b66-98c0-e3e6f504573c">4,106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTktMy0xLTEtMjExNjE_045ef7cb-2646-45a4-9ba3-1bffedf1a111">14,687</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTktNS0xLTEtMjExNjE_b1bed8bd-276a-4bb2-8ca4-99ab592a83e1">2,071</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTktNy0xLTEtMjExNjE_a4226a02-7b05-4ed5-9eb7-6c100ea540bc">17,456</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjEtMS0xLTEtMjExNjE_78c78d45-b777-451f-ac84-e06060e2faf6">4,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjEtMy0xLTEtMjExNjE_82a603f4-0e0a-44c6-baf7-704c5f06570b">4,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjEtNS0xLTEtMjExNjE_7325e7f7-19e0-45e8-9d44-40110a010a8a">12,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjEtNy0xLTEtMjExNjE_5b90c052-6a41-4528-8a8d-e374f17ba23d">12,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjItMS0xLTEtMjExNjE_6b6c9fac-7a4a-4604-a9a5-7bc7d359fbbb">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjItMy0xLTEtMjExNjE_c5811ce6-a5cf-4c8f-b996-e78b80d6e9c3">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjItNS0xLTEtMjExNjE_fa388f5f-f29d-43a0-b27f-6bec0da014d3">86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjItNy0xLTEtMjExNjE_6d206c40-1908-4ee3-8421-1830f1f2cf7f">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjMtMS0xLTEtMjExNjE_9a48d5a4-cc23-49ff-ae22-168bc5961792">3,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjMtMy0xLTEtMjExNjE_df0b4a04-2253-4705-af8a-75253746ebb1">2,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjMtNS0xLTEtMjExNjE_df556807-d72d-4aee-9748-bff6d36b5a6d">7,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjMtNy0xLTEtMjExNjE_340e0eda-3cad-4bd5-8ca0-d76286c79646">3,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjUtMS0xLTEtMjExNjE_c5f4b147-f71e-4121-90d3-7ab24edc322f">12,532</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjUtMy0xLTEtMjExNjE_483c8e0e-d1b0-46ac-a782-0e2c2b6d55dc">7,944</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjUtNS0xLTEtMjExNjE_094b3623-b1a3-48e6-9998-a2609172ef1e">18,261</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjUtNy0xLTEtMjExNjE_bd94c2ba-9b1c-460b-bad7-93c223b4752b">1,260</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjYtMS0xLTEtMjExNjE_44df776a-bae9-484a-ad99-055b0af2c612">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjYtMy0xLTEtMjExNjE_c734e45f-ee64-4017-83b8-59a6fd4f0f66">2,638</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjYtNS0xLTEtMjExNjE_543c8749-cbcf-4ac1-a1b4-2e631409479f">3,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjYtNy0xLTEtMjExNjE_12631bf4-0357-45cb-9f6b-3727da3d8a48">4,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjgtMS0xLTEtMjExNjE_e839439d-5636-4003-a122-03f8b8d93209">13,713</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjgtMy0xLTEtMjExNjE_589b093c-d155-4ea5-a903-133b640500e6">10,582</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjgtNS0xLTEtMjExNjE_c65bde17-768a-476c-9926-25d80db52ff0">21,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjgtNy0xLTEtMjExNjE_5683a974-f88f-4285-b2ec-789d882fb27d">5,266</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzEtMS0xLTEtMjExNjE_4dbddfe9-9feb-4079-9b56-388d48102544">0.34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzEtMy0xLTEtMjExNjE_73598f17-746b-4784-875e-5ee159964fc7">0.27</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzEtNS0xLTEtMjExNjE_94d61521-79c4-4fec-9d57-2536ba6031f4">0.53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzEtNy0xLTEtMjExNjE_a6277234-aff8-4452-98d6-f0a94c04ca51">0.13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzItMS0xLTEtMjExNjE_7e66ad2e-625a-4aec-8f4c-497a6acb403e">0.34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzItMy0xLTEtMjExNjE_66482b4c-2fe7-4d44-806f-fa26189694e9">0.26</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzItNS0xLTEtMjExNjE_457bfc38-3a66-439c-99f8-71831c97627e">0.53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzItNy0xLTEtMjExNjE_ace55c43-01c3-4cf3-a5a8-8ac5e029de66">0.13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzUtMS0xLTEtMjExNjE_fb094439-464f-46a3-b1ce-da9189bd6434">40,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzUtMy0xLTEtMjExNjE_6eb8a48a-6474-4b11-88d3-715c263027f7">39,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzUtNS0xLTEtMjExNjE_54324268-8e9d-4499-9a7e-5756bce4a745">39,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzUtNy0xLTEtMjExNjE_dce9c8d4-9e6a-424e-a6ca-d23f0236c3df">38,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzYtMS0xLTEtMjExNjE_7262a0fa-0b97-4ec9-94dc-afc6753e60fc">40,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzYtMy0xLTEtMjExNjE_ae91f0ae-6c5f-4eff-8b79-2ead88c70aa8">44,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzYtNS0xLTEtMjExNjE_e4ff6bb8-743d-43d5-b621-215a3fafe180">39,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzYtNy0xLTEtMjExNjE_37ed9260-40c4-495c-87b4-f1a56b9d7a1e">39,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzgtMS0xLTEtMjExNjE_c483e212-ef79-4bd5-a7bb-3b9e2ac7d678">13,713</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzgtMy0xLTEtMjExNjE_2474683d-102c-4cf2-a6df-f5d7188542e0">10,582</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzgtNS0xLTEtMjExNjE_a188923f-5dc2-4239-bd55-e387ab947fb2">21,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzgtNy0xLTEtMjExNjE_b276f6b2-777a-4b9d-9fe8-78965dd51f12">5,266</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDAtMS0xLTEtMjExNjE_1245d3ca-d2c4-4008-920e-f732557c9c69">16,895</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDAtMy0xLTEtMjExNjE_d72ef60f-ad23-47ab-b77f-a0d150b613db">5,010</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDAtNS0xLTEtMjExNjE_1ea3bc92-b2f5-468e-85f8-6d62d95f93a5">35,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDAtNy0xLTEtMjExNjE_a24129f8-f42b-4a3c-8412-9206342dee21">12,327</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive (loss) income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDEtMS0xLTEtMjExNjE_0f6fa46b-77d0-412b-a405-7154552b18ca">30,608</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDEtMy0xLTEtMjExNjE_1ee5507b-a564-4ab8-9ab6-6a89aaff20b2">5,572</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDEtNS0xLTEtMjExNjE_4c567fa7-68d4-4313-9bb4-1075550afe13">56,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDEtNy0xLTEtMjExNjE_9c280b17-e62d-4671-8dd3-487b0ec86b70">7,061</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3</span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artivion, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Unaudited) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNC0xLTEtMS0yMTE2MQ_cc64cac5-8f8c-4a09-a420-5f9faa16d4ab">37,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNC0zLTEtMS0yMTE2MQ_8d82c04c-b3b7-46fa-bdf8-3e1a2996053a">55,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNS0xLTEtMS0yMTE2MQ_670cb280-f3ca-49e8-af21-17ed9bf39fc3">57,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNS0zLTEtMS0yMTE2MQ_67094d57-af0b-47c6-8154-200fa7c8e3be">53,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNi0xLTEtMS0yMTE2MQ_9ddde526-9301-4850-83d5-42ce33225f19">7,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNi0zLTEtMS0yMTE2MQ_15b2be40-cdb0-481b-9dd1-8b80b66b818f">5,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNy0xLTEtMS0yMTE2MQ_12f4557e-5644-4901-8792-e1a693794236">73,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNy0zLTEtMS0yMTE2MQ_ea9b0f03-3fcc-43a4-87f0-abdb4681838b">76,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred preservation costs, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:DeferredPreservationCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfOC0xLTEtMS0yMTE2MQ_ee0e1237-faf0-4d47-9792-15cd0798b456">45,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="aort:DeferredPreservationCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfOC0zLTEtMS0yMTE2MQ_27a764d1-53f0-4d6f-ba76-1791a7ccaec7">42,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfOS0xLTEtMS0yMTE2MQ_0f15e000-70f6-4d26-98aa-056a92f52194">16,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfOS0zLTEtMS0yMTE2MQ_22112af3-05da-4ef1-91c5-8700494d7c28">14,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTAtMS0xLTEtMjExNjE_b6dbaacb-bad6-4ba1-bce7-c7835c9cfe5d">237,989</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTAtMy0xLTEtMjExNjE_92a68ba9-2957-4705-90f7-d5483ab042ce">247,697</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTItMS0xLTEtMjExNjE_17aeb34e-d792-43e9-991b-e47c7c817e68">234,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTItMy0xLTEtMjExNjE_6c380b98-02ca-4288-8093-e7cabe17d784">250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquired technology, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTMtMS0xLTEtMjExNjE_9df97e00-fd3b-4557-af17-948478ad2ef1">148,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTMtMy0xLTEtMjExNjE_53439247-48e0-45cd-83bf-417e9668c0c6">166,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTQtMS0xLTEtMjExNjE_c5d3a9b0-adc3-4162-991e-aad3164b169d">41,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTQtMy0xLTEtMjExNjE_dabcdda5-a0bd-4b68-aaea-1ed186efd2bf">45,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTUtMS0xLTEtMjExNjE_4b2a7278-79b2-4f65-9476-389927b55c2e">36,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTUtMy0xLTEtMjExNjE_af1ab1e5-6d50-4280-ae19-b305c77057fe">37,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangibles, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OtherIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTYtMS0xLTEtMjExNjE_d1934ebe-3716-4081-9039-de8cab0ca24e">31,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:OtherIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTYtMy0xLTEtMjExNjE_94167041-f7c5-4ae3-8200-09c4f900d94f">34,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTctMS0xLTEtMjExNjE_38fff8f0-15ea-4498-a03f-4f10050902d7">6,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTctMy0xLTEtMjExNjE_c925c249-10a6-4626-b943-dcabe6ff1f6e">2,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTgtMS0xLTEtMjExNjE_2698cfb9-a9eb-411c-ac24-ad9d762e8d38">7,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTgtMy0xLTEtMjExNjE_e05f961c-9ae6-4812-87cb-a9b7d10c8e53">8,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTktMS0xLTEtMjExNjE_00180fd1-b91b-474e-8576-47a3bb00fba1">742,731</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTktMy0xLTEtMjExNjE_2b7ee856-d171-4798-ad7f-c1dc090c884f">793,052</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjMtMS0xLTEtMjExNjE_b46c2a5c-253e-42ae-8dfd-3b2b214d25ed">10,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjMtMy0xLTEtMjExNjE_64482a40-413a-419f-b56d-0b83c3a5f193">10,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjQtMS0xLTEtMjExNjE_78fde84e-a017-4042-ab15-967d30646ff3">11,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjQtMy0xLTEtMjExNjE_2750a442-eee3-4179-a59e-9e0c7285d7f2">13,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjUtMS0xLTEtMjExNjE_fd814993-7143-406b-be04-f6efe54a6ff9">10,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjUtMy0xLTEtMjExNjE_6df4ccfc-cf6e-4e9f-b891-82d18b2514a9">7,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjYtMS0xLTEtMjExNjE_51ca954f-c7f1-43fb-8204-3bf78a610f95">5,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjYtMy0xLTEtMjExNjE_9e311381-ae2c-4d49-877c-2fd9d632dfd2">3,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued procurement fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:AccruedProcurementFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjctMS0xLTEtMjExNjE_02c473d6-d63f-424c-9e81-e80434a00660">2,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="aort:AccruedProcurementFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjctMy0xLTEtMjExNjE_5b41d22f-b3e1-467e-b970-4a20ca2f7bf0">3,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjgtMS0xLTEtMjExNjE_95d43722-a684-46ff-bc3e-37418e22ff93">3,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjgtMy0xLTEtMjExNjE_2fabb848-d0e7-4808-a08f-2eda11a506c2">3,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjktMS0xLTEtMjExNjE_2ae2a861-7009-4431-a319-863a788ae57e">1,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjktMy0xLTEtMjExNjE_95762b2c-6fee-4988-82b1-e1ccfe73c5bf">1,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzAtMS0xLTEtMjExNjE_8bf7a364-6f0b-422e-add8-215d645f5d5f">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzAtMy0xLTEtMjExNjE_c4496916-6f8a-4d60-9bb5-cc22ffca4c73">1,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzEtMS0xLTEtMjExNjE_d5fb1641-d009-4a26-90e0-edb8ffda651d">45,992</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzEtMy0xLTEtMjExNjE_b0d0093d-6682-4001-b194-9b73d4b5ea56">44,953</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzMtMS0xLTEtMjExNjE_f96d07a5-27d4-4fe2-a157-a88c831abb74">306,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzMtMy0xLTEtMjExNjE_023d9982-1bad-435e-8fa0-ba6acc123b1a">307,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzQtMS0xLTEtMjExNjE_f5709bf0-66cd-4108-a955-7fd5df15b04c">44,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzQtMy0xLTEtMjExNjE_a03721f2-15f9-4f8c-8156-8da1c35b4b27">49,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current maturities of operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzUtMS0xLTEtMjExNjE_6e16669b-ccd4-421f-a545-212008b24e3a">40,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzUtMy0xLTEtMjExNjE_6d345779-d165-42f2-bddc-3a54f4930dcc">44,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current finance lease obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzYtMS0xLTEtMjExNjE_f1b9b011-72ff-45e3-a475-3802cd6bcbcf">3,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzYtMy0xLTEtMjExNjE_91682428-89e5-47d7-8e08-ed5e92535ef2">4,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzctMS0xLTEtMjExNjE_c53c244d-d70a-4adf-8596-d63e04ce4d1c">34,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzctMy0xLTEtMjExNjE_1d59ca41-eb70-4e01-9ad7-cca6b3a776f3">28,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzgtMS0xLTEtMjExNjE_6677fb93-85e8-47a1-bba9-d5459a14926a">5,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzgtMy0xLTEtMjExNjE_60a6fa1c-0a34-4777-9186-c7b7cb1537d4">5,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzktMS0xLTEtMjExNjE_28671504-3a61-410a-b665-f9a8051b1920">6,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzktMy0xLTEtMjExNjE_846c0a29-32cd-4e69-86ef-dd57afb54e2c">6,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDAtMS0xLTEtMjExNjE_6a7d92a5-733b-4865-923d-664dc1c068cb">487,623</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDAtMy0xLTEtMjExNjE_73167ef4-5d8c-4d59-af5b-1677e5d92a02">492,324</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDItMS0xLTEtMjExNjE_b5f4e67c-ed18-4295-b943-1c7021e85ef1"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDItMy0xLTEtMjExNjE_af9abe2d-89cd-489a-aeb7-a33aa82c2f60"></ix:nonFraction></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shareholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDUtMS0xLTEtMjExNjE_0cd8eac5-29b7-4401-8e40-f3640383d0d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDUtMy0xLTEtMjExNjE_277fdf38-68d7-4919-aab0-666338fa595c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock (issued shares of <ix:nonFraction unitRef="shares" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDYtMC0xLTEtMjExNjEvdGV4dHJlZ2lvbjpmY2MzNjJkYzEwZTE0OGY0ODM3ZDc3YzVlMWY4MGQyN18xMDk5NTExNjI3ODUx_6882f1bb-9528-4717-bb43-d3bf87522926">41,816</ix:nonFraction> in 2022 and <ix:nonFraction unitRef="shares" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDYtMC0xLTEtMjExNjEvdGV4dHJlZ2lvbjpmY2MzNjJkYzEwZTE0OGY0ODM3ZDc3YzVlMWY4MGQyN18xMDk5NTExNjI3ODYw_db104ff0-6165-4857-b4b1-87c5bec6f227">41,397</ix:nonFraction> in 2021)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDYtMS0xLTEtMjExNjE_84285f69-b480-42f1-b78b-4b57cd7a4881">418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDYtMy0xLTEtMjExNjE_ceff7806-7ad1-4f69-b9c5-b4359164ee07">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDctMS0xLTEtMjExNjE_c52136fb-3afa-4a00-a569-d94cbdb2bef3">334,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDctMy0xLTEtMjExNjE_2a70fd3d-7d45-4a93-b420-1a9db5887d3c">322,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained (deficit) earnings </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDgtMS0xLTEtMjExNjE_71482eeb-53e6-4a3b-a94f-08f587883e0f">19,386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDgtMy0xLTEtMjExNjE_14335dc6-785e-435d-bbd0-b91f40f09ac4">1,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDktMS0xLTEtMjExNjE_fb3de999-ba28-4e54-b5e6-caa7d5869d00">45,353</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDktMy0xLTEtMjExNjE_fe615ffb-e253-4b98-93c5-1533d0e31d92">9,887</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTAtMC0xLTEtMjExNjEvdGV4dHJlZ2lvbjpiOWYyMzkxNTBhNTQ0NWMzYWQ2YzQwN2EwZWVhMDVlZF8yOQ_4d859516-548c-4ae4-aa26-fe848ae32475"><ix:nonFraction unitRef="shares" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTAtMC0xLTEtMjExNjEvdGV4dHJlZ2lvbjpiOWYyMzkxNTBhNTQ0NWMzYWQ2YzQwN2EwZWVhMDVlZF8yOQ_e716b0f6-85ac-48c1-9999-214ef1dc36dc">1,487</ix:nonFraction></ix:nonFraction> shares as of September&#160;30, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTAtMS0xLTEtMjExNjE_b15ed6a8-a399-4bf8-ac26-6813d4281387">14,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTAtMy0xLTEtMjExNjE_f9c2c894-e065-4ecd-bb4c-f132253025c6">14,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total shareholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTEtMS0xLTEtMjExNjE_a616f334-13ab-4b6d-915a-8fef83b53d66">255,108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTEtMy0xLTEtMjExNjE_6d468c9a-95f1-4dfe-865a-884a2616ad18">300,728</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities and shareholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTMtMS0xLTEtMjExNjE_13dc3741-1083-4a98-a2d0-0e3dde96cc63">742,731</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTMtMy0xLTEtMjExNjE_1987c53c-286c-4fea-b658-0b01379bdd63">793,052</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4</span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artivion, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Thousands </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMy0xLTEtMS0yMTE2MQ_426cb798-186c-41ce-aee2-4b0c4993b6d8">21,361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMy0zLTEtMS0yMTE2MQ_0cc44ea8-c8ac-4928-b7f8-1f80d4e1dd09">5,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net (loss) income to net cash from operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfNi0xLTEtMS0yMTE2MQ_cfff51fa-bd8b-4bbb-9844-89f4bdedfeb9">17,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfNi0zLTEtMS0yMTE2MQ_69faa21c-2119-473e-a685-8795b2886656">18,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfNy0xLTEtMS0yMTE2MQ_006551df-247d-422a-9195-2d09731588e3">9,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfNy0zLTEtMS0yMTE2MQ_a96abf1f-89d2-49e9-8c98-f1899cde44f9">7,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="aort:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfOC0xLTEtMS0yMTE2MQ_037371d9-009f-455d-b5a5-e03ea09e0d73">5,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="aort:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfOC0zLTEtMS0yMTE2MQ_beed1551-ba85-458b-8f39-bb9d642de64d">5,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfOS0xLTEtMS0yOTAzNg_e9a94fcb-c5cf-4814-af36-be3267c04d0e">5,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfOS0zLTEtMS0yOTAzNg_f5d9507f-5d0a-465a-b17b-1e9c062a1753">8,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-down of inventories and deferred preservation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="aort:WriteDownOfDeferredPreservationCostsAndInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfOS0xLTEtMS0yMTE2MQ_6b1057a9-adb4-46b9-8353-5f7cd1c7aaf5">3,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="aort:WriteDownOfDeferredPreservationCostsAndInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfOS0zLTEtMS0yMTE2MQ_a65cd2e2-1fc1-4947-b126-230458ca363b">3,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="aort:NoncashInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTAtMS0xLTEtMjgwMzI_944f5450-ebed-4602-93c1-23dd490cadfa">1,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="aort:NoncashInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTAtMy0xLTEtMjgwNDE_85feb210-0aab-4a50-8755-6e0153431d72">2,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTAtMS0xLTEtMjExNjE_d4a9ad6c-2f30-4fe9-91a1-e027aba3f93e">4,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTAtMy0xLTEtMjExNjE_a9f9108f-522b-416a-a8ac-870da5151514">4,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from sale of non-financial assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTMtMS0xLTEtMjE2MzI_48b297f8-af77-4884-a170-2812dce60dbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTMtMy0xLTEtMjE2MjQ_73dca91d-dc97-452e-8647-373ff067d6d0">15,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:OtherNoncashExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTItMS0xLTEtMjExNjE_837e9dab-3855-440f-8be7-1b3b39829c20">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:OtherNoncashExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTItMy0xLTEtMjExNjE_38a202be-5fac-450f-beca-3d395586f1b3">678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTQtMS0xLTEtMjExNjE_0f7f2a8c-dbae-4faa-b8cd-19478fd3b249">1,788</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTQtMy0xLTEtMjExNjE_c41a45f4-bf21-43a7-822a-345f97b11ca3">2,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses, and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTctMS0xLTEtMjkwNTU_59b57e2d-ab5f-484f-ac9e-40334c953031">2,103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTctMy0xLTEtMjkwNTU_5b4dc128-655d-4b8d-87ef-944864572b47">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories and deferred preservation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="aort:IncreaseDecreaseInDeferredPreservationCostsAndInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTUtMS0xLTEtMjExNjE_6772b230-fdc3-4f39-957c-f4bf23a9b883">5,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="aort:IncreaseDecreaseInDeferredPreservationCostsAndInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTUtMy0xLTEtMjExNjE_5ad461b9-35d7-4687-827c-137f339b11ac">16,986</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTYtMS0xLTEtMjExNjE_e80a3882-6cc1-4b28-bf7f-c7d5b06fb5a0">10,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTYtMy0xLTEtMjExNjE_d10d4895-8845-47ae-bb77-68fadd21b4d9">8,032</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTgtMS0xLTEtMjExNjE_da065e41-57bc-4a76-8875-8979b48678ac">4,936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTgtMy0xLTEtMjExNjE_6c1621e0-5bee-4a48-be59-b781b8e11819">3,301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjUtMS0xLTEtMjc5NDE_f84c6bdd-1786-4bac-9b1e-6308d170296f">1,123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjUtMy0xLTEtMjc5NTA_0552b200-7ecc-498b-aee0-9492e344a7ce">726</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjQtMS0xLTEtMzAwNTk_bbdabfb1-8314-4739-b551-446e9b0db663">6,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjQtMy0xLTEtMzAwNTk_421c82a5-80ba-484d-8a97-c5716c719ca7">10,524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of non-financial assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjUtMS0xLTEtMjkzMzA_8c5b3215-2842-47a4-a661-b5d5b5fbf0d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjUtMy0xLTEtMjkzMzA_2a88e5da-8850-41e4-a7c2-362abc1e1673">19,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjItMS0xLTEtMjExNjE_224fe417-0151-4a25-8c05-adb13d46b5de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjItMy0xLTEtMjExNjE_026b2de7-f650-468f-ae6d-6153ec68d436">722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjMtMS0xLTEtMjExNjE_464d6f00-7e11-4d9b-91b8-0fb2f5fd30f7">8,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjMtMy0xLTEtMjExNjE_1b859dc2-6119-438d-b509-3194fbed46ac">8,472</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options and issuance of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjYtMS0xLTEtMjExNjE_b7212612-3c36-4972-bc17-d55a07aef8e0">3,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjYtMy0xLTEtMjExNjE_2fd9ea6e-e72b-45d8-a612-00d0346a326c">3,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and repurchase of stock to cover tax withholdings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzEtMS0xLTEtMzAwNzQ_a864e2f8-144e-4128-bb87-44f8f91303be">1,791</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzEtMy0xLTEtMzAwNzQ_0c17f7e0-b2e4-4b05-9ac3-3ae9820ae9de">1,898</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzEtMS0xLTEtMjgyMTY_da5cbc23-308e-4a4e-8a33-7af5fb815ff1">2,033</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzEtMy0xLTEtMjgyMTY_060e8c33-1404-49ab-810c-ee72b58a7fc1">2,397</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of debt issuance costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjctMS0xLTEtMjExNjE_a0fffd9f-e898-4868-aa03-161643c9e80f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjctMy0xLTEtMjExNjE_a0b5e97b-cb89-493f-bbd7-61028738e124">2,219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzAtMS0xLTEtMjExNjE_a19927e9-b532-48df-a991-b9d91f7b4ebe">300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzAtMy0xLTEtMjExNjE_53f4853a-c382-4c4b-be3d-99bbf6ac09d4">439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzEtMS0xLTEtMjExNjE_426a4def-ef6f-4377-9cde-ba21d8bc588c">780</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzEtMy0xLTEtMjExNjE_7eeb8296-9b9d-45ff-8ee2-e5bb98de051e">3,422</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzMtMS0xLTEtMjExNjE_47d6fd35-6398-4324-8276-ae8340c26b88">3,675</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzMtMy0xLTEtMjExNjE_ba692f5c-81f5-4a6a-bc73-de55940e30bb">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzQtMS0xLTEtMjExNjE_400f952e-b1a5-4dcc-b743-d5adfb08229c">17,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzQtMy0xLTEtMjExNjE_c7ca414a-272e-4bfd-b9c3-adcdec183afa">3,167</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzYtMS0xLTEtMjExNjE_1a6d87fa-ba3c-42b0-930d-086066bef152">55,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02c95f38d9b543ae84f37d41d8baa157_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzYtMy0xLTEtMjExNjE_ddbdfca2-1d2b-49a7-98df-abc6674d6094">61,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzctMS0xLTEtMjExNjE_48a018e2-b603-4103-98f5-8c44e146426a">37,572</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfb7570230e54f50941fc14b31243894_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzctMy0xLTEtMjExNjE_649a5e60-467c-4676-abcc-cf67b17769ae">65,125</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5</span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artivion, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Shareholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Thousands</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.555%"><tr><td style="width:1.0%"></td><td style="width:36.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.615%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated <br/>Other<br/>Comprehensive <br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders'<br/>Equity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f32d331c65a4d77abae1c29bfd76fad_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi0xLTEtMS0yMTE2MQ_a6b01f66-bd9a-4d39-b487-2184c9cf1a30">41,744</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f32d331c65a4d77abae1c29bfd76fad_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi0zLTEtMS0yMTE2MQ_4f54f0c6-4ba8-4929-8703-66662e265445">417</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75cedf86a43b46479cf2b7e2e4ffa5b6_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi01LTEtMS0yMTE2MQ_ad7959cb-da8d-48c8-b245-92008dbe07f6">329,871</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2327fb17357843d49351125df49690ce_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi03LTEtMS0yMTE2MQ_3b57411f-5847-4d40-ad46-b2d340d3e486">5,673</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i500babc0c996435a9c7bf3de79597910_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi05LTEtMS0yMTE2MQ_1fa29faf-9917-4ced-a93f-5ab4d8024a49">28,458</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5517182634564914ba321ae01406e558_I20220630" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi0xMS0xLTEtMjExNjE_3809f1ce-ec0c-4951-8863-224f60f1e45d">1,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5517182634564914ba321ae01406e558_I20220630" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi0xMy0xLTEtMjExNjE_783102ae-dc8f-4ca7-abcc-6c6608328e91">14,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0173bc1ef6e4cd89e057d607f1488e3_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi0xNS0xLTEtMjExNjE_83c14c3e-b867-474f-a37f-b9dbfcab4890">281,509</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie53b06b7fc644641930b5fae9767bb47_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMy03LTEtMS0yMTE2MQ_264811e6-335c-46a8-9fec-e7982c0b8a0e">13,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMy0xNS0xLTEtMjExNjE_41e932c2-5c07-4a68-98ab-679df512a652">13,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b4dd9bf4a1461f8c3787382c8bdc2c_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNC05LTEtMS0yMTE2MQ_3e57dab3-20a7-4f54-a785-d538b3b36634">16,895</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNC0xNS0xLTEtMjExNjE_805d4166-8036-4a7b-82af-f50261f173b5">16,895</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d654e08061c4d2eb225d927a13203b2_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNS0xLTEtMS0yMTE2MQ_89dd115c-9db6-49ab-baba-4b1f2594431a">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4351c2916a14e6583947067dccfd48f_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNS01LTEtMS0yMTE2MQ_7bde48cd-373a-4db6-a198-651977886db3">3,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNS0xNS0xLTEtMjExNjE_a734cb9b-039c-4552-9cf5-d7c7568ad22e">3,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d654e08061c4d2eb225d927a13203b2_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNi0xLTEtMS0yMTE2MQ_87794f6f-d14b-4f78-802c-ee12ee1eebfb">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4351c2916a14e6583947067dccfd48f_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNi01LTEtMS0yMTE2MQ_51a76d9a-e430-4bb5-8682-73c0dd217ad8">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNi0xNS0xLTEtMjExNjE_2b26e93a-4c52-4c53-a596-8e1202a99365">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d654e08061c4d2eb225d927a13203b2_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNy0xLTEtMS0yMTE2MQ_1c8d4bcb-2900-477a-ae00-959ab362f0c5">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d654e08061c4d2eb225d927a13203b2_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNy0zLTEtMS0yMTE2MQ_e53474da-523d-43c5-983b-7adb4b365c0e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4351c2916a14e6583947067dccfd48f_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNy01LTEtMS0yMTE2MQ_77ac4b4e-f57e-497e-801f-6a1775a090a0">940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNy0xNS0xLTEtMjExNjE_657b1c7a-0986-4eb4-8e29-37c9dca016ef">941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and repurchase of stock to cover tax withholdings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4d654e08061c4d2eb225d927a13203b2_D20220701-20220930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOC0xLTEtMS0yMTE2MQ_f5ed024d-66a1-4b01-ad69-ebcce42fbb22">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4351c2916a14e6583947067dccfd48f_D20220701-20220930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOC01LTEtMS0yMTE2MQ_f25be2f1-a883-47a9-9bc2-b515a9f3e8cc">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOC0xNS0xLTEtMjExNjE_8770528f-7fb9-40dd-8630-0f07358dd7a2">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb24e4445f234f45bd7b3b6d182b317a_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS0xLTEtMS0yMTE2MQ_f57636e9-8dfe-4869-a94d-faecb4e7a3db">41,816</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb24e4445f234f45bd7b3b6d182b317a_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS0zLTEtMS0yMTE2MQ_4493094e-05f4-4988-8e7e-5102151d3900">418</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ebbddb2f6f04869aef50eed79a94a0a_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS01LTEtMS0yMTE2MQ_87520455-544e-4e42-9112-2e33968a30a9">334,077</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c92a5fd903b49a588c3ceab6bf0fd71_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS03LTEtMS0yMTE2MQ_f3c9432f-4a77-4889-8adf-977374f2d82f">19,386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idcf07ce8eeae433881f120218ee9a339_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS05LTEtMS0yMTE2MQ_435e8c31-3762-4b64-a9c1-3d1818db2cde">45,353</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i855b2caffaf74a64b3f2ef74285e23ad_I20220930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS0xMS0xLTEtMjExNjE_c74c2d71-ca96-44b2-984b-b32ded3f906c">1,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i855b2caffaf74a64b3f2ef74285e23ad_I20220930" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS0xMy0xLTEtMjExNjE_71fed71c-df64-4141-a783-42f310a527dc">14,648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS0xNS0xLTEtMjExNjE_374890e6-210b-4657-aebf-522ce370d079">255,108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:37.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.056%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings <br/>(Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated <br/>Other<br/>Comprehensive <br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders'<br/>Equity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i707205b1c07e4c1988ca5ff5d74d4a17_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi0xLTEtMS0yMTE2MQ_1e0e6d7b-9e34-499a-871d-d2ef9ff31162">41,397</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i707205b1c07e4c1988ca5ff5d74d4a17_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi0zLTEtMS0yMTE2MQ_bb3b280f-6ef3-4e6d-b80c-4e4ea9c2f182">414</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee6c1445ceaf40bbb5e5f10623f14612_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi01LTEtMS0yMTE2MQ_868ba4e2-4bd1-44e6-a03f-2180f022312f">322,874</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017ca17a602e45219dab10ea1da5ec48_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi03LTEtMS0yMTE2MQ_bf839bc8-21cf-439e-84ee-cba7356a4294">1,975</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d546f3304f74a65ad65e63d5f35549c_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi05LTEtMS0yMTE2MQ_1c9f1e41-ae10-47cf-b32a-4c6da051dabf">9,887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3556d5d3a27c416a831f28c2fa395382_I20211231" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi0xMS0xLTEtMjExNjE_bbeedfe1-d85c-47f7-be26-d99df946168e">1,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3556d5d3a27c416a831f28c2fa395382_I20211231" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi0xMy0xLTEtMjExNjE_f760186f-73f5-4310-87f5-5a524aa189b1">14,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi0xNS0xLTEtMjExNjE_9d875298-4b8e-427c-9678-170b49c0c630">300,728</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5632806a31294031ba676bcf8ede366e_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMy03LTEtMS0yMTE2MQ_d05a5aff-79bb-4ed5-9ce5-72d6c3f3376c">21,361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMy0xNS0xLTEtMjExNjE_7d808437-c66e-4405-bf57-75f1128f4f12">21,361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebd5d3ab6b5148ef93bef9493a895975_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNC05LTEtMS0yMTE2MQ_f72b2452-b5b8-4118-855f-82c5a5c0010b">35,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNC0xNS0xLTEtMjExNjE_38e12143-40c9-44a0-83ae-cc2cfa5691fd">35,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNS0xLTEtMS0yMTE2MQ_d1bd1f38-5055-42ee-bb5e-d758de5b56ae">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNS0zLTEtMS0yMTE2MQ_074a4e65-2111-449a-9d86-6570e7f9bc12">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic31b11b9e24042e291cfae22df2c5210_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNS01LTEtMS0yMTE2MQ_537496a8-73c6-45db-9fde-223e333e8c69">9,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNS0xNS0xLTEtMjExNjE_6da41176-475c-460a-9a5e-60c9ef22dd53">9,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNi0xLTEtMS0yMTE2MQ_8df183e1-b549-4d91-aaa0-184738da6277">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNi0zLTEtMS0yMTE2MQ_09bc7473-4194-4146-94ee-a38fc931cdc8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic31b11b9e24042e291cfae22df2c5210_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNi01LTEtMS0yMTE2MQ_d424646f-739e-4a28-8aa3-94d4ac43c4b9">1,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNi0xNS0xLTEtMjExNjE_78f96dbf-79a5-4eb4-b805-efa13b5259bc">1,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNy0xLTEtMS0yMTE2MQ_53647e8f-fdd5-48ec-a27e-8c1900316e1b">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNy0zLTEtMS0yMTE2MQ_809091f4-6faa-426b-8592-6c85115fa926">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic31b11b9e24042e291cfae22df2c5210_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNy01LTEtMS0yMTE2MQ_00914fda-cabc-4a01-a6ea-a3fca7e9dc3d">1,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNy0xNS0xLTEtMjExNjE_625d0b87-bb00-4c0f-a376-b89b1e4eaa40">1,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and repurchase of stock to cover tax withholdings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOC0xLTEtMS0yMTE2MQ_1da5cc79-073d-4662-9a0f-1aebdb076408">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOC0zLTEtMS0yMTE2MQ_116ab782-6e81-4c3a-9e0c-44cab728bd20">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic31b11b9e24042e291cfae22df2c5210_D20220101-20220930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOC01LTEtMS0yMTE2MQ_c5734572-b720-4801-b63e-d71361630d94">1,790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOC0xNS0xLTEtMjExNjE_da94ba90-a646-44fe-886e-12e70af38729">1,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb24e4445f234f45bd7b3b6d182b317a_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS0xLTEtMS0yMTE2MQ_7d1c78e9-79e2-4697-8c1d-1f7ed61375f8">41,816</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb24e4445f234f45bd7b3b6d182b317a_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS0zLTEtMS0yMTE2MQ_d489aef7-832d-446a-99c8-5e4ab4e4ce2b">418</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ebbddb2f6f04869aef50eed79a94a0a_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS01LTEtMS0yMTE2MQ_ae53e06e-ce0e-47cf-8a9c-e6d07df98001">334,077</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c92a5fd903b49a588c3ceab6bf0fd71_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS03LTEtMS0yMTE2MQ_49c049a7-077a-4ff8-9757-a1f4fcc31221">19,386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idcf07ce8eeae433881f120218ee9a339_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS05LTEtMS0yMTE2MQ_ebe0ef38-61a3-4037-bd13-108bbd8e113a">45,353</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i855b2caffaf74a64b3f2ef74285e23ad_I20220930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS0xMS0xLTEtMjExNjE_5dcfab43-46db-436e-94e5-ecb819f1ef03">1,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i855b2caffaf74a64b3f2ef74285e23ad_I20220930" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS0xMy0xLTEtMjExNjE_845d1522-0f03-43fb-8ce0-70856956c777">14,648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS0xNS0xLTEtMjExNjE_1b1c5331-4a45-4573-8514-cb54bb58d641">255,108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artivion, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Shareholders&#8217; Equity (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Thousands</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.555%"><tr><td style="width:1.0%"></td><td style="width:36.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.615%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated <br/>Other<br/>Comprehensive <br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders'<br/>Equity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie9e49d8b70744e2291a48074042aac1d_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi0xLTEtMS0yMTE2MQ_9ad0fa25-9a5f-434e-8987-fa4bf750361c">40,742</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e49d8b70744e2291a48074042aac1d_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi0zLTEtMS0yMTE2MQ_4698fa6a-f17d-4e48-b472-a64e524fb1c5">407</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd29210f343141e18bac0fa033368edb_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi01LTEtMS0yMTE2MQ_4f94a6f7-b487-44f6-a6a6-7e93c82a031f">305,157</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6cad2dbd6f2405aa20050ef52e24d72_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi03LTEtMS0yMTE2MQ_dbee0e7e-069d-4a7e-a3e6-04f98265697e">11,493</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc8bf90a94e84b16b4e0133d5e3511c8_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi05LTEtMS0yMTE2MQ_e1464268-578b-46d5-98a3-193da30b0627">574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i382d3d021f0e4fc5926b820bd792e570_I20210630" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi0xMS0xLTEtMjExNjE_cf1c6808-1771-45ec-b922-c29b7bb39ff1">1,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i382d3d021f0e4fc5926b820bd792e570_I20210630" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi0xMy0xLTEtMjExNjE_35032822-15fb-46d1-8648-8691e47d79d5">14,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8fc748ed8cc4d6197311f7f5b70f8b9_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi0xNS0xLTEtMjExNjE_548b3d31-885f-4108-9f4a-3ff65778db38">301,835</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d640434e1ec4e1f8bc779369e3c30fc_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMy03LTEtMS0yMTE2MQ_04be3321-6144-4b9c-aca9-cb61965762e8">10,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMy0xNS0xLTEtMjExNjE_37e3ba29-8276-4666-8e84-243c4e13dae7">10,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1171158da9d64ea3bb3f8187eeb9bb6a_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNC05LTEtMS0yMTE2MQ_56e6cef8-8fd3-474b-8c4a-5e8949bc0ba1">5,010</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNC0xNS0xLTEtMjExNjE_4832c725-c04c-4068-ad68-effb8ddfbbf7">5,010</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c9e6fcb6b5041a28fcbb938004e223e_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNS0xLTEtMS0yMTE2MQ_da14462d-ab8d-4a29-a655-54683fe75c0d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9e6fcb6b5041a28fcbb938004e223e_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNS0zLTEtMS0yMTE2MQ_fbc95b30-f152-4d81-8a1a-c59501cc6e37">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37d952f703594debb99cbb034f182acc_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNS01LTEtMS0yMTE2MQ_5d8cb327-6e46-4b22-afc4-1abb79e6ae23">2,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNS0xNS0xLTEtMjExNjE_26f273b5-776d-48b4-b5d2-93add6d01fe7">2,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c9e6fcb6b5041a28fcbb938004e223e_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNi0xLTEtMS0yMTE2MQ_dafe8861-adb8-4d76-aeab-5297945c636c">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37d952f703594debb99cbb034f182acc_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNi01LTEtMS0yMTE2MQ_8f0a2848-7da4-4cf1-a8f7-ca2e9c3fe69b">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNi0xNS0xLTEtMjExNjE_4b3f9932-cb8a-438d-a748-ecf401f39cfd">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c9e6fcb6b5041a28fcbb938004e223e_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNy0xLTEtMS0yMTE2MQ_619fe65e-351b-4bc5-81ac-b965bb88d354">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37d952f703594debb99cbb034f182acc_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNy01LTEtMS0yMTE2MQ_7e8b6478-50fd-4b86-9d39-f583b1a94627">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNy0xNS0xLTEtMjExNjE_d04f347d-b512-45e5-8c75-fbeeecf2b933">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and repurchase of stock to cover tax withholdings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7c9e6fcb6b5041a28fcbb938004e223e_D20210701-20210930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOC0xLTEtMS0yMTE2MQ_198c6aa5-9cf7-4510-af51-dfa0dadfc845">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37d952f703594debb99cbb034f182acc_D20210701-20210930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOC01LTEtMS0yMTE2MQ_559996f9-94f1-4fb6-a66b-50850777aa77">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOC0xNS0xLTEtMjExNjE_f9aea4fc-a26b-41ed-b939-6ef64a3ca07b">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i280bd3e07c864a7c9aaa759e2c9d499a_I20210930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS0xLTEtMS0yMTE2MQ_81eb62bd-3fc7-40e4-834a-736e26bb02f9">40,816</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280bd3e07c864a7c9aaa759e2c9d499a_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS0zLTEtMS0yMTE2MQ_68dfc2d1-c1ec-4b3c-bd26-067b2c804dc9">408</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e85ab3998944bb3b78d14636d55e58c_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS01LTEtMS0yMTE2MQ_81f92c72-1bd9-4a6c-8658-a8425d29902e">309,290</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a36f4d7f25b4eeaa95f908a94d5a7d0_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS03LTEtMS0yMTE2MQ_d821360f-2d13-43c8-8ff8-9f23a6153b69">22,075</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5259bc5ea2d48cfb9c3d8a509a38485_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS05LTEtMS0yMTE2MQ_c0f077fa-5218-4356-9231-e7de4a5740f1">5,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i874eb09dd9e04c1193c970174fefa74c_I20210930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS0xMS0xLTEtMjExNjE_e0975ac5-0321-4221-8c4e-c75f95421388">1,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i874eb09dd9e04c1193c970174fefa74c_I20210930" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS0xMy0xLTEtMjExNjE_178b56f9-911c-4652-b295-9b693ac3fcb3">14,648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfb7570230e54f50941fc14b31243894_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS0xNS0xLTEtMjExNjE_73282e41-9d44-4a23-b8ee-e05d9a0a05ef">311,541</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:37.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.056%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders'<br/>Equity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6421cdadddcd4de2b8a922abe34ec4d4_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi0xLTEtMS0yMTE2MQ_ca4e1de8-197b-49d2-8e07-bfa6d635c6b6">40,394</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6421cdadddcd4de2b8a922abe34ec4d4_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi0zLTEtMS0yMTE2MQ_7ae27756-f88f-4558-92ef-c3608fff86cc">404</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34648a7bb99f40b581988c47181998e5_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi01LTEtMS0yMTE2MQ_108f5ec7-7dfe-42ec-9608-524a229e551e">316,192</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie76736e9a34845c0be39eb23bee21d1d_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi03LTEtMS0yMTE2MQ_cfaabf71-89e8-47ff-83d1-81f7149a69dc">20,022</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3ea81c295134d2a950a870df83c0fc8_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi05LTEtMS0yMTE2MQ_1521ded9-0b2e-49d0-8c5a-f44acdcead3a">6,743</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i39b0402fe99e4b81b9cc8baa58b16782_I20201231" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi0xMS0xLTEtMjExNjE_5cde27e9-815e-4a69-9951-939dfaf1a98a">1,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39b0402fe99e4b81b9cc8baa58b16782_I20201231" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi0xMy0xLTEtMjExNjE_6af734f4-cc86-4f6e-8df1-ac49cfe2f757">14,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02c95f38d9b543ae84f37d41d8baa157_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi0xNS0xLTEtMjExNjE_31eba2b4-34ac-4fa0-afdb-d796690a3642">328,713</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib830edf09033428cbcfce9cd0d56ccd3_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMy03LTEtMS0yMTE2MQ_cbf4610a-a57e-409d-8cbb-d1bbd40e4706">5,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMy0xNS0xLTEtMjExNjE_c0705aad-3307-46d5-92b7-337782098a72">5,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfcc2e11a6ef41a4bf0b9fc74a0437c7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNC05LTEtMS0yMTE2MQ_a476d7c7-785c-4db0-a81d-2e2680e534a7">12,327</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNC0xNS0xLTEtMjExNjE_6cc843b0-bc0b-4943-827e-eb3b808f7347">12,327</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNS0wLTEtMS0yMTE2MS90ZXh0cmVnaW9uOjMwNzdjZjk4YTE0NDQ2YjliOTkyNjljODNlZGM0MTNjXzI2_24621f48-2c6f-4533-bf80-a0d0ebc54e1b">ASU 2020-06</span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88ff77f1faa34bb5a9274393c266a3c5_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNS01LTEtMS0yMTE2MQ_0ef14621-9f7a-4491-ba15-5f980b71c7d8">16,426</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c206091bc204dc2a0b88d27cd64ac1c_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNS03LTEtMS0yMTE2MQ_6be6cde8-8bcd-4e1b-8b96-a1ecc65b8853">3,213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia34aaa5e1fdf43c6976074120b87cf65_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNS0xNS0xLTEtMjExNjE_8b5974b7-cc10-408b-b94b-61a2a3391f64">19,639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNi0xLTEtMS0yMTE2MQ_ec534b3a-b164-4ecb-8e21-3d93ebe0ff34">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNi0zLTEtMS0yMTE2MQ_35f54bdf-183b-464a-be70-770cab9a4cc3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb844b6a956440a8c40b76f8ef5e9ad_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNi01LTEtMS0yMTE2MQ_d46a097b-4415-4846-a1ae-d02322fca90e">7,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNi0xNS0xLTEtMjExNjE_ec019366-9aa9-4a71-b0c8-1f7906f20cc2">7,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNy0xLTEtMS0yMTE2MQ_6490c6b7-5477-4cf2-be29-27e260878f44">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNy0zLTEtMS0yMTE2MQ_89b1dacf-914b-46b9-a319-a576a98013bf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb844b6a956440a8c40b76f8ef5e9ad_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNy01LTEtMS0yMTE2MQ_60be776b-ec42-473c-91fa-900f88d9fb4d">1,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNy0xNS0xLTEtMjExNjE_21afc4c3-6118-427b-a5c5-0dda1ba64870">1,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOC0xLTEtMS0yMTE2MQ_ff67220c-4ffa-4b4a-b73b-f88fbb14ae87">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOC0zLTEtMS0yMTE2MQ_ccfc1ddf-9330-4f3d-b9f0-5bb67fdc9495">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb844b6a956440a8c40b76f8ef5e9ad_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOC01LTEtMS0yMTE2MQ_514e2b07-7b7a-4f50-b562-4101c3403cc4">1,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOC0xNS0xLTEtMjExNjE_e622c485-551d-4311-921e-e8cdef1d31de">1,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and repurchase of stock to cover tax withholdings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOS0xLTEtMS0yMTE2MQ_0b4e073a-8863-4295-8ba5-c65ba247d0c2">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOS0zLTEtMS0yMTE2MQ_a8400146-3c6b-4753-aac4-0b0a8239376d">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb844b6a956440a8c40b76f8ef5e9ad_D20210101-20210930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOS01LTEtMS0yMTE2MQ_f65ab4cf-450c-4463-a6ba-9dd36eafadc8">1,897</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOS0xNS0xLTEtMjExNjE_81c5710e-a558-46b2-b8c4-67e53b9915ed">1,898</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i280bd3e07c864a7c9aaa759e2c9d499a_I20210930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtMS0xLTEtMjExNjE_3e1b9951-72d8-4f1d-9118-aa7f36c6deda">40,816</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280bd3e07c864a7c9aaa759e2c9d499a_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtMy0xLTEtMjExNjE_7060be81-28bc-4097-b9b9-21550691fd42">408</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e85ab3998944bb3b78d14636d55e58c_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtNS0xLTEtMjExNjE_d3405e2a-3cbb-4e92-b885-6123fe9a9d5f">309,290</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a36f4d7f25b4eeaa95f908a94d5a7d0_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtNy0xLTEtMjExNjE_cc4a2d11-a450-464d-b1b1-a1f1a8b29722">22,075</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5259bc5ea2d48cfb9c3d8a509a38485_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtOS0xLTEtMjExNjE_cfe47f0b-9c04-48a5-8cbe-bb949063f236">5,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i874eb09dd9e04c1193c970174fefa74c_I20210930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtMTEtMS0xLTIxMTYx_9c62ce4d-75d2-49a0-9b16-e81fea132472">1,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i874eb09dd9e04c1193c970174fefa74c_I20210930" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtMTMtMS0xLTIxMTYx_a714f82f-2505-40e9-9344-a1e553546a59">14,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfb7570230e54f50941fc14b31243894_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtMTUtMS0xLTIxMTYx_b5903e87-ef36-43a1-ab09-340a59625a90">311,541</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">7</span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artivion, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div id="i167b7825c15e480eba61f77e008c32de_31"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:BasisOfAccounting" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zMS9mcmFnOmMzNGY4MjI0NTI4NzRmYTBiNTI1MjVjMjhkODdmOTU0L3RleHRyZWdpb246YzM0ZjgyMjQ1Mjg3NGZhMGI1MjUyNWMyOGQ4N2Y5NTRfNDE5Nw_d4493cab-f5ff-4550-9d67-6c8e9e28fd51" continuedAt="i92f611f4c8c2440cb16f60ba0d42d0a7" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i92f611f4c8c2440cb16f60ba0d42d0a7" continuedAt="i71b4a5bf5628465488d0d4f08f1e130c"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements include the accounts of Artivion, Inc. and its subsidiaries (&#8220;Artivion,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; or &#8220;us&#8221;). All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying Condensed Consolidated Balance Sheet as of December&#160;31, 2021 has been derived from audited financial statements. The accompanying unaudited Condensed Consolidated Financial Statements as of, and for the three and nine months ended, September&#160;30, 2022 and 2021 have been prepared in accordance with (i) accounting principles generally accepted in the US for interim financial information and (ii) the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the US Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, such statements do not include all the information and disclosures that are required by accounting principles generally accepted in the US for a complete presentation of financial statements. In the opinion of management, all adjustments (including those of a normal, recurring nature) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. These Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes included in Artivion&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 filed with the SEC on February&#160;22, 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our significant accounting policies is included in Note 1 of the &#8220;Notes to Consolidated Financial Statements&#8221; contained in our Form 10-K for the year ended December&#160;31, 2021. Management believes that the consistent application of these policies enables us to provide users of the financial statements with useful and reliable information about our operating results and financial condition. The Condensed Consolidated Financial Statements are prepared in accordance with accounting principles generally accepted in the US, which require us to make estimates and assumptions. We did not experience any significant changes during the three and nine months ended September&#160;30, 2022 in any of our Significant Accounting Policies from those contained in our Form 10-K for the year ended December&#160;31, 2021.</span></div><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zMS9mcmFnOmMzNGY4MjI0NTI4NzRmYTBiNTI1MjVjMjhkODdmOTU0L3RleHRyZWdpb246YzM0ZjgyMjQ1Mjg3NGZhMGI1MjUyNWMyOGQ4N2Y5NTRfNDE5Ng_393f4a9a-79f8-4877-95b0-ccf8e431b1ef" continuedAt="ic67f92b7b21b419dbc3c816afeb595dc" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020 the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-06&#8221;). The update simplifies the accounting for convertible instruments by eliminating two accounting models (i.e., the cash conversion model and beneficial conversion feature model) and reducing the number of embedded conversion features that could be recognized separately from the host contract. ASU 2020-06 also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. On January 1, 2021 we adopted ASU 2020-06 using the modified retrospective approach. See Note 9 for further discussion of convertible debt. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Not Yet Effective </span></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-align:justify"><ix:continuation id="i71b4a5bf5628465488d0d4f08f1e130c" continuedAt="i3e2371ff1bda4f7ebc9436f185da7c99"><ix:continuation id="ic67f92b7b21b419dbc3c816afeb595dc" continuedAt="i7015beae907c4055b44033b6bf83a53a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020 the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 848&#8221;). The amendments in this ASU were put forth in response to the market transition from the LIBOR and other interbank offered rates to alternative reference rates. Accounting principles generally accepted in the United States of America require entities to evaluate whether a contract modification, such as the replacement or change of a reference rate, results in the establishment of a new contract or continuation of an existing contract. ASC 848 allows an entity to elect not to apply certain modification accounting requirements to contracts affected by reference rate reform. The standard provides this temporary election through December&#160;31, 2022 and cannot be applied to contract modifications that occur after December&#160;31, 2022. </span></ix:continuation></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3e2371ff1bda4f7ebc9436f185da7c99"><ix:continuation id="i7015beae907c4055b44033b6bf83a53a">We are in the process of evaluating the effect that the adoption of this standard will have on our financial position and results of operations.</ix:continuation></ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8</span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_476"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzEwOTk1MTE2MzI3NTY_1d1c9feb-9a72-4776-b76e-639dce424dcd" continuedAt="i6eaaf7ee3f9245439007d4e40afb15f0" escape="true">Sale of PerClot</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6eaaf7ee3f9245439007d4e40afb15f0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2021 we entered into an asset purchase agreement and other ancillary agreements related to the sale of PerClot&#174;, a polysaccharide hemostatic agent used in surgery (&#8220;PerClot&#8221;), to a subsidiary of Baxter International, Inc. (&#8220;Baxter&#8221;) and an agreement to terminate all of our material agreements with Starch Medical, Inc. (&#8220;SMI&#8221;) related to PerClot (collectively the &#8220;Baxter Transaction&#8221;). Under the terms of the Baxter Transaction, Baxter will pay an aggregate of up to $<ix:nonFraction unitRef="usd" contextRef="i93965fb5672a40aaa73943e5e32c7968_I20210728" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxNDY_5f88d329-c644-4d38-8d1a-86c7ac5c5a6f">60.8</ix:nonFraction> million in consideration (we will receive up to $<ix:nonFraction unitRef="usd" contextRef="if7419f77f0164d6e8bbfd14061a58dc8_I20210728" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxNTQ_7aa3ec57-d92e-4caf-8015-a8a299c18c13">45.8</ix:nonFraction> million and SMI will receive up to $<ix:nonFraction unitRef="usd" contextRef="i6db073c52b794f6f9307cf9c09aa6840_I20210728" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxNjI_56095147-d787-40a6-a0f5-8eee4655c000">15.0</ix:nonFraction> million), consisting of (i) $<ix:nonFraction unitRef="usd" contextRef="i474797d7697b4b30bbed0e1b1e4c0c1f_D20210728-20210728" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxNzA_0574bdf1-7795-49f7-ac23-df66b89dfb5b">25.0</ix:nonFraction> million at closing, of which $<ix:nonFraction unitRef="usd" contextRef="ic8c37cb40b344c3fba9bdc98b545a5de_D20210728-20210728" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxNzg_eb3270e4-8062-4d78-a16d-4edd823ba47f">6.0</ix:nonFraction> million was paid to SMI; (ii) up to $<ix:nonFraction unitRef="usd" contextRef="i1e2e38f130ed4105acb2e32af2c464db_I20210728" decimals="-3" name="aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxODY_69604dd6-5eaa-4220-afe3-3e286f693444">25.0</ix:nonFraction> million upon our receipt of Premarket Approval (&#8220;PMA&#8221;) approval from the US Food and Drug Administration (the &#8220;FDA&#8221;) for PerClot and our transfer of the PMA to Baxter, of which up to $<ix:nonFraction unitRef="usd" contextRef="ieec45bdddc8041219cabad03cec97440_I20210728" decimals="-3" name="aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxOTQ_a9210058-27c9-4abd-bd64-82b73591e071">6.0</ix:nonFraction> million is payable to SMI, subject to certain reductions for delay in PMA approval; and (iii) up to $<ix:nonFraction unitRef="usd" contextRef="i377d4fb97be743429e52f8c0cf18419e_I20210728" decimals="-3" name="aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyMDI_7331ec2e-44e5-47bb-8ad6-5c17cc649f50">10.0</ix:nonFraction> million upon Baxter&#8217;s achievement of certain cumulative worldwide net sales of PerClot prior to December 31, 2026 and December 31, 2027, of which up to $<ix:nonFraction unitRef="usd" contextRef="ic721009275b44299b76bee3aab313494_I20210728" decimals="-3" name="aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyMTA_d9e65a21-8d65-4f54-a798-a069319e22d4">3.0</ix:nonFraction> million is payable to SMI. In addition, at the conclusion of our manufacturing and supply services for Baxter, Baxter will pay $<ix:nonFraction unitRef="usd" contextRef="iea42e8fd134e416a8ca4bf1b048423f4_I20210728" decimals="-3" name="aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyMjA_ae2501ec-2c3e-4fdd-b2c6-5be9ba865ccb">780,000</ix:nonFraction> upon transfer of our PerClot manufacturing equipment. Under the terms of the Baxter Transaction, we will continue to provide to Baxter certain transition and manufacturing and supply services relating to the sale of SMI PerClot outside of the US and manufacture and supply of PerClot to Baxter post PMA approval.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for the Transaction</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the Baxter Transaction, we received $<ix:nonFraction unitRef="usd" contextRef="i474797d7697b4b30bbed0e1b1e4c0c1f_D20210728-20210728" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyMzI_0574bdf1-7795-49f7-ac23-df66b89dfb5b">25.0</ix:nonFraction> million from Baxter and paid $<ix:nonFraction unitRef="usd" contextRef="ic8c37cb40b344c3fba9bdc98b545a5de_D20210728-20210728" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyNDA_eb3270e4-8062-4d78-a16d-4edd823ba47f">6.0</ix:nonFraction> million to SMI. We derecognized intangible assets with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="if7419f77f0164d6e8bbfd14061a58dc8_I20210728" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyNDg_e0a8ef19-8699-4c26-b75c-2c73394051c7">1.6</ix:nonFraction> million and wrote-off $<ix:nonFraction unitRef="usd" contextRef="i3c6ab9a4a9c64f29a055949f7555bfee_D20210728-20210728" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyNTY_7460abf8-ec61-448e-a433-bc4ebafa677e">1.5</ix:nonFraction> million of prepaid royalties previously recorded on our Condensed Consolidated Balance Sheets related to PerClot. Under the terms of the agreement, Baxter acquired intellectual property related to our development efforts for PerClot. We recorded a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="i3c6ab9a4a9c64f29a055949f7555bfee_D20210728-20210728" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyNjQ_03dcfed6-2332-4e4c-83ca-1d5d3583a6da">15.9</ix:nonFraction> million, included as Gain from sale of non-financial assets within the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2021. The PerClot product line was included as part of our Medical Devices segment.</span></div></ix:continuation><div id="i167b7825c15e480eba61f77e008c32de_34"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjkzMQ_35afa3ae-b11e-4680-99eb-6074c2802e65" continuedAt="i8e11e43c1def4441bf7445a69e4ea28b" escape="true">Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="i8e11e43c1def4441bf7445a69e4ea28b" continuedAt="i19023ac5544341aa84e2531897935e21"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjkzMg_0b623d3b-54f0-4922-a3df-a216047533b1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our financial instruments measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950e76f991cb4fe09eff1721971650dd_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMi0yLTEtMS0yMTE2MQ_bf1f68fc-f8c8-401a-ada5-e126799d3fd4">10,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9b82a7f6604a2bbbe148b7d4abe182_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMi00LTEtMS0yMTE2MQ_12517dc8-c756-49aa-b255-baa024d0c609">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf831653ca749c6acafb610a2e28758_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMi02LTEtMS0yMTE2MQ_d8dcc448-998e-4ae4-abb9-114e81e8b6b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e42ab1c54464099a18768bdfff45114_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMi04LTEtMS0yMTE2MQ_e06582fa-245e-47c9-8b69-f5884e1f2392">10,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8204321837cc4faeaa2f049f14c3892b_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMy0yLTEtMS0yMTE2MQ_572dfeaa-669f-492c-affe-5e1b2dc6131a">10,051</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6561a8259c80412f9d65d166fc210a1a_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMy00LTEtMS0yMTE2MQ_a04590c9-34ae-4d39-b9f9-5e89b48e1d9b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7196597c5deb49e1bb184bfb4947a913_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMy02LTEtMS0yMTE2MQ_1c152f17-8e65-4b79-abce-70a31b45dff0">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMy04LTEtMS0yMTE2MQ_9579032c-ab45-4bef-b3a5-24b3c28e006f">10,051</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8204321837cc4faeaa2f049f14c3892b_I20220930" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNi0yLTEtMS0yMTE2MQ_89470468-221a-4eca-93b6-66909c8cd3c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6561a8259c80412f9d65d166fc210a1a_I20220930" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNi00LTEtMS0yMTE2MQ_136825d6-a256-4082-a1ec-8fdbb0b078fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7196597c5deb49e1bb184bfb4947a913_I20220930" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNi02LTEtMS0yMTE2MQ_bbfb52dd-5d2a-44ec-851f-141cd07e434e">44,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNi04LTEtMS0yMTE2MQ_278d4c3a-81a0-4a75-83c3-4baee1d93c0b">44,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8204321837cc4faeaa2f049f14c3892b_I20220930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNy0yLTEtMS0yMTE2MQ_c1884402-0ced-40e4-880b-89eb0c622409">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6561a8259c80412f9d65d166fc210a1a_I20220930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNy00LTEtMS0yMTE2MQ_ba84e6a3-028b-44ad-b594-19a22d5ccd4d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7196597c5deb49e1bb184bfb4947a913_I20220930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNy02LTEtMS0yMTE2MQ_57b1735d-7d31-4ac3-af7b-3204ed5a9ecd">44,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNy04LTEtMS0yMTE2MQ_6d99e362-f78b-4991-84d6-675a6498c003">44,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc99e11cae64b9ea4455cb43369f79c_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMi0yLTEtMS0yMTE2MQ_ef81dc56-99e8-4daf-baeb-71631dffcc4c">10,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3c1df5f3a046efb727e88f49e41f79_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMi00LTEtMS0yMTE2MQ_135b560a-b983-45e8-81d3-e077eb7cf325">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic70a37d9dc5d47ff92c7cf4a36a1f693_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMi02LTEtMS0yMTE2MQ_515b0ee9-7626-437a-8801-9dd485b16b01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedfc3424257043348e41663c5bdc6fd2_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMi04LTEtMS0yMTE2MQ_47ca99a5-9da9-4633-960c-a99290138ee0">10,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7748b61019a4fd4a51f83204e8a357b_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMy0yLTEtMS0yMTE2MQ_062fafe6-d529-4115-9da3-5524592ddfb9">10,015</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f304425672d48179954b9c1f45b94c7_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMy00LTEtMS0yMTE2MQ_d5add3b3-bfcb-4a48-85d0-5e79ccde9c3f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81cb3cd3d95849408779cbf36a73bfc6_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMy02LTEtMS0yMTE2MQ_de735c21-9278-4c54-9c3c-3c01b8b6ff17">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMy04LTEtMS0yMTE2MQ_38c40c75-19d1-4b25-a313-f0cb1ef637ec">10,015</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7748b61019a4fd4a51f83204e8a357b_I20211231" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNi0yLTEtMS0yMTE2MQ_fb359734-f02d-4bdb-8b00-1f33fb3cf36d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f304425672d48179954b9c1f45b94c7_I20211231" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNi00LTEtMS0yMTE2MQ_39d88226-3121-4ae9-ad91-a29fecadf16c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81cb3cd3d95849408779cbf36a73bfc6_I20211231" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNi02LTEtMS0yMTE2MQ_28c486f3-3904-4ee6-8e69-dd8ae34e8e7f">49,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNi04LTEtMS0yMTE2MQ_54bb6fbb-dd9d-4c15-887b-9434ff66844f">49,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7748b61019a4fd4a51f83204e8a357b_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNy0yLTEtMS0yMTE2MQ_05ff1729-27e5-404e-a0e0-a8b7d2692c6c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f304425672d48179954b9c1f45b94c7_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNy00LTEtMS0yMTE2MQ_b1a94e7f-6c6c-432b-a1b5-2edae3cf8bb2">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81cb3cd3d95849408779cbf36a73bfc6_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNy02LTEtMS0yMTE2MQ_b8a66f97-4e40-4ce8-a357-4e00c26dde7e">49,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNy04LTEtMS0yMTE2MQ_cf71d80b-272e-47cf-8ea9-af39003550f6">49,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used prices quoted from our investment advisors to determine the Level 1 valuation of our investments in money market funds.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><ix:continuation id="i19023ac5544341aa84e2531897935e21"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;2, 2020 we entered into a Securities Purchase Agreement to acquire <ix:nonFraction unitRef="number" contextRef="i6525e7731ff74ad0828ab59973e96ed9_I20200902" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMzQz_2bae9dfd-1795-4964-a576-9ef1399d13fe">100</ix:nonFraction>% of the outstanding equity interests of Ascyrus Medical LLC (&#8220;Ascyrus&#8221;). Ascyrus developed the AMDS, the world&#8217;s first aortic arch remodeling device for use in the treatment of acute Type A aortic dissections. As part of the acquisition, we may be required to pay additional consideration in cash of up to $<ix:nonFraction unitRef="usd" contextRef="i6525e7731ff74ad0828ab59973e96ed9_I20200902" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfNjUx_33f0e4af-fe88-405c-9b6d-c3f128352124">100.0</ix:nonFraction> million to the former shareholders of Ascyrus upon the achievement of certain milestones and the sales-based additional earn-out. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration represents the estimated fair value of future potential payments. The fair value of the contingent consideration liability was estimated by discounting to present value the contingent payments expected to be made based on a probability-weighted scenario approach. We applied a discount rate based on our unsecured credit spread and the term commensurate risk-free rate to the additional consideration to be paid, and then applied a risk-based estimate of the probability of achieving each scenario to calculate the fair value of the contingent consideration. This fair value measurement was based on unobservable inputs, including management estimates and assumptions about the future achievement of milestones and future estimate of revenues, and is, therefore, classified as Level 3 within the fair value hierarchy. We used a discount rate of approximately <ix:nonFraction unitRef="number" contextRef="i0da58d4628e84024a2ac81e40f54f818_I20220930" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMTY2NQ_1b109f82-0016-42a8-a888-8efefb2568c9">13</ix:nonFraction>% and estimated future achievement of milestone dates between 2025 and 2026 to calculate the fair value of contingent consideration as of September&#160;30, 2022. We will remeasure this liability at each reporting date and will record changes in the fair value of the contingent consideration in General, administrative, and marketing expenses on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. Increases or decreases in the fair value of the contingent consideration liability can result from changes in passage of time, discount rates, the timing and amount of our revenue estimates, and the timing and expectation of regulatory approvals.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed an assessment of the fair value of the contingent consideration and recorded expense of $<ix:nonFraction unitRef="usd" contextRef="id93794b724d14804926854714e119380_D20220701-20220930" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjQyMA_62e07e4f-21d2-4c8b-8fb5-df52b46199bc">400,000</ix:nonFraction> and income of $<ix:nonFraction unitRef="usd" contextRef="i260c7a4a20d1487d8c43eb7ccdbcf577_D20220101-20220930" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjQyNw_57e256d4-a255-4b63-a667-509096df4887">4.6</ix:nonFraction> million for the three and nine months ended September&#160;30, 2022, respectively, and expense of $<ix:nonFraction unitRef="usd" contextRef="i4a6f190d5fa245329e12192250fb7f35_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjQ4Nw_3ae99122-7563-4ab8-8b03-e69c4f8ae8d1">700,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie7832872936b4b9fb5d8ab87dfa734ae_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjQ5NA_d7b06d38-b367-4d31-b8db-7896aba64ef5">5.0</ix:nonFraction> million for the three and nine months ended September&#160;30, 2021, respectively, in General, administrative, and marketing expenses on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income, as a result of this assessment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent consideration component of the Ascyrus acquisition was updated using Level 3 inputs. <ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjkzMw_898f87e8-6b92-479c-b7be-2a5b184ff35c" continuedAt="i736290956ab943a2a13223e5c89df5f6" escape="true">Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i736290956ab943a2a13223e5c89df5f6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmI2YjY2MWI4ZDk1ZTRjZTk5Y2I0ZWZlZjFlYWUzZWUxL3RhYmxlcmFuZ2U6YjZiNjYxYjhkOTVlNGNlOTljYjRlZmVmMWVhZTNlZTFfMS0xLTEtMS0yMTE2MQ_91a4d4e5-b7ab-4e6c-a34a-c6a84f5b04e5">49,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmI2YjY2MWI4ZDk1ZTRjZTk5Y2I0ZWZlZjFlYWUzZWUxL3RhYmxlcmFuZ2U6YjZiNjYxYjhkOTVlNGNlOTljYjRlZmVmMWVhZTNlZTFfMi0xLTEtMS0yMTE2MQ_bed41ac4-cc1a-4ebd-bce6-9f1af50e55fb">4,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmI2YjY2MWI4ZDk1ZTRjZTk5Y2I0ZWZlZjFlYWUzZWUxL3RhYmxlcmFuZ2U6YjZiNjYxYjhkOTVlNGNlOTljYjRlZmVmMWVhZTNlZTFfMy0xLTEtMS0yMTE2MQ_d3840702-7708-4710-84cc-57212d7246ca">44,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="i167b7825c15e480eba61f77e008c32de_37"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RleHRyZWdpb246MjRjNGIxNmUwNzNiNDE4ZDg0ZmZkMmQ4OTEwYmFjMzRfMTkx_04e18fcb-d31c-472d-9dd9-78cf8ea43003" continuedAt="i03783e6670d745c6b75dd76e0d8ac9cb" escape="true">Cash Equivalents </ix:nonNumeric></span></div><ix:continuation id="i03783e6670d745c6b75dd76e0d8ac9cb" continuedAt="i160158028375442a8f8a224a01319ff4"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RleHRyZWdpb246MjRjNGIxNmUwNzNiNDE4ZDg0ZmZkMmQ4OTEwYmFjMzRfMTky_1ce62adf-cbbd-4773-8c71-e410f4f8705a" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of cash equivalents (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost Basis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Holding<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8491b725aa2a46399318dc2aa090e37e_I20220930" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOmJhOGViYTJhODIyYjQzODRhNzdlYTIwMmRmOTgzYmEzL3RhYmxlcmFuZ2U6YmE4ZWJhMmE4MjJiNDM4NGE3N2VhMjAyZGY5ODNiYTNfMi0yLTEtMS0yMTE2MQ_f337dc80-6453-46a1-8726-94f25608fa69">10,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18a5ff4b2e4444f818e82a116bbe4cf_D20220101-20220930" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOmJhOGViYTJhODIyYjQzODRhNzdlYTIwMmRmOTgzYmEzL3RhYmxlcmFuZ2U6YmE4ZWJhMmE4MjJiNDM4NGE3N2VhMjAyZGY5ODNiYTNfMi00LTEtMS0yMTE2MQ_5946cb7d-211c-4791-947a-9eb3c570f13b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8491b725aa2a46399318dc2aa090e37e_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOmJhOGViYTJhODIyYjQzODRhNzdlYTIwMmRmOTgzYmEzL3RhYmxlcmFuZ2U6YmE4ZWJhMmE4MjJiNDM4NGE3N2VhMjAyZGY5ODNiYTNfMi02LTEtMS0yMTE2MQ_709dacaf-7a66-44d0-a447-d64ed0e43cca">10,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOmJhOGViYTJhODIyYjQzODRhNzdlYTIwMmRmOTgzYmEzL3RhYmxlcmFuZ2U6YmE4ZWJhMmE4MjJiNDM4NGE3N2VhMjAyZGY5ODNiYTNfMy0yLTEtMS0yMTE2MQ_b54c7d8e-f27b-41e5-9a10-58c9db893cb5">10,051</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOmJhOGViYTJhODIyYjQzODRhNzdlYTIwMmRmOTgzYmEzL3RhYmxlcmFuZ2U6YmE4ZWJhMmE4MjJiNDM4NGE3N2VhMjAyZGY5ODNiYTNfMy00LTEtMS0yMTE2MQ_3b527a3e-ebae-4da6-b715-bc3b71a81bf4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOmJhOGViYTJhODIyYjQzODRhNzdlYTIwMmRmOTgzYmEzL3RhYmxlcmFuZ2U6YmE4ZWJhMmE4MjJiNDM4NGE3N2VhMjAyZGY5ODNiYTNfMy02LTEtMS0yMTE2MQ_652a9ba8-e4b6-4ad2-a0b2-45286669806c">10,051</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost Basis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Holding<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47ea06876fd54ecdab5ff8648c2c9200_I20211231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOjVmZjM5Nzg1NzJkMTQ5NmU5ODQ3NmQwMzMzZjU3YjYyL3RhYmxlcmFuZ2U6NWZmMzk3ODU3MmQxNDk2ZTk4NDc2ZDAzMzNmNTdiNjJfMi0yLTEtMS0yMTE2MQ_e662031e-5fe4-4165-83e6-7dc89303c919">10,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic210a1a5c32344f8a0d5bb24192cd622_D20210101-20211231" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOjVmZjM5Nzg1NzJkMTQ5NmU5ODQ3NmQwMzMzZjU3YjYyL3RhYmxlcmFuZ2U6NWZmMzk3ODU3MmQxNDk2ZTk4NDc2ZDAzMzNmNTdiNjJfMi00LTEtMS0yMTE2MQ_3e460ba6-92a9-4169-9b3c-47f913efed6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47ea06876fd54ecdab5ff8648c2c9200_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOjVmZjM5Nzg1NzJkMTQ5NmU5ODQ3NmQwMzMzZjU3YjYyL3RhYmxlcmFuZ2U6NWZmMzk3ODU3MmQxNDk2ZTk4NDc2ZDAzMzNmNTdiNjJfMi02LTEtMS0yMTE2MQ_d511eca0-5caa-47ab-b95d-4057d2150d95">10,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOjVmZjM5Nzg1NzJkMTQ5NmU5ODQ3NmQwMzMzZjU3YjYyL3RhYmxlcmFuZ2U6NWZmMzk3ODU3MmQxNDk2ZTk4NDc2ZDAzMzNmNTdiNjJfMy0yLTEtMS0yMTE2MQ_2fd56ad4-0bdd-4229-ba1a-69dbf516ce52">10,015</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92f2162a5f2c42d99bb26f8349f42660_D20210101-20211231" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOjVmZjM5Nzg1NzJkMTQ5NmU5ODQ3NmQwMzMzZjU3YjYyL3RhYmxlcmFuZ2U6NWZmMzk3ODU3MmQxNDk2ZTk4NDc2ZDAzMzNmNTdiNjJfMy00LTEtMS0yMTE2MQ_db7e9c8e-668e-4623-ae7d-31de1b21626c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOjVmZjM5Nzg1NzJkMTQ5NmU5ODQ3NmQwMzMzZjU3YjYyL3RhYmxlcmFuZ2U6NWZmMzk3ODU3MmQxNDk2ZTk4NDc2ZDAzMzNmNTdiNjJfMy02LTEtMS0yMTE2MQ_a9ae0e9e-87f3-46e0-b6ba-27d183a420c4">10,015</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i160158028375442a8f8a224a01319ff4">There were <ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="INF" name="us-gaap:RealizedInvestmentGainsLosses" format="ixt:fixed-zero" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RleHRyZWdpb246MjRjNGIxNmUwNzNiNDE4ZDg0ZmZkMmQ4OTEwYmFjMzRfMTA0_35336718-a400-4a86-aa36-09c2982672ef"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="INF" name="us-gaap:RealizedInvestmentGainsLosses" format="ixt:fixed-zero" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RleHRyZWdpb246MjRjNGIxNmUwNzNiNDE4ZDg0ZmZkMmQ4OTEwYmFjMzRfMTA0_3f061c26-630d-4e07-84ed-12dea4b58ffb"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="INF" name="us-gaap:RealizedInvestmentGainsLosses" format="ixt:fixed-zero" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RleHRyZWdpb246MjRjNGIxNmUwNzNiNDE4ZDg0ZmZkMmQ4OTEwYmFjMzRfMTA0_7a111df5-7622-4727-bb35-477af1c66860"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="INF" name="us-gaap:RealizedInvestmentGainsLosses" format="ixt:fixed-zero" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RleHRyZWdpb246MjRjNGIxNmUwNzNiNDE4ZDg0ZmZkMmQ4OTEwYmFjMzRfMTA0_fa8e353c-c42a-4d61-85dc-db1acfc12ef3">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> gross realized gains or losses on cash equivalents for the three and nine months ended September&#160;30, 2022 and 2021.</ix:continuation></span></div><div id="i167b7825c15e480eba61f77e008c32de_40"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfOTI1_1ad61947-a517-4fe9-9e22-20f99460dc05" continuedAt="iaf64946b14d74297af46bf32a6271239" escape="true">Inventories, net and Deferred Preservation Costs </ix:nonNumeric></span></div><ix:continuation id="iaf64946b14d74297af46bf32a6271239"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfOTI2_3118ce58-3a33-4d5b-87ec-9b36f666935c" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories at September&#160;30, 2022 and December&#160;31, 2021 were comprised of the following (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:71.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.881%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfMS0xLTEtMS0yMTE2MQ_80bf16fe-5dff-4f3b-adc3-2bc4cb7cc85e">35,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfMS0zLTEtMS0yMTE2MQ_e628c321-2b5c-43c2-8b95-4c09d610ccf5">35,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfMi0xLTEtMS0yMTE2MQ_7e80d0aa-0d27-444c-ba29-510e40e2654f">11,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfMi0zLTEtMS0yMTE2MQ_23860bb0-f0b8-4aac-b26e-298bf4270ed3">9,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfMy0xLTEtMS0yMTE2MQ_51810796-7d44-4b1e-9f0c-2d3ed60b9fb4">25,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfMy0zLTEtMS0yMTE2MQ_43e8bc18-7f35-4cec-a7a8-9654223a5be7">31,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total inventories, net </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfNC0xLTEtMS0yMTE2MQ_416cb7b3-c7bb-4036-9690-f265d5407d7b">73,044</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfNC0zLTEtMS0yMTE2MQ_7b9ef9ac-792d-4394-b2a7-59902ccc7b80">76,971</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To facilitate product usage, we maintain consignment inventory of our On-X heart valves at domestic hospital locations and On-X heart valves and aortic stent grafts at international hospital locations. We retain title and control over this consignment inventory until the device is implanted, at which time we invoice the hospital and recognize revenue. As of September&#160;30, 2022 we had $<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-5" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNTA0_4b31f561-5808-4317-82ec-e0bf8a558688">13.2</ix:nonFraction> million in consignment inventory, with approximately <ix:nonFraction unitRef="number" contextRef="ic5f9cb6f422b426ea46da0e9c04c8488_I20220930" decimals="2" name="aort:ConsignmentInventoryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNTUy_44779586-8077-4424-93ab-3c58c9e8fe53">39</ix:nonFraction>% in domestic locations and <ix:nonFraction unitRef="number" contextRef="i5bf438e13a654ecf8c83a67427ed9c00_I20220930" decimals="2" name="aort:ConsignmentInventoryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNTgx_24be7b66-e853-4240-8e3c-51dc0c9a3a20">61</ix:nonFraction>% in international locations. As of December&#160;31, 2021 we had $<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-5" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNjI4_df0b5e5e-7be9-4b17-923b-b96f5f77c8a5">12.9</ix:nonFraction> million in consignment inventory, with approximately <ix:nonFraction unitRef="number" contextRef="iedf397d3ddca43f3bc7c0be07a26764c_I20211231" decimals="2" name="aort:ConsignmentInventoryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNjc2_1ba39fa2-c242-4238-b297-3f14e1a5318e">43</ix:nonFraction>% in domestic locations and <ix:nonFraction unitRef="number" contextRef="i415a7398d0b44f30b0c2ac4c3cd52d77_I20211231" decimals="2" name="aort:ConsignmentInventoryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNzA1_32b9b8ff-8c6c-40fa-929e-ee1b138d449b">57</ix:nonFraction>% in international locations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred preservation costs were $<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-5" name="aort:DeferredPreservationCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNzc1_0b7a0f4f-7508-4c1f-830c-349ede7ad220">45.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-5" name="aort:DeferredPreservationCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNzgy_527be094-4180-40e3-beb9-2820eb7842a1">42.9</ix:nonFraction> million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory and deferred preservation costs obsolescence reserves were $<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfODg2_9438c8eb-c647-49cd-b095-ab5b5b8fb896">1.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfODkz_8a51d873-669e-4072-a22b-51553ca6b800">3.2</ix:nonFraction> million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div></ix:continuation><div id="i167b7825c15e480eba61f77e008c32de_43"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RleHRyZWdpb246YzNmODdmM2ZiZGViNGIxZThmNDc4ZTdmNDRhMmE2ZThfMjkyNw_8769ad21-bf5a-4ea5-aee1-69ce0397850c" continuedAt="i4a3356e6b5964e47bd2ba2b8e8d019bc" escape="true">Goodwill and Other Intangible Assets </ix:nonNumeric></span></div><ix:continuation id="i4a3356e6b5964e47bd2ba2b8e8d019bc" continuedAt="ia2576938f69e4f36903f96d873de6c15"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite Lived Intangible Assets </span></div><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RleHRyZWdpb246YzNmODdmM2ZiZGViNGIxZThmNDc4ZTdmNDRhMmE2ZThfMjkyOA_b3ba1264-dd41-413a-83cf-e987075775c0" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021 the carrying values of our indefinite lived intangible assets were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfMS0xLTEtMS0yMTE2MQ_3fca925e-9662-4133-bb22-dea755166f8e">234,773</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfMS0zLTEtMS0yMTE2MQ_ba07bfcb-1085-4991-9d4f-3fa3c6b241e8">250,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">In-process R&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i5d1dafbd2f6f4fe292ea508a5b6aae73_I20220930" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfMi0xLTEtMS0yMTE2MQ_5563735f-3429-4866-b996-22808a268240">1,901</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i9458b6ce90844216a730adfd5f9304f1_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfMi0zLTEtMS0yMTE2MQ_dcec5a44-30eb-44a1-951b-3dfae1efee11">2,208</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Procurement contracts and agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bc1a93076b240cdb83aca83562c898c_I20220930" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfMy0xLTEtMS0yMTE2MQ_4996d8c3-03fe-40c4-acda-453a9a2eba1e">2,013</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i33d83b59bd714eed96ac088c627a3bb4_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfMy0zLTEtMS0yMTE2MQ_7768519f-ad7b-4911-bd32-6917b3b95037">2,013</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2f7ee96a23d84973bb23f2b986cd0caa_I20220930" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfNC0xLTEtMS0yMTE2MQ_5d64529a-c990-4477-8849-e97f8dd93727">247</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ibc1a239494bc4d77b7d869dfb120b17b_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfNC0zLTEtMS0yMTE2MQ_79a29f13-79d3-4ce8-ad87-a26eda88c590">66</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the phases of development of our acquired in-process research and development projects, including the risks associated with further development and the amount and timing of benefits expected to be derived from the completed projects. Incremental costs associated with development are charged to expense as incurred. Capitalized costs are amortized over the estimated useful life of the developed asset once completed. Our in-process research and development projects are reviewed for impairment annually, or more frequently, if events or changes in circumstances indicate that the asset might be impaired. We did not record any impairment of indefinite lived intangible assets during the three and nine months ended September&#160;30, 2022. In-process research and development, procurement contracts and agreements, and trademarks are included in Other intangibles, net on the Condensed Consolidated Balance Sheets as of September&#160;30, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our experience with similar agreements, we believe that our acquired procurement contracts and agreements have indefinite useful lives, as we expect to continue to renew these contracts for the foreseeable future. We believe that our trademarks have indefinite useful lives as we currently anticipate that our trademarks will contribute to our cash flows indefinitely.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><ix:continuation id="ia2576938f69e4f36903f96d873de6c15" continuedAt="i1b582254e4b348cdbb3c4c3e22b36a47"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our goodwill and non-amortizing intangible assets for impairment on an annual basis during the fourth quarter of the year, and, if necessary, during interim periods if factors indicate that an impairment review is warranted. As of September&#160;30, 2022 we concluded that our assessment of current factors did not indicate that goodwill or non-amortizing intangible assets are more likely than not to be impaired. We will continue to evaluate the recoverability of these non-amortizing intangible assets in future periods as necessary.</span></div><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RleHRyZWdpb246YzNmODdmM2ZiZGViNGIxZThmNDc4ZTdmNDRhMmE2ZThfMjkyOQ_d7f7f3b6-204a-4cf5-bb25-872d399e65e1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021 the carrying value of goodwill, all of which is related to our Medical devices segment, is as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Medical Devices Segment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI4ZDNiNjAzNmQwNjQzZjY5Njg5NDFjYTc2MjA5NDE4L3RhYmxlcmFuZ2U6YjhkM2I2MDM2ZDA2NDNmNjk2ODk0MWNhNzYyMDk0MThfMS0xLTEtMS0yMTE2MQ_d90fd63a-db98-4ab4-bc5b-522b72fd7b4e">250,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI4ZDNiNjAzNmQwNjQzZjY5Njg5NDFjYTc2MjA5NDE4L3RhYmxlcmFuZ2U6YjhkM2I2MDM2ZDA2NDNmNjk2ODk0MWNhNzYyMDk0MThfMi0xLTEtMS0yMTE2MQ_a603da48-7196-434e-b622-039e2f2b9760">15,227</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI4ZDNiNjAzNmQwNjQzZjY5Njg5NDFjYTc2MjA5NDE4L3RhYmxlcmFuZ2U6YjhkM2I2MDM2ZDA2NDNmNjk2ODk0MWNhNzYyMDk0MThfMy0xLTEtMS0yMTE2MQ_c58b0bbe-bd44-4340-b3ab-c9c7e0e69b62">234,773</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definite Lived Intangible Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The definite lived intangible assets balance includes balances related to acquired technology, customer relationships, distribution and manufacturing rights and know-how, patents, and other definite lived intangible assets. <ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RleHRyZWdpb246YzNmODdmM2ZiZGViNGIxZThmNDc4ZTdmNDRhMmE2ZThfMjkzMA_99feaaf2-16fd-4d1d-b9ce-9255139172ab" continuedAt="icf56e4484ab64088826459c03a590ff5" escape="true">As of September&#160;30, 2022 and December&#160;31, 2021 the gross carrying values, accumulated amortization, and approximate amortization period of our definite lived intangible assets were as follows (in thousands, except weighted average useful life): </ix:nonNumeric></span></div><ix:continuation id="icf56e4484ab64088826459c03a590ff5"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net Carrying <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted Average<br/>Useful Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Acquired technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fb32fabff8742a98b5467dff62122bf_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMS0yLTEtMS0yMTE2MQ_7568f34a-b7b1-4492-bd7d-0209798619f5">190,108</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fb32fabff8742a98b5467dff62122bf_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMS00LTEtMS0yMTE2MQ_596aa571-4a1e-4c88-988f-3468f47e6fab">42,048</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fb32fabff8742a98b5467dff62122bf_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMS02LTEtMS0yMTE2MQ_34543463-948c-499e-bbe8-78b02015704a">148,060</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="ida30868564d148eca610e7d10cfd5e6f_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMS04LTEtMS0yMTE2MQ_859021cd-7a35-46c4-91b3-feb820883479">18.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Other intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Customer lists and relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ideb42e83c22b42c3bb0af7e0655023df_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMy0yLTEtMS0yMTE2MQ_0ca8ec64-c275-46fa-bd59-e8bfcb507cd2">30,868</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ideb42e83c22b42c3bb0af7e0655023df_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMy00LTEtMS0yMTE2MQ_c5622a9c-4dc8-4ff8-9710-317d9dd1e942">10,677</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ideb42e83c22b42c3bb0af7e0655023df_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMy02LTEtMS0yMTE2MQ_61396f78-980c-48a4-817d-b80ccecc10df">20,191</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i5927140a3ae44b469c4565ca6f2dc116_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMy04LTEtMS0yMTE2MQ_71db0a49-f094-44be-9551-240c72416b06">20.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Distribution and manufacturing rights and know-how</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3d32d2810d144a3f896cf0d85612aeb7_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNC0yLTEtMS0yMTE2MQ_2bbbfea0-f313-4933-b518-70042f08ae7b">8,476</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3d32d2810d144a3f896cf0d85612aeb7_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNC00LTEtMS0yMTE2MQ_3e0a7122-71ad-49ce-836f-7bae45f15dc9">4,900</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3d32d2810d144a3f896cf0d85612aeb7_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNC02LTEtMS0yMTE2MQ_c2f3ee35-4a2e-4d30-afc0-e6491e20636f">3,576</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i92c5d5cd7490482d80b5d6c02da7f08d_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNC04LTEtMS0yMTE2MQ_bc8ea700-f080-461a-b317-6f93d082fb45">5.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iaf210313db394b1ba95827556680cf9d_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNS0yLTEtMS0yMTE2MQ_dd8bee50-2d41-47c6-8c66-ec14eedf5111">4,171</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iaf210313db394b1ba95827556680cf9d_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNS00LTEtMS0yMTE2MQ_cf697a82-c124-4b6c-8edd-41e9118f416d">3,168</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iaf210313db394b1ba95827556680cf9d_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNS02LTEtMS0yMTE2MQ_79ae8d5a-5c48-47e2-aa1f-dfe92689dbc2">1,003</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="ia1ef7a095c054e5bb5088a9e425e637d_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNS04LTEtMS0yMTE2MQ_fe2902d4-a8db-40cd-bfaa-fc7964e9c6df">17.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i7d4aa5c197a74658b6b130f04486afd2_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNi0yLTEtMS0yMTE2MQ_edb42971-7527-475f-9f34-ef0d3abfa3ae">4,325</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i7d4aa5c197a74658b6b130f04486afd2_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNi00LTEtMS0yMTE2MQ_772934e3-9a1a-43c6-b669-d26c2d1b70d7">2,144</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i7d4aa5c197a74658b6b130f04486afd2_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNi02LTEtMS0yMTE2MQ_8a91807d-ca98-444c-a214-6657d1a53df9">2,181</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="iffdb325d037c49f5ad546b5419a0a089_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNi04LTEtMS0yMTE2MQ_281950d2-28ac-44d0-b372-c1ae88927fc1">4.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ib74a27dcdc9b4dd6af46f79ebbdf834b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNy0yLTEtMS0yMTE2MQ_de7c4d2b-38d8-46d1-8e93-afdecfdea2da">47,840</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ib74a27dcdc9b4dd6af46f79ebbdf834b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNy00LTEtMS0yMTE2MQ_e40583a0-d8ea-4ea4-b05b-68d91923d631">20,889</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ib74a27dcdc9b4dd6af46f79ebbdf834b_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNy02LTEtMS0yMTE2MQ_2e2d859b-6bf4-4422-be90-6b71b37d3a9e">26,951</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="i2d72e53f0f1a452eb2f9cac1876bdd95_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNy04LTEtMS0yMTE2MQ_96402881-ff2a-4978-b9ab-4320a11c4614">10.8</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net Carrying <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted Average<br/>Useful Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Acquired technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i5835fa7529b2441f8256f2039dcd4977_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMS0yLTEtMS0yMTE2MQ_4cccdc18-3a09-4499-b505-617190304799">213,626</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i5835fa7529b2441f8256f2039dcd4977_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMS00LTEtMS0yMTE2MQ_6e8778eb-d913-4d5e-97f2-064861985e53">46,632</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i5835fa7529b2441f8256f2039dcd4977_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMS02LTEtMS0yMTE2MQ_dcda0d87-ae53-408c-8099-9dd77849e0f4">166,994</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i4ec8b963122c48c1bc141284ae59b0cd_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMS04LTEtMS0yMTE2MQ_f7ac3e41-15f7-4a10-96f7-6eb1f194b6c5">17.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Other intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Customer lists and relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i1319adccede54d05b8a215934cf0b015_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMy0yLTEtMS0yMTE2MQ_e09095b3-aa98-4392-80a0-4aea07b95451">31,148</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i1319adccede54d05b8a215934cf0b015_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMy00LTEtMS0yMTE2MQ_85332d1a-b93a-45a8-a329-c040776a7c5d">9,618</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i1319adccede54d05b8a215934cf0b015_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMy02LTEtMS0yMTE2MQ_3e53ad53-f52e-472d-9474-e3da0577842d">21,530</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i3e3f166e92e3409b8d455325985327e8_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMy04LTEtMS0yMTE2MQ_7870b0c9-3a2d-4bcd-9d90-9d65fc6be083">20.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Distribution and manufacturing rights and know-how</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2b943d5080d34bec84109493c800df5f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNC0yLTEtMS0yMTE2MQ_9f680324-8e2e-4afe-a286-c0eb4ceaf703">9,847</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2b943d5080d34bec84109493c800df5f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNC00LTEtMS0yMTE2MQ_196ad97a-3e39-4d39-8023-f873e4e38e2e">4,308</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2b943d5080d34bec84109493c800df5f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNC02LTEtMS0yMTE2MQ_64d536b1-a5cd-4305-9cc0-66d3ed0b41b5">5,539</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="ia15d0aa664ea4a7f97d1948f098fd347_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNC04LTEtMS0yMTE2MQ_4539fa18-933c-47a0-b3fc-74c20871ffaa">5.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i30ad3a0d685c4b1fa5f05ae3aeeb8d54_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNS0yLTEtMS0yMTE2MQ_fa9dbe1b-6d49-4dad-852e-8def53963b33">4,083</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i30ad3a0d685c4b1fa5f05ae3aeeb8d54_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNS00LTEtMS0yMTE2MQ_c88f7333-d7dd-4663-b4a4-a0e13f35829d">3,144</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i30ad3a0d685c4b1fa5f05ae3aeeb8d54_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNS02LTEtMS0yMTE2MQ_efabf410-a853-4896-8321-59a2741aae99">939</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="ie597e010fff64cb687fea5326f697ce7_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNS04LTEtMS0yMTE2MQ_3423bb56-58e8-48ad-94a6-6687975c4441">17.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i90c63eb879c049d8a922a2011f7756e8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNi0yLTEtMS0yMTE2MQ_872ae80a-05ce-456f-9b81-a8e51ceb8c83">3,969</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i90c63eb879c049d8a922a2011f7756e8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNi00LTEtMS0yMTE2MQ_e88da0b1-5bf7-468a-81d4-9a54a5632ad8">1,762</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i90c63eb879c049d8a922a2011f7756e8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNi02LTEtMS0yMTE2MQ_70a904c5-efba-416e-9218-f5d334110d09">2,207</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i8267638c5c76419694cfdd6148d710ec_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNi04LTEtMS0yMTE2MQ_2bf726a6-d498-48fd-a144-92a11e767a8e">4.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i0452204939dc44418b4b735573daceb1_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNy0yLTEtMS0yMTE2MQ_30be6f81-1611-4807-9ab5-5a3802663fb3">49,047</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i0452204939dc44418b4b735573daceb1_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNy00LTEtMS0yMTE2MQ_168a15c2-3627-4905-8e66-362c2591bdf4">18,832</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i0452204939dc44418b4b735573daceb1_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNy02LTEtMS0yMTE2MQ_155eb785-3ca4-4337-a746-296f7e6b45f3">30,215</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="i1b5b7de541014928a789871dab61c5b8_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNy04LTEtMS0yMTE2MQ_5e06b7c4-cee0-4eb2-a4e3-462c9344bd15">10.6</ix:nonNumeric></span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><ix:continuation id="i1b582254e4b348cdbb3c4c3e22b36a47"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization Expense </span></div><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RleHRyZWdpb246YzNmODdmM2ZiZGViNGIxZThmNDc4ZTdmNDRhMmE2ZThfMjkzMQ_29acec9c-da2b-4b7e-bfef-ae54678f63c3" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of amortization expense as recorded in General, administrative, and marketing expenses on our Condensed Consolidated Statement of Operations and Comprehensive (Loss) Income (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjQ4MzJiZDhkYzU2NzRjMGQ5OGI0Y2VmYWI3OTVmOTE4L3RhYmxlcmFuZ2U6NDgzMmJkOGRjNTY3NGMwZDk4YjRjZWZhYjc5NWY5MThfMi0xLTEtMS0yMTE2MQ_7d4992a0-fe93-468c-97b4-0068252fb41d">3,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjQ4MzJiZDhkYzU2NzRjMGQ5OGI0Y2VmYWI3OTVmOTE4L3RhYmxlcmFuZ2U6NDgzMmJkOGRjNTY3NGMwZDk4YjRjZWZhYjc5NWY5MThfMi0zLTEtMS0yMTE2MQ_91445e98-86e8-4266-92ab-4abd3ab57c90">4,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjQ4MzJiZDhkYzU2NzRjMGQ5OGI0Y2VmYWI3OTVmOTE4L3RhYmxlcmFuZ2U6NDgzMmJkOGRjNTY3NGMwZDk4YjRjZWZhYjc5NWY5MThfMi01LTEtMS0yMTE2MQ_5f17457a-5e02-4b04-ba7b-cda9431d2f64">11,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjQ4MzJiZDhkYzU2NzRjMGQ5OGI0Y2VmYWI3OTVmOTE4L3RhYmxlcmFuZ2U6NDgzMmJkOGRjNTY3NGMwZDk4YjRjZWZhYjc5NWY5MThfMi03LTEtMS0yMTE2MQ_1092c0b6-d07a-46a5-b85b-997e540c20e4">12,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RleHRyZWdpb246YzNmODdmM2ZiZGViNGIxZThmNDc4ZTdmNDRhMmE2ZThfMjkzMg_e1195a24-7dad-427b-a707-ce694128a882" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 scheduled amortization of intangible assets for the next five years is as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.965%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remainder<br/>of 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS0xLTEtMS0yMTE2MQ_e8667189-3360-44b1-9f54-990de78d00ff">3,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS0zLTEtMS0yMTE2MQ_86a2f514-bce5-4ce1-8dbd-fd8c6898c58b">14,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS01LTEtMS0yMTE2MQ_05562bfa-d4e7-4e39-858c-2708a88647ce">13,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS03LTEtMS0yMTE2MQ_f7bf4e37-510e-4a93-a705-56f3451137dc">12,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS05LTEtMS0yMTE2MQ_168d4352-9dcc-41da-848c-f7c610f8980f">11,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS0xMS0xLTEtMjExNjE_4d176a39-b099-4540-a7c1-efc77a1486df">11,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS0xMy0xLTEtMjExNjE_502aa335-8748-45d4-9a1d-b63890c869ac">67,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i167b7825c15e480eba61f77e008c32de_46"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTU4MQ_36813065-0289-4734-bfe7-eba9f0c3ffc6" continuedAt="i7136d1c1b54a45abab451f259df38ff6" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="i7136d1c1b54a45abab451f259df38ff6"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was an expense of <ix:nonFraction unitRef="number" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfODE_db8c2e8d-342f-4341-9e22-3c8f6225b24e">9</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfODg_6850d5e0-6480-4ddb-92c0-e166987f8ea9">17</ix:nonFraction>% for the three and nine months ended September&#160;30, 2022, respectively, as compared to a benefit of <ix:nonFraction unitRef="number" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTYw_6f4782f8-638c-4ca1-91af-489c4929e708">33</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTY3_a8bbd752-07a6-4c65-b105-be2bc4c9a989">318</ix:nonFraction>% for the three and nine months ended September&#160;30, 2021, respectively. Our income tax rate for the three and nine months ended September&#160;30, 2022 was primarily impacted by changes in our valuation allowance against our net deferred tax assets, non-deductible executive compensation, the foreign derived intangible income deduction, the research and development tax credit, changes in our uncertain tax position liabilities, and tax shortfalls on stock compensation. Our income tax rate for the three and nine months ended September&#160;30, 2021 was primarily impacted by non-deductible executive compensation, changes in our valuation allowance against our net deferred tax assets, changes in our uncertain tax position liabilities, the research and development tax credit, and excess tax benefits on stock compensation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Income Taxes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate deferred tax assets primarily as a result of finance leases, net operating losses, amortization of research and development expenses, excess interest carryforward, stock compensation, and accrued compensation. Our deferred tax liabilities are primarily made up of intangible assets acquired in previous years, finance leases, and unrealized gains and losses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintained a net deferred tax liability of $<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-5" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTM0MQ_11bfcf4d-c8c8-4631-8954-75a93b81e824">28.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTM0OA_f0b17fd9-72c5-4cf2-b1e9-72ba14bb9be5">26.4</ix:nonFraction> million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. Our valuation allowance against our deferred tax assets was $<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTQ0Mg_fd0ef1fb-ae0c-44d5-b93b-601a80efb7ae">17.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTQ0OQ_d054b2a2-52d5-403d-9e03-a78f4c068048">13.3</ix:nonFraction> million as of September&#160;30, 2022 and December&#160;31, 2021, respectively, primarily related to net operating loss carryforwards and disallowed excess interest carryforwards.</span></div></ix:continuation><div id="i167b7825c15e480eba61f77e008c32de_49"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyMg_008a5e25-1b2f-4abc-b360-e453944cb855" continuedAt="i36630337ab96430d98acd5da9046d032" escape="true">Leases </ix:nonNumeric></span></div><ix:continuation id="i36630337ab96430d98acd5da9046d032" continuedAt="i29d40c1525b4427b8b4931f6a7417b62"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating and finance lease obligations resulting from the lease of land and buildings that comprise our corporate headquarters and various manufacturing facilities; leases related to additional manufacturing, office, and warehouse space; leases on company vehicles; and leases on a variety of office and other equipment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;6, 2021 we executed a modification to extend the lease of our headquarters located in Kennesaw, Georgia. This modification resulted in an increase in the present value of future lease obligations and corresponding right-of-use asset of $<ix:nonFraction unitRef="usd" contextRef="i1155d3f6605345d9bf6e5eff5b2ff517_D20210106-20210106" decimals="-5" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfNTgw_4a5ca26a-3ce2-4db7-961a-d6ad49b65dd6"><ix:nonFraction unitRef="usd" contextRef="i98cd2d841a0d40e39000ad02cbe23dfe_I20210106" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfNTgw_abf5adc3-f765-41a0-bcef-dcad71f28a9e">23.3</ix:nonFraction></ix:nonFraction> million, using a discount rate of <ix:nonFraction unitRef="number" contextRef="i98cd2d841a0d40e39000ad02cbe23dfe_I20210106" decimals="4" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfNjA5_3a3b36dd-d323-41f2-957c-61eef7b26ad5">6.41</ix:nonFraction>%.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;1, 2021 we began occupancy of the newly constructed addition to our leased international headquarters located in Hechingen, Germany. This lease resulted in an increase in the present value of future lease obligations and corresponding right-of-use asset of $<ix:nonFraction unitRef="usd" contextRef="i91ff9b76a1ca40d280c764ffb11b5962_D20210601-20210601" decimals="-5" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfODY4_4d0bd569-34cf-41fc-bcd3-45f7bce1f828"><ix:nonFraction unitRef="usd" contextRef="i704c126d4e494f8d8caab84f162c9d5f_I20210601" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfODY4_b7d34cf4-3ef0-4a9c-a882-21ae7c8a36cc">9.8</ix:nonFraction></ix:nonFraction> million, using a discount rate of <ix:nonFraction unitRef="number" contextRef="i704c126d4e494f8d8caab84f162c9d5f_I20210601" decimals="4" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfODk3_040199d2-148d-422a-a45d-8085dd2a7991">5.46</ix:nonFraction>%.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><ix:continuation id="i29d40c1525b4427b8b4931f6a7417b62" continuedAt="if077364b09f245bb88ce808436488bda"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="aort:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyMw_beed89b0-56b4-4663-9f92-fdd8abc50cde" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to leases included in the Condensed Consolidated Balance Sheets is as follows (in thousands, except lease term and discount rate):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating leases:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMS0xLTEtMS0yMTE2MQ_d6fddd26-5913-47f1-a678-4ee70ce05a9f">55,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMS0zLTEtMS0yMTE2MQ_df596b2a-22f1-4571-9161-309097193721">58,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMi0xLTEtMS0yMTE2MQ_27ec1913-278f-4ec8-b255-140bf472f11b">14,085</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMi0zLTEtMS0yMTE2MQ_cbf75ecd-e96b-49c4-81bf-108eebe5a48c">12,383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating lease right-of-use assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMy0xLTEtMS0yMTE2MQ_36a807df-b870-4000-9a06-16193bcd9be6">41,320</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMy0zLTEtMS0yMTE2MQ_53d4fa91-eea6-4a63-bb09-4dc5898abf9a">45,714</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Current maturities of operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfNS0xLTEtMS0yMTE2MQ_6bb34a3c-5ff5-4add-a539-53d330421811">3,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfNS0zLTEtMS0yMTE2MQ_b94506ba-c1c7-45f0-a7c0-ad065f17baf2">3,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-current maturities of operating leases </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfNi0xLTEtMS0yMTE2MQ_becfcd81-7d5b-4526-86c4-462c8b1759d1">40,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfNi0zLTEtMS0yMTE2MQ_3738ad64-1f10-4fde-ab8e-5478a84f3573">44,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfNy0xLTEtMS0yMTE2MQ_0525b4e9-6d2a-4414-888e-07897e0b2a3b">43,976</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfNy0zLTEtMS0yMTE2MQ_9ca33741-b8a6-4772-a6e6-520b29b2ff04">48,018</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Property and equipment, at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTAtMS0xLTEtMjExNjE_2a8f8e1d-3f84-4131-8776-ebdbb48b9a96">5,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTAtMy0xLTEtMjExNjE_38c1922d-a698-4fff-8e47-e194d0e7b945">6,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTEtMS0xLTEtMjExNjE_dd2d14de-4675-40bf-8e30-15dc5b7a3bba">2,166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTEtMy0xLTEtMjExNjE_4cd9b62d-f339-4c6d-b63d-6b33c348e6de">2,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTItMS0xLTEtMjExNjE_5e587483-9ac4-4eb1-a8a9-56a4867ea598">3,695</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTItMy0xLTEtMjExNjE_dc3928de-4f9c-4e99-aa3d-899adccb9c47">4,654</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Current maturities of finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTQtMS0xLTEtMjExNjE_d03fce1c-60ff-48ad-9552-8386b69ed79b">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTQtMy0xLTEtMjExNjE_10d123e4-5869-4ae9-961a-d77471bad4db">528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-current maturities of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTUtMS0xLTEtMjExNjE_6a34c30b-6a84-43fe-8066-9cc7ab683230">3,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTUtMy0xLTEtMjExNjE_6be89756-214d-493f-b04b-44354332c895">4,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTYtMS0xLTEtMjExNjE_0b18f93f-108e-4564-a9bd-8fcb94c2bd99">3,919</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTYtMy0xLTEtMjExNjE_e85188d0-debb-45c1-b948-c960a29567e3">4,902</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTktMS0xLTEtMjExNjE_0b6d93a8-43c2-4938-b6c5-923be737e781">12.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTktMy0xLTEtMjExNjE_780e72be-a65f-4c61-a80b-d371625acb47">12.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMjAtMS0xLTEtMjExNjE_31a5489d-882b-485f-bf42-399d1d75298a">8.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMjAtMy0xLTEtMjExNjE_be4aeeee-8d53-46f9-b0b5-5389a342a848">8.8</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMjMtMS0xLTEtMjExNjE_efb9eecd-d1c0-4b1a-81d4-c6402b10c0f9">5.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMjMtMy0xLTEtMjExNjE_4f79cfc7-6e8c-4a7f-b6eb-3e1e29b39080">5.8</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMjQtMS0xLTEtMjExNjE_819fe2dc-663b-44ca-a301-f315288d0e9c">2.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMjQtMy0xLTEtMjExNjE_a9c5ee38-a5ad-45a0-b6f9-312cb9d9c013">2.0</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current maturities of finance leases are included as a component of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyNA_232befca-efbd-4242-931d-c2e23c341abe"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyNA_bf517df5-2808-40a4-b74d-94a6a829e5d0">Other current liabilities</span></span> on our Condensed Consolidated Balance Sheets. <ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYxOQ_3aca6295-3471-41bc-8768-055118374bc4" continuedAt="i1483257705ae4df9be1b833f38f0c101" escape="true">A summary of lease expenses for our finance and operating leases included in General, administrative, and marketing expenses on our Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income is as follows (in thousands): </ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i1483257705ae4df9be1b833f38f0c101" continuedAt="i3bbbd08114e7462eb3ffd48333f56d9a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Amortization of property and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMi0xLTEtMS0yMTE2MQ_2f4de146-b692-4948-bd5a-5589d66140ac">127</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMi0zLTEtMS0yMTE2MQ_e1adaeae-50ad-4062-ade7-0d70e51a41af">190</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMi01LTEtMS0yMTE2MQ_599ae88a-55f0-442e-86d2-476bf7e9fc18">395</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMi03LTEtMS0yMTE2MQ_10a5976a-1ac2-49f4-9b73-40ee40e7a845">500</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Interest expense on finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMy0xLTEtMS0yMTE2MQ_69b496da-c194-453f-8cac-ecc1064b34dc">22</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMy0zLTEtMS0yMTE2MQ_8f2b0572-9755-4d4c-96b5-8f0a818a04c7">27</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMy01LTEtMS0yMTE2MQ_100b1c1c-5bee-494f-b5c9-e3d44907a0be">69</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMy03LTEtMS0yMTE2MQ_99afd7ec-0c12-45b4-b998-83db24e58a95">85</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total finance lease expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="aort:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNC0xLTEtMS0yMTE2MQ_d40854d4-8f7b-4338-bf2d-ce2a206c9b2f">149</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="aort:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNC0zLTEtMS0yMTE2MQ_98ea3ca3-ca1f-484a-8086-4559494bafa8">217</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="aort:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNC01LTEtMS0yMTE2MQ_bf1235fe-c858-4429-a896-f8bfa50102e2">464</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="aort:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNC03LTEtMS0yMTE2MQ_0ff6bde9-5979-45ce-af12-1f16aa052aa1">585</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNS0xLTEtMS0yMTE2MQ_91b56cc5-521b-4bc5-9b74-47afbec2d4dc">1,853</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNS0zLTEtMS0yMTE2MQ_4059940c-ef0a-4176-bacb-6648852e398b">1,989</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNS01LTEtMS0yMTE2MQ_4de08043-c67d-4020-b1f5-aad59a2e9181">5,656</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNS03LTEtMS0yMTE2MQ_64b3f474-c4db-473d-b767-1104cf44adec">5,566</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNi0xLTEtMS0yMTE2MQ_1ae02452-6d77-46c6-8884-9f770a0e2db7">92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNi0zLTEtMS0yMTE2MQ_c1828a46-84a2-4a56-8272-259bd582b77b">92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNi01LTEtMS0yMTE2MQ_3727249f-82e8-41f3-b752-6b9bad349597">275</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNi03LTEtMS0yMTE2MQ_1d21e853-5ef2-481e-8d11-c0aa7c818891">308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total lease expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNy0xLTEtMS0yMTE2MQ_8f4c8c5e-a553-4857-bae8-668a01b98b24">1,910</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNy0zLTEtMS0yMTE2MQ_7ae83422-f4ab-4d51-ba86-05c2aada2c6d">2,114</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNy01LTEtMS0yMTE2MQ_f3b2b5e5-a7dd-460c-a158-cd9d2eb86d0d">5,845</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNy03LTEtMS0yMTE2MQ_daa448f7-3f07-4cce-8c3e-9902667d92e7">5,843</ix:nonFraction></span></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><ix:continuation id="if077364b09f245bb88ce808436488bda"><ix:continuation id="i3bbbd08114e7462eb3ffd48333f56d9a"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our cash flow information related to leases is as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating cash flows for operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOjM1NzM5YjA5OGRhYjQ0M2FiYzQ1MzA1YTY4Yjk5MTU0L3RhYmxlcmFuZ2U6MzU3MzliMDk4ZGFiNDQzYWJjNDUzMDVhNjhiOTkxNTRfMi0xLTEtMS0yMTE2MQ_b421aaff-34d0-405f-83a2-9d2fb2e95998">4,939</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOjM1NzM5YjA5OGRhYjQ0M2FiYzQ1MzA1YTY4Yjk5MTU0L3RhYmxlcmFuZ2U6MzU3MzliMDk4ZGFiNDQzYWJjNDUzMDVhNjhiOTkxNTRfMi0zLTEtMS0yMTE2MQ_b27c9ac3-30cc-4a4c-a3af-7931ab3951c1">4,536</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOjM1NzM5YjA5OGRhYjQ0M2FiYzQ1MzA1YTY4Yjk5MTU0L3RhYmxlcmFuZ2U6MzU3MzliMDk4ZGFiNDQzYWJjNDUzMDVhNjhiOTkxNTRfMy0xLTEtMS0yMTE2MQ_bf686fd2-6309-4f0d-b81c-bccb35446611">346</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOjM1NzM5YjA5OGRhYjQ0M2FiYzQ1MzA1YTY4Yjk5MTU0L3RhYmxlcmFuZ2U6MzU3MzliMDk4ZGFiNDQzYWJjNDUzMDVhNjhiOTkxNTRfMy0zLTEtMS0yMTE2MQ_90536f40-f77d-4e7c-9e54-abd7ce5d1834">446</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOjM1NzM5YjA5OGRhYjQ0M2FiYzQ1MzA1YTY4Yjk5MTU0L3RhYmxlcmFuZ2U6MzU3MzliMDk4ZGFiNDQzYWJjNDUzMDVhNjhiOTkxNTRfNC0xLTEtMS0yMTE2MQ_75a480bc-9033-4bad-822c-970ccfd3fb5c">62</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOjM1NzM5YjA5OGRhYjQ0M2FiYzQ1MzA1YTY4Yjk5MTU0L3RhYmxlcmFuZ2U6MzU3MzliMDk4ZGFiNDQzYWJjNDUzMDVhNjhiOTkxNTRfNC0zLTEtMS0yMTE2MQ_209b790b-b092-4ef5-8949-cb13f7dfe68e">82</ix:nonFraction></span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyMQ_e207bb54-320f-468a-97dd-1930e48ce2bb" escape="true"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyMQ_e7de1887-fec3-4525-bbb0-f59caf36f6fb" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments and sublease rental income are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance<br/>Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating<br/>Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Sublease<br/>Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Remainder of 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMS0xLTEtMS0yMTE2MQ_8216e124-b97b-42ec-b097-988911d66a6d">120</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMS0zLTEtMS0yMTE2MQ_51a039aa-7021-4fc8-98b8-ad8cb0371bd0">660</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMS01LTEtMS0yMTE2MQ_123e28bd-a58c-4497-9009-f97939ecac1b">31</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMi0xLTEtMS0yMTE2MQ_c908163c-e2ca-473c-8865-864986ae9065">549</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMi0zLTEtMS0yMTE2MQ_e70b1d86-20aa-4e28-bf27-6228fd9c24b6">5,624</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMi01LTEtMS0yMTE2MQ_7e43c6d8-f000-4e0f-80a3-cf14020c0395">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMy0xLTEtMS0yMTE2MQ_228f6d12-0ff8-4ebd-95d2-525f8d7484b6">545</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMy0zLTEtMS0yMTE2MQ_a534ed58-4b19-46cd-a205-14428f471a4f">6,252</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMy01LTEtMS0yMTE2MQ_18d7f8f4-6f20-48af-b259-765b1686187d">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNC0xLTEtMS0yMTE2MQ_b6c986a8-e021-46d9-9a09-540c7722cf1e">525</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNC0zLTEtMS0yMTE2MQ_bf2538a8-887a-4f02-89d8-08f93e298a5b">5,173</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNC01LTEtMS0yMTE2MQ_6c690c9d-290f-429b-abb3-dc50bcc1e9c1">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNS0xLTEtMS0yMTE2MQ_3d8f7d3a-06ad-4028-9175-8ccaa2e91005">508</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNS0zLTEtMS0yMTE2MQ_7abd643d-b952-4089-887c-86431cd4c318">4,719</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNS01LTEtMS0yMTE2MQ_a33cd97c-7160-4417-a8a6-ded9680731dc">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:FinanceLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNi0xLTEtMS0yMTE2MQ_079c8609-4a97-48c3-8f41-b2774ccacb9d">2,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNi0zLTEtMS0yMTE2MQ_76ea031d-4191-4ef9-bad3-07751903ed8c">40,986</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNi01LTEtMS0yMTE2MQ_dfa331d7-0ecf-41db-ab27-fabf207942cc">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNy0xLTEtMS0yMTE2MQ_2e03b0fb-ef2b-49fb-a396-908999fab01b">4,247</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNy0zLTEtMS0yMTE2MQ_e45ace64-15e1-44fd-89cd-25d5d3fd8725">63,414</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNy01LTEtMS0yMTE2MQ_46fe7588-cada-463a-a07b-fd57935282e2">31</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfOC0xLTEtMS0yMTE2MQ_1a3fa6d8-f0f7-49ff-95c2-dd9aed8dff2e">328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfOC0zLTEtMS0yMTE2MQ_9400e51a-6543-4674-9c33-d7b309603bef">19,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Present value of net minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfOS0xLTEtMS0yMTE2MQ_ae826f1d-2583-4547-8bb0-f768842f4ff2">3,919</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfOS0zLTEtMS0yMTE2MQ_63ddb292-341c-4de3-a1f3-93bd6192e2de">43,976</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less current maturities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMTAtMS0xLTEtMjExNjE_c4b85b1d-0ab3-47a0-a4a8-7395fe63a343">469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMTAtMy0xLTEtMjExNjE_10012213-f615-4456-9207-559047170103">3,061</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Lease liabilities, less current maturities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMTEtMS0xLTEtMjExNjE_100fbb9f-8ccc-48dd-9c3f-16ea03ec1b7f">3,450</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMTEtMy0xLTEtMjExNjE_e2a8dd86-a44d-4957-a818-2aae7d6ceb4a">40,915</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div id="i167b7825c15e480eba61f77e008c32de_52"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfODIyMw_59fd09ae-aab8-41c3-ac15-a6fbacc3acc3" continuedAt="i6167b5c7f54741c184f0392157e12334" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="i6167b5c7f54741c184f0392157e12334" continuedAt="if88db6a95d5b4ed6aad0269f6af4b8f9"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;1, 2017 we entered into a credit and guaranty agreement for a $<ix:nonFraction unitRef="usd" contextRef="i48b9bbe85c68425d911ee0c362147e39_I20171201" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfOTA_680fce03-9d85-4d9a-ab3b-1d95761ceea3">255.0</ix:nonFraction> million senior secured credit facility, consisting of a $<ix:nonFraction unitRef="usd" contextRef="if48526739d454c7aa0ead75443f922f1_I20171201" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMTQx_d3183b5e-6a73-4951-b1da-f7700e6685b4">225.0</ix:nonFraction> million secured term loan facility (the &#8220;Term Loan Facility&#8221;) and a $<ix:nonFraction unitRef="usd" contextRef="ib252a536e8c2403f88b1f7002f4ad93d_I20171201" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjA0_b9c0aff8-4b6d-4afb-af62-78d2ec7680cb">30.0</ix:nonFraction> million secured revolving credit facility (the &#8220;Revolving Credit Facility&#8221; and, together with the Term Loan Facility, the &#8220;Credit Agreement&#8221;). We and each of our existing domestic subsidiaries (subject to certain exceptions and exclusions) guarantee the obligations under the Credit Agreement (the &#8220;Guarantors&#8221;). The Credit Agreement is secured by a security interest in substantially all existing and after-acquired real and personal property (subject to certain exceptions and exclusions) of us and the Guarantors.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;2, 2021 we entered into an amendment to our Credit Agreement to extend the maturity dates of our Term Loan and Revolving Credit Facility. As part of the amendment, the maturity dates of both our Term Loan and Revolving Credit Facility were each extended by two and one-half years, until June 1, 2027 and June 1, 2025, respectively, subject to earlier springing maturities triggered if our <ix:nonFraction unitRef="number" contextRef="i0a9e96716e2d43fc8cb58b6a571003ac_I20210602" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMTEwMw_f373b21f-cdee-493f-9f01-b1aa0cbb2314">4.25</ix:nonFraction>% Convertible Senior Notes, described below, remain outstanding on April 1, 2025 and December 31, 2024, respectively. With respect to the Term Loan, if the Convertible Senior Notes remain outstanding on April 1, 2025, the Term Loan&#8217;s maturity date will be April 1, 2025, or, if the Convertible Senior Notes&#8217; own maturity date has been extended, the earlier of (i) <ix:nonNumeric contextRef="ibd8fae709fff4c1da4933fc5331a3616_D20210602-20210602" name="aort:DebtInstrumentExtensionCircumstancePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMTQ2OA_4f33015a-6040-4916-8453-713e9c22ef61">91</ix:nonNumeric> days prior to the Convertible Senior Notes&#8217; new maturity date and (ii) June 1, 2027. In the case of the Revolving Credit Facility, if the Convertible Senior Notes are still outstanding on December 31, 2024, the Revolving Credit Facility&#8217;s maturity date will be either December 31, 2024 or, if the Convertible Senior Notes&#8217; own maturity date has been extended, the earlier of (i) <ix:nonNumeric contextRef="i308d3c512f144d22ba8f06fad96609aa_D20210602-20210602" name="aort:DebtInstrumentExtensionCircumstancePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMTg0NQ_95041a4a-0aa8-4005-92da-10fac1d2fef5">182</ix:nonNumeric> days prior to the Convertible Senior Notes&#8217; new maturity date and (ii) June 1, 2025. Under the amendment, the Term Loan Facility bears interest, at our option, at a floating annual rate equal to either the base rate, plus a margin of <ix:nonFraction unitRef="number" contextRef="iaea6f089ed074e359ce7c3f017e6b10b_D20210602-20210602" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjA3Nw_d5c89334-d46a-4413-aad1-0d768d75027f">2.50</ix:nonFraction>%, or LIBOR, plus a margin of <ix:nonFraction unitRef="number" contextRef="i3079296817f64fe0829aa2166586dc63_D20210602-20210602" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjEwOA_d23ceee1-daf4-4711-b099-12127f7b5b22">3.50</ix:nonFraction>%. Prior to the amendment, the optional floating annual rate was equal to either the base rate plus a margin of <ix:nonFraction unitRef="number" contextRef="i2c4d08f8fa5d4fa69f8b6d4049e4bb52_D20210601-20210601" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjIyMQ_66aa3a3c-48aa-438d-9fdd-bbadd8100d1c">2.25</ix:nonFraction>%, or LIBOR, plus a margin of <ix:nonFraction unitRef="number" contextRef="i7d9fad1b5e5f409ab72291a10865c569_D20210601-20210601" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjI1Mg_9d27b698-c715-4464-8f84-2df73eed0c0c">3.25</ix:nonFraction>%. We paid debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i7ee1e8077bf9471fbd587c9b736b28e0_D20210602-20210602" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjI4Nw_6ed7d29f-364c-4cb4-a550-7451d7aadb89">2.1</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i7ee1e8077bf9471fbd587c9b736b28e0_D20210602-20210602" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjMwMA_3853b618-b9ad-4c89-8c72-1e112e644ec3">1.8</ix:nonFraction> million will be amortized over the life of the Term Loan Facility and included in current and long-term debt on the Condensed Consolidated Balance Sheets. The remaining $<ix:nonFraction unitRef="usd" contextRef="ie5eabbbcdab349c69c7b71952f9f1c67_D20210602-20210602" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjQ2NA_2c8a4ba6-96c6-4440-b6da-c07e1fc7f1d9">361,000</ix:nonFraction> of debt issuance costs and $<ix:nonFraction unitRef="usd" contextRef="ie5eabbbcdab349c69c7b71952f9f1c67_D20210602-20210602" decimals="-3" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjQ5NA_6db054c5-fd61-41c7-bcfe-750d2bf3fc2d">474,000</ix:nonFraction> of non-cash debt extinguishment costs were recorded in Interest expense on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><ix:continuation id="if88db6a95d5b4ed6aad0269f6af4b8f9" continuedAt="i68f12003cf1540fdb2334ec06b623fc1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 the Credit Agreement contains certain customary affirmative and negative covenants, including covenants that limit our ability and the ability of our subsidiaries to, among other things, grant liens, incur debt, dispose of assets, make loans and investments, make acquisitions, make certain restricted payments (including cash dividends), merge or consolidate, change business or accounting or reporting practices, in each case subject to customary exceptions for a credit facility of this size and type. Beginning in 2021 if we repay borrowings under our Revolving Credit Facility to <ix:nonFraction unitRef="number" contextRef="i7ea6eb948294472ab4381af301387075_D20220101-20220930" decimals="INF" name="aort:RevolvingCreditFacilityPercentageRepaidForNoCovenants" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMzMxMA_16db16bb-3866-437e-a7a2-4566df68f47d">25</ix:nonFraction>% or less, no financial maintenance covenants, including the minimum liquidity covenant and the maximum first lien net leverage ratio covenant, are applicable. We are in compliance with our debt covenants as of September&#160;30, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;18, 2020 we issued $<ix:nonFraction unitRef="usd" contextRef="i18723f9aeb154e06b9755af8e0a35dc0_I20200618" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMzU2OA_3e58ec24-a08b-4f01-a370-1d524f98ec7e">100.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i18723f9aeb154e06b9755af8e0a35dc0_I20200618" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMzYwMQ_da508608-c598-4a83-9868-bd843455db83">4.25</ix:nonFraction>% Convertible Senior Notes with a maturity date of July&#160;1, 2025 (the &#8220;Convertible Senior Notes&#8221;). The net proceeds from this offering, after deducting initial purchasers&#8217; discounts and costs directly related to this offering, were approximately $<ix:nonFraction unitRef="usd" contextRef="i0f3ad67fb29042d3a507e43f558ecda8_D20200618-20200618" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMzgzNw_9c765930-d69e-4aae-9d88-797802d6deb4">96.5</ix:nonFraction> million. On January 1, 2021 we adopted ASU 2020-06 and adjusted the carrying balance of the Convertible Senior Notes to notional. The Convertible Senior Notes balance was $<ix:nonFraction unitRef="usd" contextRef="i57c5164417a34d7cad7bfcdca48c018d_I20220930" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDAwMw_8be7ca79-02c0-419f-8577-94ff76fa9f9f">100.0</ix:nonFraction> million recorded in Long-term debt on the Condensed Consolidated Balance Sheets as of September&#160;30, 2022. The Convertible Senior Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. The initial conversion rate of the Convertible Senior Notes is 42.6203 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i18723f9aeb154e06b9755af8e0a35dc0_I20200618" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDM1Nw_0fe49c63-ee12-41f6-bb21-976f85559641">23.46</ix:nonFraction> per share, subject to adjustments. We use the if-converted method for assumed conversion of the Convertible Senior Notes for the diluted earnings per share calculation. The fair value and the effective interest rate of the Convertible Senior Notes as of September&#160;30, 2022 was approximately $<ix:nonFraction unitRef="usd" contextRef="icc66c0e69857453e9e2dfc50dbf9e1be_I20220930" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDYzNQ_2ec84e04-0885-4f01-8f18-07b1a643f983">92.3</ix:nonFraction> million and <ix:nonFraction unitRef="number" contextRef="icc66c0e69857453e9e2dfc50dbf9e1be_I20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDY0Mg_60376191-a68e-4923-821a-f7ccbf61ef43">5.05</ix:nonFraction>%, respectively. The fair value was based on market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest expense recognized on the Convertible Senior Notes includes $<ix:nonFraction unitRef="usd" contextRef="i027b214348ca447cb2405a448216447e_D20220701-20220930" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDg2Ng_0fe7e9b5-9928-4429-b7a0-5bec0f702d64">1.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibaad6e3991c64789be68b008759c87e6_D20220101-20220930" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDg3NA_ae18bee1-d7b8-4e8e-a3d8-544ba15b1c4d">3.7</ix:nonFraction> million for the </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended September&#160;30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, and $<ix:nonFraction unitRef="usd" contextRef="icbe178457b16413291bbf12b116f4451_D20210701-20210930" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDkyMw_821a000b-5494-4113-9395-9f7289f4efbe">1.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibaf43f6c29284708b18275267e3af457_D20210101-20210930" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDkzMA_a2ddf465-96b7-46e5-bdd4-ac863d79dade">3.7</ix:nonFraction> million for the </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended September&#160;30, 2021, respectively, related to the aggregate of the contractual coupon interest, and the amortization of the debt issuance costs</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Interest on the Convertible Senior Notes began accruing upon issuance and is payable semi-annually. As of September&#160;30, 2022 there were $<ix:nonFraction unitRef="usd" contextRef="icc66c0e69857453e9e2dfc50dbf9e1be_I20220930" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNTIwNQ_527424cf-790b-48b6-83a9-83848ca1c757">2.0</ix:nonFraction> million of unamortized debt issuance costs related to Convertible Senior Notes. </span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Convertible Senior Notes may convert their notes at their option at any time prior to January 1, 2025, but only under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of our common stock for at least <ix:nonFraction unitRef="day" contextRef="idb55cd7b1c67424e83334b51ddeeed75_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNTY0OA_2716fc83-02ed-4b71-a716-68a5cce10d58">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="day" contextRef="idb55cd7b1c67424e83334b51ddeeed75_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNTcxMg_e816bd60-d67b-4458-a908-10509ec9aecf">30</ix:nonFraction> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="idb55cd7b1c67424e83334b51ddeeed75_D20220101-20220930" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNTg2MQ_437ac25f-cc97-49c6-a86f-b0f205fa4359">130</ix:nonFraction>% of the conversion price on each applicable trading day; (ii) during the <ix:nonFraction unitRef="day" contextRef="i3162fd9f3aad4da4b4a6c31ca14cc416_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNTkzNg_d942f530-565b-4189-990c-e8f4a874cf24">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="day" contextRef="i3162fd9f3aad4da4b4a6c31ca14cc416_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNTk2OQ_cc8bca95-2413-4b21-b4ee-ef52a4f8557c">five</ix:nonFraction> consecutive trading day period in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="i3162fd9f3aad4da4b4a6c31ca14cc416_D20220101-20220930" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNjEyNA_82ecabfb-2cb3-497f-9c8f-4d4785e2ce55">98</ix:nonFraction>% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (iii) we give a notice of redemption with respect to any or all of the notes, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate events. On or after January 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their notes at any time, regardless of the foregoing circumstances.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot redeem the Convertible Senior Notes before July 5, 2023. We can redeem them on or after July 5, 2023, in whole or in part, at our option, if the last reported sale price per share of our common stock has been at least <ix:nonFraction unitRef="number" contextRef="iee01dabe643e479586ec04799b683ba4_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNjk1Mg_6e54f696-869b-4eaa-bce4-abb657a18735">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="day" contextRef="iee01dabe643e479586ec04799b683ba4_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNzAwNw_62b6f31b-9630-49cf-89de-4bca8afe3678">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="day" contextRef="iee01dabe643e479586ec04799b683ba4_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNzA2Mw_efb6c633-221b-441d-951c-9dba986d019f">30</ix:nonFraction> consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption. We may redeem for cash all or part of the Convertible Senior Notes at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="iee01dabe643e479586ec04799b683ba4_D20220101-20220930" decimals="INF" name="aort:DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNzM1OA_ccd04e71-d19a-4ed3-ad2f-abb95bedbd80">100</ix:nonFraction>% of the principal amount of the redeemable Convertible Senior Notes, plus accrued and unpaid interest to, but excluding, the redemption date. No principal payments are due on the Convertible Senior Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the Convertible Senior Notes do not contain any financial covenants and do not restrict us from conducting significant restructuring transactions or issuing or repurchasing any of its other securities.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><ix:continuation id="i68f12003cf1540fdb2334ec06b623fc1" continuedAt="i3909f0964bf440f392a222395da20dc4"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan Balances</span></div><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfODIyNA_9be787ee-d704-4ac4-95c7-6900a1dca259" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The short-term and long-term balances of our term loan and other long-term borrowings were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:71.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.708%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.104%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Term loan balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i33db3b1cd5a744adaf668932b3d7a752_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMS0xLTEtMS0yMTE2MQ_f0880971-3c5c-4e02-894d-15b4167fc39e">214,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifda76d72993449d1998f915ef6c42d12_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMS0zLTEtMS0yMTE2MQ_62ff535a-9fe9-436b-863f-309daff104f4">216,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iacc74ff3ae064710b11fbf91c5b4da32_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMi0xLTEtMS0yMTE2MQ_e3a32b03-8dd1-4719-b7f8-bdbfac50113e">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ieb17620c310648b8a165d09b227c1a9d_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMi0zLTEtMS0yMTE2MQ_a1ec6c45-ac4f-4375-aeed-b64a20d0e6ca">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="i2917e811dec840bfa296f07c2b87727d_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMy0wLTEtMS0yMTE2MS90ZXh0cmVnaW9uOmUxOGI5ZGY5NjhjMTQ5M2ZhMDEyNTkyOTFlNGUxZjg0XzQ_b4234b10-b1f6-4f21-8731-2f9a92983680">2.45</ix:nonFraction>% Sparkasse Zollernalb (KFW Loan 1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2917e811dec840bfa296f07c2b87727d_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMy0xLTEtMS0yMTE2MQ_aa698a9f-95d1-48c0-918a-57ff15fac653">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ib6c541e6344348c7932037179bc9a6a0_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMy0zLTEtMS0yMTE2MQ_536392df-62f3-4115-9d5e-0fa259d4bbbf">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="i7d9322af829e4028a7955119f8529d4f_I20220930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNC0wLTEtMS0yMTE2MS90ZXh0cmVnaW9uOjdmZTRjNWIxOTBkNjRhNzFiOGNlZDRhYmM3Y2ViOTYzXzQ_a8f3cdd3-2d68-4266-b6d8-94327d1a5524">1.40</ix:nonFraction>% Sparkasse Zollernalb (KFW Loan 2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i7d9322af829e4028a7955119f8529d4f_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNC0xLTEtMS0yMTE2MQ_1a49e448-a06a-4987-a87a-5cf5c20b8db1">731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id8d8863bba6645fab208cbec4e5af0c4_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNC0zLTEtMS0yMTE2MQ_c64f44c7-89c1-472a-a750-ee15ca802112">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total loan balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNS0xLTEtMS0yMTE2MQ_66389956-bda8-4593-8900-d7ba215c6033">315,369</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNS0zLTEtMS0yMTE2MQ_779c4634-ad90-43c4-835f-b6a816246d4c">317,627</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less unamortized loan origination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNi0xLTEtMS0yMTE2MQ_05e50421-cccf-4344-b228-200fb62d66c7">7,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNi0zLTEtMS0yMTE2MQ_bf585f29-9bd9-4a37-9eb3-0a7f6a74e7c1">8,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net borrowings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNy0xLTEtMS0yMTE2MQ_5d61ec09-efe8-43a7-8ed4-b91629cf3b48">308,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNy0zLTEtMS0yMTE2MQ_7adc88ba-2a39-422d-a64e-c1f1079429a1">309,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less short-term loan balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfOC0xLTEtMS0yMTE2MQ_48e3e2f8-17a2-48f7-b4cd-09cf5c81bd1f">1,562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfOC0zLTEtMS0yMTE2MQ_c5c3bbc1-62d8-4028-9fa5-985ccc53f2fb">1,630</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Long-term loan balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfOS0xLTEtMS0yMTE2MQ_fef5fa17-2ccf-4355-b981-29680d00d6ab">306,674</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfOS0zLTEtMS0yMTE2MQ_2d0bde54-bd75-45ba-9f9a-cccc3a3252cd">307,493</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3909f0964bf440f392a222395da20dc4">Interest expense was $<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfODEwNQ_bccbdc51-c110-402f-8dc2-c845f8c7f826">4.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfODExMg_3899681a-ea06-42fa-abce-ae3e7fb0b92a">12.9</ix:nonFraction> million for the three and nine months ended September&#160;30, 2022, respectively, as compared to $<ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfODE3Mg_d6c6a7b1-ff02-472e-aa1e-ffbcc960793e">4.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfODE3OQ_0c618c51-71c1-4d82-8b0a-6cf8534a09dc">13.0</ix:nonFraction> million for the three and nine months ended September&#160;30, 2021, respectively.</ix:continuation> </span></div><div id="i167b7825c15e480eba61f77e008c32de_58"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81OC9mcmFnOmIwOTM0YzA4N2I2YjRlOGRiNDZjMWFhNTlkNDBjYTVkL3RleHRyZWdpb246YjA5MzRjMDg3YjZiNGU4ZGI0NmMxYWE1OWQ0MGNhNWRfOTI3_016b3242-694a-4aa2-a840-16322c91f902" continuedAt="ie92ccf958554488781fd32f3efc11cb0" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="ie92ccf958554488781fd32f3efc11cb0" continuedAt="i706c2f95d3094397b658e3e5e62e72c8"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liability Claims</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are made aware of adverse events involving our products and tissues. Future adverse events could ultimately give rise to a lawsuit against us, and liability claims may be asserted against us in the future based on past events that we are not aware of at the present time. We maintain claims-made insurance policies to mitigate our financial exposure to product and tissue processing liability claims. Claims-made insurance policies generally cover only those asserted claims and incidents that are reported to the insurance carrier while the policy is in effect. The amounts recorded in these Condensed Consolidated Financial Statements as of September&#160;30, 2022 represent our estimate of the probable losses and anticipated recoveries for incurred but not reported claims related to products sold and services performed prior to the balance sheet date.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PROACT Xa Clinical Trial Termination</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i706c2f95d3094397b658e3e5e62e72c8">On September 23, 2022 we announced that we were stopping the PROACT Xa clinical trial as recommended by the trial's independent Data and Safety Monitoring Board. The PROACT Xa clinical trial was a prospective, randomized, trial designed to determine if patients with  On-X mechanical aortic valves could be maintained safely and effectively on apixaban rather than on warfarin. As a result of PROACT Xa's early termination, we recorded $<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-5" name="aort:ResearchAndDevelopmentExpenseTerminationAndWindDownCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81OC9mcmFnOmIwOTM0YzA4N2I2YjRlOGRiNDZjMWFhNTlkNDBjYTVkL3RleHRyZWdpb246YjA5MzRjMDg3YjZiNGU4ZGI0NmMxYWE1OWQ0MGNhNWRfNTQ5NzU1ODE1MjU3_83b44fdc-94ef-4190-87ef-40a98da3edfc"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-5" name="aort:ResearchAndDevelopmentExpenseTerminationAndWindDownCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81OC9mcmFnOmIwOTM0YzA4N2I2YjRlOGRiNDZjMWFhNTlkNDBjYTVkL3RleHRyZWdpb246YjA5MzRjMDg3YjZiNGU4ZGI0NmMxYWE1OWQ0MGNhNWRfNTQ5NzU1ODE1MjU3_c7d6b4e9-2b46-4f3a-9d6e-6dd451ed2318">4.7</ix:nonFraction></ix:nonFraction> million of termination and wind-down expenses that are included in Research and development operating expenses on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income for the three and nine months ended September 30, 2022. The majority of these costs include future administrative costs that will be incurred during the fourth quarter of 2022 and the first quarter of 2023, as well as the estimated cost of clinical drugs purchased for patients participating in the study that are not expected to be recovered.</ix:continuation> </span></div><div id="i167b7825c15e480eba61f77e008c32de_61"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RleHRyZWdpb246MGNjNjM2Y2RjY2YxNDMxM2JmYTRkYjk4NTUxYzUyZTZfMTcxNw_5f71a00e-5b48-4811-88f0-67818dc8be33" continuedAt="id1e55d328ed8444b953218b7446eaafc" escape="true">Revenue Recognition</ix:nonNumeric></span></div><ix:continuation id="id1e55d328ed8444b953218b7446eaafc" continuedAt="i9c2aaeb4ded34b358772d21965c2fffe"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Revenue</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have identified the following revenues disaggregated by revenue source:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Domestic hospitals &#8211; direct sales of products and preservation services.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International hospitals &#8211; direct sales of products and preservation services.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International distributors &#8211; generally these contracts specify a geographic area that the distributor will service, terms and conditions of the relationship, and purchase targets for the next calendar year.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><ix:continuation id="i9c2aaeb4ded34b358772d21965c2fffe"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CardioGenesis cardiac laser console trials and sales &#8211; CardioGenesis cardiac trialed laser consoles are delivered under separate agreements.</span></div><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RleHRyZWdpb246MGNjNjM2Y2RjY2YxNDMxM2JmYTRkYjk4NTUxYzUyZTZfMTcxOA_126add70-5d7d-4ea9-87b6-d00c3af53ed4" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2022 and 2021 the sources of revenue were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Domestic hospitals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i19857ac737a849ee839c3f22bc8089c2_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMi0xLTEtMS0yMTE2MQ_2ba8ee51-a229-4ead-a477-9bda13b025fa">40,842</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i11915924fe704fb89347da42e1ef2eb2_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMi0zLTEtMS0yMTE2MQ_e956b928-ff4a-46fb-9029-6385e54a98b2">36,129</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ia809a613bd144fa0a274104dcd26acb1_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMi01LTEtMS0yMTE2MQ_c210c98d-c188-43fc-b394-b7b1144d11fb">117,343</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i899343d6cb944a4681fdbfcdbd5d1ca8_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMi03LTEtMS0yMTE2MQ_1ade94a8-eada-4bb1-984a-ce15b7ff0d64">111,291</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">International hospitals</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id714b6b2b6a64790a42d603abb8e18f3_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMy0xLTEtMS0yMTE2MQ_4b1ab3b0-176c-4034-bd81-31146268df2f">24,119</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i68e49df3a3c64e688b8a31a561b96ed9_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMy0zLTEtMS0yMTE2MQ_f916af3f-8dab-4534-af81-1dd9a5c56b32">25,458</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iaa5de9333d824fe48fda6782f64fdc3c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMy01LTEtMS0yMTE2MQ_d8b61572-1e4f-408b-b7a9-6b8f1b93a0f0">79,768</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i4668dfae4f444b93ac2d0b184ad2f75e_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMy03LTEtMS0yMTE2MQ_e69ec47f-14c4-4099-948d-d1e556a8d7fb">79,219</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">International distributors</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i45c79bfd4d6346bb876c81a81a51573a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNC0xLTEtMS0yMTE2MQ_a91d3173-a85b-4e31-a64b-f659b5cd1272">11,469</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i281a6ea681e94b3b8da636232186b497_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNC0zLTEtMS0yMTE2MQ_2046faa3-90bf-41ae-9078-9ab1d65af3ec">10,544</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i48e4181561d94c5fbb84354840056db1_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNC01LTEtMS0yMTE2MQ_21c7c121-0e82-4e56-b79a-dcf5c613cf04">34,685</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i1599f4e6f31b49738062fad1654aec04_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNC03LTEtMS0yMTE2MQ_b656ef86-1e32-4ea5-92af-c44b32620698">28,694</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">CardioGenesis cardiac laser therapy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ib9704cb4285d424bbc6f7b1dfef34dc5_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNS0xLTEtMS0yMTE2MQ_92d3ffbf-de27-461c-8298-242a57041981">408</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i342b33ea32d64961aa1bcb645535ae46_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNS0zLTEtMS0yMTE2MQ_6532b82d-7700-4a70-a736-c4f6469eaaba">76</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i42999e55d750436abb4dc19f0fde883f_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNS01LTEtMS0yMTE2MQ_6cca7ef9-3510-4877-81c6-5764723a3f7f">2,595</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fdd33ca91264d388735248eee07f5b7_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNS03LTEtMS0yMTE2MQ_9813d3c9-eb10-4bca-9a50-9188793d38b0">238</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total sources of revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNi0xLTEtMS0yMTE2MQ_7df14d68-e2c0-4f3d-bbe5-a8b72becb3dc">76,838</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNi0zLTEtMS0yMTE2MQ_cd543aad-feb7-4793-97f5-15db4c261a6d">72,207</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNi01LTEtMS0yMTE2MQ_1b37d4c7-449b-4ab3-86d6-43c2c03fe11d">234,391</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNi03LTEtMS0yMTE2MQ_708c9b8e-d8d1-4060-8c0b-7b1ae7cb6d3f">219,442</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also see segment disaggregation information in Note 14 below.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may generate contract assets during the pre-delivery design and manufacturing stage of E-xtra Design Engineering product order fulfillment. We assess the balance related to any arrangements in process and determine if the enforceable right to payment creates a material contract asset requiring disclosure. No material arrangements in process existed as of September&#160;30, 2022 and 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also incur contract obligations on general customer purchase orders that have been accepted but unfulfilled. Due to the short duration of time between order acceptance and delivery of the related product or service, we have determined that the balance related to these contract obligations is generally immaterial at any point in time. We monitor the value of orders accepted but unfulfilled at the close of each reporting period to determine if disclosure is appropriate. The value of orders accepted but unfulfilled as of September&#160;30, 2022 and 2021 was not material.</span></div></ix:continuation><div id="i167b7825c15e480eba61f77e008c32de_64"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjg2NQ_189d9b04-69f8-4aad-91cc-c3842c957b70" continuedAt="ifc8833ac3dd648adad93ce177308317b" escape="true">Stock Compensation </ix:nonNumeric></span></div><ix:continuation id="ifc8833ac3dd648adad93ce177308317b" continuedAt="i11309e9d34da4baaa420dc26fb415e52"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), performance stock units (&#8220;PSUs&#8221;), and options to purchase shares of our common stock at exercise prices generally equal to the fair value of such stock at the dates of grant. We also maintain a shareholder-approved Employee Stock Purchase Plan (&#8220;ESPP&#8221;) for the benefit of our employees. The ESPP allows eligible employees to purchase common stock on a regular basis at the lower of <ix:nonFraction unitRef="number" contextRef="iee66ca91fc234b09b3c2d8a46621d0df_D20220101-20220930" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfNjAy_82970806-b999-4e6b-bec7-293118e9e86c">85</ix:nonFraction>% of the market price at the beginning or end of each offering period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Grants</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022 the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Compensation Committee of our Board of Directors (the &#8220;Committee&#8221;) authorized awards from approved stock incentive plans of RSAs to non-employee directors and RSUs and PSUs to certain employees and company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together totaled <ix:nonFraction unitRef="shares" contextRef="i15ccab14e00e482fa8cc9b73fec811d4_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTA0MQ_76bbfd37-161c-4985-b931-a7daeac03789">520,000</ix:nonFraction> shares and had an aggregate grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="i15ccab14e00e482fa8cc9b73fec811d4_D20220101-20220930" decimals="-5" name="aort:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTA5Nw_5e36be95-6c44-4d62-bc29-ee4d87e29b9d">9.7</ix:nonFraction> million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021 the Committee authorized awards from approved stock incentive plans of RSAs to non-employee directors, RSUs to certain employees, and RSAs and PSUs to certain Company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together totaled <ix:nonFraction unitRef="shares" contextRef="i8cfd4278c4d54da3ad77a6c6aa2631c6_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTQxMg_a39d692a-26f2-45ba-a2bd-5c7852f9502b">494,000</ix:nonFraction> shares and had an aggregate grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="i8cfd4278c4d54da3ad77a6c6aa2631c6_D20210101-20210930" decimals="-5" name="aort:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTQ2OA_24e82834-c603-4671-945c-a43efe9588d5">12.5</ix:nonFraction> million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee authorized, from approved stock incentive plans, grants of stock options to purchase a total of <ix:nonFraction unitRef="shares" contextRef="i2743263dde35403486ed30d48ff92d6f_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTU4Mw_7cf17319-a5b3-458d-91e7-75368686a104">314,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i41e84a48d560438c8c1d2cd5b2e60304_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTU5MA_f5dd1704-4403-4bd5-b72a-4683a8d48d22">226,000</ix:nonFraction> shares to certain Company officers during the nine months ended September&#160;30, 2022 and 2021, respectively. The exercise prices of the options were equal to the closing stock prices on their respective grant dates.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><ix:continuation id="i11309e9d34da4baaa420dc26fb415e52" continuedAt="i5ec1025c761b4fc8828600510e386d18"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employees purchased common stock totaling <ix:nonFraction unitRef="shares" contextRef="i7fb88599f3ba47168b057695501cbbcf_D20220701-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTgyOQ_e11999d0-e419-4fd6-b96e-3a6b178c76aa">58,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iee66ca91fc234b09b3c2d8a46621d0df_D20220101-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfNDk0NzgwMjMyODA1Mw_3886090e-cad2-4369-97b0-59b4643da3d5">95,000</ix:nonFraction> shares in the three and nine months ended September&#160;30, 2022, respectively, as compared to <ix:nonFraction unitRef="shares" contextRef="i461739b4f0b94d58b483520fd7eacf68_D20210701-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfNDk0NzgwMjMyODA1Nw_94d06333-5f68-41e0-9fb6-428f0c090c65">51,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i014313fc131f48999cd3c9dec9fb977c_D20210101-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfNDk0NzgwMjMyODA2MQ_85885d6a-bcfb-42fd-b582-48a094086e60">87,000</ix:nonFraction> shares in the three and nine months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, through the ESPP. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Compensation Expense </span></div><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjg2Ng_cb827b1c-4259-4524-9bc5-26a4ae69bc75" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used to determine the fair value of options and shares purchased under the ESPP: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Stock<br/>Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">ESPP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i7fb88599f3ba47168b057695501cbbcf_D20220701-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfMi0zLTEtMS0yMTE2MQ_7ff104af-657e-44ca-ae2f-aea34f60056a">0.5</ix:nonNumeric> Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i42eac7fb937149b19cdc9f258f5ac32e_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfMi01LTEtMS0yMTE2MQ_baac7d95-3eb5-42d6-8216-4958b2e8eb4e">5.0</ix:nonNumeric> Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="iee66ca91fc234b09b3c2d8a46621d0df_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfMi03LTEtMS0yMTE2MQ_0231c6c9-a662-4e41-9d07-4eb33de19f2a">0.5</ix:nonNumeric> Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="i7fb88599f3ba47168b057695501cbbcf_D20220701-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfMy0zLTEtMS0yMTE2MQ_ba149bcf-eac7-495f-96e9-ff9ac4509fbb">0.49</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="i42eac7fb937149b19cdc9f258f5ac32e_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfMy01LTEtMS0yMTE2MQ_e2cbdcb8-5f8b-4aa3-b1ff-a2bc263c3291">0.40</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="iee66ca91fc234b09b3c2d8a46621d0df_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfMy03LTEtMS0yMTE2MQ_546d15af-ae66-409c-83e4-700881fffafa">0.31</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="i7fb88599f3ba47168b057695501cbbcf_D20220701-20220930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfNC0zLTEtMS0yMTE2MQ_61efe5c9-8619-4062-8459-d4936b205e7a">2.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="i42eac7fb937149b19cdc9f258f5ac32e_D20220101-20220930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfNC01LTEtMS0yMTE2MQ_e0db0db9-f245-49a8-b93d-655c0eb498c1">1.89</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="iee66ca91fc234b09b3c2d8a46621d0df_D20220101-20220930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfNC03LTEtMS0yMTE2MQ_21d0597b-df46-4e24-9d33-aefd9ec39ff2">0.22</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjg2NA_3423c464-97ff-4a8a-b3c7-42a236ae23cf" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total stock compensation expenses prior to the capitalization of amounts into Deferred preservation and Inventory costs (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">RSA, RSU, and PSU expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i7b553a2641f34d9fbc27aa2ae76e41e4_D20220701-20220930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMi0xLTEtMS0yMTE2MQ_cbce07ae-02b2-414e-90f5-e37d6256ba90">2,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i89e0d9a60d324513b3fdf16f71bc2d39_D20210701-20210930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMi0zLTEtMS0yMTE2MQ_602da83c-35af-459a-99ed-ee9b15a09cff">2,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i381fc1148e2b43d8bbc80cf38962e6a1_D20220101-20220930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMi01LTEtMS0yMTE2MQ_a2e8a68f-2741-4eb2-befa-dcfc82a41cf3">7,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i298934a6b2a54c778e6398d092865235_D20210101-20210930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMi03LTEtMS0yMTE2MQ_b8e309f8-e15b-4755-8031-dbe88ea8a380">6,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Stock option and ESPP expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ie9c2d41d46d24d208d34d8d8f2b436e1_D20220701-20220930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMy0xLTEtMS0yMTE2MQ_8eacb6a6-71ec-4898-b648-4bc4b4410efc">611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i6984cade7c05443d9b12c962524d654d_D20210701-20210930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMy0zLTEtMS0yMTE2MQ_b13b6c26-f1a6-4eb5-932f-71fbe2d60558">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i354fb63b18a2436c9633c0f1845308b2_D20220101-20220930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMy01LTEtMS0yMTE2MQ_eea78d05-b4fd-4b86-90a5-cef21e3b80ff">1,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ib4a80aa36fc046ebb86b318c4afa0f59_D20210101-20210930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMy03LTEtMS0yMTE2MQ_55a28ffb-c272-45a4-98dd-55d64a920e26">1,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total stock compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfNC0xLTEtMS0yMTE2MQ_7a4e7f91-88c6-4f2b-ba5c-689d415655d6">3,233</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfNC0zLTEtMS0yMTE2MQ_d447c0ae-9dcd-40c2-a60e-214f0876d258">2,990</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfNC01LTEtMS0yMTE2MQ_af965f13-49c3-4770-8c72-fc0b78efea90">9,654</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfNC03LTEtMS0yMTE2MQ_b47246a3-93f5-468b-bb87-bfc9517fe579">7,895</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5ec1025c761b4fc8828600510e386d18">Included in the total stock compensation expense, as applicable in each period, were expenses related to RSAs, RSUs, PSUs, and stock options issued in each respective year, as well as those issued in prior periods that continue to vest during the period, and compensation related to the ESPP. These amounts were recorded as stock compensation expense and were subject to our normal allocation of expenses to inventory costs and deferred preservation costs. We capitalized $<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjY5OA_4c967e49-369a-40d4-99fe-522695ca7123">144,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjcwNQ_333ec157-7447-4cd3-bcfa-c33a8be7cff2">465,000</ix:nonFraction> in the three and nine months ended September 30, 2022, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjczNw_d01eda82-f131-4c1e-b06b-a04284ce7f5c">115,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjc0NA_56a1c72c-c99a-4dc9-847f-e097b2c05d9d">424,000</ix:nonFraction> in the three and nine months ended September 30, 2021, respectively, of the stock compensation expense into our inventory costs and deferred preservation costs.</ix:continuation> </span></div><div id="i167b7825c15e480eba61f77e008c32de_67"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RleHRyZWdpb246M2I0Y2ZhYTc4ZjJmNDhlMWJkNGJjYTdiMjIyODUwMmNfODAx_b3e5a239-5e26-4548-89df-24e4489241d5" continuedAt="i9f466e3c71fa4ea0a6e074e616f2a86f" escape="true">(Loss) Earnings Per Common Share </ix:nonNumeric></span></div><ix:continuation id="i9f466e3c71fa4ea0a6e074e616f2a86f" continuedAt="i2a2cd86d979a46eb9f74bcf8262abfcb"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RleHRyZWdpb246M2I0Y2ZhYTc4ZjJmNDhlMWJkNGJjYTdiMjIyODUwMmNfODAy_ea2205ea-c2a7-4c4c-b31d-b9639e12661a" continuedAt="ifb26b611ceaa4e3ca39a6cb7cc2ba955" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted (loss) income per common share (in thousands, except per share data): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"></td><td style="width:47.680%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic (loss) income per common share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMi0yLTEtMS0yMTE2MQ_9a7720e6-29c8-4297-91fc-7549a42ea72b">13,713</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMi00LTEtMS0yMTE2MQ_52d4fcd5-0f3d-4bba-af12-201fc85d3dbe">10,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMi02LTEtMS0yMTE2MQ_42f8c92d-8c3c-42f1-ac99-e1e0c71da31e">21,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMi04LTEtMS0yMTE2MQ_d08cd39d-5550-4d94-855d-71b27ac97b80">5,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss (income) allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMy0yLTEtMS0yMTE2MQ_bc63931e-ce06-4342-afc5-c87c41cc80c3">70</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMy00LTEtMS0yMTE2MQ_ffeeb880-f992-4d30-8015-2ba1e136f730">63</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMy02LTEtMS0yMTE2MQ_d96f7764-2060-41c8-87e7-4e861ebafd41">109</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMy04LTEtMS0yMTE2MQ_6c2e1294-72ff-48c2-8953-cbed6ebe3275">34</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net (loss) income allocated to common shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNC0yLTEtMS0yMTE2MQ_4c519e9e-233a-46e6-bd81-31e204ab471f">13,643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNC00LTEtMS0yMTE2MQ_79d7554e-6cca-45bd-97af-e2f15d2fd57a">10,519</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNC02LTEtMS0yMTE2MQ_6e12073b-671c-483e-b7cf-ffabf9330c04">21,252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNC04LTEtMS0yMTE2MQ_345c5ebd-f508-4358-91ea-811bc2ae022c">5,232</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNi0yLTEtMS0yMTE2MQ_485a300e-cfa6-407b-ae98-00451b5f75e4">40,115</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNi00LTEtMS0yMTE2MQ_e7f9634e-894b-473e-916a-a4499bee03bd">39,086</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNi02LTEtMS0yMTE2MQ_5d7a016a-1c4d-440e-89c3-fe4529c81c86">39,999</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNi04LTEtMS0yMTE2MQ_56691b54-c8b3-48b0-98ab-f51746e6d8c1">38,924</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic (loss) income per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNy0yLTEtMS0yMTE2MQ_26214ed2-1590-4c7e-b4a0-9ee8d87da872">0.34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usdPerShare" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNy00LTEtMS0yMTE2MQ_68c7897b-57dc-44b5-97b8-d309d9d906fa">0.27</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNy02LTEtMS0yMTE2MQ_0a3c78ef-6427-4e1a-8620-eb5df3347ab9">0.53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNy04LTEtMS0yMTE2MQ_c4b4c5ac-459d-4b61-b24b-796912c9b3dd">0.13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><ix:continuation id="i2a2cd86d979a46eb9f74bcf8262abfcb" continuedAt="i2c0e2e46ac454b17a349f4e458aedf39"><ix:continuation id="ifb26b611ceaa4e3ca39a6cb7cc2ba955"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"></td><td style="width:47.680%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted (loss) income per common share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMi0yLTEtMS0yMTE2MQ_bf65b2e0-b00f-4cb5-9d84-a6f7af99e2ee">13,713</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMi00LTEtMS0yMTE2MQ_3775cc7c-7cad-4ee8-ade3-532907477edb">10,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMi02LTEtMS0yMTE2MQ_745b07ed-e51e-463f-b51a-db421a18e267">21,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMi04LTEtMS0yMTE2MQ_f72d3880-caf4-446c-b1f3-6ba9edc973ef">5,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss (income) allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMy0yLTEtMS0yMTE2MQ_d63b8332-5135-4c30-b020-eaf3ae426135">70</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMy00LTEtMS0yMTE2MQ_f869f8c5-4331-46f7-8899-04a642e4f64b">55</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMy02LTEtMS0yMTE2MQ_591b5cd3-ac2f-4c51-8644-34786b90d3ec">109</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMy04LTEtMS0yMTE2MQ_4ac65ff3-a825-416a-920f-b5307c263e49">34</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss attributable to convertible senior notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:InterestOnConvertibleDebtNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC0yLTEtMS0yMzgzOA_12fa691b-76bb-4ad6-89df-f06172bf1e03">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC00LTEtMS0yMzgzOA_b40208e4-40c0-4313-a88c-e01b3accfa61">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:InterestOnConvertibleDebtNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC02LTEtMS0yMzgzOA_35f0cdae-57d8-4c8c-957f-a2bb58180e19">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:InterestOnConvertibleDebtNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC04LTEtMS0yMzgzOA_6c928697-6ad1-4189-997b-90fb459ceafb">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net (loss) income allocated to common shareholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC0yLTEtMS0yMTE2MQ_6f2c349e-a541-42cb-b096-804d8bd2a870">13,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC00LTEtMS0yMTE2MQ_35dcf56b-bfd9-40b7-a338-485068342d60">11,446</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC02LTEtMS0yMTE2MQ_7d424174-933b-4b55-8172-b1cc0fa6c8b0">21,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC04LTEtMS0yMTE2MQ_d13f3e48-043a-4b1b-93db-e08cbb9d0998">5,232</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNi0yLTEtMS0yMTE2MQ_52af7fe9-783f-4d53-8d52-171c763488e1">40,115</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNi00LTEtMS0yMTE2MQ_0485388d-b45f-430e-807f-9c1b6f150073">39,086</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNi02LTEtMS0yMTE2MQ_e93182df-8c1a-48a3-9408-e88af208a1c4">39,999</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNi04LTEtMS0yMTE2MQ_e055b82e-79bb-4600-9a32-c2fe1aaa98da">38,924</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Effect of dilutive stock options and awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1.25pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC0yLTEtMS0zMDE5MQ_1d677c72-6328-491a-921b-280f8258a559">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC00LTEtMS0zMDE5MQ_6865c4e1-8c7f-4c3a-9328-221775b38b9d">505</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC02LTEtMS0zMDE5MQ_45fb1e63-9d60-4e12-ad9b-de9efccb276c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC04LTEtMS0zMDE5MQ_4f3a1f68-d933-4492-8fbc-12ca3ec088d5">572</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Effect of convertible senior notes </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1.25pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOS0yLTEtMS0zMDE5MQ_9824e7bd-4989-460d-ad0b-2e2841e51c01">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOS00LTEtMS0zMDE5MQ_89817233-4cce-4d25-826e-a79922835fb8">4,862</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOS02LTEtMS0zMDE5MQ_9ceeedb5-91c9-4423-956c-555e2dec1575">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOS04LTEtMS0zMDE5MQ_a79a18ad-cfff-4c58-a894-68072f24a301">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNy0yLTEtMS0yMTE2MQ_04fcee66-4e1e-40f6-b126-04f5013016cd">40,115</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNy00LTEtMS0yMTE2MQ_7b81b47b-9d4f-4326-885c-e2249b422147">44,453</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNy02LTEtMS0yMTE2MQ_5cc6bd29-d450-48f3-9f05-cdb1f2e5eaa6">39,999</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNy04LTEtMS0yMTE2MQ_76c3dd35-4564-4205-aa6c-051c25429fa4">39,496</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted (loss) income per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC0yLTEtMS0yMTE2MQ_d91959de-053c-44b8-ba5e-b09ed2ab5940">0.34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usdPerShare" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC00LTEtMS0yMTE2MQ_2a5ab59c-e603-4f39-8566-109b903dd18c">0.26</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC02LTEtMS0yMTE2MQ_b27cc972-6a13-43ae-9dc5-f616672ab4c8">0.53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC04LTEtMS0yMTE2MQ_fe1e66fb-049f-4d45-bd41-aceb8add176a">0.13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-top:12pt;text-align:justify"><ix:continuation id="i2c0e2e46ac454b17a349f4e458aedf39" continuedAt="i53a5a54b4a0c4649afa32244b798ae13"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares because the inclusion of these stock options would be antidilutive to loss per common share. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2022 all stock options and awards were excluded from the calculation of diluted weighted-average common shares outstanding as these would be antidilutive due to the net loss. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="shares" contextRef="if109928fc6f647eab134f6bf056db23a_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RleHRyZWdpb246M2I0Y2ZhYTc4ZjJmNDhlMWJkNGJjYTdiMjIyODUwMmNfNzE0NjgyNTU4MTgzMA_0e2cf8ef-2877-4d0a-9b9b-5f8955366c34">539,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="idb0051e154454d23a5b025f8cdd2f9a0_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RleHRyZWdpb246M2I0Y2ZhYTc4ZjJmNDhlMWJkNGJjYTdiMjIyODUwMmNfNzE0NjgyNTU4MTg0MA_5a5e7ca7-94ed-4f19-a031-7d15bdccd461">517,000</ix:nonFraction> of potential common shares relating to stock options, respectively, were antidilutive and excluded from the calculation of diluted weighted-average common shares outstanding. We excluded <ix:nonFraction unitRef="shares" contextRef="ibba44be2c273425fa97ea9bf1feae546_D20210101-20210930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RleHRyZWdpb246M2I0Y2ZhYTc4ZjJmNDhlMWJkNGJjYTdiMjIyODUwMmNfNTQ5NzU1ODE1NDI0_faab1cb8-18b7-479f-ab7f-74ea7c4488af">4,860,685</ix:nonFraction> of potential common shares related to our Convertible Senior Notes calculated under the if-converted method, as these shares would be antidilutive for the nine months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i53a5a54b4a0c4649afa32244b798ae13">.</ix:continuation> </span></div><div id="i167b7825c15e480eba61f77e008c32de_70"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RleHRyZWdpb246NjM3YmQwNzRhOGEzNDk0OWE0YjNkYWFjMjBjMGE2YmRfMTM4Mg_39cdbe61-32fa-4d16-b652-e19bbea2fe55" continuedAt="i0ffe2be8977941e199e3bd3608f609c9" escape="true">Segment Information </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i0ffe2be8977941e199e3bd3608f609c9" continuedAt="ia9ba25150b764915a866aa37d19cc09c"> </ix:continuation></span></div><ix:continuation id="ia9ba25150b764915a866aa37d19cc09c" continuedAt="ie5613fc536804c11a4b1620863749feb"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonFraction unitRef="segment" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RleHRyZWdpb246NjM3YmQwNzRhOGEzNDk0OWE0YjNkYWFjMjBjMGE2YmRfMjI_a349f839-dd57-40fd-b865-19cb1e609d62">two</ix:nonFraction> reportable segments organized according to our products and services: Medical devices and Preservation services. The Medical devices segment includes external revenues from product sales of aortic stent grafts, surgical sealants, On-X, and other product revenues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Aortic arch stent grafts include our E-vita Open NEO, E-vita Open Plus, AMDS, NEXUS, E-vita Thoracic 3G, and E-nya products. Abdominal stent grafts include our E-xtra Design Engineering, E-nside, E-tegra, E-ventus BX, and E-liac products. Surgical sealants include BioGlue Surgical Adhesive products. The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues. There are <ix:nonFraction unitRef="usd" contextRef="i9cc67891184f42aca2e8fcb53d876e27_D20220101-20220930" decimals="INF" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RleHRyZWdpb246NjM3YmQwNzRhOGEzNDk0OWE0YjNkYWFjMjBjMGE2YmRfODM0_65d3b6bc-be8f-47b5-b8f8-ec7acfe22076">no</ix:nonFraction> intersegment revenues. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary measure of segment performance, as viewed by our management, is segment gross margin or net external revenues less cost of products and preservation services. We do not segregate assets by segment, therefore, asset information is excluded from the segment disclosures below. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><ix:continuation id="ie5613fc536804c11a4b1620863749feb"><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RleHRyZWdpb246NjM3YmQwNzRhOGEzNDk0OWE0YjNkYWFjMjBjMGE2YmRfMTM4Mw_b09e80d5-ffe8-4de9-8b61-982534b11193" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i4ed6e56bac6643c2b13e09943b8594b7_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMy0xLTEtMS0yMTE2MQ_a4b52f87-002f-4a72-b42c-5f95ee9cb3d2">55,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i9b620f0bebe540458a2e554bbc88fa32_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMy0zLTEtMS0yMTE2MQ_a70c48dd-a433-40d9-b305-3ef82e67497b">53,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="if7ee257b1f5e474fa73da9aed693faf2_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMy01LTEtMS0yMTE2MQ_dc907863-fa03-45d4-8823-8338e51acf7e">171,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id7dd6b35f20045999c192f8de847c482_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMy03LTEtMS0yMTE2MQ_86df50a9-c58f-4518-a4f2-12d874bdba45">162,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i1220aed07ca14aa8abe0c90027bf1bd1_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNC0xLTEtMS0yMTE2MQ_a762a41b-2aab-4345-98d6-dd1d66c5693f">21,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifc4c0fa38f304458a49eead228b1f066_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNC0zLTEtMS0yMTE2MQ_50f6eefe-9cdb-4c59-ab36-3b8743cbd5ac">19,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id9732a2ada58456da4367d2ad51237e4_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNC01LTEtMS0yMTE2MQ_8776e974-b0e1-4eb4-a971-d407488955c8">62,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iae2dfd5024fd4d04a7f0acbdbbea5062_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNC03LTEtMS0yMTE2MQ_4f11526d-2c4e-4536-a432-f5a94a9a3764">56,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNS0xLTEtMS0yMTE2MQ_a0023f8b-9f2b-492e-8bd3-b7889d8d8b1b">76,838</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNS0zLTEtMS0yMTE2MQ_a90bd242-2790-46fe-b736-aaa87e90d27f">72,207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNS01LTEtMS0yMTE2MQ_eaefb9c5-d569-40e0-a4e1-1264871058ab">234,391</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNS03LTEtMS0yMTE2MQ_d2b87e53-f1af-4a3e-8d89-32b8bc077d91">219,442</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Cost of products and preservation services:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i4ed6e56bac6643c2b13e09943b8594b7_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOC0xLTEtMS0yMTE2MQ_ba3e799c-6a14-4c81-b9e5-7437530c0560">17,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i9b620f0bebe540458a2e554bbc88fa32_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOC0zLTEtMS0yMTE2MQ_bc422665-7870-4953-abe1-57c2c4f0565e">15,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="if7ee257b1f5e474fa73da9aed693faf2_D20220101-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOC01LTEtMS0yMTE2MQ_0d7d78e0-596e-48f4-934f-0d411e7ac0a6">53,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id7dd6b35f20045999c192f8de847c482_D20210101-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOC03LTEtMS0yMTE2MQ_fce35df8-5eaf-482b-937a-464283d23b19">46,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i1220aed07ca14aa8abe0c90027bf1bd1_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOS0xLTEtMS0yMTE2MQ_baa975cc-517d-4677-91e9-11a20cdca7e0">10,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifc4c0fa38f304458a49eead228b1f066_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOS0zLTEtMS0yMTE2MQ_e5c26ee3-4a7c-4b5f-9b93-30f7043884f9">8,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id9732a2ada58456da4367d2ad51237e4_D20220101-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOS01LTEtMS0yMTE2MQ_db0726f1-d725-432e-b7fb-bbd5ab60486d">29,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iae2dfd5024fd4d04a7f0acbdbbea5062_D20210101-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOS03LTEtMS0yMTE2MQ_73ccb653-9a7e-4965-8809-dab8b3ba9fa9">26,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total cost of products and preservation services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTAtMS0xLTEtMjExNjE_5270f308-1f82-4882-8590-ebc9b9f699e7">28,094</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTAtMy0xLTEtMjExNjE_7e744054-522e-4f87-9a59-3957ff0f8f69">24,418</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTAtNS0xLTEtMjExNjE_cf2eb229-aab1-4f89-adb8-2bef5649c61e">82,756</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTAtNy0xLTEtMjExNjE_8a55297b-c160-42c5-bc94-551018c049a2">73,302</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Gross margin:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i4ed6e56bac6643c2b13e09943b8594b7_D20220701-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTMtMS0xLTEtMjExNjE_f5fcb216-9396-4ba6-9762-805f555cd01d">37,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i9b620f0bebe540458a2e554bbc88fa32_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTMtMy0xLTEtMjExNjE_444cb510-6548-47a1-a3e6-f6fae556ef36">37,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="if7ee257b1f5e474fa73da9aed693faf2_D20220101-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTMtNS0xLTEtMjExNjE_d7054824-0c5b-4581-b9ba-f8b35d88a18a">118,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id7dd6b35f20045999c192f8de847c482_D20210101-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTMtNy0xLTEtMjExNjE_3aa10cac-c966-43a6-8878-5768763fa12c">115,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i1220aed07ca14aa8abe0c90027bf1bd1_D20220701-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTQtMS0xLTEtMjExNjE_f1171f35-5d6f-46ad-bb7e-4953eba20e75">11,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifc4c0fa38f304458a49eead228b1f066_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTQtMy0xLTEtMjExNjE_7bf5ddaf-2c8a-49e7-99af-ed3ffc504151">10,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id9732a2ada58456da4367d2ad51237e4_D20220101-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTQtNS0xLTEtMjExNjE_f09af5c1-c6d2-4ac2-b858-b303df44758d">33,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iae2dfd5024fd4d04a7f0acbdbbea5062_D20210101-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTQtNy0xLTEtMjExNjE_c156a2e6-d88b-4c28-9208-77ee5e3bdfe4">30,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total gross margin</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTUtMS0xLTEtMjExNjE_f43e0f85-3c9d-4643-892d-93f436741228">48,744</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTUtMy0xLTEtMjExNjE_405cd7f3-0377-423a-b9de-6fb6579845ef">47,789</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTUtNS0xLTEtMjExNjE_ab048001-b1da-469b-ac89-f37661e5f347">151,635</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTUtNy0xLTEtMjExNjE_0f7cd3d0-f407-4e61-ae13-08290a9ecc30">146,140</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RleHRyZWdpb246NjM3YmQwNzRhOGEzNDk0OWE0YjNkYWFjMjBjMGE2YmRfMTM4NA_8181da81-8567-41b4-9bae-1d9fa8bc39c5" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes net revenues by product and service (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Aortic stent grafts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ie06e2f5450764fcd97b8a391bba3cd2d_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMy0xLTEtMS0yMTE2MQ_a22fa86e-5f01-482c-8a24-efa9d4bb93aa">19,674</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i5c63bff320e64af081a5cce353c3a62f_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMy0zLTEtMS0yMTE2MQ_ff87fa30-0857-4e85-8ea9-917401f12140">20,896</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifae4dce6ca1b41baa6d2d313ffead3fa_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMy01LTEtMS0yMTE2MQ_bb0207bf-9fe6-414f-bbb1-e40d6b40bd3a">69,013</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ie049d9169eb74ff0b2390aefc7f182e5_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMy03LTEtMS0yMTE2MQ_9b6d4728-481d-4eea-be62-73b3504793f8">62,165</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Surgical sealants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="if3c197a3565b4c02b9d51132c7d4c1b9_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNC0xLTEtMS0yMTE2MQ_479de71a-64b4-4065-a1a6-d90e065c1a0f">17,374</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i82adeb266a2341f1901704b9be13d09a_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNC0zLTEtMS0yMTE2MQ_1c14ed2f-36c5-4a8b-88e0-caedac8ac1bd">16,544</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i7616c3cb7c904ae6b62508a5b0cc36f6_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNC01LTEtMS0yMTE2MQ_aa224a9f-7358-4f2e-8d63-50a5fdad1c32">49,022</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i487be8addd144d008e7c5a14b09cc518_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNC03LTEtMS0yMTE2MQ_c5fbf10c-d412-4762-bdb2-8e786403d22b">52,236</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">On-X</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3211f9da72d54b2cab2ccedbc087d2ba_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNS0xLTEtMS0yMTE2MQ_624fb0e5-9a31-4c8f-8534-6d3ec5ce4ff8">16,456</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i96b0754bb93c43ceb3c6ef24d7d19ba5_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNS0zLTEtMS0yMTE2MQ_7a32a01b-f275-403a-b3b4-965df26b61b4">14,022</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="if29b95e231c94833a32e361d0662e465_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNS01LTEtMS0yMTE2MQ_dae82f44-8798-4f3f-9ec2-01a27b827501">47,082</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2a377880ef554ca480923257a9fe5357_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNS03LTEtMS0yMTE2MQ_492ee37b-d5a9-4963-b82d-f1da0139efde">41,843</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ib053fe4e77a849b7bafcb527494112c2_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNi0xLTEtMS0yMTE2MQ_6f1bf3bb-b4c1-4be9-8d83-803f26f84dae">1,744</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ic4b2d900fb184620875c7570364d036e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNi0zLTEtMS0yMTE2MQ_fe982409-b240-44e3-a506-25c9b631fd30">1,645</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ibf398fc9c82649119889d264cbda9dbf_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNi01LTEtMS0yMTE2MQ_e7680465-6d3e-4dcc-a84a-99d7e6f1b976">6,609</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id7aeb442b84a4ce49062b5e2c520b373_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNi03LTEtMS0yMTE2MQ_ede0a6ec-184b-4eb4-86a0-4ac0b32334fa">6,284</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total products</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc916650fa81469598a7b03003c27168_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNy0xLTEtMS0yMTE2MQ_2d8137a8-fb29-4584-82b0-80831ff40a73">55,248</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i9f5bc0203be146e5bb0bd8b45cbdb2b7_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNy0zLTEtMS0yMTE2MQ_1c17c5ad-8d4f-43fc-9b28-8328c0b8f268">53,107</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i5e5a4f6af84f4ddeae300f7b08e9e59d_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNy01LTEtMS0yMTE2MQ_c5b10574-3273-48af-a2c1-0fa39f4b8659">171,726</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idd7debfcacac4069a398cab44625bd73_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNy03LTEtMS0yMTE2MQ_3914514c-951c-415e-9863-18c81df973fa">162,528</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i640c303a0a1c4e72a4879aa8b98e0402_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfOS0xLTEtMS0yMTE2MQ_f02f7632-2469-4baf-886f-76f795789749">21,590</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i377e56bf409a455ba20de5d37520ea48_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfOS0zLTEtMS0yMTE2MQ_f5036458-dcc7-4fe2-9c99-ece55f1849b2">19,100</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i84212de5e3c34a078a34d879bfeeb394_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfOS01LTEtMS0yMTE2MQ_1d691d51-4c00-4b65-96d9-6fd582821cb8">62,665</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i8faff0cacc944396b07783c2a5b064e3_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfOS03LTEtMS0yMTE2MQ_385d1515-ca5d-427b-b712-fdb73f511c00">56,914</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMTAtMS0xLTEtMjExNjE_f1bec906-77af-48cb-83f3-d98c6acc8fc5">76,838</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMTAtMy0xLTEtMjExNjE_6e49f410-a2cd-4afa-b6df-128f9db5f110">72,207</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMTAtNS0xLTEtMjExNjE_0ce58f4c-9ddb-4f11-a404-26ed36c29191">234,391</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMTAtNy0xLTEtMjExNjE_65325cb1-a13f-46d1-8542-25b64898bab8">219,442</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21</span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Form 10-Q includes &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;). Forward-looking statements give our expectations or forecasts of future events as of the date of this Form 10-Q. In some cases, words such as &#8220;could,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;shall,&#8221; &#8220;should,&#8221; &#8220;pro forma,&#8221; &#8220;potential,&#8221; &#8220;pending,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;future,&#8221; &#8220;assume,&#8221; and variations of these types of words or other similar expressions identify forward-looking statements. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements, which are made as of the date of this Form 10-Q. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All statements included herein, other than statements of historical facts, that address activities, events, or developments that we expect or anticipate will or may occur in the future, or that reflect our beliefs about the future and/or expectations, are forward-looking statements, including statements about the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our belief that new products, new indications, global expansion, and business development are the four growth areas that will drive our business in the future;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impact of the COVID-19 pandemic and the war in Ukraine on demand for and sales of our products and services, business operations, manufacturing operations, supply chain, cash flow, workforce, clinical and regulatory timelines, and our research and development projects;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our belief that our distributors may delay or reduce purchases of products in US Dollars depending on the relative price of goods in their local currencies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs that the use of surgical adhesives and sealants, with or without sutures and staples, for certain indications can enhance the efficacy and cost-effectiveness of certain procedures through more effective and rapid wound closure; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs and anticipation regarding the favorable attributes and benefits of our products and services, the basis on which our products and services compete, our physician education activities, the advantages of our relationships with organ and tissue procurement organizations and tissue banks, the FDA classification of our medical devices, our compliance with applicable laws and regulations, and the advantages of our intellectual property and its significance to our segments and our business as a whole, our relations with our employees, timelines regarding product launches and regulatory certifications, clearances, renewals, and approvals;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about potential competition and competitive products and services, potential adverse regulatory consequences, potential security vulnerabilities, and the associated potential adverse effects on our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs regarding our global expansion efforts, including the international growth opportunity that would be provided by obtaining regulatory approval for BioGlue in China;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The dependencies affecting our ability to realize the anticipated business opportunities, growth prospects, synergies, and other benefits of the agreements with Endospan and Baxter and our acquisition of Ascyrus, and our beliefs about the costs and timelines for certain regulatory approvals and clinical trial milestones related to PerClot and the NEXUS stent graft system in the US and the AMDS globally;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs regarding the fair value of our acquisitions, divestitures, and other business development activities and the estimates and assumptions about the future achievements of milestones and future revenues and cash flows related to those business development activities, including our ability to achieve the milestones in the Baxter Transaction;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about the anticipated benefits from our corporate reincorporation and rebranding and the risks posed by the same;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about the present value and potential impairment of our intangible assets and leases;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about handpiece availability and CardioGenesis cardiac laser therapy revenue;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs regarding the impact alternative anticoagulation therapy and transcatheter heart valve replacement may have on the number of patients choosing On-X mechanical heart valves;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about our ability to make timely transitions to our notified bodies and obtain renewals for our CE Marks impacted by Brexit and the transition to the Medical Device Regulation (&#8220;MDR&#8221;) in Europe, our ability to timely obtain derogations related to the same, and the impact these transitions, renewals, and derogations may have on our business, including any impact on our customers' ordering patterns and our ability to supply products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about our R&amp;D and product pipeline, including our beliefs about the timing of our clinical trials and product launches; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our belief that revenues for preservation services, particularly revenues for certain high-demand cardiac tissues, can vary from quarter-to-quarter and year-to-year due to a variety of factors including: quantity and type of incoming tissues, yields of tissue through the preservation process, timing of receipt of donor information, staffing levels, timing of the release of tissues to an implantable status, demand for certain tissue types due to the number and type of procedures being performed, and pressures from competing products or services;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs regarding the seasonal nature of the demand for some of our products and services and the reasons for such seasonality, if any, and regarding the impact of consignment inventory on product sales, if any;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our belief that our cash from operations and existing cash and cash equivalents will enable us to meet our current operational liquidity needs for at least the next twelve months, our expectations regarding future cash requirements, and the impact that our cash requirements might have on our cash flows for the next twelve months;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectation regarding the impact on cash flows of undertaking significant business development activities and the potential need to obtain additional debt financing or equity financing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our belief that we will incur expenses for research and development projects, including for clinical research projects to gain regulatory approvals for products or indications, including On-X, aortic stent grafts, and BioGlue products, and for research and development for new products despite reduced planned spending due to COVID-19 and that our efforts to develop new products and technologies will likely require additional investment, research, and new clinical studies or data;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about pending and potential legal or other governmental or regulatory proceedings;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations regarding the timing and impact of clinical research work and regulatory approvals for certain products or indications, including On-X, aortic stent grafts, and BioGlue products, and CryoValve SGPV if the FDA reclassifies allograft heart valves as Class III medical devices;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our expectations regarding the impact of and costs associated with the conclusion of the PROACT Xa Trial;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs and expectations regarding the utilization of net operating loss carryforwards from our acquisitions of JOTEC, On-X, Hemosphere, Inc., and Cardiogenesis Corporation; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about our operating results which may fluctuate significantly on a periodic basis as a result of internal and external factors, including reduced demand for our products, availability of products, materials, and supplies, strategic actions we take such as acquisitions or divestitures, unanticipated costs and expenses, market reception of our new or improved product offerings, and interest rate and currency fluctuations; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other statements regarding projections of future financial and business performance; anticipated growth and trends in our business and the markets relevant to our business, including as our growth relates to our competitors; the robustness and reliability of our workforce and supply chain; future production capacity and product supply; the availability and benefits of our products in the future; and the expected timing and impact of our strategic initiatives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These and other forward-looking statements reflect the views of management at the time and such statements are originally made based on certain assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions, and expected future developments as well as other factors we believe are appropriate in the circumstances and are subject to a number of risks, uncertainties, estimates, and assumptions. Whether actual results and developments will conform with our expectations and predictions is subject to a number of risks and uncertainties which could cause actual results to differ materially and adversely from our expectations, including, without limitation, in addition to those specified in the text surrounding such statements, the risks described in Part II, Item 1A, &#8220;Risks Factors&#8221; in this Form 10-Q and elsewhere throughout this report, the risks described in our other filings with the Securities and Exchange Commission including the risks described in Part I, Item 1A, &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 and elsewhere throughout that report, and other risks which we may not be able to identify in advance, many of which are beyond our control. Consequently, all of the forward-looking statements made in this Form 10-Q are qualified by these cautionary statements, and there can be no assurance that the actual results or developments anticipated by us will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, us or our business or operations. We assume no obligation, and expressly disclaim any duty, to update publicly any such forward-looking statements, whether as a result of new information, future events, or otherwise. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">23</span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div id="i167b7825c15e480eba61f77e008c32de_79"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Artivion, Inc. (&#8220;Artivion,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; or &#8220;us&#8221;), is a leader in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. We have four major product families: aortic stent grafts, surgical sealants, On-X</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Aortic arch stent grafts include our E-vita Open NEO, E-vita Open Plus, AMDS, NEXUS, E-vita Thoracic 3G, and E-nya products. Abdominal stent grafts include our E-xtra Design Engineering, E-nside, E-tegra, E-ventus BX, and E-liac products. Surgical sealants include BioGlue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Surgical Adhesive (&#8220;BioGlue&#8221;) products. In addition to these four major product families, we sell or distribute PhotoFix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> bovine surgical patches, CardioGenesis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cardiac laser therapy, Therion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> chorioamniotic allografts (previously marketed as NeoPatch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), and PerClot</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hemostatic powder (prior to the sale to a subsidiary of Baxter International, Inc (&#8220;Baxter&#8221;)). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reported quarterly revenues of $76.8 million for the three months ended September&#160;30, 2022, a 6% increase from the three months ended September&#160;30, 2021. The increase in revenues for the three months ended September&#160;30, 2022 was primarily due to an increase in revenues from preservation services, On-X products, surgical sealants, and other products, partially offset by a decrease in revenues from aortic stent grafts. Excluding the effects of foreign exchange, revenues increased 11% for the three months ended September&#160;30, 2022, as compared to the three months ended September&#160;30, 2021 which reflects an increase in revenues for all product lines. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the &#8220;Results of Operations&#8221; section below for additional analysis of the three and nine months ended September&#160;30, 2022.</span></div><div id="i167b7825c15e480eba61f77e008c32de_82"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effects of COVID-19</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019 an outbreak of a respiratory illness caused by a new coronavirus named &#8220;2019-nCoV&#8221; (&#8220;COVID-19&#8221;) was detected, and by March 11, 2020, the World Health Organization declared the COVID-19 outbreak a &#8220;pandemic.&#8221;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in March 2020 we took steps to address the potential impact of COVID-19 on our employees and operations, and to preserve cash, including reducing expenditures and delaying investments. These steps included, but were not limited to, implementing specific protocols to minimize workplace exposures to COVID-19 by our employees; implementing remote work arrangements for most employees we deemed able to do so; restricting business travel; implementing hiring restrictions; reducing planned expenditures on some pending clinical trials; imposing senior management cash salary reductions in exchange for cash payments in the second quarter of 2021; requiring our Board of Directors to accept Artivion stock instead of cash compensation for a six month period through October 2020; and suspending management merit increases for seven months in 2020. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our efforts to protect our supply chain and reduce the spread of COVID-19 among our employees, including our work-from-home arrangements, have been successful to date as we have continued to operate all manufacturing sites at full production. These efforts have not materially affected our ability to maintain our business operations, including the operation of financial reporting systems, internal control over financial reporting, or disclosure controls and procedures; however, there is no guarantee that these efforts and arrangements, if they are continued, will continue to be successful in the future. Further, our reductions or delays in expenditures slowed our progress on certain key R&amp;D initiatives and could in the future continue to adversely impact our business operations or further delay our recovery from the pandemic.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Although we have scaled back most of our COVID-19 mitigation efforts, we continue to monitor the impact of the pande</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">mic and the emergence of new variants on our business and recognize that COVID-19 and its effects could continue to negatively impact our business and results of operations during the remainder of 2022 and beyond. As an example, the COVID-19 pandemic has impacted certain aspects of the global supply chain and resulted in supply chain inflation. Although we have yet to experience any material effects of this impact on our supply chain or operations, we face an increasing risk that upstream disruptions may occur or worsen. As global economies continue to recover from the COVID-19 downturn, increased opportunities for remote work, and increasing compensation pressure have resulted in competition for talent and an unprecedented number of retirements or career changes. The resulting worker shortages at all levels have impacted supply chains, distribution channels, and employers&#8217; and our own ability to adequately staff operations. These shortages to date, including a shortage of trained staff capable of meeting the increased demand </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">associated with releasing quarantined tissue, have impacted, and may impact our operations going forward. Hospitals and other healthcare providers have also experienced staffing shortages impacting our business including increased restrictions on elective and non-emergent p</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">rocedures, restrictions on access to healthcare facilities, cancellation of elective procedures, and the re-allocation of scarce resources. New variants of COVID-19 continue to emerge around the globe, increasing the case numbers and short-term quarantines which can each further impact our workforce and business and those of our customers and suppliers.</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The extent to which our operations and financial performance will be impacted by the pandemic for the remainder of 2022 and beyond will depend largely on future developments, including changes in hospital utilization rates and staffing, prevalence and severity of new variants and their impact on case numbers and short-term quarantines, the impact of vaccines on the spread of COVID-19 and its variants, global availability and acceptance of vaccines and their effectiveness against variants, disruptions to workforce availability, and any continuing impact on the global supply chain. If COVID-19 or its variants become more contagious, if efforts to further contain the effects of COVID-19 or its variants, including vaccine availability, are unsuccessful, if COVID-19, its variants, or disruptions to the global supply chain impact our supply chain or employee availability or productivity, or if we continue to experience periods of uncertainty due to COVID-19 or its variants, it could materially, adversely affect our revenues, financial condition, profitability, and cash flows.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the &#8220;Risk Factors&#8221; identified in Part II, Item 1A of this form 10-Q for risks related to COVID-19.</span></div><div id="i167b7825c15e480eba61f77e008c32de_85"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 of &#8220;Notes to Condensed Consolidated Financial Statements&#8221; identified in Part I, Item I of this form 10-Q for further discussion of new accounting standards that have been adopted. </span></div><div id="i167b7825c15e480eba61f77e008c32de_91"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Tables in thousands)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Revenues for the<br/>Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Percent<br/>Change<br/>From Prior<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Revenues as a Percentage of<br/>Total Revenues for the<br/>Three Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Aortic stent grafts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,674</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20,896</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">-6%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">26%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">29%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Surgical sealants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,374</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">16,544</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">23%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">23%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">On-X</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">16,456</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">14,022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,744</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,645</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total products</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">55,248</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">53,107</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">72%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">74%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21,590</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">13%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">26%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">76,838</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">72,207</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">100%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">100%</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Revenues for the<br/>Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Percent<br/>Change<br/>From Prior<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Revenues as a Percentage of<br/>Total Revenues for the<br/>Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Aortic stent grafts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">69,013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">62,165</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">29%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">28%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Surgical sealants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">49,022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">52,236</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">-6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">24%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">On-X</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">47,082</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">41,843</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">13%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,609</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,284</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total products</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">171,726</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">162,528</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">6%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">73%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">74%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">62,665</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">56,914</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">27%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">26%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">234,391</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">219,442</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">7%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">100%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">100%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues increased 6% and 7% for the three and nine months ended September 30, 2022, respectively, as compared to the three and nine months ended September 30, 2021. The increase in revenues for the three months ended September 30, 2022 was due to an increase in revenues from preservation services, On-X products, surgical sealants, and other products, partially offset by a decrease in revenues from aortic stent grafts. The increase in revenues for the nine months ended September 30, 2022 was due to an increase in revenues from aortic stent grafts, preservation services, On-X products, and other products, partially offset by a decrease in revenues from surgical sealants. Excluding the effects of foreign exchange, revenues increased 11% for the three and nine months ended September 30, 2022, as compared to the three and nine months ended September 30, 2021. Revenues for the three and nine months ended September 30, 2022 and 2021 were negatively impacted in certain regions by delays or cancellations of some surgical procedures as a result of reduced hospital capacity and staffing and hospital restrictions due to the COVID-19 pandemic. The revenue impact from COVID-19 was smaller and varied regionally during the three and nine months ended September 30, 2022, as compared to the three and nine months ended September 30, 2021. A detailed discussion of the changes in product revenues and preservation services revenues for the three and nine months ended September 30, 2022 is presented below. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Products</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues from products increased 4% and 6% for the three and nine months ended September 30, 2022, respectively, as compared to the three and nine months ended September 30, 2021. The increase for the three months ended September 30, 2022 was due to an increase in revenues from On-X products, surgical sealants, and other products, partially offset by a decrease in revenues from aortic stent grafts. The increase in revenues for the nine months ended September 30, 2022 was due to an increase in revenues from aortic stent grafts, On-X products, and other products, partially offset by a decrease in revenues from surgical sealants. A discussion of the changes in product revenues for aortic stent grafts, surgical sealants, On-X products, and other product revenues is presented below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sales of certain products through our direct sales force and distributors across Europe and various other countries are denominated in a variety of currencies including Euros, British Pounds, Polish Zlotys, Swiss Francs, Brazilian Reals, and Canadian Dollars, with a concentration denominated in Euros. Each currency is subject to exchange rate fluctuations. For the three and nine months ended September 30, 2022, as compared to the three and nine months ended September 30, 2021, the US Dollar strengthened in comparison to major currencies, resulting in revenue decreases when these foreign currency denominated transactions were translated into US Dollars. Future changes in these exchange rates could have a material, adverse effect on our revenues denominated in these currencies. Additionally, our sales to many distributors around the world are denominated in US Dollars, and although these sales are not directly impacted by currency exchange rates, we believe that some of our distributors may delay or reduce purchases of products in US Dollars depending on the relative price of these goods in their local currencies.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aortic Stent Grafts</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, synthetic vascular grafts, and original equipment manufacturing (&#8220;OEM&#8221;) aortic stent graft products. Aortic arch stent grafts include our E-vita Open NEO, E-vita Open Plus, AMDS, NEXUS, E-vita Thoracic 3G, and E-nya products. Abdominal stent grafts include our E-xtra Design Engineering, E-nside, E-tegra, E-ventus BX, and E-liac products. Aortic stent grafts are used in endovascular and open </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vascular surgery for the treatment of complex aortic arch, thoracic, and abdominal aortic diseases. Our aortic stent grafts are primarily distributed in international markets. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from aortic stent grafts decreased 6% for the three months ended September 30, 2022, as compared to the three months ended September 30, 2021. Revenues from aortic stent grafts increased 11% for the nine months ended September 30, 2022, as compared to the nine months ended September 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues from aortic stent grafts, excluding OEM, decreased 4% for the three months ended September 30, 2022, as compared to the three months ended September 30, 2021. This decrease was primarily due to the effect of foreign exchange rates, which decreased revenues by 11%, partially offset by an increase in units sold, which increased revenues by 6%, and an increase in average sales prices, which increased revenues by 1%. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues from aortic stent grafts, excluding OEM, increased 13% for the nine months ended September 30, 2022, as compared to the nine months ended September 30, 2021. This increase was primarily due to an increase in the volume of units sold, which increased revenues by 21%, and an increase in average sales prices, which increased revenues by 1%, partially offset by the effect of foreign exchange rates, which decreased revenues by 9%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On a constant currency basis, revenues from aortic stent grafts, excluding OEM, increased 8% and 23% for the three and nine months ended September 30, 2022, respectively, as compared to the three and nine months ended September 30, 2021. The increase in revenues was partially due to improved conditions from the COVID-19 pandemic for the three and nine months ended September 30, 2022, as compared to the three and nine months ended September 30, 2021. Revenues for the three months ended September 30, 2022 increased primarily in the Asia Pacific ("APAC") and Latin American regions. Revenues for the nine months ended September 30, 2022 increased primarily in Europe, the Middle East, and Africa (collectively, "EMEA"), APAC, and Latin America. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The revenue increase in EMEA for the nine months ended September 30, 2022 was primarily due to buying patterns in certain direct and indirect markets. The revenue increase in APAC for the three and nine months ended September 30, 2022 was primarily due to an increase in sales of newly launched aortic stent grafts and distributor buying patterns in certain markets. The revenue increase in Latin America for the three and nine months ended September 30, 2022 was primarily due to market penetration in certain regions. OEM sales of aortic stent grafts accounted for less than 1% of product revenues for the three and nine months ended September 30, 2022 and 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Surgical Sealants </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical sealants include BioGlue products used as an adjunct to standard methods of achieving hemostasis (such as sutures and staples) in adult patients in open surgical repair of large vessels (such as aorta, femoral, and carotid arteries).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from the sales of surgical sealants increased 5% for the three months ended September 30, 2022, as compared to the three months ended September 30, 2021. This increase was primarily due to an increase in volume of milliliters sold, which increased revenues by 7%, and an increase in average sales prices, which increased revenues by 3%, partially offset by the effect of foreign exchange rates, which decreased revenues by 5%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues from the sales of surgical sealants decreased 6% for the nine months ended September 30, 2022, as compared to the nine months ended September 30, 2021. This decrease was primarily due to a change in the mix of milliliters sold and a decrease in volume of milliliters sold, which decreased revenues by 4%, and the effect of foreign exchange rates, which decreased revenues by 3%, partially offset by an increase in average sales prices, which increased revenues by 1%. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On a constant currency basis, revenues from sales of surgical sealants increased 9% for the three months ended September 30, 2022, as compared to the three months ended September 30, 2021. On a constant currency basis, revenues from sales of surgical sealants decreased 4% for the nine months ended September 30, 2022, as compared to the nine months ended September 30, 2021. The increase in revenues in the three months ended September 30, 2022 was primarily due to revenue increases in EMEA. The decrease in revenues in the nine months ended September 30, 2022 was primarily due to revenue decreases in North America. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the nine months ended September 30, 2021 revenues from the sales of surgical sealants in North America were larger than in the nine months ended September 30, 2022, primarily due to inventory restocking orders placed during the first half of 2021 as hospitals experienced reduced impact from the COVID-19 pandemic and began resuming more normal operations. Revenues were negatively impacted during the first quarter of 2022 due to delays and cancellations of some surgical procedures due to hospital staffing challenges as a result of a new COVID-19 variant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The revenue increase in EMEA during the three months ended September 30, 2022 was primarily due to customers accelerating orders in certain countries in anticipation of the potential expiration of certain BioGlue derogations, which have since been extended. Surgical sealant revenue in EMEA was adversely impacted during the first half of 2022 primarily due to temporary commercialization restrictions resulting from the expiration of our BioGlue CE Mark during our transition to a new notified body. During this ongoing transition period, we have requested, and certain countries have granted, derogations to allow us to continue to commercialize BioGlue in those countries until we can complete our transition to a new notified body. We have obtained or anticipate obtaining extension of early-expiring derogations and currently anticipate completing the remaining transition and the renewal of our BioGlue CE Mark in the fourth quarter of 2022. We anticipate EMEA BioGlue revenues during the three months ended December 31, 2022 will be impacted by orders accelerated during the three months ended September 30, 2022. See Part II, Item 1A, &#8220;Risk Factors&#8212;Industry Risks&#8212; Our products and tissues are highly regulated and subject to significant quality and regulatory risks.&#8221; for further background on our transition to a new notified body; see also, Part II, Item 1A, &#8220;Risk Factors&#8212;Operational Risks&#8212; We may not be successful in obtaining necessary clinical results or regulatory clearances/approvals for new and existing products and services, and our approved products and services may not achieve market acceptance.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Domestic revenues from surgical sealants accounted for 46% and 48% of total surgical sealant revenues for the three and nine months ended September 30, 2022, respectively, and 48% and 52% of total surgical sealant revenues for the three and nine months ended September 30, 2021, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">On-X</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The On-X products include the On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis (&#8220;AAP&#8221;) for heart valve replacement. On-X product revenues also include revenues from the distribution of CarbonAid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diffusion catheters and from the sale of Chord-X</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ePTFE sutures for mitral chordal replacement. On-X products also generates revenue from pyrolytic carbon coating products produced for OEM customers. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On-X product revenues increased 17% and 13% for the three and nine months ended September 30, 2022, respectively, as compared to the three and nine months ended September 30, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On-X product revenues, excluding OEM, increased 19% for the three months ended September 30, 2022, as compared to the three months ended September 30, 2021. This increase was primarily due to an increase in volume of units sold, which increased revenues by 19%, and an increase in average sales prices, which increased revenues by 1%, partially offset by the effect of foreign exchange rates, which decreased revenues by 1%. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On-X product revenues, excluding OEM, increased 13% for the nine months ended September 30, 2022, as compared to the nine months ended September 30, 2021. This increase was primarily due to an increase in volume of units sold, which increased revenues by 12%, and an increase in average sales prices, which increased revenues by 2%, partially offset by the effect of foreign exchange rates, which decreased revenues by 1%. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On a constant currency basis, On-X product revenues, excluding OEM, increased 20% and 15% for the three and nine months ended September 30, 2022, respectively, as compared to the three and nine months ended September 30, 2021. The increase in revenues in the three months ended September 30, 2022 was primarily due to revenue increases in North America, EMEA and APAC. The increase in revenues in the nine months ended September 30, 2022 was primarily due to revenue increases in North America, EMEA, and Latin America. The revenue increases in these markets were partially due to improved conditions from the COVID-19 pandemic for the three and nine months ended September 30, 2022, as compared to the three and nine months ended September 30, 2021. The increase in revenues in North America for the three and nine months ended September 30, 2022 was also impacted by customer buying patterns. The increase in revenues in EMEA was also impacted by an increase of shipments in direct markets for the three and nine months ended September 30, 2022, and an increase of shipments in indirect markets for the three months ended September 30, 2022. The increase in revenues in Latin America for the three and nine months ended September 30, 2022 was also impacted by market penetration in certain regions. On-X OEM sales accounted for less than 1% of product revenues for both the three and nine months ended September 30, 2022 and 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenues are comprised of PhotoFix, PerClot (prior to the Baxter Transaction, described below), and CardioGenesis cardiac laser therapy product revenues.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2021 we entered into an asset purchase agreement and other ancillary agreements related to the sale of PerClot, a polysaccharide hemostatic agent used in surgery, to Baxter, and an agreement to terminate all of our material agreements with Starch Medical, Inc. (&#8220;SMI&#8221;) related to PerClot (collectively the &#8220;Baxter Transaction&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenues increased 6% and 5% for the three and nine months ended September 30, 2022, respectively, as compared to the three and nine months ended September 30, 2021. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in other revenues for the three and nine months ended September 30, 2022, as compared to the three and nine months ended September 30, 2021 was primarily due to an increase in CardioGenesis cardiac laser therapy product revenues, partially offset by a decrease in PerClot product revenues. The increase in CardioGenesis cardiac laser therapy product revenues for the three and nine months ended September 30, 2022 was primarily due to our ability to resume limited sales of handpieces during the fourth quarter of 2021, as further described below. The decrease in PerClot product revenues for the three and nine months ended September 30, 2022 was due to the Baxter Transaction, described in more detail in Part II, Item 7, &#8220;Sale of PerClot&#8221; of our annual report on Form 10-K for the year ended December 31, 2021. </span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from our CardioGenesis cardiac laser therapy product line historically consisted primarily of sales of handpieces and, in certain periods, the sale of laser consoles. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended September 30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> we had minimal revenues from the CardioGenesis cardiac laser therapy product line as we did not have a supply of handpieces due to the FDA&#8217;s review of our supplier&#8217;s change in manufacturing location. After obtaining approval, our supplier resumed manufacturing a limited supply of handpieces allowing us to resume limited sales during the fourth quarter of 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preservation Services</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preservation services include service revenues from processing cardiac and vascular tissues. Our cardiac valves are primarily used in cardiac replacement and reconstruction surgeries, including the Ross procedure, for patients with endocarditis or congenital heart defects. The majority of our vascular preservation services revenues are related to shipments of saphenous veins, which are mainly used in peripheral vascular reconstruction surgeries to avoid limb amputations. Competition with synthetic product alternatives and the availability of tissues for processing are key factors affecting revenue volume that can fluctuate from quarter to quarter. Our cardiac and vascular tissues are primarily distributed in domestic markets. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to evaluate modifications to our tissue processing procedures in an effort to improve tissue processing throughput, reduce costs, and maintain quality across our tissue processing business. Preservation services revenues, particularly revenues for certain high-demand cardiac tissues, can vary from quarter to quarter and year to year due to a variety of factors, including quantity and type of incoming tissues, yields of tissue through the preservation process, timing of receipt of donor information, timing of the release of tissues for implant, demand for certain tissue types due to the number and type of procedures being performed, and pressures from competing products or services. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2020 we became aware that a supplier shipped to us a saline solution lot that we use in our tissue processing that contained some contamination in a small number of bottles of the solution lot. The contamination was identified by our in-process quality controls. The contaminated solution was estimated to have impacted a small percentage of tissue processed with this solution lot, causing us to write-off approximately $826,000 of tissue in the fourth quarter of 2020. An additional $5.0 million of tissue was quarantined in process pending further testing. Upon completion, and FDA acceptance of the testing, we began releasing tissue meeting our release criteria late in the second quarter of 2021. We believe that the written-off and quarantined tissue impacted the availability of tissue for distribution, which had a negative impact on revenue in the first quarter of 2021, and, to a lesser extent, the second quarter of 2021. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from tissue processing increased 13% for the three months ended September 30, 2022, as compared to the three months ended September 30, 2021. The increase in revenues for the three months ended September 30, 2022 was primarily due to an increase in tissue shipments, which increased revenues by 10%, and an increase in average sales prices, which increased revenues by 3%. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from tissue processing increased 10% for the nine months ended September 30, 2022, as compared to the nine months ended September 30, 2021. The increase in revenues for the nine months ended September 30, 2022 was primarily due to an increase of tissues shipped, which increased revenues by 7%, and an increase in average sales prices, which increased revenues by 3%.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in revenues from tissue processing for the three and nine months ended September 30, 2022 was primarily due to an increase in medical procedures that utilize our cardiac tissues. </span></div><div id="i167b7825c15e480eba61f77e008c32de_94"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Products and Preservation Services</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Cost of products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">15,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">53,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">46,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products increased 14% and 15% for the three and nine months ended September 30, 2022, respectively, as compared to the three and nine months ended September 30, 2021. Cost of products for the three and nine months ended September 30, 2022 and 2021 included costs related to aortic stent grafts, On-X products, surgical sealants, and other products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in cost of products for the three and nine months ended September 30, 2022 was primarily due to an increase in shipments of aortic stent grafts and On-X products as well as an increase in the cost of surgical sealants and aortic stent grafts, as compared to the three and nine months ended September 30, 2021. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Preservation Services</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Cost of preservation services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,351</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8,915</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">29,375</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of preservation services increased 16% and 10% for the three and nine months ended September 30, 2022, respectively, as compared to the three and nine months ended September 30, 2021. Cost of preservation services included costs for cardiac and vascular tissue preservation services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The increase in cost of preservation services for the three and nine months ended September 30, 2022 was primarily due to an increase in the processing cost of cardiac and vascular tissues, and, to a lesser extent, due to an increase in shipments, as compared to the three and nine months ended September 30, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Gross Margin</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Gross margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">48,744</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">47,789</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">151,635</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">146,140</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Gross margin as a percentage of total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">63%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">66%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">67%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin increased 2% and 4% for the three and nine months ended September 30, 2022, respectively, as compared to the three and nine months ended September 30, 2021. The increase for the three months ended September 30, 2022, as compared to the three months ended September 30, 2021, was primarily due to an increase in shipments of all products, partially offset by the effect of foreign exchange rates and an increase in cost of certain products. Gross margin as a percentage of total revenues decreased for the three months ended September 30, 2022, as compared to the three months ended September 30, 2021, primarily due to an increase in product costs of certain products sold resulting from inflationary pressures of materials and labor, and to a lesser extent, the mix of products shipped, partially offset by favorable pricing of certain products during the three months ended September 30, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase for the nine months ended September 30, 2022, as compared to the nine months ended September 30, 2021, was primarily due to an increase in shipments of aortic stent grafts, On-X products, and preservation services partially offset by the effect of foreign exchange rates and an increase in cost of certain products. Gross margin as a percentage of total revenues decreased for the nine months ended September 30, 2022, as compared to the nine months ended September 30, 2021, primarily due to an increase in product costs of certain products sold resulting from inflationary pressures of materials and labor, and to a lesser extent, the mix of products shipped, partially offset by favorable pricing of certain products during the nine months ended September 30, 2022.</span></div><div id="i167b7825c15e480eba61f77e008c32de_97"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General, Administrative, and Marketing Expenses</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">General, administrative, and marketing expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">41,051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">39,053</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">118,989</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">118,521</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">General, administrative, and marketing expenses as a percentage of total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">53%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">54%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">51%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">54%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General, administrative, and marketing expenses increased 5% for the three months ended September 30, 2022, as compared to the three months ended September 30, 2021. General, administrative, and marketing expenses were flat in the nine months ended September 30, 2022, as compared to the nine months ended September 30, 2021. The increase in General, administrative, and marketing expenses for the three months ended September 30, 2022 was primarily due to an increase in personnel-related and marketing costs. General, administrative, and marketing expenses for the nine months ended September 30, 2022 included an increase in personnel-related and marketing costs offset by a decrease in business development expenses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General, administrative, and marketing expenses included $864,000 of business development expense and $3.8 million of business development income for the three and nine months ended September 30, 2022, respectively, as compared to $1.3 million and $6.1 million of expense for the three and nine months ended September 30, 2021, respectively. We incurred $400,000 of business development expense and $4.6 million of business development income during the three and nine months ended September 30, 2022, respectively, related to the fair value adjustments for the Ascyrus contingent consideration, as compared to $700,000 and $5.0 million of business development expense during the three and nine months ended September 30, 2021, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.782%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11,799</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,972</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">30,575</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">26,086</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Research and development expenses as a percentage of total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">15%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">14%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">13%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">12%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased 18% and 17% for the three and nine months ended September 30, 2022, respectively, as compared to the three and nine months ended September 30, 2021. Research and development spending for the three and nine months ended September 30, 2022 was primarily focused on clinical work to gain regulatory approvals for On-X, certain aortic stent grafts, and PerClot products. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 23, 2022 we announced that we were stopping the PROACT Xa clinical trial as recommended by the trial's independent Data and Safety Monitoring Board. The PROACT Xa clinical trial was a prospective, randomized, trial designed to determine if patients with  On-X mechanical aortic valves could be maintained safely and effectively on apixaban rather than on warfarin. As a result of PROACT Xa's early termination, we recorded $4.7 million of termination and wind-down expenses that are included in Research and development operating expenses on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income for the three and nine months ended September 30, 2022. The majority of these costs include future administrative costs that will be incurred during the fourth quarter of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 and the first quarter of 2023, as well as the estimated cost of clinical drugs purchased for patients participating in the study that are not expected to be recovered. See Part II, Item 1, &#8220;Business&#8221; of our annual report on Form 10-K for the year ended December 31, 2021 for further detail of the PROACT Xa trial. </span></div><div id="i167b7825c15e480eba61f77e008c32de_504"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gain from Sale of Non-Financial Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain from sale of non-financial assets for the three and nine months ended September 30, 2021 consisted of the net $15.9 million gain from the sale of PerClot assets as part of the Baxter Transaction on July 28, 2021.</span></div><div id="i167b7825c15e480eba61f77e008c32de_100"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $4.8 million and $12.9 million for the three and nine months ended September 30, 2022, respectively, as compared to $4.1 million and $13.0 million for the three and nine months ended September 30, 2021, respectively. Interest expense for the three and nine months ended September 30, 2022 and 2021 relates to interest on debt and uncertain tax positions. </span></div><div id="i167b7825c15e480eba61f77e008c32de_103"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Expense, Net</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net was $3.7 million and $7.6 million for the three and nine months ended September 30, 2022, respectively, as compared to $2.7 million and $3.3 million for the three and nine months ended September 30, 2021, respectively. Other expense, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net primarily includes the realized and unrealized effects of foreign currency gains and losses.</span></div><div id="i167b7825c15e480eba61f77e008c32de_106"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Table in thousands, except per share data) </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(Loss) income before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(12,532)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">7,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(18,261)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,260&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(2,638)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(4,006)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(13,713)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">10,582</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(21,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">5,266</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted (loss) income per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">0.26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">0.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,115</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">44,453</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,999</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,496</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred a loss before income taxes for the three and nine months ended September&#160;30, 2022 and experienced an income before income taxes for the three and nine months ended September&#160;30, 2021. The loss before income taxes for the three and nine months ended September&#160;30, 2022 was negatively impacted by an increase in certain operating expenses to support revenue expansion, an increase in investments in the research and development pipeline, and an unfavorable impact of foreign currency gains and losses. The loss before income taxes was partially offset by the change in fair value of our financial instruments for the nine months ended September 30, 2022. The income before income taxes for the three and nine months ended September&#160;30, 2021 was primarily due to a gain from sale of non-financial assets related to the Baxter Transaction described above, partially offset by business development, integration and severance expenses primarily related to the Ascyrus acquisition, and investments in the research and development pipeline. Revenues for the three and nine months ended September&#160;30, 2022 and 2021 were also unfavorably impacted by delays or cancellations of some surgical procedures as a result of reduced hospital capacity and staffing and hospital restrictions due to the COVID-19 pandemic in certain regions. The revenue impact from COVID-19 was smaller and varied regionally during the three and nine months ended September 30, 2022, as compared to the three and nine months ended September 30, 2021. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was an expense of 9% and 17% for the three and nine months ended September&#160;30, 2022, respectively, as compared to a benefit of 33% and 318% for the three and nine months ended September&#160;30, 2021, respectively. The change in the tax rate for the three and nine months ended September&#160;30, 2022 was primarily due to changes in pre-tax book income, a decrease in the excess tax benefit related to stock compensation, and an increase in the estimated current year valuation allowance, as compared to the three and nine months ended September&#160;30, 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax rate for the three and nine months ended September&#160;30, 2022 was primarily impacted by changes in our valuation allowance against our net deferred tax assets, non-deductible executive compensation, the foreign derived intangible income deduction, the research and development tax credit, changes in our uncertain tax position liabilities, and tax shortfalls on stock compensation.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our income tax rate for the three and nine months ended September&#160;30, 2021 was primarily impacted by non-deductible executive compensation, changes in our valuation allowance against our deferred tax assets, changes in our uncertain tax position liabilities, the research and development tax credit, and excess tax benefits on stock compensation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred net loss and diluted loss per common share for the three and nine months ended September&#160;30, 2022 and experienced net income and diluted income per common share for the three and nine months ended September&#160;30, 2021. Net loss and diluted loss per common share for the three and nine months ended September&#160;30, 2022 was primarily due to loss before income taxes, as discussed above. </span></div><div id="i167b7825c15e480eba61f77e008c32de_109"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the uncertainty and other impacts of the COVID-19 pandemic and the resulting shifts of timing in some revenue, our historically observable seasonality of revenues has been impacted or obscured in 2021 and 2022 and potentially beyond.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we believe the demand for most of our aortic stent grafts is seasonal, with a decline in demand generally occurring in the third quarter due to the summer holiday season in Europe. We are uncertain whether the demand for AMDS and NEXUS products is seasonal, as these products have not fully penetrated many markets and, therefore, the nature of any seasonal trends may not yet be obvious.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we believe the demand for BioGlue and On-X products is seasonal, with a decline in demand generally occurring in the third quarter followed by stronger demand in the fourth quarter. We believe that this trend may be due to the summer holiday season in Europe and the US.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe the demand for our other products is seasonal.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand for our cardiac preservation services has traditionally been seasonal, with peak demand generally occurring in the third quarter. We believe this trend for cardiac preservation services is primarily due to the high number of surgeries scheduled during the summer months for school-aged patients. Based on experience in recent years, we believe that this trend is lessening as we are distributing a higher percentage of our tissues for use in adult populations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand for our vascular preservation services has also traditionally been seasonal, with lowest demand generally occurring in the fourth quarter. We believe this trend for vascular preservation services was primarily due to fewer vascular surgeries being scheduled during the winter holiday months.</span></div><div id="i167b7825c15e480eba61f77e008c32de_112"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Working Capital</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 net working capital (current assets of $238.0 million less current liabilities of $46.0 million) was $192.0 million, with a current ratio (current assets divided by current liabilities) of 5 to 1, as compared to net working capital of $202.7 million and a current ratio of 6 to 1 at December&#160;31, 2021. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overall Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary cash requirements for the nine months ended September 30, 2022 were for general working capital needs, capital expenditures for facilities and equipment, interest and principal payments under our Credit Agreement (defined below), interest payments under our Convertible Senior Notes (defined below), and repurchases of stock to cover tax withholdings. We funded our cash requirements through our existing cash reserves and proceeds from stock option exercises.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our cash from operations and existing cash and cash equivalents will enable us to meet our current operational liquidity needs for at least the next twelve months. Our future cash requirements are expected to include interest and principal payments under our Credit Agreement and Convertible Senior Notes (described in &#8220;Significant Sources and Uses </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of Liquidity&#8221; section below), expenditures for clinical trials, research and development expenditures, general working capital needs, capital expenditures, and other corporate purposes and may include cash to fund business development activities including obligations in the agreements related to the Endospan and Ascyrus transactions. These items may have a significant effect on our future cash flows during the next twelve months. Subject to the terms of our Credit Agreement, we may seek additional borrowing capacity or financing, pursuant to our current or any future shelf registration statement, for general corporate purposes or to fund other future cash requirements. If we undertake any further significant business development activity, we may need to finance such activities by obtaining additional debt financing or using a registration statement to sell equity securities. There can be no assurance that we will be able to obtain any additional debt or equity financing at the time needed or that such financing will be available on terms that are favorable or acceptable to us. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Sources and Uses of Liquidity</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2017 we entered into a credit and guaranty agreement for a $255.0 million senior secured credit facility, consisting of a $225.0 million secured term loan facility (the &#8220;Term Loan Facility&#8221;) and a $30.0 million secured revolving credit facility (the &#8220;Revolving Credit Facility&#8221; and, together with the Term Loan Facility, the &#8220;Credit Agreement&#8221;). We and each of our existing domestic subsidiaries (subject to certain exceptions and exclusions) guarantee the obligations under the Credit Agreement (the &#8220;Guarantors&#8221;). The Credit Agreement is secured by a security interest in substantially all existing and after-acquired real and personal property (subject to certain exceptions and exclusions) of us and the Guarantors.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2021 we entered into an amendment to our Credit Agreement to extend the maturity dates of both our Term Loan and Revolving Credit Facility. As part of the amendment, the maturity dates of both our Term Loan and Revolving Credit Facility were each extended by two and one-half years, until June 1, 2027 and June 1, 2025, respectively, subject to earlier springing maturities triggered if our 4.25% Convertible Senior Notes, described below, remain outstanding on April 1, 2025 and December 31, 2024, respectively. With respect to the Term Loan, if the Convertible Senior Notes remain outstanding on April 1, 2025, the Term Loan&#8217;s Maturity Date will be April 1, 2025, or, if the Convertible Senior Notes&#8217; own maturity date has been extended, the earlier of (i) 91 days prior to the Convertible Senior Notes&#8217; new maturity date and (ii) June 1, 2027. In the case of the Revolving Credit Facility, if the Convertible Senior Notes are still outstanding on December 31, 2024, the Revolving Credit Facility&#8217;s Maturity Date will be either December 31, 2024 or, if the Convertible Senior Notes&#8217; own maturity date has been extended, the earlier of (i) 182 days prior to the Convertible Senior Notes&#8217; new maturity date and (ii) June 1, 2025. Under the amendment, the Term Loan Facility bears interest, at our option, at a floating annual rate equal to either the base rate, plus a margin of 2.50%, or LIBOR, plus a margin of 3.50%. Prior to the amendment, the optional floating annual rate was equal to either the base rate plus a margin of 2.25%, or LIBOR, plus a margin of 3.25%.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2020 we issued $100.0 million aggregate principal amount of 4.25% Convertible Senior Notes with a maturity date of July 1, 2025 (the &#8220;Convertible Senior Notes&#8221;). The net proceeds from this offering, after deducting initial purchasers&#8217; discounts and costs directly related to this offering, were approximately $96.5 million. On January 1, 2021 we adopted ASU 2020-06 and adjusted the carrying balance of the Convertible Senior Notes to notional. The Convertible Senior Notes balance was $100.0 million recorded in Long-term debt on the Condensed Consolidated Balance Sheets as of September&#160;30, 2022. The Convertible Senior Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. The initial conversion rate of the Convertible Senior Notes is 42.6203 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $23.46 per share, subject to adjustments. We use the if-converted method for assumed conversion of the Convertible Senior Notes for the diluted earnings per share calculation. The fair value and the effective interest rate of the Convertible Senior Notes as of September&#160;30, 2022 was approximately $92.3 million and 5.05%, respectively. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he fair value was based on market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest expense recognized on the Convertible Senior Notes includes $1.2 million and $3.7 million for the </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended September&#160;30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, and $1.2 million and $3.7 million for the </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended September&#160;30, 2021, respectively, related to the aggregate of the contractual coupon interest, and the amortization of the debt issuance costs</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Interest on the Convertible Senior Notes began accruing upon issuance and is payable semi-annually. </span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Convertible Senior Notes may convert their notes at their option at any time prior to January 1, 2025 but only under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each applicable trading day; (ii) during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (iii) we give a notice of redemption with respect to any or all of the notes, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate events. On or after January 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their notes at any time, regardless of the foregoing circumstances.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot redeem the Convertible Senior Notes before July 5, 2023. We can redeem them on or after July 5, 2023, in whole or in part, at our option, if the last reported sale price per share of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption. We may redeem for cash all or part of the Convertible Senior Notes at a redemption price equal to 100% of the principal amount of the redeemable Convertible Senior Notes, plus accrued and unpaid interest to, but excluding, the redemption date. No principal payments are due on the Convertible Senior Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the Convertible Senior Notes do not contain any financial covenants and do not restrict us from conducting significant restructuring transactions or issuing or repurchasing any of its other securities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 approximately 44% of our cash and cash equivalents were held in foreign jurisdictions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes cash flows from operating activities, investing activities, and financing activities for the periods indicated (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Cash flows (used in) provided by:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(4,936)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(3,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,047)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(3,422)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,675)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,418</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(Decrease) increase in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(17,438)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Operating Activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $4.9 million and $3.3 million for the nine months ended September 30, 2022 and 2021, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the indirect method to prepare our cash flow statement and, accordingly, the operating cash flows are based on our net income, which is then adjusted to remove non-cash items, items classified as investing and financing cash flows, and changes in operating assets and liabilities from the prior year end. For the nine months ended September 30, 2022 these non-cash items included $17.0 million in depreciation and amortization expenses, $9.2 million in non-cash compensation, $5.7 million of lease expenses, $5.1 million of deferred income tax changes, and $4.6 million in fair value adjustments of financial instruments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our working capital needs, or changes in operating assets and liabilities, also affected cash from operations. For the nine months ended September 30, 2022 these included the unfavorable effect of $10.9 million due to the timing differences between recording receivables and the receipt of cash, $5.8 million due to an increase in inventory balances and deferred preservation costs, $2.1 million due to timing differences between the recording of accounts payable and other current liabilities, and $1.8 million due to an increase in prepaid expenses and other assets. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Investing Activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $8.0 million for the nine months ended September 30, 2022. Net cash provided by investing activities was $8.5 million for the nine months ended September&#160;30, 2021. During the nine months ended September 30, 2022 cash used in investing activities primarily included $6.9 million of cash used for capital expenditures. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Financing Activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $780,000 and $3.4 million for the nine months ended September 30, 2022 and 2021, respectively. The current year cash used in financing activities was primarily due to $2.0 million for the repayment of debt and $1.8 million for repurchases of common stock to cover tax withholdings, partially offset by $3.3 million of proceeds from the exercise of stock options and issuances of common stock.</span></div><div id="i167b7825c15e480eba61f77e008c32de_115"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Scheduled Contractual Obligations and Future Payments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term debt obligations and interest payments include $315.4 million of scheduled principal payments and $82.8 million in anticipated interest payments related to our Credit Agreement, Convertible Senior Notes, and other governmental loans. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have contingent payment obligations that include up to $100.0 million to be paid to the former shareholders of Ascyrus, upon the achievement of certain milestones. We are obliged to make a $5.0 million third tranche payment under our loan agreement with Endospan upon receipt of certification that certain clinical trial milestones have been achieved. As part of the Baxter Transaction, we may be required to pay up to $9.0 million if certain milestones are met. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating and finance lease obligations result from the lease of land and buildings that comprise our corporate headquarters and our various manufacturing facilities; leases related to additional manufacturing, office, and warehouse space; leases on Company vehicles; and leases on a variety of office equipment and other equipment. </span></div><div id="i167b7825c15e480eba61f77e008c32de_118"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Expenditures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital expenditures were $6.9 million and $10.5 million for the nine months ended September 30, 2022 and 2021, respectively. Capital expenditures for the nine months ended September 30, 2022 were primarily related to routine purchases of manufacturing and tissue processing equipment, computer software, leasehold improvements needed to support our business, and computer equipment.</span></div><div id="i167b7825c15e480eba61f77e008c32de_121"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the &#8220;Risk Factors&#8221; identified in Part II, Item 1A of this Form 10-Q.</span></div><div id="i167b7825c15e480eba61f77e008c32de_124"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest income and interest expense are sensitive to changes in the general level of US interest rates. In this regard, changes in US interest rates affect the interest earned on our cash and cash equivalents of $37.6 million as of September&#160;30, 2022 and interest paid on the outstanding balances, if any, of our variable rate Revolving Credit Facility, Term Loan Facility, and Convertible Senior Notes. A 10% adverse change in interest rates, as compared to the rates experienced by us for the nine months ended September 30, 2022, affecting our cash and cash equivalents, Term Loan Facility, Revolving Credit Facility, and Convertible Senior Notes would not have a material effect on our financial position, results of operations, or cash flows. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have balances, such as cash, accounts receivable, accounts payable, and accruals that are denominated in foreign currencies. These foreign currency denominated balances are sensitive to changes in exchange rates. In this regard, changes in exchange rates could cause a change in the US Dollar equivalent of cash or funds that we will receive in payment for assets or that we would have to pay to settle liabilities. As a result, we could be required to record these changes as gains or losses on foreign currency translation. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have revenues and expenses that are denominated in foreign currencies. Specifically, a portion of our international revenues from aortic stent grafts, surgical sealants, On-X, and other products are denominated in Euros, British Pounds, Swiss Francs, Polish Zlotys, Canadian Dollars, and Brazilian Reals and a portion of our General, administrative, and marketing expenses are denominated in Euros, British Pounds, Swiss Francs, Polish Zlotys, Canadian Dollars, Brazilian Reals, and Singapore Dollars. These foreign currency transactions are sensitive to changes in exchange rates. In this regard, changes in exchange rates could cause a change in the US Dollar equivalent of net income from transactions conducted in other currencies. As a result, we could recognize a reduction in revenues or an increase in expenses related to a change in exchange rates. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional 10% adverse change in exchange rates from the exchange rates in effect on September&#160;30, 2022 affecting our balances denominated in foreign currencies could impact our financial position or cash flows by approximately $7.0 million. An additional 10% adverse change in exchange rates from the weighted-average exchange rates experienced by us for the nine months ended September 30, 2022 affecting our revenue and expense transactions denominated in foreign currencies would not have had a material impact on our financial position, profitability, or cash flows. </span></div><div id="i167b7825c15e480eba61f77e008c32de_127"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures (&#8220;Disclosure Controls&#8221;) as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act. These Disclosure Controls are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms and that such information is accumulated and communicated to management, including to the Chief Executive Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;), as appropriate, to allow timely decisions regarding required disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our President and CEO and our Executive Vice President of Finance and CFO, does not expect that our Disclosure Controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving our stated goals under all potential future conditions. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within Artivion have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Our Disclosure Controls have been designed to provide reasonable assurance of achieving their objectives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management utilizes the criteria set forth in &#8220;Internal Control-Integrated Framework (2013)&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission to evaluate the effectiveness of our Disclosure Controls over financial reporting. Based upon the most recent Disclosure Controls evaluation conducted by management with the participation of the CEO and CFO, as of September&#160;30, 2022 the CEO and CFO have concluded that our Disclosure Controls were effective at a reasonable assurance level to satisfy their objectives and to ensure that the information required to be disclosed by us in our periodic reports is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding disclosure and is recorded, processed, summarized, and reported within the time periods specified in the US Securities and Exchange Commission&#8217;s rules and forms.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes to Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended September&#160;30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">37</span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II &#8211; OTHER INFORMATION</span></div><div id="i167b7825c15e480eba61f77e008c32de_133"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in legal proceedings concerning matters arising from the conduct of our business activities. We regularly evaluate the status of legal proceedings in which we are involved in order to assess whether a loss is probable or whether there is a reasonable possibility that a loss or additional loss may have been incurred and to determine if accruals are appropriate. We further evaluate each legal proceeding to assess whether an estimate of possible loss or range of loss can be made.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on current knowledge, we do not believe that there are any pending matters that could potentially have a material, adverse effect on our business, financial condition, results of operations, or cash flows. We are, however, engaged in various legal actions in the normal course of business. There can be no assurances in light of the inherent uncertainties involved in any potential legal proceedings, some of which are beyond our control, and an adverse outcome in any legal proceeding could be material to our results of operations or cash flows for any particular reporting period.</span></div><div id="i167b7825c15e480eba61f77e008c32de_136"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Business</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business involves a variety of risks and uncertainties, known and unknown, including, among others, the risks discussed below. These risks should be carefully considered together with the other information provided in this Quarterly Report on Form 10-Q and in our other filings with the SEC. Our failure to adequately anticipate or address these risks and uncertainties may have a material, adverse impact on our business, reputation, revenues, financial condition, profitability, and cash flows. Additional risks and uncertainties not presently known or knowable to us, or that we currently believe to be immaterial, may also adversely affect our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Business and Economic Risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19, and similar outbreaks, could have a material, adverse impact on us. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since early 2020, businesses, communities, and governments worldwide have taken, and continue to take, a wide range of actions to mitigate the spread and impact of COVID-19, leading to an unprecedented impact on the global economy. Hospitals and other healthcare providers have adopted differing approaches to address the surge and resurgence of COVID-19 cases, including their impact on healthcare workers and related global healthcare worker shortages, such as postponing elective and non-emergent procedures, restricting access to their facilities, cancelling elective procedures, or re-allocating scarce resources to some critically ill patients. Although many areas have seen a decline in COVID-19 cases, the potential for additional impact from new variants of COVID-19 remains. These conditions have, and could continue to, impact our activities, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our product sales. Certain countries experienced continued impact on revenues in the third quarter of 2022 due to the COVID-19 pandemic, and in particular, the impact of local lockdowns. In addition to COVID-19&#8217;s impact on procedure volumes, including an impact on procedure volumes due in part to COVID-19-related healthcare staffing shortages and shortages from workers exiting healthcare, we have observed additional downstream effects on our business, including an increase in delays or difficulty in collecting certain outstanding receivables, particularly with certain governmental payors in regions heavily impacted by COVID-19. The extent to which our financial performance will be impacted by the pandemic through the remainder of 2022 and beyond will depend largely on future developments, including changes in hospital utilization rates and staffing, the prevalence and severity of new variants and their impact on case numbers and short-term quarantines, and the global availability and acceptance of COVID-19 vaccines and their effectiveness against variants. COVID-19&#8217;s continued or increased impact on our financial performance may also increase the risks we face with respect to managing our indebtedness.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our business operations. In 2020 we took several steps to address the impact of COVID-19 on our employees, cash consumption, and operations, including reducing expenditures and delaying investments. Although we have scaled back most of these steps in most geographies, the COVID-19 virus and its variants remain highly contagious and may have additional impact on our business operations, including the potential to impact our workforce availability as case numbers and short-term quarantines increase due to the spread of new variants. COVID-19 also continues to impact our business partners, including the various regulators and notified bodies that we rely on, which increases the regulatory risks we face, and specifically, the risks we face with respect to timely review and approval of new and renewal certifications, clearances, and approvals for our products. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our manufacturing operations. The COVID-19 pandemic has continued to impact the global supply chain; the pandemic&#8217;s impact on workforces, global mobility, material availability, demand, costs, and shipping and reorder time and reliability has reportedly continued or worsened in many cases. Although we have yet to experience any material effects of this impact on our supply chain or operations, we have faced increasing costs and face an increasing risk that upstream disruptions may occur and that increasing case numbers and short-term quarantines impact our workforce availability. Risks relating to the lingering effects of global supply chain disruptions may even continue after COVID-19&#8217;s risk as a global pandemic has subsided.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our workforce. As some global economies have begun to emerge from the COVID-19 downturn, increased opportunities for remote work, the Great Resignation and increasing compensation pressure have resulted in a war for talent and an unprecedented number of career changes. The resulting worker shortages and increased labor costs at all levels have impacted supply chains, distribution channels, and employers&#8217; ability to adequately staff their operations. This has impacted not only our own ability to attract and retain employees, but also the ability of our customers who face increasing staffing pressures throughout their healthcare organizations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our research and development projects. In 2020 and parts of 2021 we reduced spending on research and development projects, including clinical research projects. These reductions could adversely impact future revenue, and additional reductions in spending could be implemented, further impacting future revenue. In addition, our ability to conduct our ongoing research and development projects in markets that are affected by COVID-19 has been, and could continue to be, adversely impacted. Enrollment and timelines for our clinical trials have been, and might continue to be, impacted as healthcare providers re-prioritize resources, address staffing shortages, and limit access to healthcare facilities or as patients decline to participate or are hesitant to voluntarily visit healthcare facilities. In addition, staffing shortages and COVID-19-related impacts on government and regulatory agencies have slowed and might continue to slow timelines for regulatory actions, including approvals and re-certifications.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If COVID-19 or its variants continue to spread, if efforts to contain COVID-19 or its variants continue or are unsuccessful, if we experience new outbreaks of COVID-19 in areas previously successful in containing its spread, if staffing shortages continue to impact us, governmental or regulatory bodies, or our customers, or if COVID-19, its variants, or disruptions to the global supply chain impact our supply chain or employee productivity, it could materially, adversely affect our revenues, financial condition, profitability, and cash flows. The nature and extent of these developments are highly uncertain and unpredictable and may vary greatly by region. These adverse developments or a prolonged period of uncertainty could adversely affect our financial performance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to a variety of risks due to our international operations and continued global expansion.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations subject us to a number of risks, which may vary significantly from the risks we face in our US operations, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Greater difficulties and costs associated with staffing, establishing and maintaining internal controls, managing foreign operations and distributor relationships, and selling directly to customers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Broader exposure to corruption and expanded compliance obligations, including under the Foreign Corrupt Practices Act, the UK Bribery Law, local anti-corruption laws, Office of Foreign Asset Control administered sanction programs, the European Union&#8217;s General Data Protection Regulation, and other emerging corruption and data privacy regulations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Overlapping and potentially conflicting, or unexpected changes in, international legal and regulatory requirements or reimbursement policies and programs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Longer and more expensive collection cycles in certain countries, particularly those in which our primary customers are government-funded hospitals;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in currency exchange rates, particularly fluctuations in the Euro as compared to the US Dollar and inflationary pressures in Latin America;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential adverse financial impact and negative erosion of our operating profit margin over time due to increasing inflationary pressures, particularly impacting our Latin American business as well as impact felt through our supply chain; our exposure may be increased through our limited ability to raise prices and through global expansion where business occurs with, or pricing is set directly by, government entities, or we are party to long term pricing agreements with governments or local distributors, impacting our ability to pass on rising costs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential adverse tax consequences of overlapping tax structures or potential changes in domestic and international tax policy, laws, and treaties; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential adverse financial and regulatory consequences resulting from the exit of the UK from the European Union, or &#8220;Brexit.&#8221; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and performance may also be impacted by regional and global geopolitical conditions, domestic and foreign trade and monetary policies, and other factors beyond our control. As an example of these risks, Russia&#8217;s invasion and military attacks on Ukraine have triggered significant sanctions from the US and foreign governments and retaliatory actions from Russia, resulting in significant banking and trade disruptions. The war has also resulted in significant devastation to the people and infrastructure in the region, significantly impacting trade and transportation which may impact our global supply chain, increase prices, and limit our ability to continue to do business in affected regions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, sanctions and other disruptions in the region have not materially impacted our business or ability to supply products to Russia, Belarus, Ukraine, and the region generally; however, continuation or escalation of the war or increased export controls or additional sanctions imposed on or by Russia, its allies, or related entities could adversely affect our financial performance. Although we do not have any direct operations in Russia or Ukraine, it is difficult to predict the ultimate course of the war and we may face business operations and supply chain disruptions as a result, including disruptions related to shortages of materials, higher costs of materials and freight, freight delays, increased energy costs or energy shortages, travel disruptions, currency fluctuation, and disruptions to banking systems or capital markets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We operate in highly competitive market segments, face competition from large, well-established medical device companies and tissue service providers with greater resources and we may not be able to compete effectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for our products and services is competitive and affected by new product introductions and activities of other industry participants. We face intense competition in virtually all of our product lines. A significant percentage of market revenues from competitive products are generated by Baxter International, Inc.; Ethicon (a Johnson &amp; Johnson Company); Medtronic, Inc.; Abbott Laboratories; Edwards Lifesciences Corp.; C.R. Bard, Inc., a subsidiary of Becton, Dickinson and Company; Integra Life Sciences Holdings; LifeNet; CORCYM; Anteris Technologies, Inc.; Aziyo Biologics; Cook Medical; Gore &amp; Associates; Terumo Aortic Corp.; LeMaitre Vascular, Inc.; Maquet, Inc.; Pfizer, Inc.; and BioCer Entwicklungs-GmbH. Several of our competitors enjoy competitive advantages over us, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Greater financial and other resources for research and development, commercialization, acquisitions, and litigation and to weather the impacts of COVID-19 and increased workforce competition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Greater name recognition as well as more recognizable trademarks for products similar to products that we sell; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">More established record of obtaining and maintaining regulatory product clearances or approvals;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">More established relationships with healthcare providers and payors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Lower cost of goods sold or preservation costs; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Larger direct sales forces and more established distribution networks.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are significantly dependent on our revenues from tissue preservation services and are subject to a variety of risks affecting them.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tissue preservation services are a significant source of our revenues, and as such, we face risks if we are unable to:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Source sufficient quantities of some human tissue or address potential excess supply of others. We rely primarily upon the efforts of third-parties to educate the public and foster a willingness to donate tissue. Factors beyond our control such as supply, regulatory changes, negative publicity concerning methods of tissue recovery or disease transmission from donated tissue, or public opinion of the donor process as well as our own reputation in the industry can negatively impact the supply of tissue;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Compete effectively, as we may be unable to capitalize on our clinical advantages or our competitors may have advantages over us in terms of cost structure, pricing, back-office automation, marketing, and sourcing; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mitigate sufficiently the risk that tissue can become contaminated during processing; that processed tissue cannot be end-sterilized and hence carries an inherent risk of infection or disease transmission or that our quality controls can eliminate that risk.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of this risk, in the fourth quarter of 2020 we became aware that a supplier shipped to us a lot of saline solution that we use in our tissue processing that contained some contamination. The contamination was identified by our routine quality controls. While we were able to mitigate the impact of this contamination through our own efforts and additional testing that was reviewed with the FDA, the contaminated solution impacted a small percentage of the tissue processed with this lot of solution, requiring us to write-off approximately $826,000 in contaminated tissues in the fourth quarter of 2020. The written off and temporarily quarantined tissue impacted our ability to fully meet demand for certain tissues and sizes in the fourth quarter of 2020, the first quarter of 2021, and to a lesser extent the second quarter of 2021.  See also, Part I, Item 1A, &#8220;Risk Factors&#8212;Operational Risks&#8212; We are dependent on our specialized workforce.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, US and foreign governmental authorities have adopted laws and regulations that restrict tissue preservation services. Any of these laws or regulations could change, including becoming more restrictive or our interpretation of them could be challenged by governmental authorities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are significantly dependent on our revenues from BioGlue and are subject to a variety of related risks.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioGlue Surgical Adhesive (&#8220;BioGlue&#8221;) is a significant source of our revenues, and as such, any risk adversely affecting our BioGlue products or business would likely be material to our financial results. We face the following risks related to BioGlue:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competing effectively with our major and start up competitors, as they may have advantages over us in terms of cost structure, supply chain, pricing, sales force footprint, and brand recognition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to obtain approval to commercialize BioGlue in certain non US countries as fast as our competitors do of their products or at all. We also may not be able to capitalize on new BioGlue approvals, including for new indications, in non US countries; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">BioGlue contains a bovine blood protein. Animal-based products are subject to increased scrutiny from the public and regulators, who may seek to impose additional regulations, regulatory hurdles or product bans in certain countries on such products; BioGlue is a mature product and other companies may use the inventions disclosed in expired BioGlue patents to develop and make competing products; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">BioGlue faces potential adverse regulatory consequences resulting from the exit of the UK from the European Union, or &#8220;Brexit, as well as the impact of COVID-19 on regulatory authorities&#8217; ability to timely re-certify the Conformit&#233; Europ&#233;ene Mark (&#8220;CE Mark&#8221;) for BioGlue&#8221; See Part I, Item 1A, &#8220;Risk Factors&#8212;Industry Risks&#8212; Our products and tissues are highly regulated and subject to significant quality and regulatory risks.&#8221;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are significantly dependent on our revenues from aortic stent grafts and are subject to a variety of related risks.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aortic stent grafts are a significant source of our revenues, and as such, any risk adversely affecting aortic stent grafts would likely be material to our financial results. We face risks related to aortic stent grafts based on our ability to: </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Compete effectively with our major competitors, as they may have advantages over us in terms of cost structure, supply chain, pricing, sales force footprint, and brand recognition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Develop innovative, high quality, and in-demand aortic repair products; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Respond adequately to enhanced regulatory requirements and enforcement activities, and particularly, our ability to obtain regulatory approvals and renewals globally; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Meet demand for aortic stent grafts as we seek to expand our business globally; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Maintain a productive working relationship with our Works Council in Germany.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are significantly dependent on our revenues from On-X products and are subject to a variety of related risks.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On-X products are a significant source of our revenues, and as such, any risk adversely affecting our On-X products or business would likely be material to our financial results. We face risks based on our ability to: </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Compete effectively with some of our major competitors, as they may have advantages over us in terms of cost structure, supply chain, pricing, sales force footprint, and brand recognition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Take market share in the mechanical heart valve market based on the FDA&#8217;s approved lower International Normalized Ratio (&#8220;INR&#8221;) indication for the On-X aortic heart valve or complete the associated FDA mandated post-approval studies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Address clinical trial data or changes in technology that may reduce the demand for mechanical heart valves, such as data regarding transcatheter aortic valve replacement, or &#8220;TAVR&#8221; devices; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Manage risks associated with less favorable contract terms for On-X products on consignment at hospitals; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Respond adequately to enhanced international regulatory requirements or enforcement activities; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Receive timely renewal certifications in certain markets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Continued fluctuation of foreign currencies relative to the US Dollar could materially, adversely affect our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our foreign product revenues are denominated in Euros and, as such, are sensitive to changes in exchange rates. In addition, a portion of our dollar-denominated and euro-denominated product sales are made to customers in other countries who must convert local currencies into US Dollars or Euros in order to purchase these products. We also have </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">balances, such as cash, accounts receivable, accounts payable, and accruals that are denominated in foreign currencies. These foreign currency transactions and balances are sensitive to changes in exchange rates. Additionally, as a result of global inflationary pressures, and in some cases, currency crises, it is possible that foreign currency controls, the development of parallel exchange rates, or highly inflationary economies could arise in certain countries. Fluctuations in exchange rates of Euros or other local currencies in relation to the US Dollar could materially reduce our future revenues as compared to the comparable prior periods. Should this occur, it could have a material, adverse impact on our revenues, financial condition, profitability, and cash flows.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our charges resulting from acquisitions, restructurings, and integrations may materially, adversely affect the market value of our common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the completion of acquisitions using the purchase method of accounting. Our financial results could be adversely affected by a number of financial adjustments required by purchase accounting such as:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may incur added amortization expense over the estimated useful lives of some acquired intangible assets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may incur additional depreciation expense as a result of recording purchased tangible assets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be required to incur material charges relating to any impairment of goodwill and intangible assets; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost of sales may increase temporarily if acquired inventory is recorded at fair market value;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If acquisition consideration consists of earn-outs, our earnings may be affected by changes in estimates of future contingent consideration; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Earnings may be affected by transaction and integration costs, which are expensed immediately.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of this risk, in the fourth quarter of 2021, we fully impaired the value of the Endospan Option and fully wrote-down the value of the Endospan Loan, primarily driven by a decrease in forecasted operating results. This impairment, and other potential risks like those mentioned above, may adversely affect the market value of our common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Operational Risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are heavily dependent on our suppliers and contract manufacturers to provide quality products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The materials and supplies used in our product manufacturing and tissue processing are subject to regulatory requirements and oversight. If materials or supplies used in our processes fail to meet these requirements or are subject to regulatory enforcement action, they may have to be scrapped, or our products or tissues could be rejected during or after processing, recalled, or rejected by customers. In these cases, we may have to immediately scrap raw or in process materials or expense the costs of manufacturing or preservation. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of this risk, in the fourth quarter of 2020 we became aware that a supplier shipped to us a lot of saline solution that we use in our tissue processing that contained some contamination. The contamination was identified by our routine quality controls. While we were able to mitigate the impact of this contamination through our own efforts and additional testing that was reviewed with the FDA, the contaminated solution impacted a small percentage of the tissue processed with this lot of solution, requiring us to write-off those contaminated tissues in the fourth quarter of 2020 and impacting our ability to fully meet demand for certain tissues and sizes in the fourth quarter of 2020, the first quarter of 2021, and to a lesser extent the second quarter of 2021. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if these materials or supplies or changes to them do not receive regulatory approval or are recalled, if the related suppliers and/or their facilities are shut down temporarily or permanently, for any reason, or if the related suppliers are otherwise unable or unwilling to supply us, we may not have sufficient materials or supplies to manufacture our products or process tissues. In addition, we rely on contract manufacturers to manufacture some of our products or to provide additional manufacturing capacity for some products. If these contract manufacturers fail to meet our quality standards or other requirements or if they are unable or unwilling to supply the products, we may not be able to meet demand for these products. Our ability to fully recover all possible losses from these suppliers and contract manufacturers may have practical limitations imposed by factors like industry standard contractual terms or the financial resources of the adverse party. As a further example of this risk, our supplier of TMR handpieces was informed in the fourth quarter of 2021 that the sole-source manufacturer of tubing used in the handpiece assembly had gone out of business, requiring us to work with our supplier to identify and qualify a new supplier before a disruption in handpiece availability occurs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the COVID-19 pandemic and now inflation continued to impact the global supply chain; the pandemic&#8217;s impact on workforces, global mobility, material availability, demand, and shipping and reorder time and reliability has reportedly continued or worsened in many cases. The ongoing war in Ukraine may add to or exacerbate challenges faced by the global supply chain. See Part I, Item 1A, &#8220;Risk Factors &#8211; Business and Economic Risks - We are subject to a variety of risks due to our international operations and continued global expansion.&#8221; Although we have yet to experience any material effects of this impact on our supply chain or operations, we face an increasing risk that upstream disruptions may occur. Risks relating to the lingering effects of global supply chain disruptions may even continue after COVID-19&#8217;s risk as a global pandemic and the war in Ukraine have subsided.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are dependent on single and sole-source suppliers and single facilities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the materials, supplies, and services used in our product manufacturing and tissue processing, as well as some of our products, are sourced from single- or sole-source suppliers. As a result, our ability to negotiate favorable terms with those suppliers may be limited, and if those suppliers experience operational, financial, quality, or regulatory difficulties, or if those suppliers and/or their facilities refuse to supply us or cease operations temporarily or permanently, or if those suppliers take unreasonable business positions, we could be forced to cease product manufacturing or tissue processing until the suppliers resume operations, until alternative suppliers could be identified and qualified, or permanently if the suppliers do not resume operations and no alternative suppliers could be identified and qualified. We could also be forced to purchase alternative materials, supplies, or services with unfavorable terms due to diminished bargaining power. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of these risks, in 2019 we lost our supply of handpieces for cardiac laser therapy resulting from a manufacturing location change at our supplier that ultimately required a Premarket Approval (&#8220;PMA&#8221;) supplement and FDA approval before handpiece manufacturing and distribution could resume. Even though the FDA approved the PMA-S, our supplier was unable to fully resume production due to factors outside of our control. Due to these and other supplier issues, we had virtually no supply of handpieces during the first three quarters of 2021. Although handpiece supply resumed on a limited basis during the last quarter of 2021, we remain dependent on a sole-source manufacturer for these handpieces. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By way of additional non-limiting examples, our BioGlue product has three main product components: bovine protein, a cross linker, and a molded plastic resin delivery device. The bovine protein and cross linker are obtained from a small number of qualified suppliers. The delivery devices are manufactured by a single supplier, using resin supplied by a single supplier. We purchase grafts for our On-X AAP from a single supplier and various other components for our On-X valves come from single source suppliers. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our preservation services business and our ability to supply needed tissues is dependent upon donation of tissues from human donors by donor families. Donated human tissue is procured from deceased human donors by OPOs and tissue banks. We must rely on the OPOs and tissue banks that we work with to educate the public on the need for donation, to foster a willingness to donate tissue, to follow our donor screening and procurement procedures, and to send donated tissue to us. We have active relationships with 59 OPOs and tissue banks throughout the US. As with any vendor, we believe these relationships with our OPOs are critical in the preservation services industry and that the breadth of these existing relationships provides us with a significant advantage over potential new entrants to this market. We also use various raw materials, including medicines and solutions, in our tissue processing. Some of these raw materials are manufactured by single suppliers or by a small group of suppliers. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our aortic stent graft systems consist of two main product components: the stent graft and the delivery system. The stent graft is manufactured from several different raw materials that are manufactured internally or at various external suppliers, including single suppliers. The delivery systems we manufacture are comprised of several different raw materials and subassemblies. Our internal manufacturing processes include injection molding and machining of plastic parts, suturing of stent grafts, processing of Nitinol, and weaving of textiles. Our conventional polyester grafts consist of two main product components: polyester fabric and collagen coating. The polyester fabric is woven from a few different yarns that are supplied by an external supplier. The collagen suspension we manufacture is comprised of a collagenous tissue that is supplied by a single supplier. The conventional ePTFE grafts we manufacture are comprised of various raw materials supplied by several suppliers. For some products the ePTFE grafts are heparin coated. For these products, the heparin suspension we manufacture is comprised of a heparin solution that is also supplied by an external supplier.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also conduct all of our own manufacturing operations at three facilities: Austin, Texas for On-X products, Hechingen, Germany for internally manufactured aortic stent grafts, and Kennesaw, Georgia for BioGlue, PerClot, PhotoFix, and tissue preservation services. The AMDS product is solely manufactured by a supplier in Charlotte, North Carolina, the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CardioGensis handpieces are solely manufactured by a supplier in Merrillville, Indiana, and the NEXUS product is solely manufactured by Endospan in Herzlia, Israel. If one of these facilities ceases operations temporarily or permanently, for any reason including a pandemic or climate change related event, our business could be substantially disrupted.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we work diligently to maintain adequate inventories of raw materials, components, supplies, subassemblies, and finished goods, there can be no assurance that we will be able to avoid all disruptions to our global supply chain, or disruptions to our sterilization or distribution networks. Any of these disruptions could have a material, adverse effect on our revenues, reputation, or profitability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are dependent on our specialized workforce.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and future operating results depend in significant part upon the continued contributions of our specialized workforce, including key personnel, qualified personnel with medical device and tissue processing experience, and senior management with experience in the medical device or tissue processing space, some of whom would be difficult to replace. Our business and future operating results, including production at our manufacturing and tissue processing facilities, also depend in significant part on our ability to attract and retain qualified management, operations, processing, marketing, sales, and support personnel. Our primary facilities are in Kennesaw, Georgia; Austin, Texas; and Hechingen, Germany, where the supply of qualified medical device and tissue processing and other personnel is limited, competition for such personnel is significant, and we cannot ensure that we will be successful in attracting or retaining them. We face risks if we lose any key employees to other employers or due to severe illness, death, or retirement, if any of our key employees fail to perform adequately, or if we are unable to attract and retain skilled employees. This risk was exacerbated during 2021, and is expected to continue, as the competition for talent in the medical device industry and in the workforce generally has intensified substantially. As some global economies have begun to emerge from the COVID-19 downturn, the expiration of COVID-19 related hiring freezes, the Great Resignation, increased opportunities for remote work, and increasing compensation pressure have resulted in a war for talent and an unprecedented number of career changes. The resulting competition and worker shortages at all levels have impacted supply chains and distribution channels and our ability to attract and retain the specialized workforce necessary for our business and operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We continue to evaluate expansion through acquisitions of, or licenses with, investments in, and distribution arrangements with, other companies or technologies, which may carry significant risks.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of our growth strategies is to pursue select acquisitions, licensing, or distribution rights with companies or technologies that complement our existing products, services, and infrastructure. In connection with one or more of these transactions, we may:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Issue additional equity securities that would dilute our stockholders&#8217; ownership interest;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Use cash we may need in the future to operate our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Incur debt, including on terms that could be unfavorable to us or debt we might be unable to repay;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Structure the transaction resulting in unfavorable tax consequences, such as a stock purchase that does not permit a step-up in basis for the assets acquired;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Be unable to realize the anticipated benefits of the transaction; or </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assume material unknown liabilities associated with the acquired business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not realize all the anticipated benefits of our business development activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our efforts to drive growth by pursuing select acquisition, license, and distribution opportunities that are aligned to our objectives and complement our existing products, services, and infrastructure or to divest non-core product lines, we have completed several transactions in recent years and may pursue similar additional transactions in the future. Examples of these activities include the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On December 1, 2017 we acquired JOTEC AG, a Swiss entity that we converted to JOTEC GmbH and subsequently merged with our Swiss acquisition entity, Jolly Buyer Acquisition GmbH and its subsidiaries;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On September 11, 2019 we entered into various agreements with Endospan, Ltd. (&#8220;Endospan&#8221;), an Israeli medical device manufacturer (the &#8220;Endospan Transaction&#8221;). The Endospan Transaction included an exclusive distribution agreement for the NEXUS stent graft system (&#8220;NEXUS&#8221;) in Europe; an agreement (&#8220;Endospan Loan&#8221;) for a secured loan from Artivion to Endospan; and a security purchase option agreement for Artivion to purchase all the then outstanding Endospan securities from Endospan&#8217;s existing security holders upon FDA approval of NEXUS;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On September 2, 2020 we acquired 100% of the outstanding shares of Ascyrus Medical LLC (&#8220;Ascyrus&#8221;), the developer of the Ascyrus Medical Dissection Stent (&#8220;AMDS&#8221;); and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 28, 2021 we entered into various agreements with Baxter International, Inc. (&#8220;Baxter&#8221;) and Starch Medical, Inc. (&#8220;SMI&#8221;) related to the sale of our PerClot assets to Baxter and the termination of our existing material agreements with SMI (collectively the &#8220;Baxter Transaction&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to realize the anticipated business opportunities, growth prospects, cost savings, synergies, and other benefits of these transactions depends on a number of factors including our ability to:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Leverage our global infrastructure to sell and cross-market the acquired products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Drive adoption of NEXUS and AMDS in the European and other markets, including our ability to manage the substantial product training, implant support, and proctoring requirements for NEXUS procedures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Bring acquired products to the US market, including our acquired aortic stent grafts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Harness the aortic stent graft product pipeline and our research and development capabilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Obtain regulatory approvals in relevant markets, including our ability to timely obtain FDA PMA for PerClot under the terms of the Baxter Transaction and to obtain or maintain Conformit&#233; Europ&#233;ene Mark (&#8220;CE Mark&#8221;) product certifications for pipeline and current products; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Execute on development and clinical trial timelines for acquired products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Manage global inventories, including our ability to manage inventories for product lines with large numbers of product configurations and manage manufacturing and demand cycles to avoid excess inventory obsolescence due to shelf life expiration, particularly for processed tissues and aortic stent grafts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Carry, service, and manage significant debt and repayment obligations; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Manage the unforeseen risks and uncertainties related to these transactions, including any related to intellectual property rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our ability to realize the anticipated business opportunities, growth prospects, synergies, and other benefits of the Endospan Transaction depends on a number of additional factors including Endospan&#8217;s ability to: (a) comply with the Endospan Loan and other debt obligations, and avoid an event of default; (b) successfully commercialize NEXUS, raise capital and drive adoption in markets in and outside of Europe; (c) meet demand for NEXUS; (d) meet quality and regulatory requirements; (e) manage any intellectual property risks and uncertainties associated with NEXUS; (f) obtain FDA approval of NEXUS; (g) remain a going concern; and (h) develop NEXUS product improvements to meet competitive threats and physician demand. As an example of this risk, the forecasted operating results related to NEXUS decreased in the fourth quarter of 2021, resulting in an impairment in the value of the Endospan Option, and a full write-down of the value of the Endospan Loan, reflecting decreased expectations with respect to the anticipated benefits of the Endospan Transaction.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of these factors are outside of our control and any one of them could result in increased costs, decreased revenues, and diversion of management&#8217;s time and energy. The benefits of these transactions may not be achieved within the anticipated time frame or at all. Any of these factors could negatively impact our earnings per share, decrease or delay the expected accretive effect of the transaction, and negatively impact the price of our common stock. In addition, if we fail to realize the anticipated benefits of a transaction, we could experience an interruption or loss of momentum in our existing business activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not realize all the anticipated benefits of our corporate rebranding and it may result in unanticipated disruptions to our on-going business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to reflect our evolution to focus on providing innovative technologies to surgeons who treat patients with aortic disease, we changed our name to Artivion, Inc., effective January 18, 2022 (the &#8220;Corporate Rebrand&#8221;). The Corporate Rebrand also involved the adoption of a new ticker symbol on the New York Stock Exchange, &#8220;AORT.&#8221; We may face unanticipated disruptions to our business arising from the Corporate Rebrand, and it may expose us to additional risks, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions to our day-to-day business operations including disruptions to our ability to receive or our customers&#8217; ability to make timely payments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions to access to certain markets or segments due to delays or other issues with regulatory approvals or updates arising from the Corporate Rebrand;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unanticipated delays or other impact on our pending regulatory applications or clinical trials arising from the Corporate Rebrand;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Confusion within the marketplace, particularly with multiple points of contact in our downstream product flow involving purchasing and accounts payable departments and end users;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Intellectual property risks associated with the adoption of a new corporate identity and trade dress; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of brand equity associated with our legacy brands, including our CryoLife and JOTEC brands that will become less prominent over time.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate Rebrand involved significant financial and resource investment and will continue to do so as we complete our global brand transitions over the coming years. The anticipated benefits of the Corporate Rebrand may not be achieved within the anticipated timeframe, without additional near or long-term investment, or at all. Any of these factors could negatively impact our revenues, earnings per share, decrease or delay the expected accretive effect of the Corporate Rebrand, and negatively impact the price of our common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant disruptions of information technology systems or breaches of information security systems could adversely affect our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely upon a combination of sophisticated information technology systems as well as traditional recordkeeping to operate our business. In the ordinary course of business, we collect, store, and transmit confidential information (including, but not limited to, information about our business, financial information, personal data, intellectual property, and, in some instances, patient data). Our information technology and information security systems and records are potentially vulnerable to security breaches, service interruptions, data loss, or malicious attacks resulting from inadvertent or intentional actions by our employees, vendors, or other third parties. In addition, due to the COVID-19 pandemic, we have implemented remote work arrangements for some employees, and those employees may use outside technology and systems that are vulnerable to security breaches, service interruptions, data loss or malicious attacks, including by third parties.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of these risks, on November 1, 2019 we were notified that we had become a victim of a business e-mail compromise. During the fourth quarter of 2019, a company email account was compromised by a third-party impersonator and a payment intended for one of our US vendors in the amount of $2.6 million was fraudulently re-directed into an individual bank account controlled by this third-party impersonator. Our cyber-insurance covered all but $25,000 of the unrecovered losses from this compromise.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have invested, and continue to invest, in our information technology and information security systems and employee information security training, there can be no assurance that our efforts will prevent all security breaches, service interruptions, or data losses. We have limited cyber-insurance coverage that may not cover all possible events, and this insurance is subject to deductibles and coverage limitations. Any security breaches, service interruptions, or data losses could adversely affect our business operations or result in the loss of critical or sensitive confidential information or intellectual property, or in financial, legal, business, and reputational harm to us or allow third parties to gain material, inside information that they may use to trade in our securities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Industry Risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our products and tissues are highly regulated and subject to significant quality and regulatory risks.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commercialization of medical devices and processing and distribution of human tissues are highly complex and subject to significant global quality and regulatory risks and as such, we face the following risks:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our products and tissues allegedly have caused, and may in the future cause, patient injury, which has exposed, and could in the future expose, us to liability claims that could lead to additional regulatory scrutiny;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our manufacturing and tissue processing operations are subject to regulatory scrutiny, inspections and enforcement actions, and regulatory agencies could require us to change or modify our operations or take other action, such as issuing product recalls or holds;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulatory agencies could reclassify, re-evaluate, or suspend our clearances or approvals, or fail, or decline to, issue or reissue our clearances or approvals that are necessary to sell our products and distribute tissues;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulatory and quality requirements are subject to change, which could adversely affect our ability to sell our products or distribute tissues; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adverse publicity associated with our products, processed tissues, or our industry could lead to a decreased use of our products or tissues, increased regulatory scrutiny, or product or tissue processing liability claims.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, on May 25, 2017 the European Union adopted a new Medical Device Regulation (MDR 2017/745) (&#8220;MDR&#8221;), which was fully implemented on May 26, 2021. The MDR places stricter requirements on manufacturers and European Notified Bodies regarding, among other things, product classifications and pre- and post-market clinical studies for product clearances and approvals which could result in product reclassifications or the imposition of other regulatory requirements that could delay, impede, or prevent our ability to commercialize existing, improved, or new products in the European Economic Area and other markets that require CE Marking. Additionally, to the extent the MDR places stricter requirements on manufacturers of custom-made devices, those new requirements could delay, impede, or otherwise impact the availability of our E-xtra Design Engineering products. Finally, COVID-19 has impacted the predictability and timelines associated with the MDR transition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the implementation of the MDR, Notified Bodies must review any proposed changes to determine if they require evaluation under the MDR or if they can still be evaluated under currently held MDD certifications. Our inability to obtain certifications for changes under the transitional provisions of the MDR&#8217;s Article 120 or successfully submit proposed changes requiring MDR evaluation will delay implementation of those changes which could adversely impact our ability to obtain or renew certifications, clearances, or approvals for our products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, as MDD-based CE Marks expire, recertification must be obtained under the MDR. Industry-wide, companies are experiencing delays in obtaining new and updated certifications under the MDR as notified bodies struggle to recover from COVID-19, deal with depleted workforces, and handle the volume of work required to transition tens of thousands of currently-marketed devices from the MDD to the MDR. As one such example, our MDD-based CE Mark for Chord-X expired in September 2022, which will impact our ability to supply certain territories once our saleable inventory is depleted. If Notified Bodies continue to struggle to meet demand and timely process submissions and recertifications, we may face additional disruptions associated with the MDR transition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, we anticipate additional regulatory impact as a result of the United Kingdom&#8217;s exit from the European Union (&#8220;Brexit&#8221;). The UK Medicines and Healthcare Products Regulatory Agency has announced that CE Marking will continue to be recognized in the UK and certificates issued by EU-recognized Notified Bodies will continue to be valid in the UK market until June 30, 2023. Thereafter, all devices marketed in the UK will require UK Conformity Assessed Marks certified by a UK Approved Body (the re-designation of the UK Notified Body).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019 our notified body in the UK, Lloyd&#8217;s Register Quality Assurance Limited (&#8220;LRQA&#8221;), informed us that it would no longer provide Notified Body services for medical devices effective September 2019. The governing German competent authority, the Regierungspraesidium-Tubingen, granted us an extended grace period until December 31, 2021 to transfer LRQA-issued certifications for BioGlue and PhotoFix to a new Notified Body. We are currently in the process of transferring BioGlue and PhotoFix to our new Notified Body, DEKRA. While positive progress has been made, DEKRA has been unable to complete the registration and the renewal of our BioGlue CE Mark because it significantly delayed its last audit in that process, a Phase 2 onsite audit, due to COVID-19 restrictions on travel, staffing shortages, and workload related to the transition to the MDR. With the Phase 2 audit complete, we currently anticipate completing the registration and renewal process during the fourth quarter of 2022. In the interim, we have requested and received from the majority of relevant territories, derogations from certain individual European countries to allow us to continue to commercialize BioGlue in those countries until we can complete the certification process with DEKRA. For derogations expiring before we anticipate receiving the renewal of the BioGlue CE Mark, we have requested and anticipate receiving, extensions of the previously granted derogations. That said, failure to maintain key derogations in certain countries, or any other delays in the MDR transition, may have a material, adverse effect on our ability to supply demand in affected jurisdictions, have a material, adverse impact on our business, and may also impact our Medical Device Single Audit Program (&#8220;MDSAP&#8221;) certifications. Failure to timely obtain new MDSAP certifications following their expiration may impact our ability to distribute covered products in Australia, Brazil, Canada, and Japan. Additionally, although we don&#8217;t anticipate a material impact, failure to obtain timely recertification for PhotoFix may impact our ability to supply certain markets with PhotoFix.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification by the FDA of CryoValve SG pulmonary heart valve (&#8220;CryoValve SGPV&#8221;) may make it commercially infeasible to continue processing the CryoValve SGPV.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019 we learned that the FDA is preparing to issue a proposed rule for reclassification of more than minimally manipulated (&#8220;MMM&#8221;) allograft heart valves to Class III medical devices, which could include our CryoValve SGPV. Following a comment period and subsequent publication of any final rule, should the CryoValve SGPV be determined to be MMM, we expect to have approximately thirty months to submit an FDA PMA application, after which the FDA will determine if, and for how long, we may continue to provide these tissues to customers during review of the PMA application. To date, the FDA has not issued such a proposed final rule.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA ultimately classifies our CryoValve SGPV as a Class III medical device, and if there are delays in obtaining the PMA, if we are unsuccessful in obtaining the PMA, or if the costs associated with these activities are significant, we could decide that the requirements for continued processing of the CryoValve SGPV are too onerous, leading us to discontinue distribution of these tissues.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not be successful in obtaining clinical results or regulatory clearances/approvals for new and existing products and services, and our approved products and services may not achieve market acceptance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth and profitability depends in part upon our ability to develop, and successfully introduce, new products and services, or expand upon existing indications, clearances, and approvals, requiring that we invest significant time and resources to obtain new regulatory clearances/approvals, including investment into pre- and post-market clinical studies. Although we believe certain products and services in our portfolio or under development may be effective in a particular application, we cannot be certain until we successfully execute on relevant clinical trials, and the results we obtain from pre- and post-market clinical studies may be insufficient for us to obtain or maintain any required regulatory approvals or clearances.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently seeking regulatory approval for BioGlue in China, where the Chinese regulatory body has made additional requests, and expressed several concerns, related to the application. We have obtained an extension of time until February 2024 in which to secure approval for BioGlue in China. If we cannot obtain approval by then or the costs to do so are prohibitive, we ultimately may be unable to sell BioGlue in China.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of this risk, in September 2022, we halted the PROACT Xa clinical trial based on the recommendation of the trial&#8217;s Data and Safety Monitoring Board (&#8220;DSMB&#8221;) due to insufficient evidence to support non-inferiority of apixaban to warfarin for valve thrombosis and thromboembolism. The DSMB found that continuing the trial was unlikely to achieve the primary endpoint while possibly exposing patients to increased risk. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our trials, studies, and approvals is subject to the risks outlined herein.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot give assurance that regulatory agencies will clear or approve these products and services or indications, or any new products and services or new indications, on a timely basis, if ever, or that the products and services or new indications will adequately meet the requirements of the market or achieve market acceptance. Pre- and post-market clinical studies may also be delayed or halted due to many factors beyond our control.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to successfully complete the development of a product, service, or application, or if we determine for any reason not to complete development or obtain regulatory approval or clearance of any product, service, or application, particularly in instances when we have expended significant capital, this could materially, adversely affect our financial performance. Research and development efforts are time consuming and expensive, and we cannot be certain that these efforts will lead to commercially successful products or services. Halting R&amp;D efforts and clinical trials prematurely may lead to accelerated or unanticipated wind down costs. Even the successful commercialization of a new product or service in the medical industry can be characterized by slow growth and high costs associated with marketing, under-utilized production capacity, and continuing research and development and education costs, among other things. The introduction of new products or services may require significant physician training or years of clinical evidence in order to gain acceptance in the medical community.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory enforcement activities regarding Ethylene Oxide, which is used to sterilize some of our products and components, could have a material, adverse impact on us.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our products, including our On-X products, are sterilized using Ethylene Oxide (&#8220;EtO&#8221;). Although we have a small-scale EtO facility in Austin, Texas, we rely primarily on large-scale EtO facilities to sterilize our products. In addition, some of our suppliers use, or rely upon third parties to use, EtO to sterilize some of our product components. Concerns about the release of EtO into the environment at unsafe levels have led to increased activism and lobbying as well as various regulatory enforcement activities against EtO facilities, including closures and temporary closures, lawsuits against EtO service providers, and proposals increasing regulations related to EtO. The number of EtO facilities in the US is limited, and any permanent or temporary closures or disruption to their operations for any reason could delay, impede, or prevent our ability to commercialize our products. In addition, any regulatory enforcement activities against us for our use of EtO could result in financial, legal, business, and reputational harm to us.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be subject to fines, penalties, and other sanctions if we are deemed to be promoting the use of our products for unapproved, or off-label, uses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and future growth depend on the continued use of our products for approved uses. Generally, regulators contend that, unless our products are approved or cleared by a regulatory body for alternative uses, we may not make claims about the safety or effectiveness of our products or promote them for such uses. Such limitations present a risk that law enforcement could allege that the nature and scope of our sales, marketing, or support activities, though designed to comply with all regulatory requirements, constitute unlawful promotion of our products for an unapproved use. We also face the risk that such authorities might pursue enforcement based on past activities that we discontinued or changed. Investigations concerning the promotion of unapproved uses and related issues are typically expensive, disruptive, and burdensome and generate negative publicity. If our promotional activities are found to be in violation of the law, we may face significant fines and penalties and may be required to substantially change our sales, promotion, grant, and educational activities. In addition, we or our officers could be excluded from participation in government healthcare programs such as Medicare and Medicaid.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthcare policy changes may have a material, adverse effect on us.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to perceived increases in healthcare costs in recent years, there have been, and continue to be, proposals by the governmental authorities, third-party payors, and elected office holders and candidates to impact public health, control healthcare costs and, more generally, to reform the healthcare systems. Additional uncertainty is anticipated as debates about healthcare, vaccines, and public health continue in light of the COVID-19 pandemic which may have an impact on US law relating to the healthcare industry. Many US healthcare laws, such as the Affordable Care Act, are complex, subject to change, and dependent on interpretation and enforcement decisions from government agencies with broad discretion. The application of these laws to us, our customers, or the specific services and relationships we have with our customers is not always clear. Our failure to anticipate accurately any changes to, or the repeal or invalidation of all or part of the Affordable Care Act and similar or future laws and regulations, or our failure to comply with them, could create liability for us, result in adverse publicity and negatively affect our business, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the growth of our business, results of operations and financial condition rely, in part, on customers in the healthcare industry that receive substantial revenues from governmental and other third-party payer programs. A reduction or less than expected increase in government funding for these programs or a change in reimbursement or allocation methodologies, or a change in reimbursement related to products designated as &#8220;breakthrough devices&#8221; by the FDA, could negatively affect our customers&#8217; businesses and, in turn, negatively impact our business, results of operations and financial condition. Any changes that lower reimbursement for our products or reduce medical procedure volumes, could adversely affect our business and profitability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Legal, Quality, and Regulatory Risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As a medical device manufacturer and tissue services provider we are exposed to risk of product liability claims and our existing insurance coverage may be insufficient, or we may be unable to obtain insurance in the future, to cover any resulting liability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and processed tissues allegedly have caused, and may in the future cause, injury or result in other serious complications that may result in product or other liability claims from our customers or their patients. If our products are defectively designed, manufactured, or labeled, or contain inadequate warnings, defective components, or are misused, or are used contrary to our warnings, instructions, and approved indications, we may become subject to costly litigation that can have unpredictable and sometimes extreme outcomes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain claims-made insurance policies to mitigate our financial exposure to product and tissue processing liability and securities, claims, among others, that are reported to the insurance carrier while the policy is in effect. These policies do not include coverage for punitive damages. Although we have insurance for product and tissue processing liabilities, securities, property, and general liabilities, if we are unsuccessful in arranging cost-effective acceptable resolutions of claims, it is possible that our insurance program may not be adequate to cover any or all possible claims or losses, including losses arising out of natural disasters or catastrophic circumstances. Any significant claim could result in an increase in our insurance rates or jeopardize our ability to secure coverage on reasonable terms, if at all.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any securities or product liability/tissue processing claim, even a meritless or unsuccessful one, could be costly to defend, and result in diversion of our management&#8217;s attention from our business, adverse publicity, withdrawal of clinical trial participants, injury to our reputation, or loss of revenue.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to various US and international bribery, anti-kickback, false claims, privacy, transparency, and similar laws, any breach of which could cause a material, adverse effect on our business, financial condition, and profitability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our relationships with physicians, hospitals, and other healthcare providers are subject to scrutiny under various US and international bribery, anti-kickback, false claims, privacy, transparency, and similar laws, often referred to collectively as &#8220;healthcare compliance laws.&#8221; Healthcare compliance laws are broad, sometimes ambiguous, complex, and subject to change and changing interpretations. The ongoing war in Ukraine and the current and future sanctions imposed on Russia and others as a result may exacerbate these risks. See also Part I, Item 1A, &#8220;Risk Factors &#8211; Business and Economic Risks - We are subject to a variety of risks due to our international operations and continued global expansion.&#8221; Possible sanctions for violation of these healthcare compliance laws include fines, civil and criminal penalties, exclusion from government healthcare programs, and despite our compliance efforts, we face the risk of an enforcement activity or a finding of a violation of these laws.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into consulting and product development agreements with healthcare professionals and healthcare organizations, including some who may order our products or make decisions to use them. We have also adopted the AdvaMed Code of Conduct, the MedTech Europe Code of Ethical Business Practice, and the APACMed Code of Ethical Conduct which govern our relationships with healthcare professionals to bolster our compliance with healthcare compliance laws. While our relationships with healthcare professionals and organizations are structured to comply with such laws and we conduct training sessions on these laws and Codes, it is possible that enforcement authorities may view our relationships as prohibited arrangements that must be restructured or for which we would be subject to other significant civil or criminal penalties or debarment. In any event, any enforcement review of or action against us as a result of such review, regardless of outcome, could be costly and time consuming. Additionally, we cannot predict the impact of any changes in or interpretations of these laws, whether these changes will be retroactive or will have effect on a going-forward basis only.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The proliferation of new and expanded data privacy laws, including the General Data Protection Regulation in the European Union, could adversely affect our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An increasing number of federal, state, and foreign data privacy laws and regulations, which can be enforced by private parties or governmental entities, have been or are being promulgated and are constantly evolving. These laws and regulations may include new requirements for companies that receive or process an individual&#8217;s personal data (including employees), which increases our operating costs and requires significant management time and energy. Many of these laws and regulations, including the European Union&#8217;s General Data Protection Regulation (&#8220;GDPR&#8221;) also include significant penalties for noncompliance. Although our personal data practices, policies, and procedures are intended to comply with GDPR and other data privacy laws and regulations, there can be no assurance that regulatory or enforcement authorities will view our arrangements as being in compliance with applicable laws, or that one or more of our employees or agents will not disregard the rules we have established. Any privacy related government enforcement activities may be costly, result in negative publicity, or subject us to significant penalties.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Some of our products and technologies are subject to significant intellectual property risks and uncertainty.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own trade secrets, patents, patent applications, and licenses relating to our technologies and trademarks and goodwill related to our products and services, which we believe provide us with important competitive advantages. We cannot be certain that we will be able to maintain our trade secrets, that our pending patent applications will issue as patents, or that no one will challenge the validity or enforceability of any intellectual property that we adopt, own, or license. Competitors may independently develop our proprietary technologies or design non-infringing alternatives to patented inventions. We do not control the maintenance, prosecution, enforcement, or strategy for in-licensed intellectual property and as such are dependent in part on the owners of these rights to maintain their viability. Their failure to do so could significantly impair our ability to exploit those technologies. Additionally, our technologies, products, or services could infringe intellectual property rights owned by others, or others could infringe our intellectual property rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we become involved in intellectual property disputes, the costs could be expensive, and if we were to lose or decide to settle, the amounts or effects of the settlement or award by a tribunal could be costly.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risks Relating to Our Indebtedness</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The agreements governing our indebtedness contain restrictions that limit our flexibility in operating our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements governing our indebtedness contain, and any instruments governing future indebtedness of ours may contain, covenants that impose significant operating and financial restrictions on us and certain of our subsidiaries, including (subject in each case to certain exceptions) restrictions or prohibitions on our and certain of our subsidiaries&#8217; ability to, among other things:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Incur or guarantee additional debt or create liens on certain assets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pay dividends on or make distributions of our share capital, including repurchasing or redeeming capital stock, or make other restricted payments, including restricted junior payments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enter into agreements that restrict our subsidiaries&#8217; ability to pay dividends to us, repay debt owed to us or our subsidiaries, or make loans or advances to us or our other subsidiaries;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enter into certain transactions with our affiliates including any transaction or merger or consolidation, liquidation, winding-up, or dissolution; convey, sell, lease, exchange, transfer or otherwise dispose of all or any part of our business, assets or property; or sell, assign, or otherwise dispose of any capital stock of any subsidiary;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enter into certain rate swap transactions, basis swaps, credit derivative transactions, and other similar transactions, whether relating to interest rates, commodities, investments, securities, currencies, or any other relevant measure, or transactions of any kind subject to any form of master purchase agreement governed by the International Swaps and Derivatives Association, Inc., any International Foreign Exchange Master Agreement, or any other master agreement;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Amend, supplement, waive, or otherwise modify our or our subsidiaries' organizational documents in a manner that would be materially adverse to the interests of the lenders, or change or amend the terms of documentation regarding junior financing in a manner that would be materially adverse to the interests of the lenders;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Make changes to our and our subsidiaries&#8217; fiscal year without notice to the administrative agent;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enter into agreements which restrict our ability to incur liens;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Engage in any line of business substantially different from that in which we are currently engaged; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Make certain investments, including strategic acquisitions or joint ventures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our indebtedness could adversely affect our ability to raise additional capital to fund operations and limit our ability to react to changes in the economy or our industry.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current and future levels of indebtedness could adversely affect our ability to raise additional capital, limit our operational flexibility, and hinder our ability to react to changes in the economy or our industry. It may also limit our ability to borrow money, require us to dedicate substantial portions of our cash flow to repayment, and restrict our ability to invest in business opportunities. Because most of our borrowings are at a variable rate of interest, we are exposed to interest rate fluctuations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We have pledged substantially all of our US assets as collateral under our existing Credit Agreement. If we default on the terms of such credit agreements and the holders of our indebtedness accelerate the repayment of such indebtedness, there can be no assurance that we will have sufficient assets to repay our indebtedness.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A failure to comply with the covenants in our existing Credit Agreement could result in an event of default, which, if not cured or waived, could have a material, adverse effect on our business, financial condition, and profitability. In the event of any such default, the holders of our indebtedness:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Will not be required to lend any additional amounts to us; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Could elect to declare all indebtedness outstanding, together with accrued and unpaid interest and fees, to be due and payable and terminate all commitments to extend further credit, if applicable.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to repay those amounts, the holders of our secured indebtedness could proceed against their secured collateral to seek repayment out of proceeds from the sale or liquidation of our assets. If our indebtedness were to be accelerated, there can be no assurance that our assets would be sufficient to repay such indebtedness in full.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risks Related to Ownership of our Common Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business could be negatively impacted as a result of shareholder activism.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, shareholder activists have become involved in numerous public companies. Shareholder activists from time to time propose to involve themselves in the governance, strategic direction, and operations of a company. Such involvement may disrupt our business and divert the attention of our management, and any perceived uncertainties as to our future direction resulting from such involvement could result in the loss of business opportunities, be exploited by our competitors, cause concern for our current or potential customers, cause significant fluctuations in stock price, or make it more difficult to attract and retain qualified personnel and business partners.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business could be impacted by increased shareholder emphasis on environmental, social, and governance matters.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors and other key stakeholders are increasingly focusing on areas of corporate responsibility, and particularly matters related to environmental, social, and governance (&#8220;ESG&#8221;) factors. Institutional investors have expressed expectations with respect to ESG matters that they use to guide their investment strategies and may, in some cases, choose not to invest in us if they believe our ESG policies are lagging or inadequate. Other stakeholders also have expectations regarding ESG factors, such as employees or potential employees who desire to work for a company that reflects their personal values. These areas of focus are continuing to evolve, as are the criteria that investors assess companies&#8217; performance in these areas. Investors are increasingly looking to companies that demonstrate strong ESG and sustainability practices as an indicator of long-term resilience, especially in light of events such as the COVID-19 pandemic. Keeping up with and meeting these expectations may disrupt our business and divert the attention of our management, and we may be unable to make the investments in ESG that our competitors with greater financial resources are able to make. Failure to meet the expectations of investors and other stakeholders in these areas may damage our reputation, impact employee retention, impact the willingness of our customers to do business with us, or otherwise impact our financial results and stock price.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We do not anticipate paying any dividends on our common stock for the foreseeable future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2015 our Board of Directors discontinued dividend payments on our common stock for the foreseeable future. If we do not pay cash dividends, our shareholders may receive a return on their investment in our common stock only through appreciation of shares of our common stock that they own. In addition, restrictions in our credit facility limit our ability to pay future dividends.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provisions of Delaware law and anti-takeover provisions in our organizational documents may discourage or prevent a change of control, even if an acquisition would be beneficial to shareholders, which could affect our share price adversely and prevent attempts by shareholders to remove current management.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2022 we reincorporated in Delaware. Our status as a Delaware corporation and the anti-takeover provisions of the Delaware General Corporation Law may discourage, delay, or prevent a change in control by prohibiting us from engaging in a business combination with an interested stockholder for a period of three years after the person becomes an interested stockholder, even if a change of control would be beneficial to our existing stockholders. In addition, the organizational documents adopted in connection with our reincorporation contain provisions that restrict persons who may call shareholder meetings, allow the issuance of blank-check preferred stock without the vote of shareholders, and allow the Board of Directors to fill vacancies and fix the number of directors. These provisions of Delaware law and our articles of incorporation and bylaws could prevent attempts by shareholders to remove current management, prohibit or delay mergers or other changes of control transactions, and discourage attempts by other companies to acquire us, even if such a transaction would be beneficial to our shareholders. The effects of reincorporation in Delaware are detailed in our 2021 Special Proxy Statement and Notice of Special Meeting filed with the SEC on October 7, 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">52</span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The following table provides information about purchases by us during the three months ended September&#160;30, 2022 of equity securities that are registered by us pursuant to Section 12 of the Securities Exchange Act of 1934:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total Number of<br/>Common Shares<br/>and Common Stock<br/>Units Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Average Price<br/>Paid per<br/>Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total Number<br/>of Common Shares<br/>Purchased as<br/>Part of Publicly<br/>Announced<br/>Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Dollar Value<br/>of Common Shares<br/>That May Yet Be<br/>Purchased Under the<br/>Plans or Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">07/01/22 - 07/31/22</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">08/01/22 - 08/31/22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,706</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21.71</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">09/01/22 - 09/30/22</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">709</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21.10</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#CCEEFF;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#CCEEFF;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 40.13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2,415</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">21.53</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The common shares purchased during the three months ended September&#160;30, 2022 were tendered to us in payment of taxes on stock compensation and were not part of a publicly announced plan or program.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Credit Agreement, we are prohibited from repurchasing our common stock, except for the repurchase of stock from our employees or directors when tendered in payment of taxes or the exercise price of stock options, upon the satisfaction of certain requirements.</span></div><div id="i167b7825c15e480eba61f77e008c32de_142"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i167b7825c15e480eba61f77e008c32de_145"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i167b7825c15e480eba61f77e008c32de_148"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">53</span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_151"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibit index can be found below.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Exhibit</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Number</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Description</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/784199/000078419922000006/cry-20220101xex3_2.htm">3.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delaware Certificate of Incorporation, effective January 1, 2022. (Incorporated herein by reference to Exhibit 3.2 to the Registrant&#8217;s Current Report on Form 8-K filed January 4, 2022).</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/784199/000078419922000014/cry-20220118xex3_1.htm">3.2</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delaware Certificate of Amendment of Certificate of Incorporation, effective January 18, 2022. (Incorporated herein by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K filed January 20, 2022).</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/784199/000078419922000014/cry-20220118xex3_2.htm">3.3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amended and Restated Bylaws of Artivion, Inc., a Delaware Corporation (Incorporated herein by reference to Exhibit 3.2 to the Registrant&#8217;s Current Report on Form 8-K filed January 20, 2022).</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a101-form10xqexxformofinde.htm">10.1*</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form of Indemnification Agreement for Non-Employee Directors and Executive Officers. </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a102-redactedxdavisxchange.htm">10.2*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change of Control Agreement, by and between the Company and John E. Davis, dated Aug. 2, 2022.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a103-redactedxhollowayxcha.htm">10.3*</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change of Control Agreement, by and between the Company and Jean F. Holloway, dated Aug. 2, 2022.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a104-redactedxleexchangeof.htm">10.4*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change of Control Agreement, by and between the Company and D. Ashley Lee, dated Aug. 2, 2022.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="aort-20220930xex311.htm">31.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification by J. Patrick Mackin pursuant to section 302 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="aort-20220930xex312.htm">31.2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification by D. Ashley Lee pursuant to section 302 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="aort-20220930xex32.htm">32</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification Pursuant To 18 USC. Section 1350, As Adopted Pursuant To Section 906 Of The Sarbanes-Oxley Act Of 2002.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.INS*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.SCH*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.CAL*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.DEF*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Definition Linkbase</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.LAB*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.PRE*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File &#8211; formatted as Inline XBRL and contained in Exhibit 101</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Filed herewith.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Furnished herewith.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">54</span></div></div></div><div id="i167b7825c15e480eba61f77e008c32de_154"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i167b7825c15e480eba61f77e008c32de_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">                              SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">ARTIVION, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;text-indent:-9.35pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">/s/ J. PATRICK MACKIN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">/s/ D. ASHLEY LEE</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">J. PATRICK MACKIN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">D. ASHLEY LEE</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Chairman, President, and<br/>Chief Executive Officer<br/>(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Executive Vice President, and<br/>Chief Financial Officer<br/>(Principal Financial and<br/>Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">November&#160;4, 2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DATE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">55</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a101-form10xqexxformofinde.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8fd914c786014242b14e66245ebd7141_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt;margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">INDEMNIFICATION AGREEMENT</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">THIS INDEMNIFICATION AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made and entered into as of August 2, 2022, between ARTIVION, INC., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and _____________________, a resident of the State of _________________ (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">W I T N E S S E T H</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, at the request of the Corporation, Indemnitee is an executive officer and&#47;or a member of the board of directors of the Corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and in such capacity is performing a valuable service for the Corporation&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, both the Corporation and Indemnitee recognize the increased risk of litigation and other claims being asserted against directors and officers of public companies&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, in addition to the indemnification to which Indemnitee is entitled pursuant to the Certificate of Incorporation and Bylaws of the Corporation (as amended, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and as additional consideration for Indemnitee&#8217;s service, the Corporation has obtained or may in the future obtain, at its expense, directors&#8217; and officers&#8217; liability insurance protecting Indemnitee in connection with such service&#59; and </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, Indemnitee and the Corporation acknowledge that the indemnities available under the Governing Documents and such insurance may not, in all situations, be adequate to protect Indemnitee against the risks associated with service to the Corporation. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the premises and the covenants in this Agreement, the parties hereto, intending to be legally bound hereby, agree as follows&#58; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Subject to Sections&#160;3 and 5 of this Agreement, the Corporation shall indemnify Indemnitee to the fullest extent permitted by the Delaware General Corporation Law and any other applicable law. This obligation includes the obligation to indemnify Indemnitee whenever Indemnitee is or was a party or witness or is threatened to be made a party or witness to any Proceeding (capitalized terms not otherwise defined are defined in Section 13) because (or arising in part because) Indemnitee is or was (or is alleged to be or have been) a director, officer, employee, partner, fiduciary or agent of the Corporation or is or was (or is alleged to be or have been) serving at the request of the Corporation as a director, officer, employee, partner, fiduciary or agent of another corporation, partnership, joint venture, limited liability company, limited liability partnership, limited partnership, employee benefit plan, trust or other enterprise, or because of anything done or not done by Indemnitee in such capacity (any such event or occurrence, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnifiable Event&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), against Expenses and Liabilities as defined below (including the costs of any investigation, defense, service as a witness, settlement or appeal), actually and reasonably incurred by Indemnitee or on Indemnitee&#8217;s behalf in connection with such Proceeding. The foregoing indemnification, including the conditions thereto, shall also apply to any such Proceeding brought by or in the right of the Corporation. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">To the extent that Indemnitee has been successful on the merits or otherwise in defense of any Proceeding, including dismissal without prejudice, Indemnitee shall be indemnified against Expenses and Liabilities actually and reasonably incurred by Indemnitee in connection therewith. &#160; </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">If the indemnification provided for in Section 1(a) above for any reason is held by a court of competent jurisdiction to be unavailable to Indemnitee in respect of any losses, claims, damages, expenses or liabilities referred to therein due to public policy related to applicable federal or state securities laws, then the Corporation, in lieu of indemnifying Indemnitee thereunder, shall contribute to the amount paid or payable by Indemnitee as a result of such losses, claims, damages, expenses or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Corporation and Indemnitee, or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.12pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">clause (i) above but also the relative fault of the Corporation and Indemnitee in connection with the action or inaction which resulted in such losses, claims, damages, expenses or liabilities, as well as any other relevant equitable considerations. In connection with the registration of the Corporation&#8217;s securities, the relative benefits received by the Corporation and Indemnitee shall be deemed to be in the same respective proportions that the net proceeds from the offering (before deducting expenses) received by the Corporation and Indemnitee, in each case as set forth in the table on the cover page of the applicable prospectus, bear to the aggregate public offering price of the securities so offered. The relative fault of the Corporation and Indemnitee shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Corporation or Indemnitee and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</font></div><div style="text-align:justify;text-indent:108pt"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Corporation and Indemnitee agree that it would not be just and equitable if contribution pursuant to this Section 1(c) were determined by pro rata or per capita allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the immediately preceding paragraph. In connection with the registration of the Corporation&#8217;s securities, in no event shall Indemnitee be required to contribute any amount under this Section 1(c) in excess of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">lesser of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (i) that proportion of the total of such losses, claims, damages or liabilities indemnified against equal to the proportion of the total securities sold under such registration statement which was sold by Indemnitee or (ii) the proceeds received by Indemnitee from sale of securities under such registration statement. No person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not found guilty of such fraudulent misrepresentation. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Mandatory Advancement of Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:23.18pt">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Unless a determination has been made pursuant to Section 5 (and remains in effect) that Indemnitee is not entitled to indemnification pursuant to Section 1, all reasonable Expenses incurred by or on behalf of Indemnitee shall be advanced from time to time by the Corporation to Indemnitee within twenty (20) days after the Corporation&#8217;s receipt of a written request for an advance of Expenses by Indemnitee, whether prior to or after final disposition of a Proceeding. For the sake of clarity, the Corporation shall not be obligated to make an affirmative determination under Section 5 in order to advance expenses prior to final disposition of a Proceeding. Furthermore, any Section 5 determination that Indemnitee is not entitled to advancement of expenses, if made prior to the final disposition of the relevant Proceeding, must be </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reasonable and must be based on facts that, in the reasonable opinion of the decision-making party, at the time such determination is made, demonstrate by clear and convincing evidence, sufficient to overcome the presumption of entitlement set forth in Section 5, that Indemnitee did not meet the applicable standard of conduct under Delaware law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The written request for an advancement of any and all Expenses under this Section shall contain reasonable detail of the Expenses incurred by Indemnitee, provided that Indemnitee shall not be required to provide any documentation or information to the extent that the provision thereof would undermine or otherwise jeopardize attorney-client privilege. Indemnitee shall agree, at the time of such written request for an advance, to repay the amounts advanced if it is ultimately determined that Indemnitee is not entitled to be indemnified pursuant to the terms of this Agreement. Any advances made shall be unsecured and no interest shall be charged thereon.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:23.8pt">Indemnification for Expenses in Enforcing Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. To the fullest extent allowable under applicable law, the Corporation shall also indemnify against, and, if requested by Indemnitee, shall advance to Indemnitee subject to and in accordance with the terms of Section&#160;2(a), any Expenses actually and reasonably paid or incurred by Indemnitee in connection with any action or proceeding by Indemnitee for (a) indemnification or reimbursement or advance payment of Expenses by the Corporation under any provision of this Agreement, or under any other agreement or provision of the Governing Documents now or hereafter in effect relating to Proceedings regarding Indemnifiable Events, and&#47;or (b) recovery under any directors&#8217; and officers&#8217; liability insurance policies maintained by the Corporation, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification or insurance recovery, as the case may be. However, in the event that Indemnitee is ultimately determined not to be entitled to such indemnification or insurance recovery, as the case may be, then all amounts advanced under this Section&#160;2(b) shall be repaid. Indemnitee shall be required to reimburse the Corporation in the event that a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">final judicial determination is made that such action brought by Indemnitee was frivolous or not made in good faith.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The foregoing indemnity and advancement of Expenses shall apply only to the extent that Indemnitee has not been indemnified and reimbursed pursuant to such insurance as the Corporation may maintain for Indemnitee&#8217;s benefit or pursuant to the Governing Documents or otherwise&#59; provided, however, that notwithstanding the availability of such other indemnification and reimbursement pursuant to such Corporation-maintained policies, Indemnitee may, with the Corporation&#8217;s consent, claim indemnification and advancement of Expenses pursuant to this Agreement by assigning Indemnitee&#8217;s claims under such insurance to the Corporation to the extent Indemnitee is paid by the Corporation. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Furthermore, any other provision herein to the contrary notwithstanding, the Corporation shall not be obligated pursuant to the terms of this Agreement to (a) indemnify or advance Expenses to Indemnitee with respect to any Proceeding initiated or brought voluntarily by such Indemnitee and not by way of defense, except (i) with respect to actions or proceedings to establish or enforce a right to indemnity under this Agreement or any other agreement or insurance policy or under the Governing Documents now or hereafter in effect relating to a Proceeding and (ii) in specific cases in which the Board of Directors has approved the initiation or bringing of such Proceeding, (b) indemnify Indemnitee for expenses and&#47;or the payment of profits with respect to any short swing profit liability owed to the Corporation by Indemnitee pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended, or any similar successor statute, and the regulations promulgated thereunder, or (c) indemnify Indemnitee with respect to any proceeding instituted by Indemnitee to enforce or interpret this Agreement, if a court of competent jurisdiction determines that each of the material assertions made by the Indemnitee in such proceeding was not made in good faith or was frivolous. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Corporation may, but is not obligated to, maintain insurance to protect itself and&#47;or Indemnitee against Expenses and Liabilities in connection with Proceedings to the fullest extent permitted by applicable laws or its Governing Documents. The Corporation may, but is not obligated to, create a trust fund, grant a security interest or use other means (including, without limitation, a letter of credit) to ensure the payment of such amounts as may be necessary to effect indemnification or advancement of Expenses as provided in this Agreement. If, at the time of the receipt by the Corporation of a notice of a claim by Indemnitee pursuant to Section 5 hereof (or upon the Corporation otherwise becoming aware of such a claim), the Corporation has liability insurance in effect which may cover such claim, then the Corporation shall give timely notice of the commencement of such claim to the insurers in accordance with the procedures set forth in the respective policies. The Corporation shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such action, suit, proceeding, inquiry or investigation in accordance with the terms of such policies. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Procedures and Presumptions for Determination of Entitlement to Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:25.02pt">Mandatory Indemnification&#59; Indemnification as a Witness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">To the extent that Indemnitee shall have been successful on the merits or otherwise in defense of any Proceeding relating to an Indemnifiable Event or any portion thereof or in defense of any issue or matter therein, including without limitation dismissal without prejudice, Indemnitee shall be indemnified against all Liabilities relating to such Proceeding in accordance with Section&#160;1 to the fullest extent allowable by law, and no Standard of Conduct Determination (as defined in Section&#160;5(b)) shall be required.</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">To the extent that Indemnitee&#8217;s involvement in a Proceeding relating to an Indemnifiable Event is to prepare to serve and serve as a witness, and not as a party, the Indemnitee shall be indemnified against all Liabilities and Expenses incurred in connection therewith to the fullest extent allowable by law and no Standard of Conduct Determination shall be required.</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:23.18pt">Standard of Conduct</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the extent that the provisions of Section&#160;5(a) are inapplicable to a Proceeding related to an Indemnifiable Event that shall have been finally disposed of, any determination of whether Indemnitee has satisfied any applicable standard of conduct under Delaware </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">law that is a legally required condition to indemnification of Indemnitee hereunder against Liabilities relating to such Proceeding and any determination that an advancement of Expenses must be repaid to the Corporation (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Standard of Conduct Determination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) shall be made as follows&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">if no Change in Control has occurred, (A) by a majority vote of the Disinterested Directors, even if less than a quorum of the Board of Directors, (B) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum or (C) if there are no such Disinterested Directors, by Independent Counsel in a written opinion addressed to the Board of Directors, a copy of which shall be delivered to Indemnitee&#59; and</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">if a Change in Control shall have occurred, (A) if the Indemnitee so requests in writing, by a majority vote of the Disinterested Directors, even if less than a quorum of the Board of Directors, or (B) otherwise, by Independent Counsel in a written opinion addressed to the Board of Directors, a copy of which shall be delivered to Indemnitee.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Corporation shall indemnify and hold harmless Indemnitee against and, if requested by Indemnitee, shall reimburse Indemnitee for, or advance to Indemnitee, within fifteen (15) days of such request, any and all Expenses incurred by Indemnitee in cooperating with the person or persons making such Standard of Conduct Determination.</font></div><div style="text-align:justify;text-indent:108pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:23.18pt">Making the Standard of Conduct Determination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Corporation shall use its reasonable best efforts to cause any Standard of Conduct Determination required under Section&#160;5(b) to be made as promptly as practicable. If the person or persons designated to make the Standard of Conduct Determination under Section&#160;5(b) shall not have made a determination within thirty (30) days after the later of (A)&#160;receipt by the Corporation of a written request from Indemnitee for indemnification pursuant to Section&#160;1 (the date of such receipt being the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notification Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and (B) the selection of an Independent Counsel, if such determination is to be made by Independent Counsel, then Indemnitee shall be deemed to have satisfied the applicable standard of conduct&#59; provided that such 30-day period may be extended for a reasonable time, not to exceed an additional thirty (30) days, if the person or persons making such determination in good faith requires such additional time to obtain or evaluate information relating thereto. Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement of Indemnitee to indemnification under this Agreement shall be required to be made prior to the final disposition of any Proceeding.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:25.63pt">Payment of Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If, in regard to any Liabilities&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">Indemnitee shall be entitled to indemnification pursuant to Section&#160;5(a),</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">No Standard of Conduct Determination is legally required as a condition to indemnification of Indemnitee hereunder, or</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Indemnitee has been determined or deemed pursuance to Section&#160;5(b) or 5(c) to have satisfied the Standard of Conduct Determination, </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">then the Corporation shall pay to Indemnitee, within fifteen (15) days after the later of (A) the Notification Date or (B) the earliest date on which the applicable criterion specified in clause (i), (ii) or (iii) is satisfied, an amount equal to such Liabilities.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:25.63pt">Selection of Independent Counsel for Standard of Conduct Determination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If a Standard of Conduct Determination is to be made by Independent Counsel pursuant to Section&#160;5(b)(i), the Independent Counsel shall be selected by the Board of Directors, and the Corporation shall give written notice to Indemnitee advising Indemnitee of the identity of the Independent Counsel so selected. If a Standard of Conduct Determination is to be made by Independent Counsel pursuant to Section&#160;5(b)(ii), the Independent Counsel shall be selected by Indemnitee, and Indemnitee shall give written notice to the Corporation advising it of the identity of the Independent Counsel so selected. In either case, Indemnitee or the Corporation, as applicable, may, within five (5) days after receiving written notice of selection from the other, deliver to the other a written objection to such selection&#59; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not satisfy the criteria set forth in the definition of &#8220;Independent Counsel&#8221; in Section&#160;13(f), and the objection shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person or firm so selected shall act as Independent Counsel. If such written objection is properly and timely made and substantiated, (i) the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit&#59; and (ii) the non-objecting party may, at its option, select an alternative Independent Counsel and give written notice to the other party advising such other party of the identity of the alternative Independent Counsel so selected, in which case the provisions of the two immediately preceding sentences, the introductory clause of this sentence and numbered clause (i) of this sentence shall apply to such subsequent selection and notice. If applicable, the provisions of clause (ii) of the immediately preceding sentence shall apply to successive alternative selections. If no Independent Counsel that is permitted under the foregoing provisions of this Section&#160;5(e) to make the Standard of Conduct Determination shall have been selected within twenty (20) days after the Corporation gives its initial notice pursuant to the first sentence of this Section&#160;5(e) or Indemnitee gives its initial notice pursuant to the second sentence of this Section&#160;5(e), as the case may be, either the Corporation or Indemnitee may petition the Court of Chancery of the State of Delaware (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Delaware Court</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to resolve any objection which shall have been made by the Corporation or Indemnitee to the other&#8217;s selection of Independent Counsel and&#47;or to appoint as Independent Counsel a person to be selected by the Court or such other person as the Court shall designate, and the person or firm with respect to whom all objections are so resolved or the person or firm so appointed will act as Independent Counsel. In all events, the Corporation shall pay all of the reasonable fees and expenses of the Independent Counsel incurred in connection with the Independent Counsel&#8217;s determination pursuant to Section&#160;5(b).</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:23.18pt">Presumptions and Defenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt;text-decoration:underline">Indemnitee&#8217;s Entitlement to Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In making any Standard of Conduct Determination, the person or persons making such determination shall presume that Indemnitee has satisfied the applicable standard of conduct and is entitled to indemnification, and the Corporation shall have the burden of proof to overcome that presumption and establish that Indemnitee is not so entitled. Any Standard of Conduct Determination that is adverse to Indemnitee may be challenged by the Indemnitee in the Delaware Court. No determination by the Corporation (including by its directors or any Independent Counsel) that Indemnitee has not satisfied any applicable standard of conduct may be used as a defense to any legal proceedings brought by Indemnitee to secure indemnification or reimbursement or advance payment of Expenses by the Corporation hereunder or create a presumption that Indemnitee has not met any applicable standard of conduct. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt;text-decoration:underline">Reliance as a Safe Harbor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, and without creating any presumption as to a lack of good faith if the following circumstances do not exist, Indemnitee shall be deemed to have acted in good faith and in a manner Indemnitee reasonably believed to&#160;be in or not opposed to the best interests of the Corporation if Indemnitee&#8217;s actions or omissions to act are taken in good faith reliance upon the records of the Corporation, including its financial statements, or upon information, opinions, reports or statements furnished to Indemnitee by the officers or employees of the Corporation or any of its subsidiaries in the course of their duties, or by committees of the Board of Directors or by any other Person (including legal counsel, accountants and financial advisors) as to matters Indemnitee reasonably believes are within such other Person&#8217;s professional or expert competence and who has been selected with reasonable care by or on behalf of the Corporation.&#160;In addition, the knowledge and&#47;or actions, or failures to act, of any other director, officer, agent or employee of the Corporation shall not be imputed to Indemnitee for purposes of determining the right to indemnity hereunder. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">No Other Presumptions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, the termination of any Proceeding by judgment, order, settlement (whether with or without court approval) or conviction, or upon a plea of nolo contendere or its equivalent, will not create a presumption that Indemnitee did not meet any applicable standard of conduct or have any particular belief, or that indemnification hereunder is otherwise not permitted.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt;text-decoration:underline">Defense to Indemnification and Burden of Proof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  It shall be a defense to any action brought by Indemnitee against the Corporation to enforce this Agreement (other than an action brought to enforce a claim for Liabilities incurred in defending against a Proceeding related to an Indemnifiable Event in advance of its final disposition) that it is not permissible under applicable law for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Corporation to indemnify Indemnitee for the amount claimed. In connection with any such action or any related Standard of Conduct Determination, the burden of proving such a defense or that the Indemnitee did not satisfy the applicable standard of conduct shall be on the Corporation.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Fees and Expenses of Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Corporation agrees to pay the reasonable fees and expenses of independent legal counsel (including appropriate retainers) should such counsel be retained to make a determination of Indemnitee&#8217;s entitlement to indemnification pursuant to Section 5 of this Agreement. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Remedies of Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">In the event that (i) a determination pursuant to Section 5 hereof is made that Indemnitee is not entitled to indemnification, (ii) advances of Expenses are not made pursuant to this Agreement for any reason, (iii) payment has not been timely made following a determination of entitlement to indemnification pursuant to this Agreement, or (iv) Indemnitee otherwise seeks enforcement of this Agreement, Indemnitee shall be entitled to a final adjudication of Indemnitee&#8217;s rights in an appropriate court. The Corporation shall not oppose Indemnitee&#8217;s right to seek any such adjudication. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">In the event that a determination that Indemnitee is not entitled to indemnification, in whole or in part, has been made pursuant to Section 5 hereof, the decision in the judicial proceeding provided in paragraph (a) of this Section 7 shall be made de novo and Indemnitee shall not be prejudiced by reason of a determination that Indemnitee is not entitled to indemnification. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">If a determination that Indemnitee is entitled to indemnification has been made pursuant to Section 5 hereof or otherwise pursuant to the terms of this Agreement, the Corporation shall be bound by such determination in the absence of (i) misrepresentation of a material fact by Indemnitee or (ii)&#160;a specific finding (which has become final) by an appropriate court that all or any part of such indemnification is expressly prohibited by law. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">In any court proceeding pursuant to this Section 7, the Corporation shall be precluded from asserting that the procedures and presumptions of this Agreement are not valid, binding and enforceable. The Corporation shall stipulate in any such court that the Corporation is bound by all the provisions of this Agreement (including the rebuttable presumptions specified in Section 5(f)(i)) and is precluded from making any assertion to the contrary.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Modification. Waiver, Termination and Cancellation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  No supplement, modification, termination, cancellation or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar), nor shall any such waiver constitute a continuing waiver. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Notice by Indemnitee and Defense of Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Indemnitee shall promptly notify the Corporation in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any matter, whether civil, criminal, administrative or investigative, but the omission to so notify the Corporation will not relieve it from any liability which it may have to Indemnitee if such omission does not prejudice the Corporation&#8217;s rights. If such omission does prejudice the Corporation&#8217;s rights, the Corporation will be relieved from liability only to the extent of such prejudice. With respect to any Proceeding as to which Indemnitee notifies the Corporation of the commencement thereof&#58; </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Corporation will be entitled to participate therein at its own expense&#59; and </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The Corporation jointly with any other indemnifying party similarly notified will be entitled to assume the defense thereof, with counsel reasonably satisfactory to Indemnitee&#59; provided, however, that the Corporation shall not be entitled to assume the defense of any Proceeding if Indemnitee shall have reasonably concluded that there may be a conflict of interest between the Corporation and Indemnitee with respect to such Proceeding. After notice from the Corporation to Indemnitee of its election to assume the defense thereof, the Corporation will not be liable to Indemnitee under this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agreement for any Expenses subsequently incurred by Indemnitee in connection with the defense thereof, other than reasonable costs of investigation or as otherwise provided below. Indemnitee shall have the right to employ Indemnitee&#8217;s own counsel in such Proceeding but the fees and expenses of such counsel incurred after notice from the Corporation of its assumption of the defense thereof shall be at the expense of Indemnitee unless&#58; </font></div><div style="text-align:justify;text-indent:117pt"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">The employment of counsel by Indemnitee has been authorized in writing by the Corporation&#59; </font></div><div style="text-align:justify;text-indent:117pt"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">Indemnitee shall have reasonably concluded that counsel engaged by the Corporation may not adequately represent Indemnitee&#59; or </font></div><div style="text-align:justify;text-indent:117pt"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">The Corporation shall not in fact have employed counsel to assume the defense in such Proceeding or shall not in fact have assumed such defense and be acting in connection therewith with reasonable diligence&#59; </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in each of which cases the fees and expenses of such counsel shall be at the expense of the Corporation. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Corporation shall not settle any Proceeding in any manner which would impose any penalty or limitation on Indemnitee, other than monetary penalties paid by the Corporation, without Indemnitee&#8217;s written consent&#59; provided, however, that Indemnitee will not unreasonably withhold Indemnitee&#8217;s consent to any such proposed settlement. In addition, the Corporation shall not enter into any settlement of any Proceeding unless such settlement provides for a full and final release of all claims asserted against Indemnitee. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt;text-decoration:underline">Deposit of Funds in Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the Corporation voluntarily decides to dissolve or to file a petition for relief under any applicable bankruptcy, moratorium or similar laws, then not later than 10 days prior to such dissolution or filing, the Corporation shall deposit in trust for the sole and exclusive benefit of Indemnitee a cash amount equal to all amounts previously authorized to be paid to Indemnitee hereunder, such amounts to be used to discharge the Corporation&#8217;s obligations to Indemnitee hereunder. Any amounts in such trust not required for such purpose shall be returned to the Corporation. This Section 10 shall not apply to the dissolution of the Corporation in connection with a transaction as to which Section 13(b)(iii) applies. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All notices, requests, consents and other communications hereunder shall be in writing and shall be sent by Federal Express or other nationally recognized overnight or same day courier service providing a return receipt (and shall be effective when received, when refused or when the same cannot be delivered, as evidenced on the return receipt) to the following addresses (or to such other address as a party may subsequently provide written notification of to the other party)&#58; </font></div><div><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:72pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:44.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To Corporation&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Artivion, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1655 Roberts Blvd., NW</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kennesaw, GA 30144</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Attn&#58; General Counsel</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:72pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:44.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To Indemnitee&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">_____________________</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1655 Roberts Blvd., NW</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt 2px 4.87pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kennesaw, GA 30144</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt;text-decoration:underline">Nonexclusivity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The rights of Indemnitee hereunder shall not be deemed exclusive of any other rights to which Indemnitee may now or in the future be entitled under the Delaware General Corporation Law, the Governing Documents, or any agreements, insurance policies, vote of stockholders, resolution of the Board of Directors or Disinterested Directors, or otherwise. The provisions of this Agreement are hereby deemed to be a contract right between the Corporation and the Indemnitee and any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">repeal of the relevant provisions of the Delaware General Corporation Law, or other applicable law, shall not affect this Agreement or its enforceability. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt;text-decoration:underline">Certain Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">References to the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall include, in addition to the resulting corporation, any constituent corporation or other enterprise (including any constituent of a constituent or other enterprise) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees, partners, fiduciaries or agents, so that any person who is or was a director, officer, employee, partner, fiduciary or agent of such constituent corporation or other enterprise, or is or was serving at the request of such constituent corporation or other enterprise as a director, officer, employee, partner, fiduciary or agent of another corporation, partnership, joint venture, limited liability company, limited liability partnership, limited partnership, employee benefit plan, trust or other enterprise, shall stand in the same position under this Agreement with respect to the resulting or surviving corporation as Indemnitee would have with respect to such constituent corporation or other enterprise if its separate existence had continued. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">A &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall be deemed to have occurred if </font></div><div style="text-align:justify;text-indent:117pt"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">any &#8220;Person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than a trustee or other fiduciary holding securities under an employee benefit plan of the Corporation or a corporation owned directly or indirectly by the stockholders of the Corporation in substantially the same proportions as their ownership of stock of the Corporation, </font></div><div style="text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">who is or becomes the beneficial owner, directly or indirectly, of securities of the Corporation representing 20% or more of the combined voting power of the Corporation&#8217;s then outstanding voting securities, increases his beneficial ownership of such securities by 5% or more over the percentage so owned by such person, or </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">becomes the &#8220;beneficial owner&#8221; (as defined in rule 13d-3 under said Act), directly or indirectly, of securities of the Corporation representing more than 30% of the total voting power represented by the Corporation&#8217;s then outstanding voting securities, </font></div><div style="text-align:justify;text-indent:117pt"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">during any period of two consecutive years, individuals who at the beginning of such period constitute the Board of Directors of the Corporation and any new director whose election by the Board of Directors or nomination for election by the Corporation&#8217;s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof, or</font></div><div style="text-align:justify;text-indent:117pt"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">the stockholders of the Corporation approve a merger or consolidation of the Corporation with any other corporation, other than a merger or consolidation which would result in the voting securities of the Corporation outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least 80% of the total voting power represented by the voting securities of the Corporation or such surviving entity outstanding immediately after such merger or consolidation, or the stockholders of the Corporation approve a plan of complete liquidation of the Corporation or an agreement for the sale or disposition by the Corporation of (in one transaction or a series of transactions) all or substantially all of the Corporation&#8217;s assets. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disinterested Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a director of the Corporation who is not and was not a party to the Proceeding in respect of which indemnification is being sought by Indemnitee. If there has been a Change in Control since the date hereof, to qualify as a Disinterested Director, such director must also have been a director of the Corporation prior to such Change in Control. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean all direct and indirect costs (including, without limitation, attorneys&#8217; fees, retainers, court costs, transcripts, costs of investigation, costs of defense, costs of defending witnesses or preparing to be a witness, costs of negotiating settlements, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">service fees, costs of attachment, appeal or similar bonds, and all other disbursements or out-of-pocket expenses) actually and reasonably incurred in connection with a Proceeding or establishing or enforcing a right to indemnification or advances under this Agreement, applicable law or otherwise&#59; provided, however, that &#8220;Expenses&#8221; shall not include any Liabilities. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the period of time during which Indemnitee shall continue to serve as a director or executive officer of the Corporation, and thereafter so long as Indemnitee shall be subject to any possible Proceeding arising out of acts or omissions of Indemnitee as a director or executive officer, which may include serving as a fiduciary or agent of the Corporation or otherwise acting or omitting at the request of or on behalf of the Corporation. For non-directors, status as an executive officer is required for this Agreement to provide indemnification related to a person&#8217;s actions or omissions. Should a non-director Indemnitee cease to be an executive officer, his or her actions and omissions, performed as a non-officer employee, are not entitled to indemnification under this Agreement. Furthermore, only those executive officers who hold a validly executed Indemnification Agreement are entitled to the rights and privileges herein.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Independent Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently performs, nor in the past five (5) years has performed, services for either&#58; (i) the Corporation (including any affiliate of the Corporation) or Indemnitee (other than in connection with matters concerning Indemnitee under this Agreement or of other indemnitees under similar agreements) or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term &#8220;Independent Counsel&#8221; shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Corporation or Indemnitee in an action to determine Indemnitee&#8217;s rights under this Agreement.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean liabilities of any type whatsoever including, but not limited to, any damages, judgments, fines, ERISA excise taxes and penalties, penalties and amounts paid in settlement (including all interest assessments and other charges paid or payable in connection with or in respect of such judgments, fines, penalties or amounts paid in settlement) related to any Proceeding, as well as any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any individual, corporation, firm, partnership, joint venture, limited liability company, estate, trust, business association, organization, governmental entity or other entity. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any threatened, asserted, pending or completed action, claim, suit, arbitration, alternate dispute resolution mechanism, investigation, administrative hearing or any other proceeding whether civil, criminal, administrative or investigative, including any appeal therefrom. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">For purposes of this Agreement, references to an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">other enterprise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall include employee benefit plans&#59; references to &#8220;fines&#8221; shall include any excise taxes assessed on a person with respect to any employee benefit plan&#59; and references to &#8220;serving at the request of the corporation&#8221; shall include any service as a director, officer, employee, partner, fiduciary or agent of the corporation which imposes duties on, or involves services by, such director, officer, employee, partner, fiduciary or agent with respect to an employee benefit plan, its participants or beneficiaries&#59; and a person who acted in good faith and in a manner Indemnitee reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#8220;not opposed to the best interests of the Corporation&#8221; as referred to in this Agreement. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt;text-decoration:underline">Binding Effect, Duration and Scope of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors and assigns (including the executors, administrators and heirs of Indemnitee&#8217;s estate (including without limitation, spouses), and any direct or indirect successor by purchase, merger, consolidation or otherwise, to all or substantially all of the business or assets of the Corporation), heirs, and personal and legal representatives. This Agreement shall continue in effect during the Indemnification Period, regardless of whether Indemnitee continues to serve as a director, officer, employee, fiduciary or agent. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any provision or provisions of this Agreement (or any portion thereof) shall be held to be invalid, illegal or unenforceable for any reason whatsoever&#58; </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the validity, legality and enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby&#59; and </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">to the fullest extent legally possible, the provisions of this Agreement shall be construed so as to give effect to the intent of any provision held invalid, illegal or unenforceable. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt;text-decoration:underline">Governing Law, Interpretation of Agreement, and Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware (without regard to its conflict of laws rules, other than the internal affairs doctrine). It is the intent of this agreement to indemnify Indemnitee to the fullest extent permitted by the Delaware General Corporation Law and other applicable law as in effect on the date hereof or as they may be amended from time to time, to the extent such amendments may broaden the scope of indemnification permitted. For the sake of clarity, no change in the Delaware General Corporation Law shall have the effect of reducing the benefits available to Indemnitee except to the extent expressly so required by law. However, if the Governing Documents or the Delaware General Corporation Law are amended to provide for greater indemnification rights or privileges, this Agreement shall not be construed so as to limit Indemnitee&#8217;s rights and privileges to the terms hereof and Indemnitee shall be entitled to the full benefits of any such additional rights and privileges. The Corporation and Indemnitee each hereby irrevocably consent to the jurisdiction of the courts of the State of Georgia for all purposes in connection with any action or proceeding which arises out of or relates to this Agreement and agree that any action instituted under this Agreement shall be commenced, prosecuted and continued only in the federal and state courts of the State of Georgia in and for Fulton County, which shall be the exclusive and only proper forum for adjudicating such a claim. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement represents the entire agreement between the parties hereto, and there are no other agreements, contracts or understandings between the parties hereto with respect to the subject matter of this Agreement, except as specifically referred to herein or as provided in Section 12 hereof. In furtherance and not in limitation of the foregoing, and notwithstanding the provisions of Section 12 hereof, the indemnification agreement between the Corporation and the Indemnitee dated ____________ is hereby terminated in its entirety, shall have no further force and effect, and is superseded by this Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt;text-decoration:underline">Partial Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If Indemnitee is entitled under any provision of this Agreement to indemnification by the Corporation for some or a portion of any Expenses or Liabilities, but not, however, for the total amount thereof, the Corporation shall nevertheless indemnify Indemnitee for the portion of such Expenses or Liabilities to which Indemnitee is entitled. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#91;signatures on following page(s)&#93;</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div></div></div><div id="i8fd914c786014242b14e66245ebd7141_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt;text-align:justify"><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first written above. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CORPORATION&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:198pt"><font><br></font></div><div style="padding-left:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTIVION, INC. </font></div><div style="padding-left:198pt"><font><br></font></div><div style="padding-left:198pt"><font><br></font></div><div style="padding-left:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:198pt"><font><br></font></div><div style="padding-left:198pt"><font><br></font></div><div style="padding-left:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">INDEMNITEE&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:198pt"><font><br></font></div><div style="padding-left:198pt"><font><br></font></div><div style="padding-left:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>a102-redactedxdavisxchange.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="if472eff484a24680b565eae76a2fb001_1"></div><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">CERTAIN INFORMATION HAS BEEN OMITTED OR REDACTED FROM THE VERSION OF THIS EXHIBIT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION TO PROTECT PERSONAL PRIVACY</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTIVION, INC.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Change of Control Severance Agreement</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Change of Control Severance Agreement (this &#8220;Agreement&#8221;) dated as of the 2nd day of August, 2022 is made and entered into by and between Artivion, Inc., a Delaware corporation (&#8220;Artivion&#8221; or the &#8220;Company&#8221;) and John E. Davis (the &#8220;Executive&#8221;).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1. It is expected that the Company from time to time will consider the possibility of an acquisition by another company or other change of control.  The Board of Directors of the Company (the &#8220;Board&#8221;), upon the recommendation of its Compensation Committee, has determined that it is in the best interests of the Company and its shareholders to enter into this Change of Control Agreement in order to assure that the Company will have the continued dedication of Executive, notwithstanding the possibility, threat or occurrence of a Change of Control (as defined herein) of the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2. The Board believes that it is in the best interests of the Company and its stockholders to provide Executive with an incentive to continue Executive&#8217;s employment and to motivate Executive to maximize the value of the Company upon a Change in Control for the benefit of the stockholders.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3. The Board believes it is imperative to provide Executive with certain severance benefits upon Executive&#8217;s termination of employment both prior to and following a Change in Control.  These benefits will provide Executive with enhanced financial security and incentive and encouragement to remain with the Company notwithstanding the possibility of a Change in Control. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.  Certain capitalized terms used in the Agreement are as defined below. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows&#58;   </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1. &#160;&#160;&#160;&#160;CERTAIN DEFINITIONS.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the first date during the Change of Control Period (as defined herein) on which a Change of Control occurs.  Notwithstanding anything in this Agreement to the contrary, if the Executive&#8217;s employment with the Company is Terminated by the Company without Cause or by Executive for Good Reason (as such terms are defined herein) within the six (6) month period prior to the date on which the Change of Control occurs and if such Change of Control is consummated (such a Termination of employment, an &#8220;Anticipatory Termination&#8221;), then for all purposes of this Agreement the &#8220;Effective Date&#8221; means the date immediately prior to the date of such Termination of employment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the period commencing on the date hereof and ending on December 31 of the year above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that, commencing on December 31 of the year above, and each one-year anniversary of such date (such date and each such one-year anniversary thereof, the &#8220;Renewal Date&#8221;) unless previously terminated, the Change of Control Period shall be automatically extended so as to terminate one (1) year from such Renewal Date, unless, at least thirty (30) days prior to the next Renewal Date, the Company shall give notice to the Executive that the Change of Control Period shall not be so extended.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliated Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any company controlled by, controlling or under common control with the Company.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a change in the ownership or effective control of, or in the ownership of a substantial portion of the assets of, the Company, as described in paragraphs (i) through (iii) below.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div><div style="text-align:justify;text-indent:81pt"><font style="color:#3a3a3a;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.24pt;text-decoration:underline">Change in Ownership of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  A change in the ownership of the Company shall occur on the date that any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), other than a group of which Executive is a member, acquires ownership of the Company stock that, together with the Company stock held by such person or group, constitutes more than 50% of the total voting power of the stock of the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.74pt">If any one person or more than one person acting as a group (within the meaning of paragraph (iv)), other than a group of which Executive is a member, is considered to own more than 50% of the total voting power of the stock of the Company, the acquisition of additional the Company stock by such person or persons shall not be considered to cause a change in the ownership of the Company  or to cause a change in the effective control of the Company (within the meaning of paragraph (ii) below).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">An increase in the percentage of the Company stock owned by any one person, or persons acting as a group (within the meaning of paragraph (iv)), as a result of a transaction in which the Company acquires its stock in exchange for property, shall be treated as an acquisition of stock for purposes of this paragraph (i).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">Except as provided in (B) above, the provisions of this paragraph (i) shall apply only to the transfer or issuance of the Company stock if such stock remains outstanding after such transfer or issuance.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Effective Control of the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.74pt">A change in the effective control of the Company shall occur on the date that either of (1) or (2) below occurs&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">Any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), other than a group of which Executive is a member, acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons) ownership of stock of the Company possessing 30% or more of the total voting power of the stock of the Company (the provisions of Sections l(d)(i) (B) and (C) above shall apply equally to this Section l(d)(ii)(A)(l)&#59; or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">A majority of the members of the Company Board of Directors are replaced during any twelve (12) month period by Directors whose appointment or election is not endorsed by a majority of the Board of Directors prior to the date of the appointment or election.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">A change in effective control of the Company also may occur with respect to any transaction in which either of the Company or the other entity involved in a transaction described in paragraph (iii) experiences a Change of Control event described in paragraphs (i) or (iii).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">If any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), is considered to effectively control the Company (within the meaning of this paragraph (ii)), the acquisition of additional control of the Company by the same person or persons shall not be considered to cause a change in the effective control of the Company (or to cause a change in the ownership of the Company within the meaning of paragraph (i)).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.53pt;text-decoration:underline">Change in Ownership of a Substantial Portion of the Company&#8217;s Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  A change in the ownership of a substantial portion of the Company&#8217;s assets shall occur on the date that any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), other than a group of which Executive is a member, acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value (within the meaning of paragraph (iii)(B)) equal to or more than 40% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.74pt">A transfer of the Company's assets shall not be treated as a change in the ownership of such assets if the assets are transferred to one or more of the following&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">A shareholder of the Company (immediately before the asset transfer) in exchange for or with respect to Company stock&#59;</font></div><div style="text-align:justify;text-indent:126pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">An entity, 50% or more of the total value or voting power of which is owned, directly or indirectly, by the Company&#59;</font></div><div style="text-align:justify;text-indent:126pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div><div style="text-align:justify;text-indent:126pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">A person, or more than one person acting as a group (within the meaning of paragraph (iv)) that owns, directly or indirectly, 50% or more of the total value or voting power of all of the outstanding stock of the Company&#59; or</font></div><div style="text-align:justify;text-indent:126pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">An entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by a person described in paragraph (iii)(A)(3).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this paragraph (iii)(A), and except as otherwise provided herein, a person&#8217;s status is determined immediately after the transfer of assets.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">For purposes of this paragraph (iii), gross fair market value means the value of all the Company assets, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.13pt">For purposes of this Section 1(d), persons shall be considered to be acting as a group if they are owners of an entity that enters into a merger, consolidation, purchase, or acquisition of assets, or similar business transaction with the Company.  If a person, including an entity shareholder, owns stock in the Company and another entity with which the Company enters into a merger, consolidation, purchase, or acquisition of stock, or similar business transaction, such shareholder shall be considered to be acting as a group with the other shareholders in a corporation only to the extent of the ownership  in that corporation prior to the transaction giving rise to the change and not with respect to the ownership interest in the other corporation.  Persons shall not be considered to be acting as a group solely because they purchase or own stock of the Company at the same time, or as a result of the same public offering of the Company&#8217;s stock.</font></div><div style="padding-left:81pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.18pt">Under no circumstances shall the reincorporation of the Company in a different state, or any action or inaction taken in furtherance thereof, constitute a Change of Control under this Agreement, including but not limited to efforts to end incorporation in the current state of incorporation or alterations to equity that facilitate such an event. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt;text-decoration:underline">Terminate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means a &#8220;separation from service&#8221; within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2. &#160;&#160;&#160;&#160;EMPLOYMENT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive and the Company acknowledge that the employment of the Executive by the Company is &#8220;at will,&#8221; and Executive shall have no rights under this Agreement unless Executive is Terminated by the Company without Cause or by the Executive with Good Reason during the period commencing on the Effective Date and ending on the second first anniversary of such date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3. &#160;&#160;&#160;&#160;TERMS OF AT WILL EMPLOYMENT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The terms of Executive&#8217;s at will employment, as recorded in the Employee Proprietary Information Agreement executed by the Executive and the Company, are incorporated herein.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4. &#160;&#160;&#160;&#160;TERMINATION OF EMPLOYMENT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) &#160;&#160;&#160;&#160;For purposes of this Agreement, &#8220;Cause&#8221; shall mean&#58;  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) an act of fraud, embezzlement, theft or any other material violation of law that occurs during or in the course of the Executive&#8217;s employment with the Company&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) intentional or grossly negligent damage by Executive to the Company&#8217;s assets&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii) intentional or grossly negligent disclosure by Executive of the Company&#8217;s confidential information contrary to the Company policies&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv) material breach of the Executive's obligations under this Agreement or any other Agreement with the Company&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v) engagement by the Executive in any activity which would constitute a breach of the Executive&#8217;s duty of loyalty or of the Executive&#8217;s assigned duties&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="padding-left:81pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi) breach by the Executive of any of the company&#8217;s policies and procedures&#59;</font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii) &#160;&#160;&#160;&#160;the willful and continued failure by Executive to perform the Executive&#8217;s assigned duties (other than as a result of incapacity due to physical or mental illness)&#59; or</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii) &#160;&#160;&#160;&#160;willful conduct by the Executive that is demonstrably and materially injurious to the Company, monetarily or otherwise.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean the assignment to the Executive, without the Executive&#8217;s consent, of any duties materially inconsistent with the Executive&#8217;s position (including changes in status, offices, or titles and any change in the Executive's reporting requirements that would cause Executive to report to an Executive who is junior in seniority to the employee to whom Executive reports), authority, duties or responsibilities, determined as of the later of the date of this Agreement or the date of any modification to Executive&#8217;s position (including status, offices, titles and reporting requirements, as described above), authority, duties or responsibilities that is agreed to by Executive, or any other action by the Company that results in a material diminution in such position, authority, duties, responsibilities or Executive&#8217;s aggregate compensation, excluding for this purpose an isolated, insubstantial and inadvertent action taken in good faith and which is remedied by the Company within thirty (30) days after receipt of notice thereof given by the Executive (each of these an &#8220;Event&#8221; for purposes of this Section 4(b)).  Executive must notify the Company of any Event that constitutes Good Reason within ninety (90) days following Executive&#8217;s knowledge of the existence of such Event or such Event shall not constitute Good Reason under this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt;text-decoration:underline">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any Termination by the Company for Cause, or by the Executive for Good Reason, shall be communicated by Notice of Termination to the other party hereto given in accordance with Section 11(b) of this Agreement.  For purposes of this Agreement, a &#8220;Notice of Termination&#8221; means a written notice which (i) indicates the specific termination provision in this Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive&#8217;s employment under the provision so indicated and (iii) specifies the termination date (which date shall not be more than thirty (30) days after the giving of such notice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">if Executive is terminating for Good Reason such date shall not be less than thirty (30) nor more than forty-five (45) days after giving of such notice). The failure by the Executive or the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of the Executive or the Company, respectively, hereunder or preclude the Executive or the Company, respectively, from asserting such fact or circumstance in enforcing the Executive&#8217;s or the Company&#8217;s rights hereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt;text-decoration:underline">Date of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  &#8220;Date of Termination&#8221; means the date of receipt of the Notice of Termination, or any later date specified therein, as the case may be.  The Company and the Executive shall take all steps necessary (including with regard to any post-Termination services by the Executive) to ensure that any Termination described in this Section 4 constitutes a &#8220;separation from service&#8221; within the meaning of Section 409A of the Code, and notwithstanding anything contained herein to the contrary, the date on which the separation from service takes place shall be the &#8220;Date of Termination.&#8221;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(e) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Covenants Necessary to the Company&#8217;s Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The covenants recorded in the Employee Proprietary Information Agreement executed by the Executive and the Company are incorporated herein, including but not limited to the covenant not to compete, the covenant regarding customer solicitation and interference, and the covenant regarding solicitation of employees.  Officer covenants and agrees that the payment of any Severance Payment (as defined in Section 5(e) below) shall be subject to and expressly conditioned upon Officer&#8217;s compliance with the covenants set forth in the Employee Proprietary Information Agreement, which have been incorporated herein.  Should Officer fail to comply with these covenants, the Company shall not be required to make the Severance Payment (or any portion of the Severance Payment that remains unpaid), and the Officer shall be required to repay any portion of the Severance Payment that the Officer has already received from the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5. &#160;&#160;&#160;&#160;OBLIGATIONS OF THE COMPANY UPON TERMINATION.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">If, during the two (2) year period commencing on the Effective Date and ending on the second anniversary of the Effective Date, (i) the Company shall Terminate the Executive&#8217;s employment without Cause, or (ii) the Executive shall Terminate employment for Good Reason, then the Company shall pay to Executive the Severance Payment (defined below).</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt;text-decoration:underline">Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The &#8220;Severance Payment&#8221; shall be an amount equal to one and one-half (1&#189;) times the aggregate of Executive&#8217;s base salary as of the Date of Termination and cash bonus compensation for the year in which the Termination of employment occurs.  For purposes of determining Executive&#8217;s cash bonus compensation for purposes of this Section 5(b), if the Date of Termination occurs before the awarding of </font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">bonuses for the year in which the Date of Termination occurs, the cash bonus compensation component of the Severance Payment shall be computed based on Executive&#8217;s most recent awarded cash bonus.  Cash bonus compensation shall include only the Annual Bonus paid in cash and shall specifically exclude the value of any non-cash bonuses, such as options or restricted stock.  For the sake of clarification, all cash paid in payment of all or a portion of the bonus pursuant to the Company&#8217;s 2007 Executive Incentive Plan or any successor thereto shall be bonus compensation for purposes of this Agreement for the year in which paid or issued.  The Severance Payment shall be payable to Executive as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.63pt">Except for the group health plan benefits payments or as otherwise provided herein, the Severance Payment, if any is due hereunder, shall be paid to Executive in a lump sum not later than thirty (30) days following Executive's Date of Termination, unless the Termination is an Anticipatory Termination.</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.58pt">In the event of an Anticipatory Termination, the Severance Payment, except for the group health plan benefits payments, shall be paid to Executive in a lump sum not later than thirty (30) days following the date of the Change of Control.</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;Notwithstanding the foregoing, if any amount paid pursuant to this Section 5(b) is deferred compensation within the meaning of Section 409A of the Code and as of the Date of Termination Executive is a Specified Employee, amounts that would otherwise be payable during the six-month period immediately following the Date of Termination shall instead be paid, with interest on any delayed payment at the applicable federal rate provided for in Section 7872(f)(2)(A) of the Code, on the first business day after the date that is six months following Executive&#8217;s &#8220;separation from service&#8221; within the meaning of Section 409A of the Code (the &#8220;Delayed Payment Date&#8221;).  As used in this Agreement, the term &#8220;Specified Employee&#8221; means a &#8220;specified employee&#8221; as defined in Section 409A(a)(2)(B)(i) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;).  By way of clarification, &#8220;specified employee&#8221; means a &#8220;key employee&#8221; (as defined in Section 416(i) of the Code, disregarding Section 416(i)(5) of the Code) of the Company.  Executive shall be treated as a key employee if the Executive meets the requirement of Section 416(i)(l)(A)(i), (ii), or (iii) at any time during the twelve (12) month period ending on an &#8220;identification date.&#8221;  For purposes of any &#8220;Specified Employee&#8221; determination hereunder, the &#8220;identification date&#8221; shall mean the last day of each calendar year.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">Medical Coverage.  In addition, group health plan coverage for the Executive and covered dependents, with the same contribution by the Executive, will be provided as part of the Severance Payment for the lesser of eighteen (18) months following the Date of Termination or until the Executive is provided comparable benefits by another employer.</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">Separation Agreement and Release of Claims.  The receipt of any Severance Payment pursuant to this Agreement will be subject to the Executive signing and not revoking a separation agreement and release of claims in a form provided by the Company (the &#8220;Release&#8221;), which may include restatements of covenants contained in the Employee Proprietary Information Agreement among others, and provided that such Release becomes effective and irrevocable no later than sixty (60) days following the termination date (such deadline, the &#8220;Release Deadline&#8221;). If the Release does not become effective and irrevocable by the Release Deadline, Executive will forfeit any rights to severance under this Agreement.  In no event will any Severance Payment be paid or provided until the Release becomes effective and irrevocable.  Except as required by Section 5(b)(iii), any Severance Payment that would have been made to Executive prior to the Release becoming effective and irrevocable but for the preceding sentence will be paid to Executive on the first regularly scheduled Company payroll date following the date the Release becomes effective and irrevocable, and any remaining payments will be made as provided in the Agreement.  </font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6. &#160;&#160;&#160;&#160;FULL SETTLEMENT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement and such amounts shall not be reduced whether or not the Executive obtains other employment.  The Company agrees to pay, to the full extent permitted  by law, all legal fees and expenses which the may reasonably incur as a result of any contest by the Company or Executive with respect to liability under or the interpretation of the validity or enforceability of, any provision of this Agreement, but only in the event and to the extent that (i) the Executive receives a final, non-appealable judgment  in his favor in any such action or receives a final judgment in his favor that has not been appealed by the Company within thirty (30) days of the date of the judgment&#59; or (ii) the parties agree to dismiss any such action upon the Company&#8217;s payment of the sums allegedly due the Executive or performance of the covenants by the Company allegedly breached by it.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7. &#160;&#160;&#160;&#160;PAYMENT CUT-BACK.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div><div style="text-align:justify;text-indent:54pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">Notwithstanding anything to the contrary contained herein, the Company will not pay to Executive any excise tax gross up pursuant to this Agreement or any other agreement between Executive and the Company.  Further notwithstanding anything to the contrary contained herein, the Company shall reduce any payment contingent on a Change of Control pursuant to any plan, agreement, or arrangement of the Company that would be considered in determining whether a &#8220;parachute payment&#8221; (as defined in Section 280G (&#8220;Section 280G&#8221;) of the Code), has occurred (&#8220;Change of Control Severance Payment&#8221;) to 2.99 times Employee&#8217;s average compensation, as indicated on such Employee&#8217;s Form W-2, for the five (5) years ending immediately prior to the year containing the date of the Change of Control (the &#8220;Safe Harbor Amount&#8221;) if, and only if, reducing the Change of Control Severance Payment would provide Executive with a greater net after-tax Change of Control Severance Payment than would be the case if no such reduction took place.  The Safe Harbor Amount, as defined herein, is an amount expressed in present value which maximizes the aggregate present value of the Change of Control Severance Payment without causing the Change of Control Severance Payment to be subject to the excise tax under Section 4999 (and related Section 280G) of the Code (the &#8220;Excise Tax&#8221;), determined in accordance with Section 280G(d)(4).  Any reduction in the Change of Control Severance Payment shall be implemented in accordance with Section 7(b).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">(i)&#160;&#160;&#160;&#160;Any reduction in payments pursuant to Section 7(a) shall apply so as to minimize the amount of compensation that is reduced (i.e., it applies to payments that to the greatest extent represent parachute payments), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no reduction shall be applied to an amount that constitutes a deferral of compensation under Section 409A except for amounts that have become payable at the time of the reduction and as to which the reduction will not result in a non-reduction in a corresponding amount that is a deferral of compensation under Section 409A that is not currently payable.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;For purposes of determining whether the Change of Control Severance Payment will be subject to the Excise Tax and the amount of such Excise Tax&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;The Change of Control Severance Payment shall be treated as a &#8220;parachute payment&#8221; within the meaning of Section 280G(b)(2), and if it is an &#8220;excess parachute payment&#8221; within the meaning of Section 280G(b)(l), it shall be treated as subject to the Excise Tax, unless, and except to the extent that, in the written opinion of independent compensation consultants, counsel or auditors of nationally recognized standing (&#8220;Independent Advisors&#8221;) selected by the Company and reasonably acceptable to Executive, the Change of Control Severance Payment (in whole or in part) does not constitute a parachute payment, or such excess parachute payment (in whole or in part) represents reasonable compensation for services actually rendered within the meaning of Section 280G(b)(4) in excess of the base amount within the meaning of Section 280G(b)(3) or are otherwise not subject to the Excise Tax.</font></div><div style="text-align:justify;text-indent:99pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;The value of any non-cash benefits or any deferred payment or benefit shall be determined by the Independent Advisors in accordance with the principles of Sections 280G(d)(3) and (4).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.03pt">For purposes of determining reductions in compensation pursuant to this Section 7(b), if any, Executive will be deemed (A) to pay federal income taxes at the applicable rates of federal income taxation for the calendar year in which the compensation would be payable&#59; and (B) to pay any applicable state and local income taxes at the applicable rates of taxation for the calendar year in which the compensation would be payable, taking into account any effect on federal income taxes from payment of state and local income taxes.  Compensation will be adjusted not later than the applicable deadline under Section 409A to provide for accurate payments under the cut-back provision of this Section 7(b), but after any such deadline no further adjustment will be made if it would result in a tax penalty under Section 409A.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">Furthermore, notwithstanding anything in this Agreement to the contrary, aggregate Severance Payments, separation payments and&#47;or similar payments made to Executive pursuant to this Agreement and otherwise shall be limited to the equivalent of Executive&#8217;s salary paid during the three (3) completed fiscal years ended prior to the Date of Termination, including any bonuses and guaranteed benefits paid during those years.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8. &#160;&#160;&#160;&#160;CONFIDENTIAL INFORMATION.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Executive and the Company will also be parties to one or more separate agreements respecting confidential information, trade secrets, inventions and non-competition, including but not limited to the Employee Proprietary Information Agreement, (collectively, the &#8220;IP Agreements&#8221;).  The parties agree that the IP Agreements shall not be superseded or terminated by this Agreement and shall survive any termination of this Agreement&#59; provided, however, that to the extent that there is any conflict or overlap between the provisions of this Agreement and any of the IP Agreements, those provisions that provide the Company with the greatest rights and protections shall control.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9. &#160;&#160;&#160;&#160;SUCCESSORS.</font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">This Agreement is personal to the Executive and without the prior written consent of the Company shall not be assignable by the Executive otherwise than by will or the laws of descent and distribution.  This Agreement shall inure to the benefit of and be enforceable by the Executive&#8217;s legal representatives.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.  As used in this Agreement, &#8220;the Company&#8221; shall mean Artivion as hereinbefore defined and any successor to its business and&#47;or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10. &#160;&#160;&#160;&#160;COMPLIANCE WITH SECTION 409A.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) &#160;&#160;&#160;&#160;This Agreement is intended to comply with, or otherwise be exempt from, Section 409A of the Code and any regulations and Treasury guidance promulgated thereunder.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">The Company and Executive agree that they will execute any and all amendments to this Agreement as they mutually agree in good faith may be necessary to ensure compliance with Section 409A of the Code.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">The Company makes no representation or warranty as to the tax effect of any of the preceding provisions, and the provisions of this Agreement shall not be construed as a guarantee by the Company of any particular tax effect to Executive under this Agreement.  The Company shall not be liable to Executive or any other person for any payment made under this Agreement which is determined to result in the imposition of an excise tax, penalty or interest under Section 409A of the Code, nor for reporting in good faith any payment made under this Agreement as an amount includible in gross income under Section 409A of the Code.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11. &#160;&#160;&#160;&#160;MISCELLANEOUS.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without reference to principles of conflict of laws.  Both the Executive and the Company expressly consent to the exclusive venue of and personal jurisdiction within the state and federal courts located in Delaware for any lawsuit arising from or related to this Agreement</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">The captions of this Agreement are not part of the provisions hereof and shall have no force and effect.  This Agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">All notices and other communications hereunder shall be in writing and shall be given by hand delivery (which shall include delivery via Federal Express or UPS) to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows&#58;</font></div><div><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div><div style="margin-bottom:0.1pt;padding-left:0.36pt"><font><br></font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">If to the Executive&#58; </font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">John E. Davis</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;REDACTED&#93;</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;REDACTED&#93;</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">           </font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to the Company&#58; </font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Artivion, Inc.</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1655 Roberts Boulevard, N.W</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kennesaw, GA  30144</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Attention&#58;  Chief Executive Officer</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or to such other address as either party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually received by the addressee.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">If any provision of this Agreement or the application of any provision hereof to any person or circumstance is held invalid, unenforceable or otherwise illegal, the remainder of this Agreement and the application of such provision to any other person or circumstance shall not be affected, and the provision so held to be invalid, unenforceable or otherwise illegal shall be reformed to the extent (and only to the extent) necessary to make it valid, enforceable and legal&#59; provided, however, if the provision so held to be invalid, unenforceable or otherwise illegal cannot be reformed so as to be valid  and enforceable, then it shall be severed from, and shall not affect the enforceability of, the remaining provisions of the Agreement.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">The Company may withhold from any amounts payable under this Agreement such federal, state, local or foreign taxes as shall be required to be withheld pursuant to any applicable law or regulation.</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7.02pt">This Agreement supersedes any Change of Control Agreements previously entered into by and between Executive and Company and, along with the Employee Proprietary Information Agreements and other agreements noted herein, embodies the entire agreement between the parties with respect to the subject matter addressed herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; John E. Davis&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;John E. Davis, SVP, Global Sales and Marketing</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ARTIVION, INC.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; J. Patrick Mackin&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;J. Patrick Mackin</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Chairman, President and CEO</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>a103-redactedxhollowayxcha.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6965dd7b172047df819bb60005902d31_1"></div><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">CERTAIN INFORMATION HAS BEEN OMITTED OR REDACTED FROM THE VERSION OF THIS EXHIBIT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION TO PROTECT PERSONAL PRIVACY</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTIVION, INC.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Change of Control Severance Agreement</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Change of Control Severance Agreement (this &#8220;Agreement&#8221;) dated as of the 2nd day of August 2022 is made and entered into by and between Artivion, Inc., a Delaware corporation (&#8220;Artivion&#8221; or the &#8220;Company&#8221;) and Jean F. Holloway (the &#8220;Executive&#8221;).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1. It is expected that the Company from time to time will consider the possibility of an acquisition by another company or other change of control.  The Board of Directors of the Company (the &#8220;Board&#8221;), upon the recommendation of its Compensation Committee, has determined that it is in the best interests of the Company and its shareholders to enter into this Change of Control Agreement in order to assure that the Company will have the continued dedication of Executive, notwithstanding the possibility, threat or occurrence of a Change of Control (as defined herein) of the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2. The Board believes that it is in the best interests of the Company and its stockholders to provide Executive with an incentive to continue Executive&#8217;s employment and to motivate Executive to maximize the value of the Company upon a Change in Control for the benefit of the stockholders.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3. The Board believes it is imperative to provide Executive with certain severance benefits upon Executive&#8217;s termination of employment both prior to and following a Change in Control.  These benefits will provide Executive with enhanced financial security and incentive and encouragement to remain with the Company notwithstanding the possibility of a Change in Control. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.  Certain capitalized terms used in the Agreement are as defined below. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows&#58;   </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1. &#160;&#160;&#160;&#160;CERTAIN DEFINITIONS.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the first date during the Change of Control Period (as defined herein) on which a Change of Control occurs.  Notwithstanding anything in this Agreement to the contrary, if the Executive&#8217;s employment with the Company is Terminated by the Company without Cause or by Executive for Good Reason (as such terms are defined herein) within the six (6) month period prior to the date on which the Change of Control occurs and if such Change of Control is consummated (such a Termination of employment, an &#8220;Anticipatory Termination&#8221;), then for all purposes of this Agreement the &#8220;Effective Date&#8221; means the date immediately prior to the date of such Termination of employment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the period commencing on the date hereof and ending on December 31 of the year above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that, commencing on December 31 of the year above, and each one-year anniversary of such date (such date and each such one-year anniversary thereof, the &#8220;Renewal Date&#8221;) unless previously terminated, the Change of Control Period shall be automatically extended so as to terminate one (1) year from such Renewal Date, unless, at least thirty (30) days prior to the next Renewal Date, the Company shall give notice to the Executive that the Change of Control Period shall not be so extended.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliated Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any company controlled by, controlling or under common control with the Company.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a change in the ownership or effective control of, or in the ownership of a substantial portion of the assets of, the Company, as described in paragraphs (i) through (iii) below.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:81pt"><font style="color:#3a3a3a;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.24pt;text-decoration:underline">Change in Ownership of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  A change in the ownership of the Company shall occur on the date that any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), other than a group of which Executive is a member, acquires ownership of the Company stock that, together with the Company stock held by such person or group, constitutes more than 50% of the total voting power of the stock of the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.74pt">If any one person or more than one person acting as a group (within the meaning of paragraph (iv)), other than a group of which Executive is a member, is considered to own more than 50% of the total voting power of the stock of the Company, the acquisition of additional the Company stock by such person or persons shall not be considered to cause a change in the ownership of the Company  or to cause a change in the effective control of the Company (within the meaning of paragraph (ii) below).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">An increase in the percentage of the Company stock owned by any one person, or persons acting as a group (within the meaning of paragraph (iv)), as a result of a transaction in which the Company acquires its stock in exchange for property, shall be treated as an acquisition of stock for purposes of this paragraph (i).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">Except as provided in (B) above, the provisions of this paragraph (i) shall apply only to the transfer or issuance of the Company stock if such stock remains outstanding after such transfer or issuance.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Effective Control of the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.74pt">A change in the effective control of the Company shall occur on the date that either of (1) or (2) below occurs&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">Any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), other than a group of which Executive is a member, acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons) ownership of stock of the Company possessing 30% or more of the total voting power of the stock of the Company (the provisions of Sections l(d)(i) (B) and (C) above shall apply equally to this Section l(d)(ii)(A)(l)&#59; or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">A majority of the members of the Company Board of Directors are replaced during any twelve (12) month period by Directors whose appointment or election is not endorsed by a majority of the Board of Directors prior to the date of the appointment or election.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">A change in effective control of the Company also may occur with respect to any transaction in which either of the Company or the other entity involved in a transaction described in paragraph (iii) experiences a Change of Control event described in paragraphs (i) or (iii).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">If any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), is considered to effectively control the Company (within the meaning of this paragraph (ii)), the acquisition of additional control of the Company by the same person or persons shall not be considered to cause a change in the effective control of the Company (or to cause a change in the ownership of the Company within the meaning of paragraph (i)).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.53pt;text-decoration:underline">Change in Ownership of a Substantial Portion of the Company&#8217;s Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  A change in the ownership of a substantial portion of the Company&#8217;s assets shall occur on the date that any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), other than a group of which Executive is a member, acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value (within the meaning of paragraph (iii)(B)) equal to or more than 40% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.74pt">A transfer of the Company's assets shall not be treated as a change in the ownership of such assets if the assets are transferred to one or more of the following&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">A shareholder of the Company (immediately before the asset transfer) in exchange for or with respect to Company stock&#59;</font></div><div style="text-align:justify;text-indent:126pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">An entity, 50% or more of the total value or voting power of which is owned, directly or indirectly, by the Company&#59;</font></div><div style="text-align:justify;text-indent:126pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:126pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">A person, or more than one person acting as a group (within the meaning of paragraph (iv)) that owns, directly or indirectly, 50% or more of the total value or voting power of all of the outstanding stock of the Company&#59; or</font></div><div style="text-align:justify;text-indent:126pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">An entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by a person described in paragraph (iii)(A)(3).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this paragraph (iii)(A), and except as otherwise provided herein, a person&#8217;s status is determined immediately after the transfer of assets.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">For purposes of this paragraph (iii), gross fair market value means the value of all the Company assets, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.13pt">For purposes of this Section 1(d), persons shall be considered to be acting as a group if they are owners of an entity that enters into a merger, consolidation, purchase, or acquisition of assets, or similar business transaction with the Company.  If a person, including an entity shareholder, owns stock in the Company and another entity with which the Company enters into a merger, consolidation, purchase, or acquisition of stock, or similar business transaction, such shareholder shall be considered to be acting as a group with the other shareholders in a corporation only to the extent of the ownership  in that corporation prior to the transaction giving rise to the change and not with respect to the ownership interest in the other corporation.  Persons shall not be considered to be acting as a group solely because they purchase or own stock of the Company at the same time, or as a result of the same public offering of the Company&#8217;s stock.</font></div><div style="padding-left:81pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.18pt">Under no circumstances shall the reincorporation of the Company in a different state, or any action or inaction taken in furtherance thereof, constitute a Change of Control under this Agreement, including but not limited to efforts to end incorporation in the current state of incorporation or alterations to equity that facilitate such an event. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt;text-decoration:underline">Terminate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means a &#8220;separation from service&#8221; within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2. &#160;&#160;&#160;&#160;EMPLOYMENT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive and the Company acknowledge that the employment of the Executive by the Company is &#8220;at will,&#8221; and Executive shall have no rights under this Agreement unless Executive is Terminated by the Company without Cause or by the Executive with Good Reason during the period commencing on the Effective Date and ending on the second first anniversary of such date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3. &#160;&#160;&#160;&#160;TERMS OF AT WILL EMPLOYMENT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The terms of Executive&#8217;s at will employment, as recorded in the Employee Proprietary Information Agreement executed by the Executive and the Company, are incorporated herein.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4. &#160;&#160;&#160;&#160;TERMINATION OF EMPLOYMENT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) &#160;&#160;&#160;&#160;For purposes of this Agreement, &#8220;Cause&#8221; shall mean&#58;  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) an act of fraud, embezzlement, theft or any other material violation of law that occurs during or in the course of the Executive&#8217;s employment with the Company&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) intentional or grossly negligent damage by Executive to the Company&#8217;s assets&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii) intentional or grossly negligent disclosure by Executive of the Company&#8217;s confidential information contrary to the Company policies&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv) material breach of the Executive's obligations under this Agreement or any other Agreement with the Company&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v) engagement by the Executive in any activity which would constitute a breach of the Executive&#8217;s duty of loyalty or of the Executive&#8217;s assigned duties&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="padding-left:81pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi) breach by the Executive of any of the company&#8217;s policies and procedures&#59;</font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii) &#160;&#160;&#160;&#160;the willful and continued failure by Executive to perform the Executive&#8217;s assigned duties (other than as a result of incapacity due to physical or mental illness)&#59; or</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii) &#160;&#160;&#160;&#160;willful conduct by the Executive that is demonstrably and materially injurious to the Company, monetarily or otherwise.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean the assignment to the Executive, without the Executive&#8217;s consent, of any duties materially inconsistent with the Executive&#8217;s position (including changes in status, offices, or titles and any change in the Executive's reporting requirements that would cause Executive to report to an Executive who is junior in seniority to the employee to whom Executive reports), authority, duties or responsibilities, determined as of the later of the date of this Agreement or the date of any modification to Executive&#8217;s position (including status, offices, titles and reporting requirements, as described above), authority, duties or responsibilities that is agreed to by Executive, or any other action by the Company that results in a material diminution in such position, authority, duties, responsibilities or Executive&#8217;s aggregate compensation, excluding for this purpose an isolated, insubstantial and inadvertent action taken in good faith and which is remedied by the Company within thirty (30) days after receipt of notice thereof given by the Executive (each of these an &#8220;Event&#8221; for purposes of this Section 4(b)).  Executive must notify the Company of any Event that constitutes Good Reason within ninety (90) days following Executive&#8217;s knowledge of the existence of such Event or such Event shall not constitute Good Reason under this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt;text-decoration:underline">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any Termination by the Company for Cause, or by the Executive for Good Reason, shall be communicated by Notice of Termination to the other party hereto given in accordance with Section 11(b) of this Agreement.  For purposes of this Agreement, a &#8220;Notice of Termination&#8221; means a written notice which (i) indicates the specific termination provision in this Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive&#8217;s employment under the provision so indicated and (iii) specifies the termination date (which date shall not be more than thirty (30) days after the giving of such notice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">if Executive is terminating for Good Reason such date shall not be less than thirty (30) nor more than forty-five (45) days after giving of such notice). The failure by the Executive or the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of the Executive or the Company, respectively, hereunder or preclude the Executive or the Company, respectively, from asserting such fact or circumstance in enforcing the Executive&#8217;s or the Company&#8217;s rights hereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt;text-decoration:underline">Date of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  &#8220;Date of Termination&#8221; means the date of receipt of the Notice of Termination, or any later date specified therein, as the case may be.  The Company and the Executive shall take all steps necessary (including with regard to any post-Termination services by the Executive) to ensure that any Termination described in this Section 4 constitutes a &#8220;separation from service&#8221; within the meaning of Section 409A of the Code, and notwithstanding anything contained herein to the contrary, the date on which the separation from service takes place shall be the &#8220;Date of Termination.&#8221;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(e) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Covenants Necessary to the Company&#8217;s Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The covenants recorded in the Employee Proprietary Information Agreement executed by the Executive and the Company are incorporated herein, including but not limited to the covenant not to compete, the covenant regarding customer solicitation and interference, and the covenant regarding solicitation of employees.  Officer covenants and agrees that the payment of any Severance Payment (as defined in Section 5(e) below) shall be subject to and expressly conditioned upon Officer&#8217;s compliance with the covenants set forth in the Employee Proprietary Information Agreement, which have been incorporated herein.  Should Officer fail to comply with these covenants, the Company shall not be required to make the Severance Payment (or any portion of the Severance Payment that remains unpaid), and the Officer shall be required to repay any portion of the Severance Payment that the Officer has already received from the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5. &#160;&#160;&#160;&#160;OBLIGATIONS OF THE COMPANY UPON TERMINATION.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">If, during the two (2) year period commencing on the Effective Date and ending on the second anniversary of the Effective Date, (i) the Company shall Terminate the Executive&#8217;s employment without Cause, or (ii) the Executive shall Terminate employment for Good Reason, then the Company shall pay to Executive the Severance Payment (defined below).</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt;text-decoration:underline">Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The &#8220;Severance Payment&#8221; shall be an amount equal to one and one-half (1&#189;) times the aggregate of Executive&#8217;s base salary as of the Date of Termination and cash bonus compensation for the year in which the Termination of employment occurs.  For purposes of determining Executive&#8217;s cash bonus compensation for purposes of this Section 5(b), if the Date of Termination occurs before the awarding of </font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">bonuses for the year in which the Date of Termination occurs, the cash bonus compensation component of the Severance Payment shall be computed based on Executive&#8217;s most recent awarded cash bonus.  Cash bonus compensation shall include only the Annual Bonus paid in cash and shall specifically exclude the value of any non-cash bonuses, such as options or restricted stock.  For the sake of clarification, all cash paid in payment of all or a portion of the bonus pursuant to the Company&#8217;s 2007 Executive Incentive Plan or any successor thereto shall be bonus compensation for purposes of this Agreement for the year in which paid or issued.  The Severance Payment shall be payable to Executive as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.63pt">Except for the group health plan benefits payments or as otherwise provided herein, the Severance Payment, if any is due hereunder, shall be paid to Executive in a lump sum not later than thirty (30) days following Executive's Date of Termination, unless the Termination is an Anticipatory Termination.</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.58pt">In the event of an Anticipatory Termination, the Severance Payment, except for the group health plan benefits payments, shall be paid to Executive in a lump sum not later than thirty (30) days following the date of the Change of Control.</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;Notwithstanding the foregoing, if any amount paid pursuant to this Section 5(b) is deferred compensation within the meaning of Section 409A of the Code and as of the Date of Termination Executive is a Specified Employee, amounts that would otherwise be payable during the six-month period immediately following the Date of Termination shall instead be paid, with interest on any delayed payment at the applicable federal rate provided for in Section 7872(f)(2)(A) of the Code, on the first business day after the date that is six months following Executive&#8217;s &#8220;separation from service&#8221; within the meaning of Section 409A of the Code (the &#8220;Delayed Payment Date&#8221;).  As used in this Agreement, the term &#8220;Specified Employee&#8221; means a &#8220;specified employee&#8221; as defined in Section 409A(a)(2)(B)(i) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;).  By way of clarification, &#8220;specified employee&#8221; means a &#8220;key employee&#8221; (as defined in Section 416(i) of the Code, disregarding Section 416(i)(5) of the Code) of the Company.  Executive shall be treated as a key employee if the Executive meets the requirement of Section 416(i)(l)(A)(i), (ii), or (iii) at any time during the twelve (12) month period ending on an &#8220;identification date.&#8221;  For purposes of any &#8220;Specified Employee&#8221; determination hereunder, the &#8220;identification date&#8221; shall mean the last day of each calendar year.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">Medical Coverage.  In addition, group health plan coverage for the Executive and covered dependents, with the same contribution by the Executive, will be provided as part of the Severance Payment for the lesser of eighteen (18) months following the Date of Termination or until the Executive is provided comparable benefits by another employer.</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">Separation Agreement and Release of Claims.  The receipt of any Severance Payment pursuant to this Agreement will be subject to the Executive signing and not revoking a separation agreement and release of claims in a form provided by the Company (the &#8220;Release&#8221;), which may include restatements of covenants contained in the Employee Proprietary Information Agreement among others, and provided that such Release becomes effective and irrevocable no later than sixty (60) days following the termination date (such deadline, the &#8220;Release Deadline&#8221;). If the Release does not become effective and irrevocable by the Release Deadline, Executive will forfeit any rights to severance under this Agreement.  In no event will any Severance Payment be paid or provided until the Release becomes effective and irrevocable.  Except as required by Section 5(b)(iii), any Severance Payment that would have been made to Executive prior to the Release becoming effective and irrevocable but for the preceding sentence will be paid to Executive on the first regularly scheduled Company payroll date following the date the Release becomes effective and irrevocable, and any remaining payments will be made as provided in the Agreement.  </font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6. &#160;&#160;&#160;&#160;FULL SETTLEMENT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement and such amounts shall not be reduced whether or not the Executive obtains other employment.  The Company agrees to pay, to the full extent permitted  by law, all legal fees and expenses which the may reasonably incur as a result of any contest by the Company or Executive with respect to liability under or the interpretation of the validity or enforceability of, any provision of this Agreement, but only in the event and to the extent that (i) the Executive receives a final, non-appealable judgment  in his favor in any such action or receives a final judgment in his favor that has not been appealed by the Company within thirty (30) days of the date of the judgment&#59; or (ii) the parties agree to dismiss any such action upon the Company&#8217;s payment of the sums allegedly due the Executive or performance of the covenants by the Company allegedly breached by it.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7. &#160;&#160;&#160;&#160;PAYMENT CUT-BACK.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:54pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">Notwithstanding anything to the contrary contained herein, the Company will not pay to Executive any excise tax gross up pursuant to this Agreement or any other agreement between Executive and the Company.  Further notwithstanding anything to the contrary contained herein, the Company shall reduce any payment contingent on a Change of Control pursuant to any plan, agreement, or arrangement of the Company that would be considered in determining whether a &#8220;parachute payment&#8221; (as defined in Section 280G (&#8220;Section 280G&#8221;) of the Code), has occurred (&#8220;Change of Control Severance Payment&#8221;) to 2.99 times Employee&#8217;s average compensation, as indicated on such Employee&#8217;s Form W-2, for the five (5) years ending immediately prior to the year containing the date of the Change of Control (the &#8220;Safe Harbor Amount&#8221;) if, and only if, reducing the Change of Control Severance Payment would provide Executive with a greater net after-tax Change of Control Severance Payment than would be the case if no such reduction took place.  The Safe Harbor Amount, as defined herein, is an amount expressed in present value which maximizes the aggregate present value of the Change of Control Severance Payment without causing the Change of Control Severance Payment to be subject to the excise tax under Section 4999 (and related Section 280G) of the Code (the &#8220;Excise Tax&#8221;), determined in accordance with Section 280G(d)(4).  Any reduction in the Change of Control Severance Payment shall be implemented in accordance with Section 7(b).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">(i)&#160;&#160;&#160;&#160;Any reduction in payments pursuant to Section 7(a) shall apply so as to minimize the amount of compensation that is reduced (i.e., it applies to payments that to the greatest extent represent parachute payments), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no reduction shall be applied to an amount that constitutes a deferral of compensation under Section 409A except for amounts that have become payable at the time of the reduction and as to which the reduction will not result in a non-reduction in a corresponding amount that is a deferral of compensation under Section 409A that is not currently payable.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;For purposes of determining whether the Change of Control Severance Payment will be subject to the Excise Tax and the amount of such Excise Tax&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;The Change of Control Severance Payment shall be treated as a &#8220;parachute payment&#8221; within the meaning of Section 280G(b)(2), and if it is an &#8220;excess parachute payment&#8221; within the meaning of Section 280G(b)(l), it shall be treated as subject to the Excise Tax, unless, and except to the extent that, in the written opinion of independent compensation consultants, counsel or auditors of nationally recognized standing (&#8220;Independent Advisors&#8221;) selected by the Company and reasonably acceptable to Executive, the Change of Control Severance Payment (in whole or in part) does not constitute a parachute payment, or such excess parachute payment (in whole or in part) represents reasonable compensation for services actually rendered within the meaning of Section 280G(b)(4) in excess of the base amount within the meaning of Section 280G(b)(3) or are otherwise not subject to the Excise Tax.</font></div><div style="text-align:justify;text-indent:99pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;The value of any non-cash benefits or any deferred payment or benefit shall be determined by the Independent Advisors in accordance with the principles of Sections 280G(d)(3) and (4).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.03pt">For purposes of determining reductions in compensation pursuant to this Section 7(b), if any, Executive will be deemed (A) to pay federal income taxes at the applicable rates of federal income taxation for the calendar year in which the compensation would be payable&#59; and (B) to pay any applicable state and local income taxes at the applicable rates of taxation for the calendar year in which the compensation would be payable, taking into account any effect on federal income taxes from payment of state and local income taxes.  Compensation will be adjusted not later than the applicable deadline under Section 409A to provide for accurate payments under the cut-back provision of this Section 7(b), but after any such deadline no further adjustment will be made if it would result in a tax penalty under Section 409A.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">Furthermore, notwithstanding anything in this Agreement to the contrary, aggregate Severance Payments, separation payments and&#47;or similar payments made to Executive pursuant to this Agreement and otherwise shall be limited to the equivalent of Executive&#8217;s salary paid during the three (3) completed fiscal years ended prior to the Date of Termination, including any bonuses and guaranteed benefits paid during those years.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8. &#160;&#160;&#160;&#160;CONFIDENTIAL INFORMATION.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Executive and the Company will also be parties to one or more separate agreements respecting confidential information, trade secrets, inventions and non-competition, including but not limited to the Employee Proprietary Information Agreement, (collectively, the &#8220;IP Agreements&#8221;).  The parties agree that the IP Agreements shall not be superseded or terminated by this Agreement and shall survive any termination of this Agreement&#59; provided, however, that to the extent that there is any conflict or overlap between the provisions of this Agreement and any of the IP Agreements, those provisions that provide the Company with the greatest rights and protections shall control.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9. &#160;&#160;&#160;&#160;SUCCESSORS.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">This Agreement is personal to the Executive and without the prior written consent of the Company shall not be assignable by the Executive otherwise than by will or the laws of descent and distribution.  This Agreement shall inure to the benefit of and be enforceable by the Executive&#8217;s legal representatives.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.  As used in this Agreement, &#8220;the Company&#8221; shall mean Artivion as hereinbefore defined and any successor to its business and&#47;or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10. &#160;&#160;&#160;&#160;COMPLIANCE WITH SECTION 409A.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) &#160;&#160;&#160;&#160;This Agreement is intended to comply with, or otherwise be exempt from, Section 409A of the Code and any regulations and Treasury guidance promulgated thereunder.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">The Company and Executive agree that they will execute any and all amendments to this Agreement as they mutually agree in good faith may be necessary to ensure compliance with Section 409A of the Code.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">The Company makes no representation or warranty as to the tax effect of any of the preceding provisions, and the provisions of this Agreement shall not be construed as a guarantee by the Company of any particular tax effect to Executive under this Agreement.  The Company shall not be liable to Executive or any other person for any payment made under this Agreement which is determined to result in the imposition of an excise tax, penalty or interest under Section 409A of the Code, nor for reporting in good faith any payment made under this Agreement as an amount includible in gross income under Section 409A of the Code.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11. &#160;&#160;&#160;&#160;MISCELLANEOUS.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without reference to principles of conflict of laws.  Both the Executive and the Company expressly consent to the exclusive venue of and personal jurisdiction within the state and federal courts located in Delaware for any lawsuit arising from or related to this Agreement</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">The captions of this Agreement are not part of the provisions hereof and shall have no force and effect.  This Agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">All notices and other communications hereunder shall be in writing and shall be given by hand delivery (which shall include delivery via Federal Express or UPS) to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows&#58;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to the Executive&#58; </font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Jean F. Holloway</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;REDACTED&#93;</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;REDACTED&#93;</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">             </font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">           </font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to the Company&#58; </font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Artivion, Inc.</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1655 Roberts Boulevard, N.W</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kennesaw, GA  30144</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Attention&#58;  Chief Executive Officer</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or to such other address as either party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually received by the addressee.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">If any provision of this Agreement or the application of any provision hereof to any person or circumstance is held invalid, unenforceable or otherwise illegal, the remainder of this Agreement and the application of such provision to any other person or circumstance shall not be affected, and the provision so held to be invalid, unenforceable or otherwise illegal shall be reformed to the extent (and only to the extent) necessary to make it valid, enforceable and legal&#59; provided, however, if the provision so held to be invalid, unenforceable or otherwise illegal cannot be reformed so as to be valid  and enforceable, then it shall be severed from, and shall not affect the enforceability of, the remaining provisions of the Agreement.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">The Company may withhold from any amounts payable under this Agreement such federal, state, local or foreign taxes as shall be required to be withheld pursuant to any applicable law or regulation.</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7.02pt">This Agreement supersedes any Change of Control Agreements previously entered into by and between Executive and Company and, along with the Employee Proprietary Information Agreements and other agreements noted herein, embodies the entire agreement between the parties with respect to the subject matter addressed herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Jean F. Holloway&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Jean F. Holloway</font></div><div style="padding-left:252pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SVP, General Counsel, Chief Compliance Officer<br> and Corporate Secretary</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ARTIVION, INC.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; J. Patrick Mackin&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;J. Patrick Mackin</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Chairman, President and CEO</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>a104-redactedxleexchangeof.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id40451b90d3c40e492b63850f81aa52e_1"></div><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:124%">CERTAIN INFORMATION HAS BEEN OMITTED OR REDACTED FROM THE VERSION OF THIS EXHIBIT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION TO PROTECT PERSONAL PRIVACY</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTIVION, INC.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Change of Control Severance Agreement</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Change of Control Severance Agreement (this &#8220;Agreement&#8221;) dated as of the 2nd day of August, 2022 is made and entered into by and between Artivion, Inc., a Delaware corporation (&#8220;Artivion&#8221; or the &#8220;Company&#8221;) and D. Ashley Lee (the &#8220;Executive&#8221;).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1. It is expected that the Company from time to time will consider the possibility of an acquisition by another company or other change of control.  The Board of Directors of the Company (the &#8220;Board&#8221;), upon the recommendation of its Compensation Committee, has determined that it is in the best interests of the Company and its shareholders to enter into this Change of Control Agreement in order to assure that the Company will have the continued dedication of Executive, notwithstanding the possibility, threat or occurrence of a Change of Control (as defined herein) of the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2. The Board believes that it is in the best interests of the Company and its stockholders to provide Executive with an incentive to continue Executive&#8217;s employment and to motivate Executive to maximize the value of the Company upon a Change in Control for the benefit of the stockholders.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3. The Board believes it is imperative to provide Executive with certain severance benefits upon Executive&#8217;s termination of employment both prior to and following a Change in Control.  These benefits will provide Executive with enhanced financial security and incentive and encouragement to remain with the Company notwithstanding the possibility of a Change in Control. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.  Certain capitalized terms used in the Agreement are as defined below. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows&#58;   </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1. &#160;&#160;&#160;&#160;CERTAIN DEFINITIONS.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the first date during the Change of Control Period (as defined herein) on which a Change of Control occurs.  Notwithstanding anything in this Agreement to the contrary, if the Executive&#8217;s employment with the Company is Terminated by the Company without Cause or by Executive for Good Reason (as such terms are defined herein) within the six (6) month period prior to the date on which the Change of Control occurs and if such Change of Control is consummated (such a Termination of employment, an &#8220;Anticipatory Termination&#8221;), then for all purposes of this Agreement the &#8220;Effective Date&#8221; means the date immediately prior to the date of such Termination of employment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the period commencing on the date hereof and ending on December 31 of the year above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that, commencing on December 31 of the year above, and each one-year anniversary of such date (such date and each such one-year anniversary thereof, the &#8220;Renewal Date&#8221;) unless previously terminated, the Change of Control Period shall be automatically extended so as to terminate one (1) year from such Renewal Date, unless, at least thirty (30) days prior to the next Renewal Date, the Company shall give notice to the Executive that the Change of Control Period shall not be so extended.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliated Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any company controlled by, controlling or under common control with the Company.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a change in the ownership or effective control of, or in the ownership of a substantial portion of the assets of, the Company, as described in paragraphs (i) through (iii) below.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:81pt"><font style="color:#3a3a3a;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.24pt;text-decoration:underline">Change in Ownership of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  A change in the ownership of the Company shall occur on the date that any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), other than a group of which Executive is a member, acquires ownership of the Company stock that, together with the Company stock held by such person or group, constitutes more than 50% of the total voting power of the stock of the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.74pt">If any one person or more than one person acting as a group (within the meaning of paragraph (iv)), other than a group of which Executive is a member, is considered to own more than 50% of the total voting power of the stock of the Company, the acquisition of additional the Company stock by such person or persons shall not be considered to cause a change in the ownership of the Company  or to cause a change in the effective control of the Company (within the meaning of paragraph (ii) below).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">An increase in the percentage of the Company stock owned by any one person, or persons acting as a group (within the meaning of paragraph (iv)), as a result of a transaction in which the Company acquires its stock in exchange for property, shall be treated as an acquisition of stock for purposes of this paragraph (i).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">Except as provided in (B) above, the provisions of this paragraph (i) shall apply only to the transfer or issuance of the Company stock if such stock remains outstanding after such transfer or issuance.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Effective Control of the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.74pt">A change in the effective control of the Company shall occur on the date that either of (1) or (2) below occurs&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">Any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), other than a group of which Executive is a member, acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons) ownership of stock of the Company possessing 30% or more of the total voting power of the stock of the Company (the provisions of Sections l(d)(i) (B) and (C) above shall apply equally to this Section l(d)(ii)(A)(l)&#59; or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">A majority of the members of the Company Board of Directors are replaced during any twelve (12) month period by Directors whose appointment or election is not endorsed by a majority of the Board of Directors prior to the date of the appointment or election.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">A change in effective control of the Company also may occur with respect to any transaction in which either of the Company or the other entity involved in a transaction described in paragraph (iii) experiences a Change of Control event described in paragraphs (i) or (iii).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">If any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), is considered to effectively control the Company (within the meaning of this paragraph (ii)), the acquisition of additional control of the Company by the same person or persons shall not be considered to cause a change in the effective control of the Company (or to cause a change in the ownership of the Company within the meaning of paragraph (i)).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.53pt;text-decoration:underline">Change in Ownership of a Substantial Portion of the Company&#8217;s Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  A change in the ownership of a substantial portion of the Company&#8217;s assets shall occur on the date that any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), other than a group of which Executive is a member, acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value (within the meaning of paragraph (iii)(B)) equal to or more than 40% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.74pt">A transfer of the Company's assets shall not be treated as a change in the ownership of such assets if the assets are transferred to one or more of the following&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">A shareholder of the Company (immediately before the asset transfer) in exchange for or with respect to Company stock&#59;</font></div><div style="text-align:justify;text-indent:126pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">An entity, 50% or more of the total value or voting power of which is owned, directly or indirectly, by the Company&#59;</font></div><div style="text-align:justify;text-indent:126pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:126pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">A person, or more than one person acting as a group (within the meaning of paragraph (iv)) that owns, directly or indirectly, 50% or more of the total value or voting power of all of the outstanding stock of the Company&#59; or</font></div><div style="text-align:justify;text-indent:126pt"><font><br></font></div><div style="text-align:justify;text-indent:126pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">An entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by a person described in paragraph (iii)(A)(3).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this paragraph (iii)(A), and except as otherwise provided herein, a person&#8217;s status is determined immediately after the transfer of assets.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.35pt">For purposes of this paragraph (iii), gross fair market value means the value of all the Company assets, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.13pt">For purposes of this Section 1(d), persons shall be considered to be acting as a group if they are owners of an entity that enters into a merger, consolidation, purchase, or acquisition of assets, or similar business transaction with the Company.  If a person, including an entity shareholder, owns stock in the Company and another entity with which the Company enters into a merger, consolidation, purchase, or acquisition of stock, or similar business transaction, such shareholder shall be considered to be acting as a group with the other shareholders in a corporation only to the extent of the ownership  in that corporation prior to the transaction giving rise to the change and not with respect to the ownership interest in the other corporation.  Persons shall not be considered to be acting as a group solely because they purchase or own stock of the Company at the same time, or as a result of the same public offering of the Company&#8217;s stock.</font></div><div style="padding-left:81pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.18pt">Under no circumstances shall the reincorporation of the Company in a different state, or any action or inaction taken in furtherance thereof, constitute a Change of Control under this Agreement, including but not limited to efforts to end incorporation in the current state of incorporation or alterations to equity that facilitate such an event. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt;text-decoration:underline">Terminate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means a &#8220;separation from service&#8221; within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2. &#160;&#160;&#160;&#160;EMPLOYMENT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive and the Company acknowledge that the employment of the Executive by the Company is &#8220;at will,&#8221; and Executive shall have no rights under this Agreement unless Executive is Terminated by the Company without Cause or by the Executive with Good Reason during the period commencing on the Effective Date and ending on the second first anniversary of such date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3. &#160;&#160;&#160;&#160;TERMS OF AT WILL EMPLOYMENT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The terms of Executive&#8217;s at will employment, as recorded in the Employee Proprietary Information Agreement executed by the Executive and the Company, are incorporated herein.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4. &#160;&#160;&#160;&#160;TERMINATION OF EMPLOYMENT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) &#160;&#160;&#160;&#160;For purposes of this Agreement, &#8220;Cause&#8221; shall mean&#58;  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) an act of fraud, embezzlement, theft or any other material violation of law that occurs during or in the course of the Executive&#8217;s employment with the Company&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) intentional or grossly negligent damage by Executive to the Company&#8217;s assets&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii) intentional or grossly negligent disclosure by Executive of the Company&#8217;s confidential information contrary to the Company policies&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv) material breach of the Executive's obligations under this Agreement or any other Agreement with the Company&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v) engagement by the Executive in any activity which would constitute a breach of the Executive&#8217;s duty of loyalty or of the Executive&#8217;s assigned duties&#59;</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="padding-left:81pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi) breach by the Executive of any of the company&#8217;s policies and procedures&#59;</font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii) &#160;&#160;&#160;&#160;the willful and continued failure by Executive to perform the Executive&#8217;s assigned duties (other than as a result of incapacity due to physical or mental illness)&#59; or</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii) &#160;&#160;&#160;&#160;willful conduct by the Executive that is demonstrably and materially injurious to the Company, monetarily or otherwise.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, &#8220;Good Reason&#8221; shall mean the assignment to the Executive, without the Executive&#8217;s consent, of any duties materially inconsistent with the Executive&#8217;s position (including changes in status, offices, or titles and any change in the Executive's reporting requirements that would cause Executive to report to an Executive who is junior in seniority to the employee to whom Executive reports), authority, duties or responsibilities, determined as of the later of the date of this Agreement or the date of any modification to Executive&#8217;s position (including status, offices, titles and reporting requirements, as described above), authority, duties or responsibilities that is agreed to by Executive, or any other action by the Company that results in a material diminution in such position, authority, duties, responsibilities or Executive&#8217;s aggregate compensation, excluding for this purpose an isolated, insubstantial and inadvertent action taken in good faith and which is remedied by the Company within thirty (30) days after receipt of notice thereof given by the Executive (each of these an &#8220;Event&#8221; for purposes of this Section 4(b)).  Executive must notify the Company of any Event that constitutes Good Reason within ninety (90) days following Executive&#8217;s knowledge of the existence of such Event or such Event shall not constitute Good Reason under this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt;text-decoration:underline">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any Termination by the Company for Cause, or by the Executive for Good Reason, shall be communicated by Notice of Termination to the other party hereto given in accordance with Section 11(b) of this Agreement.  For purposes of this Agreement, a &#8220;Notice of Termination&#8221; means a written notice which (i) indicates the specific termination provision in this Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive&#8217;s employment under the provision so indicated and (iii) specifies the termination date (which date shall not be more than thirty (30) days after the giving of such notice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">if Executive is terminating for Good Reason such date shall not be less than thirty (30) nor more than forty-five (45) days after giving of such notice). The failure by the Executive or the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of the Executive or the Company, respectively, hereunder or preclude the Executive or the Company, respectively, from asserting such fact or circumstance in enforcing the Executive&#8217;s or the Company&#8217;s rights hereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3b3b3b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt;text-decoration:underline">Date of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  &#8220;Date of Termination&#8221; means the date of receipt of the Notice of Termination, or any later date specified therein, as the case may be.  The Company and the Executive shall take all steps necessary (including with regard to any post-Termination services by the Executive) to ensure that any Termination described in this Section 4 constitutes a &#8220;separation from service&#8221; within the meaning of Section 409A of the Code, and notwithstanding anything contained herein to the contrary, the date on which the separation from service takes place shall be the &#8220;Date of Termination.&#8221;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(e) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Covenants Necessary to the Company&#8217;s Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The covenants recorded in the Employee Proprietary Information Agreement executed by the Executive and the Company are incorporated herein, including but not limited to the covenant not to compete, the covenant regarding customer solicitation and interference, and the covenant regarding solicitation of employees.  Officer covenants and agrees that the payment of any Severance Payment (as defined in Section 5(e) below) shall be subject to and expressly conditioned upon Officer&#8217;s compliance with the covenants set forth in the Employee Proprietary Information Agreement, which have been incorporated herein.  Should Officer fail to comply with these covenants, the Company shall not be required to make the Severance Payment (or any portion of the Severance Payment that remains unpaid), and the Officer shall be required to repay any portion of the Severance Payment that the Officer has already received from the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5. &#160;&#160;&#160;&#160;OBLIGATIONS OF THE COMPANY UPON TERMINATION.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">If, during the two (2) year period commencing on the Effective Date and ending on the second anniversary of the Effective Date, (i) the Company shall Terminate the Executive&#8217;s employment without Cause, or (ii) the Executive shall Terminate employment for Good Reason, then the Company shall pay to Executive the Severance Payment (defined below).</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt;text-decoration:underline">Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The &#8220;Severance Payment&#8221; shall be an amount equal to two (2) times the aggregate of Executive&#8217;s base salary as of the Date of Termination and cash bonus compensation for the year in which the Termination of employment occurs.  For purposes of determining Executive&#8217;s cash bonus compensation for purposes of this Section 5(b), if the Date of Termination occurs before the awarding of bonuses </font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">for the year in which the Date of Termination occurs, the cash bonus compensation component of the Severance Payment shall be computed based on Executive&#8217;s most recent awarded cash bonus.  Cash bonus compensation shall include only the Annual Bonus paid in cash and shall specifically exclude the value of any non-cash bonuses, such as options or restricted stock.  For the sake of clarification, all cash paid in payment of all or a portion of the bonus pursuant to the Company&#8217;s 2007 Executive Incentive Plan or any successor thereto shall be bonus compensation for purposes of this Agreement for the year in which paid or issued.  The Severance Payment shall be payable to Executive as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.63pt">Except for the group health plan benefits payments or as otherwise provided herein, the Severance Payment, if any is due hereunder, shall be paid to Executive in a lump sum not later than thirty (30) days following Executive's Date of Termination, unless the Termination is an Anticipatory Termination.</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.58pt">In the event of an Anticipatory Termination, the Severance Payment, except for the group health plan benefits payments, shall be paid to Executive in a lump sum not later than thirty (30) days following the date of the Change of Control.</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;Notwithstanding the foregoing, if any amount paid pursuant to this Section 5(b) is deferred compensation within the meaning of Section 409A of the Code and as of the Date of Termination Executive is a Specified Employee, amounts that would otherwise be payable during the six-month period immediately following the Date of Termination shall instead be paid, with interest on any delayed payment at the applicable federal rate provided for in Section 7872(f)(2)(A) of the Code, on the first business day after the date that is six months following Executive&#8217;s &#8220;separation from service&#8221; within the meaning of Section 409A of the Code (the &#8220;Delayed Payment Date&#8221;).  As used in this Agreement, the term &#8220;Specified Employee&#8221; means a &#8220;specified employee&#8221; as defined in Section 409A(a)(2)(B)(i) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;).  By way of clarification, &#8220;specified employee&#8221; means a &#8220;key employee&#8221; (as defined in Section 416(i) of the Code, disregarding Section 416(i)(5) of the Code) of the Company.  Executive shall be treated as a key employee if the Executive meets the requirement of Section 416(i)(l)(A)(i), (ii), or (iii) at any time during the twelve (12) month period ending on an &#8220;identification date.&#8221;  For purposes of any &#8220;Specified Employee&#8221; determination hereunder, the &#8220;identification date&#8221; shall mean the last day of each calendar year.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">Medical Coverage.  In addition, group health plan coverage for the Executive and covered dependents, with the same contribution by the Executive, will be provided as part of the Severance Payment for the lesser of eighteen (18) months following the Date of Termination or until the Executive is provided comparable benefits by another employer.</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#3a3a3a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">Separation Agreement and Release of Claims.  The receipt of any Severance Payment pursuant to this Agreement will be subject to the Executive signing and not revoking a separation agreement and release of claims in a form provided by the Company (the &#8220;Release&#8221;), which may include restatements of covenants contained in the Employee Proprietary Information Agreement among others, and provided that such Release becomes effective and irrevocable no later than sixty (60) days following the termination date (such deadline, the &#8220;Release Deadline&#8221;). If the Release does not become effective and irrevocable by the Release Deadline, Executive will forfeit any rights to severance under this Agreement.  In no event will any Severance Payment be paid or provided until the Release becomes effective and irrevocable.  Except as required by Section 5(b)(iii), any Severance Payment that would have been made to Executive prior to the Release becoming effective and irrevocable but for the preceding sentence will be paid to Executive on the first regularly scheduled Company payroll date following the date the Release becomes effective and irrevocable, and any remaining payments will be made as provided in the Agreement.  </font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6. &#160;&#160;&#160;&#160;FULL SETTLEMENT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement and such amounts shall not be reduced whether or not the Executive obtains other employment.  The Company agrees to pay, to the full extent permitted  by law, all legal fees and expenses which the may reasonably incur as a result of any contest by the Company or Executive with respect to liability under or the interpretation of the validity or enforceability of, any provision of this Agreement, but only in the event and to the extent that (i) the Executive receives a final, non-appealable judgment  in his favor in any such action or receives a final judgment in his favor that has not been appealed by the Company within thirty (30) days of the date of the judgment&#59; or (ii) the parties agree to dismiss any such action upon the Company&#8217;s payment of the sums allegedly due the Executive or performance of the covenants by the Company allegedly breached by it.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7. &#160;&#160;&#160;&#160;PAYMENT CUT-BACK.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:54pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">Notwithstanding anything to the contrary contained herein, the Company will not pay to Executive any excise tax gross up pursuant to this Agreement or any other agreement between Executive and the Company.  Further notwithstanding anything to the contrary contained herein, the Company shall reduce any payment contingent on a Change of Control pursuant to any plan, agreement, or arrangement of the Company that would be considered in determining whether a &#8220;parachute payment&#8221; (as defined in Section 280G (&#8220;Section 280G&#8221;) of the Code), has occurred (&#8220;Change of Control Severance Payment&#8221;) to 2.99 times Employee&#8217;s average compensation, as indicated on such Employee&#8217;s Form W-2, for the five (5) years ending immediately prior to the year containing the date of the Change of Control (the &#8220;Safe Harbor Amount&#8221;) if, and only if, reducing the Change of Control Severance Payment would provide Executive with a greater net after-tax Change of Control Severance Payment than would be the case if no such reduction took place.  The Safe Harbor Amount, as defined herein, is an amount expressed in present value which maximizes the aggregate present value of the Change of Control Severance Payment without causing the Change of Control Severance Payment to be subject to the excise tax under Section 4999 (and related Section 280G) of the Code (the &#8220;Excise Tax&#8221;), determined in accordance with Section 280G(d)(4).  Any reduction in the Change of Control Severance Payment shall be implemented in accordance with Section 7(b).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">(i)&#160;&#160;&#160;&#160;Any reduction in payments pursuant to Section 7(a) shall apply so as to minimize the amount of compensation that is reduced (i.e., it applies to payments that to the greatest extent represent parachute payments), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no reduction shall be applied to an amount that constitutes a deferral of compensation under Section 409A except for amounts that have become payable at the time of the reduction and as to which the reduction will not result in a non-reduction in a corresponding amount that is a deferral of compensation under Section 409A that is not currently payable.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;For purposes of determining whether the Change of Control Severance Payment will be subject to the Excise Tax and the amount of such Excise Tax&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;The Change of Control Severance Payment shall be treated as a &#8220;parachute payment&#8221; within the meaning of Section 280G(b)(2), and if it is an &#8220;excess parachute payment&#8221; within the meaning of Section 280G(b)(l), it shall be treated as subject to the Excise Tax, unless, and except to the extent that, in the written opinion of independent compensation consultants, counsel or auditors of nationally recognized standing (&#8220;Independent Advisors&#8221;) selected by the Company and reasonably acceptable to Executive, the Change of Control Severance Payment (in whole or in part) does not constitute a parachute payment, or such excess parachute payment (in whole or in part) represents reasonable compensation for services actually rendered within the meaning of Section 280G(b)(4) in excess of the base amount within the meaning of Section 280G(b)(3) or are otherwise not subject to the Excise Tax.</font></div><div style="text-align:justify;text-indent:99pt"><font><br></font></div><div style="text-align:justify;text-indent:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;The value of any non-cash benefits or any deferred payment or benefit shall be determined by the Independent Advisors in accordance with the principles of Sections 280G(d)(3) and (4).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:76.5pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.03pt">For purposes of determining reductions in compensation pursuant to this Section 7(b), if any, Executive will be deemed (A) to pay federal income taxes at the applicable rates of federal income taxation for the calendar year in which the compensation would be payable&#59; and (B) to pay any applicable state and local income taxes at the applicable rates of taxation for the calendar year in which the compensation would be payable, taking into account any effect on federal income taxes from payment of state and local income taxes.  Compensation will be adjusted not later than the applicable deadline under Section 409A to provide for accurate payments under the cut-back provision of this Section 7(b), but after any such deadline no further adjustment will be made if it would result in a tax penalty under Section 409A.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">Furthermore, notwithstanding anything in this Agreement to the contrary, aggregate Severance Payments, separation payments and&#47;or similar payments made to Executive pursuant to this Agreement and otherwise shall be limited to the equivalent of Executive&#8217;s salary paid during the three (3) completed fiscal years ended prior to the Date of Termination, including any bonuses and guaranteed benefits paid during those years.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8. &#160;&#160;&#160;&#160;CONFIDENTIAL INFORMATION.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Executive and the Company will also be parties to one or more separate agreements respecting confidential information, trade secrets, inventions and non-competition, including but not limited to the Employee Proprietary Information Agreement, (collectively, the &#8220;IP Agreements&#8221;).  The parties agree that the IP Agreements shall not be superseded or terminated by this Agreement and shall survive any termination of this Agreement&#59; provided, however, that to the extent that there is any conflict or overlap between the provisions of this Agreement and any of the IP Agreements, those provisions that provide the Company with the greatest rights and protections shall control.</font></div><div style="margin-bottom:0.1pt;text-align:justify"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9. &#160;&#160;&#160;&#160;SUCCESSORS.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">This Agreement is personal to the Executive and without the prior written consent of the Company shall not be assignable by the Executive otherwise than by will or the laws of descent and distribution.  This Agreement shall inure to the benefit of and be enforceable by the Executive&#8217;s legal representatives.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.  As used in this Agreement, &#8220;the Company&#8221; shall mean Artivion as hereinbefore defined and any successor to its business and&#47;or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10. &#160;&#160;&#160;&#160;COMPLIANCE WITH SECTION 409A.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) &#160;&#160;&#160;&#160;This Agreement is intended to comply with, or otherwise be exempt from, Section 409A of the Code and any regulations and Treasury guidance promulgated thereunder.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">The Company and Executive agree that they will execute any and all amendments to this Agreement as they mutually agree in good faith may be necessary to ensure compliance with Section 409A of the Code.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#363636;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">The Company makes no representation or warranty as to the tax effect of any of the preceding provisions, and the provisions of this Agreement shall not be construed as a guarantee by the Company of any particular tax effect to Executive under this Agreement.  The Company shall not be liable to Executive or any other person for any payment made under this Agreement which is determined to result in the imposition of an excise tax, penalty or interest under Section 409A of the Code, nor for reporting in good faith any payment made under this Agreement as an amount includible in gross income under Section 409A of the Code.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11. &#160;&#160;&#160;&#160;MISCELLANEOUS.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without reference to principles of conflict of laws.  Both the Executive and the Company expressly consent to the exclusive venue of and personal jurisdiction within the state and federal courts located in Delaware for any lawsuit arising from or related to this Agreement</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">The captions of this Agreement are not part of the provisions hereof and shall have no force and effect.  This Agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">All notices and other communications hereunder shall be in writing and shall be given by hand delivery (which shall include delivery via Federal Express or UPS) to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows&#58;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:53.46pt;width:100%"><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;margin-top:12pt;text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to the Executive&#58; </font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D. Ashley Lee</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;REDACTED&#93;</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;REDACTED&#93;</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">           </font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to the Company&#58; </font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Artivion, Inc.</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1655 Roberts Boulevard, N.W</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kennesaw, GA  30144</font></div><div style="text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Attention&#58;  Chief Executive Officer</font></div><div style="text-align:justify;text-indent:81pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or to such other address as either party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually received by the addressee.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">If any provision of this Agreement or the application of any provision hereof to any person or circumstance is held invalid, unenforceable or otherwise illegal, the remainder of this Agreement and the application of such provision to any other person or circumstance shall not be affected, and the provision so held to be invalid, unenforceable or otherwise illegal shall be reformed to the extent (and only to the extent) necessary to make it valid, enforceable and legal&#59; provided, however, if the provision so held to be invalid, unenforceable or otherwise illegal cannot be reformed so as to be valid  and enforceable, then it shall be severed from, and shall not affect the enforceability of, the remaining provisions of the Agreement.</font></div><div style="text-align:justify;text-indent:54pt"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">The Company may withhold from any amounts payable under this Agreement such federal, state, local or foreign taxes as shall be required to be withheld pursuant to any applicable law or regulation.</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#343434;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7.02pt">This Agreement supersedes any Change of Control Agreements previously entered into by and between Executive and Company and, along with the Employee Proprietary Information Agreements and other agreements noted herein, embodies the entire agreement between the parties with respect to the subject matter addressed herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; D. Ashley Lee&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;D. Ashley Lee, EVP and CFO</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ARTIVION, INC.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; J. Patrick Mackin&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;J. Patrick Mackin</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Chairman, President and CEO</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>aort-20220930xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iefc7380a11be41c8afdcafbf2e297f68_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CERTIFICATIONS</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James Patrick Mackin, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Artivion, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#8209;15(f) and 15d&#8209;15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;4, 2022</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; J. PATRICK MACKIN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chairman, President, and<br>Chief Executive Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>aort-20220930xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3f824b014a0e4acdb3f57936217fc01b_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David Ashley Lee, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Artivion, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#8209;15(f) and 15d&#8209;15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;4, 2022</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; D. ASHLEY LEE</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, and<br>Chief Financial Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>8
<FILENAME>aort-20220930xex32.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i43d193e182a94a719b53031f2ad8b754_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font></div></div><div style="margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Artivion, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ending September&#160;30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of James Patrick Mackin, the Chairman, President, and Chief Executive Officer of the Company, and David Ashley Lee, the Executive Vice President, and Chief Financial Officer of the Company, hereby certifies, pursuant to and for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, in his capacity as an officer of the Company and to his knowledge&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; J. PATRICK MACKIN</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; D. ASHLEY LEE</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. PATRICK MACKIN</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D. ASHLEY LEE</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chairman, President, and<br>Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, and<br>Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November&#160;4, 2022</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November&#160;4, 2022</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>aort-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e6891988-c797-4972-93bc-9ac5fa18c933,g:19ec5362-98a4-465a-8335-497bfcde1bb2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:aort="http://www.cryolife.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cryolife.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aort-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aort-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aort-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aort-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.cryolife.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome" roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome">
        <link:definition>0000002 - Statement - Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquity" roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>0000007 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofPerClot" roleURI="http://www.cryolife.com/role/SaleofPerClot">
        <link:definition>0000008 - Disclosure - Sale of PerClot</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.cryolife.com/role/FinancialInstruments">
        <link:definition>0000009 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalents" roleURI="http://www.cryolife.com/role/CashEquivalents">
        <link:definition>0000010 - Disclosure - Cash Equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesnetandDeferredPreservationCosts" roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts">
        <link:definition>0000011 - Disclosure - Inventories, net and Deferred Preservation Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>0000012 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cryolife.com/role/IncomeTaxes">
        <link:definition>0000013 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.cryolife.com/role/Leases">
        <link:definition>0000014 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.cryolife.com/role/Debt">
        <link:definition>0000015 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.cryolife.com/role/CommitmentsandContingencies">
        <link:definition>0000016 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.cryolife.com/role/RevenueRecognition">
        <link:definition>0000017 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensation" roleURI="http://www.cryolife.com/role/StockCompensation">
        <link:definition>0000018 - Disclosure - Stock Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossEarningsPerCommonShare" roleURI="http://www.cryolife.com/role/LossEarningsPerCommonShare">
        <link:definition>0000019 - Disclosure - (Loss) Earnings Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.cryolife.com/role/SegmentInformation">
        <link:definition>0000020 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.cryolife.com/role/FinancialInstrumentsTables">
        <link:definition>0000022 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalentsTables" roleURI="http://www.cryolife.com/role/CashEquivalentsTables">
        <link:definition>0000023 - Disclosure - Cash Equivalents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNetAndDeferredPreservationCostsTables" roleURI="http://www.cryolife.com/role/InventoriesNetAndDeferredPreservationCostsTables">
        <link:definition>0000024 - Disclosure - Inventories, Net And Deferred Preservation Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>0000025 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.cryolife.com/role/LeasesTables">
        <link:definition>0000026 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.cryolife.com/role/DebtTables">
        <link:definition>0000027 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.cryolife.com/role/RevenueRecognitionTables">
        <link:definition>0000028 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationTables" roleURI="http://www.cryolife.com/role/StockCompensationTables">
        <link:definition>0000029 - Disclosure - Stock Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossEarningsPerCommonShareTables" roleURI="http://www.cryolife.com/role/LossEarningsPerCommonShareTables">
        <link:definition>0000030 - Disclosure - (Loss) Earnings Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.cryolife.com/role/SegmentInformationTables">
        <link:definition>0000031 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofPerClotDetails" roleURI="http://www.cryolife.com/role/SaleofPerClotDetails">
        <link:definition>0000032 - Disclosure - Sale of PerClot (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" roleURI="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails">
        <link:definition>0000033 - Disclosure - Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>0000034 - Disclosure - Financial Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails" roleURI="http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails">
        <link:definition>0000035 - Disclosure - Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails" roleURI="http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails">
        <link:definition>0000036 - Disclosure - Cash Equivalents (Summary Of Cash Equivalents And Restricted Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashEquivalentsNarrativeDetails" roleURI="http://www.cryolife.com/role/CashEquivalentsNarrativeDetails">
        <link:definition>0000037 - Disclosure - Cash Equivalents (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails" roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails">
        <link:definition>0000038 - Disclosure - Inventories, net and Deferred Preservation Costs (Schedule Of Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesnetandDeferredPreservationCostsNarrativeDetails" roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails">
        <link:definition>0000039 - Disclosure - Inventories, net and Deferred Preservation Costs (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails">
        <link:definition>0000040 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Carrying Values of Indefinite Lived Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails">
        <link:definition>0000041 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails">
        <link:definition>0000042 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails">
        <link:definition>0000043 - Disclosure - Goodwill and Other Intangible Assets (Summary of Amortization Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails">
        <link:definition>0000044 - Disclosure - Goodwill and Other Intangible Assets (Scheduled Amortization of Intangible Assets for Next Five Years) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.cryolife.com/role/IncomeTaxesDetails">
        <link:definition>0000045 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.cryolife.com/role/LeasesNarrativeDetails">
        <link:definition>0000046 - Disclosure - Leases (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" roleURI="http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails">
        <link:definition>0000047 - Disclosure - Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryOfLeaseCostsDetails" roleURI="http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails">
        <link:definition>0000048 - Disclosure - Leases (Summary Of Lease Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails" roleURI="http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails">
        <link:definition>0000049 - Disclosure - Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails" roleURI="http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails">
        <link:definition>0000050 - Disclosure - Leases (Schedule Of Minimum Lease Payments For Finance, Operating, And Sublease Income Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.cryolife.com/role/DebtNarrativeDetails">
        <link:definition>0000051 - Disclosure - Debt (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" roleURI="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails">
        <link:definition>0000052 - Disclosure - Debt (Schedule Of Short-Term And Long-Term Balances Of Term Loan) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.cryolife.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000053 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregationOfRevenueDetails" roleURI="http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails">
        <link:definition>0000054 - Disclosure - Revenue Recognition (Disaggregation Of Revenue) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationNarrativeDetails" roleURI="http://www.cryolife.com/role/StockCompensationNarrativeDetails">
        <link:definition>0000055 - Disclosure - Stock Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails" roleURI="http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails">
        <link:definition>0000056 - Disclosure - Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationSummaryOfTotalStockCompensationExpensesDetails" roleURI="http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails">
        <link:definition>0000057 - Disclosure - Stock Compensation (Summary Of Total Stock Compensation Expenses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails" roleURI="http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails">
        <link:definition>0000058 - Disclosure - (Loss) Earnings Per Common Share (Computation Of Basic And Diluted (Loss) Income Per Common Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.cryolife.com/role/SegmentInformationNarrativeDetails">
        <link:definition>0000059 - Disclosure - Segment Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails" roleURI="http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails">
        <link:definition>0000060 - Disclosure - Segment Information (Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails" roleURI="http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails">
        <link:definition>0000061 - Disclosure - Segment Information (Summary Of Net Revenues By Product And Service) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="aort_StarchMedicalInc.Member" abstract="false" name="StarchMedicalInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_AscyrusMedicalLlcMember" abstract="false" name="AscyrusMedicalLlcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo" abstract="false" name="OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_InternationalDistributorMember" abstract="false" name="InternationalDistributorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_MedicalDevicesMember" abstract="false" name="MedicalDevicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" abstract="false" name="StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" abstract="false" name="DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour" abstract="false" name="OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_CircumstanceAfterJuly52023Member" abstract="false" name="CircumstanceAfterJuly52023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_ProductsMember" abstract="false" name="ProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_DomesticHospitalsMember" abstract="false" name="DomesticHospitalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear" abstract="false" name="OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_DebtInstrumentExtensionPeriod" abstract="false" name="DebtInstrumentExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_GovernmentSponsoredDebtKfwLoan1Member" abstract="false" name="GovernmentSponsoredDebtKfwLoan1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" abstract="false" name="PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree" abstract="false" name="OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_ConsignmentInventoryPercentage" abstract="false" name="ConsignmentInventoryPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aort_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="aort_DebtPeriodAxis" abstract="true" name="DebtPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="aort_BaxterAchievementOfWorldwideSalesMember" abstract="false" name="BaxterAchievementOfWorldwideSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour" abstract="false" name="OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_DebtPeriodDomain" abstract="true" name="DebtPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_ContingentConsiderationNoncurrentFairValue" abstract="false" name="ContingentConsiderationNoncurrentFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" abstract="false" name="PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" abstract="false" name="RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_AorticStentGraftsMember" abstract="false" name="AorticStentGraftsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_CardiogenesisMember" abstract="false" name="CardiogenesisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_PmaApprovalMember" abstract="false" name="PmaApprovalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_NoncashInterestExpense" abstract="false" name="NoncashInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_RevolvingCreditFacilityAndTermLoanMember" abstract="false" name="RevolvingCreditFacilityAndTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_PerClotMember" abstract="false" name="PerClotMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_DebtInstrumentExtensionCircumstancePeriod" abstract="false" name="DebtInstrumentExtensionCircumstancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_DeferredPreservationCosts" abstract="false" name="DeferredPreservationCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_WriteDownOfDeferredPreservationCostsAndInventories" abstract="false" name="WriteDownOfDeferredPreservationCostsAndInventories" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" abstract="false" name="RevolvingCreditFacilityPercentageRepaidForNoCovenants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" abstract="false" name="IncreaseDecreaseInDeferredPreservationCostsAndInventories" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_CircumstanceIiMember" abstract="false" name="CircumstanceIiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_FinanceLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="FinanceLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_NoncashLeaseExpense" abstract="false" name="NoncashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_ArtivionInc.AndStarchMedicalInc.Member" abstract="false" name="ArtivionInc.AndStarchMedicalInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_OnXMember" abstract="false" name="OnXMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne" abstract="false" name="OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_PreservationServicesMember" abstract="false" name="PreservationServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_CircumstanceIMember" abstract="false" name="CircumstanceIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_TransferOfPerclotManufacturingEquipmentMember" abstract="false" name="TransferOfPerclotManufacturingEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_AccruedProcurementFees" abstract="false" name="AccruedProcurementFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_InternationalHospitalsMember" abstract="false" name="InternationalHospitalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_GovernmentSponsoredDebtKfwLoan2Member" abstract="false" name="GovernmentSponsoredDebtKfwLoan2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts" abstract="false" name="ResearchAndDevelopmentExpenseTerminationAndWindDownCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_OtherProductsMember" abstract="false" name="OtherProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember" abstract="false" name="RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" abstract="false" name="IntangibleAssetsOtherThanAcquiredTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_SurgicalSealantsMember" abstract="false" name="SurgicalSealantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>aort-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e6891988-c797-4972-93bc-9ac5fa18c933,g:19ec5362-98a4-465a-8335-497bfcde1bb2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome" xlink:type="simple" xlink:href="aort-20220930.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d5ceee2-ce31-4cda-b545-db9220e7d29c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7e5bf7e8-8639-4512-a78f-4a519036856e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d5ceee2-ce31-4cda-b545-db9220e7d29c" xlink:to="loc_us-gaap_OperatingIncomeLoss_7e5bf7e8-8639-4512-a78f-4a519036856e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_70a94f03-22c1-4c4f-8df1-2162c4f3d6da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d5ceee2-ce31-4cda-b545-db9220e7d29c" xlink:to="loc_us-gaap_InterestExpense_70a94f03-22c1-4c4f-8df1-2162c4f3d6da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_7d5becca-5842-4d0b-96c3-4ea428fea023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d5ceee2-ce31-4cda-b545-db9220e7d29c" xlink:to="loc_us-gaap_InvestmentIncomeInterest_7d5becca-5842-4d0b-96c3-4ea428fea023" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5e3a1ae1-9d88-4107-bffe-3f6925a72539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d5ceee2-ce31-4cda-b545-db9220e7d29c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5e3a1ae1-9d88-4107-bffe-3f6925a72539" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_caf8fb10-a520-4617-8316-8bd4c09d2217" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a42af48c-cba5-4571-b830-b1a9e1219e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_caf8fb10-a520-4617-8316-8bd4c09d2217" xlink:to="loc_us-gaap_GrossProfit_a42af48c-cba5-4571-b830-b1a9e1219e10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e570330f-793a-4a85-a20e-0338f32d469a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_caf8fb10-a520-4617-8316-8bd4c09d2217" xlink:to="loc_us-gaap_OperatingExpenses_e570330f-793a-4a85-a20e-0338f32d469a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_999e9014-f6e1-4c13-8076-cb4151d6d9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_caf8fb10-a520-4617-8316-8bd4c09d2217" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_999e9014-f6e1-4c13-8076-cb4151d6d9f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_2f3778a7-712d-4783-a005-2b9a7e753ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c7ec8839-22a5-450d-82a8-3dcd763647e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2f3778a7-712d-4783-a005-2b9a7e753ba7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c7ec8839-22a5-450d-82a8-3dcd763647e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_9828749c-88fa-4759-b875-116e6f1d74d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2f3778a7-712d-4783-a005-2b9a7e753ba7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_9828749c-88fa-4759-b875-116e6f1d74d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bf1b9b19-10a4-4d03-8e13-3b238e1cef90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_8a98c5b2-3299-41fe-81b5-179908d681fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_bf1b9b19-10a4-4d03-8e13-3b238e1cef90" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_8a98c5b2-3299-41fe-81b5-179908d681fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_77dee7cd-e85f-4a00-8685-8f4872106d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_bf1b9b19-10a4-4d03-8e13-3b238e1cef90" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_77dee7cd-e85f-4a00-8685-8f4872106d7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_752fe65e-09a4-4e54-8ce2-6383d26fc685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_726bf3ce-e494-4f8f-91cc-3cf22e58fbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_752fe65e-09a4-4e54-8ce2-6383d26fc685" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_726bf3ce-e494-4f8f-91cc-3cf22e58fbb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cfba6748-96d5-4301-88f9-b6bc3f7a2dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_752fe65e-09a4-4e54-8ce2-6383d26fc685" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cfba6748-96d5-4301-88f9-b6bc3f7a2dd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4d4e7549-8818-4248-9c1d-74d2bf3c7b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cbbbec9b-cb9d-4a3e-a2bb-9558aa97e561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4d4e7549-8818-4248-9c1d-74d2bf3c7b8d" xlink:to="loc_us-gaap_NetIncomeLoss_cbbbec9b-cb9d-4a3e-a2bb-9558aa97e561" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bc2ff5d2-691e-4afb-995f-07662a90f99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4d4e7549-8818-4248-9c1d-74d2bf3c7b8d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bc2ff5d2-691e-4afb-995f-07662a90f99d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="aort-20220930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_537f07c7-3b3a-4cdd-92e5-524170c65eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bdac4665-e451-4e88-a534-9dca85a50963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_537f07c7-3b3a-4cdd-92e5-524170c65eb0" xlink:to="loc_us-gaap_Liabilities_bdac4665-e451-4e88-a534-9dca85a50963" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5686042b-86a4-4f26-9a81-a62b427dc7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_537f07c7-3b3a-4cdd-92e5-524170c65eb0" xlink:to="loc_us-gaap_StockholdersEquity_5686042b-86a4-4f26-9a81-a62b427dc7cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7553033c-a6ab-4314-bdc0-d7b3ffc72414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e190f4b7-a4a1-435a-b4c5-52b170022439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7553033c-a6ab-4314-bdc0-d7b3ffc72414" xlink:to="loc_us-gaap_AssetsCurrent_e190f4b7-a4a1-435a-b4c5-52b170022439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e49dc408-7e74-4a45-a701-b28653bd80e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7553033c-a6ab-4314-bdc0-d7b3ffc72414" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e49dc408-7e74-4a45-a701-b28653bd80e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c861ebc6-0f60-4b4e-83f1-f6ddea16c702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7553033c-a6ab-4314-bdc0-d7b3ffc72414" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c861ebc6-0f60-4b4e-83f1-f6ddea16c702" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a88f673a-2e32-4328-b69f-ab73168bdf8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7553033c-a6ab-4314-bdc0-d7b3ffc72414" xlink:to="loc_us-gaap_Goodwill_a88f673a-2e32-4328-b69f-ab73168bdf8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ad6dc033-f425-46dc-b577-f68feacb8729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7553033c-a6ab-4314-bdc0-d7b3ffc72414" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ad6dc033-f425-46dc-b577-f68feacb8729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_30ecdcd5-de46-4bd1-90bf-0f6a11d16267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7553033c-a6ab-4314-bdc0-d7b3ffc72414" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_30ecdcd5-de46-4bd1-90bf-0f6a11d16267" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_bd4a1ebf-c55b-45d6-b3d6-2bd0c9b55f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7553033c-a6ab-4314-bdc0-d7b3ffc72414" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_bd4a1ebf-c55b-45d6-b3d6-2bd0c9b55f27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4ee87091-30ae-4237-9e68-93455be14082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7553033c-a6ab-4314-bdc0-d7b3ffc72414" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4ee87091-30ae-4237-9e68-93455be14082" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bf70db84-c197-4fb0-87fe-24cee075af67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d915b89c-4b30-4231-892a-796dfbf8eb75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bf70db84-c197-4fb0-87fe-24cee075af67" xlink:to="loc_us-gaap_AccountsPayableCurrent_d915b89c-4b30-4231-892a-796dfbf8eb75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_0d2c3371-8af2-4196-8241-5b3108d786a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bf70db84-c197-4fb0-87fe-24cee075af67" xlink:to="loc_us-gaap_TaxesPayableCurrent_0d2c3371-8af2-4196-8241-5b3108d786a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_63e86496-5a79-443f-83c8-39d367c9efca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bf70db84-c197-4fb0-87fe-24cee075af67" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_63e86496-5a79-443f-83c8-39d367c9efca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AccruedProcurementFees_a7031df2-1445-4df3-a2fb-11295a8c75de" xlink:href="aort-20220930.xsd#aort_AccruedProcurementFees"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bf70db84-c197-4fb0-87fe-24cee075af67" xlink:to="loc_aort_AccruedProcurementFees_a7031df2-1445-4df3-a2fb-11295a8c75de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2fe0c4d7-6f49-47ef-9fb9-ec18a08c5898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bf70db84-c197-4fb0-87fe-24cee075af67" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2fe0c4d7-6f49-47ef-9fb9-ec18a08c5898" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_622be76f-72e9-4f14-b4eb-0954d919d071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bf70db84-c197-4fb0-87fe-24cee075af67" xlink:to="loc_us-gaap_LongTermDebtCurrent_622be76f-72e9-4f14-b4eb-0954d919d071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f4647cc8-d34e-4b3c-b7da-6972c4d5dd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bf70db84-c197-4fb0-87fe-24cee075af67" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f4647cc8-d34e-4b3c-b7da-6972c4d5dd1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_0852e5ce-4223-466e-b4b9-4d183e0ed11a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bf70db84-c197-4fb0-87fe-24cee075af67" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_0852e5ce-4223-466e-b4b9-4d183e0ed11a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8f5c62f9-a1f3-4b8c-b6ce-36842826e8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_d42769a6-84b3-4c67-9dfd-38864ba0c20a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8f5c62f9-a1f3-4b8c-b6ce-36842826e8d2" xlink:to="loc_us-gaap_PreferredStockValue_d42769a6-84b3-4c67-9dfd-38864ba0c20a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b96019b2-2aa1-4878-8f59-d1ade8885130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8f5c62f9-a1f3-4b8c-b6ce-36842826e8d2" xlink:to="loc_us-gaap_CommonStockValue_b96019b2-2aa1-4878-8f59-d1ade8885130" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9ade7810-8564-43bf-9df0-d3742bd36a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8f5c62f9-a1f3-4b8c-b6ce-36842826e8d2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9ade7810-8564-43bf-9df0-d3742bd36a93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_73f21090-0796-4184-a2a0-31805ac0e470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8f5c62f9-a1f3-4b8c-b6ce-36842826e8d2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_73f21090-0796-4184-a2a0-31805ac0e470" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1e2a3eb5-286c-4aaf-9821-69e88b92e895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8f5c62f9-a1f3-4b8c-b6ce-36842826e8d2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1e2a3eb5-286c-4aaf-9821-69e88b92e895" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_22738d18-6da7-4455-b1b0-2c7dba13ca8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8f5c62f9-a1f3-4b8c-b6ce-36842826e8d2" xlink:to="loc_us-gaap_TreasuryStockCommonValue_22738d18-6da7-4455-b1b0-2c7dba13ca8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_147ca729-6f90-4fb1-92ad-1bc96a2499e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_131b10d3-9d1d-41a3-93e1-c293c67a2e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_147ca729-6f90-4fb1-92ad-1bc96a2499e6" xlink:to="loc_us-gaap_LiabilitiesCurrent_131b10d3-9d1d-41a3-93e1-c293c67a2e72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_94e34a7c-44e7-44d7-8f71-ff342886203e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_147ca729-6f90-4fb1-92ad-1bc96a2499e6" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_94e34a7c-44e7-44d7-8f71-ff342886203e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_050527f4-ba29-478c-ac1c-adc7efcd5b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_147ca729-6f90-4fb1-92ad-1bc96a2499e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_050527f4-ba29-478c-ac1c-adc7efcd5b1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ba7e7b8a-4dc8-4b7c-9985-5603fa8e83b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_147ca729-6f90-4fb1-92ad-1bc96a2499e6" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ba7e7b8a-4dc8-4b7c-9985-5603fa8e83b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_10a2fb42-bdea-4f23-bf9f-9abc2128cbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_147ca729-6f90-4fb1-92ad-1bc96a2499e6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_10a2fb42-bdea-4f23-bf9f-9abc2128cbc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8063dcea-39a7-45d7-961f-83ce302d1fce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_147ca729-6f90-4fb1-92ad-1bc96a2499e6" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8063dcea-39a7-45d7-961f-83ce302d1fce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_50101a35-9595-4473-a299-28541467a21c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_147ca729-6f90-4fb1-92ad-1bc96a2499e6" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_50101a35-9595-4473-a299-28541467a21c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_e66f61ac-f5bd-41f1-8fb8-fc021c369c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_147ca729-6f90-4fb1-92ad-1bc96a2499e6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_e66f61ac-f5bd-41f1-8fb8-fc021c369c8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b6986b95-a9b7-45b7-9fa2-1f60300bdab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_89cf2e4e-f6a1-4b41-a0dc-147fe3505757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b6986b95-a9b7-45b7-9fa2-1f60300bdab7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_89cf2e4e-f6a1-4b41-a0dc-147fe3505757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f74d5fdd-1f14-4e06-846b-3105680faff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b6986b95-a9b7-45b7-9fa2-1f60300bdab7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f74d5fdd-1f14-4e06-846b-3105680faff3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_55053657-094c-4d5a-86ca-d43aa2b90658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b6986b95-a9b7-45b7-9fa2-1f60300bdab7" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_55053657-094c-4d5a-86ca-d43aa2b90658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_38fad515-170d-4ee4-b6a1-fb3255a0487c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b6986b95-a9b7-45b7-9fa2-1f60300bdab7" xlink:to="loc_us-gaap_InventoryNet_38fad515-170d-4ee4-b6a1-fb3255a0487c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DeferredPreservationCosts_95a53276-be57-48bd-9ed4-a9c7f406bd93" xlink:href="aort-20220930.xsd#aort_DeferredPreservationCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b6986b95-a9b7-45b7-9fa2-1f60300bdab7" xlink:to="loc_aort_DeferredPreservationCosts_95a53276-be57-48bd-9ed4-a9c7f406bd93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_74a89f05-73ac-4db7-a770-fadebc19fde5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b6986b95-a9b7-45b7-9fa2-1f60300bdab7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_74a89f05-73ac-4db7-a770-fadebc19fde5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="aort-20220930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_08bb0209-f63c-4f47-bca9-e8bb4c702bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2b1ae061-6206-4570-a058-4ae52397f613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_08bb0209-f63c-4f47-bca9-e8bb4c702bf2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2b1ae061-6206-4570-a058-4ae52397f613" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_225ed05b-892d-4a34-939e-6d608d6138a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_08bb0209-f63c-4f47-bca9-e8bb4c702bf2" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_225ed05b-892d-4a34-939e-6d608d6138a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_d350a760-9af6-43aa-a444-d242ea60886d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_08bb0209-f63c-4f47-bca9-e8bb4c702bf2" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_d350a760-9af6-43aa-a444-d242ea60886d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_5a14c90d-3d89-4661-a418-75cc7b878205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_08bb0209-f63c-4f47-bca9-e8bb4c702bf2" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_5a14c90d-3d89-4661-a418-75cc7b878205" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_485eb0bd-81e4-406b-8915-c9f9331f176f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_us-gaap_NetIncomeLoss_485eb0bd-81e4-406b-8915-c9f9331f176f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ba937742-72d9-461c-846f-fb31eeaf92c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ba937742-72d9-461c-846f-fb31eeaf92c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6a478b0b-4be8-4321-9e65-11cf9a6c6656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_us-gaap_ShareBasedCompensation_6a478b0b-4be8-4321-9e65-11cf9a6c6656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_NoncashLeaseExpense_03ba65f3-ee20-49e6-9e2a-99861a6fd836" xlink:href="aort-20220930.xsd#aort_NoncashLeaseExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_aort_NoncashLeaseExpense_03ba65f3-ee20-49e6-9e2a-99861a6fd836" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_WriteDownOfDeferredPreservationCostsAndInventories_74b3ea12-c6d1-4172-ba10-070a025bf6a2" xlink:href="aort-20220930.xsd#aort_WriteDownOfDeferredPreservationCostsAndInventories"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_aort_WriteDownOfDeferredPreservationCostsAndInventories_74b3ea12-c6d1-4172-ba10-070a025bf6a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d8d03702-08a1-4397-81ae-30e3de005c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d8d03702-08a1-4397-81ae-30e3de005c7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_4c6de8cc-71bf-4dd9-957a-024b139cc914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_4c6de8cc-71bf-4dd9-957a-024b139cc914" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashExpense_b60fc600-2a72-487f-84f2-c5340dca6b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_us-gaap_OtherNoncashExpense_b60fc600-2a72-487f-84f2-c5340dca6b2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_14bb14e7-00cf-41fa-9b84-c9599e27e7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_14bb14e7-00cf-41fa-9b84-c9599e27e7ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_fe90a117-7df4-4a70-8892-ed99f25710e2" xlink:href="aort-20220930.xsd#aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_fe90a117-7df4-4a70-8892-ed99f25710e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9b9cd01d-73d0-4a2f-ad6e-8a6e1fb815b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9b9cd01d-73d0-4a2f-ad6e-8a6e1fb815b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_5690ea16-fe18-4f43-9ea3-f937fe2b3070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_5690ea16-fe18-4f43-9ea3-f937fe2b3070" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_NoncashInterestExpense_5588753f-b6a5-4946-9836-195e9e98390d" xlink:href="aort-20220930.xsd#aort_NoncashInterestExpense"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_aort_NoncashInterestExpense_5588753f-b6a5-4946-9836-195e9e98390d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_04daf9d7-4135-46f8-bd88-d02b383dd13f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e5bcd5b4-68ab-4703-b573-1c1ce4129781" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_04daf9d7-4135-46f8-bd88-d02b383dd13f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a829f36b-4ca8-4574-800e-a40176cdc21e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_f15d3373-5b69-4351-8fbf-404d136967d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a829f36b-4ca8-4574-800e-a40176cdc21e" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_f15d3373-5b69-4351-8fbf-404d136967d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_0070aa4f-bde0-48e7-a4b0-479809305501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a829f36b-4ca8-4574-800e-a40176cdc21e" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_0070aa4f-bde0-48e7-a4b0-479809305501" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_089c89d1-8ec2-40a7-af70-c952cdf8f1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a829f36b-4ca8-4574-800e-a40176cdc21e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_089c89d1-8ec2-40a7-af70-c952cdf8f1b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_815e8191-1ef5-4918-9c53-cee7abdce993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a829f36b-4ca8-4574-800e-a40176cdc21e" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_815e8191-1ef5-4918-9c53-cee7abdce993" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_671034d2-1d56-4f6f-bc42-cfb9402bc603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a829f36b-4ca8-4574-800e-a40176cdc21e" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_671034d2-1d56-4f6f-bc42-cfb9402bc603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f07f1b87-3975-4a96-844a-b2e30e63d3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a79f00e6-aa02-4400-bfc7-9a68a8733a90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f07f1b87-3975-4a96-844a-b2e30e63d3a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a79f00e6-aa02-4400-bfc7-9a68a8733a90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3a993de5-4ff2-4f63-8652-e97a4a8203cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f07f1b87-3975-4a96-844a-b2e30e63d3a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3a993de5-4ff2-4f63-8652-e97a4a8203cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d56b63f-5f30-4940-b9c6-a16c8b6e504a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f07f1b87-3975-4a96-844a-b2e30e63d3a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d56b63f-5f30-4940-b9c6-a16c8b6e504a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fb14dc5d-68ac-4790-9cb4-7e285ed1f11d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f07f1b87-3975-4a96-844a-b2e30e63d3a1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fb14dc5d-68ac-4790-9cb4-7e285ed1f11d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d6bf2e10-e358-4729-aabc-25d2e37b1cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_fcddd25b-acd8-4ceb-b931-a98a9e621dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_d6bf2e10-e358-4729-aabc-25d2e37b1cc3" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_fcddd25b-acd8-4ceb-b931-a98a9e621dea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_b212bc17-b275-4823-8180-2fe15cabcd88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ContingentConsiderationNoncurrentFairValue_cbc5db0c-02fd-4799-8f62-404415f4cb02" xlink:href="aort-20220930.xsd#aort_ContingentConsiderationNoncurrentFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_b212bc17-b275-4823-8180-2fe15cabcd88" xlink:to="loc_aort_ContingentConsiderationNoncurrentFairValue_cbc5db0c-02fd-4799-8f62-404415f4cb02" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_43ecf0c9-22fc-4225-a01f-0d6622b21d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_6b978822-d41c-4eac-be6b-d3803867f539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_43ecf0c9-22fc-4225-a01f-0d6622b21d04" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_6b978822-d41c-4eac-be6b-d3803867f539" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_48a1baf5-e0e3-49d9-8377-407d3a21837c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_43ecf0c9-22fc-4225-a01f-0d6622b21d04" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_48a1baf5-e0e3-49d9-8377-407d3a21837c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_6bed667f-dde0-4738-9931-550dfc225fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_43ecf0c9-22fc-4225-a01f-0d6622b21d04" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_6bed667f-dde0-4738-9931-550dfc225fb0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3a9dc43-16df-4923-bd5e-3b8b5b84796b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_59ba3e17-cb24-4f9a-9bda-85db20fa87e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3a9dc43-16df-4923-bd5e-3b8b5b84796b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_59ba3e17-cb24-4f9a-9bda-85db20fa87e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_def4ac55-efb7-4e19-afb2-a469549bcf92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3a9dc43-16df-4923-bd5e-3b8b5b84796b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_def4ac55-efb7-4e19-afb2-a469549bcf92" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_75d117e1-a935-4b9d-80c9-f94f0d7ea53a" xlink:href="aort-20220930.xsd#aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3f04d46f-4873-4754-9d42-48bb454bbe05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_75d117e1-a935-4b9d-80c9-f94f0d7ea53a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3f04d46f-4873-4754-9d42-48bb454bbe05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_5882f5f9-e5ee-408b-9ee8-5a428d49570c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_75d117e1-a935-4b9d-80c9-f94f0d7ea53a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_5882f5f9-e5ee-408b-9ee8-5a428d49570c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_5264b730-50b1-40b0-b613-e6f7be98f9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_75d117e1-a935-4b9d-80c9-f94f0d7ea53a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_5264b730-50b1-40b0-b613-e6f7be98f9f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c4e08836-92d7-4f32-8d2e-274e72c89e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_75d117e1-a935-4b9d-80c9-f94f0d7ea53a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c4e08836-92d7-4f32-8d2e-274e72c89e16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_53279f66-ae47-44ac-9a97-b97f9da15f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_75d117e1-a935-4b9d-80c9-f94f0d7ea53a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_53279f66-ae47-44ac-9a97-b97f9da15f61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_137382f0-6609-4354-94e1-3af73dae2d53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_75d117e1-a935-4b9d-80c9-f94f0d7ea53a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_137382f0-6609-4354-94e1-3af73dae2d53" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a1811ce6-18fc-4602-87d5-b086338b642a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bc4672cd-258a-4bfc-8221-05cc8c9372f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a1811ce6-18fc-4602-87d5-b086338b642a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bc4672cd-258a-4bfc-8221-05cc8c9372f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c17aae55-10f2-49da-8bab-e5d3f5fa74e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a1811ce6-18fc-4602-87d5-b086338b642a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c17aae55-10f2-49da-8bab-e5d3f5fa74e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_c808d590-a7be-41d0-bf34-5d34bc0e0e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_e3ea2332-2cc5-4ec9-b61b-1314d266c141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_c808d590-a7be-41d0-bf34-5d34bc0e0e33" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_e3ea2332-2cc5-4ec9-b61b-1314d266c141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5359f10b-5b8f-4fff-aba1-14666b7e2af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_c808d590-a7be-41d0-bf34-5d34bc0e0e33" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5359f10b-5b8f-4fff-aba1-14666b7e2af8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_5e1c5bd0-db82-461f-82bd-dda4457b634f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_cb34073b-13d0-4e99-849a-3bbac7505aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_5e1c5bd0-db82-461f-82bd-dda4457b634f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_cb34073b-13d0-4e99-849a-3bbac7505aea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_abb6332f-cd68-4177-9b8f-89e372706e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_5e1c5bd0-db82-461f-82bd-dda4457b634f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_abb6332f-cd68-4177-9b8f-89e372706e89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9b318c55-0d2d-4254-b52d-b562cdf5e215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_f5860e5f-1537-4889-ba57-064ab0f5f67f" xlink:href="aort-20220930.xsd#aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_9b318c55-0d2d-4254-b52d-b562cdf5e215" xlink:to="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_f5860e5f-1537-4889-ba57-064ab0f5f67f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_5e9fbfc8-f915-4f91-8109-057930a654bd" xlink:href="aort-20220930.xsd#aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_9b318c55-0d2d-4254-b52d-b562cdf5e215" xlink:to="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_5e9fbfc8-f915-4f91-8109-057930a654bd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#LeasesSummaryOfLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseCost_90c0d83b-1bd8-4b42-80c4-80ece6d370a7" xlink:href="aort-20220930.xsd#aort_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a8e919d5-29cb-47da-916c-85f4443d7b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FinanceLeaseCost_90c0d83b-1bd8-4b42-80c4-80ece6d370a7" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a8e919d5-29cb-47da-916c-85f4443d7b20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_7b165b0b-80f8-4238-8dc9-a8a6b96e2591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FinanceLeaseCost_90c0d83b-1bd8-4b42-80c4-80ece6d370a7" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_7b165b0b-80f8-4238-8dc9-a8a6b96e2591" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_a04e8453-e75a-4c80-908b-ffa9e55cfb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_4a317452-5d4a-46b4-a1e6-64f27516e5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_a04e8453-e75a-4c80-908b-ffa9e55cfb6a" xlink:to="loc_us-gaap_OperatingLeaseCost_4a317452-5d4a-46b4-a1e6-64f27516e5c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_378ebb78-4ed7-467d-96e2-3b8922e202c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_a04e8453-e75a-4c80-908b-ffa9e55cfb6a" xlink:to="loc_us-gaap_SubleaseIncome_378ebb78-4ed7-467d-96e2-3b8922e202c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseCost_6cabf755-2d68-4dd0-b375-a9b3196b6f6a" xlink:href="aort-20220930.xsd#aort_FinanceLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_a04e8453-e75a-4c80-908b-ffa9e55cfb6a" xlink:to="loc_aort_FinanceLeaseCost_6cabf755-2d68-4dd0-b375-a9b3196b6f6a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d84f8089-acf8-47d9-9428-1cffba69d545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_c0d97d2e-0b34-43dc-ae6a-ed764e2e9643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d84f8089-acf8-47d9-9428-1cffba69d545" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_c0d97d2e-0b34-43dc-ae6a-ed764e2e9643" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b100d40f-28f4-46d5-bfd1-4b7de0c3c454" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d84f8089-acf8-47d9-9428-1cffba69d545" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b100d40f-28f4-46d5-bfd1-4b7de0c3c454" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c812f9a5-c38c-40c3-922e-6d486bef7fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d84f8089-acf8-47d9-9428-1cffba69d545" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c812f9a5-c38c-40c3-922e-6d486bef7fde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ad2799d4-72de-41f5-a626-88ed398934e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d84f8089-acf8-47d9-9428-1cffba69d545" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ad2799d4-72de-41f5-a626-88ed398934e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9ed4fc2e-e0ea-4276-8132-c9b6099b4dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d84f8089-acf8-47d9-9428-1cffba69d545" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9ed4fc2e-e0ea-4276-8132-c9b6099b4dad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_a363d49a-6e2d-44e3-bde4-81d776ef8229" xlink:href="aort-20220930.xsd#aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d84f8089-acf8-47d9-9428-1cffba69d545" xlink:to="loc_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_a363d49a-6e2d-44e3-bde4-81d776ef8229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_49aed744-d99f-49d7-871d-e7bba9b8001d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_d11b5ff2-2a67-4e11-8b24-e9cb4280322b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_49aed744-d99f-49d7-871d-e7bba9b8001d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_d11b5ff2-2a67-4e11-8b24-e9cb4280322b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_3a0d6897-12bc-4593-95b6-7921ba96acbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_49aed744-d99f-49d7-871d-e7bba9b8001d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_3a0d6897-12bc-4593-95b6-7921ba96acbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_61137aff-7230-4d6d-b2df-08f230bb8138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_49aed744-d99f-49d7-871d-e7bba9b8001d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_61137aff-7230-4d6d-b2df-08f230bb8138" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_655805dc-b94b-491d-84c6-5f524c9ff755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_49aed744-d99f-49d7-871d-e7bba9b8001d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_655805dc-b94b-491d-84c6-5f524c9ff755" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_d15bcdc6-de51-4901-9569-d120519dd226" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_49aed744-d99f-49d7-871d-e7bba9b8001d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_d15bcdc6-de51-4901-9569-d120519dd226" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_471fbb6b-da88-43e6-a5e7-75e32678e34a" xlink:href="aort-20220930.xsd#aort_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_49aed744-d99f-49d7-871d-e7bba9b8001d" xlink:to="loc_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_471fbb6b-da88-43e6-a5e7-75e32678e34a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_94b27b7f-b9c1-4546-8d24-2ef588ca88c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo_158d2758-ae52-4391-a1fa-13390320e3c0" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_94b27b7f-b9c1-4546-8d24-2ef588ca88c3" xlink:to="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo_158d2758-ae52-4391-a1fa-13390320e3c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour_4b687bb1-eead-4cea-9118-959449d6d77e" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_94b27b7f-b9c1-4546-8d24-2ef588ca88c3" xlink:to="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour_4b687bb1-eead-4cea-9118-959449d6d77e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour_13f08f1a-ceeb-4d31-86b5-3e2b057f38f3" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_94b27b7f-b9c1-4546-8d24-2ef588ca88c3" xlink:to="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour_13f08f1a-ceeb-4d31-86b5-3e2b057f38f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne_28b73d49-a014-4e4a-acbc-7946f27db957" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_94b27b7f-b9c1-4546-8d24-2ef588ca88c3" xlink:to="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne_28b73d49-a014-4e4a-acbc-7946f27db957" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear_7b640fd2-c09f-4076-acd6-158472978762" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_94b27b7f-b9c1-4546-8d24-2ef588ca88c3" xlink:to="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear_7b640fd2-c09f-4076-acd6-158472978762" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree_8b952ee1-949c-4f33-a787-5fc71e367920" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_94b27b7f-b9c1-4546-8d24-2ef588ca88c3" xlink:to="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree_8b952ee1-949c-4f33-a787-5fc71e367920" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4a04f385-aae2-4838-bcbe-537cb866b37f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_cb901124-1739-4e0d-9b8a-2c40a6eddfda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4a04f385-aae2-4838-bcbe-537cb866b37f" xlink:to="loc_us-gaap_LongTermDebtCurrent_cb901124-1739-4e0d-9b8a-2c40a6eddfda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_10b87cbe-391a-452c-801b-6ea0465e36dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4a04f385-aae2-4838-bcbe-537cb866b37f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_10b87cbe-391a-452c-801b-6ea0465e36dc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_157be40a-87ae-4d04-90ea-cfc073a49f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_67b4faf0-5577-4798-8cad-50ea9f927b46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_157be40a-87ae-4d04-90ea-cfc073a49f48" xlink:to="loc_us-gaap_NetIncomeLoss_67b4faf0-5577-4798-8cad-50ea9f927b46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_df1d1390-8152-4e46-8025-d53159c81b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_157be40a-87ae-4d04-90ea-cfc073a49f48" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_df1d1390-8152-4e46-8025-d53159c81b26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2cdb1dc2-69d5-4638-84e1-e50683ce7286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_bae4f4c0-48a3-4305-ab11-f4ef4a4c0f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2cdb1dc2-69d5-4638-84e1-e50683ce7286" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_bae4f4c0-48a3-4305-ab11-f4ef4a4c0f9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_1c07c589-25ee-4fbc-aa93-b27ff8dafcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2cdb1dc2-69d5-4638-84e1-e50683ce7286" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_1c07c589-25ee-4fbc-aa93-b27ff8dafcaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dca5ab02-0c46-4a9a-87c7-00795d48fdeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2cdb1dc2-69d5-4638-84e1-e50683ce7286" xlink:to="loc_us-gaap_NetIncomeLoss_dca5ab02-0c46-4a9a-87c7-00795d48fdeb" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>aort-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e6891988-c797-4972-93bc-9ac5fa18c933,g:19ec5362-98a4-465a-8335-497bfcde1bb2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome" xlink:type="simple" xlink:href="aort-20220930.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome" xlink:type="extended" id="i10ed6c4aa4664bfa8f89bae66d6c6658_CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_389f12a5-4bec-477f-b222-5d814e37b8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_RevenuesAbstract_389f12a5-4bec-477f-b222-5d814e37b8d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ed7f47b3-f688-42ea-822e-52b3e9ae202a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_389f12a5-4bec-477f-b222-5d814e37b8d7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ed7f47b3-f688-42ea-822e-52b3e9ae202a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_2b723351-6791-49a6-a277-2700302c1b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_CostOfRevenueAbstract_2b723351-6791-49a6-a277-2700302c1b4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_867e4c5e-14f6-4152-921d-213992fe592d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_2b723351-6791-49a6-a277-2700302c1b4c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_867e4c5e-14f6-4152-921d-213992fe592d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_17435bf5-7049-4c76-83f0-b3e4ec0a6ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_GrossProfit_17435bf5-7049-4c76-83f0-b3e4ec0a6ca7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_866037a1-d4f6-45a6-a86e-db4e7b5d4823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_OperatingExpensesAbstract_866037a1-d4f6-45a6-a86e-db4e7b5d4823" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_553d042b-094f-4ed1-9dbe-b805d033d01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_866037a1-d4f6-45a6-a86e-db4e7b5d4823" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_553d042b-094f-4ed1-9dbe-b805d033d01b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_65155278-731e-417d-8600-55ee3404fba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_866037a1-d4f6-45a6-a86e-db4e7b5d4823" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_65155278-731e-417d-8600-55ee3404fba2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_993b29ab-ffef-4204-9a12-3946cca78846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_866037a1-d4f6-45a6-a86e-db4e7b5d4823" xlink:to="loc_us-gaap_OperatingExpenses_993b29ab-ffef-4204-9a12-3946cca78846" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_3fe77b3f-a188-4363-bb11-4e2d0b29ba80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_3fe77b3f-a188-4363-bb11-4e2d0b29ba80" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6560cbfa-3036-4ab8-a0ed-5d1d10759edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_OperatingIncomeLoss_6560cbfa-3036-4ab8-a0ed-5d1d10759edd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c52ec567-5bc5-40f5-b761-88dd7248e42a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_InterestExpense_c52ec567-5bc5-40f5-b761-88dd7248e42a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_d480c31a-ec58-49db-94ab-13fc34fb7425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_InvestmentIncomeInterest_d480c31a-ec58-49db-94ab-13fc34fb7425" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ae0faf92-412b-4fc7-8fe5-2869841d2b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ae0faf92-412b-4fc7-8fe5-2869841d2b09" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e2bac714-6fe7-453b-8aae-e914fe671032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e2bac714-6fe7-453b-8aae-e914fe671032" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_907828f4-9e44-4237-b59f-7dbefb7ce980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_907828f4-9e44-4237-b59f-7dbefb7ce980" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_09065252-27d5-41df-9d36-e0c70d04cdbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_NetIncomeLoss_09065252-27d5-41df-9d36-e0c70d04cdbc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_67194260-1ef5-4a5f-9ada-378ec3603547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_67194260-1ef5-4a5f-9ada-378ec3603547" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1ce6c7bd-2a96-4f21-8c3c-65a8eebb0892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_67194260-1ef5-4a5f-9ada-378ec3603547" xlink:to="loc_us-gaap_EarningsPerShareBasic_1ce6c7bd-2a96-4f21-8c3c-65a8eebb0892" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c306dfcf-0af7-40c4-adc0-179bf6ca258f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_67194260-1ef5-4a5f-9ada-378ec3603547" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c306dfcf-0af7-40c4-adc0-179bf6ca258f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_6c1f60b2-84de-49b0-bd88-ac1eda147427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_6c1f60b2-84de-49b0-bd88-ac1eda147427" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_77707b12-7f90-4c98-825b-f82a94226895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_6c1f60b2-84de-49b0-bd88-ac1eda147427" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_77707b12-7f90-4c98-825b-f82a94226895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7deb9fcc-1881-428d-a6af-b8db241acc60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_6c1f60b2-84de-49b0-bd88-ac1eda147427" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7deb9fcc-1881-428d-a6af-b8db241acc60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_736924e0-079e-4778-aeaf-c97098a843ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_f30350ff-66f9-4ea9-a525-0a172d928eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfOtherComprehensiveIncomeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_f30350ff-66f9-4ea9-a525-0a172d928eed" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_360d2c16-db9a-4bed-bbda-8c79d86a0466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_f30350ff-66f9-4ea9-a525-0a172d928eed" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_360d2c16-db9a-4bed-bbda-8c79d86a0466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6269c2f9-d1da-4392-85b0-70bf0a2eaafb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_6269c2f9-d1da-4392-85b0-70bf0a2eaafb" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_85ce7474-a9b6-4772-8ab7-fe675e806094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_StatementTable_85ce7474-a9b6-4772-8ab7-fe675e806094" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2802d2a2-5318-425e-9119-9371bbfe61ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_85ce7474-a9b6-4772-8ab7-fe675e806094" xlink:to="loc_srt_ProductOrServiceAxis_2802d2a2-5318-425e-9119-9371bbfe61ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2802d2a2-5318-425e-9119-9371bbfe61ef_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_2802d2a2-5318-425e-9119-9371bbfe61ef" xlink:to="loc_srt_ProductsAndServicesDomain_2802d2a2-5318-425e-9119-9371bbfe61ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a5a63085-c174-4231-90a3-3d391840df77" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_2802d2a2-5318-425e-9119-9371bbfe61ef" xlink:to="loc_srt_ProductsAndServicesDomain_a5a63085-c174-4231-90a3-3d391840df77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ProductsMember_103e2833-ad7d-44ef-944d-77a74fc77f90" xlink:href="aort-20220930.xsd#aort_ProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a5a63085-c174-4231-90a3-3d391840df77" xlink:to="loc_aort_ProductsMember_103e2833-ad7d-44ef-944d-77a74fc77f90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember_129fa78b-bb3a-4be1-89f9-e69f90dd94b0" xlink:href="aort-20220930.xsd#aort_PreservationServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a5a63085-c174-4231-90a3-3d391840df77" xlink:to="loc_aort_PreservationServicesMember_129fa78b-bb3a-4be1-89f9-e69f90dd94b0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="aort-20220930.xsd#CondensedConsolidatedStatementsofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="extended" id="i9400a1bcebe640ad9300c04bcf36003e_CondensedConsolidatedStatementsofShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4d6d8d12-4ba0-4ce4-b19c-d63cdd7e20ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4d6d8d12-4ba0-4ce4-b19c-d63cdd7e20ae" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_91e08278-5059-46b5-bcff-a5a388329d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_91e08278-5059-46b5-bcff-a5a388329d3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6b1260b9-d6db-4048-b9ab-0ec5db7a2587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockholdersEquity_6b1260b9-d6db-4048-b9ab-0ec5db7a2587" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_27c14f21-3087-4c24-980f-6b4b50c705c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_TreasuryStockCommonShares_27c14f21-3087-4c24-980f-6b4b50c705c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_2a1c818b-31f2-4b9e-9452-66dc26898d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_TreasuryStockCommonValue_2a1c818b-31f2-4b9e-9452-66dc26898d2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f2da7b7c-931b-407e-8972-a61a86407626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_NetIncomeLoss_f2da7b7c-931b-407e-8972-a61a86407626" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1a9bbb24-16aa-4d96-ad95-6e750efa72e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1a9bbb24-16aa-4d96-ad95-6e750efa72e7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_32634fb1-fc14-4dec-8358-d4110e581e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_32634fb1-fc14-4dec-8358-d4110e581e67" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4004b7be-0aa9-4251-b949-f0b87e405afd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4004b7be-0aa9-4251-b949-f0b87e405afd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3725c47d-101b-43c5-b0b9-43a20d3b9f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3725c47d-101b-43c5-b0b9-43a20d3b9f23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_138018c1-e9b9-422e-b4dc-0a6a58141e38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_138018c1-e9b9-422e-b4dc-0a6a58141e38" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9cc8c7a2-6af0-43cc-b143-2b17e48e0416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9cc8c7a2-6af0-43cc-b143-2b17e48e0416" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_ab47e2c0-53a5-4781-b206-0db2b91e0d55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_ab47e2c0-53a5-4781-b206-0db2b91e0d55" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3b14e702-b1c8-4b1a-b82b-99ce2ba2f66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3b14e702-b1c8-4b1a-b82b-99ce2ba2f66d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_1186ee1e-22e9-4d1f-b380-bb099e53d716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_1186ee1e-22e9-4d1f-b380-bb099e53d716" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_a952899f-338f-4ed3-af2f-353ee77777da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_a952899f-338f-4ed3-af2f-353ee77777da" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e514c218-5554-4215-a3ca-0f95754c30b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9622c86a-a080-4407-8cb5-4898b11ff1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_090f7648-dd45-4563-a72b-6e91ffa31ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_69e4b06b-57ad-4c37-becf-1a7f78e18196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f8296294-eac2-4e7d-b557-014b519fc7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4d6d8d12-4ba0-4ce4-b19c-d63cdd7e20ae" xlink:to="loc_us-gaap_StatementTable_f8296294-eac2-4e7d-b557-014b519fc7b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_abe28156-fd4c-42ed-977d-9e9bacc38d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f8296294-eac2-4e7d-b557-014b519fc7b9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_abe28156-fd4c-42ed-977d-9e9bacc38d4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_abe28156-fd4c-42ed-977d-9e9bacc38d4b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abe28156-fd4c-42ed-977d-9e9bacc38d4b" xlink:to="loc_us-gaap_EquityComponentDomain_abe28156-fd4c-42ed-977d-9e9bacc38d4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abe28156-fd4c-42ed-977d-9e9bacc38d4b" xlink:to="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c3d68199-89eb-443e-ad5d-6c2502f6b2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:to="loc_us-gaap_CommonStockMember_c3d68199-89eb-443e-ad5d-6c2502f6b2ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_13651831-ff9c-4e79-ae6b-19103f32dfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_13651831-ff9c-4e79-ae6b-19103f32dfbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_2c327d22-8bd8-42dc-a9be-94b376e8edf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:to="loc_us-gaap_RetainedEarningsMember_2c327d22-8bd8-42dc-a9be-94b376e8edf2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c5f66bf6-9266-4da9-a233-96655fbbfd49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c5f66bf6-9266-4da9-a233-96655fbbfd49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_6d251667-9253-4324-9dbe-dfabf4bb1294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:to="loc_us-gaap_TreasuryStockCommonMember_6d251667-9253-4324-9dbe-dfabf4bb1294" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1a7348fb-eb02-4eb2-ada2-d3fc65aa0096" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f8296294-eac2-4e7d-b557-014b519fc7b9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1a7348fb-eb02-4eb2-ada2-d3fc65aa0096" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1a7348fb-eb02-4eb2-ada2-d3fc65aa0096_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1a7348fb-eb02-4eb2-ada2-d3fc65aa0096" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1a7348fb-eb02-4eb2-ada2-d3fc65aa0096_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_264d1504-d45d-4080-9647-0788fa6454f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1a7348fb-eb02-4eb2-ada2-d3fc65aa0096" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_264d1504-d45d-4080-9647-0788fa6454f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_d9e0f060-a667-4000-abe5-bdcdd91499e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_264d1504-d45d-4080-9647-0788fa6454f1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_d9e0f060-a667-4000-abe5-bdcdd91499e3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SaleofPerClotDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#SaleofPerClotDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/SaleofPerClotDetails" xlink:type="extended" id="ib09d72156b164906a70819f8e8915822_SaleofPerClotDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_6ef3df5e-7062-414a-84cf-e6155f995020" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_6ef3df5e-7062-414a-84cf-e6155f995020" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_e19d3079-e69c-42ec-bb24-f0706103ffea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_e19d3079-e69c-42ec-bb24-f0706103ffea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable_7038a6b7-8fbf-4eec-84ea-30f317b1c49d" xlink:href="aort-20220930.xsd#aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable_7038a6b7-8fbf-4eec-84ea-30f317b1c49d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_a2d327e8-a3fb-4ce6-8598-745c02637fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_a2d327e8-a3fb-4ce6-8598-745c02637fff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_c4de6d8d-35a8-4cca-82d3-da3e6a625b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_c4de6d8d-35a8-4cca-82d3-da3e6a625b84" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_1b3395a0-853f-4acd-bb02-02d9c86f0f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_1b3395a0-853f-4acd-bb02-02d9c86f0f08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5128a21f-f42b-4cc8-b019-8c70c313621d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5128a21f-f42b-4cc8-b019-8c70c313621d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d415482a-1894-4da4-a0fa-39d973f544f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5128a21f-f42b-4cc8-b019-8c70c313621d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d415482a-1894-4da4-a0fa-39d973f544f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d415482a-1894-4da4-a0fa-39d973f544f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d415482a-1894-4da4-a0fa-39d973f544f7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d415482a-1894-4da4-a0fa-39d973f544f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3977935e-a1e8-4e3b-a5bb-e32a63457ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d415482a-1894-4da4-a0fa-39d973f544f7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3977935e-a1e8-4e3b-a5bb-e32a63457ffc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PerClotMember_496f99d8-c173-4f18-bd22-4a8ddde0ace6" xlink:href="aort-20220930.xsd#aort_PerClotMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3977935e-a1e8-4e3b-a5bb-e32a63457ffc" xlink:to="loc_aort_PerClotMember_496f99d8-c173-4f18-bd22-4a8ddde0ace6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_22c8cbc0-65c7-40d5-8c2c-cbb35175f5d1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5128a21f-f42b-4cc8-b019-8c70c313621d" xlink:to="loc_dei_LegalEntityAxis_22c8cbc0-65c7-40d5-8c2c-cbb35175f5d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_22c8cbc0-65c7-40d5-8c2c-cbb35175f5d1_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_22c8cbc0-65c7-40d5-8c2c-cbb35175f5d1" xlink:to="loc_dei_EntityDomain_22c8cbc0-65c7-40d5-8c2c-cbb35175f5d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8629e155-b281-4141-98a0-671b7e888458" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_22c8cbc0-65c7-40d5-8c2c-cbb35175f5d1" xlink:to="loc_dei_EntityDomain_8629e155-b281-4141-98a0-671b7e888458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ArtivionInc.AndStarchMedicalInc.Member_1afd6119-b1c8-435d-b217-5615af7cb8df" xlink:href="aort-20220930.xsd#aort_ArtivionInc.AndStarchMedicalInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8629e155-b281-4141-98a0-671b7e888458" xlink:to="loc_aort_ArtivionInc.AndStarchMedicalInc.Member_1afd6119-b1c8-435d-b217-5615af7cb8df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_StarchMedicalInc.Member_f2f33ab0-066e-46ce-a017-7618019e1e3e" xlink:href="aort-20220930.xsd#aort_StarchMedicalInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8629e155-b281-4141-98a0-671b7e888458" xlink:to="loc_aort_StarchMedicalInc.Member_f2f33ab0-066e-46ce-a017-7618019e1e3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_70636cd9-b712-4b3b-a0e1-b9b979d4977f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5128a21f-f42b-4cc8-b019-8c70c313621d" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_70636cd9-b712-4b3b-a0e1-b9b979d4977f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_70636cd9-b712-4b3b-a0e1-b9b979d4977f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_70636cd9-b712-4b3b-a0e1-b9b979d4977f" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_70636cd9-b712-4b3b-a0e1-b9b979d4977f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_9c42897e-6e20-4a74-b6ca-424453bf8c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_70636cd9-b712-4b3b-a0e1-b9b979d4977f" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_9c42897e-6e20-4a74-b6ca-424453bf8c8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PmaApprovalMember_6660946d-9569-4a96-919b-1364be38ca90" xlink:href="aort-20220930.xsd#aort_PmaApprovalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9c42897e-6e20-4a74-b6ca-424453bf8c8d" xlink:to="loc_aort_PmaApprovalMember_6660946d-9569-4a96-919b-1364be38ca90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_BaxterAchievementOfWorldwideSalesMember_6b9629d0-619e-4a68-a7ac-1f9dc02907ab" xlink:href="aort-20220930.xsd#aort_BaxterAchievementOfWorldwideSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9c42897e-6e20-4a74-b6ca-424453bf8c8d" xlink:to="loc_aort_BaxterAchievementOfWorldwideSalesMember_6b9629d0-619e-4a68-a7ac-1f9dc02907ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_TransferOfPerclotManufacturingEquipmentMember_eb91ae38-62a9-448a-a270-3322252327ca" xlink:href="aort-20220930.xsd#aort_TransferOfPerclotManufacturingEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9c42897e-6e20-4a74-b6ca-424453bf8c8d" xlink:to="loc_aort_TransferOfPerclotManufacturingEquipmentMember_eb91ae38-62a9-448a-a270-3322252327ca" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="extended" id="i66de811aef3e476a8baee1037c60646c_FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98e0d65f-7099-4791-8c33-9768da3e6de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_583d2a6e-9cee-48b3-a802-6bb1f3912b03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98e0d65f-7099-4791-8c33-9768da3e6de6" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_583d2a6e-9cee-48b3-a802-6bb1f3912b03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6054ac10-85cd-4031-96fc-cc85e73a2146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98e0d65f-7099-4791-8c33-9768da3e6de6" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_6054ac10-85cd-4031-96fc-cc85e73a2146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ContingentConsiderationNoncurrentFairValue_4d1fdbf8-c676-4e43-ae3e-74da3600696d" xlink:href="aort-20220930.xsd#aort_ContingentConsiderationNoncurrentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98e0d65f-7099-4791-8c33-9768da3e6de6" xlink:to="loc_aort_ContingentConsiderationNoncurrentFairValue_4d1fdbf8-c676-4e43-ae3e-74da3600696d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_71b042bf-9cd2-4e46-831c-2571de906dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98e0d65f-7099-4791-8c33-9768da3e6de6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_71b042bf-9cd2-4e46-831c-2571de906dc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_565fe7ee-f2f5-4191-ab97-5bbe8bfe3602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98e0d65f-7099-4791-8c33-9768da3e6de6" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_565fe7ee-f2f5-4191-ab97-5bbe8bfe3602" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6802aa72-0ec4-40e2-bb78-5562ff2a6026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_565fe7ee-f2f5-4191-ab97-5bbe8bfe3602" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6802aa72-0ec4-40e2-bb78-5562ff2a6026" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6802aa72-0ec4-40e2-bb78-5562ff2a6026_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6802aa72-0ec4-40e2-bb78-5562ff2a6026" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6802aa72-0ec4-40e2-bb78-5562ff2a6026_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f91f53f8-e21b-4cf2-9abe-a055b6ba14dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6802aa72-0ec4-40e2-bb78-5562ff2a6026" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f91f53f8-e21b-4cf2-9abe-a055b6ba14dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e224f079-3989-4a8d-a3c8-506ecbad8f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f91f53f8-e21b-4cf2-9abe-a055b6ba14dd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e224f079-3989-4a8d-a3c8-506ecbad8f49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_bf646943-06ea-48d5-a485-b1e874fe52be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f91f53f8-e21b-4cf2-9abe-a055b6ba14dd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_bf646943-06ea-48d5-a485-b1e874fe52be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_2eb26c24-6a0c-452f-9290-a7aff9a052c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f91f53f8-e21b-4cf2-9abe-a055b6ba14dd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_2eb26c24-6a0c-452f-9290-a7aff9a052c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_71c8e4b5-16e2-4fb0-acde-6755fc94bf31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_565fe7ee-f2f5-4191-ab97-5bbe8bfe3602" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_71c8e4b5-16e2-4fb0-acde-6755fc94bf31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_71c8e4b5-16e2-4fb0-acde-6755fc94bf31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_71c8e4b5-16e2-4fb0-acde-6755fc94bf31" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_71c8e4b5-16e2-4fb0-acde-6755fc94bf31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f2e7fe3a-110f-479f-ad8c-e1de5b08882d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_71c8e4b5-16e2-4fb0-acde-6755fc94bf31" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f2e7fe3a-110f-479f-ad8c-e1de5b08882d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_607e5526-208a-4b65-8bef-a5eff89ef0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f2e7fe3a-110f-479f-ad8c-e1de5b08882d" xlink:to="loc_us-gaap_MoneyMarketFundsMember_607e5526-208a-4b65-8bef-a5eff89ef0d7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended" id="i021a41c67cc449c9ac832d18a691e242_FinancialInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ba7b14-21c9-4500-bc6a-f34984dacc56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6f6b4675-03a8-4592-bdc4-93e997b257cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ba7b14-21c9-4500-bc6a-f34984dacc56" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6f6b4675-03a8-4592-bdc4-93e997b257cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2624cef8-c9cd-4077-b96d-e4fc235337f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ba7b14-21c9-4500-bc6a-f34984dacc56" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2624cef8-c9cd-4077-b96d-e4fc235337f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_7b2c1f58-9737-4ab0-aed3-73e18e5e9e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ba7b14-21c9-4500-bc6a-f34984dacc56" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_7b2c1f58-9737-4ab0-aed3-73e18e5e9e82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_39594f90-059d-49da-a8d4-2c8066125053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ba7b14-21c9-4500-bc6a-f34984dacc56" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_39594f90-059d-49da-a8d4-2c8066125053" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b5a146b-0caa-469c-ad09-9f76ec2d9719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ba7b14-21c9-4500-bc6a-f34984dacc56" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b5a146b-0caa-469c-ad09-9f76ec2d9719" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ee6126f9-3936-4d67-8e9d-38aad4740e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b5a146b-0caa-469c-ad09-9f76ec2d9719" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ee6126f9-3936-4d67-8e9d-38aad4740e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ee6126f9-3936-4d67-8e9d-38aad4740e63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ee6126f9-3936-4d67-8e9d-38aad4740e63" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ee6126f9-3936-4d67-8e9d-38aad4740e63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e907839a-5527-48aa-bd0a-97657dee5f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ee6126f9-3936-4d67-8e9d-38aad4740e63" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e907839a-5527-48aa-bd0a-97657dee5f7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AscyrusMedicalLlcMember_4d10c377-eec9-4e75-aed7-d7db3221856e" xlink:href="aort-20220930.xsd#aort_AscyrusMedicalLlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e907839a-5527-48aa-bd0a-97657dee5f7e" xlink:to="loc_aort_AscyrusMedicalLlcMember_4d10c377-eec9-4e75-aed7-d7db3221856e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_faf80bc5-b7cb-4aba-a897-c6ede50d0c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b5a146b-0caa-469c-ad09-9f76ec2d9719" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_faf80bc5-b7cb-4aba-a897-c6ede50d0c20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_faf80bc5-b7cb-4aba-a897-c6ede50d0c20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_faf80bc5-b7cb-4aba-a897-c6ede50d0c20" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_faf80bc5-b7cb-4aba-a897-c6ede50d0c20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_09cb1d8d-5d8c-40f8-8768-3282ff844f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_faf80bc5-b7cb-4aba-a897-c6ede50d0c20" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_09cb1d8d-5d8c-40f8-8768-3282ff844f6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_3e352786-7ecd-44a8-8f81-4fd907a966e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_09cb1d8d-5d8c-40f8-8768-3282ff844f6f" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_3e352786-7ecd-44a8-8f81-4fd907a966e7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails" xlink:type="extended" id="i046d6eaac2f440a483cd0e1e1d01c1a2_CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_f10641dd-7aac-457c-aef1-c558fd7492dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_f958cf21-263d-4a90-96c7-7bca17528770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_f10641dd-7aac-457c-aef1-c558fd7492dc" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_f958cf21-263d-4a90-96c7-7bca17528770" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_643f56b0-b888-4db3-adc9-4c0e249e5ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_f10641dd-7aac-457c-aef1-c558fd7492dc" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_643f56b0-b888-4db3-adc9-4c0e249e5ebb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6c980cd9-19bb-49dc-939a-acb7dee2e2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_f10641dd-7aac-457c-aef1-c558fd7492dc" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6c980cd9-19bb-49dc-939a-acb7dee2e2d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_a659f131-deb5-41ea-8d31-0d1f000b93df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_f10641dd-7aac-457c-aef1-c558fd7492dc" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_a659f131-deb5-41ea-8d31-0d1f000b93df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_43d54c92-aa82-410f-872e-a4cfc10d9f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_a659f131-deb5-41ea-8d31-0d1f000b93df" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_43d54c92-aa82-410f-872e-a4cfc10d9f29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_43d54c92-aa82-410f-872e-a4cfc10d9f29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_43d54c92-aa82-410f-872e-a4cfc10d9f29" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_43d54c92-aa82-410f-872e-a4cfc10d9f29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9bad3116-63fb-400b-87fa-5f0908e96936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_43d54c92-aa82-410f-872e-a4cfc10d9f29" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9bad3116-63fb-400b-87fa-5f0908e96936" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_a4adf491-9bee-44a4-b4fc-89e54405bbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9bad3116-63fb-400b-87fa-5f0908e96936" xlink:to="loc_us-gaap_MoneyMarketFundsMember_a4adf491-9bee-44a4-b4fc-89e54405bbf1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#InventoriesnetandDeferredPreservationCostsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails" xlink:type="extended" id="ic361e6d0cbb846ffb94159b4aef88f65_InventoriesnetandDeferredPreservationCostsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_3de184a8-3dbc-4c16-83a2-28b574ab7905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_36559b01-8a01-49bf-a5c6-5be1d3020043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_3de184a8-3dbc-4c16-83a2-28b574ab7905" xlink:to="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_36559b01-8a01-49bf-a5c6-5be1d3020043" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ConsignmentInventoryPercentage_d00775ea-8777-47d9-9f21-d757d943f58e" xlink:href="aort-20220930.xsd#aort_ConsignmentInventoryPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_3de184a8-3dbc-4c16-83a2-28b574ab7905" xlink:to="loc_aort_ConsignmentInventoryPercentage_d00775ea-8777-47d9-9f21-d757d943f58e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DeferredPreservationCosts_59a03bd7-dddc-4d1e-b9eb-001f83baba01" xlink:href="aort-20220930.xsd#aort_DeferredPreservationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_3de184a8-3dbc-4c16-83a2-28b574ab7905" xlink:to="loc_aort_DeferredPreservationCosts_59a03bd7-dddc-4d1e-b9eb-001f83baba01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_863a9ecb-e0da-44dd-acc7-b73ab6fe07e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_3de184a8-3dbc-4c16-83a2-28b574ab7905" xlink:to="loc_us-gaap_InventoryValuationReserves_863a9ecb-e0da-44dd-acc7-b73ab6fe07e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_5fc81206-8a1c-49fb-a1f8-fad01caf1e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_3de184a8-3dbc-4c16-83a2-28b574ab7905" xlink:to="loc_us-gaap_InventoryCurrentTable_5fc81206-8a1c-49fb-a1f8-fad01caf1e8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_97770421-358e-410b-8fef-22c89e98088f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_5fc81206-8a1c-49fb-a1f8-fad01caf1e8f" xlink:to="loc_srt_StatementGeographicalAxis_97770421-358e-410b-8fef-22c89e98088f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_97770421-358e-410b-8fef-22c89e98088f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_97770421-358e-410b-8fef-22c89e98088f" xlink:to="loc_srt_SegmentGeographicalDomain_97770421-358e-410b-8fef-22c89e98088f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_29818004-92f1-42df-9e92-8d772063c767" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_97770421-358e-410b-8fef-22c89e98088f" xlink:to="loc_srt_SegmentGeographicalDomain_29818004-92f1-42df-9e92-8d772063c767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8df7a4ac-a9ba-474e-8d80-2437d1e91794" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_29818004-92f1-42df-9e92-8d772063c767" xlink:to="loc_country_US_8df7a4ac-a9ba-474e-8d80-2437d1e91794" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_8dc220b0-6792-4379-9b8a-519bd47da3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_29818004-92f1-42df-9e92-8d772063c767" xlink:to="loc_us-gaap_NonUsMember_8dc220b0-6792-4379-9b8a-519bd47da3c0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails" xlink:type="extended" id="if69d8e3cfba041489b746e2fbd3f0205_GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_29f4e5cd-1a1c-4e95-a0a0-1898dc795b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1b020aa1-7ff9-4886-9bb5-f50e5db997c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_29f4e5cd-1a1c-4e95-a0a0-1898dc795b0b" xlink:to="loc_us-gaap_Goodwill_1b020aa1-7ff9-4886-9bb5-f50e5db997c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_652d7d77-be45-4a7d-954a-08947b674382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_29f4e5cd-1a1c-4e95-a0a0-1898dc795b0b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_652d7d77-be45-4a7d-954a-08947b674382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_26fe787f-f614-4957-845b-69fd2b905afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_29f4e5cd-1a1c-4e95-a0a0-1898dc795b0b" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_26fe787f-f614-4957-845b-69fd2b905afc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ffe4f304-660b-43ac-830d-ccc097866f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_26fe787f-f614-4957-845b-69fd2b905afc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ffe4f304-660b-43ac-830d-ccc097866f89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ffe4f304-660b-43ac-830d-ccc097866f89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ffe4f304-660b-43ac-830d-ccc097866f89" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ffe4f304-660b-43ac-830d-ccc097866f89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0190f206-cd0f-454b-9091-fb1e46d5464e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ffe4f304-660b-43ac-830d-ccc097866f89" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0190f206-cd0f-454b-9091-fb1e46d5464e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_26717db1-3f23-4970-b88e-c2c90283931f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0190f206-cd0f-454b-9091-fb1e46d5464e" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_26717db1-3f23-4970-b88e-c2c90283931f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_d8759f97-53e9-44ef-845b-391c2bd7dade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0190f206-cd0f-454b-9091-fb1e46d5464e" xlink:to="loc_us-gaap_ContractualRightsMember_d8759f97-53e9-44ef-845b-391c2bd7dade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_b9b061d1-2f75-470a-baa9-e75c014e539c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0190f206-cd0f-454b-9091-fb1e46d5464e" xlink:to="loc_us-gaap_TrademarksMember_b9b061d1-2f75-470a-baa9-e75c014e539c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" xlink:type="extended" id="i3702b64e785a4f9eb5b27eea9a12da02_GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_feb048ba-1127-42f0-97d2-1d5037d33fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c699ac1e-728f-4c2e-bece-3c2e2c3ea558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_feb048ba-1127-42f0-97d2-1d5037d33fd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c699ac1e-728f-4c2e-bece-3c2e2c3ea558" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_80743c3f-0624-42f7-9f9d-45ddf91446a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_feb048ba-1127-42f0-97d2-1d5037d33fd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_80743c3f-0624-42f7-9f9d-45ddf91446a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9f86673f-9076-4604-8374-c1030b615c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_feb048ba-1127-42f0-97d2-1d5037d33fd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9f86673f-9076-4604-8374-c1030b615c19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3bf8e82b-0514-4805-9b56-39cee574e239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_feb048ba-1127-42f0-97d2-1d5037d33fd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3bf8e82b-0514-4805-9b56-39cee574e239" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2e79ee89-6349-4a36-961f-ba07b577625b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_feb048ba-1127-42f0-97d2-1d5037d33fd4" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2e79ee89-6349-4a36-961f-ba07b577625b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07979815-80dc-4e0e-a73b-f72dac3d1b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2e79ee89-6349-4a36-961f-ba07b577625b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07979815-80dc-4e0e-a73b-f72dac3d1b76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_07979815-80dc-4e0e-a73b-f72dac3d1b76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07979815-80dc-4e0e-a73b-f72dac3d1b76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_07979815-80dc-4e0e-a73b-f72dac3d1b76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d623d3c-80a9-416c-a3a8-a9173633e010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07979815-80dc-4e0e-a73b-f72dac3d1b76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d623d3c-80a9-416c-a3a8-a9173633e010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_01d58db0-7525-4af7-8d63-80ed53eb0b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d623d3c-80a9-416c-a3a8-a9173633e010" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_01d58db0-7525-4af7-8d63-80ed53eb0b0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_3d4b5f25-5494-4da1-8461-ae819361caee" xlink:href="aort-20220930.xsd#aort_IntangibleAssetsOtherThanAcquiredTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d623d3c-80a9-416c-a3a8-a9173633e010" xlink:to="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_3d4b5f25-5494-4da1-8461-ae819361caee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerListsMember_f8277fa7-bbab-4021-8181-61a112b3f9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerListsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_3d4b5f25-5494-4da1-8461-ae819361caee" xlink:to="loc_us-gaap_CustomerListsMember_f8277fa7-bbab-4021-8181-61a112b3f9c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember_a19d613e-83b7-4b4b-a14d-c7aad1b481b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_3d4b5f25-5494-4da1-8461-ae819361caee" xlink:to="loc_us-gaap_DistributionRightsMember_a19d613e-83b7-4b4b-a14d-c7aad1b481b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_1c0eab4d-067b-43d6-9846-8acfc63fca5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_3d4b5f25-5494-4da1-8461-ae819361caee" xlink:to="loc_us-gaap_PatentsMember_1c0eab4d-067b-43d6-9846-8acfc63fca5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_93103f54-1719-42d5-8f1d-0244712c9e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_3d4b5f25-5494-4da1-8461-ae819361caee" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_93103f54-1719-42d5-8f1d-0244712c9e7b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/DebtNarrativeDetails" xlink:type="extended" id="i1465d887df8544788cedf29de379e6ec_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fec25602-9cb2-4bac-ba73-9fce90e84744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fec25602-9cb2-4bac-ba73-9fce90e84744" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_0c425a03-b001-4dfc-aa04-05bcb13e4edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_0c425a03-b001-4dfc-aa04-05bcb13e4edc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentExtensionPeriod_3a5794d9-b8fa-4302-b288-83538a9b3f9a" xlink:href="aort-20220930.xsd#aort_DebtInstrumentExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_aort_DebtInstrumentExtensionPeriod_3a5794d9-b8fa-4302-b288-83538a9b3f9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8ec5aa59-c939-4b75-b4e0-1d7ca9db9eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8ec5aa59-c939-4b75-b4e0-1d7ca9db9eb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentExtensionCircumstancePeriod_56883ba1-fe78-466d-b597-6298e6764bb5" xlink:href="aort-20220930.xsd#aort_DebtInstrumentExtensionCircumstancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_aort_DebtInstrumentExtensionCircumstancePeriod_56883ba1-fe78-466d-b597-6298e6764bb5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4566b0e1-b142-41c7-9e5c-1a939926bac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4566b0e1-b142-41c7-9e5c-1a939926bac1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f17b817d-ce09-4dc7-813d-dcf8da7a0e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f17b817d-ce09-4dc7-813d-dcf8da7a0e90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_3a17ca9d-2909-4951-b855-72b3865a9be3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_3a17ca9d-2909-4951-b855-72b3865a9be3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_d47f02ec-1fc1-479a-b496-69a39a431727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_d47f02ec-1fc1-479a-b496-69a39a431727" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_d40a8c13-bdcb-43e8-9754-ac011c5cb260" xlink:href="aort-20220930.xsd#aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_d40a8c13-bdcb-43e8-9754-ac011c5cb260" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_717aa5c2-d5b5-4451-bdc4-0edf4446bd08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_717aa5c2-d5b5-4451-bdc4-0edf4446bd08" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_3a635309-5dd5-4891-bb5e-39cccfb4a9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_3a635309-5dd5-4891-bb5e-39cccfb4a9b1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b983f152-4cd1-4843-84d0-5c382edcd977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_LongTermDebt_b983f152-4cd1-4843-84d0-5c382edcd977" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_26fc1a2a-55bd-4b7e-ac49-982abf4510b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_26fc1a2a-55bd-4b7e-ac49-982abf4510b2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_c5c31788-60f7-4ac6-ba85-0105dc2c6dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_c5c31788-60f7-4ac6-ba85-0105dc2c6dde" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_0ec4c706-ace1-46a3-a39a-971302d056ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentFairValue_0ec4c706-ace1-46a3-a39a-971302d056ef" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_9a7065a6-5836-4e03-b886-b09063ca1cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_9a7065a6-5836-4e03-b886-b09063ca1cdf" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_183e865c-cb42-4765-aced-5eaeba7d4ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_InterestExpenseDebt_183e865c-cb42-4765-aced-5eaeba7d4ad6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_e7af3d74-fbd2-48a6-93b5-e045e4645487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_e7af3d74-fbd2-48a6-93b5-e045e4645487" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_558cd996-4fdf-48ea-b9c1-f5b13a3f3485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_558cd996-4fdf-48ea-b9c1-f5b13a3f3485" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_171c23ca-e500-4704-82e6-9d4e609ac113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_171c23ca-e500-4704-82e6-9d4e609ac113" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_657bec74-019d-4aac-b326-a8ab33bd40fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_657bec74-019d-4aac-b326-a8ab33bd40fe" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_3fefc338-4424-4f8d-a824-a7a0aac12c57" xlink:href="aort-20220930.xsd#aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_3fefc338-4424-4f8d-a824-a7a0aac12c57" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bc773fc7-d183-418c-b925-c9442ebd68b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bc773fc7-d183-418c-b925-c9442ebd68b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_bc773fc7-d183-418c-b925-c9442ebd68b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bc773fc7-d183-418c-b925-c9442ebd68b9" xlink:to="loc_us-gaap_TypeOfAdoptionMember_bc773fc7-d183-418c-b925-c9442ebd68b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_543c5f23-cdb2-4fa9-b8a0-ed5570d21463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bc773fc7-d183-418c-b925-c9442ebd68b9" xlink:to="loc_us-gaap_TypeOfAdoptionMember_543c5f23-cdb2-4fa9-b8a0-ed5570d21463" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_7e60e96f-18bd-4f27-ac5f-8ccb9a6377a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_543c5f23-cdb2-4fa9-b8a0-ed5570d21463" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_7e60e96f-18bd-4f27-ac5f-8ccb9a6377a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e50b1321-9252-41a8-9569-c2e6185afe32" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e50b1321-9252-41a8-9569-c2e6185afe32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e50b1321-9252-41a8-9569-c2e6185afe32_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e50b1321-9252-41a8-9569-c2e6185afe32" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e50b1321-9252-41a8-9569-c2e6185afe32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_abba0ca3-c12c-4009-977e-97ee43ead2e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e50b1321-9252-41a8-9569-c2e6185afe32" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_abba0ca3-c12c-4009-977e-97ee43ead2e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ad0dee00-4ca0-4945-ac8c-5eca7a175a70" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_abba0ca3-c12c-4009-977e-97ee43ead2e8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ad0dee00-4ca0-4945-ac8c-5eca7a175a70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_677b865f-e78f-4bc8-a9c4-84424a7b7b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_CreditFacilityAxis_677b865f-e78f-4bc8-a9c4-84424a7b7b1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_677b865f-e78f-4bc8-a9c4-84424a7b7b1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_677b865f-e78f-4bc8-a9c4-84424a7b7b1c" xlink:to="loc_us-gaap_CreditFacilityDomain_677b865f-e78f-4bc8-a9c4-84424a7b7b1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cce2af24-93da-406b-a072-d634d0a9cc01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_677b865f-e78f-4bc8-a9c4-84424a7b7b1c" xlink:to="loc_us-gaap_CreditFacilityDomain_cce2af24-93da-406b-a072-d634d0a9cc01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_872d480e-a03d-4e37-ad27-955b41135394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cce2af24-93da-406b-a072-d634d0a9cc01" xlink:to="loc_us-gaap_SecuredDebtMember_872d480e-a03d-4e37-ad27-955b41135394" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_fde835d2-55f6-4d52-a7ba-38fe8e3db73b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cce2af24-93da-406b-a072-d634d0a9cc01" xlink:to="loc_us-gaap_LoansPayableMember_fde835d2-55f6-4d52-a7ba-38fe8e3db73b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9723de3e-571a-45ab-a22a-399e64ab7fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cce2af24-93da-406b-a072-d634d0a9cc01" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9723de3e-571a-45ab-a22a-399e64ab7fbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RevolvingCreditFacilityAndTermLoanMember_0fb3904c-ba55-414c-9842-92d271487ed0" xlink:href="aort-20220930.xsd#aort_RevolvingCreditFacilityAndTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cce2af24-93da-406b-a072-d634d0a9cc01" xlink:to="loc_aort_RevolvingCreditFacilityAndTermLoanMember_0fb3904c-ba55-414c-9842-92d271487ed0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_452b0a40-83c5-4103-aa14-f9a8d8f963e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_VariableRateAxis_452b0a40-83c5-4103-aa14-f9a8d8f963e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_452b0a40-83c5-4103-aa14-f9a8d8f963e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_452b0a40-83c5-4103-aa14-f9a8d8f963e0" xlink:to="loc_us-gaap_VariableRateDomain_452b0a40-83c5-4103-aa14-f9a8d8f963e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6dad04bc-f25a-4cc3-9973-cd95fabc7559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_452b0a40-83c5-4103-aa14-f9a8d8f963e0" xlink:to="loc_us-gaap_VariableRateDomain_6dad04bc-f25a-4cc3-9973-cd95fabc7559" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_e759e009-c163-4c6b-a28a-436c10ba9139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6dad04bc-f25a-4cc3-9973-cd95fabc7559" xlink:to="loc_us-gaap_BaseRateMember_e759e009-c163-4c6b-a28a-436c10ba9139" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ed1c96c5-37f5-4291-9713-762e996e1272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6dad04bc-f25a-4cc3-9973-cd95fabc7559" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ed1c96c5-37f5-4291-9713-762e996e1272" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_46166542-9470-4064-8f43-ef804990f1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_46166542-9470-4064-8f43-ef804990f1a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_46166542-9470-4064-8f43-ef804990f1a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_46166542-9470-4064-8f43-ef804990f1a4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_46166542-9470-4064-8f43-ef804990f1a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b9dd852c-5720-49a5-84f6-5597efd0d65e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_46166542-9470-4064-8f43-ef804990f1a4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b9dd852c-5720-49a5-84f6-5597efd0d65e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_1d35af14-bb0d-485b-b99c-012831248b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b9dd852c-5720-49a5-84f6-5597efd0d65e" xlink:to="loc_us-gaap_ConvertibleDebtMember_1d35af14-bb0d-485b-b99c-012831248b55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b3816734-5dbc-4459-a64a-7ce40dedac70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_DebtInstrumentAxis_b3816734-5dbc-4459-a64a-7ce40dedac70" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b3816734-5dbc-4459-a64a-7ce40dedac70_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b3816734-5dbc-4459-a64a-7ce40dedac70" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b3816734-5dbc-4459-a64a-7ce40dedac70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d818f169-8974-4f08-803e-ca618aa2ca04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b3816734-5dbc-4459-a64a-7ce40dedac70" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d818f169-8974-4f08-803e-ca618aa2ca04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CreditAgreementMember_cbc625f9-b1bf-484f-8d92-5d0e5528e6a9" xlink:href="aort-20220930.xsd#aort_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d818f169-8974-4f08-803e-ca618aa2ca04" xlink:to="loc_aort_CreditAgreementMember_cbc625f9-b1bf-484f-8d92-5d0e5528e6a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1cc9448b-7f5d-41dd-bb26-646bf72117f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1cc9448b-7f5d-41dd-bb26-646bf72117f4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1cc9448b-7f5d-41dd-bb26-646bf72117f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1cc9448b-7f5d-41dd-bb26-646bf72117f4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1cc9448b-7f5d-41dd-bb26-646bf72117f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_14a82650-ef47-4008-84ea-477491f3b709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1cc9448b-7f5d-41dd-bb26-646bf72117f4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_14a82650-ef47-4008-84ea-477491f3b709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_85a60426-c7f8-4195-af4d-c195a0fb492a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_14a82650-ef47-4008-84ea-477491f3b709" xlink:to="loc_us-gaap_InterestExpenseMember_85a60426-c7f8-4195-af4d-c195a0fb492a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodAxis_baf57b17-9698-4d2d-aaad-f1cd86c9455e" xlink:href="aort-20220930.xsd#aort_DebtPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_aort_DebtPeriodAxis_baf57b17-9698-4d2d-aaad-f1cd86c9455e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodDomain_baf57b17-9698-4d2d-aaad-f1cd86c9455e_default" xlink:href="aort-20220930.xsd#aort_DebtPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_aort_DebtPeriodAxis_baf57b17-9698-4d2d-aaad-f1cd86c9455e" xlink:to="loc_aort_DebtPeriodDomain_baf57b17-9698-4d2d-aaad-f1cd86c9455e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodDomain_d249f14f-65a3-4a29-8fa1-10e213500309" xlink:href="aort-20220930.xsd#aort_DebtPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_aort_DebtPeriodAxis_baf57b17-9698-4d2d-aaad-f1cd86c9455e" xlink:to="loc_aort_DebtPeriodDomain_d249f14f-65a3-4a29-8fa1-10e213500309" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceIMember_bebf7827-207f-410b-839e-cfccc6872f42" xlink:href="aort-20220930.xsd#aort_CircumstanceIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_DebtPeriodDomain_d249f14f-65a3-4a29-8fa1-10e213500309" xlink:to="loc_aort_CircumstanceIMember_bebf7827-207f-410b-839e-cfccc6872f42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceIiMember_356ab154-d785-4a1b-8752-318f589065d9" xlink:href="aort-20220930.xsd#aort_CircumstanceIiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_DebtPeriodDomain_d249f14f-65a3-4a29-8fa1-10e213500309" xlink:to="loc_aort_CircumstanceIiMember_356ab154-d785-4a1b-8752-318f589065d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceAfterJuly52023Member_ab75d77f-df80-438b-bfad-5d0318f6ca5b" xlink:href="aort-20220930.xsd#aort_CircumstanceAfterJuly52023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_DebtPeriodDomain_d249f14f-65a3-4a29-8fa1-10e213500309" xlink:to="loc_aort_CircumstanceAfterJuly52023Member_ab75d77f-df80-438b-bfad-5d0318f6ca5b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" xlink:type="extended" id="i8cd5215dcb9c43deb34e49ade262a524_DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2af52785-b9c1-4a37-a3bc-1e4882a7582e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2af52785-b9c1-4a37-a3bc-1e4882a7582e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_01173f27-fb49-420e-a807-d47fb65ee620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_01173f27-fb49-420e-a807-d47fb65ee620" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c6a03556-d08a-47dd-bbd4-a4df19ddaf00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_LongTermDebt_c6a03556-d08a-47dd-bbd4-a4df19ddaf00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_53b6170b-1ef4-4ab0-ae46-fa9eead25ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_LongTermDebtCurrent_53b6170b-1ef4-4ab0-ae46-fa9eead25ad3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a374049f-e98a-47e5-ac6b-bd9ff2cd7c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a374049f-e98a-47e5-ac6b-bd9ff2cd7c94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bc48b59c-60d8-4eb9-a042-e523120d80b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bc48b59c-60d8-4eb9-a042-e523120d80b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1f5a2ccf-741c-47b0-92e3-b74b216ce336" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_DebtInstrumentTable_1f5a2ccf-741c-47b0-92e3-b74b216ce336" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b1473590-0094-417b-b7a9-8ca9cff5ebbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1f5a2ccf-741c-47b0-92e3-b74b216ce336" xlink:to="loc_us-gaap_CreditFacilityAxis_b1473590-0094-417b-b7a9-8ca9cff5ebbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b1473590-0094-417b-b7a9-8ca9cff5ebbd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b1473590-0094-417b-b7a9-8ca9cff5ebbd" xlink:to="loc_us-gaap_CreditFacilityDomain_b1473590-0094-417b-b7a9-8ca9cff5ebbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2cf5feea-33ce-4603-9444-31dab9415951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b1473590-0094-417b-b7a9-8ca9cff5ebbd" xlink:to="loc_us-gaap_CreditFacilityDomain_2cf5feea-33ce-4603-9444-31dab9415951" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_1c930f07-3ccd-4ade-bc6c-17719bcaa92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2cf5feea-33ce-4603-9444-31dab9415951" xlink:to="loc_us-gaap_LoansPayableMember_1c930f07-3ccd-4ade-bc6c-17719bcaa92e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_95286c2d-1050-415c-b47a-3db339c6868e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2cf5feea-33ce-4603-9444-31dab9415951" xlink:to="loc_us-gaap_ConvertibleDebtMember_95286c2d-1050-415c-b47a-3db339c6868e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7511e4dc-0726-4bba-bc2b-c5adefb4b710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1f5a2ccf-741c-47b0-92e3-b74b216ce336" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7511e4dc-0726-4bba-bc2b-c5adefb4b710" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7511e4dc-0726-4bba-bc2b-c5adefb4b710_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7511e4dc-0726-4bba-bc2b-c5adefb4b710" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7511e4dc-0726-4bba-bc2b-c5adefb4b710_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8616b7f9-119f-42f6-ac05-d1d024bb969b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7511e4dc-0726-4bba-bc2b-c5adefb4b710" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8616b7f9-119f-42f6-ac05-d1d024bb969b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_GovernmentSponsoredDebtKfwLoan1Member_6987a733-a22e-450b-8ac9-7d0a7ea85820" xlink:href="aort-20220930.xsd#aort_GovernmentSponsoredDebtKfwLoan1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8616b7f9-119f-42f6-ac05-d1d024bb969b" xlink:to="loc_aort_GovernmentSponsoredDebtKfwLoan1Member_6987a733-a22e-450b-8ac9-7d0a7ea85820" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_GovernmentSponsoredDebtKfwLoan2Member_d8bc548e-f672-4853-abec-feae4e743ab6" xlink:href="aort-20220930.xsd#aort_GovernmentSponsoredDebtKfwLoan2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8616b7f9-119f-42f6-ac05-d1d024bb969b" xlink:to="loc_aort_GovernmentSponsoredDebtKfwLoan2Member_d8bc548e-f672-4853-abec-feae4e743ab6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#RevenueRecognitionDisaggregationOfRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="extended" id="i10352a991ae24e10a73bc241dd26542d_RevenueRecognitionDisaggregationOfRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8f3cbd27-bbcc-47d7-a17e-e0c3dfdbc5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_144b914d-18ea-48ae-8789-0133f3c30696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8f3cbd27-bbcc-47d7-a17e-e0c3dfdbc5f1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_144b914d-18ea-48ae-8789-0133f3c30696" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_5950b469-5545-45d8-95c6-ac11c01acadd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8f3cbd27-bbcc-47d7-a17e-e0c3dfdbc5f1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_5950b469-5545-45d8-95c6-ac11c01acadd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_808a19b6-f4e9-4a7d-93e7-2daadac34a78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5950b469-5545-45d8-95c6-ac11c01acadd" xlink:to="loc_srt_ProductOrServiceAxis_808a19b6-f4e9-4a7d-93e7-2daadac34a78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_808a19b6-f4e9-4a7d-93e7-2daadac34a78_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_808a19b6-f4e9-4a7d-93e7-2daadac34a78" xlink:to="loc_srt_ProductsAndServicesDomain_808a19b6-f4e9-4a7d-93e7-2daadac34a78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ec371dd1-95ac-4a9b-beb8-8194063e782c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_808a19b6-f4e9-4a7d-93e7-2daadac34a78" xlink:to="loc_srt_ProductsAndServicesDomain_ec371dd1-95ac-4a9b-beb8-8194063e782c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DomesticHospitalsMember_fa2d9b3e-f6c5-4c02-88c6-b5baa6f9c9b3" xlink:href="aort-20220930.xsd#aort_DomesticHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ec371dd1-95ac-4a9b-beb8-8194063e782c" xlink:to="loc_aort_DomesticHospitalsMember_fa2d9b3e-f6c5-4c02-88c6-b5baa6f9c9b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_InternationalHospitalsMember_d3753259-6522-498b-8834-fc08b429c396" xlink:href="aort-20220930.xsd#aort_InternationalHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ec371dd1-95ac-4a9b-beb8-8194063e782c" xlink:to="loc_aort_InternationalHospitalsMember_d3753259-6522-498b-8834-fc08b429c396" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_InternationalDistributorMember_93be0529-716b-42ba-b80b-ed663da5a4a0" xlink:href="aort-20220930.xsd#aort_InternationalDistributorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ec371dd1-95ac-4a9b-beb8-8194063e782c" xlink:to="loc_aort_InternationalDistributorMember_93be0529-716b-42ba-b80b-ed663da5a4a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CardiogenesisMember_288dd76b-a615-44d4-8aab-d3133a8e8815" xlink:href="aort-20220930.xsd#aort_CardiogenesisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ec371dd1-95ac-4a9b-beb8-8194063e782c" xlink:to="loc_aort_CardiogenesisMember_288dd76b-a615-44d4-8aab-d3133a8e8815" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationNarrativeDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#StockCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/StockCompensationNarrativeDetails" xlink:type="extended" id="ic5e7ac71a43045298cb115450ac964ea_StockCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c300df51-84c8-4028-9bc4-a8cfbae28482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c300df51-84c8-4028-9bc4-a8cfbae28482" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_219abef9-c30b-41b2-88cf-c6589e1660f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_219abef9-c30b-41b2-88cf-c6589e1660f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_f03d4bc1-3735-4aa2-93ac-b96f04576701" xlink:href="aort-20220930.xsd#aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_f03d4bc1-3735-4aa2-93ac-b96f04576701" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d1916d73-50ed-4c93-8c69-bee038794081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d1916d73-50ed-4c93-8c69-bee038794081" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4e5fb2a5-076b-418d-9757-e25ccd918415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4e5fb2a5-076b-418d-9757-e25ccd918415" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_32da6a45-cafc-4c3d-a339-8ae29821caf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_32da6a45-cafc-4c3d-a339-8ae29821caf0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c88753-9deb-46e8-a510-c39b58a9f9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c88753-9deb-46e8-a510-c39b58a9f9b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_c4699ec4-49d5-4d61-9b11-3345a2dd5ea0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c88753-9deb-46e8-a510-c39b58a9f9b2" xlink:to="loc_srt_TitleOfIndividualAxis_c4699ec4-49d5-4d61-9b11-3345a2dd5ea0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c4699ec4-49d5-4d61-9b11-3345a2dd5ea0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_c4699ec4-49d5-4d61-9b11-3345a2dd5ea0" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c4699ec4-49d5-4d61-9b11-3345a2dd5ea0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_654c09b6-41c2-4554-9a02-75069abac4d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_c4699ec4-49d5-4d61-9b11-3345a2dd5ea0" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_654c09b6-41c2-4554-9a02-75069abac4d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember_d2eb9bf9-c16c-4af8-a215-028befe1c03c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_654c09b6-41c2-4554-9a02-75069abac4d7" xlink:to="loc_srt_OfficerMember_d2eb9bf9-c16c-4af8-a215-028befe1c03c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_251ac5f3-970e-4c04-820f-7fab64db60c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c88753-9deb-46e8-a510-c39b58a9f9b2" xlink:to="loc_us-gaap_AwardTypeAxis_251ac5f3-970e-4c04-820f-7fab64db60c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_251ac5f3-970e-4c04-820f-7fab64db60c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_251ac5f3-970e-4c04-820f-7fab64db60c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_251ac5f3-970e-4c04-820f-7fab64db60c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_345d6960-f469-41da-90fc-eb371bc94b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_251ac5f3-970e-4c04-820f-7fab64db60c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_345d6960-f469-41da-90fc-eb371bc94b2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_0934277b-1161-4009-bbe9-845605e66c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_345d6960-f469-41da-90fc-eb371bc94b2c" xlink:to="loc_us-gaap_EmployeeStockMember_0934277b-1161-4009-bbe9-845605e66c2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember_16d9f2c0-80d5-4b9c-a8bc-3109ae18c974" xlink:href="aort-20220930.xsd#aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_345d6960-f469-41da-90fc-eb371bc94b2c" xlink:to="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember_16d9f2c0-80d5-4b9c-a8bc-3109ae18c974" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails" xlink:type="extended" id="i81e3b4e89b334a58ba39ebc47b38eb6c_StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a369c28a-7cb1-4df5-bb3c-2361c8f90d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2f83b5be-1fda-407e-b524-55dbafe10f94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a369c28a-7cb1-4df5-bb3c-2361c8f90d8b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2f83b5be-1fda-407e-b524-55dbafe10f94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8dd239b5-938b-4d28-b332-f9f62658c010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a369c28a-7cb1-4df5-bb3c-2361c8f90d8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8dd239b5-938b-4d28-b332-f9f62658c010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_27cf3b8a-1f1d-497d-82cd-ca54d9154f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a369c28a-7cb1-4df5-bb3c-2361c8f90d8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_27cf3b8a-1f1d-497d-82cd-ca54d9154f51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc70f02e-9716-4744-92e9-32716cfb3a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a369c28a-7cb1-4df5-bb3c-2361c8f90d8b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc70f02e-9716-4744-92e9-32716cfb3a85" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a2855e25-7cd5-4a2b-b277-5f4f13e5e4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc70f02e-9716-4744-92e9-32716cfb3a85" xlink:to="loc_us-gaap_AwardTypeAxis_a2855e25-7cd5-4a2b-b277-5f4f13e5e4c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2855e25-7cd5-4a2b-b277-5f4f13e5e4c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a2855e25-7cd5-4a2b-b277-5f4f13e5e4c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2855e25-7cd5-4a2b-b277-5f4f13e5e4c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719dfd06-350e-4779-84ab-7b892d942493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a2855e25-7cd5-4a2b-b277-5f4f13e5e4c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719dfd06-350e-4779-84ab-7b892d942493" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d9ee4460-3c37-40fd-b94c-908b9d75a0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719dfd06-350e-4779-84ab-7b892d942493" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d9ee4460-3c37-40fd-b94c-908b9d75a0f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_2671cf44-fa9b-42fd-ab91-9896477c0483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719dfd06-350e-4779-84ab-7b892d942493" xlink:to="loc_us-gaap_EmployeeStockMember_2671cf44-fa9b-42fd-ab91-9896477c0483" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#StockCompensationSummaryOfTotalStockCompensationExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails" xlink:type="extended" id="i1d450531b9c24fcf98a4ae2562259b57_StockCompensationSummaryOfTotalStockCompensationExpensesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfa3501e-26be-4b8e-bd35-c37bd02ad9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1b24b58c-737e-4c31-b74b-9a2980169354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfa3501e-26be-4b8e-bd35-c37bd02ad9d8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1b24b58c-737e-4c31-b74b-9a2980169354" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18f83137-8a31-4285-a7f6-8ca7486f1fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfa3501e-26be-4b8e-bd35-c37bd02ad9d8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18f83137-8a31-4285-a7f6-8ca7486f1fd5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6e65e3fe-8968-4d83-80a8-8ea6f59b3e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18f83137-8a31-4285-a7f6-8ca7486f1fd5" xlink:to="loc_us-gaap_AwardTypeAxis_6e65e3fe-8968-4d83-80a8-8ea6f59b3e21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e65e3fe-8968-4d83-80a8-8ea6f59b3e21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6e65e3fe-8968-4d83-80a8-8ea6f59b3e21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e65e3fe-8968-4d83-80a8-8ea6f59b3e21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a702867-0a2a-40b4-b80c-b05278575c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6e65e3fe-8968-4d83-80a8-8ea6f59b3e21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a702867-0a2a-40b4-b80c-b05278575c0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_c51be5dd-d1be-41e0-848f-4a2c4d3e8293" xlink:href="aort-20220930.xsd#aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a702867-0a2a-40b4-b80c-b05278575c0e" xlink:to="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_c51be5dd-d1be-41e0-848f-4a2c4d3e8293" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_474c9921-c756-4177-bcfc-9d7081e483f6" xlink:href="aort-20220930.xsd#aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a702867-0a2a-40b4-b80c-b05278575c0e" xlink:to="loc_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_474c9921-c756-4177-bcfc-9d7081e483f6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails" xlink:type="extended" id="if25a5bea6e2b4491a17ba260a5b00368_LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_afbc39e7-e2ee-4993-aafa-4c64036d5295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_afbc39e7-e2ee-4993-aafa-4c64036d5295" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8b888d3f-062c-4d01-b585-176366aef7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:to="loc_us-gaap_NetIncomeLoss_8b888d3f-062c-4d01-b585-176366aef7af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_4449d833-a96c-49f6-8894-e18a21a5c716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_4449d833-a96c-49f6-8894-e18a21a5c716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a52efb1f-4a00-4f90-b3c1-a9b421817cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a52efb1f-4a00-4f90-b3c1-a9b421817cb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_82b9db25-9e59-4f77-8f35-2d6d119c210f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_82b9db25-9e59-4f77-8f35-2d6d119c210f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b77c5fc7-57c1-4fdf-8964-74abb7662852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:to="loc_us-gaap_EarningsPerShareBasic_b77c5fc7-57c1-4fdf-8964-74abb7662852" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_afbc39e7-e2ee-4993-aafa-4c64036d5295" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e424cf9a-4ffc-46bf-a433-fd9c88794b96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_3a3c46d8-f17f-4277-8527-e6048a242b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_3a3c46d8-f17f-4277-8527-e6048a242b3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_4966ef56-6ec0-4202-bcd2-562dddf2548a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_4966ef56-6ec0-4202-bcd2-562dddf2548a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_f84c55e6-ec9e-461a-8f83-12537cf9ade9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_f84c55e6-ec9e-461a-8f83-12537cf9ade9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6a731e7c-41b1-4690-9c62-7c775fb91c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6a731e7c-41b1-4690-9c62-7c775fb91c86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_a65917fe-bf34-4ca6-8d65-f090ef926b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_a65917fe-bf34-4ca6-8d65-f090ef926b1f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f19ade02-2ac6-43e2-8220-78022b007459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f19ade02-2ac6-43e2-8220-78022b007459" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a4af06d0-b1ed-4c16-afc2-870a1b899890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a4af06d0-b1ed-4c16-afc2-870a1b899890" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c5744013-c51a-41e1-a5a1-122fa0c85273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_afbc39e7-e2ee-4993-aafa-4c64036d5295" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c5744013-c51a-41e1-a5a1-122fa0c85273" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_38588a7f-6399-4147-a59e-f2f1aacec128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_afbc39e7-e2ee-4993-aafa-4c64036d5295" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_38588a7f-6399-4147-a59e-f2f1aacec128" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_252cca1e-d454-4915-9ef4-cc91534335a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_38588a7f-6399-4147-a59e-f2f1aacec128" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_252cca1e-d454-4915-9ef4-cc91534335a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_252cca1e-d454-4915-9ef4-cc91534335a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_252cca1e-d454-4915-9ef4-cc91534335a6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_252cca1e-d454-4915-9ef4-cc91534335a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1e5d66aa-8932-48b8-a480-37619a60f963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_252cca1e-d454-4915-9ef4-cc91534335a6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1e5d66aa-8932-48b8-a480-37619a60f963" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d74c39bd-c740-4f65-858d-1a70a05f8703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1e5d66aa-8932-48b8-a480-37619a60f963" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d74c39bd-c740-4f65-858d-1a70a05f8703" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_68f6487a-66c4-445d-b09d-12f9d21e505c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1e5d66aa-8932-48b8-a480-37619a60f963" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_68f6487a-66c4-445d-b09d-12f9d21e505c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#SegmentInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" id="i3bc49583438f4a519fa96a2db904d3f6_SegmentInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d85c57d0-a2f1-430f-9496-e6452a988ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_07f684b2-8a5e-46a5-9631-9d2df06cffac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d85c57d0-a2f1-430f-9496-e6452a988ae2" xlink:to="loc_us-gaap_NumberOfReportableSegments_07f684b2-8a5e-46a5-9631-9d2df06cffac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_de7b3820-e67a-4c18-9f10-f7a573c90bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d85c57d0-a2f1-430f-9496-e6452a988ae2" xlink:to="loc_us-gaap_Revenues_de7b3820-e67a-4c18-9f10-f7a573c90bfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0d6df301-0e17-4ace-b28d-b0a988a5f1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d85c57d0-a2f1-430f-9496-e6452a988ae2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0d6df301-0e17-4ace-b28d-b0a988a5f1a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5dbd5251-5557-4d21-9449-07183ad507b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0d6df301-0e17-4ace-b28d-b0a988a5f1a3" xlink:to="loc_srt_ConsolidationItemsAxis_5dbd5251-5557-4d21-9449-07183ad507b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5dbd5251-5557-4d21-9449-07183ad507b2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5dbd5251-5557-4d21-9449-07183ad507b2" xlink:to="loc_srt_ConsolidationItemsDomain_5dbd5251-5557-4d21-9449-07183ad507b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b0309ced-ec6b-41d7-809f-c8cda83468a6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5dbd5251-5557-4d21-9449-07183ad507b2" xlink:to="loc_srt_ConsolidationItemsDomain_b0309ced-ec6b-41d7-809f-c8cda83468a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_b48afe23-a0a7-402b-a1ca-4a5513b30dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b0309ced-ec6b-41d7-809f-c8cda83468a6" xlink:to="loc_us-gaap_IntersegmentEliminationMember_b48afe23-a0a7-402b-a1ca-4a5513b30dea" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails" xlink:type="extended" id="id05fb24ec92842fdbb9698fa0b5abadd_SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e06ef104-0e10-4ccd-b57e-920809e289a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ee04c7b3-f511-4ac3-8b29-1b558706cd91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e06ef104-0e10-4ccd-b57e-920809e289a2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ee04c7b3-f511-4ac3-8b29-1b558706cd91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3568bc2d-aa8e-41c5-a89e-0ad17d97bc15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e06ef104-0e10-4ccd-b57e-920809e289a2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3568bc2d-aa8e-41c5-a89e-0ad17d97bc15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_46ba0efa-3918-46d8-a2b1-fa0c43bfd3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e06ef104-0e10-4ccd-b57e-920809e289a2" xlink:to="loc_us-gaap_GrossProfit_46ba0efa-3918-46d8-a2b1-fa0c43bfd3ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6cb28012-3451-442a-b82d-48cc18dec2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e06ef104-0e10-4ccd-b57e-920809e289a2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6cb28012-3451-442a-b82d-48cc18dec2bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_86eaaaa3-6dba-478b-9881-6d6a58c450de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6cb28012-3451-442a-b82d-48cc18dec2bb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_86eaaaa3-6dba-478b-9881-6d6a58c450de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_86eaaaa3-6dba-478b-9881-6d6a58c450de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_86eaaaa3-6dba-478b-9881-6d6a58c450de" xlink:to="loc_us-gaap_SegmentDomain_86eaaaa3-6dba-478b-9881-6d6a58c450de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2bd527f7-86fe-404b-ab35-8ceb7c76a0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_86eaaaa3-6dba-478b-9881-6d6a58c450de" xlink:to="loc_us-gaap_SegmentDomain_2bd527f7-86fe-404b-ab35-8ceb7c76a0ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_MedicalDevicesMember_f4d8e342-bbaa-4c98-a009-6b672f282901" xlink:href="aort-20220930.xsd#aort_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2bd527f7-86fe-404b-ab35-8ceb7c76a0ea" xlink:to="loc_aort_MedicalDevicesMember_f4d8e342-bbaa-4c98-a009-6b672f282901" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember_bbcfc11a-efb6-444f-a0e4-619af6e7d84e" xlink:href="aort-20220930.xsd#aort_PreservationServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2bd527f7-86fe-404b-ab35-8ceb7c76a0ea" xlink:to="loc_aort_PreservationServicesMember_bbcfc11a-efb6-444f-a0e4-619af6e7d84e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails" xlink:type="extended" id="if38666e5f7e4432c96afc6ba01dacd02_SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_f85672fe-f9e0-423c-9690-c20949a9b424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fbc9779c-7e60-4ea2-9272-49d35b736379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_f85672fe-f9e0-423c-9690-c20949a9b424" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fbc9779c-7e60-4ea2-9272-49d35b736379" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_65c15db4-9caa-4699-9334-cf443deba9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_f85672fe-f9e0-423c-9690-c20949a9b424" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_65c15db4-9caa-4699-9334-cf443deba9ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b018a4fe-e1d9-44cb-a9db-22091f88745d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_65c15db4-9caa-4699-9334-cf443deba9ba" xlink:to="loc_srt_ProductOrServiceAxis_b018a4fe-e1d9-44cb-a9db-22091f88745d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b018a4fe-e1d9-44cb-a9db-22091f88745d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b018a4fe-e1d9-44cb-a9db-22091f88745d" xlink:to="loc_srt_ProductsAndServicesDomain_b018a4fe-e1d9-44cb-a9db-22091f88745d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_204947ab-9a73-4c5c-98b0-984b84e4303b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b018a4fe-e1d9-44cb-a9db-22091f88745d" xlink:to="loc_srt_ProductsAndServicesDomain_204947ab-9a73-4c5c-98b0-984b84e4303b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ProductsMember_7e5ec14b-3268-41e6-b1be-478d3f8c5fd6" xlink:href="aort-20220930.xsd#aort_ProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_204947ab-9a73-4c5c-98b0-984b84e4303b" xlink:to="loc_aort_ProductsMember_7e5ec14b-3268-41e6-b1be-478d3f8c5fd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AorticStentGraftsMember_100e2888-521d-4b98-9630-29d24b52c2c0" xlink:href="aort-20220930.xsd#aort_AorticStentGraftsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_ProductsMember_7e5ec14b-3268-41e6-b1be-478d3f8c5fd6" xlink:to="loc_aort_AorticStentGraftsMember_100e2888-521d-4b98-9630-29d24b52c2c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_SurgicalSealantsMember_cdbe1031-e62a-4794-8b44-48d84a64adf5" xlink:href="aort-20220930.xsd#aort_SurgicalSealantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_ProductsMember_7e5ec14b-3268-41e6-b1be-478d3f8c5fd6" xlink:to="loc_aort_SurgicalSealantsMember_cdbe1031-e62a-4794-8b44-48d84a64adf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OnXMember_ee4297ef-bf95-4bef-8294-2433d548d957" xlink:href="aort-20220930.xsd#aort_OnXMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_ProductsMember_7e5ec14b-3268-41e6-b1be-478d3f8c5fd6" xlink:to="loc_aort_OnXMember_ee4297ef-bf95-4bef-8294-2433d548d957" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OtherProductsMember_0b8ed095-33fe-47a9-947a-75f9af390d46" xlink:href="aort-20220930.xsd#aort_OtherProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_ProductsMember_7e5ec14b-3268-41e6-b1be-478d3f8c5fd6" xlink:to="loc_aort_OtherProductsMember_0b8ed095-33fe-47a9-947a-75f9af390d46" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember_cdf17b83-436d-4c5b-bc19-2ae486d33291" xlink:href="aort-20220930.xsd#aort_PreservationServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_204947ab-9a73-4c5c-98b0-984b84e4303b" xlink:to="loc_aort_PreservationServicesMember_cdf17b83-436d-4c5b-bc19-2ae486d33291" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>aort-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e6891988-c797-4972-93bc-9ac5fa18c933,g:19ec5362-98a4-465a-8335-497bfcde1bb2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_aort_ContingentConsiderationNoncurrentFairValue_3c1164d4-1bc5-4e3c-b770-312aad36a8cc_negatedLabel_en-US" xlink:label="lab_aort_ContingentConsiderationNoncurrentFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_aort_ContingentConsiderationNoncurrentFairValue_label_en-US" xlink:label="lab_aort_ContingentConsiderationNoncurrentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Noncurrent, Fair Value</link:label>
    <link:label id="lab_aort_ContingentConsiderationNoncurrentFairValue_documentation_en-US" xlink:label="lab_aort_ContingentConsiderationNoncurrentFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Noncurrent, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ContingentConsiderationNoncurrentFairValue" xlink:href="aort-20220930.xsd#aort_ContingentConsiderationNoncurrentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ContingentConsiderationNoncurrentFairValue" xlink:to="lab_aort_ContingentConsiderationNoncurrentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_c83f0c3d-bfba-4655-9edb-be04023b05bd_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_OnXMember_4938040d-63b4-4949-9e05-11f6558cb699_terseLabel_en-US" xlink:label="lab_aort_OnXMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">On-X</link:label>
    <link:label id="lab_aort_OnXMember_label_en-US" xlink:label="lab_aort_OnXMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">On X [Member]</link:label>
    <link:label id="lab_aort_OnXMember_documentation_en-US" xlink:label="lab_aort_OnXMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">On-X [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OnXMember" xlink:href="aort-20220930.xsd#aort_OnXMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_OnXMember" xlink:to="lab_aort_OnXMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cd4b2305-c6ac-48dc-bf5c-50abefa73dc9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_73a4c3a3-9e11-4868-bb22-10bf1d2ac141_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3f2c98c6-a2d1-4d24-bbdf-0b1b3d415fff_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_44738c9c-8f34-4d70-a6e2-058baa135a29_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_210d7180-f563-42e7-adfe-0ab5cc4d3d97_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b23e67a2-a73d-44c2-b42b-3908f2a4a9d3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in the present value of future lease obligations and corresponding right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_8238d3c1-6ed5-4a15-9d41-2f3b624cf13c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_fc3f46a0-c334-492d-baba-ed4b3b8fe220_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_386ece58-12da-40c7-9d6c-79ec20fc3d39_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bec077b0-045d-4ea3-b159-5711cdfceaca_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_0a96bfa7-30e6-49b2-b8b2-31a51fd35df4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DebtPeriodDomain_34fca965-7246-42f0-9840-5f0a8d35c4bc_terseLabel_en-US" xlink:label="lab_aort_DebtPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Period [Domain]</link:label>
    <link:label id="lab_aort_DebtPeriodDomain_label_en-US" xlink:label="lab_aort_DebtPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Period [Domain]</link:label>
    <link:label id="lab_aort_DebtPeriodDomain_documentation_en-US" xlink:label="lab_aort_DebtPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodDomain" xlink:href="aort-20220930.xsd#aort_DebtPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DebtPeriodDomain" xlink:to="lab_aort_DebtPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_PerClotMember_507d105b-5d3c-4bc7-b34b-bd19d4cd4152_terseLabel_en-US" xlink:label="lab_aort_PerClotMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per Clot</link:label>
    <link:label id="lab_aort_PerClotMember_label_en-US" xlink:label="lab_aort_PerClotMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per Clot [Member]</link:label>
    <link:label id="lab_aort_PerClotMember_documentation_en-US" xlink:label="lab_aort_PerClotMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PerClot [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PerClotMember" xlink:href="aort-20220930.xsd#aort_PerClotMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_PerClotMember" xlink:to="lab_aort_PerClotMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_5be7d95b-518c-40f4-9296-c9cfb782e420_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9f1fa8b1-8627-4d04-a1b0-a8a8f57807fa_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration for sale of assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_00aa6e81-ace7-4e0f-9d93-2bd348374da8_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_991b809b-433c-4155-a0a1-2bc7b5557d7a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_0f7ca3e5-eb2d-4446-96ca-704c827a7650_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_3addd654-b7e8-4b8c-acf8-d94dc06c46a4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0ae9db5c-fdc5-4ca9-a54f-5615fc2828fd_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years): Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_MedicalDevicesMember_17efe25f-0191-4275-9859-2adaf4b9ba17_terseLabel_en-US" xlink:label="lab_aort_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical devices</link:label>
    <link:label id="lab_aort_MedicalDevicesMember_label_en-US" xlink:label="lab_aort_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Devices [Member]</link:label>
    <link:label id="lab_aort_MedicalDevicesMember_documentation_en-US" xlink:label="lab_aort_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Devices [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_MedicalDevicesMember" xlink:href="aort-20220930.xsd#aort_MedicalDevicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_MedicalDevicesMember" xlink:to="lab_aort_MedicalDevicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9636b762-98c3-46f1-a9b8-a437050e07b7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2975f51-12d8-4df0-9a5c-e50d2a22f2a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_b0773933-9c48-4e04-a888-7f177e628cad_totalLabel_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:label id="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_label_en-US" xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment, Lessor Asset under Operating Lease, after Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:to="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_d69db8a5-99d3-4d5d-877f-35281d09082e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_c8f9cec8-1a8d-4254-90f4-14c5805e9f94_terseLabel_en-US" xlink:label="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangibles:</link:label>
    <link:label id="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_label_en-US" xlink:label="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Other Than Acquired Technology [Member]</link:label>
    <link:label id="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_documentation_en-US" xlink:label="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Other Than Acquired Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" xlink:href="aort-20220930.xsd#aort_IntangibleAssetsOtherThanAcquiredTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" xlink:to="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_9a84e03a-a5ee-47b3-8cc0-d46856ee3f84_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process R&amp;D</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8a4ec6c6-d4b0-4240-80fb-54ad00553e1e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_18e2acf2-f29b-4ff0-ad03-2ee4c5488014_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials and supplies</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c68d9f2b-9026-40f8-bf41-aea958048119_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_de9e1e8b-ee42-4aec-8802-4650c7258d96_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected stock price volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_ConsignmentInventoryPercentage_f389083d-26ed-4692-b518-085f2c6b9757_terseLabel_en-US" xlink:label="lab_aort_ConsignmentInventoryPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consignment inventory percentage</link:label>
    <link:label id="lab_aort_ConsignmentInventoryPercentage_label_en-US" xlink:label="lab_aort_ConsignmentInventoryPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consignment Inventory Percentage</link:label>
    <link:label id="lab_aort_ConsignmentInventoryPercentage_documentation_en-US" xlink:label="lab_aort_ConsignmentInventoryPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consignment inventory percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ConsignmentInventoryPercentage" xlink:href="aort-20220930.xsd#aort_ConsignmentInventoryPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ConsignmentInventoryPercentage" xlink:to="lab_aort_ConsignmentInventoryPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_9761eac6-77c9-43ee-a43e-370a69d05cb5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of PerClot</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DebtInstrumentExtensionCircumstancePeriod_d341782c-a8ae-4740-82e0-3ff86fb6f6e1_terseLabel_en-US" xlink:label="lab_aort_DebtInstrumentExtensionCircumstancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension circumstance period</link:label>
    <link:label id="lab_aort_DebtInstrumentExtensionCircumstancePeriod_label_en-US" xlink:label="lab_aort_DebtInstrumentExtensionCircumstancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension circumstance period</link:label>
    <link:label id="lab_aort_DebtInstrumentExtensionCircumstancePeriod_documentation_en-US" xlink:label="lab_aort_DebtInstrumentExtensionCircumstancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension circumstance period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentExtensionCircumstancePeriod" xlink:href="aort-20220930.xsd#aort_DebtInstrumentExtensionCircumstancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DebtInstrumentExtensionCircumstancePeriod" xlink:to="lab_aort_DebtInstrumentExtensionCircumstancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_b60417b1-2b7e-41b4-960d-98e9abd64b8f_negatedLabel_en-US" xlink:label="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:label id="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_documentation_en-US" xlink:label="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from operating lease.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="aort-20220930.xsd#aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0d3e8f69-1165-4f3d-bde0-3c308603f33f_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_a27ebc92-5cf4-49d4-be8f-4a8898b3cf97_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_b7940053-8e8f-4a46-af94-186368018b86_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of convertible senior notes (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b656600d-4987-4cc5-bfcb-7be2ffc0c895_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e252df31-9fb3-4464-bf77-7d129cf95c61_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate: Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c6a5d916-742b-44b8-b98c-1e0786dbabc9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_a39240bf-ad63-4085-b7c4-f2831c6caefb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories_7e059f02-f2a0-4259-b03c-043e986f8271_terseLabel_en-US" xlink:label="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-down of inventories and deferred preservation costs</link:label>
    <link:label id="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories_label_en-US" xlink:label="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-Down of Deferred Preservation Costs and Inventories</link:label>
    <link:label id="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories_documentation_en-US" xlink:label="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts of the current period expense charged to cost of products and preservation services for the purpose of reducing deferred preservation costs and inventory, respectively, to amounts that approximate their net realizable value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_WriteDownOfDeferredPreservationCostsAndInventories" xlink:href="aort-20220930.xsd#aort_WriteDownOfDeferredPreservationCostsAndInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_WriteDownOfDeferredPreservationCostsAndInventories" xlink:to="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_8070de9b-529a-433b-9690-39c9b29053b5_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_cedd902d-f684-4eaa-9b5c-0c13187b1ebf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, Property and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_3f70b1e7-59c0-4d39-86f2-32e3d4e0a72d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DebtPeriodAxis_bc11b990-9aac-493c-adfd-01d66b6c0c14_terseLabel_en-US" xlink:label="lab_aort_DebtPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Period [Axis]</link:label>
    <link:label id="lab_aort_DebtPeriodAxis_label_en-US" xlink:label="lab_aort_DebtPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Period [Axis]</link:label>
    <link:label id="lab_aort_DebtPeriodAxis_documentation_en-US" xlink:label="lab_aort_DebtPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodAxis" xlink:href="aort-20220930.xsd#aort_DebtPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DebtPeriodAxis" xlink:to="lab_aort_DebtPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8591563-6c65-4e78-a839-aa7d869bf6fe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d9bc5042-5476-4aee-9a8f-7c05f15f1df9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_e1980933-7cc7-4616-91e7-81d3adda3213_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_9e453c21-59ac-426d-b835-e765ee2149c6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e78f1627-c3be-4faf-9ea3-d472a9c26898_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized awards from approved stock incentive plans (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dd63eb3e-29a6-4c78-914c-30b21846ab9d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_5fef590a-31fe-4c82-a718-cee7d87041a1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_39953b32-9ccb-445d-929e-b09b26deef40_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion consecutive trading day threshold</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_eb61cc1e-07df-4f58-8ac3-e3bf3cf2e21a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_c5895baa-fa22-476d-a735-3209d3346b0b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_077df9bf-3f51-4c5c-a2ae-8cd20decfcb0_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember_50dd5564-78fd-4fee-b5bc-6ef1171a2f62_terseLabel_en-US" xlink:label="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSAs, RSUs, And PSUs</link:label>
    <link:label id="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember_label_en-US" xlink:label="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards Restricted Stock Units Preferred Stock Units [Member]</link:label>
    <link:label id="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember_documentation_en-US" xlink:label="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards, Restricted Stock Units, Preferred Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember" xlink:href="aort-20220930.xsd#aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember" xlink:to="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_afc60a53-85a4-4b83-b1f8-d900023ecfcf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e2cdf27c-752e-41d6-be6b-b61928524912_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_794ec2c5-e92d-4f31-b0a1-374bdbcbe799_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_cebeb052-819f-4190-bde2-aba0ff43a001_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases:</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_fd249635-84e8-49be-bc38-1b0305c57165_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_bdd5e051-d5a5-488f-adbd-8176b65d8ae2_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_c8c44eb8-389f-4540-9a2d-941c5b478bb8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_2da5be12-2a6c-4630-8dfb-b1512a215a91_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized stock compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3d900910-4ebe-48bd-bbda-11e130d66af8_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3db580c6-fd70-42a0-89e4-3fb4b96f623c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_ArtivionInc.AndStarchMedicalInc.Member_8b30888a-a4ab-4e08-9ed5-860d18f6e203_terseLabel_en-US" xlink:label="lab_aort_ArtivionInc.AndStarchMedicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Artivion Inc. And Starch Medical Inc.</link:label>
    <link:label id="lab_aort_ArtivionInc.AndStarchMedicalInc.Member_label_en-US" xlink:label="lab_aort_ArtivionInc.AndStarchMedicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Artivion Inc. And Starch Medical Inc. [Member]</link:label>
    <link:label id="lab_aort_ArtivionInc.AndStarchMedicalInc.Member_documentation_en-US" xlink:label="lab_aort_ArtivionInc.AndStarchMedicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Artivion, Inc. And Starch Medical, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ArtivionInc.AndStarchMedicalInc.Member" xlink:href="aort-20220930.xsd#aort_ArtivionInc.AndStarchMedicalInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ArtivionInc.AndStarchMedicalInc.Member" xlink:to="lab_aort_ArtivionInc.AndStarchMedicalInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_e5949cf2-e363-4dc2-9a17-217aa4f99333_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_40c58a11-999b-4250-b7bc-6f9c388eea19_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income per share, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d5d46e35-f480-4195-92f6-b1fbb9222c51_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (loss) income per common share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_42c5a550-20fb-462b-8632-e3d18146f49c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of non-financial assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_be410a15-f435-49d6-a704-00d8b211b11c_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of non-financial assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_16d70fea-10e3-4248-a129-812da96abf14_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a90da924-4732-4b38-8807-32cc8c2f075a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_b015e916-ee0e-4889-a0c7-684e84470d1c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_9e3df0c3-c8a8-45db-a6da-d80453da834f_negatedLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_38143e9b-19df-4b5a-8ba4-8ec81137e6ee_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_afe660f3-b5c4-42b1-9210-1947136736b0_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_20541657-6bb8-4703-9944-29a50775cac6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_b2368c9a-74a5-4da8-b8f4-c809b4422993_terseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_524650b8-4c26-4dfd-a796-353a064055bb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_252eb85b-be9b-476a-9864-ad8f3a3735aa_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_2ce47596-c8dd-481f-9b1e-2ec1507e0c6b_terseLabel_en-US" xlink:label="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion percentage of principal amount</link:label>
    <link:label id="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_label_en-US" xlink:label="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Redemption Percentage Of Principal Amount</link:label>
    <link:label id="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_documentation_en-US" xlink:label="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Redemption Percentage Of Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" xlink:href="aort-20220930.xsd#aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" xlink:to="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a75392f8-9f59-4772-9367-19bc96041aa3_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_87a6f00f-c453-4b10-a028-ba5b58ec0665_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_7d6b1442-f6bf-412d-b0ea-80238a7f51b7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_PmaApprovalMember_32b95d8b-ed28-4844-b397-05cc57382dd8_terseLabel_en-US" xlink:label="lab_aort_PmaApprovalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pma Approval</link:label>
    <link:label id="lab_aort_PmaApprovalMember_label_en-US" xlink:label="lab_aort_PmaApprovalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pma Approval [Member]</link:label>
    <link:label id="lab_aort_PmaApprovalMember_documentation_en-US" xlink:label="lab_aort_PmaApprovalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PMA Approval [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PmaApprovalMember" xlink:href="aort-20220930.xsd#aort_PmaApprovalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_PmaApprovalMember" xlink:to="lab_aort_PmaApprovalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_8cd152c7-2f5e-4cc9-ac8b-b543429f71f0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_88a18a2e-7da9-41b8-86d0-37d5683bf32f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_99ca7ade-08de-44a4-ac31-c55a987ef12f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured term loan facility</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_5095d064-cefc-4f58-8077-02562d16723f_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total loan balance</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_5e05cf01-9091-4c4e-a9b2-2351d3a97501_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_81d40f25-23f7-4de9-8e27-42b1e000beef_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_ea8fa19d-ae69-407c-bff3-29bf02a71ba3_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_eba6699d-d466-43f7-a06f-bbf798b1f9ef_terseLabel_en-US" xlink:label="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:href="aort-20220930.xsd#aort_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_f631a01a-17b1-41b5-aa40-509b8c05dd01_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_90766d4f-c6ac-4347-965b-850679a206fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_035a756b-09b6-4dbd-b38a-8847c7dca042_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d39c5bff-6765-48cc-b155-e7e7486d7bdf_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_54b7a366-791a-4fb4-90fa-1bc25b071115_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_c29c153c-9913-4329-a7ca-e7cae0eb4909_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_8e33cde0-7df5-444b-a08f-622da619dca7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_b961d5c0-cdd6-4bdc-940d-2bd45b5c1383_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_46c75805-a944-4e14-a514-c361eb9b2bd7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_fb015a15-395e-4dce-aa33-e0c9a51c9935_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_NoncashLeaseExpense_ecd86f9b-5926-465c-82d9-93cd479cd5dd_terseLabel_en-US" xlink:label="lab_aort_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_aort_NoncashLeaseExpense_label_en-US" xlink:label="lab_aort_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:label id="lab_aort_NoncashLeaseExpense_documentation_en-US" xlink:label="lab_aort_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_NoncashLeaseExpense" xlink:href="aort-20220930.xsd#aort_NoncashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_NoncashLeaseExpense" xlink:to="lab_aort_NoncashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_5feb1256-6929-4dd5-9011-2b4086025340_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Basis</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbc61321-6ae3-4196-8e0f-d68b542d7926_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_8b90bdc0-944e-4a36-b3a5-069daf629e0b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) Earnings Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_c89c45b1-1a4d-49cf-ab01-838feeda05aa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_73f10dba-025b-496f-85a8-c8be7b59d6f6_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b8fdd256-6247-4aae-b9b3-9d1fbf4182b8_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_db6e3056-20e6-407c-9d6d-5c7388d4e2f1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5d2530c5-68fe-4803-8a60-5d0955ba244f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8693f8c5-034b-4011-ae14-2ee0d777d5db_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6dbee05d-1815-4466-bc9a-1d80dd45535f_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b7fc472c-70b3-46aa-b780-e82f1bf7a740_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_1486aca0-7bb0-4151-b82f-8d1152e0ae0a_terseLabel_en-US" xlink:label="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="aort-20220930.xsd#aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_1b6eeaaf-526a-4a30-a4db-72a8ad1ccffb_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_4729ceee-3b98-411c-b895-a61567ce5a1d_verboseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_dbf60f3b-18f0-467b-9947-fb4661157656_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9cfe1d46-46a3-4ffd-bfc0-c17015e77ad5_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_6167cb1d-88e4-4b18-80aa-3c92dfad18a4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_10768ea8-07e2-4dd0-8804-ccdaf6b01f18_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_0d6b6752-5451-4a8d-bf26-659af0a9874b_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General, administrative, and marketing</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fdcb5d6b-d898-4a03-b583-8ea35987300b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_30a378df-1516-46d9-a9fe-bc37e6a1fdff_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of non-financial assets, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_ab752cc5-9a11-42c1-ae5b-59ab662c7035_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_fa7b19d4-63e6-4f2d-acd7-b6d44699c483_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRedeemedOrCalledDuringPeriodValue_5572ac6f-3450-483a-a469-b6d63fa00009_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and repurchase of stock to cover tax withholdings</link:label>
    <link:label id="lab_us-gaap_StockRedeemedOrCalledDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Redeemed or Called During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="lab_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts_65ea286a-ca4f-4aec-9e0d-88231a2f12d8_terseLabel_en-US" xlink:label="lab_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination and wind-down expenses</link:label>
    <link:label id="lab_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts_label_en-US" xlink:label="lab_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Expense, Termination and Wind-down Costs</link:label>
    <link:label id="lab_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts_documentation_en-US" xlink:label="lab_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Expense, Termination and Wind-down Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts" xlink:href="aort-20220930.xsd#aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts" xlink:to="lab_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2737e09d-553b-404e-8f6a-d11697164e94_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_3650c107-7ceb-4a99-a00f-fe45da76ebb5_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_02090674-84d6-4ef8-871d-2e2a1a2b0187_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding equity acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_9da5262f-9cc6-405e-8525-837ac79bc5e9_terseLabel_en-US" xlink:label="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, percentage repaid for no covenants</link:label>
    <link:label id="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_label_en-US" xlink:label="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Percentage Repaid for No Covenants</link:label>
    <link:label id="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_documentation_en-US" xlink:label="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Percentage Repaid for No Covenants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" xlink:href="aort-20220930.xsd#aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" xlink:to="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_820ba1da-360e-4aab-add3-cf2f2a57b7bf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_46036d11-3481-497f-9c46-5ca275161aad_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_d6928f4b-85d5-4029-b63c-1f5e4a1133fe_totalLabel_en-US" xlink:label="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_label_en-US" xlink:label="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Estimate</link:label>
    <link:label id="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_documentation_en-US" xlink:label="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the first five fiscal years following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" xlink:href="aort-20220930.xsd#aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" xlink:to="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0895e8f2-4688-454f-8600-6dfdeabf2fdc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in operating lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_cfb77632-0031-447e-b397-a0b7722984a7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f46aec1b-705b-4b8e-8050-f0d5cd4f065f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_25a150d4-e0d0-4068-b7c1-c650f9c722c8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_6ca1614b-4e04-4f88-b661-cf98c22fe358_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net and Deferred Preservation Costs</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_b0414d79-d92c-48bc-93a6-7329287c3a21_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_c0fd3600-5b74-4677-988f-0ac9d509dfd8_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_cf07010f-8f00-4204-b64f-07dc1e02f4c3_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_d74e91ff-5c29-484c-a233-e1f0bda30638_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products and preservation services:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_13cf1417-567f-46a1-a9ec-2b69ffb4fc3f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_18608499-9bd8-43f8-8b40-7a7282d69e60_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of net minimum lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_a758287d-df4d-4d14-812e-a3946558277e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Revenues by Product and Service</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_45d2d1df-ee19-4ea8-ae60-83799a17497e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_d0b440c4-6875-4ca1-945e-c0d732b70780_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock (issued shares of 41,816 in 2022 and 41,397 in 2021)</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_0df3803a-a56f-478f-8744-245da4feaa69_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_c24dff50-0907-4db5-a2c4-f47eb31a9dc1_netLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate: Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_fe44fe3a-bf68-4fe6-85fc-d571bdb0d1f0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_9ea4ea95-76fe-4f66-aab3-e3240abe7842_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_17dc8343-e49c-4a66-9744-98150d82fcce_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Procurement contracts and agreements</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_cc33ebd9-e5e0-460d-893e-51b4b00bea72_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aa5d6b2c-1ba7-4cd5-a07c-cacb3330e2e5_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_faed52b2-f54d-4134-904b-fb4d110e62ca_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Instruments Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DeferredPreservationCosts_90c47ef8-cfb2-4ec4-be2d-e881a4eb1869_terseLabel_en-US" xlink:label="lab_aort_DeferredPreservationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred preservation costs, net</link:label>
    <link:label id="lab_aort_DeferredPreservationCosts_label_en-US" xlink:label="lab_aort_DeferredPreservationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Preservation Costs</link:label>
    <link:label id="lab_aort_DeferredPreservationCosts_documentation_en-US" xlink:label="lab_aort_DeferredPreservationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Donated human tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. By federal law, human tissues cannot be bought or sold, so the preservation process is a manufacturing process that is accounted for using the same principles as inventory costing. Preservation costs consist primarily of direct labor and materials and indirect costs which are stated at the lower of cost or market value on a first in, first out basis and are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DeferredPreservationCosts" xlink:href="aort-20220930.xsd#aort_DeferredPreservationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DeferredPreservationCosts" xlink:to="lab_aort_DeferredPreservationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_fa04aa84-7bda-4009-97c6-3ca66be9304f_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c3016ee9-6f4c-4c8a-bfc1-bcaa17477c72_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of property and equipment</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_993ca981-557b-4364-ba2a-5ef68a48b738_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour_3f0be1f1-685f-4386-b9dd-294234ffbcc7_terseLabel_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income, Thereafter</link:label>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour_label_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals After Year Four</link:label>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour_documentation_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour" xlink:to="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_39e279dd-35e0-4cc7-ba4d-864985309173_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_0ef7fb3a-41cf-4bad-9a74-0c4eb729c219_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_dc11c27f-7c7f-4e6e-85a1-0ff2b92f48d9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted-Average Assumptions Used to Determine the Fair Value of Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_1c813468-0063-4157-873c-66744ce78c5b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_91db4b45-1a97-420a-9c55-5dbf1b92feb6_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_dd630ae1-ba08-4754-8ebe-ea04f17f33e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive stock options and awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_862c09b0-45ae-4b4b-9cf3-09c4689024de_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_50c39b6e-fad0-4636-a6f3-32b0509549da_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (loss) income per common share</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8edff0a0-4b53-4cd2-9eeb-275ad303a6a3_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amount representing interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_f31ec724-44f8-43ae-bc2b-99b01baa7d53_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_CardiogenesisMember_52daeb1f-0a25-4126-9c98-aa21ce8f1573_terseLabel_en-US" xlink:label="lab_aort_CardiogenesisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CardioGenesis cardiac laser therapy</link:label>
    <link:label id="lab_aort_CardiogenesisMember_label_en-US" xlink:label="lab_aort_CardiogenesisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiogenesis [Member]</link:label>
    <link:label id="lab_aort_CardiogenesisMember_documentation_en-US" xlink:label="lab_aort_CardiogenesisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiogenesis [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CardiogenesisMember" xlink:href="aort-20220930.xsd#aort_CardiogenesisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_CardiogenesisMember" xlink:to="lab_aort_CardiogenesisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9e83c76f-43cb-4f1d-9795-ed18c0c24da5_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_4752ae68-b821-4b05-9cef-a1d3c7428854_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_47a067a0-35df-4dd8-aa1a-368c0285c1c8_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b6aca87f-3caa-4ec5-842a-b60d6350d71b_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f74166e-48ae-40d1-8a7a-530d68697a64_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total sources of revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DebtInstrumentExtensionPeriod_b58c6cb8-4178-4b2c-a8b0-88e98dc692ee_terseLabel_en-US" xlink:label="lab_aort_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension period</link:label>
    <link:label id="lab_aort_DebtInstrumentExtensionPeriod_label_en-US" xlink:label="lab_aort_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension period</link:label>
    <link:label id="lab_aort_DebtInstrumentExtensionPeriod_documentation_en-US" xlink:label="lab_aort_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentExtensionPeriod" xlink:href="aort-20220930.xsd#aort_DebtInstrumentExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DebtInstrumentExtensionPeriod" xlink:to="lab_aort_DebtInstrumentExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_90f2c545-f333-475e-8aa7-d4afbacaaf03_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amount representing interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_5ba7a92f-a19d-4ebe-b2fa-49f9c1652692_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_20707100-cafa-4132-a7f4-40d1efaf5f2f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (loss) income per common share</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_e5fdcd31-2e7d-4547-9e5f-1006a0a0e39d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_b78e71f8-b732-498f-8918-c1c89034790d_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive stock options and awards</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_06e73444-14d0-46d3-be0e-592fbabac730_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9e42b89e-bee3-4051-b585-f143a1968f66_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_e0b199a8-2f08-4f34-81b0-d9da4262e564_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_28e45494-24d4-4d8f-8d69-a30697dea987_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_5e834c93-3d2b-4100-a1ca-b71e1e87e514_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_64c1b512-bc5d-4e50-afd3-51949f904e44_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_70d21391-7d65-4f60-b368-ba613de70fe1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_58489687-df09-4b1d-baa2-3abde6a48daa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangibles, net</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsNet" xlink:to="lab_us-gaap_OtherIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_41b1b94d-1aa7-4c40-9d57-6a4534ad15d9_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years): Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_9d260a14-0fdd-43b5-a765-e8aeca41d232_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_088f5f2d-6092-4cab-870f-2f547d73a36b_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating (loss) income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_9f4851cc-6282-49cc-81b8-ba51422333e4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_e0f3e913-944a-4ed4-993c-2eed1315365b_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current maturities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_FinanceLeaseCost_89418f6c-243f-4395-a106-e0a84f3d5590_totalLabel_en-US" xlink:label="lab_aort_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease expense</link:label>
    <link:label id="lab_aort_FinanceLeaseCost_label_en-US" xlink:label="lab_aort_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_aort_FinanceLeaseCost_documentation_en-US" xlink:label="lab_aort_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of finance lease cost recognized by lessee for lease contract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseCost" xlink:href="aort-20220930.xsd#aort_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_FinanceLeaseCost" xlink:to="lab_aort_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dba40c42-159f-4360-8115-5e5d7d3ea925_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_67edfdc3-a2e3-4af4-bbb8-daee47469f8d_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock at cost, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_4e9008ca-b967-4a47-a3f3-75c23fff9fda_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_8a14b0cc-f948-4035-acd8-9db083b5a28e_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_09a3d606-57eb-4e8d-9e0a-8b793a38f4a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9dac52aa-f9ce-4736-873d-dbc19c9f5d3d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_fac6eff0-87df-470b-a8a6-f3453d6b61bd_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_9946c362-1b78-4e75-9bde-ec271977df7a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_cca288b2-adb3-4da2-a204-c98f73890f01_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_InternationalDistributorMember_84f76be6-788f-41b6-9316-357e1661a151_terseLabel_en-US" xlink:label="lab_aort_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International distributors</link:label>
    <link:label id="lab_aort_InternationalDistributorMember_label_en-US" xlink:label="lab_aort_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor [Member]</link:label>
    <link:label id="lab_aort_InternationalDistributorMember_documentation_en-US" xlink:label="lab_aort_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_InternationalDistributorMember" xlink:href="aort-20220930.xsd#aort_InternationalDistributorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_InternationalDistributorMember" xlink:to="lab_aort_InternationalDistributorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e71cfb6b-ec94-4ca9-af34-b4112dd48eb6_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f6e0f236-ad56-4308-8d20-08f3b36a8511_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_c1f0f76e-4319-4faf-bf55-60ae8b93bb1a_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_20ade45c-318a-4b5c-8a56-b4da28556118_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_AscyrusMedicalLlcMember_59822cf8-ed64-4314-a5d7-5cd05b2cf5ef_terseLabel_en-US" xlink:label="lab_aort_AscyrusMedicalLlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ascyrus Medical LLC</link:label>
    <link:label id="lab_aort_AscyrusMedicalLlcMember_label_en-US" xlink:label="lab_aort_AscyrusMedicalLlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ascyrus Medical Llc [Member]</link:label>
    <link:label id="lab_aort_AscyrusMedicalLlcMember_documentation_en-US" xlink:label="lab_aort_AscyrusMedicalLlcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ascyrus Medical LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AscyrusMedicalLlcMember" xlink:href="aort-20220930.xsd#aort_AscyrusMedicalLlcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_AscyrusMedicalLlcMember" xlink:to="lab_aort_AscyrusMedicalLlcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_6be5c22f-a525-4d7b-b685-8358ab8aac46_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_6fa66449-a9da-4748-9e7e-100015f585d4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_NoncashInterestExpense_8517b1aa-d8dd-49ed-8ae6-d118dd0f9daf_terseLabel_en-US" xlink:label="lab_aort_NoncashInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_aort_NoncashInterestExpense_label_en-US" xlink:label="lab_aort_NoncashInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Interest Expense</link:label>
    <link:label id="lab_aort_NoncashInterestExpense_documentation_en-US" xlink:label="lab_aort_NoncashInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_NoncashInterestExpense" xlink:href="aort-20220930.xsd#aort_NoncashInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_NoncashInterestExpense" xlink:to="lab_aort_NoncashInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ecf358e7-8b05-49bc-bcf9-0fa3c045c5d1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liability</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_a9b3f353-4242-465d-b71d-61c0f7e80718_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5863c2bf-21da-4f4e-9ed2-68f6a988f275_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3f785f88-2ab4-4534-91a3-15b82d344272_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_eb8f5d24-6ab2-4f98-a709-f44276a5c77e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_639e6a17-ef6e-4a2d-b200-01832af31a02_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8976a595-01fa-46ec-9989-9c1a43b3a46f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_01ee5fdf-6fb4-4457-95e2-f5fdccca763c_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_70cc0bc5-f974-4baf-961e-66c970b22438_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_b43df95e-f5c8-4de1-acf4-aae96bbddba2_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_aa013528-6ca0-4b41-a44d-9ac9183f017e_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_30d671b8-71e2-454c-a0f7-8aed21adba44_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_d1b6db28-2d4c-42ec-8f94-4f7b328dd521_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock compensation expense</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_bf8202b1-5501-4b29-8d3a-efe21a11d118_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_0404b2d4-e5a4-4c6c-a3a6-ac1e2dbe00ac_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_aa1bb4ba-8c3b-4034-9f31-307b15f30b95_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_cf1ca7d1-901d-4db4-be6b-8c478eed04bd_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c9af8111-4bc9-470e-b7de-78c15c614d93_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_eaa897e0-4836-40f3-8527-64aa424786cd_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_28a2e3d0-dec0-4746-abed-789ea33fcfc8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a746c9aa-b410-4903-9d14-cd6164cc3ac2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_de24f2cc-b9f7-4be9-a8ce-402a6226ee5f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses, and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_e8821239-23cb-45f0-bd03-10de555c1b9d_terseLabel_en-US" xlink:label="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option and ESPP expense</link:label>
    <link:label id="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_label_en-US" xlink:label="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Employee Stock Purchase Plan Option Expense [Member]</link:label>
    <link:label id="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_documentation_en-US" xlink:label="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Employee Stock Purchase Plan Option Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" xlink:href="aort-20220930.xsd#aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" xlink:to="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_StarchMedicalInc.Member_7aa36bfc-69da-4bed-8125-096f57b3d99b_terseLabel_en-US" xlink:label="lab_aort_StarchMedicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Starch Medical Inc.</link:label>
    <link:label id="lab_aort_StarchMedicalInc.Member_label_en-US" xlink:label="lab_aort_StarchMedicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Starch Medical Inc. [Member]</link:label>
    <link:label id="lab_aort_StarchMedicalInc.Member_documentation_en-US" xlink:label="lab_aort_StarchMedicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Starch Medical, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_StarchMedicalInc.Member" xlink:href="aort-20220930.xsd#aort_StarchMedicalInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_StarchMedicalInc.Member" xlink:to="lab_aort_StarchMedicalInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b63923c8-8e74-4bf0-aa0a-4ea382134a2e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_761450b4-4c82-43c3-bbf1-fe85642feb0b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_ed885288-1856-4e03-bb1a-4628376fd5e2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consignment inventory</link:label>
    <link:label id="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_label_en-US" xlink:label="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:to="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_315391e0-7a67-4437-93c4-85f8fdffbc7c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to convertible senior notes</link:label>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_label_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on Convertible Debt, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:to="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_CircumstanceIMember_2e9c440e-4d79-4292-849e-a7b580ac38ce_terseLabel_en-US" xlink:label="lab_aort_CircumstanceIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance I</link:label>
    <link:label id="lab_aort_CircumstanceIMember_label_en-US" xlink:label="lab_aort_CircumstanceIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance I [Member]</link:label>
    <link:label id="lab_aort_CircumstanceIMember_documentation_en-US" xlink:label="lab_aort_CircumstanceIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance I [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceIMember" xlink:href="aort-20220930.xsd#aort_CircumstanceIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_CircumstanceIMember" xlink:to="lab_aort_CircumstanceIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_8a121e82-bc6e-4681-ad23-1e1a4718915f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_95334879-3407-476d-a2c9-b9391a220965_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_e5824fa4-88b6-4034-91e2-b8fe9789c0ce_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current maturities of operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_bf2b2af0-9446-4006-86cc-1c2f06404c19_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current maturities of operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1a1fdb8f-cd58-42f0-ae78-7ee74cd66bde_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities, less current maturities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_50aa94ac-d5bb-4e66-a06f-f7cda75d86a9_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_c566d31c-70da-49a0-bd1a-e8946049cd7f_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_40e440e2-b890-44e0-b1dc-94047c0b7674_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_a553e842-49c3-485b-be24-4f7592dac02a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_bf95c32b-1f9d-483a-aa96-66bd87a5625b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_3a71c9be-efe2-4724-8efe-3292965baa62_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_PreservationServicesMember_8292f0da-fc26-42d8-90af-1e7c72c3dd6b_terseLabel_en-US" xlink:label="lab_aort_PreservationServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preservation services</link:label>
    <link:label id="lab_aort_PreservationServicesMember_label_en-US" xlink:label="lab_aort_PreservationServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preservation Services [Member]</link:label>
    <link:label id="lab_aort_PreservationServicesMember_documentation_en-US" xlink:label="lab_aort_PreservationServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preservation Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember" xlink:href="aort-20220930.xsd#aort_PreservationServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_PreservationServicesMember" xlink:to="lab_aort_PreservationServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_856593c9-95eb-42d8-8463-298fb942ef59_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained (deficit) earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_48c8cc37-5c16-4216-a7f5-da2cf6a08eaa_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b564b1b5-dc56-49c4-98d7-4aadece3fc79_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c54fb584-08ca-49af-89dc-53d37f5730a4_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_7b649487-92b3-4aca-af6f-170fd25969cc_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_a56fdfcd-3643-45b5-b8af-eaf98081a63b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of net minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ff561ad2-8b89-4d56-b4cf-67719a05905a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_02f643d0-91b6-4f53-92f7-16fa480b9bf3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable_aa3f2e09-d375-4c1e-86ac-01d2c4321f91_terseLabel_en-US" xlink:label="lab_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration receivable</link:label>
    <link:label id="lab_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable_label_en-US" xlink:label="lab_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Contingent Consideration Receivable</link:label>
    <link:label id="lab_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable_documentation_en-US" xlink:label="lab_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Contingent Consideration Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" xlink:href="aort-20220930.xsd#aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" xlink:to="lab_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_35ae6362-4d58-4f87-9b02-002f641d1ebd_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_8d522d64-a988-4d25-b81b-c01c12995be6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_f89ceb3f-10ad-4291-812b-b5222fc15ebb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_a2182866-6a0f-4729-be23-708b9965d514_terseLabel_en-US" xlink:label="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:label id="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_documentation_en-US" xlink:label="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount, before accumulated depreciation and amortization, of property, plant, and equipment and operating lease right-of-use asset.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="aort-20220930.xsd#aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_8af9cd42-77a2-4fed-9d7b-efd4c504a6cd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Changes in Fair Value of Level 3 Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_1db04eff-2089-4e34-b8af-da97a941b1ce_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_d46d6f3f-cfd9-4edf-92d5-651d4d965d23_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2ef8fa3c-015b-4e0e-8ac5-204ad6177725_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a9b1355b-f2b7-4d82-b04d-266914f64f46_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4da58f28-5adc-4782-890c-8be5d2253beb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1d99ffc6-0908-427f-8f2f-980c68954e53_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_27c2dba2-2647-4bd2-a256-cce1697b4984_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9e3a64be-72b4-41d4-96ff-d01ebf5e8250_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_48d29d8a-1777-471b-aa78-b887826b3b6c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_68eac1d8-27e7-41eb-84fa-d184a23ea61a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Cash Equivalents and Restricted Securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_e14f2857-2593-4d44-8d80-cb97a4b668de_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_37bd4ad1-3491-4ae6-ad2f-20c652bae2fc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_58481289-1583-4556-9ea0-5c8e020c69c1_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_1cfa8929-182d-4c58-828f-5d87e905d049_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_b4c9a320-65ea-4b93-8db2-5ac67491dae6_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_dd00189e-3681-4049-a18b-2c37e17379c6_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f7c36581-67e1-4133-8f6d-d19f60ef1258_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_6afb8c85-a568-4b6c-8106-a5efc73941f7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_eb0b44bf-1d1e-4347-a300-cd5a8447f260_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b6bc9fa9-def5-4a97-bb38-fed78544b0cd_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues, Cost of Products and Services, and Gross Margins for Operating Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87f73a43-45d1-4aac-b3e3-7e0d735c5050_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_2a1ef135-fe4f-417b-af49-4c181b228e6d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_c9b1a08c-5ae3-42f9-ace8-ab2a80f4d47f_negatedLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (income) allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_56688241-91a2-4e61-9bd2-2bce9ddba7a4_netLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_67e00cc1-e411-417a-8443-2533bb617df5_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_dbe16e94-6793-4e3c-aef0-a964b86be83d_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less short-term loan balance</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_3e7ee3ae-29a4-4442-b1e4-d285e610246a_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_fed4439c-91de-4686-b537-eef6ebe245a0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccounting_d0f926be-76c7-4fd9-a63b-6becffe0e31c_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfAccounting_label_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccounting" xlink:to="lab_us-gaap_BasisOfAccounting" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_InternationalHospitalsMember_4675df91-ef04-4dee-84b8-32a0cee8aa9f_terseLabel_en-US" xlink:label="lab_aort_InternationalHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International hospitals</link:label>
    <link:label id="lab_aort_InternationalHospitalsMember_label_en-US" xlink:label="lab_aort_InternationalHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Hospitals [Member]</link:label>
    <link:label id="lab_aort_InternationalHospitalsMember_documentation_en-US" xlink:label="lab_aort_InternationalHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Hospitals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_InternationalHospitalsMember" xlink:href="aort-20220930.xsd#aort_InternationalHospitalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_InternationalHospitalsMember" xlink:to="lab_aort_InternationalHospitalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b15ebcec-988e-4001-9a91-8275fdd90fe0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ba3bd627-5979-48cb-b755-fdb0472b028c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_000bb85d-878e-4212-8ba9-e757b95a406f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e2adcda4-34af-4cb3-b86e-afe13d5f1ecd_netLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_42dfe376-ce48-4634-9b4a-621325cb7204_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_98ad9a83-6530-447e-b22d-8060c6531c91_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d87eb11b-54c0-4aa4-aa11-ef4f60e9aae6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_cb9d86e4-1144-4664-bbee-a31f6c4bf952_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_17bd5b48-c6be-4748-af13-744c6d55ebdb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_8a634de7-3847-4cb7-8609-08a381b2e40b_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_78de9b95-9b5c-487f-99d3-312f588373c9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_44a1c0dd-e273-427a-a821-e03fbb16f835_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Total Stock Compensation Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_0bf708ff-1da6-4369-b484-5d48e90679aa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum amount of future consideration payment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_baf59167-75eb-4d40-ac9f-3ef4910ea8d1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_d6510f91-9137-4414-a52c-3300cb692720_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_8802ab8c-deea-42c4-b6d4-482c505c79ff_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_7154e1ca-7973-424b-af9a-8388e4c28410_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current maturities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_13af731e-a002-45d0-ae67-8a4ce159faa3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP, percentage of market price for eligible employees</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cf21c57a-067b-4e42-b983-3b09ab06f37d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_c0f07978-e9e0-48ea-8cf6-161b61b40c6f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_12b17f59-c8dd-40fc-99f2-1db5106f4138_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_2bac86ec-fae1-4240-8661-5bfc6f968df3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values of Indefinite Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_8af7e869-3431-47be-8444-df3827b19a38_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances against deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_c6c2c2a2-4bac-457c-a6ed-bfcbe562800b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases:</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_ae200f5f-a550-4245-9215-0c2680919ee1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DomesticHospitalsMember_0a79e1b0-6935-4056-a6f8-874ec7ac26d3_terseLabel_en-US" xlink:label="lab_aort_DomesticHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic hospitals</link:label>
    <link:label id="lab_aort_DomesticHospitalsMember_label_en-US" xlink:label="lab_aort_DomesticHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Hospitals [Member]</link:label>
    <link:label id="lab_aort_DomesticHospitalsMember_documentation_en-US" xlink:label="lab_aort_DomesticHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Hospitals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DomesticHospitalsMember" xlink:href="aort-20220930.xsd#aort_DomesticHospitalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DomesticHospitalsMember" xlink:to="lab_aort_DomesticHospitalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_247cffaf-bb40-4ff7-bc81-b79a389185fa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Useful Life (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_f71bd4f4-eab5-4562-9d49-c0caed1209e4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_082f9855-089a-4388-b341-2f2931bd624b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_885621cc-a7e7-4c5f-9f4d-9c4054a4c7b7_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted (Loss) Income Per Common Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_c4b1d30b-90fb-4e8f-ae64-3aeb9e4e96b7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion trading day threshold</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_2ebfa302-f13c-4a24-8855-8c10cf299b23_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_dbcd789c-9a7b-4168-9cea-b658b630cc89_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_17b854f3-a1e2-4ed7-9191-4fb254b3aed1_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_89378d94-a4bc-45ec-9fa7-30d8d1a7b809_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options and issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_c4a2ff30-cb6a-4316-931d-acd1fd19dffc_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_2f1e8243-4e07-4dc1-9f71-a81c176a6ccf_verboseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized gains or losses on cash equivalents</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_73ceebf5-1d41-4a10-98bd-634dc85920ab_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income allocated to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_a3bbacc2-aa0e-4b86-9d24-42a5925f4a52_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c1785ef8-fca3-4488-b148-f3942903a5fd_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income allocated to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_904355d6-2cd4-40fc-a195-66436874b1e7_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_abd37dd3-ab37-4cb1-b7b9-37fd4dedf9ef_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_2ef94f73-fbd5-499c-8203-c871b7fc7f04_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_739def80-e1cc-4e06-b751-a4566602b6da_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_cb9da3fc-157c-47ac-b981-4d209e75e7d1_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and Services [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_93750c80-6431-4259-85f4-44c3cd8ba3c3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on amounts borrowed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRedeemedOrCalledDuringPeriodShares_b581f548-c97f-4e6c-9b92-b7c55d45648b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and repurchase of stock to cover tax withholdings (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRedeemedOrCalledDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Redeemed or Called During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="lab_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_f00df922-6c19-49e4-9129-f2ec164274e1_terseLabel_en-US" xlink:label="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA, RSU, and PSU expense</link:label>
    <link:label id="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_label_en-US" xlink:label="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards Restricted Stock Units Performance Stock Awards Performance Stock Units [Member]</link:label>
    <link:label id="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_documentation_en-US" xlink:label="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards Restricted Stock Units Performance Stock Awards Performance Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" xlink:href="aort-20220930.xsd#aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" xlink:to="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_870b420e-c483-4cf2-86a2-b7a7b9af96bf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_9ac68bca-fd5e-4381-85b5-4c22eb2acbee_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_4fb020dc-3971-4b8c-a67d-e4247dd1eee4_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_409ba062-45dc-487f-bdff-c4a9709e72e9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_17d03737-51d3-4521-a2cf-6cba9b7dd8d4_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term and Long-Term Balances of Term Loan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a48b2685-a8c2-4327-9a2f-b6c17721707e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_4b93d54e-ef30-48f5-ac0e-7606084f7593_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_10eb91f2-16ff-4f7a-89de-9f4b9920230e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_b6ab0bc3-8ec6-42ec-9c6d-f4074c3b2ceb_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:to="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_020bbf27-3a23-4da2-8de7-170db1f41403_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_e231f45a-68f7-453f-9ad3-7557a84501a5_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a8811c4e-ae91-4f7b-8925-e6e079923aeb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0f896981-325d-4187-8e02-c1d0ecfda53d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5617edd2-a40f-4d66-88a4-021cf6fd1a60_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income per share, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7b5308bb-80a4-465b-8dd3-ecbeeb7f49ed_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (loss) income per common share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_7e3ad803-4cf1-4575-aaec-78ad99cbfa61_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_f617a6e2-fae7-4446-846e-876f20d5898d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion percentage of stock price threshold</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_2756424b-583b-473b-baf0-92c40f40f973_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_e1107e61-f169-42f3-a3b5-57dd204510c3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_84671011-37d6-405b-9198-316f92b13bfd_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_1b7d688a-efed-4613-84e8-1486dd5ff450_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Amortization Expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_9d573fe5-32e3-47cd-b113-a1db68fd8772_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_ac474695-0f1a-4b83-9834-bf641ac97398_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_6cdc4edf-ac3b-4aff-ad49-8161bf435f55_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Other Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfOtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_CircumstanceIiMember_3dc541f3-6eb4-48e2-8702-70fb1db3f689_terseLabel_en-US" xlink:label="lab_aort_CircumstanceIiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance II</link:label>
    <link:label id="lab_aort_CircumstanceIiMember_label_en-US" xlink:label="lab_aort_CircumstanceIiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance Ii [Member]</link:label>
    <link:label id="lab_aort_CircumstanceIiMember_documentation_en-US" xlink:label="lab_aort_CircumstanceIiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance II [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceIiMember" xlink:href="aort-20220930.xsd#aort_CircumstanceIiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_CircumstanceIiMember" xlink:to="lab_aort_CircumstanceIiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_eb71fce3-447d-454e-aa3b-80f5066645d5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_2a3b8d5c-7735-49a4-823c-e245657d3dd4_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan balance</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_cd445761-7748-424d-a64f-fc3d57652ca6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_e4a1297b-4b5b-41e4-9d3e-8f249e6f1b83_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_fab545a8-131d-415b-8ed2-9eab162424e0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DistributionRightsMember_521b0271-b324-4335-bc3e-125714085920_terseLabel_en-US" xlink:label="lab_us-gaap_DistributionRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and manufacturing rights and know-how</link:label>
    <link:label id="lab_us-gaap_DistributionRightsMember_label_en-US" xlink:label="lab_us-gaap_DistributionRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DistributionRightsMember" xlink:to="lab_us-gaap_DistributionRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_48dd02c1-ca7c-4afa-a52f-0758af62be0e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashExpense_335e6e5a-f5f8-43da-9aba-4f3e8c8bd5ca_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashExpense" xlink:to="lab_us-gaap_OtherNoncashExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_2297644f-389b-4873-9afc-9bfc708ffce3_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_RevolvingCreditFacilityAndTermLoanMember_ee0259f3-ca3f-4dca-ada5-d3ce8da7f3f8_terseLabel_en-US" xlink:label="lab_aort_RevolvingCreditFacilityAndTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan</link:label>
    <link:label id="lab_aort_RevolvingCreditFacilityAndTermLoanMember_label_en-US" xlink:label="lab_aort_RevolvingCreditFacilityAndTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan [Member]</link:label>
    <link:label id="lab_aort_RevolvingCreditFacilityAndTermLoanMember_documentation_en-US" xlink:label="lab_aort_RevolvingCreditFacilityAndTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RevolvingCreditFacilityAndTermLoanMember" xlink:href="aort-20220930.xsd#aort_RevolvingCreditFacilityAndTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_RevolvingCreditFacilityAndTermLoanMember" xlink:to="lab_aort_RevolvingCreditFacilityAndTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_eab4d66d-7227-457d-b4b7-56b272fe3b97_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_CircumstanceAfterJuly52023Member_383024ce-2b41-4b66-97b5-81c2bc73fcbb_terseLabel_en-US" xlink:label="lab_aort_CircumstanceAfterJuly52023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance After July 5, 2023</link:label>
    <link:label id="lab_aort_CircumstanceAfterJuly52023Member_label_en-US" xlink:label="lab_aort_CircumstanceAfterJuly52023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance After July52023 [Member]</link:label>
    <link:label id="lab_aort_CircumstanceAfterJuly52023Member_documentation_en-US" xlink:label="lab_aort_CircumstanceAfterJuly52023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance After July 5, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceAfterJuly52023Member" xlink:href="aort-20220930.xsd#aort_CircumstanceAfterJuly52023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_CircumstanceAfterJuly52023Member" xlink:to="lab_aort_CircumstanceAfterJuly52023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_174d947d-8caf-4fd7-b976-3201c1e796e6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of convertible debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dab64545-65a6-4cfd-bf6c-2264bee907d5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_efa90a8f-21bd-4b4b-b531-070401247acf_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ac015030-b227-4b6a-a0f3-8499ee8b8b4b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_410710be-29d7-4cec-b353-1ba76bcd2f72_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_GovernmentSponsoredDebtKfwLoan2Member_1459d64d-7360-4e08-b191-f28f42df3dac_terseLabel_en-US" xlink:label="lab_aort_GovernmentSponsoredDebtKfwLoan2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.40% Sparkasse Zollernalb (KFW Loan 2)</link:label>
    <link:label id="lab_aort_GovernmentSponsoredDebtKfwLoan2Member_label_en-US" xlink:label="lab_aort_GovernmentSponsoredDebtKfwLoan2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Sponsored Debt Kfw Loan2 [Member]</link:label>
    <link:label id="lab_aort_GovernmentSponsoredDebtKfwLoan2Member_documentation_en-US" xlink:label="lab_aort_GovernmentSponsoredDebtKfwLoan2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Sponsored Debt (KFW Loan 2) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_GovernmentSponsoredDebtKfwLoan2Member" xlink:href="aort-20220930.xsd#aort_GovernmentSponsoredDebtKfwLoan2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_GovernmentSponsoredDebtKfwLoan2Member" xlink:to="lab_aort_GovernmentSponsoredDebtKfwLoan2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_a8b771d8-ee06-45ba-8053-0b1aac87b0a3_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of products and preservation services</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_772c6e5a-c95d-41ce-b19d-653c0b9b53e3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5e216f64-c4ff-4380-8adf-ee2b3b917d10_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_4b9dd37f-70a6-4126-abc1-20a6376aa988_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_ProductsMember_bdad6738-2f72-49b6-85c4-36393380c9b4_terseLabel_en-US" xlink:label="lab_aort_ProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_aort_ProductsMember_label_en-US" xlink:label="lab_aort_ProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products [Member]</link:label>
    <link:label id="lab_aort_ProductsMember_documentation_en-US" xlink:label="lab_aort_ProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ProductsMember" xlink:href="aort-20220930.xsd#aort_ProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ProductsMember" xlink:to="lab_aort_ProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f7f8ec0b-c574-47b8-a53c-f041446855ae_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7dc9a3e8-a62b-4ee0-acfe-ed783cef3052_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_6544dc0e-f2ad-40fe-9b94-1334661b2dcc_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease expense</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_f695216d-779c-4ff6-aa4d-b2b997dac632_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_ea06ac3a-2a15-49c0-9922-2ae44592566f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_e9569e58-9672-4c7e-a2d2-971ce6cfd82d_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_427a7f3c-e64b-4611-a82b-a1fd4dff725d_negatedLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (income) allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_072830e2-3080-4651-ae3e-de02e74bff11_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_dbb97f28-031f-4ca4-a024-4d15143a7981_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_f253ef00-477b-4a2b-b78d-9727658d630e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree_5331bf36-8046-440a-8bbf-c0e60e5e3db7_terseLabel_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income, 2025</link:label>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree_label_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Three</link:label>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree_documentation_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree" xlink:to="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_AccruedProcurementFees_35c95d4f-d583-4a68-b686-cb47ae9b9fe8_terseLabel_en-US" xlink:label="lab_aort_AccruedProcurementFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued procurement fees</link:label>
    <link:label id="lab_aort_AccruedProcurementFees_label_en-US" xlink:label="lab_aort_AccruedProcurementFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Procurement Fees</link:label>
    <link:label id="lab_aort_AccruedProcurementFees_documentation_en-US" xlink:label="lab_aort_AccruedProcurementFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Donated tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. The Company accrues estimated procurement fees due at the time tissues are received based on contractual agreements between the Company and the tissue banks and organ procurement organizations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AccruedProcurementFees" xlink:href="aort-20220930.xsd#aort_AccruedProcurementFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_AccruedProcurementFees" xlink:to="lab_aort_AccruedProcurementFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_4de1161b-4c6b-4c46-9cf6-13870070101a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled Amortization of Intangible Assets for Next Five Years</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_a1863334-74d6-40bf-92bb-63e893016a75_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d3c356ac-28b3-4f3e-bdfc-9d2aa9663cb3_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_163070b0-37f4-4020-8604-c76a0d6ca7fd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_c91c2c8e-b495-4cd0-b38f-1c51581744bc_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_fc0145f3-4cf0-408c-9320-dff33f8f236c_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo_4c0b6656-a2a2-455b-9edf-60cc4a43dac9_terseLabel_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income, 2024</link:label>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo_label_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Two</link:label>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo_documentation_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo" xlink:to="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_1a07bd4e-fef6-4cfb-9482-412d4ed1ad29_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_723accd1-226e-4a35-8a37-42290a43430e_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost, 1,487 shares as of September&#160;30, 2022 and December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_a74a2641-e031-4311-bd90-bc6e3b79b0a1_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_a3d8f5df-edcf-4f2b-acd2-049b6d2c18cf_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear_7611e0b8-6f65-4caf-b211-92926ac69133_terseLabel_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income, Remainder of 2022</link:label>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear_label_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Remainder of Fiscal Year</link:label>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractually required future rental payments receivable on noncancelable subleasing arrangements, having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear" xlink:to="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_cb295de8-0537-418f-a1d9-62e1d2e18b21_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_986e3d6a-cacf-483c-b988-85d0f9ea906e_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term loan balance</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_2467eac7-fabe-4388-bc79-09948a78bd7f_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_67bac476-8991-4f20-8052-f0a9d3c9b4b0_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_ed57b54c-d2a3-47bf-ba13-d82032dc72d1_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e82dfd51-f4e8-4970-a442-3d2e562992c6_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3efb105d-849c-471a-8534-2753c8eb3442_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate expense (benefit)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne_e0e2abd3-2716-47a3-b891-823a2766f975_terseLabel_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income, 2023</link:label>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne_label_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year One</link:label>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne_documentation_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne" xlink:to="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_b8a1b9f3-1156-4931-bd31-4da8d6598c90_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of the debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_dfea98ff-6f70-47a9-ab70-b3fc74558845_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation reserve</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_83938089-abe9-4829-94dd-62d53b5e138c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f4e1fad8-e0ad-42a0-8825-02caca42452e_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_8552ce62-0080-4c0b-8f2a-b31e5a86faa8_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_AorticStentGraftsMember_ce0b601f-550b-45f6-9921-a3225f25b63f_terseLabel_en-US" xlink:label="lab_aort_AorticStentGraftsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aortic stent grafts</link:label>
    <link:label id="lab_aort_AorticStentGraftsMember_label_en-US" xlink:label="lab_aort_AorticStentGraftsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aortic Stent Grafts [Member]</link:label>
    <link:label id="lab_aort_AorticStentGraftsMember_documentation_en-US" xlink:label="lab_aort_AorticStentGraftsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aortic Stent Grafts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AorticStentGraftsMember" xlink:href="aort-20220930.xsd#aort_AorticStentGraftsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_AorticStentGraftsMember" xlink:to="lab_aort_AorticStentGraftsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_3beaab1e-6bb1-4d3a-9cca-152c8ab2d91a_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_3fc7fa98-6c2b-4743-83b5-9be2c0075f9e_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_SurgicalSealantsMember_4204d7e9-d225-4ca2-8063-b226a0ce3d1d_terseLabel_en-US" xlink:label="lab_aort_SurgicalSealantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical sealants</link:label>
    <link:label id="lab_aort_SurgicalSealantsMember_label_en-US" xlink:label="lab_aort_SurgicalSealantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Sealants [Member]</link:label>
    <link:label id="lab_aort_SurgicalSealantsMember_documentation_en-US" xlink:label="lab_aort_SurgicalSealantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Sealants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_SurgicalSealantsMember" xlink:href="aort-20220930.xsd#aort_SurgicalSealantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_SurgicalSealantsMember" xlink:to="lab_aort_SurgicalSealantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_b11537e6-2b94-4a7e-b2aa-661636522057_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_f6b33188-cdc9-43b3-aa96-f329c4d7378e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b0d59251-accf-4e8d-ad5e-8bc854b597b3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_a01e3db7-8db1-474f-8a75-3aa2494928e5_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_3b54ab43-0ece-4c65-93bd-e815a586bf97_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_OtherProductsMember_6c844a2b-9ee5-4cd4-8cae-336cedfe3ffa_terseLabel_en-US" xlink:label="lab_aort_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_aort_OtherProductsMember_label_en-US" xlink:label="lab_aort_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products [Member]</link:label>
    <link:label id="lab_aort_OtherProductsMember_documentation_en-US" xlink:label="lab_aort_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OtherProductsMember" xlink:href="aort-20220930.xsd#aort_OtherProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_OtherProductsMember" xlink:to="lab_aort_OtherProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_26ef01c5-f60f-4d62-b593-920209d0c9e3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_30580d7a-206a-4d2a-acbb-a49abbd5c78b_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2245ffd7-4b6a-49cd-827a-1de1f9faf50a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_28996a8b-edf6-4e4f-a706-a9094b5ac736_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Market Value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b76e76ae-97fe-4935-a0dd-509e56dec2f3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7be21e01-7a98-4ffa-8b1d-86f09d7f49ab_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b33ccb8d-ce2c-43b6-9def-38184efa20ee_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_729a640c-b235-4444-ae3d-fdbca697fd76_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_86990c2b-344b-4952-8919-57f9494f817f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derecognition of intangible assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_151a3fd7-0613-466a-9269-f4c5e4e8a428_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_bc1f7a66-413f-490a-b3ed-b0b519f3daa0_negatedLabel_en-US" xlink:label="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories and deferred preservation costs</link:label>
    <link:label id="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_label_en-US" xlink:label="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Preservation Costs and Inventories</link:label>
    <link:label id="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_documentation_en-US" xlink:label="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in deferred preservation costs and inventories, associated with underlying transactions that are classified as operating activities. Preservation costs consists primarily of direct labor and materials and indirect costs which are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" xlink:href="aort-20220930.xsd#aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" xlink:to="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_2be16f98-52a2-42f1-a4ed-325bfb46adef_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5db7a77b-d72c-4108-93a7-e5dc8c273bf9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_27337ceb-aa55-4435-8b00-c8e1058090a6_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OfficerMember_e4647d1b-1ff5-4a9c-8d57-900dd33c79ed_terseLabel_en-US" xlink:label="lab_srt_OfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officers</link:label>
    <link:label id="lab_srt_OfficerMember_label_en-US" xlink:label="lab_srt_OfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OfficerMember" xlink:to="lab_srt_OfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_GovernmentSponsoredDebtKfwLoan1Member_78ac72ae-5297-4e69-97cb-317e89923601_terseLabel_en-US" xlink:label="lab_aort_GovernmentSponsoredDebtKfwLoan1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Sparkasse Zollernalb (KFW Loan 1)</link:label>
    <link:label id="lab_aort_GovernmentSponsoredDebtKfwLoan1Member_label_en-US" xlink:label="lab_aort_GovernmentSponsoredDebtKfwLoan1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Sponsored Debt Kfw Loan1 [Member]</link:label>
    <link:label id="lab_aort_GovernmentSponsoredDebtKfwLoan1Member_documentation_en-US" xlink:label="lab_aort_GovernmentSponsoredDebtKfwLoan1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Sponsored Debt (KFW Loan 1) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_GovernmentSponsoredDebtKfwLoan1Member" xlink:href="aort-20220930.xsd#aort_GovernmentSponsoredDebtKfwLoan1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_GovernmentSponsoredDebtKfwLoan1Member" xlink:to="lab_aort_GovernmentSponsoredDebtKfwLoan1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_b439837f-ef66-43e4-a2fc-7a24879fb3a5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_2c2e92e5-ae41-4085-9445-c7b0f76f266f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_fd7d1800-8c33-4c3c-9c85-fba66e9f4b9b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32aa4481-b212-4e06-b1f5-400675c2456c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_4d908f07-a32c-46f6-9958-6efb5bab79c0_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_390252cd-c0de-494b-86ac-b46098af552e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_TransferOfPerclotManufacturingEquipmentMember_7e92be33-0f51-4f37-ac78-5246a0543fa9_terseLabel_en-US" xlink:label="lab_aort_TransferOfPerclotManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Of Perclot Manufacturing Equipment</link:label>
    <link:label id="lab_aort_TransferOfPerclotManufacturingEquipmentMember_label_en-US" xlink:label="lab_aort_TransferOfPerclotManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Of Perclot Manufacturing Equipment [Member]</link:label>
    <link:label id="lab_aort_TransferOfPerclotManufacturingEquipmentMember_documentation_en-US" xlink:label="lab_aort_TransferOfPerclotManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Of PerClot Manufacturing Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_TransferOfPerclotManufacturingEquipmentMember" xlink:href="aort-20220930.xsd#aort_TransferOfPerclotManufacturingEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_TransferOfPerclotManufacturingEquipmentMember" xlink:to="lab_aort_TransferOfPerclotManufacturingEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_27be198a-e393-46aa-a48b-567161d296f2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_33aad662-f0fc-4dc2-8d91-7830b0493777_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1a29fe87-ef28-4c94-82a7-477663d75557_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8fb66ded-3b27-4245-a3de-b85b618e839f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_9e19991c-a60b-4a79-97f5-32dd83158858_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_74afebda-cf97-4974-a66a-91a72dafd2db_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_eb42ae7e-6e9f-44f8-9035-f35270667cb8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_2abb104e-998b-4b7f-a05a-8e8a3aa9a5c2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c0750514-2d6f-4876-b067-dd3e18d0c95a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and repurchase of stock to cover tax withholdings</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_37306a83-fea4-46fa-866e-e10e9ec01bab_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_c2c63b38-ec06-42a8-9a4c-7705e1392d2d_terseLabel_en-US" xlink:label="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate grant date market value</link:label>
    <link:label id="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_label_en-US" xlink:label="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Market Value Of Shares Granted</link:label>
    <link:label id="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_documentation_en-US" xlink:label="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market value of share based compensation arrangement by share based payment award other than options granted during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" xlink:href="aort-20220930.xsd#aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" xlink:to="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour_772ad72b-c9df-4c48-91c1-b0b854784164_terseLabel_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income, 2026</link:label>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour_label_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Four</link:label>
    <link:label id="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour_documentation_en-US" xlink:label="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour" xlink:to="lab_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_937a57c7-82ed-467a-837a-4c9ec22d2bca_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility aggregate commitments</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_6165b237-227d-49f9-8486-b6b443523de2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c898c902-b9c6-49bb-a17f-df6c8602183c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_e6d64655-d40d-498e-b5ea-d4ccace8b8d8_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_b45a7b16-b436-4c87-865a-47c8d219457e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_afbf78b8-9301-4ae3-b2bb-24da0c2a8a7a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_6d89bd1a-576f-4575-ad0d-222880a438d4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_f31a4aff-5342-457f-93c3-55978a69cef0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_4aefa393-631d-470f-8490-26f3fe700f7e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_d971bb05-d1b8-4816-9f2a-55a95cfbe97f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerListsMember_4a7d15d6-1156-4854-bd72-00b3809a8809_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerListsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer lists and relationships</link:label>
    <link:label id="lab_us-gaap_CustomerListsMember_label_en-US" xlink:label="lab_us-gaap_CustomerListsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Lists [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerListsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerListsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerListsMember" xlink:to="lab_us-gaap_CustomerListsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_444d1888-12d8-4335-b81e-695ca6a1751c_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Holding Gains</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_BaxterAchievementOfWorldwideSalesMember_eb4800b5-d8d2-4228-ad47-5f6e46ae028f_terseLabel_en-US" xlink:label="lab_aort_BaxterAchievementOfWorldwideSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baxter Achievement Of Worldwide Sales</link:label>
    <link:label id="lab_aort_BaxterAchievementOfWorldwideSalesMember_label_en-US" xlink:label="lab_aort_BaxterAchievementOfWorldwideSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baxter Achievement Of Worldwide Sales [Member]</link:label>
    <link:label id="lab_aort_BaxterAchievementOfWorldwideSalesMember_documentation_en-US" xlink:label="lab_aort_BaxterAchievementOfWorldwideSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baxter Achievement Of Worldwide Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_BaxterAchievementOfWorldwideSalesMember" xlink:href="aort-20220930.xsd#aort_BaxterAchievementOfWorldwideSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_BaxterAchievementOfWorldwideSalesMember" xlink:to="lab_aort_BaxterAchievementOfWorldwideSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_48eed6ac-d4df-452c-a3eb-bb2b12831965_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock_09e7a3d3-9a7f-425b-a70d-18e3c3f05fa9_terseLabel_en-US" xlink:label="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Balance Sheet Information Related to Leases</link:label>
    <link:label id="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Supplemental Balance Sheet Information Related To Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="aort-20220930.xsd#aort_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_61814ea5-196d-49fb-8b94-c34001731259_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current finance lease obligation</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_9a626980-5824-455c-b743-6c79aad2a08d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current maturities of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_1ba2ae64-6468-4fd0-9b21-91121bec2171_netLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities, less current maturities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_03f65cb8-7406-4955-9341-103581d59ec9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired technology, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_fd678f5c-3346-4a86-9152-b95606a38f47_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_b806a8e7-b207-4dc0-940a-65a610f8fc30_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_2e7cfad6-f8c9-4dda-9899-5bf709c5a451_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_32af4534-2d50-48d4-a3f1-357e70754072_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_b110db7a-0b36-4c7f-bb2f-6cc2b58ba54b_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment costs</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_08289e85-cd6f-4039-bc09-8c5fa92036a5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_23ebf25e-7fdd-4c58-aa04-e551530b58e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59f34d76-5db0-4884-b6cd-a33868b788af_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash from operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_CreditAgreementMember_9019851b-c8ed-4b85-8b87-36ce0316d6fe_terseLabel_en-US" xlink:label="lab_aort_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_aort_CreditAgreementMember_label_en-US" xlink:label="lab_aort_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_aort_CreditAgreementMember_documentation_en-US" xlink:label="lab_aort_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CreditAgreementMember" xlink:href="aort-20220930.xsd#aort_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_CreditAgreementMember" xlink:to="lab_aort_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_8a3ff45e-dcc3-483d-a341-f78b0e3be055_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_189d9c5b-38db-412e-adfd-da822f6d2576_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_cecce3f6-07a8-4d55-8c0e-737b68bc201a_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less unamortized loan origination costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_1381d5be-7de0-4313-892c-21a5303a1831_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a4e7f0d5-e367-4477-9ff6-1e2e135419e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>aort-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e6891988-c797-4972-93bc-9ac5fa18c933,g:19ec5362-98a4-465a-8335-497bfcde1bb2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cryolife.com/role/Cover" xlink:type="simple" xlink:href="aort-20220930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_570fa843-a0b3-4773-bf66-a833ef2b6782" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_DocumentType_570fa843-a0b3-4773-bf66-a833ef2b6782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_ec33bfd4-f839-4b82-ac5e-10ee62c1f960" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_DocumentQuarterlyReport_ec33bfd4-f839-4b82-ac5e-10ee62c1f960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8d9d96ed-76f3-4599-a500-d3543e1e98f7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_DocumentPeriodEndDate_8d9d96ed-76f3-4599-a500-d3543e1e98f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_242cda50-7e92-4f22-8d84-9e405aafd599" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_DocumentTransitionReport_242cda50-7e92-4f22-8d84-9e405aafd599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e38db0bd-f0d9-4270-b96f-d1b8257c68a6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityFileNumber_e38db0bd-f0d9-4270-b96f-d1b8257c68a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6185ad5b-b740-4fc1-b82f-a0b24e1554ed" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityRegistrantName_6185ad5b-b740-4fc1-b82f-a0b24e1554ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_34c91e01-d065-4dbe-aecd-cb97fea7f1a7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityIncorporationStateCountryCode_34c91e01-d065-4dbe-aecd-cb97fea7f1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_19e798fd-f31b-4e39-92a5-b28f64e2fc3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityTaxIdentificationNumber_19e798fd-f31b-4e39-92a5-b28f64e2fc3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_1b1621fa-e586-431d-b5d2-38893e0a027f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityAddressAddressLine1_1b1621fa-e586-431d-b5d2-38893e0a027f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_4678e0b1-b01f-40c2-8644-a2fb42bce42b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityAddressCityOrTown_4678e0b1-b01f-40c2-8644-a2fb42bce42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6d344b40-4a53-4f30-a6fb-8278c3ae16dc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityAddressStateOrProvince_6d344b40-4a53-4f30-a6fb-8278c3ae16dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_dbf546bc-37d3-409b-a29c-96698d1fbc4b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityAddressPostalZipCode_dbf546bc-37d3-409b-a29c-96698d1fbc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c65cb76a-5a45-47f4-b1c2-66c78f90a3c9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_CityAreaCode_c65cb76a-5a45-47f4-b1c2-66c78f90a3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2ac61447-f740-4867-9c91-f7d2b73bf05f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_LocalPhoneNumber_2ac61447-f740-4867-9c91-f7d2b73bf05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ff45806e-48da-4cf2-884a-5124b4268020" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_Security12bTitle_ff45806e-48da-4cf2-884a-5124b4268020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_151a378e-3887-4d31-87a3-91d488679d7a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_TradingSymbol_151a378e-3887-4d31-87a3-91d488679d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_cd5952cd-feae-43ee-ae96-e52adef1625a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_SecurityExchangeName_cd5952cd-feae-43ee-ae96-e52adef1625a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_24fe1393-48ed-4a16-8d26-75720e91e13c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityCurrentReportingStatus_24fe1393-48ed-4a16-8d26-75720e91e13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_533b1d86-0078-4964-b6a8-a20ac2ebf748" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityInteractiveDataCurrent_533b1d86-0078-4964-b6a8-a20ac2ebf748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_40cf4311-c996-4255-bf0b-bcdb968288db" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityFilerCategory_40cf4311-c996-4255-bf0b-bcdb968288db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f5339c52-8da2-4699-bbee-060742d91a61" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntitySmallBusiness_f5339c52-8da2-4699-bbee-060742d91a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_cc45518a-6eb0-497c-a731-af73d55a9f36" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityEmergingGrowthCompany_cc45518a-6eb0-497c-a731-af73d55a9f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a1892952-05de-4cec-8d40-e90960110b38" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityShellCompany_a1892952-05de-4cec-8d40-e90960110b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_249e2d97-1a02-4c61-8676-a32eb714a747" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_249e2d97-1a02-4c61-8676-a32eb714a747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_98c558ac-3550-4e28-8de6-35a55dd08b83" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_EntityCentralIndexKey_98c558ac-3550-4e28-8de6-35a55dd08b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_ade5038a-9fbc-4c48-9e23-92b37fb068f9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_CurrentFiscalYearEndDate_ade5038a-9fbc-4c48-9e23-92b37fb068f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_be44adeb-0335-4e4f-b2fa-b7c618760ba5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_DocumentFiscalYearFocus_be44adeb-0335-4e4f-b2fa-b7c618760ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_49c39f75-b096-4166-b758-20b9ab417947" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_DocumentFiscalPeriodFocus_49c39f75-b096-4166-b758-20b9ab417947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6d1ce117-7960-477e-8f39-8ff1d7b99647" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_199d51c3-32fd-4aa4-be6d-7763de55bad3" xlink:to="loc_dei_AmendmentFlag_6d1ce117-7960-477e-8f39-8ff1d7b99647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome" xlink:type="simple" xlink:href="aort-20220930.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ce989965-ada4-4a9f-8489-edde05274dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_85ce7474-a9b6-4772-8ab7-fe675e806094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ce989965-ada4-4a9f-8489-edde05274dca" xlink:to="loc_us-gaap_StatementTable_85ce7474-a9b6-4772-8ab7-fe675e806094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2802d2a2-5318-425e-9119-9371bbfe61ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_85ce7474-a9b6-4772-8ab7-fe675e806094" xlink:to="loc_srt_ProductOrServiceAxis_2802d2a2-5318-425e-9119-9371bbfe61ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a5a63085-c174-4231-90a3-3d391840df77" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2802d2a2-5318-425e-9119-9371bbfe61ef" xlink:to="loc_srt_ProductsAndServicesDomain_a5a63085-c174-4231-90a3-3d391840df77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ProductsMember_103e2833-ad7d-44ef-944d-77a74fc77f90" xlink:href="aort-20220930.xsd#aort_ProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a5a63085-c174-4231-90a3-3d391840df77" xlink:to="loc_aort_ProductsMember_103e2833-ad7d-44ef-944d-77a74fc77f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember_129fa78b-bb3a-4be1-89f9-e69f90dd94b0" xlink:href="aort-20220930.xsd#aort_PreservationServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a5a63085-c174-4231-90a3-3d391840df77" xlink:to="loc_aort_PreservationServicesMember_129fa78b-bb3a-4be1-89f9-e69f90dd94b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_85ce7474-a9b6-4772-8ab7-fe675e806094" xlink:to="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_389f12a5-4bec-477f-b222-5d814e37b8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_RevenuesAbstract_389f12a5-4bec-477f-b222-5d814e37b8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ed7f47b3-f688-42ea-822e-52b3e9ae202a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_389f12a5-4bec-477f-b222-5d814e37b8d7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ed7f47b3-f688-42ea-822e-52b3e9ae202a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_2b723351-6791-49a6-a277-2700302c1b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_CostOfRevenueAbstract_2b723351-6791-49a6-a277-2700302c1b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_867e4c5e-14f6-4152-921d-213992fe592d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_2b723351-6791-49a6-a277-2700302c1b4c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_867e4c5e-14f6-4152-921d-213992fe592d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_17435bf5-7049-4c76-83f0-b3e4ec0a6ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_GrossProfit_17435bf5-7049-4c76-83f0-b3e4ec0a6ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_866037a1-d4f6-45a6-a86e-db4e7b5d4823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_OperatingExpensesAbstract_866037a1-d4f6-45a6-a86e-db4e7b5d4823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_553d042b-094f-4ed1-9dbe-b805d033d01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_866037a1-d4f6-45a6-a86e-db4e7b5d4823" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_553d042b-094f-4ed1-9dbe-b805d033d01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_65155278-731e-417d-8600-55ee3404fba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_866037a1-d4f6-45a6-a86e-db4e7b5d4823" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_65155278-731e-417d-8600-55ee3404fba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_993b29ab-ffef-4204-9a12-3946cca78846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_866037a1-d4f6-45a6-a86e-db4e7b5d4823" xlink:to="loc_us-gaap_OperatingExpenses_993b29ab-ffef-4204-9a12-3946cca78846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_3fe77b3f-a188-4363-bb11-4e2d0b29ba80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_3fe77b3f-a188-4363-bb11-4e2d0b29ba80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6560cbfa-3036-4ab8-a0ed-5d1d10759edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_OperatingIncomeLoss_6560cbfa-3036-4ab8-a0ed-5d1d10759edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c52ec567-5bc5-40f5-b761-88dd7248e42a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_InterestExpense_c52ec567-5bc5-40f5-b761-88dd7248e42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_d480c31a-ec58-49db-94ab-13fc34fb7425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_InvestmentIncomeInterest_d480c31a-ec58-49db-94ab-13fc34fb7425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ae0faf92-412b-4fc7-8fe5-2869841d2b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ae0faf92-412b-4fc7-8fe5-2869841d2b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e2bac714-6fe7-453b-8aae-e914fe671032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e2bac714-6fe7-453b-8aae-e914fe671032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_907828f4-9e44-4237-b59f-7dbefb7ce980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_907828f4-9e44-4237-b59f-7dbefb7ce980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_09065252-27d5-41df-9d36-e0c70d04cdbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_NetIncomeLoss_09065252-27d5-41df-9d36-e0c70d04cdbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_67194260-1ef5-4a5f-9ada-378ec3603547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_67194260-1ef5-4a5f-9ada-378ec3603547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1ce6c7bd-2a96-4f21-8c3c-65a8eebb0892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_67194260-1ef5-4a5f-9ada-378ec3603547" xlink:to="loc_us-gaap_EarningsPerShareBasic_1ce6c7bd-2a96-4f21-8c3c-65a8eebb0892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c306dfcf-0af7-40c4-adc0-179bf6ca258f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_67194260-1ef5-4a5f-9ada-378ec3603547" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c306dfcf-0af7-40c4-adc0-179bf6ca258f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_6c1f60b2-84de-49b0-bd88-ac1eda147427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_6c1f60b2-84de-49b0-bd88-ac1eda147427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_77707b12-7f90-4c98-825b-f82a94226895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_6c1f60b2-84de-49b0-bd88-ac1eda147427" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_77707b12-7f90-4c98-825b-f82a94226895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7deb9fcc-1881-428d-a6af-b8db241acc60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_6c1f60b2-84de-49b0-bd88-ac1eda147427" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7deb9fcc-1881-428d-a6af-b8db241acc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_736924e0-079e-4778-aeaf-c97098a843ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_NetIncomeLoss_736924e0-079e-4778-aeaf-c97098a843ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_f30350ff-66f9-4ea9-a525-0a172d928eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfOtherComprehensiveIncomeAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_f30350ff-66f9-4ea9-a525-0a172d928eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_360d2c16-db9a-4bed-bbda-8c79d86a0466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_f30350ff-66f9-4ea9-a525-0a172d928eed" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_360d2c16-db9a-4bed-bbda-8c79d86a0466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6269c2f9-d1da-4392-85b0-70bf0a2eaafb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_39e02d3c-36f8-415e-89f1-b105ebb0995a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_6269c2f9-d1da-4392-85b0-70bf0a2eaafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="aort-20220930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_55c90cc1-c181-44e0-a731-70c22258f587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b21c02ec-e2ef-41ac-b975-55bbf1343cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_55c90cc1-c181-44e0-a731-70c22258f587" xlink:to="loc_us-gaap_AssetsAbstract_b21c02ec-e2ef-41ac-b975-55bbf1343cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_9b534d67-11cf-423b-a231-35e224733fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b21c02ec-e2ef-41ac-b975-55bbf1343cb0" xlink:to="loc_us-gaap_AssetsCurrentAbstract_9b534d67-11cf-423b-a231-35e224733fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_830a3add-2b39-4ef2-8748-d681f65370b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b534d67-11cf-423b-a231-35e224733fde" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_830a3add-2b39-4ef2-8748-d681f65370b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_33053536-59d7-4de9-811e-148886dcb4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b534d67-11cf-423b-a231-35e224733fde" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_33053536-59d7-4de9-811e-148886dcb4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_75660a89-66ee-4ebb-90b4-434f7bfdf033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b534d67-11cf-423b-a231-35e224733fde" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_75660a89-66ee-4ebb-90b4-434f7bfdf033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7f99a179-6d4a-4ce1-85f6-8df8b55dac41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b534d67-11cf-423b-a231-35e224733fde" xlink:to="loc_us-gaap_InventoryNet_7f99a179-6d4a-4ce1-85f6-8df8b55dac41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DeferredPreservationCosts_270b4201-01f9-4547-b756-8e892917ed89" xlink:href="aort-20220930.xsd#aort_DeferredPreservationCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b534d67-11cf-423b-a231-35e224733fde" xlink:to="loc_aort_DeferredPreservationCosts_270b4201-01f9-4547-b756-8e892917ed89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_297ee561-9e8e-4a14-9057-79fda4283777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b534d67-11cf-423b-a231-35e224733fde" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_297ee561-9e8e-4a14-9057-79fda4283777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5bfd4175-8f75-4be3-bf4c-ef19e88a7d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9b534d67-11cf-423b-a231-35e224733fde" xlink:to="loc_us-gaap_AssetsCurrent_5bfd4175-8f75-4be3-bf4c-ef19e88a7d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_794b02e9-809f-4b6b-be1d-6e2620cb0fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b21c02ec-e2ef-41ac-b975-55bbf1343cb0" xlink:to="loc_us-gaap_Goodwill_794b02e9-809f-4b6b-be1d-6e2620cb0fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_47106625-4a93-41ab-a7a1-4c443aa8d753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b21c02ec-e2ef-41ac-b975-55bbf1343cb0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_47106625-4a93-41ab-a7a1-4c443aa8d753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1ba1f941-242b-4601-bf5d-4074abd51fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b21c02ec-e2ef-41ac-b975-55bbf1343cb0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1ba1f941-242b-4601-bf5d-4074abd51fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bf8cc558-faba-4995-a2c9-c361fe651e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b21c02ec-e2ef-41ac-b975-55bbf1343cb0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_bf8cc558-faba-4995-a2c9-c361fe651e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_8e018997-ff82-4831-a31f-3bd9a576274c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b21c02ec-e2ef-41ac-b975-55bbf1343cb0" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_8e018997-ff82-4831-a31f-3bd9a576274c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ca81fdb3-2491-4093-861b-40427e73fa84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b21c02ec-e2ef-41ac-b975-55bbf1343cb0" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ca81fdb3-2491-4093-861b-40427e73fa84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_77bb6bca-767a-4f5b-8645-5d2e4b5dee17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b21c02ec-e2ef-41ac-b975-55bbf1343cb0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_77bb6bca-767a-4f5b-8645-5d2e4b5dee17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_225bbeaf-3923-499a-b279-fa77900bc377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b21c02ec-e2ef-41ac-b975-55bbf1343cb0" xlink:to="loc_us-gaap_Assets_225bbeaf-3923-499a-b279-fa77900bc377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_55c90cc1-c181-44e0-a731-70c22258f587" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_5a8b4448-939f-4e09-bcc7-c3cb46299f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_5a8b4448-939f-4e09-bcc7-c3cb46299f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_828f19db-da6a-411f-8173-8636b2f885de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5a8b4448-939f-4e09-bcc7-c3cb46299f16" xlink:to="loc_us-gaap_AccountsPayableCurrent_828f19db-da6a-411f-8173-8636b2f885de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6e191efc-0199-4508-83a5-e910d3fb9fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5a8b4448-939f-4e09-bcc7-c3cb46299f16" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6e191efc-0199-4508-83a5-e910d3fb9fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_dc60d971-ca31-4600-adca-c50f4b9cfabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5a8b4448-939f-4e09-bcc7-c3cb46299f16" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_dc60d971-ca31-4600-adca-c50f4b9cfabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_dbf88a6f-ea0c-469d-b029-e8e5696774b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5a8b4448-939f-4e09-bcc7-c3cb46299f16" xlink:to="loc_us-gaap_TaxesPayableCurrent_dbf88a6f-ea0c-469d-b029-e8e5696774b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AccruedProcurementFees_5ba95cb9-400a-41a2-8021-85c7d6d45a9f" xlink:href="aort-20220930.xsd#aort_AccruedProcurementFees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5a8b4448-939f-4e09-bcc7-c3cb46299f16" xlink:to="loc_aort_AccruedProcurementFees_5ba95cb9-400a-41a2-8021-85c7d6d45a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ff1c1850-bc65-4e3e-8efd-7dc7721ca76f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5a8b4448-939f-4e09-bcc7-c3cb46299f16" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ff1c1850-bc65-4e3e-8efd-7dc7721ca76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_87e3972d-ea9d-40d3-b577-10fb4f5da36a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5a8b4448-939f-4e09-bcc7-c3cb46299f16" xlink:to="loc_us-gaap_LongTermDebtCurrent_87e3972d-ea9d-40d3-b577-10fb4f5da36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_aa1d9bf3-3b8a-4e44-9b67-9abc93834295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5a8b4448-939f-4e09-bcc7-c3cb46299f16" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_aa1d9bf3-3b8a-4e44-9b67-9abc93834295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_af281caa-38f8-4353-b23f-f9614cc36fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5a8b4448-939f-4e09-bcc7-c3cb46299f16" xlink:to="loc_us-gaap_LiabilitiesCurrent_af281caa-38f8-4353-b23f-f9614cc36fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_07ae1c4a-a2b9-4ff8-b7ef-1add0bd422aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_07ae1c4a-a2b9-4ff8-b7ef-1add0bd422aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_dd81ac7b-9568-4ca5-9615-ea3e5c1a9eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_dd81ac7b-9568-4ca5-9615-ea3e5c1a9eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_67f49a5c-a220-4850-ba84-d652fa70a5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_67f49a5c-a220-4850-ba84-d652fa70a5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_d5b19545-6fb4-4ece-bbc0-4fe8a135bd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_d5b19545-6fb4-4ece-bbc0-4fe8a135bd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3f46e290-80c5-4780-967c-441ea4ce79a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3f46e290-80c5-4780-967c-441ea4ce79a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_48ef7b66-e159-4b88-9713-4623a3e58edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_48ef7b66-e159-4b88-9713-4623a3e58edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_de9ff6c5-7a27-4d3a-9950-8197a9b84f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_de9ff6c5-7a27-4d3a-9950-8197a9b84f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_01ae6d13-40fd-4d3b-9a36-a408ac1fb587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:to="loc_us-gaap_Liabilities_01ae6d13-40fd-4d3b-9a36-a408ac1fb587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3ab3f39d-fbb4-4910-9b43-a88131d9df87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3ab3f39d-fbb4-4910-9b43-a88131d9df87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_a40ba1c9-8444-4b52-aa48-1bf7cb113f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:to="loc_us-gaap_StockholdersEquityAbstract_a40ba1c9-8444-4b52-aa48-1bf7cb113f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9847cb81-e35d-498c-873d-e7692eb84786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a40ba1c9-8444-4b52-aa48-1bf7cb113f4b" xlink:to="loc_us-gaap_PreferredStockValue_9847cb81-e35d-498c-873d-e7692eb84786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c44ae416-0cee-48c1-8bea-f5d9e906ba6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a40ba1c9-8444-4b52-aa48-1bf7cb113f4b" xlink:to="loc_us-gaap_CommonStockValue_c44ae416-0cee-48c1-8bea-f5d9e906ba6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ec950f20-7ce0-44f4-b4f0-32d43c108761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a40ba1c9-8444-4b52-aa48-1bf7cb113f4b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ec950f20-7ce0-44f4-b4f0-32d43c108761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_16d5c13b-95a9-4ad2-85a3-d40115511b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a40ba1c9-8444-4b52-aa48-1bf7cb113f4b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_16d5c13b-95a9-4ad2-85a3-d40115511b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_34e14b78-7250-4715-9bcc-f7554f9371fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a40ba1c9-8444-4b52-aa48-1bf7cb113f4b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_34e14b78-7250-4715-9bcc-f7554f9371fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_4bbf50f3-7cc0-4753-a75c-1acb357b7b81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a40ba1c9-8444-4b52-aa48-1bf7cb113f4b" xlink:to="loc_us-gaap_TreasuryStockCommonValue_4bbf50f3-7cc0-4753-a75c-1acb357b7b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_82995492-afaa-40df-96c9-4ecd96f6c254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a40ba1c9-8444-4b52-aa48-1bf7cb113f4b" xlink:to="loc_us-gaap_StockholdersEquity_82995492-afaa-40df-96c9-4ecd96f6c254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8deddbf8-a7ea-4cd0-82b0-21241b62493c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cb416cd4-9e61-49d4-bbc6-3c6484714256" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8deddbf8-a7ea-4cd0-82b0-21241b62493c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="aort-20220930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bdf3a086-d5ae-4735-9f79-b66cdce4efbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d45313b0-ac89-44b7-a2d7-84326a1ee729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bdf3a086-d5ae-4735-9f79-b66cdce4efbe" xlink:to="loc_us-gaap_CommonStockSharesIssued_d45313b0-ac89-44b7-a2d7-84326a1ee729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_f1dcc823-fe09-45ac-b92b-ef6e6567e2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bdf3a086-d5ae-4735-9f79-b66cdce4efbe" xlink:to="loc_us-gaap_TreasuryStockCommonShares_f1dcc823-fe09-45ac-b92b-ef6e6567e2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="aort-20220930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5d68ecc3-983c-4110-86cd-8dd19023e534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_760f63ac-6f4d-452c-96b6-74c8807d81f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5d68ecc3-983c-4110-86cd-8dd19023e534" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_760f63ac-6f4d-452c-96b6-74c8807d81f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e3ee4ccb-d08b-4dcd-99eb-f60228abfc34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_760f63ac-6f4d-452c-96b6-74c8807d81f8" xlink:to="loc_us-gaap_NetIncomeLoss_e3ee4ccb-d08b-4dcd-99eb-f60228abfc34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e25a6f4-e6ce-46b3-989e-40b9ee086751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_760f63ac-6f4d-452c-96b6-74c8807d81f8" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e25a6f4-e6ce-46b3-989e-40b9ee086751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2da832a5-35c4-497f-8faf-1d0c05b8663e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e25a6f4-e6ce-46b3-989e-40b9ee086751" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2da832a5-35c4-497f-8faf-1d0c05b8663e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9aa52db4-8456-4d2b-aab8-13bdb0cd54ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e25a6f4-e6ce-46b3-989e-40b9ee086751" xlink:to="loc_us-gaap_ShareBasedCompensation_9aa52db4-8456-4d2b-aab8-13bdb0cd54ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_NoncashLeaseExpense_4b6cdcdb-4220-4a3b-a063-57559c938b19" xlink:href="aort-20220930.xsd#aort_NoncashLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e25a6f4-e6ce-46b3-989e-40b9ee086751" xlink:to="loc_aort_NoncashLeaseExpense_4b6cdcdb-4220-4a3b-a063-57559c938b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_6afbdafc-5c1a-466b-9af5-38fde2855da4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e25a6f4-e6ce-46b3-989e-40b9ee086751" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_6afbdafc-5c1a-466b-9af5-38fde2855da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_WriteDownOfDeferredPreservationCostsAndInventories_b5fb424c-7557-4b2b-a54c-27409a2db2f8" xlink:href="aort-20220930.xsd#aort_WriteDownOfDeferredPreservationCostsAndInventories"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e25a6f4-e6ce-46b3-989e-40b9ee086751" xlink:to="loc_aort_WriteDownOfDeferredPreservationCostsAndInventories_b5fb424c-7557-4b2b-a54c-27409a2db2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_NoncashInterestExpense_7b50a0a4-66b7-40fc-a71a-f81a382e5b6f" xlink:href="aort-20220930.xsd#aort_NoncashInterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e25a6f4-e6ce-46b3-989e-40b9ee086751" xlink:to="loc_aort_NoncashInterestExpense_7b50a0a4-66b7-40fc-a71a-f81a382e5b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f2dae5c1-220f-40f9-91fe-21df5616dde4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e25a6f4-e6ce-46b3-989e-40b9ee086751" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f2dae5c1-220f-40f9-91fe-21df5616dde4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_24b1990d-aae5-4d0d-910e-ea724d9d1e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e25a6f4-e6ce-46b3-989e-40b9ee086751" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_24b1990d-aae5-4d0d-910e-ea724d9d1e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashExpense_fb4dab06-af22-417c-ac05-bb5ade5054cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e25a6f4-e6ce-46b3-989e-40b9ee086751" xlink:to="loc_us-gaap_OtherNoncashExpense_fb4dab06-af22-417c-ac05-bb5ade5054cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_85abcdaf-29b8-4892-a3b3-bf4a144b2efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e25a6f4-e6ce-46b3-989e-40b9ee086751" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_85abcdaf-29b8-4892-a3b3-bf4a144b2efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_55f20c8c-6959-4730-86b2-fd13992e8045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_85abcdaf-29b8-4892-a3b3-bf4a144b2efd" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_55f20c8c-6959-4730-86b2-fd13992e8045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8d419a5c-42c6-403c-a756-bc1f370299d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_85abcdaf-29b8-4892-a3b3-bf4a144b2efd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8d419a5c-42c6-403c-a756-bc1f370299d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_743a5452-7d57-48b9-8fa4-cff5fb1fd487" xlink:href="aort-20220930.xsd#aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_85abcdaf-29b8-4892-a3b3-bf4a144b2efd" xlink:to="loc_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_743a5452-7d57-48b9-8fa4-cff5fb1fd487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_63df0bab-91df-4ee0-8481-191b75ae2f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_85abcdaf-29b8-4892-a3b3-bf4a144b2efd" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_63df0bab-91df-4ee0-8481-191b75ae2f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f05f009e-b275-44e5-9469-753b4bb837a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_760f63ac-6f4d-452c-96b6-74c8807d81f8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f05f009e-b275-44e5-9469-753b4bb837a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_81731bb5-ecb9-45e9-9c36-12e21388622e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5d68ecc3-983c-4110-86cd-8dd19023e534" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_81731bb5-ecb9-45e9-9c36-12e21388622e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b9267f05-5fc3-4023-98c5-23d6a35f8c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_81731bb5-ecb9-45e9-9c36-12e21388622e" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b9267f05-5fc3-4023-98c5-23d6a35f8c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3795e08a-63df-42f2-a6f5-09018ef64223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_81731bb5-ecb9-45e9-9c36-12e21388622e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3795e08a-63df-42f2-a6f5-09018ef64223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_a3e6a63a-2255-4b07-92f0-fce423942d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_81731bb5-ecb9-45e9-9c36-12e21388622e" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_a3e6a63a-2255-4b07-92f0-fce423942d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ea9a17a6-ac60-494a-a398-e21721561c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_81731bb5-ecb9-45e9-9c36-12e21388622e" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ea9a17a6-ac60-494a-a398-e21721561c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d270701f-b42c-4599-8199-1ce507db5521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_81731bb5-ecb9-45e9-9c36-12e21388622e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d270701f-b42c-4599-8199-1ce507db5521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eeaf89e5-6667-4af0-9d5d-4cb71fd63c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5d68ecc3-983c-4110-86cd-8dd19023e534" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eeaf89e5-6667-4af0-9d5d-4cb71fd63c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ac47ddf8-051c-4682-845a-8ab592788c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eeaf89e5-6667-4af0-9d5d-4cb71fd63c1c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ac47ddf8-051c-4682-845a-8ab592788c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9f611909-2a24-4b36-991a-f0eebf44428d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eeaf89e5-6667-4af0-9d5d-4cb71fd63c1c" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9f611909-2a24-4b36-991a-f0eebf44428d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_a0d7b969-8ba2-4470-a544-d8c11878f22f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eeaf89e5-6667-4af0-9d5d-4cb71fd63c1c" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_a0d7b969-8ba2-4470-a544-d8c11878f22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4e01f3b2-ec38-467d-9829-eb4343f232fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eeaf89e5-6667-4af0-9d5d-4cb71fd63c1c" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4e01f3b2-ec38-467d-9829-eb4343f232fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_41c47e30-6983-49b8-9e83-f0a411f4ca5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eeaf89e5-6667-4af0-9d5d-4cb71fd63c1c" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_41c47e30-6983-49b8-9e83-f0a411f4ca5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0375930b-2602-4088-b4b5-a1cc006ba7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_eeaf89e5-6667-4af0-9d5d-4cb71fd63c1c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0375930b-2602-4088-b4b5-a1cc006ba7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7f3e6950-8db1-4b4f-b034-13fc97589321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5d68ecc3-983c-4110-86cd-8dd19023e534" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7f3e6950-8db1-4b4f-b034-13fc97589321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_44868d6c-21bc-4851-8110-dc70d391d54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5d68ecc3-983c-4110-86cd-8dd19023e534" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_44868d6c-21bc-4851-8110-dc70d391d54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b7c5b6ff-18a8-4aaf-b5ed-0639874bdac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5d68ecc3-983c-4110-86cd-8dd19023e534" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b7c5b6ff-18a8-4aaf-b5ed-0639874bdac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1fbc186f-398b-4b4c-8e29-443ed73a37e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5d68ecc3-983c-4110-86cd-8dd19023e534" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1fbc186f-398b-4b4c-8e29-443ed73a37e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="aort-20220930.xsd#CondensedConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_65ec3c6f-c755-4c44-95a1-0e6353d3605f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f8296294-eac2-4e7d-b557-014b519fc7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_65ec3c6f-c755-4c44-95a1-0e6353d3605f" xlink:to="loc_us-gaap_StatementTable_f8296294-eac2-4e7d-b557-014b519fc7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_abe28156-fd4c-42ed-977d-9e9bacc38d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f8296294-eac2-4e7d-b557-014b519fc7b9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_abe28156-fd4c-42ed-977d-9e9bacc38d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abe28156-fd4c-42ed-977d-9e9bacc38d4b" xlink:to="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c3d68199-89eb-443e-ad5d-6c2502f6b2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:to="loc_us-gaap_CommonStockMember_c3d68199-89eb-443e-ad5d-6c2502f6b2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_13651831-ff9c-4e79-ae6b-19103f32dfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_13651831-ff9c-4e79-ae6b-19103f32dfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_2c327d22-8bd8-42dc-a9be-94b376e8edf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:to="loc_us-gaap_RetainedEarningsMember_2c327d22-8bd8-42dc-a9be-94b376e8edf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c5f66bf6-9266-4da9-a233-96655fbbfd49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c5f66bf6-9266-4da9-a233-96655fbbfd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_6d251667-9253-4324-9dbe-dfabf4bb1294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c21cc046-bb7c-4c9f-99b9-5bba7e8487d2" xlink:to="loc_us-gaap_TreasuryStockCommonMember_6d251667-9253-4324-9dbe-dfabf4bb1294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1a7348fb-eb02-4eb2-ada2-d3fc65aa0096" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f8296294-eac2-4e7d-b557-014b519fc7b9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1a7348fb-eb02-4eb2-ada2-d3fc65aa0096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_264d1504-d45d-4080-9647-0788fa6454f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1a7348fb-eb02-4eb2-ada2-d3fc65aa0096" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_264d1504-d45d-4080-9647-0788fa6454f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_d9e0f060-a667-4000-abe5-bdcdd91499e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_264d1504-d45d-4080-9647-0788fa6454f1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_d9e0f060-a667-4000-abe5-bdcdd91499e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4d6d8d12-4ba0-4ce4-b19c-d63cdd7e20ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f8296294-eac2-4e7d-b557-014b519fc7b9" xlink:to="loc_us-gaap_StatementLineItems_4d6d8d12-4ba0-4ce4-b19c-d63cdd7e20ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4d6d8d12-4ba0-4ce4-b19c-d63cdd7e20ae" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_91e08278-5059-46b5-bcff-a5a388329d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_91e08278-5059-46b5-bcff-a5a388329d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6b1260b9-d6db-4048-b9ab-0ec5db7a2587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockholdersEquity_6b1260b9-d6db-4048-b9ab-0ec5db7a2587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_27c14f21-3087-4c24-980f-6b4b50c705c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_TreasuryStockCommonShares_27c14f21-3087-4c24-980f-6b4b50c705c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_2a1c818b-31f2-4b9e-9452-66dc26898d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_TreasuryStockCommonValue_2a1c818b-31f2-4b9e-9452-66dc26898d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f2da7b7c-931b-407e-8972-a61a86407626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_NetIncomeLoss_f2da7b7c-931b-407e-8972-a61a86407626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1a9bbb24-16aa-4d96-ad95-6e750efa72e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1a9bbb24-16aa-4d96-ad95-6e750efa72e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_32634fb1-fc14-4dec-8358-d4110e581e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_32634fb1-fc14-4dec-8358-d4110e581e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4004b7be-0aa9-4251-b949-f0b87e405afd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_4004b7be-0aa9-4251-b949-f0b87e405afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3725c47d-101b-43c5-b0b9-43a20d3b9f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3725c47d-101b-43c5-b0b9-43a20d3b9f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_138018c1-e9b9-422e-b4dc-0a6a58141e38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_138018c1-e9b9-422e-b4dc-0a6a58141e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9cc8c7a2-6af0-43cc-b143-2b17e48e0416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9cc8c7a2-6af0-43cc-b143-2b17e48e0416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_ab47e2c0-53a5-4781-b206-0db2b91e0d55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_ab47e2c0-53a5-4781-b206-0db2b91e0d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3b14e702-b1c8-4b1a-b82b-99ce2ba2f66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3b14e702-b1c8-4b1a-b82b-99ce2ba2f66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_1186ee1e-22e9-4d1f-b380-bb099e53d716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_1186ee1e-22e9-4d1f-b380-bb099e53d716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_a952899f-338f-4ed3-af2f-353ee77777da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_a952899f-338f-4ed3-af2f-353ee77777da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e514c218-5554-4215-a3ca-0f95754c30b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e514c218-5554-4215-a3ca-0f95754c30b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9622c86a-a080-4407-8cb5-4898b11ff1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_StockholdersEquity_9622c86a-a080-4407-8cb5-4898b11ff1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_090f7648-dd45-4563-a72b-6e91ffa31ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_TreasuryStockCommonShares_090f7648-dd45-4563-a72b-6e91ffa31ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_69e4b06b-57ad-4c37-becf-1a7f78e18196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1fc754d9-fc5f-4de4-bd19-a515e6a2f10e" xlink:to="loc_us-gaap_TreasuryStockCommonValue_69e4b06b-57ad-4c37-becf-1a7f78e18196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="aort-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_13135e4f-a7f8-49ca-8d81-563e8966eae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting_7d7f3c60-6067-4608-b789-3f31aff19f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_13135e4f-a7f8-49ca-8d81-563e8966eae0" xlink:to="loc_us-gaap_BasisOfAccounting_7d7f3c60-6067-4608-b789-3f31aff19f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SaleofPerClot" xlink:type="simple" xlink:href="aort-20220930.xsd#SaleofPerClot"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SaleofPerClot" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_a40cd366-73b6-494a-bd2c-59896b3e0a78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c3cf7b51-840e-4e93-a253-6a0b3734717c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_a40cd366-73b6-494a-bd2c-59896b3e0a78" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c3cf7b51-840e-4e93-a253-6a0b3734717c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstruments" xlink:type="simple" xlink:href="aort-20220930.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_742461f4-b9c1-448a-b7cf-b9e4fbaad843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_4c5ef706-8581-4e52-9e64-903344440fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_742461f4-b9c1-448a-b7cf-b9e4fbaad843" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_4c5ef706-8581-4e52-9e64-903344440fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CashEquivalents" xlink:type="simple" xlink:href="aort-20220930.xsd#CashEquivalents"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CashEquivalents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_d962df25-58af-4b80-8826-8899c0c1a1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_3c87efee-c648-419d-9e40-94685ab8ced9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_d962df25-58af-4b80-8826-8899c0c1a1f7" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_3c87efee-c648-419d-9e40-94685ab8ced9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts" xlink:type="simple" xlink:href="aort-20220930.xsd#InventoriesnetandDeferredPreservationCosts"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_e6b54a4c-7c86-4578-b82c-bdbc532c20f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_c35f2fa4-9849-4675-bb3e-a69bea48c551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e6b54a4c-7c86-4578-b82c-bdbc532c20f4" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_c35f2fa4-9849-4675-bb3e-a69bea48c551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="aort-20220930.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9bd25b0b-5834-493a-86b4-ee4e4667654b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5a3391af-3872-4003-a816-79c7e5d23cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9bd25b0b-5834-493a-86b4-ee4e4667654b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5a3391af-3872-4003-a816-79c7e5d23cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/IncomeTaxes" xlink:type="simple" xlink:href="aort-20220930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3f3c0956-17e2-4be6-b80c-5c88850685fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_fe17a027-7c6b-4fa0-8d9b-79928dea3b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3f3c0956-17e2-4be6-b80c-5c88850685fb" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_fe17a027-7c6b-4fa0-8d9b-79928dea3b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/Leases" xlink:type="simple" xlink:href="aort-20220930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_72ee0caa-b56a-4780-86fa-281f8c7c0230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_de72d536-6e02-4132-b659-11ec20057f40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_72ee0caa-b56a-4780-86fa-281f8c7c0230" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_de72d536-6e02-4132-b659-11ec20057f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/Debt" xlink:type="simple" xlink:href="aort-20220930.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dc6e9db4-7d77-46c8-92cf-b411ed689dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_90172e6e-bc3d-4e23-b46f-678241d7ac34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dc6e9db4-7d77-46c8-92cf-b411ed689dd7" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_90172e6e-bc3d-4e23-b46f-678241d7ac34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="aort-20220930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6acf3c6f-5ee6-462e-94c3-a99e4aee7312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e5c20c71-dc25-49de-b422-968f18db5d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6acf3c6f-5ee6-462e-94c3-a99e4aee7312" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e5c20c71-dc25-49de-b422-968f18db5d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/RevenueRecognition" xlink:type="simple" xlink:href="aort-20220930.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e1cf4be4-a3da-4402-b7fc-22530ce61c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4c521f47-63a3-4e87-8b9d-33e442e5c986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e1cf4be4-a3da-4402-b7fc-22530ce61c4b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4c521f47-63a3-4e87-8b9d-33e442e5c986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensation" xlink:type="simple" xlink:href="aort-20220930.xsd#StockCompensation"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/StockCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_353c6f7b-abf2-4fb8-a945-a748990536d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fe785f66-8734-4387-a72e-f6c346df4999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_353c6f7b-abf2-4fb8-a945-a748990536d4" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fe785f66-8734-4387-a72e-f6c346df4999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LossEarningsPerCommonShare" xlink:type="simple" xlink:href="aort-20220930.xsd#LossEarningsPerCommonShare"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LossEarningsPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_22d72b89-ab88-4203-9f5b-8552aa2fc8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_b94ca049-862b-4f1f-b5ca-5bca849eecaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_22d72b89-ab88-4203-9f5b-8552aa2fc8f8" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_b94ca049-862b-4f1f-b5ca-5bca849eecaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformation" xlink:type="simple" xlink:href="aort-20220930.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4a9a3f52-6cd7-4d85-a8ae-6f32844edde4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_43676dd4-286b-4bc8-a391-e544555c4949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4a9a3f52-6cd7-4d85-a8ae-6f32844edde4" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_43676dd4-286b-4bc8-a391-e544555c4949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="aort-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_06f9945c-15b5-423c-bff6-eece7866742c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_73278660-a2b8-4326-aee5-ae7299a7ee45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_06f9945c-15b5-423c-bff6-eece7866742c" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_73278660-a2b8-4326-aee5-ae7299a7ee45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="aort-20220930.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cd65f03d-b020-4468-b1d5-8c1b89848589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_f966ae80-685e-4d30-9417-a1dbfe58e8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cd65f03d-b020-4468-b1d5-8c1b89848589" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_f966ae80-685e-4d30-9417-a1dbfe58e8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_70b949c4-cb32-4558-b67b-8ed9c231ffde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cd65f03d-b020-4468-b1d5-8c1b89848589" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_70b949c4-cb32-4558-b67b-8ed9c231ffde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CashEquivalentsTables" xlink:type="simple" xlink:href="aort-20220930.xsd#CashEquivalentsTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CashEquivalentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_a3b76885-5e0c-48e2-a846-efb133620d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_f622221a-ea95-4e15-843e-9407b4761d16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_a3b76885-5e0c-48e2-a846-efb133620d87" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_f622221a-ea95-4e15-843e-9407b4761d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/InventoriesNetAndDeferredPreservationCostsTables" xlink:type="simple" xlink:href="aort-20220930.xsd#InventoriesNetAndDeferredPreservationCostsTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/InventoriesNetAndDeferredPreservationCostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6185065c-abb9-4933-b5ab-5a24a1ca9f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_ed979339-1f7d-411e-9d5b-c899b7b2f0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6185065c-abb9-4933-b5ab-5a24a1ca9f3d" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_ed979339-1f7d-411e-9d5b-c899b7b2f0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="aort-20220930.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ecf19eed-d29f-4f25-810d-dc96c7287368" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_9108a2fd-6026-4d12-9a39-9006aa824f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ecf19eed-d29f-4f25-810d-dc96c7287368" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_9108a2fd-6026-4d12-9a39-9006aa824f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_107e8be3-6951-4f1d-ac93-ca7e3fd5974e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ecf19eed-d29f-4f25-810d-dc96c7287368" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_107e8be3-6951-4f1d-ac93-ca7e3fd5974e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_852c32ac-c346-472d-acc9-1766f8a8e1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ecf19eed-d29f-4f25-810d-dc96c7287368" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_852c32ac-c346-472d-acc9-1766f8a8e1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_79516f5c-16cb-422a-9b9e-a7227c5c6a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ecf19eed-d29f-4f25-810d-dc96c7287368" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_79516f5c-16cb-422a-9b9e-a7227c5c6a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7942b760-52c9-450d-a5ac-329169d23fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ecf19eed-d29f-4f25-810d-dc96c7287368" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7942b760-52c9-450d-a5ac-329169d23fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesTables" xlink:type="simple" xlink:href="aort-20220930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_40915911-185c-4c18-a57f-15bba05d21ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AssetsAndLiabilitiesLesseeTableTextBlock_87853120-31e1-4ad4-ada5-f622000ebff9" xlink:href="aort-20220930.xsd#aort_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_40915911-185c-4c18-a57f-15bba05d21ef" xlink:to="loc_aort_AssetsAndLiabilitiesLesseeTableTextBlock_87853120-31e1-4ad4-ada5-f622000ebff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_4aee62de-46e4-4479-b04d-12357dbd2447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_40915911-185c-4c18-a57f-15bba05d21ef" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_4aee62de-46e4-4479-b04d-12357dbd2447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e074e574-b032-4efa-9f67-593c7c030e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_40915911-185c-4c18-a57f-15bba05d21ef" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e074e574-b032-4efa-9f67-593c7c030e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_61688aca-435a-4c3f-ab36-0dbbeba192f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_40915911-185c-4c18-a57f-15bba05d21ef" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_61688aca-435a-4c3f-ab36-0dbbeba192f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/DebtTables" xlink:type="simple" xlink:href="aort-20220930.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8777b311-3ba8-44cc-8c95-0724f3ebc919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_da832c08-ba4c-4c7b-93fa-5c7e4cc35bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8777b311-3ba8-44cc-8c95-0724f3ebc919" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_da832c08-ba4c-4c7b-93fa-5c7e4cc35bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="aort-20220930.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_26c078db-1f01-49b1-baff-92d81503032c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_667f93ff-e932-41ea-8794-b8daf39941f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_26c078db-1f01-49b1-baff-92d81503032c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_667f93ff-e932-41ea-8794-b8daf39941f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationTables" xlink:type="simple" xlink:href="aort-20220930.xsd#StockCompensationTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/StockCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b835de0e-f03f-4807-baab-ba4fac91879e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c85784cd-27e1-4788-9cd0-1a1331aae3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b835de0e-f03f-4807-baab-ba4fac91879e" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c85784cd-27e1-4788-9cd0-1a1331aae3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_91c9a298-3d81-4f6e-932f-c9078e061dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b835de0e-f03f-4807-baab-ba4fac91879e" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_91c9a298-3d81-4f6e-932f-c9078e061dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LossEarningsPerCommonShareTables" xlink:type="simple" xlink:href="aort-20220930.xsd#LossEarningsPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LossEarningsPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e6bb6c89-d154-4576-8782-5ae4b943f040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5f25b11a-da56-42bd-aa19-abc5ab38ba5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e6bb6c89-d154-4576-8782-5ae4b943f040" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5f25b11a-da56-42bd-aa19-abc5ab38ba5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="aort-20220930.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f352287a-21e0-4d52-bde3-490784d2fe3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5d697d77-99ee-46ba-8155-970940318496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f352287a-21e0-4d52-bde3-490784d2fe3d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5d697d77-99ee-46ba-8155-970940318496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_7424fee6-bbf9-4caf-8f7c-bffcc99213a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f352287a-21e0-4d52-bde3-490784d2fe3d" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_7424fee6-bbf9-4caf-8f7c-bffcc99213a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SaleofPerClotDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#SaleofPerClotDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SaleofPerClotDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_bd8f0fe0-0fab-4038-ba7e-815d1d61d2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5128a21f-f42b-4cc8-b019-8c70c313621d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_bd8f0fe0-0fab-4038-ba7e-815d1d61d2b0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5128a21f-f42b-4cc8-b019-8c70c313621d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d415482a-1894-4da4-a0fa-39d973f544f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5128a21f-f42b-4cc8-b019-8c70c313621d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d415482a-1894-4da4-a0fa-39d973f544f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3977935e-a1e8-4e3b-a5bb-e32a63457ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d415482a-1894-4da4-a0fa-39d973f544f7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3977935e-a1e8-4e3b-a5bb-e32a63457ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PerClotMember_496f99d8-c173-4f18-bd22-4a8ddde0ace6" xlink:href="aort-20220930.xsd#aort_PerClotMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3977935e-a1e8-4e3b-a5bb-e32a63457ffc" xlink:to="loc_aort_PerClotMember_496f99d8-c173-4f18-bd22-4a8ddde0ace6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_22c8cbc0-65c7-40d5-8c2c-cbb35175f5d1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5128a21f-f42b-4cc8-b019-8c70c313621d" xlink:to="loc_dei_LegalEntityAxis_22c8cbc0-65c7-40d5-8c2c-cbb35175f5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8629e155-b281-4141-98a0-671b7e888458" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_22c8cbc0-65c7-40d5-8c2c-cbb35175f5d1" xlink:to="loc_dei_EntityDomain_8629e155-b281-4141-98a0-671b7e888458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ArtivionInc.AndStarchMedicalInc.Member_1afd6119-b1c8-435d-b217-5615af7cb8df" xlink:href="aort-20220930.xsd#aort_ArtivionInc.AndStarchMedicalInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8629e155-b281-4141-98a0-671b7e888458" xlink:to="loc_aort_ArtivionInc.AndStarchMedicalInc.Member_1afd6119-b1c8-435d-b217-5615af7cb8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_StarchMedicalInc.Member_f2f33ab0-066e-46ce-a017-7618019e1e3e" xlink:href="aort-20220930.xsd#aort_StarchMedicalInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8629e155-b281-4141-98a0-671b7e888458" xlink:to="loc_aort_StarchMedicalInc.Member_f2f33ab0-066e-46ce-a017-7618019e1e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_70636cd9-b712-4b3b-a0e1-b9b979d4977f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5128a21f-f42b-4cc8-b019-8c70c313621d" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_70636cd9-b712-4b3b-a0e1-b9b979d4977f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_9c42897e-6e20-4a74-b6ca-424453bf8c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_70636cd9-b712-4b3b-a0e1-b9b979d4977f" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_9c42897e-6e20-4a74-b6ca-424453bf8c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PmaApprovalMember_6660946d-9569-4a96-919b-1364be38ca90" xlink:href="aort-20220930.xsd#aort_PmaApprovalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9c42897e-6e20-4a74-b6ca-424453bf8c8d" xlink:to="loc_aort_PmaApprovalMember_6660946d-9569-4a96-919b-1364be38ca90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_BaxterAchievementOfWorldwideSalesMember_6b9629d0-619e-4a68-a7ac-1f9dc02907ab" xlink:href="aort-20220930.xsd#aort_BaxterAchievementOfWorldwideSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9c42897e-6e20-4a74-b6ca-424453bf8c8d" xlink:to="loc_aort_BaxterAchievementOfWorldwideSalesMember_6b9629d0-619e-4a68-a7ac-1f9dc02907ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_TransferOfPerclotManufacturingEquipmentMember_eb91ae38-62a9-448a-a270-3322252327ca" xlink:href="aort-20220930.xsd#aort_TransferOfPerclotManufacturingEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_9c42897e-6e20-4a74-b6ca-424453bf8c8d" xlink:to="loc_aort_TransferOfPerclotManufacturingEquipmentMember_eb91ae38-62a9-448a-a270-3322252327ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5128a21f-f42b-4cc8-b019-8c70c313621d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_6ef3df5e-7062-414a-84cf-e6155f995020" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_6ef3df5e-7062-414a-84cf-e6155f995020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_e19d3079-e69c-42ec-bb24-f0706103ffea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_e19d3079-e69c-42ec-bb24-f0706103ffea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable_7038a6b7-8fbf-4eec-84ea-30f317b1c49d" xlink:href="aort-20220930.xsd#aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable_7038a6b7-8fbf-4eec-84ea-30f317b1c49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_a2d327e8-a3fb-4ce6-8598-745c02637fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_a2d327e8-a3fb-4ce6-8598-745c02637fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_c4de6d8d-35a8-4cca-82d3-da3e6a625b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_c4de6d8d-35a8-4cca-82d3-da3e6a625b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_1b3395a0-853f-4acd-bb02-02d9c86f0f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_bc29a07e-a0fa-4498-81cf-42e2165b7d8f" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_1b3395a0-853f-4acd-bb02-02d9c86f0f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_99f15859-9389-4f28-a321-825437cb632c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_565fe7ee-f2f5-4191-ab97-5bbe8bfe3602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_99f15859-9389-4f28-a321-825437cb632c" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_565fe7ee-f2f5-4191-ab97-5bbe8bfe3602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6802aa72-0ec4-40e2-bb78-5562ff2a6026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_565fe7ee-f2f5-4191-ab97-5bbe8bfe3602" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6802aa72-0ec4-40e2-bb78-5562ff2a6026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f91f53f8-e21b-4cf2-9abe-a055b6ba14dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6802aa72-0ec4-40e2-bb78-5562ff2a6026" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f91f53f8-e21b-4cf2-9abe-a055b6ba14dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e224f079-3989-4a8d-a3c8-506ecbad8f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f91f53f8-e21b-4cf2-9abe-a055b6ba14dd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e224f079-3989-4a8d-a3c8-506ecbad8f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_bf646943-06ea-48d5-a485-b1e874fe52be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f91f53f8-e21b-4cf2-9abe-a055b6ba14dd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_bf646943-06ea-48d5-a485-b1e874fe52be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_2eb26c24-6a0c-452f-9290-a7aff9a052c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f91f53f8-e21b-4cf2-9abe-a055b6ba14dd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_2eb26c24-6a0c-452f-9290-a7aff9a052c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_71c8e4b5-16e2-4fb0-acde-6755fc94bf31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_565fe7ee-f2f5-4191-ab97-5bbe8bfe3602" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_71c8e4b5-16e2-4fb0-acde-6755fc94bf31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f2e7fe3a-110f-479f-ad8c-e1de5b08882d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_71c8e4b5-16e2-4fb0-acde-6755fc94bf31" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f2e7fe3a-110f-479f-ad8c-e1de5b08882d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_607e5526-208a-4b65-8bef-a5eff89ef0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_f2e7fe3a-110f-479f-ad8c-e1de5b08882d" xlink:to="loc_us-gaap_MoneyMarketFundsMember_607e5526-208a-4b65-8bef-a5eff89ef0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98e0d65f-7099-4791-8c33-9768da3e6de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_565fe7ee-f2f5-4191-ab97-5bbe8bfe3602" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98e0d65f-7099-4791-8c33-9768da3e6de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_583d2a6e-9cee-48b3-a802-6bb1f3912b03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98e0d65f-7099-4791-8c33-9768da3e6de6" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_583d2a6e-9cee-48b3-a802-6bb1f3912b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6054ac10-85cd-4031-96fc-cc85e73a2146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98e0d65f-7099-4791-8c33-9768da3e6de6" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_6054ac10-85cd-4031-96fc-cc85e73a2146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ContingentConsiderationNoncurrentFairValue_4d1fdbf8-c676-4e43-ae3e-74da3600696d" xlink:href="aort-20220930.xsd#aort_ContingentConsiderationNoncurrentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98e0d65f-7099-4791-8c33-9768da3e6de6" xlink:to="loc_aort_ContingentConsiderationNoncurrentFairValue_4d1fdbf8-c676-4e43-ae3e-74da3600696d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_71b042bf-9cd2-4e46-831c-2571de906dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98e0d65f-7099-4791-8c33-9768da3e6de6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_71b042bf-9cd2-4e46-831c-2571de906dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c22f33a8-b0cd-46b2-87ab-3bc0e72a4914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b5a146b-0caa-469c-ad09-9f76ec2d9719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c22f33a8-b0cd-46b2-87ab-3bc0e72a4914" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b5a146b-0caa-469c-ad09-9f76ec2d9719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ee6126f9-3936-4d67-8e9d-38aad4740e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b5a146b-0caa-469c-ad09-9f76ec2d9719" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ee6126f9-3936-4d67-8e9d-38aad4740e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e907839a-5527-48aa-bd0a-97657dee5f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ee6126f9-3936-4d67-8e9d-38aad4740e63" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e907839a-5527-48aa-bd0a-97657dee5f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AscyrusMedicalLlcMember_4d10c377-eec9-4e75-aed7-d7db3221856e" xlink:href="aort-20220930.xsd#aort_AscyrusMedicalLlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e907839a-5527-48aa-bd0a-97657dee5f7e" xlink:to="loc_aort_AscyrusMedicalLlcMember_4d10c377-eec9-4e75-aed7-d7db3221856e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_faf80bc5-b7cb-4aba-a897-c6ede50d0c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b5a146b-0caa-469c-ad09-9f76ec2d9719" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_faf80bc5-b7cb-4aba-a897-c6ede50d0c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_09cb1d8d-5d8c-40f8-8768-3282ff844f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_faf80bc5-b7cb-4aba-a897-c6ede50d0c20" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_09cb1d8d-5d8c-40f8-8768-3282ff844f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_3e352786-7ecd-44a8-8f81-4fd907a966e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_09cb1d8d-5d8c-40f8-8768-3282ff844f6f" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_3e352786-7ecd-44a8-8f81-4fd907a966e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ba7b14-21c9-4500-bc6a-f34984dacc56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b5a146b-0caa-469c-ad09-9f76ec2d9719" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ba7b14-21c9-4500-bc6a-f34984dacc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6f6b4675-03a8-4592-bdc4-93e997b257cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ba7b14-21c9-4500-bc6a-f34984dacc56" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6f6b4675-03a8-4592-bdc4-93e997b257cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2624cef8-c9cd-4077-b96d-e4fc235337f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ba7b14-21c9-4500-bc6a-f34984dacc56" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2624cef8-c9cd-4077-b96d-e4fc235337f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_7b2c1f58-9737-4ab0-aed3-73e18e5e9e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ba7b14-21c9-4500-bc6a-f34984dacc56" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_7b2c1f58-9737-4ab0-aed3-73e18e5e9e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_39594f90-059d-49da-a8d4-2c8066125053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_87ba7b14-21c9-4500-bc6a-f34984dacc56" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_39594f90-059d-49da-a8d4-2c8066125053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ec9d59fd-05f2-46d7-b950-64ad28444196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_0cff3f10-8985-438f-8d38-b02f5b9462ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ec9d59fd-05f2-46d7-b950-64ad28444196" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_0cff3f10-8985-438f-8d38-b02f5b9462ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_50d0a2a6-d1e6-444c-ba94-faefbe89278f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_0cff3f10-8985-438f-8d38-b02f5b9462ea" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_50d0a2a6-d1e6-444c-ba94-faefbe89278f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_05ea3182-48c2-4946-93f2-7c754a866609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_0cff3f10-8985-438f-8d38-b02f5b9462ea" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_05ea3182-48c2-4946-93f2-7c754a866609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_46b0bc06-8fa4-4505-b086-be0b9b8b1896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_0cff3f10-8985-438f-8d38-b02f5b9462ea" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_46b0bc06-8fa4-4505-b086-be0b9b8b1896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_1dcb99fc-4544-4aa4-80de-a6cf7fbe44ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_a659f131-deb5-41ea-8d31-0d1f000b93df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_1dcb99fc-4544-4aa4-80de-a6cf7fbe44ff" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_a659f131-deb5-41ea-8d31-0d1f000b93df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_43d54c92-aa82-410f-872e-a4cfc10d9f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_a659f131-deb5-41ea-8d31-0d1f000b93df" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_43d54c92-aa82-410f-872e-a4cfc10d9f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9bad3116-63fb-400b-87fa-5f0908e96936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_43d54c92-aa82-410f-872e-a4cfc10d9f29" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9bad3116-63fb-400b-87fa-5f0908e96936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_a4adf491-9bee-44a4-b4fc-89e54405bbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_9bad3116-63fb-400b-87fa-5f0908e96936" xlink:to="loc_us-gaap_MoneyMarketFundsMember_a4adf491-9bee-44a4-b4fc-89e54405bbf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_f10641dd-7aac-457c-aef1-c558fd7492dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_a659f131-deb5-41ea-8d31-0d1f000b93df" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_f10641dd-7aac-457c-aef1-c558fd7492dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_f958cf21-263d-4a90-96c7-7bca17528770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_f10641dd-7aac-457c-aef1-c558fd7492dc" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_f958cf21-263d-4a90-96c7-7bca17528770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_643f56b0-b888-4db3-adc9-4c0e249e5ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_f10641dd-7aac-457c-aef1-c558fd7492dc" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_643f56b0-b888-4db3-adc9-4c0e249e5ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6c980cd9-19bb-49dc-939a-acb7dee2e2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_f10641dd-7aac-457c-aef1-c558fd7492dc" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6c980cd9-19bb-49dc-939a-acb7dee2e2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CashEquivalentsNarrativeDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#CashEquivalentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CashEquivalentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_f0b70b63-7657-4083-bcae-ff7ddeda05c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_96052093-1c08-4f7c-9c0c-9b6ceee2555d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_f0b70b63-7657-4083-bcae-ff7ddeda05c2" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_96052093-1c08-4f7c-9c0c-9b6ceee2555d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6da9c18a-3d20-4b52-bf21-3f7301c31754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_74d947ca-a6f7-4a5d-93da-591aa0780097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6da9c18a-3d20-4b52-bf21-3f7301c31754" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_74d947ca-a6f7-4a5d-93da-591aa0780097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_28874849-c8c6-437b-8d8a-8374e7c2be49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6da9c18a-3d20-4b52-bf21-3f7301c31754" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_28874849-c8c6-437b-8d8a-8374e7c2be49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1ce31fa2-c57c-4a0a-9dda-92d01ccdba0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6da9c18a-3d20-4b52-bf21-3f7301c31754" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_1ce31fa2-c57c-4a0a-9dda-92d01ccdba0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9d22c179-c59f-4f3e-8b00-ef1f5e89fdee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6da9c18a-3d20-4b52-bf21-3f7301c31754" xlink:to="loc_us-gaap_InventoryNet_9d22c179-c59f-4f3e-8b00-ef1f5e89fdee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#InventoriesnetandDeferredPreservationCostsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_cb42f276-fd0a-475d-a06b-d4fa625b5065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_5fc81206-8a1c-49fb-a1f8-fad01caf1e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_cb42f276-fd0a-475d-a06b-d4fa625b5065" xlink:to="loc_us-gaap_InventoryCurrentTable_5fc81206-8a1c-49fb-a1f8-fad01caf1e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_97770421-358e-410b-8fef-22c89e98088f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_5fc81206-8a1c-49fb-a1f8-fad01caf1e8f" xlink:to="loc_srt_StatementGeographicalAxis_97770421-358e-410b-8fef-22c89e98088f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_29818004-92f1-42df-9e92-8d772063c767" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_97770421-358e-410b-8fef-22c89e98088f" xlink:to="loc_srt_SegmentGeographicalDomain_29818004-92f1-42df-9e92-8d772063c767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8df7a4ac-a9ba-474e-8d80-2437d1e91794" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_29818004-92f1-42df-9e92-8d772063c767" xlink:to="loc_country_US_8df7a4ac-a9ba-474e-8d80-2437d1e91794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_8dc220b0-6792-4379-9b8a-519bd47da3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_29818004-92f1-42df-9e92-8d772063c767" xlink:to="loc_us-gaap_NonUsMember_8dc220b0-6792-4379-9b8a-519bd47da3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_3de184a8-3dbc-4c16-83a2-28b574ab7905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_5fc81206-8a1c-49fb-a1f8-fad01caf1e8f" xlink:to="loc_us-gaap_InventoryLineItems_3de184a8-3dbc-4c16-83a2-28b574ab7905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_36559b01-8a01-49bf-a5c6-5be1d3020043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_3de184a8-3dbc-4c16-83a2-28b574ab7905" xlink:to="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_36559b01-8a01-49bf-a5c6-5be1d3020043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ConsignmentInventoryPercentage_d00775ea-8777-47d9-9f21-d757d943f58e" xlink:href="aort-20220930.xsd#aort_ConsignmentInventoryPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_3de184a8-3dbc-4c16-83a2-28b574ab7905" xlink:to="loc_aort_ConsignmentInventoryPercentage_d00775ea-8777-47d9-9f21-d757d943f58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DeferredPreservationCosts_59a03bd7-dddc-4d1e-b9eb-001f83baba01" xlink:href="aort-20220930.xsd#aort_DeferredPreservationCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_3de184a8-3dbc-4c16-83a2-28b574ab7905" xlink:to="loc_aort_DeferredPreservationCosts_59a03bd7-dddc-4d1e-b9eb-001f83baba01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_863a9ecb-e0da-44dd-acc7-b73ab6fe07e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_3de184a8-3dbc-4c16-83a2-28b574ab7905" xlink:to="loc_us-gaap_InventoryValuationReserves_863a9ecb-e0da-44dd-acc7-b73ab6fe07e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f4adb494-e91d-4ac7-8771-aa78489c3942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_26fe787f-f614-4957-845b-69fd2b905afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f4adb494-e91d-4ac7-8771-aa78489c3942" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_26fe787f-f614-4957-845b-69fd2b905afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ffe4f304-660b-43ac-830d-ccc097866f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_26fe787f-f614-4957-845b-69fd2b905afc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ffe4f304-660b-43ac-830d-ccc097866f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0190f206-cd0f-454b-9091-fb1e46d5464e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ffe4f304-660b-43ac-830d-ccc097866f89" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0190f206-cd0f-454b-9091-fb1e46d5464e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_26717db1-3f23-4970-b88e-c2c90283931f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0190f206-cd0f-454b-9091-fb1e46d5464e" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_26717db1-3f23-4970-b88e-c2c90283931f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_d8759f97-53e9-44ef-845b-391c2bd7dade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0190f206-cd0f-454b-9091-fb1e46d5464e" xlink:to="loc_us-gaap_ContractualRightsMember_d8759f97-53e9-44ef-845b-391c2bd7dade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_b9b061d1-2f75-470a-baa9-e75c014e539c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0190f206-cd0f-454b-9091-fb1e46d5464e" xlink:to="loc_us-gaap_TrademarksMember_b9b061d1-2f75-470a-baa9-e75c014e539c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_29f4e5cd-1a1c-4e95-a0a0-1898dc795b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_26fe787f-f614-4957-845b-69fd2b905afc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_29f4e5cd-1a1c-4e95-a0a0-1898dc795b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1b020aa1-7ff9-4886-9bb5-f50e5db997c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_29f4e5cd-1a1c-4e95-a0a0-1898dc795b0b" xlink:to="loc_us-gaap_Goodwill_1b020aa1-7ff9-4886-9bb5-f50e5db997c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_652d7d77-be45-4a7d-954a-08947b674382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_29f4e5cd-1a1c-4e95-a0a0-1898dc795b0b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_652d7d77-be45-4a7d-954a-08947b674382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8f173118-0cc8-427a-92bf-378b2b90bd68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_3fa980e4-bd94-4731-984d-464bf5ed2c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8f173118-0cc8-427a-92bf-378b2b90bd68" xlink:to="loc_us-gaap_GoodwillRollForward_3fa980e4-bd94-4731-984d-464bf5ed2c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_218f0390-861a-47ad-afaf-42ea48d65ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3fa980e4-bd94-4731-984d-464bf5ed2c77" xlink:to="loc_us-gaap_Goodwill_218f0390-861a-47ad-afaf-42ea48d65ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_71825525-e918-490e-a5b2-4c82aa90936f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3fa980e4-bd94-4731-984d-464bf5ed2c77" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_71825525-e918-490e-a5b2-4c82aa90936f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a7148f8c-03bf-43c0-91af-489a053f92d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3fa980e4-bd94-4731-984d-464bf5ed2c77" xlink:to="loc_us-gaap_Goodwill_a7148f8c-03bf-43c0-91af-489a053f92d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cd30ebc3-2161-42e7-9509-139c286da89d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2e79ee89-6349-4a36-961f-ba07b577625b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cd30ebc3-2161-42e7-9509-139c286da89d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2e79ee89-6349-4a36-961f-ba07b577625b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07979815-80dc-4e0e-a73b-f72dac3d1b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2e79ee89-6349-4a36-961f-ba07b577625b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07979815-80dc-4e0e-a73b-f72dac3d1b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d623d3c-80a9-416c-a3a8-a9173633e010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_07979815-80dc-4e0e-a73b-f72dac3d1b76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d623d3c-80a9-416c-a3a8-a9173633e010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_01d58db0-7525-4af7-8d63-80ed53eb0b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d623d3c-80a9-416c-a3a8-a9173633e010" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_01d58db0-7525-4af7-8d63-80ed53eb0b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_3d4b5f25-5494-4da1-8461-ae819361caee" xlink:href="aort-20220930.xsd#aort_IntangibleAssetsOtherThanAcquiredTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2d623d3c-80a9-416c-a3a8-a9173633e010" xlink:to="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_3d4b5f25-5494-4da1-8461-ae819361caee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerListsMember_f8277fa7-bbab-4021-8181-61a112b3f9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerListsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_3d4b5f25-5494-4da1-8461-ae819361caee" xlink:to="loc_us-gaap_CustomerListsMember_f8277fa7-bbab-4021-8181-61a112b3f9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember_a19d613e-83b7-4b4b-a14d-c7aad1b481b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_3d4b5f25-5494-4da1-8461-ae819361caee" xlink:to="loc_us-gaap_DistributionRightsMember_a19d613e-83b7-4b4b-a14d-c7aad1b481b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_1c0eab4d-067b-43d6-9846-8acfc63fca5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_3d4b5f25-5494-4da1-8461-ae819361caee" xlink:to="loc_us-gaap_PatentsMember_1c0eab4d-067b-43d6-9846-8acfc63fca5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_93103f54-1719-42d5-8f1d-0244712c9e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_3d4b5f25-5494-4da1-8461-ae819361caee" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_93103f54-1719-42d5-8f1d-0244712c9e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_feb048ba-1127-42f0-97d2-1d5037d33fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2e79ee89-6349-4a36-961f-ba07b577625b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_feb048ba-1127-42f0-97d2-1d5037d33fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c699ac1e-728f-4c2e-bece-3c2e2c3ea558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_feb048ba-1127-42f0-97d2-1d5037d33fd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c699ac1e-728f-4c2e-bece-3c2e2c3ea558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_80743c3f-0624-42f7-9f9d-45ddf91446a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_feb048ba-1127-42f0-97d2-1d5037d33fd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_80743c3f-0624-42f7-9f9d-45ddf91446a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9f86673f-9076-4604-8374-c1030b615c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_feb048ba-1127-42f0-97d2-1d5037d33fd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9f86673f-9076-4604-8374-c1030b615c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3bf8e82b-0514-4805-9b56-39cee574e239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_feb048ba-1127-42f0-97d2-1d5037d33fd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3bf8e82b-0514-4805-9b56-39cee574e239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_87833c32-cf01-422f-bd1b-e615ef71083b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1ab28ec5-fde1-408c-acf6-ba14fde85d52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_87833c32-cf01-422f-bd1b-e615ef71083b" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1ab28ec5-fde1-408c-acf6-ba14fde85d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0116eaa-2ead-411f-82be-70b4915c8e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_6b8ae06f-f8ab-40c5-a947-6fca34212376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0116eaa-2ead-411f-82be-70b4915c8e2d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_6b8ae06f-f8ab-40c5-a947-6fca34212376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_bc850b78-9876-4165-b038-1c2153756e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0116eaa-2ead-411f-82be-70b4915c8e2d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_bc850b78-9876-4165-b038-1c2153756e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fec4b54f-ff6f-407d-98d5-3da73f79286f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0116eaa-2ead-411f-82be-70b4915c8e2d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fec4b54f-ff6f-407d-98d5-3da73f79286f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_18f0b0f5-10a3-4742-bba4-3a4138fb8e63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0116eaa-2ead-411f-82be-70b4915c8e2d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_18f0b0f5-10a3-4742-bba4-3a4138fb8e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_91d9876f-a178-4659-911f-38d89fea7bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0116eaa-2ead-411f-82be-70b4915c8e2d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_91d9876f-a178-4659-911f-38d89fea7bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_67edce3a-2a0d-4eb5-967f-cfea4f97bd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0116eaa-2ead-411f-82be-70b4915c8e2d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_67edce3a-2a0d-4eb5-967f-cfea4f97bd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_4d5d04fa-fa6d-4f28-9871-1b12a5fc8baf" xlink:href="aort-20220930.xsd#aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c0116eaa-2ead-411f-82be-70b4915c8e2d" xlink:to="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_4d5d04fa-fa6d-4f28-9871-1b12a5fc8baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_116a7db7-f02e-437f-a6cf-355bbba89b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_91632c08-e5ce-46d7-a3f6-676e4fe3c542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_116a7db7-f02e-437f-a6cf-355bbba89b53" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_91632c08-e5ce-46d7-a3f6-676e4fe3c542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_dbb87299-3552-407e-8be2-4d08f327f233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_116a7db7-f02e-437f-a6cf-355bbba89b53" xlink:to="loc_us-gaap_DeferredTaxLiabilities_dbb87299-3552-407e-8be2-4d08f327f233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9867ff1c-1532-4f16-9918-ed0009a285e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_116a7db7-f02e-437f-a6cf-355bbba89b53" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9867ff1c-1532-4f16-9918-ed0009a285e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b29bc92b-c56e-42be-8afd-71bf022973d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0915879f-0968-403a-bb9c-c3bd3eaf4e00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b29bc92b-c56e-42be-8afd-71bf022973d6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0915879f-0968-403a-bb9c-c3bd3eaf4e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_36a8967b-f54c-4176-a837-f862ff3bb342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b29bc92b-c56e-42be-8afd-71bf022973d6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_36a8967b-f54c-4176-a837-f862ff3bb342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_3164093c-b63d-4337-8dde-f8b172448546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b29bc92b-c56e-42be-8afd-71bf022973d6" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_3164093c-b63d-4337-8dde-f8b172448546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_2dd5ab5c-6632-4ce9-acf9-6a2bcc5d39c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b29bc92b-c56e-42be-8afd-71bf022973d6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_2dd5ab5c-6632-4ce9-acf9-6a2bcc5d39c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b693cc2c-d1f7-457e-8815-8b96fc3558e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_252f8dc3-7c0a-4fd8-a87e-952a3a31c334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b693cc2c-d1f7-457e-8815-8b96fc3558e4" xlink:to="loc_us-gaap_LeasesOperatingAbstract_252f8dc3-7c0a-4fd8-a87e-952a3a31c334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_62a26bc6-8d6b-4565-8ab7-3842af0dac38" xlink:href="aort-20220930.xsd#aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_252f8dc3-7c0a-4fd8-a87e-952a3a31c334" xlink:to="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_62a26bc6-8d6b-4565-8ab7-3842af0dac38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_7ca1e2b2-0dda-4022-9277-db3da1abd07e" xlink:href="aort-20220930.xsd#aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_252f8dc3-7c0a-4fd8-a87e-952a3a31c334" xlink:to="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_7ca1e2b2-0dda-4022-9277-db3da1abd07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_403b6eb1-bfc6-4510-9bf0-fe7a7048ac4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_252f8dc3-7c0a-4fd8-a87e-952a3a31c334" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_403b6eb1-bfc6-4510-9bf0-fe7a7048ac4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7981f5e3-da56-44c2-be61-b7871e95ae1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_252f8dc3-7c0a-4fd8-a87e-952a3a31c334" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7981f5e3-da56-44c2-be61-b7871e95ae1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8d6cde61-22ad-422f-83c9-510dddffac11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_252f8dc3-7c0a-4fd8-a87e-952a3a31c334" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8d6cde61-22ad-422f-83c9-510dddffac11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_26bca353-675d-4eb6-9550-61bc7a8f08e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_252f8dc3-7c0a-4fd8-a87e-952a3a31c334" xlink:to="loc_us-gaap_OperatingLeaseLiability_26bca353-675d-4eb6-9550-61bc7a8f08e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract_ee975b52-8849-4ae2-bae5-894d8f1734c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b693cc2c-d1f7-457e-8815-8b96fc3558e4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityAbstract_ee975b52-8849-4ae2-bae5-894d8f1734c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_c02b3060-a5fb-4c6a-a1bc-189c6a07ade0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ee975b52-8849-4ae2-bae5-894d8f1734c4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_c02b3060-a5fb-4c6a-a1bc-189c6a07ade0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_64c40c82-f10d-4815-bbde-148aa94df6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ee975b52-8849-4ae2-bae5-894d8f1734c4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_64c40c82-f10d-4815-bbde-148aa94df6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_b56ccdd4-5a3c-45b5-a154-000799d574c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ee975b52-8849-4ae2-bae5-894d8f1734c4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_b56ccdd4-5a3c-45b5-a154-000799d574c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c44a7ef8-2b35-4806-8b23-b097acc65bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ee975b52-8849-4ae2-bae5-894d8f1734c4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c44a7ef8-2b35-4806-8b23-b097acc65bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_722c9596-ab70-49af-b89c-da776b5f0163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ee975b52-8849-4ae2-bae5-894d8f1734c4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_722c9596-ab70-49af-b89c-da776b5f0163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d7931862-67f0-4ed0-8143-f6c8d202d689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ee975b52-8849-4ae2-bae5-894d8f1734c4" xlink:to="loc_us-gaap_FinanceLeaseLiability_d7931862-67f0-4ed0-8143-f6c8d202d689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_cfebd012-424a-4084-8676-eb9187e4d973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b693cc2c-d1f7-457e-8815-8b96fc3558e4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_cfebd012-424a-4084-8676-eb9187e4d973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_868981cf-eea8-43bd-b72b-faed9ce4824b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b693cc2c-d1f7-457e-8815-8b96fc3558e4" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_868981cf-eea8-43bd-b72b-faed9ce4824b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_7d60b6d3-d1e2-4711-8150-575d3d016af6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b693cc2c-d1f7-457e-8815-8b96fc3558e4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_7d60b6d3-d1e2-4711-8150-575d3d016af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_002e0dc0-5092-45f5-b20f-9339e70690de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b693cc2c-d1f7-457e-8815-8b96fc3558e4" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_002e0dc0-5092-45f5-b20f-9339e70690de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#LeasesSummaryOfLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2882cc82-b8ae-4270-9a18-79a5f4ba6965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b21000f2-b0de-47d5-b4fd-fda5691df9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2882cc82-b8ae-4270-9a18-79a5f4ba6965" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b21000f2-b0de-47d5-b4fd-fda5691df9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_b562ff41-f559-48b9-88bb-88e858ea3c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2882cc82-b8ae-4270-9a18-79a5f4ba6965" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_b562ff41-f559-48b9-88bb-88e858ea3c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseCost_0d7740be-34f2-4244-a432-c709c9ebdc40" xlink:href="aort-20220930.xsd#aort_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2882cc82-b8ae-4270-9a18-79a5f4ba6965" xlink:to="loc_aort_FinanceLeaseCost_0d7740be-34f2-4244-a432-c709c9ebdc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_faa1cb57-3200-4423-aa34-ea50a2f65532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2882cc82-b8ae-4270-9a18-79a5f4ba6965" xlink:to="loc_us-gaap_OperatingLeaseCost_faa1cb57-3200-4423-aa34-ea50a2f65532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_8e2e1aea-0991-4f1e-a2f9-c6e53252bb95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2882cc82-b8ae-4270-9a18-79a5f4ba6965" xlink:to="loc_us-gaap_SubleaseIncome_8e2e1aea-0991-4f1e-a2f9-c6e53252bb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_9e1508ec-9903-4477-bd44-34e08fc12770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2882cc82-b8ae-4270-9a18-79a5f4ba6965" xlink:to="loc_us-gaap_LeaseCost_9e1508ec-9903-4477-bd44-34e08fc12770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f3894979-d1a2-4f4e-b3a0-445a8bd887a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_03f35733-5986-415d-967e-2462720a50cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f3894979-d1a2-4f4e-b3a0-445a8bd887a1" xlink:to="loc_us-gaap_OperatingLeasePayments_03f35733-5986-415d-967e-2462720a50cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_c0df7058-7cb4-4ea7-9645-09ccd1c2e967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f3894979-d1a2-4f4e-b3a0-445a8bd887a1" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_c0df7058-7cb4-4ea7-9645-09ccd1c2e967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_109f206c-84d2-4119-8eb0-009e5c89fd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f3894979-d1a2-4f4e-b3a0-445a8bd887a1" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_109f206c-84d2-4119-8eb0-009e5c89fd9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c965a861-7055-4030-a74c-13c5976c49eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c965a861-7055-4030-a74c-13c5976c49eb" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_cebd7bf0-ffdf-42da-8e27-077cb929a411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_cebd7bf0-ffdf-42da-8e27-077cb929a411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0906fae4-5e56-4e2a-9348-bfc0ddcca690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0906fae4-5e56-4e2a-9348-bfc0ddcca690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_58774047-be07-472b-ac96-2b1575b9451d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_58774047-be07-472b-ac96-2b1575b9451d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_00838e20-d5b6-4937-aa74-3d4886d7a5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_00838e20-d5b6-4937-aa74-3d4886d7a5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_567e367b-1b44-4084-9426-ad9a4c2b7327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_567e367b-1b44-4084-9426-ad9a4c2b7327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_92b500d3-5d5b-4063-80b6-b2d9cf3602e6" xlink:href="aort-20220930.xsd#aort_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:to="loc_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_92b500d3-5d5b-4063-80b6-b2d9cf3602e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_30814124-62a4-4973-a0f4-f2c59c8f6439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_30814124-62a4-4973-a0f4-f2c59c8f6439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_85cc1d8a-5916-4919-abaa-59c19e4d2413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_85cc1d8a-5916-4919-abaa-59c19e4d2413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_5bfd9c7e-97fc-4d75-8faf-d6624fd51c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:to="loc_us-gaap_FinanceLeaseLiability_5bfd9c7e-97fc-4d75-8faf-d6624fd51c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1e87296c-543c-417f-89fe-81a1f2bcbe54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_1e87296c-543c-417f-89fe-81a1f2bcbe54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c7c6a28a-2eca-4ce8-99bf-afe39e396445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_fe21f927-10ea-44bd-a8ad-d20a76dabcc4" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c7c6a28a-2eca-4ce8-99bf-afe39e396445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c965a861-7055-4030-a74c-13c5976c49eb" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a209fcb7-8cd8-4f84-96ad-352e6f325951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a209fcb7-8cd8-4f84-96ad-352e6f325951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5b7bc0ad-1832-4a8b-a034-3d85279db0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5b7bc0ad-1832-4a8b-a034-3d85279db0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_38e90feb-6fed-4623-874f-6a5f30bf8c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_38e90feb-6fed-4623-874f-6a5f30bf8c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_88fb4d50-769a-4131-93e2-c44a47a3c947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_88fb4d50-769a-4131-93e2-c44a47a3c947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8b51be1a-c08b-4cd8-bf3b-b9beabe8ecc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8b51be1a-c08b-4cd8-bf3b-b9beabe8ecc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_afda8c25-87e3-4ccb-9a8b-26be3d2ac48f" xlink:href="aort-20220930.xsd#aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:to="loc_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_afda8c25-87e3-4ccb-9a8b-26be3d2ac48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e19b4116-53f0-495a-90a2-27e8d94a4e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e19b4116-53f0-495a-90a2-27e8d94a4e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_139ddfe0-6548-42cf-86b7-bddde017aa98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_139ddfe0-6548-42cf-86b7-bddde017aa98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_886e0222-fb03-40d2-86eb-4a27717b2b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:to="loc_us-gaap_OperatingLeaseLiability_886e0222-fb03-40d2-86eb-4a27717b2b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ea14aad1-17bb-4dd1-b147-20084eb5d1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ea14aad1-17bb-4dd1-b147-20084eb5d1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_773f4d19-d067-42b3-94d4-ed686d5d7d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2c26c9cb-8ff6-4d5c-9f3f-56b3b888c3fc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_773f4d19-d067-42b3-94d4-ed686d5d7d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear_e1e47401-155d-4c38-acd4-bf9121d3b7c0" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c965a861-7055-4030-a74c-13c5976c49eb" xlink:to="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear_e1e47401-155d-4c38-acd4-bf9121d3b7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne_1e2cb7e0-e2c1-4a7c-8671-8579a1e1a756" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c965a861-7055-4030-a74c-13c5976c49eb" xlink:to="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne_1e2cb7e0-e2c1-4a7c-8671-8579a1e1a756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo_4153d56e-3af6-4c83-b04a-b6a5f030e08a" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c965a861-7055-4030-a74c-13c5976c49eb" xlink:to="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo_4153d56e-3af6-4c83-b04a-b6a5f030e08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree_81e0dd33-a47b-4ab0-988d-172ba71301e4" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c965a861-7055-4030-a74c-13c5976c49eb" xlink:to="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree_81e0dd33-a47b-4ab0-988d-172ba71301e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour_a5630a08-547d-4a97-8124-f9692b42ebca" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c965a861-7055-4030-a74c-13c5976c49eb" xlink:to="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour_a5630a08-547d-4a97-8124-f9692b42ebca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour_3b18d7d8-2665-4890-82a6-255d23ae5b54" xlink:href="aort-20220930.xsd#aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c965a861-7055-4030-a74c-13c5976c49eb" xlink:to="loc_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour_3b18d7d8-2665-4890-82a6-255d23ae5b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_4ec77eef-93ec-420e-9ca9-9fef3bb52667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c965a861-7055-4030-a74c-13c5976c49eb" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet_4ec77eef-93ec-420e-9ca9-9fef3bb52667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a3586122-cd1b-4d52-bf83-4675cb53110d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a3586122-cd1b-4d52-bf83-4675cb53110d" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bc773fc7-d183-418c-b925-c9442ebd68b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bc773fc7-d183-418c-b925-c9442ebd68b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_543c5f23-cdb2-4fa9-b8a0-ed5570d21463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_bc773fc7-d183-418c-b925-c9442ebd68b9" xlink:to="loc_us-gaap_TypeOfAdoptionMember_543c5f23-cdb2-4fa9-b8a0-ed5570d21463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_7e60e96f-18bd-4f27-ac5f-8ccb9a6377a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_543c5f23-cdb2-4fa9-b8a0-ed5570d21463" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_7e60e96f-18bd-4f27-ac5f-8ccb9a6377a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e50b1321-9252-41a8-9569-c2e6185afe32" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e50b1321-9252-41a8-9569-c2e6185afe32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_abba0ca3-c12c-4009-977e-97ee43ead2e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e50b1321-9252-41a8-9569-c2e6185afe32" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_abba0ca3-c12c-4009-977e-97ee43ead2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ad0dee00-4ca0-4945-ac8c-5eca7a175a70" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_abba0ca3-c12c-4009-977e-97ee43ead2e8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_ad0dee00-4ca0-4945-ac8c-5eca7a175a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_677b865f-e78f-4bc8-a9c4-84424a7b7b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_CreditFacilityAxis_677b865f-e78f-4bc8-a9c4-84424a7b7b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cce2af24-93da-406b-a072-d634d0a9cc01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_677b865f-e78f-4bc8-a9c4-84424a7b7b1c" xlink:to="loc_us-gaap_CreditFacilityDomain_cce2af24-93da-406b-a072-d634d0a9cc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_872d480e-a03d-4e37-ad27-955b41135394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cce2af24-93da-406b-a072-d634d0a9cc01" xlink:to="loc_us-gaap_SecuredDebtMember_872d480e-a03d-4e37-ad27-955b41135394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_fde835d2-55f6-4d52-a7ba-38fe8e3db73b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cce2af24-93da-406b-a072-d634d0a9cc01" xlink:to="loc_us-gaap_LoansPayableMember_fde835d2-55f6-4d52-a7ba-38fe8e3db73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9723de3e-571a-45ab-a22a-399e64ab7fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cce2af24-93da-406b-a072-d634d0a9cc01" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9723de3e-571a-45ab-a22a-399e64ab7fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RevolvingCreditFacilityAndTermLoanMember_0fb3904c-ba55-414c-9842-92d271487ed0" xlink:href="aort-20220930.xsd#aort_RevolvingCreditFacilityAndTermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cce2af24-93da-406b-a072-d634d0a9cc01" xlink:to="loc_aort_RevolvingCreditFacilityAndTermLoanMember_0fb3904c-ba55-414c-9842-92d271487ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_452b0a40-83c5-4103-aa14-f9a8d8f963e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_VariableRateAxis_452b0a40-83c5-4103-aa14-f9a8d8f963e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6dad04bc-f25a-4cc3-9973-cd95fabc7559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_452b0a40-83c5-4103-aa14-f9a8d8f963e0" xlink:to="loc_us-gaap_VariableRateDomain_6dad04bc-f25a-4cc3-9973-cd95fabc7559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_e759e009-c163-4c6b-a28a-436c10ba9139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6dad04bc-f25a-4cc3-9973-cd95fabc7559" xlink:to="loc_us-gaap_BaseRateMember_e759e009-c163-4c6b-a28a-436c10ba9139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ed1c96c5-37f5-4291-9713-762e996e1272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6dad04bc-f25a-4cc3-9973-cd95fabc7559" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ed1c96c5-37f5-4291-9713-762e996e1272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_46166542-9470-4064-8f43-ef804990f1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_46166542-9470-4064-8f43-ef804990f1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b9dd852c-5720-49a5-84f6-5597efd0d65e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_46166542-9470-4064-8f43-ef804990f1a4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b9dd852c-5720-49a5-84f6-5597efd0d65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_1d35af14-bb0d-485b-b99c-012831248b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b9dd852c-5720-49a5-84f6-5597efd0d65e" xlink:to="loc_us-gaap_ConvertibleDebtMember_1d35af14-bb0d-485b-b99c-012831248b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b3816734-5dbc-4459-a64a-7ce40dedac70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_DebtInstrumentAxis_b3816734-5dbc-4459-a64a-7ce40dedac70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d818f169-8974-4f08-803e-ca618aa2ca04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b3816734-5dbc-4459-a64a-7ce40dedac70" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d818f169-8974-4f08-803e-ca618aa2ca04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CreditAgreementMember_cbc625f9-b1bf-484f-8d92-5d0e5528e6a9" xlink:href="aort-20220930.xsd#aort_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d818f169-8974-4f08-803e-ca618aa2ca04" xlink:to="loc_aort_CreditAgreementMember_cbc625f9-b1bf-484f-8d92-5d0e5528e6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1cc9448b-7f5d-41dd-bb26-646bf72117f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1cc9448b-7f5d-41dd-bb26-646bf72117f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_14a82650-ef47-4008-84ea-477491f3b709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1cc9448b-7f5d-41dd-bb26-646bf72117f4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_14a82650-ef47-4008-84ea-477491f3b709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_85a60426-c7f8-4195-af4d-c195a0fb492a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_14a82650-ef47-4008-84ea-477491f3b709" xlink:to="loc_us-gaap_InterestExpenseMember_85a60426-c7f8-4195-af4d-c195a0fb492a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodAxis_baf57b17-9698-4d2d-aaad-f1cd86c9455e" xlink:href="aort-20220930.xsd#aort_DebtPeriodAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_aort_DebtPeriodAxis_baf57b17-9698-4d2d-aaad-f1cd86c9455e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodDomain_d249f14f-65a3-4a29-8fa1-10e213500309" xlink:href="aort-20220930.xsd#aort_DebtPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_DebtPeriodAxis_baf57b17-9698-4d2d-aaad-f1cd86c9455e" xlink:to="loc_aort_DebtPeriodDomain_d249f14f-65a3-4a29-8fa1-10e213500309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceIMember_bebf7827-207f-410b-839e-cfccc6872f42" xlink:href="aort-20220930.xsd#aort_CircumstanceIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_DebtPeriodDomain_d249f14f-65a3-4a29-8fa1-10e213500309" xlink:to="loc_aort_CircumstanceIMember_bebf7827-207f-410b-839e-cfccc6872f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceIiMember_356ab154-d785-4a1b-8752-318f589065d9" xlink:href="aort-20220930.xsd#aort_CircumstanceIiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_DebtPeriodDomain_d249f14f-65a3-4a29-8fa1-10e213500309" xlink:to="loc_aort_CircumstanceIiMember_356ab154-d785-4a1b-8752-318f589065d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceAfterJuly52023Member_ab75d77f-df80-438b-bfad-5d0318f6ca5b" xlink:href="aort-20220930.xsd#aort_CircumstanceAfterJuly52023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_DebtPeriodDomain_d249f14f-65a3-4a29-8fa1-10e213500309" xlink:to="loc_aort_CircumstanceAfterJuly52023Member_ab75d77f-df80-438b-bfad-5d0318f6ca5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7adbbcab-4764-41dd-8081-7b9580b09152" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fec25602-9cb2-4bac-ba73-9fce90e84744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fec25602-9cb2-4bac-ba73-9fce90e84744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_0c425a03-b001-4dfc-aa04-05bcb13e4edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_0c425a03-b001-4dfc-aa04-05bcb13e4edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentExtensionPeriod_3a5794d9-b8fa-4302-b288-83538a9b3f9a" xlink:href="aort-20220930.xsd#aort_DebtInstrumentExtensionPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_aort_DebtInstrumentExtensionPeriod_3a5794d9-b8fa-4302-b288-83538a9b3f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8ec5aa59-c939-4b75-b4e0-1d7ca9db9eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8ec5aa59-c939-4b75-b4e0-1d7ca9db9eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentExtensionCircumstancePeriod_56883ba1-fe78-466d-b597-6298e6764bb5" xlink:href="aort-20220930.xsd#aort_DebtInstrumentExtensionCircumstancePeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_aort_DebtInstrumentExtensionCircumstancePeriod_56883ba1-fe78-466d-b597-6298e6764bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4566b0e1-b142-41c7-9e5c-1a939926bac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4566b0e1-b142-41c7-9e5c-1a939926bac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f17b817d-ce09-4dc7-813d-dcf8da7a0e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f17b817d-ce09-4dc7-813d-dcf8da7a0e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_3a17ca9d-2909-4951-b855-72b3865a9be3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_3a17ca9d-2909-4951-b855-72b3865a9be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_d47f02ec-1fc1-479a-b496-69a39a431727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_d47f02ec-1fc1-479a-b496-69a39a431727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_d40a8c13-bdcb-43e8-9754-ac011c5cb260" xlink:href="aort-20220930.xsd#aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_d40a8c13-bdcb-43e8-9754-ac011c5cb260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_717aa5c2-d5b5-4451-bdc4-0edf4446bd08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_717aa5c2-d5b5-4451-bdc4-0edf4446bd08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_3a635309-5dd5-4891-bb5e-39cccfb4a9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_3a635309-5dd5-4891-bb5e-39cccfb4a9b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b983f152-4cd1-4843-84d0-5c382edcd977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_LongTermDebt_b983f152-4cd1-4843-84d0-5c382edcd977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_26fc1a2a-55bd-4b7e-ac49-982abf4510b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_26fc1a2a-55bd-4b7e-ac49-982abf4510b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_c5c31788-60f7-4ac6-ba85-0105dc2c6dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_c5c31788-60f7-4ac6-ba85-0105dc2c6dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_0ec4c706-ace1-46a3-a39a-971302d056ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentFairValue_0ec4c706-ace1-46a3-a39a-971302d056ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_9a7065a6-5836-4e03-b886-b09063ca1cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_9a7065a6-5836-4e03-b886-b09063ca1cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_183e865c-cb42-4765-aced-5eaeba7d4ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_InterestExpenseDebt_183e865c-cb42-4765-aced-5eaeba7d4ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_e7af3d74-fbd2-48a6-93b5-e045e4645487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_e7af3d74-fbd2-48a6-93b5-e045e4645487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_558cd996-4fdf-48ea-b9c1-f5b13a3f3485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_558cd996-4fdf-48ea-b9c1-f5b13a3f3485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_171c23ca-e500-4704-82e6-9d4e609ac113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_171c23ca-e500-4704-82e6-9d4e609ac113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_657bec74-019d-4aac-b326-a8ab33bd40fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_657bec74-019d-4aac-b326-a8ab33bd40fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_3fefc338-4424-4f8d-a824-a7a0aac12c57" xlink:href="aort-20220930.xsd#aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a2547c5a-b170-4921-9652-02f571bec846" xlink:to="loc_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_3fefc338-4424-4f8d-a824-a7a0aac12c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_59d89825-e87c-4df9-97ee-67a0f1ceb659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1f5a2ccf-741c-47b0-92e3-b74b216ce336" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_59d89825-e87c-4df9-97ee-67a0f1ceb659" xlink:to="loc_us-gaap_DebtInstrumentTable_1f5a2ccf-741c-47b0-92e3-b74b216ce336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b1473590-0094-417b-b7a9-8ca9cff5ebbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1f5a2ccf-741c-47b0-92e3-b74b216ce336" xlink:to="loc_us-gaap_CreditFacilityAxis_b1473590-0094-417b-b7a9-8ca9cff5ebbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2cf5feea-33ce-4603-9444-31dab9415951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b1473590-0094-417b-b7a9-8ca9cff5ebbd" xlink:to="loc_us-gaap_CreditFacilityDomain_2cf5feea-33ce-4603-9444-31dab9415951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_1c930f07-3ccd-4ade-bc6c-17719bcaa92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2cf5feea-33ce-4603-9444-31dab9415951" xlink:to="loc_us-gaap_LoansPayableMember_1c930f07-3ccd-4ade-bc6c-17719bcaa92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_95286c2d-1050-415c-b47a-3db339c6868e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2cf5feea-33ce-4603-9444-31dab9415951" xlink:to="loc_us-gaap_ConvertibleDebtMember_95286c2d-1050-415c-b47a-3db339c6868e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7511e4dc-0726-4bba-bc2b-c5adefb4b710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1f5a2ccf-741c-47b0-92e3-b74b216ce336" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7511e4dc-0726-4bba-bc2b-c5adefb4b710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8616b7f9-119f-42f6-ac05-d1d024bb969b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7511e4dc-0726-4bba-bc2b-c5adefb4b710" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8616b7f9-119f-42f6-ac05-d1d024bb969b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_GovernmentSponsoredDebtKfwLoan1Member_6987a733-a22e-450b-8ac9-7d0a7ea85820" xlink:href="aort-20220930.xsd#aort_GovernmentSponsoredDebtKfwLoan1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8616b7f9-119f-42f6-ac05-d1d024bb969b" xlink:to="loc_aort_GovernmentSponsoredDebtKfwLoan1Member_6987a733-a22e-450b-8ac9-7d0a7ea85820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_GovernmentSponsoredDebtKfwLoan2Member_d8bc548e-f672-4853-abec-feae4e743ab6" xlink:href="aort-20220930.xsd#aort_GovernmentSponsoredDebtKfwLoan2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8616b7f9-119f-42f6-ac05-d1d024bb969b" xlink:to="loc_aort_GovernmentSponsoredDebtKfwLoan2Member_d8bc548e-f672-4853-abec-feae4e743ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1f5a2ccf-741c-47b0-92e3-b74b216ce336" xlink:to="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2af52785-b9c1-4a37-a3bc-1e4882a7582e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2af52785-b9c1-4a37-a3bc-1e4882a7582e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_01173f27-fb49-420e-a807-d47fb65ee620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_01173f27-fb49-420e-a807-d47fb65ee620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c6a03556-d08a-47dd-bbd4-a4df19ddaf00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_LongTermDebt_c6a03556-d08a-47dd-bbd4-a4df19ddaf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_53b6170b-1ef4-4ab0-ae46-fa9eead25ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_LongTermDebtCurrent_53b6170b-1ef4-4ab0-ae46-fa9eead25ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a374049f-e98a-47e5-ac6b-bd9ff2cd7c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a374049f-e98a-47e5-ac6b-bd9ff2cd7c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bc48b59c-60d8-4eb9-a042-e523120d80b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd491207-4003-471d-aa97-36253162937b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bc48b59c-60d8-4eb9-a042-e523120d80b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_991e8469-c1c2-4410-b882-94958d8ea28a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts_e96f3baa-fe96-4e58-8f54-764ee46efdb0" xlink:href="aort-20220930.xsd#aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_991e8469-c1c2-4410-b882-94958d8ea28a" xlink:to="loc_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts_e96f3baa-fe96-4e58-8f54-764ee46efdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#RevenueRecognitionDisaggregationOfRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_435bdd55-a0cc-4e91-b439-1b1a3ae553fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_5950b469-5545-45d8-95c6-ac11c01acadd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_435bdd55-a0cc-4e91-b439-1b1a3ae553fe" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_5950b469-5545-45d8-95c6-ac11c01acadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_808a19b6-f4e9-4a7d-93e7-2daadac34a78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5950b469-5545-45d8-95c6-ac11c01acadd" xlink:to="loc_srt_ProductOrServiceAxis_808a19b6-f4e9-4a7d-93e7-2daadac34a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ec371dd1-95ac-4a9b-beb8-8194063e782c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_808a19b6-f4e9-4a7d-93e7-2daadac34a78" xlink:to="loc_srt_ProductsAndServicesDomain_ec371dd1-95ac-4a9b-beb8-8194063e782c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DomesticHospitalsMember_fa2d9b3e-f6c5-4c02-88c6-b5baa6f9c9b3" xlink:href="aort-20220930.xsd#aort_DomesticHospitalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ec371dd1-95ac-4a9b-beb8-8194063e782c" xlink:to="loc_aort_DomesticHospitalsMember_fa2d9b3e-f6c5-4c02-88c6-b5baa6f9c9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_InternationalHospitalsMember_d3753259-6522-498b-8834-fc08b429c396" xlink:href="aort-20220930.xsd#aort_InternationalHospitalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ec371dd1-95ac-4a9b-beb8-8194063e782c" xlink:to="loc_aort_InternationalHospitalsMember_d3753259-6522-498b-8834-fc08b429c396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_InternationalDistributorMember_93be0529-716b-42ba-b80b-ed663da5a4a0" xlink:href="aort-20220930.xsd#aort_InternationalDistributorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ec371dd1-95ac-4a9b-beb8-8194063e782c" xlink:to="loc_aort_InternationalDistributorMember_93be0529-716b-42ba-b80b-ed663da5a4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CardiogenesisMember_288dd76b-a615-44d4-8aab-d3133a8e8815" xlink:href="aort-20220930.xsd#aort_CardiogenesisMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ec371dd1-95ac-4a9b-beb8-8194063e782c" xlink:to="loc_aort_CardiogenesisMember_288dd76b-a615-44d4-8aab-d3133a8e8815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8f3cbd27-bbcc-47d7-a17e-e0c3dfdbc5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5950b469-5545-45d8-95c6-ac11c01acadd" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_8f3cbd27-bbcc-47d7-a17e-e0c3dfdbc5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_144b914d-18ea-48ae-8789-0133f3c30696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8f3cbd27-bbcc-47d7-a17e-e0c3dfdbc5f1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_144b914d-18ea-48ae-8789-0133f3c30696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationNarrativeDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#StockCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/StockCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4fbf81e-c59f-4c5a-b814-1f63d4a56b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c88753-9deb-46e8-a510-c39b58a9f9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4fbf81e-c59f-4c5a-b814-1f63d4a56b9f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c88753-9deb-46e8-a510-c39b58a9f9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_c4699ec4-49d5-4d61-9b11-3345a2dd5ea0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c88753-9deb-46e8-a510-c39b58a9f9b2" xlink:to="loc_srt_TitleOfIndividualAxis_c4699ec4-49d5-4d61-9b11-3345a2dd5ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_654c09b6-41c2-4554-9a02-75069abac4d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_c4699ec4-49d5-4d61-9b11-3345a2dd5ea0" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_654c09b6-41c2-4554-9a02-75069abac4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember_d2eb9bf9-c16c-4af8-a215-028befe1c03c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_654c09b6-41c2-4554-9a02-75069abac4d7" xlink:to="loc_srt_OfficerMember_d2eb9bf9-c16c-4af8-a215-028befe1c03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_251ac5f3-970e-4c04-820f-7fab64db60c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c88753-9deb-46e8-a510-c39b58a9f9b2" xlink:to="loc_us-gaap_AwardTypeAxis_251ac5f3-970e-4c04-820f-7fab64db60c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_345d6960-f469-41da-90fc-eb371bc94b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_251ac5f3-970e-4c04-820f-7fab64db60c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_345d6960-f469-41da-90fc-eb371bc94b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_0934277b-1161-4009-bbe9-845605e66c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_345d6960-f469-41da-90fc-eb371bc94b2c" xlink:to="loc_us-gaap_EmployeeStockMember_0934277b-1161-4009-bbe9-845605e66c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember_16d9f2c0-80d5-4b9c-a8bc-3109ae18c974" xlink:href="aort-20220930.xsd#aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_345d6960-f469-41da-90fc-eb371bc94b2c" xlink:to="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember_16d9f2c0-80d5-4b9c-a8bc-3109ae18c974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71c88753-9deb-46e8-a510-c39b58a9f9b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c300df51-84c8-4028-9bc4-a8cfbae28482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c300df51-84c8-4028-9bc4-a8cfbae28482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_219abef9-c30b-41b2-88cf-c6589e1660f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_219abef9-c30b-41b2-88cf-c6589e1660f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_f03d4bc1-3735-4aa2-93ac-b96f04576701" xlink:href="aort-20220930.xsd#aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_f03d4bc1-3735-4aa2-93ac-b96f04576701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d1916d73-50ed-4c93-8c69-bee038794081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d1916d73-50ed-4c93-8c69-bee038794081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4e5fb2a5-076b-418d-9757-e25ccd918415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4e5fb2a5-076b-418d-9757-e25ccd918415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_32da6a45-cafc-4c3d-a339-8ae29821caf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a48817b-09bf-46d6-9215-2fec14074352" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_32da6a45-cafc-4c3d-a339-8ae29821caf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a902a958-0697-45c9-a427-57aa12c0de75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc70f02e-9716-4744-92e9-32716cfb3a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a902a958-0697-45c9-a427-57aa12c0de75" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc70f02e-9716-4744-92e9-32716cfb3a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a2855e25-7cd5-4a2b-b277-5f4f13e5e4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc70f02e-9716-4744-92e9-32716cfb3a85" xlink:to="loc_us-gaap_AwardTypeAxis_a2855e25-7cd5-4a2b-b277-5f4f13e5e4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719dfd06-350e-4779-84ab-7b892d942493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a2855e25-7cd5-4a2b-b277-5f4f13e5e4c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719dfd06-350e-4779-84ab-7b892d942493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d9ee4460-3c37-40fd-b94c-908b9d75a0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719dfd06-350e-4779-84ab-7b892d942493" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d9ee4460-3c37-40fd-b94c-908b9d75a0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_2671cf44-fa9b-42fd-ab91-9896477c0483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719dfd06-350e-4779-84ab-7b892d942493" xlink:to="loc_us-gaap_EmployeeStockMember_2671cf44-fa9b-42fd-ab91-9896477c0483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a369c28a-7cb1-4df5-bb3c-2361c8f90d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dc70f02e-9716-4744-92e9-32716cfb3a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a369c28a-7cb1-4df5-bb3c-2361c8f90d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2f83b5be-1fda-407e-b524-55dbafe10f94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a369c28a-7cb1-4df5-bb3c-2361c8f90d8b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2f83b5be-1fda-407e-b524-55dbafe10f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8dd239b5-938b-4d28-b332-f9f62658c010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a369c28a-7cb1-4df5-bb3c-2361c8f90d8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8dd239b5-938b-4d28-b332-f9f62658c010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_27cf3b8a-1f1d-497d-82cd-ca54d9154f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a369c28a-7cb1-4df5-bb3c-2361c8f90d8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_27cf3b8a-1f1d-497d-82cd-ca54d9154f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#StockCompensationSummaryOfTotalStockCompensationExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a0102025-8c07-438a-ba5c-76e580b0e033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18f83137-8a31-4285-a7f6-8ca7486f1fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a0102025-8c07-438a-ba5c-76e580b0e033" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18f83137-8a31-4285-a7f6-8ca7486f1fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6e65e3fe-8968-4d83-80a8-8ea6f59b3e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18f83137-8a31-4285-a7f6-8ca7486f1fd5" xlink:to="loc_us-gaap_AwardTypeAxis_6e65e3fe-8968-4d83-80a8-8ea6f59b3e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a702867-0a2a-40b4-b80c-b05278575c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6e65e3fe-8968-4d83-80a8-8ea6f59b3e21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a702867-0a2a-40b4-b80c-b05278575c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_c51be5dd-d1be-41e0-848f-4a2c4d3e8293" xlink:href="aort-20220930.xsd#aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a702867-0a2a-40b4-b80c-b05278575c0e" xlink:to="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_c51be5dd-d1be-41e0-848f-4a2c4d3e8293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_474c9921-c756-4177-bcfc-9d7081e483f6" xlink:href="aort-20220930.xsd#aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a702867-0a2a-40b4-b80c-b05278575c0e" xlink:to="loc_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_474c9921-c756-4177-bcfc-9d7081e483f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfa3501e-26be-4b8e-bd35-c37bd02ad9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18f83137-8a31-4285-a7f6-8ca7486f1fd5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfa3501e-26be-4b8e-bd35-c37bd02ad9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1b24b58c-737e-4c31-b74b-9a2980169354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bfa3501e-26be-4b8e-bd35-c37bd02ad9d8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1b24b58c-737e-4c31-b74b-9a2980169354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c46c6a9b-0501-40f1-a1d0-fa6f025f33fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_38588a7f-6399-4147-a59e-f2f1aacec128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c46c6a9b-0501-40f1-a1d0-fa6f025f33fe" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_38588a7f-6399-4147-a59e-f2f1aacec128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_252cca1e-d454-4915-9ef4-cc91534335a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_38588a7f-6399-4147-a59e-f2f1aacec128" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_252cca1e-d454-4915-9ef4-cc91534335a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1e5d66aa-8932-48b8-a480-37619a60f963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_252cca1e-d454-4915-9ef4-cc91534335a6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1e5d66aa-8932-48b8-a480-37619a60f963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d74c39bd-c740-4f65-858d-1a70a05f8703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1e5d66aa-8932-48b8-a480-37619a60f963" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d74c39bd-c740-4f65-858d-1a70a05f8703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_68f6487a-66c4-445d-b09d-12f9d21e505c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1e5d66aa-8932-48b8-a480-37619a60f963" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_68f6487a-66c4-445d-b09d-12f9d21e505c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_afbc39e7-e2ee-4993-aafa-4c64036d5295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_38588a7f-6399-4147-a59e-f2f1aacec128" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_afbc39e7-e2ee-4993-aafa-4c64036d5295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_afbc39e7-e2ee-4993-aafa-4c64036d5295" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8b888d3f-062c-4d01-b585-176366aef7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:to="loc_us-gaap_NetIncomeLoss_8b888d3f-062c-4d01-b585-176366aef7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_4449d833-a96c-49f6-8894-e18a21a5c716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_4449d833-a96c-49f6-8894-e18a21a5c716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a52efb1f-4a00-4f90-b3c1-a9b421817cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a52efb1f-4a00-4f90-b3c1-a9b421817cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_82b9db25-9e59-4f77-8f35-2d6d119c210f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_82b9db25-9e59-4f77-8f35-2d6d119c210f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b77c5fc7-57c1-4fdf-8964-74abb7662852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_f7fd9728-0a25-4787-8a47-e566b5eef534" xlink:to="loc_us-gaap_EarningsPerShareBasic_b77c5fc7-57c1-4fdf-8964-74abb7662852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_afbc39e7-e2ee-4993-aafa-4c64036d5295" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e424cf9a-4ffc-46bf-a433-fd9c88794b96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_NetIncomeLoss_e424cf9a-4ffc-46bf-a433-fd9c88794b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_3a3c46d8-f17f-4277-8527-e6048a242b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_3a3c46d8-f17f-4277-8527-e6048a242b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_4966ef56-6ec0-4202-bcd2-562dddf2548a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_4966ef56-6ec0-4202-bcd2-562dddf2548a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_f84c55e6-ec9e-461a-8f83-12537cf9ade9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_f84c55e6-ec9e-461a-8f83-12537cf9ade9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6a731e7c-41b1-4690-9c62-7c775fb91c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6a731e7c-41b1-4690-9c62-7c775fb91c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_a65917fe-bf34-4ca6-8d65-f090ef926b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_a65917fe-bf34-4ca6-8d65-f090ef926b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f19ade02-2ac6-43e2-8220-78022b007459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f19ade02-2ac6-43e2-8220-78022b007459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a4af06d0-b1ed-4c16-afc2-870a1b899890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_e8389ce7-54b8-416b-b3d2-ea09e6d9a9ce" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a4af06d0-b1ed-4c16-afc2-870a1b899890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c5744013-c51a-41e1-a5a1-122fa0c85273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_afbc39e7-e2ee-4993-aafa-4c64036d5295" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c5744013-c51a-41e1-a5a1-122fa0c85273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f554bd09-7dc7-43ff-b300-3caa3683137e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0d6df301-0e17-4ace-b28d-b0a988a5f1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f554bd09-7dc7-43ff-b300-3caa3683137e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0d6df301-0e17-4ace-b28d-b0a988a5f1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5dbd5251-5557-4d21-9449-07183ad507b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0d6df301-0e17-4ace-b28d-b0a988a5f1a3" xlink:to="loc_srt_ConsolidationItemsAxis_5dbd5251-5557-4d21-9449-07183ad507b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b0309ced-ec6b-41d7-809f-c8cda83468a6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5dbd5251-5557-4d21-9449-07183ad507b2" xlink:to="loc_srt_ConsolidationItemsDomain_b0309ced-ec6b-41d7-809f-c8cda83468a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_b48afe23-a0a7-402b-a1ca-4a5513b30dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b0309ced-ec6b-41d7-809f-c8cda83468a6" xlink:to="loc_us-gaap_IntersegmentEliminationMember_b48afe23-a0a7-402b-a1ca-4a5513b30dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d85c57d0-a2f1-430f-9496-e6452a988ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0d6df301-0e17-4ace-b28d-b0a988a5f1a3" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_d85c57d0-a2f1-430f-9496-e6452a988ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_07f684b2-8a5e-46a5-9631-9d2df06cffac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d85c57d0-a2f1-430f-9496-e6452a988ae2" xlink:to="loc_us-gaap_NumberOfReportableSegments_07f684b2-8a5e-46a5-9631-9d2df06cffac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_de7b3820-e67a-4c18-9f10-f7a573c90bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d85c57d0-a2f1-430f-9496-e6452a988ae2" xlink:to="loc_us-gaap_Revenues_de7b3820-e67a-4c18-9f10-f7a573c90bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_860f2a99-7634-47ff-ab3d-9767711da0fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6cb28012-3451-442a-b82d-48cc18dec2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_860f2a99-7634-47ff-ab3d-9767711da0fe" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6cb28012-3451-442a-b82d-48cc18dec2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_86eaaaa3-6dba-478b-9881-6d6a58c450de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6cb28012-3451-442a-b82d-48cc18dec2bb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_86eaaaa3-6dba-478b-9881-6d6a58c450de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2bd527f7-86fe-404b-ab35-8ceb7c76a0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_86eaaaa3-6dba-478b-9881-6d6a58c450de" xlink:to="loc_us-gaap_SegmentDomain_2bd527f7-86fe-404b-ab35-8ceb7c76a0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_MedicalDevicesMember_f4d8e342-bbaa-4c98-a009-6b672f282901" xlink:href="aort-20220930.xsd#aort_MedicalDevicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2bd527f7-86fe-404b-ab35-8ceb7c76a0ea" xlink:to="loc_aort_MedicalDevicesMember_f4d8e342-bbaa-4c98-a009-6b672f282901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember_bbcfc11a-efb6-444f-a0e4-619af6e7d84e" xlink:href="aort-20220930.xsd#aort_PreservationServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2bd527f7-86fe-404b-ab35-8ceb7c76a0ea" xlink:to="loc_aort_PreservationServicesMember_bbcfc11a-efb6-444f-a0e4-619af6e7d84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e06ef104-0e10-4ccd-b57e-920809e289a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6cb28012-3451-442a-b82d-48cc18dec2bb" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_e06ef104-0e10-4ccd-b57e-920809e289a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ee04c7b3-f511-4ac3-8b29-1b558706cd91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e06ef104-0e10-4ccd-b57e-920809e289a2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ee04c7b3-f511-4ac3-8b29-1b558706cd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3568bc2d-aa8e-41c5-a89e-0ad17d97bc15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e06ef104-0e10-4ccd-b57e-920809e289a2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3568bc2d-aa8e-41c5-a89e-0ad17d97bc15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_46ba0efa-3918-46d8-a2b1-fa0c43bfd3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e06ef104-0e10-4ccd-b57e-920809e289a2" xlink:to="loc_us-gaap_GrossProfit_46ba0efa-3918-46d8-a2b1-fa0c43bfd3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails" xlink:type="simple" xlink:href="aort-20220930.xsd#SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_56943fb4-971d-4b11-aa74-2b5cb8543b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_65c15db4-9caa-4699-9334-cf443deba9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_56943fb4-971d-4b11-aa74-2b5cb8543b2a" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_65c15db4-9caa-4699-9334-cf443deba9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b018a4fe-e1d9-44cb-a9db-22091f88745d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_65c15db4-9caa-4699-9334-cf443deba9ba" xlink:to="loc_srt_ProductOrServiceAxis_b018a4fe-e1d9-44cb-a9db-22091f88745d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_204947ab-9a73-4c5c-98b0-984b84e4303b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b018a4fe-e1d9-44cb-a9db-22091f88745d" xlink:to="loc_srt_ProductsAndServicesDomain_204947ab-9a73-4c5c-98b0-984b84e4303b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ProductsMember_7e5ec14b-3268-41e6-b1be-478d3f8c5fd6" xlink:href="aort-20220930.xsd#aort_ProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_204947ab-9a73-4c5c-98b0-984b84e4303b" xlink:to="loc_aort_ProductsMember_7e5ec14b-3268-41e6-b1be-478d3f8c5fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AorticStentGraftsMember_100e2888-521d-4b98-9630-29d24b52c2c0" xlink:href="aort-20220930.xsd#aort_AorticStentGraftsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_ProductsMember_7e5ec14b-3268-41e6-b1be-478d3f8c5fd6" xlink:to="loc_aort_AorticStentGraftsMember_100e2888-521d-4b98-9630-29d24b52c2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_SurgicalSealantsMember_cdbe1031-e62a-4794-8b44-48d84a64adf5" xlink:href="aort-20220930.xsd#aort_SurgicalSealantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_ProductsMember_7e5ec14b-3268-41e6-b1be-478d3f8c5fd6" xlink:to="loc_aort_SurgicalSealantsMember_cdbe1031-e62a-4794-8b44-48d84a64adf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OnXMember_ee4297ef-bf95-4bef-8294-2433d548d957" xlink:href="aort-20220930.xsd#aort_OnXMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_ProductsMember_7e5ec14b-3268-41e6-b1be-478d3f8c5fd6" xlink:to="loc_aort_OnXMember_ee4297ef-bf95-4bef-8294-2433d548d957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OtherProductsMember_0b8ed095-33fe-47a9-947a-75f9af390d46" xlink:href="aort-20220930.xsd#aort_OtherProductsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_ProductsMember_7e5ec14b-3268-41e6-b1be-478d3f8c5fd6" xlink:to="loc_aort_OtherProductsMember_0b8ed095-33fe-47a9-947a-75f9af390d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember_cdf17b83-436d-4c5b-bc19-2ae486d33291" xlink:href="aort-20220930.xsd#aort_PreservationServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_204947ab-9a73-4c5c-98b0-984b84e4303b" xlink:to="loc_aort_PreservationServicesMember_cdf17b83-436d-4c5b-bc19-2ae486d33291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_f85672fe-f9e0-423c-9690-c20949a9b424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_65c15db4-9caa-4699-9334-cf443deba9ba" xlink:to="loc_us-gaap_ProductInformationLineItems_f85672fe-f9e0-423c-9690-c20949a9b424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fbc9779c-7e60-4ea2-9272-49d35b736379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_f85672fe-f9e0-423c-9690-c20949a9b424" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fbc9779c-7e60-4ea2-9272-49d35b736379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450881440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-13165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ARTIVION, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">59-2417093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1655 Roberts Boulevard, NW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kennesaw<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">419-3355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AORT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,329,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000784199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511448500800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 76,838<span></span>
</td>
<td class="nump">$ 72,207<span></span>
</td>
<td class="nump">$ 234,391<span></span>
</td>
<td class="nump">$ 219,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of products and preservation services:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of products and preservation services</a></td>
<td class="nump">28,094<span></span>
</td>
<td class="nump">24,418<span></span>
</td>
<td class="nump">82,756<span></span>
</td>
<td class="nump">73,302<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">48,744<span></span>
</td>
<td class="nump">47,789<span></span>
</td>
<td class="nump">151,635<span></span>
</td>
<td class="nump">146,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">General, administrative, and marketing</a></td>
<td class="nump">41,051<span></span>
</td>
<td class="nump">39,053<span></span>
</td>
<td class="nump">118,989<span></span>
</td>
<td class="nump">118,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">11,799<span></span>
</td>
<td class="nump">9,972<span></span>
</td>
<td class="nump">30,575<span></span>
</td>
<td class="nump">26,086<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">52,850<span></span>
</td>
<td class="nump">49,025<span></span>
</td>
<td class="nump">149,564<span></span>
</td>
<td class="nump">144,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of non-financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(15,923)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(15,923)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="num">(4,106)<span></span>
</td>
<td class="nump">14,687<span></span>
</td>
<td class="nump">2,071<span></span>
</td>
<td class="nump">17,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">4,805<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
<td class="nump">12,854<span></span>
</td>
<td class="nump">12,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="num">(40)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(86)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="nump">3,661<span></span>
</td>
<td class="nump">2,661<span></span>
</td>
<td class="nump">7,564<span></span>
</td>
<td class="nump">3,261<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income before income taxes</a></td>
<td class="num">(12,532)<span></span>
</td>
<td class="nump">7,944<span></span>
</td>
<td class="num">(18,261)<span></span>
</td>
<td class="nump">1,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">1,181<span></span>
</td>
<td class="num">(2,638)<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="num">(4,006)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (13,713)<span></span>
</td>
<td class="nump">$ 10,582<span></span>
</td>
<td class="num">$ (21,361)<span></span>
</td>
<td class="nump">$ 5,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>(Loss) income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">(Loss) income per share, basic (in usd per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">(Loss) income per share, diluted (in usd per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (in shares)</a></td>
<td class="nump">40,115<span></span>
</td>
<td class="nump">39,086<span></span>
</td>
<td class="nump">39,999<span></span>
</td>
<td class="nump">38,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">40,115<span></span>
</td>
<td class="nump">44,453<span></span>
</td>
<td class="nump">39,999<span></span>
</td>
<td class="nump">39,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (13,713)<span></span>
</td>
<td class="nump">$ 10,582<span></span>
</td>
<td class="num">$ (21,361)<span></span>
</td>
<td class="nump">$ 5,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfOtherComprehensiveIncomeAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(16,895)<span></span>
</td>
<td class="num">(5,010)<span></span>
</td>
<td class="num">(35,466)<span></span>
</td>
<td class="num">(12,327)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss) income</a></td>
<td class="num">(30,608)<span></span>
</td>
<td class="nump">5,572<span></span>
</td>
<td class="num">(56,827)<span></span>
</td>
<td class="num">(7,061)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_ProductsMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">55,248<span></span>
</td>
<td class="nump">53,107<span></span>
</td>
<td class="nump">171,726<span></span>
</td>
<td class="nump">162,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of products and preservation services:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of products and preservation services</a></td>
<td class="nump">17,743<span></span>
</td>
<td class="nump">15,503<span></span>
</td>
<td class="nump">53,381<span></span>
</td>
<td class="nump">46,592<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_PreservationServicesMember', window );">Preservation services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">21,590<span></span>
</td>
<td class="nump">19,100<span></span>
</td>
<td class="nump">62,665<span></span>
</td>
<td class="nump">56,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of products and preservation services:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of products and preservation services</a></td>
<td class="nump">$ 10,351<span></span>
</td>
<td class="nump">$ 8,915<span></span>
</td>
<td class="nump">$ 29,375<span></span>
</td>
<td class="nump">$ 26,710<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_ProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_ProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_PreservationServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_PreservationServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453470608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 37,572<span></span>
</td>
<td class="nump">$ 55,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">57,159<span></span>
</td>
<td class="nump">53,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">7,880<span></span>
</td>
<td class="nump">5,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">73,044<span></span>
</td>
<td class="nump">76,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DeferredPreservationCosts', window );">Deferred preservation costs, net</a></td>
<td class="nump">45,483<span></span>
</td>
<td class="nump">42,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">16,851<span></span>
</td>
<td class="nump">14,748<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">237,989<span></span>
</td>
<td class="nump">247,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">234,773<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Acquired technology, net</a></td>
<td class="nump">148,060<span></span>
</td>
<td class="nump">166,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="nump">41,320<span></span>
</td>
<td class="nump">45,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">36,286<span></span>
</td>
<td class="nump">37,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other intangibles, net</a></td>
<td class="nump">31,112<span></span>
</td>
<td class="nump">34,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">6,103<span></span>
</td>
<td class="nump">2,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">7,088<span></span>
</td>
<td class="nump">8,267<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">742,731<span></span>
</td>
<td class="nump">793,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">10,721<span></span>
</td>
<td class="nump">10,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">11,079<span></span>
</td>
<td class="nump">13,163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">10,088<span></span>
</td>
<td class="nump">7,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes payable</a></td>
<td class="nump">5,293<span></span>
</td>
<td class="nump">3,634<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_AccruedProcurementFees', window );">Accrued procurement fees</a></td>
<td class="nump">2,302<span></span>
</td>
<td class="nump">3,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current maturities of operating leases</a></td>
<td class="nump">3,061<span></span>
</td>
<td class="nump">3,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,562<span></span>
</td>
<td class="nump">1,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">1,886<span></span>
</td>
<td class="nump">1,606<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">45,992<span></span>
</td>
<td class="nump">44,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">306,674<span></span>
</td>
<td class="nump">307,493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration</a></td>
<td class="nump">44,800<span></span>
</td>
<td class="nump">49,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current maturities of operating leases</a></td>
<td class="nump">40,915<span></span>
</td>
<td class="nump">44,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Non-current finance lease obligation</a></td>
<td class="nump">3,450<span></span>
</td>
<td class="nump">4,374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">34,058<span></span>
</td>
<td class="nump">28,799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liability</a></td>
<td class="nump">5,082<span></span>
</td>
<td class="nump">5,952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">6,652<span></span>
</td>
<td class="nump">6,484<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">487,623<span></span>
</td>
<td class="nump">492,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock (issued shares of 41,816 in 2022 and 41,397 in 2021)</a></td>
<td class="nump">418<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">334,077<span></span>
</td>
<td class="nump">322,874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained (deficit) earnings</a></td>
<td class="num">(19,386)<span></span>
</td>
<td class="nump">1,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(45,353)<span></span>
</td>
<td class="num">(9,887)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 1,487 shares as of September&#160;30, 2022 and December&#160;31, 2021</a></td>
<td class="num">(14,648)<span></span>
</td>
<td class="num">(14,648)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">255,108<span></span>
</td>
<td class="nump">300,728<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 742,731<span></span>
</td>
<td class="nump">$ 793,052<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_AccruedProcurementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Donated tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. The Company accrues estimated procurement fees due at the time tissues are received based on contractual agreements between the Company and the tissue banks and organ procurement organizations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_AccruedProcurementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DeferredPreservationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Donated human tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. By federal law, human tissues cannot be bought or sold, so the preservation process is a manufacturing process that is accounted for using the same principles as inventory costing. Preservation costs consist primarily of direct labor and materials and indirect costs which are stated at the lower of cost or market value on a first in, first out basis and are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DeferredPreservationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511456096608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">41,816,000<span></span>
</td>
<td class="nump">41,397,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock at cost, shares (in shares)</a></td>
<td class="nump">1,487,000<span></span>
</td>
<td class="nump">1,487,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450889216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Net cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (21,361)<span></span>
</td>
<td class="nump">$ 5,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">17,016<span></span>
</td>
<td class="nump">18,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Non-cash compensation</a></td>
<td class="nump">9,189<span></span>
</td>
<td class="nump">7,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_NoncashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">5,656<span></span>
</td>
<td class="nump">5,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="nump">5,097<span></span>
</td>
<td class="num">(8,128)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_WriteDownOfDeferredPreservationCostsAndInventories', window );">Write-down of inventories and deferred preservation costs</a></td>
<td class="nump">3,116<span></span>
</td>
<td class="nump">3,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_NoncashInterestExpense', window );">Non-cash interest expense</a></td>
<td class="nump">1,372<span></span>
</td>
<td class="nump">2,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration</a></td>
<td class="num">(4,600)<span></span>
</td>
<td class="nump">4,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of non-financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(15,923)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Other</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(1,788)<span></span>
</td>
<td class="num">(2,268)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses, and other liabilities</a></td>
<td class="num">(2,103)<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories', window );">Inventories and deferred preservation costs</a></td>
<td class="num">(5,781)<span></span>
</td>
<td class="num">(16,986)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(10,900)<span></span>
</td>
<td class="num">(8,032)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash flows used in operating activities</a></td>
<td class="num">(4,936)<span></span>
</td>
<td class="num">(3,301)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Net cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Acquisition of intangible assets</a></td>
<td class="num">(1,123)<span></span>
</td>
<td class="num">(726)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(6,924)<span></span>
</td>
<td class="num">(10,524)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from sale of non-financial assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">722<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash flows (used in) provided by investing activities</a></td>
<td class="num">(8,047)<span></span>
</td>
<td class="nump">8,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Net cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from exercise of stock options and issuance of common stock</a></td>
<td class="nump">3,344<span></span>
</td>
<td class="nump">3,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Redemption and repurchase of stock to cover tax withholdings</a></td>
<td class="num">(1,791)<span></span>
</td>
<td class="num">(1,898)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of term loan</a></td>
<td class="num">(2,033)<span></span>
</td>
<td class="num">(2,397)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,219)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(300)<span></span>
</td>
<td class="num">(439)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash flows used in financing activities</a></td>
<td class="num">(780)<span></span>
</td>
<td class="num">(3,422)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(3,675)<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">(Decrease) increase in cash and cash equivalents</a></td>
<td class="num">(17,438)<span></span>
</td>
<td class="nump">3,167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents beginning of period</a></td>
<td class="nump">55,010<span></span>
</td>
<td class="nump">61,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents end of period</a></td>
<td class="nump">$ 37,572<span></span>
</td>
<td class="nump">$ 65,125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in deferred preservation costs and inventories, associated with underlying transactions that are classified as operating activities. Preservation costs consists primarily of direct labor and materials and indirect costs which are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_NoncashInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_NoncashInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_WriteDownOfDeferredPreservationCostsAndInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts of the current period expense charged to cost of products and preservation services for the purpose of reducing deferred preservation costs and inventory, respectively, to amounts that approximate their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_WriteDownOfDeferredPreservationCostsAndInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511445894288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Retained Deficit</div></th>
<th class="th">
<div>Retained Deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 328,713<span></span>
</td>
<td class="num">$ (19,639)<span></span>
</td>
<td class="nump">$ 404<span></span>
</td>
<td class="nump">$ 316,192<span></span>
</td>
<td class="num">$ (16,426)<span></span>
</td>
<td class="nump">$ 20,022<span></span>
</td>
<td class="num">$ (3,213)<span></span>
</td>
<td class="nump">$ 6,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance, treasury stock (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,487)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Beginning balance, treasury stock at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="nump">5,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(12,327)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,327)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity compensation</a></td>
<td class="nump">7,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">7,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">1,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">1,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redemption and repurchase of stock to cover tax withholdings (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption and repurchase of stock to cover tax withholdings</a></td>
<td class="num">(1,898)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(1,897)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">311,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 408<span></span>
</td>
<td class="nump">309,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury stock (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,487)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Ending balance, treasury stock at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,648)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="nump">301,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 407<span></span>
</td>
<td class="nump">305,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance, treasury stock (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,487)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Beginning balance, treasury stock at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,648)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="nump">10,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(5,010)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,010)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity compensation</a></td>
<td class="nump">2,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">1,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redemption and repurchase of stock to cover tax withholdings (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption and repurchase of stock to cover tax withholdings</a></td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">311,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 408<span></span>
</td>
<td class="nump">309,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury stock (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,487)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Ending balance, treasury stock at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,648)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 300,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
<td class="nump">322,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,887)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance, treasury stock (in shares) at Dec. 31, 2021</a></td>
<td class="num">(1,487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,487)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Beginning balance, treasury stock at Dec. 31, 2021</a></td>
<td class="num">$ (14,648)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(21,361)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,361)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(35,466)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,466)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity compensation</a></td>
<td class="nump">9,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">1,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">1,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">1,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redemption and repurchase of stock to cover tax withholdings (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption and repurchase of stock to cover tax withholdings</a></td>
<td class="num">(1,791)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(1,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 255,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 418<span></span>
</td>
<td class="nump">334,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,386)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,353)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury stock (in shares) at Sep. 30, 2022</a></td>
<td class="num">(1,487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,487)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Ending balance, treasury stock at Sep. 30, 2022</a></td>
<td class="num">$ (14,648)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,648)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="nump">281,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 417<span></span>
</td>
<td class="nump">329,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,673)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,458)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance, treasury stock (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,487)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Beginning balance, treasury stock at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,648)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(13,713)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,713)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(16,895)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,895)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity compensation</a></td>
<td class="nump">3,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redemption and repurchase of stock to cover tax withholdings (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption and repurchase of stock to cover tax withholdings</a></td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 255,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 418<span></span>
</td>
<td class="nump">$ 334,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (19,386)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (45,353)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury stock (in shares) at Sep. 30, 2022</a></td>
<td class="num">(1,487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,487)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Ending balance, treasury stock at Sep. 30, 2022</a></td>
<td class="num">$ (14,648)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,648)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453855216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements include the accounts of Artivion, Inc. and its subsidiaries (&#8220;Artivion,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; or &#8220;us&#8221;). All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying Condensed Consolidated Balance Sheet as of December&#160;31, 2021 has been derived from audited financial statements. The accompanying unaudited Condensed Consolidated Financial Statements as of, and for the three and nine months ended, September&#160;30, 2022 and 2021 have been prepared in accordance with (i) accounting principles generally accepted in the US for interim financial information and (ii) the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the US Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, such statements do not include all the information and disclosures that are required by accounting principles generally accepted in the US for a complete presentation of financial statements. In the opinion of management, all adjustments (including those of a normal, recurring nature) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. These Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes included in Artivion&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 filed with the SEC on February&#160;22, 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our significant accounting policies is included in Note 1 of the &#8220;Notes to Consolidated Financial Statements&#8221; contained in our Form 10-K for the year ended December&#160;31, 2021. Management believes that the consistent application of these policies enables us to provide users of the financial statements with useful and reliable information about our operating results and financial condition. The Condensed Consolidated Financial Statements are prepared in accordance with accounting principles generally accepted in the US, which require us to make estimates and assumptions. We did not experience any significant changes during the three and nine months ended September&#160;30, 2022 in any of our Significant Accounting Policies from those contained in our Form 10-K for the year ended December&#160;31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020 the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-06&#8221;). The update simplifies the accounting for convertible instruments by eliminating two accounting models (i.e., the cash conversion model and beneficial conversion feature model) and reducing the number of embedded conversion features that could be recognized separately from the host contract. ASU 2020-06 also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. On January 1, 2021 we adopted ASU 2020-06 using the modified retrospective approach. See Note 9 for further discussion of convertible debt. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Not Yet Effective </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020 the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 848&#8221;). The amendments in this ASU were put forth in response to the market transition from the LIBOR and other interbank offered rates to alternative reference rates. Accounting principles generally accepted in the United States of America require entities to evaluate whether a contract modification, such as the replacement or change of a reference rate, results in the establishment of a new contract or continuation of an existing contract. ASC 848 allows an entity to elect not to apply certain modification accounting requirements to contracts affected by reference rate reform. The standard provides this temporary election through December&#160;31, 2022 and cannot be applied to contract modifications that occur after December&#160;31, 2022. </span>We are in the process of evaluating the effect that the adoption of this standard will have on our financial position and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453838880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of PerClot<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Sale of PerClot</a></td>
<td class="text">Sale of PerClot<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2021 we entered into an asset purchase agreement and other ancillary agreements related to the sale of PerClot&#174;, a polysaccharide hemostatic agent used in surgery (&#8220;PerClot&#8221;), to a subsidiary of Baxter International, Inc. (&#8220;Baxter&#8221;) and an agreement to terminate all of our material agreements with Starch Medical, Inc. (&#8220;SMI&#8221;) related to PerClot (collectively the &#8220;Baxter Transaction&#8221;). Under the terms of the Baxter Transaction, Baxter will pay an aggregate of up to $60.8 million in consideration (we will receive up to $45.8 million and SMI will receive up to $15.0 million), consisting of (i) $25.0 million at closing, of which $6.0 million was paid to SMI; (ii) up to $25.0 million upon our receipt of Premarket Approval (&#8220;PMA&#8221;) approval from the US Food and Drug Administration (the &#8220;FDA&#8221;) for PerClot and our transfer of the PMA to Baxter, of which up to $6.0 million is payable to SMI, subject to certain reductions for delay in PMA approval; and (iii) up to $10.0 million upon Baxter&#8217;s achievement of certain cumulative worldwide net sales of PerClot prior to December 31, 2026 and December 31, 2027, of which up to $3.0 million is payable to SMI. In addition, at the conclusion of our manufacturing and supply services for Baxter, Baxter will pay $780,000 upon transfer of our PerClot manufacturing equipment. Under the terms of the Baxter Transaction, we will continue to provide to Baxter certain transition and manufacturing and supply services relating to the sale of SMI PerClot outside of the US and manufacture and supply of PerClot to Baxter post PMA approval.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for the Transaction</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the Baxter Transaction, we received $25.0 million from Baxter and paid $6.0 million to SMI. We derecognized intangible assets with a carrying value of $1.6 million and wrote-off $1.5 million of prepaid royalties previously recorded on our Condensed Consolidated Balance Sheets related to PerClot. Under the terms of the agreement, Baxter acquired intellectual property related to our development efforts for PerClot. We recorded a pre-tax gain of $15.9 million, included as Gain from sale of non-financial assets within the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2021. The PerClot product line was included as part of our Medical Devices segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453861056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Financial Instruments</a></td>
<td class="text">Financial Instruments<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our financial instruments measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,800)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,800)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(49,400)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(49,400)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used prices quoted from our investment advisors to determine the Level 1 valuation of our investments in money market funds.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;2, 2020 we entered into a Securities Purchase Agreement to acquire 100% of the outstanding equity interests of Ascyrus Medical LLC (&#8220;Ascyrus&#8221;). Ascyrus developed the AMDS, the world&#8217;s first aortic arch remodeling device for use in the treatment of acute Type A aortic dissections. As part of the acquisition, we may be required to pay additional consideration in cash of up to $100.0 million to the former shareholders of Ascyrus upon the achievement of certain milestones and the sales-based additional earn-out. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration represents the estimated fair value of future potential payments. The fair value of the contingent consideration liability was estimated by discounting to present value the contingent payments expected to be made based on a probability-weighted scenario approach. We applied a discount rate based on our unsecured credit spread and the term commensurate risk-free rate to the additional consideration to be paid, and then applied a risk-based estimate of the probability of achieving each scenario to calculate the fair value of the contingent consideration. This fair value measurement was based on unobservable inputs, including management estimates and assumptions about the future achievement of milestones and future estimate of revenues, and is, therefore, classified as Level 3 within the fair value hierarchy. We used a discount rate of approximately 13% and estimated future achievement of milestone dates between 2025 and 2026 to calculate the fair value of contingent consideration as of September&#160;30, 2022. We will remeasure this liability at each reporting date and will record changes in the fair value of the contingent consideration in General, administrative, and marketing expenses on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. Increases or decreases in the fair value of the contingent consideration liability can result from changes in passage of time, discount rates, the timing and amount of our revenue estimates, and the timing and expectation of regulatory approvals.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed an assessment of the fair value of the contingent consideration and recorded expense of $400,000 and income of $4.6 million for the three and nine months ended September&#160;30, 2022, respectively, and expense of $700,000 and $5.0 million for the three and nine months ended September&#160;30, 2021, respectively, in General, administrative, and marketing expenses on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income, as a result of this assessment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent consideration component of the Ascyrus acquisition was updated using Level 3 inputs. Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.809%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,400)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453842528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Equivalents<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Cash Equivalents</a></td>
<td class="text">Cash Equivalents <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of cash equivalents (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost Basis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Holding<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost Basis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Holding<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>There were no gross realized gains or losses on cash equivalents for the three and nine months ended September&#160;30, 2022 and 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511445877952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, net and Deferred Preservation Costs<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories, net and Deferred Preservation Costs</a></td>
<td class="text">Inventories, net and Deferred Preservation Costs <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories at September&#160;30, 2022 and December&#160;31, 2021 were comprised of the following (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:71.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.881%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.124%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total inventories, net </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73,044</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76,971</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To facilitate product usage, we maintain consignment inventory of our On-X heart valves at domestic hospital locations and On-X heart valves and aortic stent grafts at international hospital locations. We retain title and control over this consignment inventory until the device is implanted, at which time we invoice the hospital and recognize revenue. As of September&#160;30, 2022 we had $13.2 million in consignment inventory, with approximately 39% in domestic locations and 61% in international locations. As of December&#160;31, 2021 we had $12.9 million in consignment inventory, with approximately 43% in domestic locations and 57% in international locations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred preservation costs were $45.5 million and $42.9 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory and deferred preservation costs obsolescence reserves were $1.9 million and $3.2 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511454845264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">Goodwill and Other Intangible Assets <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite Lived Intangible Assets </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021 the carrying values of our indefinite lived intangible assets were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">234,773</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">250,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">In-process R&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,901</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,208</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Procurement contracts and agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,013</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">247</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">66</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the phases of development of our acquired in-process research and development projects, including the risks associated with further development and the amount and timing of benefits expected to be derived from the completed projects. Incremental costs associated with development are charged to expense as incurred. Capitalized costs are amortized over the estimated useful life of the developed asset once completed. Our in-process research and development projects are reviewed for impairment annually, or more frequently, if events or changes in circumstances indicate that the asset might be impaired. We did not record any impairment of indefinite lived intangible assets during the three and nine months ended September&#160;30, 2022. In-process research and development, procurement contracts and agreements, and trademarks are included in Other intangibles, net on the Condensed Consolidated Balance Sheets as of September&#160;30, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our experience with similar agreements, we believe that our acquired procurement contracts and agreements have indefinite useful lives, as we expect to continue to renew these contracts for the foreseeable future. We believe that our trademarks have indefinite useful lives as we currently anticipate that our trademarks will contribute to our cash flows indefinitely.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our goodwill and non-amortizing intangible assets for impairment on an annual basis during the fourth quarter of the year, and, if necessary, during interim periods if factors indicate that an impairment review is warranted. As of September&#160;30, 2022 we concluded that our assessment of current factors did not indicate that goodwill or non-amortizing intangible assets are more likely than not to be impaired. We will continue to evaluate the recoverability of these non-amortizing intangible assets in future periods as necessary.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021 the carrying value of goodwill, all of which is related to our Medical devices segment, is as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Medical Devices Segment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">250,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(15,227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">234,773</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definite Lived Intangible Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The definite lived intangible assets balance includes balances related to acquired technology, customer relationships, distribution and manufacturing rights and know-how, patents, and other definite lived intangible assets. As of September&#160;30, 2022 and December&#160;31, 2021 the gross carrying values, accumulated amortization, and approximate amortization period of our definite lived intangible assets were as follows (in thousands, except weighted average useful life): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net Carrying <br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted Average<br/>Useful Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Acquired technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">190,108</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">42,048</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">148,060</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">18.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Other intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Customer lists and relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">30,868</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,677</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20,191</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Distribution and manufacturing rights and know-how</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8,476</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,900</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,576</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,171</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,168</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,325</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,144</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,181</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">47,840</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">20,889</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">26,951</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">10.8</span></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net Carrying <br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted Average<br/>Useful Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Acquired technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">213,626</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">46,632</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">166,994</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Other intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Customer lists and relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31,148</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,618</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21,530</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Distribution and manufacturing rights and know-how</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,847</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,308</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,539</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,083</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,144</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">939</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,969</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,762</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,207</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">49,047</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">18,832</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">30,215</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">10.6</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization Expense </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of amortization expense as recorded in General, administrative, and marketing expenses on our Condensed Consolidated Statement of Operations and Comprehensive (Loss) Income (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,686&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 scheduled amortization of intangible assets for the next five years is as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.965%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remainder<br/>of 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511454845264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was an expense of 9% and 17% for the three and nine months ended September&#160;30, 2022, respectively, as compared to a benefit of 33% and 318% for the three and nine months ended September&#160;30, 2021, respectively. Our income tax rate for the three and nine months ended September&#160;30, 2022 was primarily impacted by changes in our valuation allowance against our net deferred tax assets, non-deductible executive compensation, the foreign derived intangible income deduction, the research and development tax credit, changes in our uncertain tax position liabilities, and tax shortfalls on stock compensation. Our income tax rate for the three and nine months ended September&#160;30, 2021 was primarily impacted by non-deductible executive compensation, changes in our valuation allowance against our net deferred tax assets, changes in our uncertain tax position liabilities, the research and development tax credit, and excess tax benefits on stock compensation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Income Taxes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate deferred tax assets primarily as a result of finance leases, net operating losses, amortization of research and development expenses, excess interest carryforward, stock compensation, and accrued compensation. Our deferred tax liabilities are primarily made up of intangible assets acquired in previous years, finance leases, and unrealized gains and losses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintained a net deferred tax liability of $28.0 million and $26.4 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. Our valuation allowance against our deferred tax assets was $17.8 million and $13.3 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively, primarily related to net operating loss carryforwards and disallowed excess interest carryforwards.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453576416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating and finance lease obligations resulting from the lease of land and buildings that comprise our corporate headquarters and various manufacturing facilities; leases related to additional manufacturing, office, and warehouse space; leases on company vehicles; and leases on a variety of office and other equipment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;6, 2021 we executed a modification to extend the lease of our headquarters located in Kennesaw, Georgia. This modification resulted in an increase in the present value of future lease obligations and corresponding right-of-use asset of $23.3 million, using a discount rate of 6.41%.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;1, 2021 we began occupancy of the newly constructed addition to our leased international headquarters located in Hechingen, Germany. This lease resulted in an increase in the present value of future lease obligations and corresponding right-of-use asset of $9.8 million, using a discount rate of 5.46%.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to leases included in the Condensed Consolidated Balance Sheets is as follows (in thousands, except lease term and discount rate):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating leases:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">55,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">58,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(14,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(12,383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating lease right-of-use assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">41,320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">45,714</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Current maturities of operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-current maturities of operating leases </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">44,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">43,976</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">48,018</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Property and equipment, at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(2,166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(2,105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,695</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,654</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Current maturities of finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-current maturities of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,919</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,902</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">12.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">12.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8.8</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.0%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current maturities of finance leases are included as a component of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyNA_232befca-efbd-4242-931d-c2e23c341abe"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyNA_bf517df5-2808-40a4-b74d-94a6a829e5d0">Other current liabilities</span></span> on our Condensed Consolidated Balance Sheets. A summary of lease expenses for our finance and operating leases included in General, administrative, and marketing expenses on our Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income is as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Amortization of property and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">127</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">190</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">395</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">500</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Interest expense on finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">22</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">27</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">69</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">85</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total finance lease expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">149</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">217</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">464</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">585</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,853</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,989</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,656</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,566</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(275)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total lease expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">1,910</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2,114</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">5,845</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">5,843</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our cash flow information related to leases is as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating cash flows for operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,939</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,536</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">346</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">446</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">62</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">82</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments and sublease rental income are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance<br/>Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating<br/>Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Sublease<br/>Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Remainder of 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">120</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">660</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">549</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,624</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">545</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,252</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">525</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,173</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">508</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,719</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,986</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,247</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">63,414</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">31</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(328)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(19,438)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Present value of net minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,919</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">43,976</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less current maturities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(3,061)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Lease liabilities, less current maturities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,450</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,915</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511455129920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;1, 2017 we entered into a credit and guaranty agreement for a $255.0 million senior secured credit facility, consisting of a $225.0 million secured term loan facility (the &#8220;Term Loan Facility&#8221;) and a $30.0 million secured revolving credit facility (the &#8220;Revolving Credit Facility&#8221; and, together with the Term Loan Facility, the &#8220;Credit Agreement&#8221;). We and each of our existing domestic subsidiaries (subject to certain exceptions and exclusions) guarantee the obligations under the Credit Agreement (the &#8220;Guarantors&#8221;). The Credit Agreement is secured by a security interest in substantially all existing and after-acquired real and personal property (subject to certain exceptions and exclusions) of us and the Guarantors.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;2, 2021 we entered into an amendment to our Credit Agreement to extend the maturity dates of our Term Loan and Revolving Credit Facility. As part of the amendment, the maturity dates of both our Term Loan and Revolving Credit Facility were each extended by two and one-half years, until June 1, 2027 and June 1, 2025, respectively, subject to earlier springing maturities triggered if our 4.25% Convertible Senior Notes, described below, remain outstanding on April 1, 2025 and December 31, 2024, respectively. With respect to the Term Loan, if the Convertible Senior Notes remain outstanding on April 1, 2025, the Term Loan&#8217;s maturity date will be April 1, 2025, or, if the Convertible Senior Notes&#8217; own maturity date has been extended, the earlier of (i) 91 days prior to the Convertible Senior Notes&#8217; new maturity date and (ii) June 1, 2027. In the case of the Revolving Credit Facility, if the Convertible Senior Notes are still outstanding on December 31, 2024, the Revolving Credit Facility&#8217;s maturity date will be either December 31, 2024 or, if the Convertible Senior Notes&#8217; own maturity date has been extended, the earlier of (i) 182 days prior to the Convertible Senior Notes&#8217; new maturity date and (ii) June 1, 2025. Under the amendment, the Term Loan Facility bears interest, at our option, at a floating annual rate equal to either the base rate, plus a margin of 2.50%, or LIBOR, plus a margin of 3.50%. Prior to the amendment, the optional floating annual rate was equal to either the base rate plus a margin of 2.25%, or LIBOR, plus a margin of 3.25%. We paid debt issuance costs of $2.1 million, of which $1.8 million will be amortized over the life of the Term Loan Facility and included in current and long-term debt on the Condensed Consolidated Balance Sheets. The remaining $361,000 of debt issuance costs and $474,000 of non-cash debt extinguishment costs were recorded in Interest expense on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 the Credit Agreement contains certain customary affirmative and negative covenants, including covenants that limit our ability and the ability of our subsidiaries to, among other things, grant liens, incur debt, dispose of assets, make loans and investments, make acquisitions, make certain restricted payments (including cash dividends), merge or consolidate, change business or accounting or reporting practices, in each case subject to customary exceptions for a credit facility of this size and type. Beginning in 2021 if we repay borrowings under our Revolving Credit Facility to 25% or less, no financial maintenance covenants, including the minimum liquidity covenant and the maximum first lien net leverage ratio covenant, are applicable. We are in compliance with our debt covenants as of September&#160;30, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;18, 2020 we issued $100.0 million aggregate principal amount of 4.25% Convertible Senior Notes with a maturity date of July&#160;1, 2025 (the &#8220;Convertible Senior Notes&#8221;). The net proceeds from this offering, after deducting initial purchasers&#8217; discounts and costs directly related to this offering, were approximately $96.5 million. On January 1, 2021 we adopted ASU 2020-06 and adjusted the carrying balance of the Convertible Senior Notes to notional. The Convertible Senior Notes balance was $100.0 million recorded in Long-term debt on the Condensed Consolidated Balance Sheets as of September&#160;30, 2022. The Convertible Senior Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. The initial conversion rate of the Convertible Senior Notes is 42.6203 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $23.46 per share, subject to adjustments. We use the if-converted method for assumed conversion of the Convertible Senior Notes for the diluted earnings per share calculation. The fair value and the effective interest rate of the Convertible Senior Notes as of September&#160;30, 2022 was approximately $92.3 million and 5.05%, respectively. The fair value was based on market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest expense recognized on the Convertible Senior Notes includes $1.2 million and $3.7 million for the </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended September&#160;30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, and $1.2 million and $3.7 million for the </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended September&#160;30, 2021, respectively, related to the aggregate of the contractual coupon interest, and the amortization of the debt issuance costs</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Interest on the Convertible Senior Notes began accruing upon issuance and is payable semi-annually. As of September&#160;30, 2022 there were $2.0 million of unamortized debt issuance costs related to Convertible Senior Notes. </span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Convertible Senior Notes may convert their notes at their option at any time prior to January 1, 2025, but only under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (iii) we give a notice of redemption with respect to any or all of the notes, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate events. On or after January 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their notes at any time, regardless of the foregoing circumstances.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot redeem the Convertible Senior Notes before July 5, 2023. We can redeem them on or after July 5, 2023, in whole or in part, at our option, if the last reported sale price per share of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption. We may redeem for cash all or part of the Convertible Senior Notes at a redemption price equal to 100% of the principal amount of the redeemable Convertible Senior Notes, plus accrued and unpaid interest to, but excluding, the redemption date. No principal payments are due on the Convertible Senior Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the Convertible Senior Notes do not contain any financial covenants and do not restrict us from conducting significant restructuring transactions or issuing or repurchasing any of its other securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan Balances</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The short-term and long-term balances of our term loan and other long-term borrowings were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:71.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Term loan balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">214,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">216,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.45% Sparkasse Zollernalb (KFW Loan 1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1.40% Sparkasse Zollernalb (KFW Loan 2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total loan balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">315,369</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">317,627</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less unamortized loan origination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(7,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(8,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net borrowings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">308,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">309,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less short-term loan balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(1,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(1,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Long-term loan balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">306,674</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">307,493</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div>Interest expense was $4.8 million and $12.9 million for the three and nine months ended September&#160;30, 2022, respectively, as compared to $4.1 million and $13.0 million for the three and nine months ended September&#160;30, 2021, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450871264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liability Claims</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are made aware of adverse events involving our products and tissues. Future adverse events could ultimately give rise to a lawsuit against us, and liability claims may be asserted against us in the future based on past events that we are not aware of at the present time. We maintain claims-made insurance policies to mitigate our financial exposure to product and tissue processing liability claims. Claims-made insurance policies generally cover only those asserted claims and incidents that are reported to the insurance carrier while the policy is in effect. The amounts recorded in these Condensed Consolidated Financial Statements as of September&#160;30, 2022 represent our estimate of the probable losses and anticipated recoveries for incurred but not reported claims related to products sold and services performed prior to the balance sheet date.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PROACT Xa Clinical Trial Termination</span></div>On September 23, 2022 we announced that we were stopping the PROACT Xa clinical trial as recommended by the trial's independent Data and Safety Monitoring Board. The PROACT Xa clinical trial was a prospective, randomized, trial designed to determine if patients with  On-X mechanical aortic valves could be maintained safely and effectively on apixaban rather than on warfarin. As a result of PROACT Xa's early termination, we recorded $4.7 million of termination and wind-down expenses that are included in Research and development operating expenses on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income for the three and nine months ended September 30, 2022. The majority of these costs include future administrative costs that will be incurred during the fourth quarter of 2022 and the first quarter of 2023, as well as the estimated cost of clinical drugs purchased for patients participating in the study that are not expected to be recovered.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511455124352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Revenue</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have identified the following revenues disaggregated by revenue source:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Domestic hospitals &#8211; direct sales of products and preservation services.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International hospitals &#8211; direct sales of products and preservation services.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International distributors &#8211; generally these contracts specify a geographic area that the distributor will service, terms and conditions of the relationship, and purchase targets for the next calendar year.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CardioGenesis cardiac laser console trials and sales &#8211; CardioGenesis cardiac trialed laser consoles are delivered under separate agreements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2022 and 2021 the sources of revenue were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Domestic hospitals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,842</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">36,129</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">117,343</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">111,291</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">International hospitals</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">24,119</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">25,458</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">79,768</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">79,219</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">International distributors</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11,469</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,544</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">34,685</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">28,694</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">CardioGenesis cardiac laser therapy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">408</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">76</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,595</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">238</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total sources of revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">76,838</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">72,207</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">234,391</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">219,442</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also see segment disaggregation information in Note 14 below.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may generate contract assets during the pre-delivery design and manufacturing stage of E-xtra Design Engineering product order fulfillment. We assess the balance related to any arrangements in process and determine if the enforceable right to payment creates a material contract asset requiring disclosure. No material arrangements in process existed as of September&#160;30, 2022 and 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also incur contract obligations on general customer purchase orders that have been accepted but unfulfilled. Due to the short duration of time between order acceptance and delivery of the related product or service, we have determined that the balance related to these contract obligations is generally immaterial at any point in time. We monitor the value of orders accepted but unfulfilled at the close of each reporting period to determine if disclosure is appropriate. The value of orders accepted but unfulfilled as of September&#160;30, 2022 and 2021 was not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450871264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Compensation</a></td>
<td class="text">Stock Compensation <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), performance stock units (&#8220;PSUs&#8221;), and options to purchase shares of our common stock at exercise prices generally equal to the fair value of such stock at the dates of grant. We also maintain a shareholder-approved Employee Stock Purchase Plan (&#8220;ESPP&#8221;) for the benefit of our employees. The ESPP allows eligible employees to purchase common stock on a regular basis at the lower of 85% of the market price at the beginning or end of each offering period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Grants</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022 the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Compensation Committee of our Board of Directors (the &#8220;Committee&#8221;) authorized awards from approved stock incentive plans of RSAs to non-employee directors and RSUs and PSUs to certain employees and company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together totaled 520,000 shares and had an aggregate grant date fair value of $9.7 million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021 the Committee authorized awards from approved stock incentive plans of RSAs to non-employee directors, RSUs to certain employees, and RSAs and PSUs to certain Company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together totaled 494,000 shares and had an aggregate grant date fair value of $12.5 million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee authorized, from approved stock incentive plans, grants of stock options to purchase a total of 314,000 and 226,000 shares to certain Company officers during the nine months ended September&#160;30, 2022 and 2021, respectively. The exercise prices of the options were equal to the closing stock prices on their respective grant dates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employees purchased common stock totaling 58,000 and 95,000 shares in the three and nine months ended September&#160;30, 2022, respectively, as compared to 51,000 and 87,000 shares in the three and nine months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, through the ESPP. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Compensation Expense </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used to determine the fair value of options and shares purchased under the ESPP: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Stock<br/>Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">ESPP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.5 Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.0 Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.5 Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.49</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.40</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1.89%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.22%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total stock compensation expenses prior to the capitalization of amounts into Deferred preservation and Inventory costs (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">RSA, RSU, and PSU expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">7,860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Stock option and ESPP expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total stock compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,233</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2,990</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">9,654</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">7,895</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Included in the total stock compensation expense, as applicable in each period, were expenses related to RSAs, RSUs, PSUs, and stock options issued in each respective year, as well as those issued in prior periods that continue to vest during the period, and compensation related to the ESPP. These amounts were recorded as stock compensation expense and were subject to our normal allocation of expenses to inventory costs and deferred preservation costs. We capitalized $144,000 and $465,000 in the three and nine months ended September 30, 2022, respectively, and $115,000 and $424,000 in the three and nine months ended September 30, 2021, respectively, of the stock compensation expense into our inventory costs and deferred preservation costs.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511457180832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(Loss) Earnings Per Common Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">(Loss) Earnings Per Common Share</a></td>
<td class="text">(Loss) Earnings Per Common Share <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted (loss) income per common share (in thousands, except per share data): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"/><td style="width:47.680%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.099%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic (loss) income per common share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(13,713)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(21,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss (income) allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(63)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">109</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(34)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net (loss) income allocated to common shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(13,643)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">10,519</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(21,252)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">5,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,115</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,086</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,999</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">38,924</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic (loss) income per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.34)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">0.27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.53)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">0.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"/><td style="width:47.680%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.099%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted (loss) income per common share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(13,713)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(21,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss (income) allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(55)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">109</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(34)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss attributable to convertible senior notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net (loss) income allocated to common shareholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(13,643)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">11,446</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(21,252)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">5,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,115</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">39,086</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">39,999</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">38,924</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Effect of dilutive stock options and awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1.25pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">505</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">572</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Effect of convertible senior notes </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1.25pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,862</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,115</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">44,453</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,999</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,496</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted (loss) income per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.34)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">0.26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.53)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">0.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares because the inclusion of these stock options would be antidilutive to loss per common share. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2022 all stock options and awards were excluded from the calculation of diluted weighted-average common shares outstanding as these would be antidilutive due to the net loss. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 539,000 and 517,000 of potential common shares relating to stock options, respectively, were antidilutive and excluded from the calculation of diluted weighted-average common shares outstanding. We excluded 4,860,685 of potential common shares related to our Convertible Senior Notes calculated under the if-converted method, as these shares would be antidilutive for the nine months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511456904208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information  <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two reportable segments organized according to our products and services: Medical devices and Preservation services. The Medical devices segment includes external revenues from product sales of aortic stent grafts, surgical sealants, On-X, and other product revenues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Aortic arch stent grafts include our E-vita Open NEO, E-vita Open Plus, AMDS, NEXUS, E-vita Thoracic 3G, and E-nya products. Abdominal stent grafts include our E-xtra Design Engineering, E-nside, E-tegra, E-ventus BX, and E-liac products. Surgical sealants include BioGlue Surgical Adhesive products. The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues. There are no intersegment revenues. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary measure of segment performance, as viewed by our management, is segment gross margin or net external revenues less cost of products and preservation services. We do not segregate assets by segment, therefore, asset information is excluded from the segment disclosures below. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">55,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">53,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">171,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">162,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">62,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">56,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">76,838</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">72,207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">234,391</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">219,442</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Cost of products and preservation services:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">15,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">53,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">46,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">29,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">26,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total cost of products and preservation services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">28,094</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">24,418</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">82,756</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">73,302</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Gross margin:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">37,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">37,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">118,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">115,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">33,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">30,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total gross margin</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">48,744</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">47,789</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">151,635</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">146,140</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes net revenues by product and service (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Aortic stent grafts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,674</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20,896</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">69,013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">62,165</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Surgical sealants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,374</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">16,544</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">49,022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">52,236</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">On-X</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">16,456</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">14,022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">47,082</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">41,843</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,744</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,645</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,609</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,284</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total products</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">55,248</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">53,107</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">171,726</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">162,528</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21,590</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">62,665</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">56,914</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">76,838</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">72,207</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">234,391</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">219,442</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511455118784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020 the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2020-06&#8221;). The update simplifies the accounting for convertible instruments by eliminating two accounting models (i.e., the cash conversion model and beneficial conversion feature model) and reducing the number of embedded conversion features that could be recognized separately from the host contract. ASU 2020-06 also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. On January 1, 2021 we adopted ASU 2020-06 using the modified retrospective approach. See Note 9 for further discussion of convertible debt. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Not Yet Effective </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020 the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 848&#8221;). The amendments in this ASU were put forth in response to the market transition from the LIBOR and other interbank offered rates to alternative reference rates. Accounting principles generally accepted in the United States of America require entities to evaluate whether a contract modification, such as the replacement or change of a reference rate, results in the establishment of a new contract or continuation of an existing contract. ASC 848 allows an entity to elect not to apply certain modification accounting requirements to contracts affected by reference rate reform. The standard provides this temporary election through December&#160;31, 2022 and cannot be applied to contract modifications that occur after December&#160;31, 2022. </span>We are in the process of evaluating the effect that the adoption of this standard will have on our financial position and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453844496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Summary of Financial Instruments Measured at Fair Value</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our financial instruments measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,800)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,800)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(49,400)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(49,400)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of Changes in Fair Value of Level 3 Liabilities</a></td>
<td class="text">Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.809%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,400)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450804272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Summary of Cash Equivalents and Restricted Securities</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of cash equivalents (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost Basis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Holding<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost Basis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Holding<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,015</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511457099808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, Net And Deferred Preservation Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories at September&#160;30, 2022 and December&#160;31, 2021 were comprised of the following (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:71.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.881%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.124%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total inventories, net </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73,044</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76,971</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450995024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Carrying Values of Indefinite Lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021 the carrying values of our indefinite lived intangible assets were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">234,773</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">250,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">In-process R&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,901</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,208</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Procurement contracts and agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,013</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">247</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">66</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill by Reportable Segment</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021 the carrying value of goodwill, all of which is related to our Medical devices segment, is as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Medical Devices Segment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">250,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(15,227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">234,773</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets</a></td>
<td class="text">As of September&#160;30, 2022 and December&#160;31, 2021 the gross carrying values, accumulated amortization, and approximate amortization period of our definite lived intangible assets were as follows (in thousands, except weighted average useful life): <div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net Carrying <br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted Average<br/>Useful Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Acquired technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">190,108</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">42,048</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">148,060</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">18.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Other intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Customer lists and relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">30,868</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,677</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20,191</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Distribution and manufacturing rights and know-how</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8,476</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,900</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,576</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,171</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,168</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,325</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,144</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,181</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">47,840</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">20,889</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">26,951</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">10.8</span></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net Carrying <br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted Average<br/>Useful Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Acquired technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">213,626</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">46,632</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">166,994</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Other intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Customer lists and relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31,148</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,618</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21,530</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Distribution and manufacturing rights and know-how</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,847</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,308</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,539</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,083</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,144</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">939</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,969</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,762</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,207</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">49,047</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">18,832</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">30,215</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">10.6</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Summary of Amortization Expense</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of amortization expense as recorded in General, administrative, and marketing expenses on our Condensed Consolidated Statement of Operations and Comprehensive (Loss) Income (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,686&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Scheduled Amortization of Intangible Assets for Next Five Years</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 scheduled amortization of intangible assets for the next five years is as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.965%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remainder<br/>of 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511455131264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Supplemental Balance Sheet Information Related to Leases</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to leases included in the Condensed Consolidated Balance Sheets is as follows (in thousands, except lease term and discount rate):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating leases:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">55,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">58,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(14,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(12,383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating lease right-of-use assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">41,320</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">45,714</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Current maturities of operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-current maturities of operating leases </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">44,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">43,976</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">48,018</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Property and equipment, at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(2,166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(2,105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,695</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,654</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Current maturities of finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-current maturities of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,919</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,902</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">12.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">12.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8.8</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.0%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Lease Costs</a></td>
<td class="text">A summary of lease expenses for our finance and operating leases included in General, administrative, and marketing expenses on our Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income is as follows (in thousands): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Amortization of property and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">127</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">190</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">395</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">500</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Interest expense on finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">22</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">27</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">69</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">85</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total finance lease expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">149</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">217</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">464</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">585</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,853</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,989</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,656</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,566</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(275)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total lease expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">1,910</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2,114</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">5,845</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">5,843</span></td></tr></table><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our cash flow information related to leases is as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating cash flows for operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,939</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,536</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">346</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">446</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">62</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">82</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments and sublease rental income are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance<br/>Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating<br/>Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Sublease<br/>Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Remainder of 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">120</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">660</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">549</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,624</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">545</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,252</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">525</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,173</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">508</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,719</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,986</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,247</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">63,414</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">31</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(328)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(19,438)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Present value of net minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,919</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">43,976</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less current maturities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(3,061)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Lease liabilities, less current maturities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,450</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,915</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance Lease, Liability, Fiscal Year Maturity</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments and sublease rental income are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance<br/>Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating<br/>Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Sublease<br/>Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Remainder of 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">120</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">660</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">549</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,624</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">545</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,252</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">525</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,173</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">508</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,719</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,986</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,247</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">63,414</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">31</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(328)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(19,438)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Present value of net minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,919</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">43,976</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less current maturities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(3,061)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Lease liabilities, less current maturities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,450</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,915</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Supplemental Balance Sheet Information Related To Leases [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511457180832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Short-Term and Long-Term Balances of Term Loan</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The short-term and long-term balances of our term loan and other long-term borrowings were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:71.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Term loan balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">214,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">216,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.45% Sparkasse Zollernalb (KFW Loan 1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1.40% Sparkasse Zollernalb (KFW Loan 2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total loan balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">315,369</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">317,627</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less unamortized loan origination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(7,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(8,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net borrowings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">308,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">309,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less short-term loan balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(1,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(1,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Long-term loan balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">306,674</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">307,493</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511455295360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2022 and 2021 the sources of revenue were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Domestic hospitals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,842</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">36,129</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">117,343</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">111,291</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">International hospitals</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">24,119</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">25,458</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">79,768</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">79,219</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">International distributors</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11,469</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,544</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">34,685</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">28,694</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">CardioGenesis cardiac laser therapy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">408</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">76</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,595</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">238</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total sources of revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">76,838</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">72,207</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">234,391</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">219,442</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450880864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted-Average Assumptions Used to Determine the Fair Value of Options</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used to determine the fair value of options and shares purchased under the ESPP: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Stock<br/>Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">ESPP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.5 Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.0 Years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.5 Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.49</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.40</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1.89%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.22%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary of Total Stock Compensation Expenses</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total stock compensation expenses prior to the capitalization of amounts into Deferred preservation and Inventory costs (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">RSA, RSU, and PSU expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">7,860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Stock option and ESPP expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total stock compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,233</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2,990</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">9,654</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">7,895</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450804272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(Loss) Earnings Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted (Loss) Income Per Common Share</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted (loss) income per common share (in thousands, except per share data): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"/><td style="width:47.680%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.099%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic (loss) income per common share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(13,713)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(21,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss (income) allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(63)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">109</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(34)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net (loss) income allocated to common shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(13,643)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">10,519</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(21,252)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">5,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,115</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,086</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,999</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">38,924</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic (loss) income per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.34)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">0.27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.53)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">0.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"/><td style="width:47.680%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.099%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted (loss) income per common share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(13,713)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,582&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(21,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss (income) allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(55)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">109</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(34)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss attributable to convertible senior notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net (loss) income allocated to common shareholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(13,643)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">11,446</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(21,252)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">5,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,115</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">39,086</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">39,999</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">38,924</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Effect of dilutive stock options and awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1.25pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">505</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">572</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Effect of convertible senior notes </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1.25pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,862</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,115</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">44,453</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,999</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,496</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted (loss) income per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.34)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">0.26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.53)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">0.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453788176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Revenues, Cost of Products and Services, and Gross Margins for Operating Segments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">55,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">53,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">171,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">162,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">62,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">56,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">76,838</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">72,207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">234,391</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">219,442</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Cost of products and preservation services:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">15,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">53,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">46,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">29,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">26,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total cost of products and preservation services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">28,094</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">24,418</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">82,756</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">73,302</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Gross margin:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">37,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">37,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">118,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">115,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">33,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">30,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total gross margin</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">48,744</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">47,789</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">151,635</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">146,140</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Summary of Net Revenues by Product and Service</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes net revenues by product and service (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Aortic stent grafts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,674</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20,896</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">69,013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">62,165</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Surgical sealants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,374</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">16,544</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">49,022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">52,236</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">On-X</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">16,456</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">14,022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">47,082</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">41,843</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,744</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,645</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,609</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,284</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total products</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">55,248</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">53,107</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">171,726</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">162,528</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21,590</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">62,665</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">56,914</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">76,838</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">72,207</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">234,391</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">219,442</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511448285792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of PerClot (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 28, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from sale of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 19,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of non-financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 15,923<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 15,923<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=aort_PerClotMember', window );">Per Clot</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Consideration for sale of assets</a></td>
<td class="nump">$ 45,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent', window );">Derecognition of intangible assets</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Write off of intangible assets</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from sale of non-financial assets</a></td>
<td class="nump">15,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=aort_PerClotMember', window );">Per Clot | Transfer Of Perclot Manufacturing Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable', window );">Contingent consideration receivable</a></td>
<td class="nump">780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=aort_PerClotMember', window );">Per Clot | Artivion Inc. And Starch Medical Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Consideration for sale of assets</a></td>
<td class="nump">60,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from sale of assets</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=aort_PerClotMember', window );">Per Clot | Artivion Inc. And Starch Medical Inc. | Pma Approval</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable', window );">Contingent consideration receivable</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=aort_PerClotMember', window );">Per Clot | Artivion Inc. And Starch Medical Inc. | Baxter Achievement Of Worldwide Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable', window );">Contingent consideration receivable</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=aort_PerClotMember', window );">Per Clot | Starch Medical Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Consideration for sale of assets</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from sale of assets</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=aort_PerClotMember', window );">Per Clot | Starch Medical Inc. | Pma Approval</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable', window );">Contingent consideration receivable</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=aort_PerClotMember', window );">Per Clot | Starch Medical Inc. | Baxter Achievement Of Worldwide Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable', window );">Contingent consideration receivable</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation, Contingent Consideration Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2510-110228<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=aort_PerClotMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=aort_PerClotMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=aort_TransferOfPerclotManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=aort_TransferOfPerclotManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=aort_ArtivionInc.AndStarchMedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=aort_ArtivionInc.AndStarchMedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=aort_PmaApprovalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=aort_PmaApprovalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=aort_BaxterAchievementOfWorldwideSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=aort_BaxterAchievementOfWorldwideSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=aort_StarchMedicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=aort_StarchMedicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511452102400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">$ 10,051<span></span>
</td>
<td class="nump">$ 10,015<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">10,051<span></span>
</td>
<td class="nump">10,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ContingentConsiderationNoncurrentFairValue', window );">Contingent consideration</a></td>
<td class="num">(44,800)<span></span>
</td>
<td class="num">(49,400)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="num">(44,800)<span></span>
</td>
<td class="num">(49,400)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">10,051<span></span>
</td>
<td class="nump">10,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">10,051<span></span>
</td>
<td class="nump">10,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ContingentConsiderationNoncurrentFairValue', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">10,051<span></span>
</td>
<td class="nump">10,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ContingentConsiderationNoncurrentFairValue', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ContingentConsiderationNoncurrentFairValue', window );">Contingent consideration</a></td>
<td class="num">(44,800)<span></span>
</td>
<td class="num">(49,400)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="num">(44,800)<span></span>
</td>
<td class="num">(49,400)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_ContingentConsiderationNoncurrentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Noncurrent, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_ContingentConsiderationNoncurrentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453347968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 02, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Increase (decrease) in fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,600)<span></span>
</td>
<td class="nump">$ 4,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=aort_AscyrusMedicalLlcMember', window );">Ascyrus Medical LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of outstanding equity acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Maximum amount of future consideration payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Increase (decrease) in fair value of contingent consideration</a></td>
<td class="num">$ (400)<span></span>
</td>
<td class="num">$ (700)<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="num">$ (5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=aort_AscyrusMedicalLlcMember', window );">Ascyrus Medical LLC | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, measurement input</a></td>
<td class="nump">0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=aort_AscyrusMedicalLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=aort_AscyrusMedicalLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511455095952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward', window );"><strong>Contingent Consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="num">$ (49,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in valuation</a></td>
<td class="nump">4,600<span></span>
</td>
<td class="num">$ (4,970)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="num">$ (44,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511445724048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Equivalents (Summary Of Cash Equivalents And Restricted Securities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cost Basis</a></td>
<td class="nump">$ 10,051<span></span>
</td>
<td class="nump">$ 10,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized Holding Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Estimated Market Value</a></td>
<td class="nump">10,051<span></span>
</td>
<td class="nump">10,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cost Basis</a></td>
<td class="nump">10,051<span></span>
</td>
<td class="nump">10,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized Holding Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Estimated Market Value</a></td>
<td class="nump">$ 10,051<span></span>
</td>
<td class="nump">$ 10,015<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453552832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Equivalents (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Gross realized gains or losses on cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453337936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories, net and Deferred Preservation Costs (Schedule Of Inventories) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials and supplies</a></td>
<td class="nump">$ 35,206<span></span>
</td>
<td class="nump">$ 35,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">11,976<span></span>
</td>
<td class="nump">9,712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">25,862<span></span>
</td>
<td class="nump">31,479<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories, net</a></td>
<td class="nump">$ 73,044<span></span>
</td>
<td class="nump">$ 76,971<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450916112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories, net and Deferred Preservation Costs (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment', window );">Consignment inventory</a></td>
<td class="nump">$ 13,200<span></span>
</td>
<td class="nump">$ 12,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DeferredPreservationCosts', window );">Deferred preservation costs, net</a></td>
<td class="nump">45,483<span></span>
</td>
<td class="nump">42,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserve</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ConsignmentInventoryPercentage', window );">Consignment inventory percentage</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ConsignmentInventoryPercentage', window );">Consignment inventory percentage</a></td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_ConsignmentInventoryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consignment inventory percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_ConsignmentInventoryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DeferredPreservationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Donated human tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. By federal law, human tissues cannot be bought or sold, so the preservation process is a manufacturing process that is accounted for using the same principles as inventory costing. Preservation costs consist primarily of direct labor and materials and indirect costs which are stated at the lower of cost or market value on a first in, first out basis and are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DeferredPreservationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450821456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Carrying Values of Indefinite Lived Intangible Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 234,773<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Total indefinite-lived intangible assets</a></td>
<td class="nump">1,901<span></span>
</td>
<td class="nump">2,208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Procurement contracts and agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Total indefinite-lived intangible assets</a></td>
<td class="nump">2,013<span></span>
</td>
<td class="nump">2,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Total indefinite-lived intangible assets</a></td>
<td class="nump">$ 247<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511451023424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="num">(15,227)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 234,773<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511451280032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 148,060<span></span>
</td>
<td class="nump">$ 166,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Acquired technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">190,108<span></span>
</td>
<td class="nump">213,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">42,048<span></span>
</td>
<td class="nump">46,632<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 148,060<span></span>
</td>
<td class="nump">$ 166,994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (Years)</a></td>
<td class="text">18 years 3 months 18 days<span></span>
</td>
<td class="text">17 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=aort_IntangibleAssetsOtherThanAcquiredTechnologyMember', window );">Other intangibles:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 47,840<span></span>
</td>
<td class="nump">$ 49,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">20,889<span></span>
</td>
<td class="nump">18,832<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 26,951<span></span>
</td>
<td class="nump">$ 30,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (Years)</a></td>
<td class="text">10 years 9 months 18 days<span></span>
</td>
<td class="text">10 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember', window );">Customer lists and relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 30,868<span></span>
</td>
<td class="nump">$ 31,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">10,677<span></span>
</td>
<td class="nump">9,618<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 20,191<span></span>
</td>
<td class="nump">$ 21,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (Years)</a></td>
<td class="text">20 years 7 months 6 days<span></span>
</td>
<td class="text">20 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember', window );">Distribution and manufacturing rights and know-how</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 8,476<span></span>
</td>
<td class="nump">$ 9,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">4,900<span></span>
</td>
<td class="nump">4,308<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 3,576<span></span>
</td>
<td class="nump">$ 5,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 4,171<span></span>
</td>
<td class="nump">$ 4,083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,168<span></span>
</td>
<td class="nump">3,144<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 1,003<span></span>
</td>
<td class="nump">$ 939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (Years)</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">17 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 4,325<span></span>
</td>
<td class="nump">$ 3,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,144<span></span>
</td>
<td class="nump">1,762<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 2,181<span></span>
</td>
<td class="nump">$ 2,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (Years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=aort_IntangibleAssetsOtherThanAcquiredTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=aort_IntangibleAssetsOtherThanAcquiredTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511448394304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Summary of Amortization Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 3,686<span></span>
</td>
<td class="nump">$ 4,203<span></span>
</td>
<td class="nump">$ 11,675<span></span>
</td>
<td class="nump">$ 12,701<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453386064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Scheduled Amortization of Intangible Assets for Next Five Years) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2022</a></td>
<td class="nump">$ 3,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">14,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">13,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">12,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">11,842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">11,748<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate', window );">Total</a></td>
<td class="nump">$ 67,249<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the first five fiscal years following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453362432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate expense (benefit)</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="num">(33.00%)<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="num">(318.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="nump">$ 28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowances against deferred tax assets</a></td>
<td class="nump">$ 17.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453367536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 01, 2021</div></th>
<th class="th"><div>Jan. 06, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Increase in the present value of future lease obligations and corresponding right-of-use asset</a></td>
<td class="nump">$ 9,800<span></span>
</td>
<td class="nump">$ 23,300<span></span>
</td>
<td class="nump">$ 41,320<span></span>
</td>
<td class="nump">$ 45,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Increase in operating lease liability</a></td>
<td class="nump">$ 9,800<span></span>
</td>
<td class="nump">$ 23,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Discount rate</a></td>
<td class="nump">5.46%<span></span>
</td>
<td class="nump">6.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other Liabilities, Current<span></span>
</td>
<td class="text">Other Liabilities, Current<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511451234912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 01, 2021</div></th>
<th class="th"><div>Jan. 06, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 55,405<span></span>
</td>
<td class="nump">$ 58,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Accumulated amortization</a></td>
<td class="num">(14,085)<span></span>
</td>
<td class="num">(12,383)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="nump">41,320<span></span>
</td>
<td class="nump">45,714<span></span>
</td>
<td class="nump">$ 9,800<span></span>
</td>
<td class="nump">$ 23,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current maturities of operating leases</a></td>
<td class="nump">3,061<span></span>
</td>
<td class="nump">3,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current maturities of operating leases</a></td>
<td class="nump">40,915<span></span>
</td>
<td class="nump">44,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">43,976<span></span>
</td>
<td class="nump">48,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityAbstract', window );"><strong>Finance leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Finance leases, Property and equipment, at cost</a></td>
<td class="nump">5,861<span></span>
</td>
<td class="nump">6,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Finance leases, Accumulated amortization</a></td>
<td class="num">(2,166)<span></span>
</td>
<td class="num">(2,105)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Finance leases, property and equipment, net</a></td>
<td class="nump">3,695<span></span>
</td>
<td class="nump">4,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current maturities of finance leases</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Non-current maturities of finance leases</a></td>
<td class="nump">3,450<span></span>
</td>
<td class="nump">4,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 3,919<span></span>
</td>
<td class="nump">$ 4,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years): Operating leases</a></td>
<td class="text">12 years 2 months 12 days<span></span>
</td>
<td class="text">12 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years): Finance leases</a></td>
<td class="text">8 years 1 month 6 days<span></span>
</td>
<td class="text">8 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate: Operating leases</a></td>
<td class="nump">5.90%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate: Finance leases</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511443723456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Summary Of Lease Costs) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of property and equipment</a></td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">$ 190<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest expense on finance leases</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_FinanceLeaseCost', window );">Total finance lease expense</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="nump">585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">1,853<span></span>
</td>
<td class="nump">1,989<span></span>
</td>
<td class="nump">5,656<span></span>
</td>
<td class="nump">5,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(92)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="num">(275)<span></span>
</td>
<td class="num">(308)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease expense</a></td>
<td class="nump">$ 1,910<span></span>
</td>
<td class="nump">$ 2,114<span></span>
</td>
<td class="nump">$ 5,845<span></span>
</td>
<td class="nump">$ 5,843<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of finance lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450981840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows for operating leases</a></td>
<td class="nump">$ 4,939<span></span>
</td>
<td class="nump">$ 4,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows for finance leases</a></td>
<td class="nump">346<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows for finance leases</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511451258752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Schedule Of Minimum Lease Payments For Finance, Operating, And Sublease Income Leases) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2022</a></td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_FinanceLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">4,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less amount representing interest</a></td>
<td class="num">(328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of net minimum lease payments</a></td>
<td class="nump">3,919<span></span>
</td>
<td class="nump">$ 4,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less current maturities</a></td>
<td class="num">(469)<span></span>
</td>
<td class="num">(528)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Lease liabilities, less current maturities</a></td>
<td class="nump">3,450<span></span>
</td>
<td class="nump">4,374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2022</a></td>
<td class="nump">660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">5,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">6,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">5,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">4,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">40,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">63,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less amount representing interest</a></td>
<td class="num">(19,438)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of net minimum lease payments</a></td>
<td class="nump">43,976<span></span>
</td>
<td class="nump">48,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less current maturities</a></td>
<td class="num">(3,061)<span></span>
</td>
<td class="num">(3,149)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities, less current maturities</a></td>
<td class="nump">40,915<span></span>
</td>
<td class="nump">$ 44,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear', window );">Sublease Income, Remainder of 2022</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne', window );">Sublease Income, 2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo', window );">Sublease Income, 2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree', window );">Sublease Income, 2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour', window );">Sublease Income, 2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour', window );">Sublease Income, Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet', window );">Sublease Income</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_FinanceLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_FinanceLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractually required future rental payments receivable on noncancelable subleasing arrangements, having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919398-209981<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123405975&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511444786704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 02, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 01, 2021</div></th>
<th class="th">
<div>Jun. 18, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>day</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 01, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Secured term loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315,369,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315,369,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 317,627,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 2,219,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308,236,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308,236,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">309,123,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="nump">$ 12,900,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="nump">$ 361,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Debt extinguishment costs</a></td>
<td class="nump">$ 474,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aort_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants', window );">Revolving credit facility, percentage repaid for no covenants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on amounts borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0426203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible senior notes | Circumstance I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion trading day threshold | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Conversion consecutive trading day threshold | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion percentage of stock price threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible senior notes | Circumstance II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion trading day threshold | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Conversion consecutive trading day threshold | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion percentage of stock price threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible senior notes | Circumstance After July 5, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion trading day threshold | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Conversion consecutive trading day threshold | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion percentage of stock price threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount', window );">Conversion percentage of principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility aggregate commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 255,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Secured term loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,313,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214,313,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 216,000,000<span></span>
</td>
<td class="nump">225,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term loan balance | Credit Agreement | Circumstance I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DebtInstrumentExtensionCircumstancePeriod', window );">Debt instrument, extension circumstance period</a></td>
<td class="text">91 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term loan balance | Credit Agreement | Circumstance II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DebtInstrumentExtensionCircumstancePeriod', window );">Debt instrument, extension circumstance period</a></td>
<td class="text">182 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term loan balance | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term loan balance | Base Rate | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility margin</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term loan balance | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term loan balance | LIBOR | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility margin</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility aggregate commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=aort_RevolvingCreditFacilityAndTermLoanMember', window );">Revolving Credit Facility And Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of the debt issuance costs</a></td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=aort_RevolvingCreditFacilityAndTermLoanMember', window );">Revolving Credit Facility And Term Loan | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DebtInstrumentExtensionPeriod', window );">Debt instrument, extension period</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=aort_RevolvingCreditFacilityAndTermLoanMember', window );">Revolving Credit Facility And Term Loan | Convertible senior notes | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on amounts borrowed</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06 | Cumulative Effect, Period of Adoption, Adjustment | Convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Redemption Percentage Of Principal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DebtInstrumentExtensionCircumstancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, extension circumstance period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DebtInstrumentExtensionCircumstancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DebtInstrumentExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, extension period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DebtInstrumentExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revolving Credit Facility, Percentage Repaid for No Covenants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aort_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aort_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DebtPeriodAxis=aort_CircumstanceIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DebtPeriodAxis=aort_CircumstanceIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DebtPeriodAxis=aort_CircumstanceIiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DebtPeriodAxis=aort_CircumstanceIiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DebtPeriodAxis=aort_CircumstanceAfterJuly52023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DebtPeriodAxis=aort_CircumstanceAfterJuly52023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=aort_RevolvingCreditFacilityAndTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=aort_RevolvingCreditFacilityAndTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511445836992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Schedule Of Short-Term And Long-Term Balances Of Term Loan) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 01, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total loan balance</a></td>
<td class="nump">$ 315,369<span></span>
</td>
<td class="nump">$ 317,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less unamortized loan origination costs</a></td>
<td class="num">(7,133)<span></span>
</td>
<td class="num">(8,504)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net borrowings</a></td>
<td class="nump">308,236<span></span>
</td>
<td class="nump">309,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less short-term loan balance</a></td>
<td class="num">(1,562)<span></span>
</td>
<td class="num">(1,630)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term loan balance</a></td>
<td class="nump">306,674<span></span>
</td>
<td class="nump">307,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=aort_GovernmentSponsoredDebtKfwLoan1Member', window );">2.45% Sparkasse Zollernalb (KFW Loan 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total loan balance</a></td>
<td class="nump">$ 325<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on amounts borrowed</a></td>
<td class="nump">2.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=aort_GovernmentSponsoredDebtKfwLoan2Member', window );">1.40% Sparkasse Zollernalb (KFW Loan 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total loan balance</a></td>
<td class="nump">$ 731<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on amounts borrowed</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total loan balance</a></td>
<td class="nump">$ 214,313<span></span>
</td>
<td class="nump">216,000<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_ConvertibleDebtMember', window );">Convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total loan balance</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=aort_GovernmentSponsoredDebtKfwLoan1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=aort_GovernmentSponsoredDebtKfwLoan1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=aort_GovernmentSponsoredDebtKfwLoan2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=aort_GovernmentSponsoredDebtKfwLoan2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511454048784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts', window );">Termination and wind-down expenses</a></td>
<td class="nump">$ 4.7<span></span>
</td>
<td class="nump">$ 4.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Expense, Termination and Wind-down Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450944784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Disaggregation Of Revenue) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sources of revenue</a></td>
<td class="nump">$ 76,838<span></span>
</td>
<td class="nump">$ 72,207<span></span>
</td>
<td class="nump">$ 234,391<span></span>
</td>
<td class="nump">$ 219,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_DomesticHospitalsMember', window );">Domestic hospitals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sources of revenue</a></td>
<td class="nump">40,842<span></span>
</td>
<td class="nump">36,129<span></span>
</td>
<td class="nump">117,343<span></span>
</td>
<td class="nump">111,291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_InternationalHospitalsMember', window );">International hospitals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sources of revenue</a></td>
<td class="nump">24,119<span></span>
</td>
<td class="nump">25,458<span></span>
</td>
<td class="nump">79,768<span></span>
</td>
<td class="nump">79,219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_InternationalDistributorMember', window );">International distributors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sources of revenue</a></td>
<td class="nump">11,469<span></span>
</td>
<td class="nump">10,544<span></span>
</td>
<td class="nump">34,685<span></span>
</td>
<td class="nump">28,694<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_CardiogenesisMember', window );">CardioGenesis cardiac laser therapy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sources of revenue</a></td>
<td class="nump">$ 408<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 2,595<span></span>
</td>
<td class="nump">$ 238<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_DomesticHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_DomesticHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_InternationalHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_InternationalHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_InternationalDistributorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_InternationalDistributorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_CardiogenesisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_CardiogenesisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511455308736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized stock compensation expense</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
<td class="nump">$ 465<span></span>
</td>
<td class="nump">$ 424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">ESPP, percentage of market price for eligible employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="nump">58,000<span></span>
</td>
<td class="nump">51,000<span></span>
</td>
<td class="nump">95,000<span></span>
</td>
<td class="nump">87,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember', window );">RSAs, RSUs, And PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Authorized awards from approved stock incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">520,000<span></span>
</td>
<td class="nump">494,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted', window );">Aggregate grant date market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,700<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_OfficerMember', window );">Officers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Grants of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314,000<span></span>
</td>
<td class="nump">226,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market value of share based compensation arrangement by share based payment award other than options granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453493056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.89%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.52%<span></span>
</td>
<td class="nump">0.22%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511450820560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation (Summary Of Total Stock Compensation Expenses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Total stock compensation expense</a></td>
<td class="nump">$ 3,233<span></span>
</td>
<td class="nump">$ 2,990<span></span>
</td>
<td class="nump">$ 9,654<span></span>
</td>
<td class="nump">$ 7,895<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember', window );">RSA, RSU, and PSU expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Total stock compensation expense</a></td>
<td class="nump">2,622<span></span>
</td>
<td class="nump">2,465<span></span>
</td>
<td class="nump">7,860<span></span>
</td>
<td class="nump">6,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember', window );">Stock option and ESPP expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Total stock compensation expense</a></td>
<td class="nump">$ 611<span></span>
</td>
<td class="nump">$ 525<span></span>
</td>
<td class="nump">$ 1,794<span></span>
</td>
<td class="nump">$ 1,684<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511444686800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(Loss) Earnings Per Common Share (Computation Of Basic And Diluted (Loss) Income Per Common Share) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Basic (loss) income per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (13,713)<span></span>
</td>
<td class="nump">$ 10,582<span></span>
</td>
<td class="num">$ (21,361)<span></span>
</td>
<td class="nump">$ 5,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Net loss (income) allocated to participating securities</a></td>
<td class="nump">70<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (loss) income allocated to common shareholders</a></td>
<td class="num">$ (13,643)<span></span>
</td>
<td class="nump">$ 10,519<span></span>
</td>
<td class="num">$ (21,252)<span></span>
</td>
<td class="nump">$ 5,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">40,115,000<span></span>
</td>
<td class="nump">39,086,000<span></span>
</td>
<td class="nump">39,999,000<span></span>
</td>
<td class="nump">38,924,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (loss) income per common share (in usd per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Diluted (loss) income per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (13,713)<span></span>
</td>
<td class="nump">$ 10,582<span></span>
</td>
<td class="num">$ (21,361)<span></span>
</td>
<td class="nump">$ 5,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted', window );">Net loss (income) allocated to participating securities</a></td>
<td class="nump">70<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Net loss attributable to convertible senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">919<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net (loss) income allocated to common shareholders</a></td>
<td class="num">$ (13,643)<span></span>
</td>
<td class="nump">$ 11,446<span></span>
</td>
<td class="num">$ (21,252)<span></span>
</td>
<td class="nump">$ 5,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive stock options and awards (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">572,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Effect of convertible senior notes (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,862,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">40,115,000<span></span>
</td>
<td class="nump">44,453,000<span></span>
</td>
<td class="nump">39,999,000<span></span>
</td>
<td class="nump">39,496,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (loss) income per common share (in usd per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Effect of dilutive stock options and awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Diluted (loss) income per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">539,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Effect of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Diluted (loss) income per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,860,685<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2740-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511451023424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Intersegment revenues | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511445756656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 76,838<span></span>
</td>
<td class="nump">$ 72,207<span></span>
</td>
<td class="nump">$ 234,391<span></span>
</td>
<td class="nump">$ 219,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of products and preservation services</a></td>
<td class="nump">28,094<span></span>
</td>
<td class="nump">24,418<span></span>
</td>
<td class="nump">82,756<span></span>
</td>
<td class="nump">73,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total gross margin</a></td>
<td class="nump">48,744<span></span>
</td>
<td class="nump">47,789<span></span>
</td>
<td class="nump">151,635<span></span>
</td>
<td class="nump">146,140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=aort_MedicalDevicesMember', window );">Medical devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">55,248<span></span>
</td>
<td class="nump">53,107<span></span>
</td>
<td class="nump">171,726<span></span>
</td>
<td class="nump">162,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of products and preservation services</a></td>
<td class="nump">17,743<span></span>
</td>
<td class="nump">15,503<span></span>
</td>
<td class="nump">53,381<span></span>
</td>
<td class="nump">46,592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total gross margin</a></td>
<td class="nump">37,505<span></span>
</td>
<td class="nump">37,604<span></span>
</td>
<td class="nump">118,345<span></span>
</td>
<td class="nump">115,936<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=aort_PreservationServicesMember', window );">Preservation services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">21,590<span></span>
</td>
<td class="nump">19,100<span></span>
</td>
<td class="nump">62,665<span></span>
</td>
<td class="nump">56,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of products and preservation services</a></td>
<td class="nump">10,351<span></span>
</td>
<td class="nump">8,915<span></span>
</td>
<td class="nump">29,375<span></span>
</td>
<td class="nump">26,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total gross margin</a></td>
<td class="nump">$ 11,239<span></span>
</td>
<td class="nump">$ 10,185<span></span>
</td>
<td class="nump">$ 33,290<span></span>
</td>
<td class="nump">$ 30,204<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=aort_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=aort_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=aort_PreservationServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=aort_PreservationServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511452121680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Summary Of Net Revenues By Product And Service) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 76,838<span></span>
</td>
<td class="nump">$ 72,207<span></span>
</td>
<td class="nump">$ 234,391<span></span>
</td>
<td class="nump">$ 219,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_ProductsMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">55,248<span></span>
</td>
<td class="nump">53,107<span></span>
</td>
<td class="nump">171,726<span></span>
</td>
<td class="nump">162,528<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_AorticStentGraftsMember', window );">Aortic stent grafts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">19,674<span></span>
</td>
<td class="nump">20,896<span></span>
</td>
<td class="nump">69,013<span></span>
</td>
<td class="nump">62,165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_SurgicalSealantsMember', window );">Surgical sealants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">17,374<span></span>
</td>
<td class="nump">16,544<span></span>
</td>
<td class="nump">49,022<span></span>
</td>
<td class="nump">52,236<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_OnXMember', window );">On-X</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">16,456<span></span>
</td>
<td class="nump">14,022<span></span>
</td>
<td class="nump">47,082<span></span>
</td>
<td class="nump">41,843<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_OtherProductsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,744<span></span>
</td>
<td class="nump">1,645<span></span>
</td>
<td class="nump">6,609<span></span>
</td>
<td class="nump">6,284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_PreservationServicesMember', window );">Preservation services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 21,590<span></span>
</td>
<td class="nump">$ 19,100<span></span>
</td>
<td class="nump">$ 62,665<span></span>
</td>
<td class="nump">$ 56,914<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_ProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_ProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_AorticStentGraftsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_AorticStentGraftsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_SurgicalSealantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_SurgicalSealantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_OnXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_OnXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_OtherProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_OtherProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_PreservationServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_PreservationServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140511453954848">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">Accounting Standards Update 2020-06 [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>aort-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:aort="http://www.cryolife.com/20220930"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="aort-20220930.xsd" xlink:type="simple"/>
    <context id="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ieb29878d56724102860bc5a9cb2fa5cc_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="idc916650fa81469598a7b03003c27168_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:ProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9f5bc0203be146e5bb0bd8b45cbdb2b7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:ProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5e5a4f6af84f4ddeae300f7b08e9e59d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:ProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idd7debfcacac4069a398cab44625bd73_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:ProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i640c303a0a1c4e72a4879aa8b98e0402_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:PreservationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i377e56bf409a455ba20de5d37520ea48_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:PreservationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i84212de5e3c34a078a34d879bfeeb394_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:PreservationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8faff0cacc944396b07783c2a5b064e3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:PreservationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i92a6652f436d43be99bd75c32c0406d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02c95f38d9b543ae84f37d41d8baa157_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idfb7570230e54f50941fc14b31243894_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3f32d331c65a4d77abae1c29bfd76fad_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i75cedf86a43b46479cf2b7e2e4ffa5b6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2327fb17357843d49351125df49690ce_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i500babc0c996435a9c7bf3de79597910_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5517182634564914ba321ae01406e558_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic0173bc1ef6e4cd89e057d607f1488e3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie53b06b7fc644641930b5fae9767bb47_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i27b4dd9bf4a1461f8c3787382c8bdc2c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4d654e08061c4d2eb225d927a13203b2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib4351c2916a14e6583947067dccfd48f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifb24e4445f234f45bd7b3b6d182b317a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0ebbddb2f6f04869aef50eed79a94a0a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1c92a5fd903b49a588c3ceab6bf0fd71_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idcf07ce8eeae433881f120218ee9a339_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i855b2caffaf74a64b3f2ef74285e23ad_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i707205b1c07e4c1988ca5ff5d74d4a17_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee6c1445ceaf40bbb5e5f10623f14612_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i017ca17a602e45219dab10ea1da5ec48_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2d546f3304f74a65ad65e63d5f35549c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3556d5d3a27c416a831f28c2fa395382_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5632806a31294031ba676bcf8ede366e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iebd5d3ab6b5148ef93bef9493a895975_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic31b11b9e24042e291cfae22df2c5210_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie9e49d8b70744e2291a48074042aac1d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibd29210f343141e18bac0fa033368edb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib6cad2dbd6f2405aa20050ef52e24d72_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idc8bf90a94e84b16b4e0133d5e3511c8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i382d3d021f0e4fc5926b820bd792e570_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic8fc748ed8cc4d6197311f7f5b70f8b9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3d640434e1ec4e1f8bc779369e3c30fc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1171158da9d64ea3bb3f8187eeb9bb6a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7c9e6fcb6b5041a28fcbb938004e223e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i37d952f703594debb99cbb034f182acc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i280bd3e07c864a7c9aaa759e2c9d499a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0e85ab3998944bb3b78d14636d55e58c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5a36f4d7f25b4eeaa95f908a94d5a7d0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if5259bc5ea2d48cfb9c3d8a509a38485_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i874eb09dd9e04c1193c970174fefa74c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6421cdadddcd4de2b8a922abe34ec4d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34648a7bb99f40b581988c47181998e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie76736e9a34845c0be39eb23bee21d1d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3ea81c295134d2a950a870df83c0fc8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i39b0402fe99e4b81b9cc8baa58b16782_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib830edf09033428cbcfce9cd0d56ccd3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idfcc2e11a6ef41a4bf0b9fc74a0437c7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i97c1b95c6b7a4740b6c54cca5ae8f0df_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i88ff77f1faa34bb5a9274393c266a3c5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0c206091bc204dc2a0b88d27cd64ac1c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia34aaa5e1fdf43c6976074120b87cf65_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4bb844b6a956440a8c40b76f8ef5e9ad_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i93965fb5672a40aaa73943e5e32c7968_I20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:ArtivionInc.AndStarchMedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="if7419f77f0164d6e8bbfd14061a58dc8_I20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="i6db073c52b794f6f9307cf9c09aa6840_I20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:StarchMedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="i474797d7697b4b30bbed0e1b1e4c0c1f_D20210728-20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:ArtivionInc.AndStarchMedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="ic8c37cb40b344c3fba9bdc98b545a5de_D20210728-20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:StarchMedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="i1e2e38f130ed4105acb2e32af2c464db_I20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">aort:PmaApprovalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:ArtivionInc.AndStarchMedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="ieec45bdddc8041219cabad03cec97440_I20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">aort:PmaApprovalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:StarchMedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="i377d4fb97be743429e52f8c0cf18419e_I20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">aort:BaxterAchievementOfWorldwideSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:ArtivionInc.AndStarchMedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="ic721009275b44299b76bee3aab313494_I20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">aort:BaxterAchievementOfWorldwideSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aort:StarchMedicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="iea42e8fd134e416a8ca4bf1b048423f4_I20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">aort:TransferOfPerclotManufacturingEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="i3c6ab9a4a9c64f29a055949f7555bfee_D20210728-20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">aort:PerClotMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="i950e76f991cb4fe09eff1721971650dd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iec9b82a7f6604a2bbbe148b7d4abe182_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6bf831653ca749c6acafb610a2e28758_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7e42ab1c54464099a18768bdfff45114_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8204321837cc4faeaa2f049f14c3892b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6561a8259c80412f9d65d166fc210a1a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7196597c5deb49e1bb184bfb4947a913_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1dc99e11cae64b9ea4455cb43369f79c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab3c1df5f3a046efb727e88f49e41f79_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic70a37d9dc5d47ff92c7cf4a36a1f693_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iedfc3424257043348e41663c5bdc6fd2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib7748b61019a4fd4a51f83204e8a357b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f304425672d48179954b9c1f45b94c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i81cb3cd3d95849408779cbf36a73bfc6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6525e7731ff74ad0828ab59973e96ed9_I20200902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-02</instant>
        </period>
    </context>
    <context id="i0da58d4628e84024a2ac81e40f54f818_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id93794b724d14804926854714e119380_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i260c7a4a20d1487d8c43eb7ccdbcf577_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4a6f190d5fa245329e12192250fb7f35_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie7832872936b4b9fb5d8ab87dfa734ae_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8491b725aa2a46399318dc2aa090e37e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie18a5ff4b2e4444f818e82a116bbe4cf_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i47ea06876fd54ecdab5ff8648c2c9200_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic210a1a5c32344f8a0d5bb24192cd622_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i92f2162a5f2c42d99bb26f8349f42660_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic5f9cb6f422b426ea46da0e9c04c8488_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5bf438e13a654ecf8c83a67427ed9c00_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iedf397d3ddca43f3bc7c0be07a26764c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i415a7398d0b44f30b0c2ac4c3cd52d77_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d1dafbd2f6f4fe292ea508a5b6aae73_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9458b6ce90844216a730adfd5f9304f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2bc1a93076b240cdb83aca83562c898c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i33d83b59bd714eed96ac088c627a3bb4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f7ee96a23d84973bb23f2b986cd0caa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibc1a239494bc4d77b7d869dfb120b17b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3fb32fabff8742a98b5467dff62122bf_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ida30868564d148eca610e7d10cfd5e6f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ideb42e83c22b42c3bb0af7e0655023df_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5927140a3ae44b469c4565ca6f2dc116_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3d32d2810d144a3f896cf0d85612aeb7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i92c5d5cd7490482d80b5d6c02da7f08d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaf210313db394b1ba95827556680cf9d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia1ef7a095c054e5bb5088a9e425e637d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7d4aa5c197a74658b6b130f04486afd2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iffdb325d037c49f5ad546b5419a0a089_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib74a27dcdc9b4dd6af46f79ebbdf834b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2d72e53f0f1a452eb2f9cac1876bdd95_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5835fa7529b2441f8256f2039dcd4977_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ec8b963122c48c1bc141284ae59b0cd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1319adccede54d05b8a215934cf0b015_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3e3f166e92e3409b8d455325985327e8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2b943d5080d34bec84109493c800df5f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia15d0aa664ea4a7f97d1948f098fd347_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i30ad3a0d685c4b1fa5f05ae3aeeb8d54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie597e010fff64cb687fea5326f697ce7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i90c63eb879c049d8a922a2011f7756e8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8267638c5c76419694cfdd6148d710ec_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0452204939dc44418b4b735573daceb1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b5b7de541014928a789871dab61c5b8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1155d3f6605345d9bf6e5eff5b2ff517_D20210106-20210106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2021-01-06</startDate>
            <endDate>2021-01-06</endDate>
        </period>
    </context>
    <context id="i98cd2d841a0d40e39000ad02cbe23dfe_I20210106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2021-01-06</instant>
        </period>
    </context>
    <context id="i91ff9b76a1ca40d280c764ffb11b5962_D20210601-20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="i704c126d4e494f8d8caab84f162c9d5f_I20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="i48b9bbe85c68425d911ee0c362147e39_I20171201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-01</instant>
        </period>
    </context>
    <context id="if48526739d454c7aa0ead75443f922f1_I20171201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-01</instant>
        </period>
    </context>
    <context id="ib252a536e8c2403f88b1f7002f4ad93d_I20171201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-01</instant>
        </period>
    </context>
    <context id="i0a9e96716e2d43fc8cb58b6a571003ac_I20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-02</instant>
        </period>
    </context>
    <context id="ibd8fae709fff4c1da4933fc5331a3616_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="i308d3c512f144d22ba8f06fad96609aa_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="iaea6f089ed074e359ce7c3f017e6b10b_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="i3079296817f64fe0829aa2166586dc63_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="i2c4d08f8fa5d4fa69f8b6d4049e4bb52_D20210601-20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="i7d9fad1b5e5f409ab72291a10865c569_D20210601-20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="i7ee1e8077bf9471fbd587c9b736b28e0_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="ie5eabbbcdab349c69c7b71952f9f1c67_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="i7ea6eb948294472ab4381af301387075_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i18723f9aeb154e06b9755af8e0a35dc0_I20200618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-18</instant>
        </period>
    </context>
    <context id="i0f3ad67fb29042d3a507e43f558ecda8_D20200618-20200618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-18</startDate>
            <endDate>2020-06-18</endDate>
        </period>
    </context>
    <context id="i57c5164417a34d7cad7bfcdca48c018d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icc66c0e69857453e9e2dfc50dbf9e1be_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i027b214348ca447cb2405a448216447e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibaad6e3991c64789be68b008759c87e6_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icbe178457b16413291bbf12b116f4451_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibaf43f6c29284708b18275267e3af457_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idb55cd7b1c67424e83334b51ddeeed75_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3162fd9f3aad4da4b4a6c31ca14cc416_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iee01dabe643e479586ec04799b683ba4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceAfterJuly52023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i33db3b1cd5a744adaf668932b3d7a752_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifda76d72993449d1998f915ef6c42d12_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iacc74ff3ae064710b11fbf91c5b4da32_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ieb17620c310648b8a165d09b227c1a9d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2917e811dec840bfa296f07c2b87727d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib6c541e6344348c7932037179bc9a6a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d9322af829e4028a7955119f8529d4f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id8d8863bba6645fab208cbec4e5af0c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5b95d5c7e8924fa28d703d9a61c60819_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="i19857ac737a849ee839c3f22bc8089c2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:DomesticHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i11915924fe704fb89347da42e1ef2eb2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:DomesticHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia809a613bd144fa0a274104dcd26acb1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:DomesticHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i899343d6cb944a4681fdbfcdbd5d1ca8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:DomesticHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id714b6b2b6a64790a42d603abb8e18f3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i68e49df3a3c64e688b8a31a561b96ed9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaa5de9333d824fe48fda6782f64fdc3c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4668dfae4f444b93ac2d0b184ad2f75e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i45c79bfd4d6346bb876c81a81a51573a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i281a6ea681e94b3b8da636232186b497_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i48e4181561d94c5fbb84354840056db1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1599f4e6f31b49738062fad1654aec04_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib9704cb4285d424bbc6f7b1dfef34dc5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:CardiogenesisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i342b33ea32d64961aa1bcb645535ae46_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:CardiogenesisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i42999e55d750436abb4dc19f0fde883f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:CardiogenesisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3fdd33ca91264d388735248eee07f5b7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:CardiogenesisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iee66ca91fc234b09b3c2d8a46621d0df_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i15ccab14e00e482fa8cc9b73fec811d4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8cfd4278c4d54da3ad77a6c6aa2631c6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2743263dde35403486ed30d48ff92d6f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i41e84a48d560438c8c1d2cd5b2e60304_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7fb88599f3ba47168b057695501cbbcf_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i461739b4f0b94d58b483520fd7eacf68_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i014313fc131f48999cd3c9dec9fb977c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i42eac7fb937149b19cdc9f258f5ac32e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7b553a2641f34d9fbc27aa2ae76e41e4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i89e0d9a60d324513b3fdf16f71bc2d39_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i381fc1148e2b43d8bbc80cf38962e6a1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i298934a6b2a54c778e6398d092865235_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie9c2d41d46d24d208d34d8d8f2b436e1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6984cade7c05443d9b12c962524d654d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i354fb63b18a2436c9633c0f1845308b2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib4a80aa36fc046ebb86b318c4afa0f59_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if109928fc6f647eab134f6bf056db23a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idb0051e154454d23a5b025f8cdd2f9a0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibba44be2c273425fa97ea9bf1feae546_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9cc67891184f42aca2e8fcb53d876e27_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4ed6e56bac6643c2b13e09943b8594b7_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9b620f0bebe540458a2e554bbc88fa32_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if7ee257b1f5e474fa73da9aed693faf2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id7dd6b35f20045999c192f8de847c482_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1220aed07ca14aa8abe0c90027bf1bd1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:PreservationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifc4c0fa38f304458a49eead228b1f066_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:PreservationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id9732a2ada58456da4367d2ad51237e4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:PreservationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iae2dfd5024fd4d04a7f0acbdbbea5062_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:PreservationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie06e2f5450764fcd97b8a391bba3cd2d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:AorticStentGraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5c63bff320e64af081a5cce353c3a62f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:AorticStentGraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifae4dce6ca1b41baa6d2d313ffead3fa_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:AorticStentGraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie049d9169eb74ff0b2390aefc7f182e5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:AorticStentGraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if3c197a3565b4c02b9d51132c7d4c1b9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:SurgicalSealantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i82adeb266a2341f1901704b9be13d09a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:SurgicalSealantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7616c3cb7c904ae6b62508a5b0cc36f6_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:SurgicalSealantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i487be8addd144d008e7c5a14b09cc518_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:SurgicalSealantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3211f9da72d54b2cab2ccedbc087d2ba_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OnXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i96b0754bb93c43ceb3c6ef24d7d19ba5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OnXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if29b95e231c94833a32e361d0662e465_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OnXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2a377880ef554ca480923257a9fe5357_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OnXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib053fe4e77a849b7bafcb527494112c2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic4b2d900fb184620875c7570364d036e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibf398fc9c82649119889d264cbda9dbf_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id7aeb442b84a4ce49062b5e2c520b373_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="day">
        <measure>aort:day</measure>
    </unit>
    <unit id="segment">
        <measure>aort:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80L2ZyYWc6ODExNjkwMWUxYzRkNGZkZWFkNDQ4YjJlY2U3OTEzNjcvdGFibGU6ZmExY2MwOWFlZmQ5NGNlN2I2YjU3OWFjNTllOGQzNGQvdGFibGVyYW5nZTpmYTFjYzA5YWVmZDk0Y2U3YjZiNTc5YWM1OWU4ZDM0ZF8yLTEtMS0xLTIxMTYx_2cff90ab-ea6c-4b74-9310-62ec00e76d8f">0000784199</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80L2ZyYWc6ODExNjkwMWUxYzRkNGZkZWFkNDQ4YjJlY2U3OTEzNjcvdGFibGU6ZmExY2MwOWFlZmQ5NGNlN2I2YjU3OWFjNTllOGQzNGQvdGFibGVyYW5nZTpmYTFjYzA5YWVmZDk0Y2U3YjZiNTc5YWM1OWU4ZDM0ZF8zLTEtMS0xLTIxMTYx_b0668ee6-11aa-4532-85f1-f9c5e6aed26c">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80L2ZyYWc6ODExNjkwMWUxYzRkNGZkZWFkNDQ4YjJlY2U3OTEzNjcvdGFibGU6ZmExY2MwOWFlZmQ5NGNlN2I2YjU3OWFjNTllOGQzNGQvdGFibGVyYW5nZTpmYTFjYzA5YWVmZDk0Y2U3YjZiNTc5YWM1OWU4ZDM0ZF80LTEtMS0xLTIxMTYx_77e3fd2a-56ab-4bc9-a29d-6c21c01ae456">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80L2ZyYWc6ODExNjkwMWUxYzRkNGZkZWFkNDQ4YjJlY2U3OTEzNjcvdGFibGU6ZmExY2MwOWFlZmQ5NGNlN2I2YjU3OWFjNTllOGQzNGQvdGFibGVyYW5nZTpmYTFjYzA5YWVmZDk0Y2U3YjZiNTc5YWM1OWU4ZDM0ZF81LTEtMS0xLTIxMTYx_08029443-fddd-4943-bc16-42ea1491f087">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80L2ZyYWc6ODExNjkwMWUxYzRkNGZkZWFkNDQ4YjJlY2U3OTEzNjcvdGFibGU6ZmExY2MwOWFlZmQ5NGNlN2I2YjU3OWFjNTllOGQzNGQvdGFibGVyYW5nZTpmYTFjYzA5YWVmZDk0Y2U3YjZiNTc5YWM1OWU4ZDM0ZF82LTEtMS0xLTIxMTYx_16b83211-d462-4af7-af96-99c7ce495b68">false</dei:AmendmentFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i97c1b95c6b7a4740b6c54cca5ae8f0df_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNS0wLTEtMS0yMTE2MS90ZXh0cmVnaW9uOjMwNzdjZjk4YTE0NDQ2YjliOTkyNjljODNlZGM0MTNjXzI2_24621f48-2c6f-4533-bf80-a0d0ebc54e1b">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyNA_232befca-efbd-4242-931d-c2e23c341abe">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyNA_bf517df5-2808-40a4-b74d-94a6a829e5d0">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <aort:DebtInstrumentExtensionPeriod
      contextRef="i5b95d5c7e8924fa28d703d9a61c60819_D20210602-20210602"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81NS9mcmFnOmY2MTAxNWI0ZTQ0ZDQ3ODJiOWM1MWZjYTY5NTNjMDc5L3RhYmxlOmNlNDM2OTIxNWQxYzQwNTA5MGY0YmIzZTg3MmY4NDNkL3RhYmxlcmFuZ2U6Y2U0MzY5MjE1ZDFjNDA1MDkwZjRiYjNlODcyZjg0M2RfMi0xLTEtMS0yMTE2MQ_35bc507a-e490-4c1f-8939-29fd7800fefe">P2Y6M</aort:DebtInstrumentExtensionPeriod>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i0f3ad67fb29042d3a507e43f558ecda8_D20200618-20200618"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81NS9mcmFnOmY2MTAxNWI0ZTQ0ZDQ3ODJiOWM1MWZjYTY5NTNjMDc5L3RhYmxlOmNlNDM2OTIxNWQxYzQwNTA5MGY0YmIzZTg3MmY4NDNkL3RhYmxlcmFuZ2U6Y2U0MzY5MjE1ZDFjNDA1MDkwZjRiYjNlODcyZjg0M2RfMy0xLTEtMS0yMTE2MQ_513538b0-a70f-4926-94f1-4dbb8523eadb"
      unitRef="number">0.0426203</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQ5_27469eae-f607-47c7-be8c-ab80cf683fdb">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQw_29b11602-f724-475a-a49c-12eb4f221d25">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTA_03c31933-4c2f-480e-91fe-94af6ec10c2e">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQx_3f9d451d-aca2-4c4d-91aa-328e50699d17">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQ0_68d78eda-1dda-4f47-a410-ffaf58468f85">1-13165</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTUw_2b001071-e4a4-4a74-897f-783ea35e30ce">ARTIVION, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6MjRmNTJmOWU4MzlmNDY2Yjk2NzRjNTc1YWI5ZjIxMGUvdGFibGVyYW5nZToyNGY1MmY5ZTgzOWY0NjZiOTY3NGM1NzVhYjlmMjEwZV8wLTAtMS0xLTIxMTYx_ecd7ab0a-ff04-4ad4-ba1a-9117273e7557">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6MjRmNTJmOWU4MzlmNDY2Yjk2NzRjNTc1YWI5ZjIxMGUvdGFibGVyYW5nZToyNGY1MmY5ZTgzOWY0NjZiOTY3NGM1NzVhYjlmMjEwZV8wLTItMS0xLTIxMTYx_f894781c-8705-4a99-abdc-e3f892d3a645">59-2417093</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6MjRmNTJmOWU4MzlmNDY2Yjk2NzRjNTc1YWI5ZjIxMGUvdGFibGVyYW5nZToyNGY1MmY5ZTgzOWY0NjZiOTY3NGM1NzVhYjlmMjEwZV8zLTAtMS0xLTIxMTYxL3RleHRyZWdpb246ZmQ3YTgxMzc1ZWNjNGYxMjgyNzBkOGVhZDVhZTY0ZmJfNA_d1ceecf3-e3f8-4b62-9933-8ed68fd753ac">1655 Roberts Boulevard, NW</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6MjRmNTJmOWU4MzlmNDY2Yjk2NzRjNTc1YWI5ZjIxMGUvdGFibGVyYW5nZToyNGY1MmY5ZTgzOWY0NjZiOTY3NGM1NzVhYjlmMjEwZV8zLTAtMS0xLTIxMTYxL3RleHRyZWdpb246ZmQ3YTgxMzc1ZWNjNGYxMjgyNzBkOGVhZDVhZTY0ZmJfOA_f9847c56-0ba7-4335-a660-0554b1f6e742">Kennesaw</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6MjRmNTJmOWU4MzlmNDY2Yjk2NzRjNTc1YWI5ZjIxMGUvdGFibGVyYW5nZToyNGY1MmY5ZTgzOWY0NjZiOTY3NGM1NzVhYjlmMjEwZV8zLTAtMS0xLTIxMTYxL3RleHRyZWdpb246ZmQ3YTgxMzc1ZWNjNGYxMjgyNzBkOGVhZDVhZTY0ZmJfMTI_781f19ff-cdfb-48b3-ab24-657393f38ccf">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6MjRmNTJmOWU4MzlmNDY2Yjk2NzRjNTc1YWI5ZjIxMGUvdGFibGVyYW5nZToyNGY1MmY5ZTgzOWY0NjZiOTY3NGM1NzVhYjlmMjEwZV8zLTItMS0xLTIxMTYx_2b11c1eb-0192-4dfb-8d52-cac83bf6cb15">30144</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQ3_572e01bb-60f1-460b-9e2f-f539a086d1ab">770</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTUx_fa14f197-a476-4fae-a560-e3e25ad45f39">419-3355</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6YTAwMzA1MzU3MWQ3NDQ3NTk1NjlkOTY0NTNmYmUxYmIvdGFibGVyYW5nZTphMDAzMDUzNTcxZDc0NDc1OTU2OWQ5NjQ1M2ZiZTFiYl8xLTAtMS0xLTIxMTYx_df3e90fb-e9e5-49e5-98cc-870628d94c4e">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6YTAwMzA1MzU3MWQ3NDQ3NTk1NjlkOTY0NTNmYmUxYmIvdGFibGVyYW5nZTphMDAzMDUzNTcxZDc0NDc1OTU2OWQ5NjQ1M2ZiZTFiYl8xLTEtMS0xLTIxMTYx_49efddd7-54c6-4680-bd2c-de2f28e7c9b1">AORT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6YTAwMzA1MzU3MWQ3NDQ3NTk1NjlkOTY0NTNmYmUxYmIvdGFibGVyYW5nZTphMDAzMDUzNTcxZDc0NDc1OTU2OWQ5NjQ1M2ZiZTFiYl8xLTItMS0xLTIxMTYx_d6258974-6455-4561-9c41-fed10195262d">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQ1_6f8f989f-65ee-459b-9036-e316acc4230f">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQ2_03d0b2ad-106c-4ab4-a6c3-8437867616f0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6OTM1YTRiNTg0MDliNGI2ODg0NjEzNzdkZDNhYmU2ZmYvdGFibGVyYW5nZTo5MzVhNGI1ODQwOWI0YjY4ODQ2MTM3N2RkM2FiZTZmZl8wLTEtMS0xLTIxMTYxL3RleHRyZWdpb246Y2E1YTY1NDA5OWRhNGZiNjgxMzVhMzQ5ODY2MWVkMGZfNA_c4fa696e-e82e-4899-9f03-eb899d2fb70e">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6OTM1YTRiNTg0MDliNGI2ODg0NjEzNzdkZDNhYmU2ZmYvdGFibGVyYW5nZTo5MzVhNGI1ODQwOWI0YjY4ODQ2MTM3N2RkM2FiZTZmZl8xLTQtMS0xLTIxMTYx_65c3863a-ba70-4bb8-b65e-b600777fa048">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6OTM1YTRiNTg0MDliNGI2ODg0NjEzNzdkZDNhYmU2ZmYvdGFibGVyYW5nZTo5MzVhNGI1ODQwOWI0YjY4ODQ2MTM3N2RkM2FiZTZmZl8yLTQtMS0xLTIxMTYx_11c9cf51-a35d-42ec-926d-3ff5c1f099a7">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGV4dHJlZ2lvbjpiYTlkYzNlYjg3M2U0YzExYjJhNTJiNWY0NmM3ZGMzOF8yMTQz_d47ac3b6-5a62-4f93-9e41-eec06542333e">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ieb29878d56724102860bc5a9cb2fa5cc_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xL2ZyYWc6YmE5ZGMzZWI4NzNlNGMxMWIyYTUyYjVmNDZjN2RjMzgvdGFibGU6NzQ5OTEyYjI2YjI1NDQxYzljNWM1NWI2NTI4N2E3ODAvdGFibGVyYW5nZTo3NDk5MTJiMjZiMjU0NDFjOWM1YzU1YjY1Mjg3YTc4MF8xLTItMS0xLTIxMTYx_75eeceac-5c9a-4448-b27b-9acbba629ec3"
      unitRef="shares">40329481</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc916650fa81469598a7b03003c27168_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMy0xLTEtMS0yMTE2MQ_3c1f293f-ecdd-4f87-b662-088146bc9c93"
      unitRef="usd">55248000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f5bc0203be146e5bb0bd8b45cbdb2b7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMy0zLTEtMS0yMTE2MQ_c8a3f703-29a1-459a-bc9a-f1c322321267"
      unitRef="usd">53107000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e5a4f6af84f4ddeae300f7b08e9e59d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMy01LTEtMS0yMTE2MQ_932eb3f2-5218-454e-aaf4-34ebb40c0f51"
      unitRef="usd">171726000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd7debfcacac4069a398cab44625bd73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMy03LTEtMS0yMTE2MQ_0ff88507-1ecb-4bd2-a269-a2b2068931ae"
      unitRef="usd">162528000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i640c303a0a1c4e72a4879aa8b98e0402_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNC0xLTEtMS0yMTE2MQ_339d641d-3fbc-4554-8b9c-c580168a824c"
      unitRef="usd">21590000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i377e56bf409a455ba20de5d37520ea48_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNC0zLTEtMS0yMTE2MQ_3f20046a-4909-4e9a-a681-9e2ff78fd054"
      unitRef="usd">19100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84212de5e3c34a078a34d879bfeeb394_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNC01LTEtMS0yMTE2MQ_6d77c7ec-73a4-4620-ae94-e55e37ea989b"
      unitRef="usd">62665000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8faff0cacc944396b07783c2a5b064e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNC03LTEtMS0yMTE2MQ_eb91ad88-b7e5-4587-97fd-ad0ac034c872"
      unitRef="usd">56914000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNS0xLTEtMS0yMTE2MQ_c56cd9df-6e3f-4214-a487-3597fa33fd5d"
      unitRef="usd">76838000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNS0zLTEtMS0yMTE2MQ_76090371-d563-47e3-9e9b-5e5987fde21a"
      unitRef="usd">72207000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNS01LTEtMS0yMTE2MQ_88f8a241-41e8-4ed9-b9ff-9189d3d80dee"
      unitRef="usd">234391000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNS03LTEtMS0yMTE2MQ_e26f9ed2-b166-429f-9bce-f4a491f39b26"
      unitRef="usd">219442000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="idc916650fa81469598a7b03003c27168_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOC0xLTEtMS0yMTE2MQ_a69c7160-d95a-4ca5-b517-be2387d75d0c"
      unitRef="usd">17743000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9f5bc0203be146e5bb0bd8b45cbdb2b7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOC0zLTEtMS0yMTE2MQ_6896480b-1804-4011-9389-3c73350a107e"
      unitRef="usd">15503000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5e5a4f6af84f4ddeae300f7b08e9e59d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOC01LTEtMS0yMTE2MQ_a3699f22-54f7-431a-9644-82637d01aa51"
      unitRef="usd">53381000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="idd7debfcacac4069a398cab44625bd73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOC03LTEtMS0yMTE2MQ_624ba31a-ed84-4d23-b90d-7a45da319069"
      unitRef="usd">46592000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i640c303a0a1c4e72a4879aa8b98e0402_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOS0xLTEtMS0yMTE2MQ_5bfd864a-7d2c-4f36-a05e-f56960ced595"
      unitRef="usd">10351000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i377e56bf409a455ba20de5d37520ea48_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOS0zLTEtMS0yMTE2MQ_ff75c5ae-a130-42d0-a348-bfb34a4f959c"
      unitRef="usd">8915000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i84212de5e3c34a078a34d879bfeeb394_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOS01LTEtMS0yMTE2MQ_c9c98c1a-d55c-4843-bb27-88e79bb70ec4"
      unitRef="usd">29375000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8faff0cacc944396b07783c2a5b064e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfOS03LTEtMS0yMTE2MQ_f1c9e7d0-9e50-400b-9b9d-85b42501a28b"
      unitRef="usd">26710000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTAtMS0xLTEtMjExNjE_0aa98858-3b8f-4a74-a9b2-e0ebaab0b146"
      unitRef="usd">28094000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTAtMy0xLTEtMjExNjE_277cd9c5-1115-4285-86c7-674f601bd762"
      unitRef="usd">24418000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTAtNS0xLTEtMjExNjE_ad648e95-c12e-45f2-9b27-6cbec0d899f0"
      unitRef="usd">82756000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTAtNy0xLTEtMjExNjE_1fb40e9e-0415-4515-a57f-b2c2fbba201a"
      unitRef="usd">73302000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTItMS0xLTEtMjExNjE_2dd1c888-4144-489b-a223-6f6ccbcee785"
      unitRef="usd">48744000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTItMy0xLTEtMjExNjE_81639731-1284-4be0-8a07-40d710dcff3c"
      unitRef="usd">47789000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTItNS0xLTEtMjExNjE_879e11ea-db91-41db-a0a9-e559fc903fdc"
      unitRef="usd">151635000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTItNy0xLTEtMjExNjE_4c589487-d066-4e5a-8eeb-bffd9819a8c1"
      unitRef="usd">146140000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTUtMS0xLTEtMjExNjE_18d70a33-aaf4-466d-a51f-c995d8f3c01e"
      unitRef="usd">41051000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTUtMy0xLTEtMjExNjE_acd0e3b3-11e1-4730-b35b-c47934ea8c09"
      unitRef="usd">39053000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTUtNS0xLTEtMjExNjE_1c2633c1-2b90-429d-9117-c6365867d41c"
      unitRef="usd">118989000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTUtNy0xLTEtMjExNjE_2bf4a713-9aba-4f5b-82c5-5e5ea0ed6ef1"
      unitRef="usd">118521000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTYtMS0xLTEtMjExNjE_adf6639e-6451-4c9b-826d-bcd6ee04e6f3"
      unitRef="usd">11799000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTYtMy0xLTEtMjExNjE_41cc0ed2-3e77-4439-9471-b7da04c04184"
      unitRef="usd">9972000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTYtNS0xLTEtMjExNjE_3bb5e75c-e4c8-4028-aaf5-6911840cad7b"
      unitRef="usd">30575000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTYtNy0xLTEtMjExNjE_4790496b-0c98-4468-bd86-6dbf0923d7f1"
      unitRef="usd">26086000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTctMS0xLTEtMjExNjE_e4944da6-6ffb-41d2-b48f-f383ab8b0a28"
      unitRef="usd">52850000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTctMy0xLTEtMjExNjE_9ae9bb8c-6271-469a-8fc2-54babc0ea5a0"
      unitRef="usd">49025000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTctNS0xLTEtMjExNjE_3e33c9c3-463f-457d-8b4a-1671eb7edb08"
      unitRef="usd">149564000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTctNy0xLTEtMjExNjE_65f162de-410f-4f5e-af3c-729e9624e2e0"
      unitRef="usd">144607000</us-gaap:OperatingExpenses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTgtMS0xLTEtMjE0MDM_8d23c34e-a3b2-4fa7-8820-f287aac0fe76"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTgtMy0xLTEtMjE0MDM_a9941443-2ac8-41f0-8c56-1448f6a70101"
      unitRef="usd">15923000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTgtNS0xLTEtMjE0MDM_6b8e73bc-8025-4b88-8ed2-d8ccf156b0ed"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTgtNy0xLTEtMjE0MDM_c84c1bdc-6d73-4b66-ae4d-58d7ef7d2729"
      unitRef="usd">15923000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTktMS0xLTEtMjExNjE_531946e5-4df7-4b66-98c0-e3e6f504573c"
      unitRef="usd">-4106000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTktMy0xLTEtMjExNjE_045ef7cb-2646-45a4-9ba3-1bffedf1a111"
      unitRef="usd">14687000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTktNS0xLTEtMjExNjE_b1bed8bd-276a-4bb2-8ca4-99ab592a83e1"
      unitRef="usd">2071000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMTktNy0xLTEtMjExNjE_a4226a02-7b05-4ed5-9eb7-6c100ea540bc"
      unitRef="usd">17456000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjEtMS0xLTEtMjExNjE_78c78d45-b777-451f-ac84-e06060e2faf6"
      unitRef="usd">4805000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjEtMy0xLTEtMjExNjE_82a603f4-0e0a-44c6-baf7-704c5f06570b"
      unitRef="usd">4100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjEtNS0xLTEtMjExNjE_7325e7f7-19e0-45e8-9d44-40110a010a8a"
      unitRef="usd">12854000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjEtNy0xLTEtMjExNjE_5b90c052-6a41-4528-8a8d-e374f17ba23d"
      unitRef="usd">12995000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjItMS0xLTEtMjExNjE_6b6c9fac-7a4a-4604-a9a5-7bc7d359fbbb"
      unitRef="usd">40000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjItMy0xLTEtMjExNjE_c5811ce6-a5cf-4c8f-b996-e78b80d6e9c3"
      unitRef="usd">18000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjItNS0xLTEtMjExNjE_fa388f5f-f29d-43a0-b27f-6bec0da014d3"
      unitRef="usd">86000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjItNy0xLTEtMjExNjE_6d206c40-1908-4ee3-8421-1830f1f2cf7f"
      unitRef="usd">60000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjMtMS0xLTEtMjExNjE_9a48d5a4-cc23-49ff-ae22-168bc5961792"
      unitRef="usd">-3661000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjMtMy0xLTEtMjExNjE_df0b4a04-2253-4705-af8a-75253746ebb1"
      unitRef="usd">-2661000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjMtNS0xLTEtMjExNjE_df556807-d72d-4aee-9748-bff6d36b5a6d"
      unitRef="usd">-7564000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjMtNy0xLTEtMjExNjE_340e0eda-3cad-4bd5-8ca0-d76286c79646"
      unitRef="usd">-3261000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjUtMS0xLTEtMjExNjE_c5f4b147-f71e-4121-90d3-7ab24edc322f"
      unitRef="usd">-12532000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjUtMy0xLTEtMjExNjE_483c8e0e-d1b0-46ac-a782-0e2c2b6d55dc"
      unitRef="usd">7944000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjUtNS0xLTEtMjExNjE_094b3623-b1a3-48e6-9998-a2609172ef1e"
      unitRef="usd">-18261000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjUtNy0xLTEtMjExNjE_bd94c2ba-9b1c-460b-bad7-93c223b4752b"
      unitRef="usd">1260000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjYtMS0xLTEtMjExNjE_44df776a-bae9-484a-ad99-055b0af2c612"
      unitRef="usd">1181000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjYtMy0xLTEtMjExNjE_c734e45f-ee64-4017-83b8-59a6fd4f0f66"
      unitRef="usd">-2638000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjYtNS0xLTEtMjExNjE_543c8749-cbcf-4ac1-a1b4-2e631409479f"
      unitRef="usd">3100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjYtNy0xLTEtMjExNjE_12631bf4-0357-45cb-9f6b-3727da3d8a48"
      unitRef="usd">-4006000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjgtMS0xLTEtMjExNjE_e839439d-5636-4003-a122-03f8b8d93209"
      unitRef="usd">-13713000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjgtMy0xLTEtMjExNjE_589b093c-d155-4ea5-a903-133b640500e6"
      unitRef="usd">10582000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjgtNS0xLTEtMjExNjE_c65bde17-768a-476c-9926-25d80db52ff0"
      unitRef="usd">-21361000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMjgtNy0xLTEtMjExNjE_5683a974-f88f-4285-b2ec-789d882fb27d"
      unitRef="usd">5266000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzEtMS0xLTEtMjExNjE_4dbddfe9-9feb-4079-9b56-388d48102544"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzEtMy0xLTEtMjExNjE_73598f17-746b-4784-875e-5ee159964fc7"
      unitRef="usdPerShare">0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzEtNS0xLTEtMjExNjE_94d61521-79c4-4fec-9d57-2536ba6031f4"
      unitRef="usdPerShare">-0.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzEtNy0xLTEtMjExNjE_a6277234-aff8-4452-98d6-f0a94c04ca51"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzItMS0xLTEtMjExNjE_7e66ad2e-625a-4aec-8f4c-497a6acb403e"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzItMy0xLTEtMjExNjE_66482b4c-2fe7-4d44-806f-fa26189694e9"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzItNS0xLTEtMjExNjE_457bfc38-3a66-439c-99f8-71831c97627e"
      unitRef="usdPerShare">-0.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzItNy0xLTEtMjExNjE_ace55c43-01c3-4cf3-a5a8-8ac5e029de66"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzUtMS0xLTEtMjExNjE_fb094439-464f-46a3-b1ce-da9189bd6434"
      unitRef="shares">40115000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzUtMy0xLTEtMjExNjE_6eb8a48a-6474-4b11-88d3-715c263027f7"
      unitRef="shares">39086000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzUtNS0xLTEtMjExNjE_54324268-8e9d-4499-9a7e-5756bce4a745"
      unitRef="shares">39999000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzUtNy0xLTEtMjExNjE_dce9c8d4-9e6a-424e-a6ca-d23f0236c3df"
      unitRef="shares">38924000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzYtMS0xLTEtMjExNjE_7262a0fa-0b97-4ec9-94dc-afc6753e60fc"
      unitRef="shares">40115000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzYtMy0xLTEtMjExNjE_ae91f0ae-6c5f-4eff-8b79-2ead88c70aa8"
      unitRef="shares">44453000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzYtNS0xLTEtMjExNjE_e4ff6bb8-743d-43d5-b621-215a3fafe180"
      unitRef="shares">39999000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzYtNy0xLTEtMjExNjE_37ed9260-40c4-495c-87b4-f1a56b9d7a1e"
      unitRef="shares">39496000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzgtMS0xLTEtMjExNjE_c483e212-ef79-4bd5-a7bb-3b9e2ac7d678"
      unitRef="usd">-13713000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzgtMy0xLTEtMjExNjE_2474683d-102c-4cf2-a6df-f5d7188542e0"
      unitRef="usd">10582000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzgtNS0xLTEtMjExNjE_a188923f-5dc2-4239-bd55-e387ab947fb2"
      unitRef="usd">-21361000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfMzgtNy0xLTEtMjExNjE_b276f6b2-777a-4b9d-9fe8-78965dd51f12"
      unitRef="usd">5266000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDAtMS0xLTEtMjExNjE_1245d3ca-d2c4-4008-920e-f732557c9c69"
      unitRef="usd">-16895000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDAtMy0xLTEtMjExNjE_d72ef60f-ad23-47ab-b77f-a0d150b613db"
      unitRef="usd">-5010000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDAtNS0xLTEtMjExNjE_1ea3bc92-b2f5-468e-85f8-6d62d95f93a5"
      unitRef="usd">-35466000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDAtNy0xLTEtMjExNjE_a24129f8-f42b-4a3c-8412-9206342dee21"
      unitRef="usd">-12327000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDEtMS0xLTEtMjExNjE_0f6fa46b-77d0-412b-a405-7154552b18ca"
      unitRef="usd">-30608000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDEtMy0xLTEtMjExNjE_1ee5507b-a564-4ab8-9ab6-6a89aaff20b2"
      unitRef="usd">5572000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDEtNS0xLTEtMjExNjE_4c567fa7-68d4-4313-9bb4-1075550afe13"
      unitRef="usd">-56827000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xNi9mcmFnOmZjNGJiNjc2Nzc3OTQ2ZjE5YTU3NWVmYTRiMGYyMmQ1L3RhYmxlOmMwZWM2OWNiYTZjOTQwMGY4MTkwOGQwZTllNmE3NTQyL3RhYmxlcmFuZ2U6YzBlYzY5Y2JhNmM5NDAwZjgxOTA4ZDBlOWU2YTc1NDJfNDEtNy0xLTEtMjExNjE_9c280b17-e62d-4671-8dd3-487b0ec86b70"
      unitRef="usd">-7061000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNC0xLTEtMS0yMTE2MQ_cc64cac5-8f8c-4a09-a420-5f9faa16d4ab"
      unitRef="usd">37572000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNC0zLTEtMS0yMTE2MQ_8d82c04c-b3b7-46fa-bdf8-3e1a2996053a"
      unitRef="usd">55010000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNS0xLTEtMS0yMTE2MQ_670cb280-f3ca-49e8-af21-17ed9bf39fc3"
      unitRef="usd">57159000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNS0zLTEtMS0yMTE2MQ_67094d57-af0b-47c6-8154-200fa7c8e3be"
      unitRef="usd">53019000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNi0xLTEtMS0yMTE2MQ_9ddde526-9301-4850-83d5-42ce33225f19"
      unitRef="usd">7880000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNi0zLTEtMS0yMTE2MQ_15b2be40-cdb0-481b-9dd1-8b80b66b818f"
      unitRef="usd">5086000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNy0xLTEtMS0yMTE2MQ_12f4557e-5644-4901-8792-e1a693794236"
      unitRef="usd">73044000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNy0zLTEtMS0yMTE2MQ_ea9b0f03-3fcc-43a4-87f0-abdb4681838b"
      unitRef="usd">76971000</us-gaap:InventoryNet>
    <aort:DeferredPreservationCosts
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfOC0xLTEtMS0yMTE2MQ_ee0e1237-faf0-4d47-9792-15cd0798b456"
      unitRef="usd">45483000</aort:DeferredPreservationCosts>
    <aort:DeferredPreservationCosts
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfOC0zLTEtMS0yMTE2MQ_27a764d1-53f0-4d6f-ba76-1791a7ccaec7"
      unitRef="usd">42863000</aort:DeferredPreservationCosts>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfOS0xLTEtMS0yMTE2MQ_0f15e000-70f6-4d26-98aa-056a92f52194"
      unitRef="usd">16851000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfOS0zLTEtMS0yMTE2MQ_22112af3-05da-4ef1-91c5-8700494d7c28"
      unitRef="usd">14748000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTAtMS0xLTEtMjExNjE_b6dbaacb-bad6-4ba1-bce7-c7835c9cfe5d"
      unitRef="usd">237989000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTAtMy0xLTEtMjExNjE_92a68ba9-2957-4705-90f7-d5483ab042ce"
      unitRef="usd">247697000</us-gaap:AssetsCurrent>
    <us-gaap:Goodwill
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTItMS0xLTEtMjExNjE_17aeb34e-d792-43e9-991b-e47c7c817e68"
      unitRef="usd">234773000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTItMy0xLTEtMjExNjE_6c380b98-02ca-4288-8093-e7cabe17d784"
      unitRef="usd">250000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTMtMS0xLTEtMjExNjE_9df97e00-fd3b-4557-af17-948478ad2ef1"
      unitRef="usd">148060000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTMtMy0xLTEtMjExNjE_53439247-48e0-45cd-83bf-417e9668c0c6"
      unitRef="usd">166994000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTQtMS0xLTEtMjExNjE_c5d3a9b0-adc3-4162-991e-aad3164b169d"
      unitRef="usd">41320000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTQtMy0xLTEtMjExNjE_dabcdda5-a0bd-4b68-aaea-1ed186efd2bf"
      unitRef="usd">45714000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTUtMS0xLTEtMjExNjE_4b2a7278-79b2-4f65-9476-389927b55c2e"
      unitRef="usd">36286000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTUtMy0xLTEtMjExNjE_af1ab1e5-6d50-4280-ae19-b305c77057fe"
      unitRef="usd">37521000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTYtMS0xLTEtMjExNjE_d1934ebe-3716-4081-9039-de8cab0ca24e"
      unitRef="usd">31112000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTYtMy0xLTEtMjExNjE_94167041-f7c5-4ae3-8200-09c4f900d94f"
      unitRef="usd">34502000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTctMS0xLTEtMjExNjE_38fff8f0-15ea-4498-a03f-4f10050902d7"
      unitRef="usd">6103000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTctMy0xLTEtMjExNjE_c925c249-10a6-4626-b943-dcabe6ff1f6e"
      unitRef="usd">2357000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTgtMS0xLTEtMjExNjE_2698cfb9-a9eb-411c-ac24-ad9d762e8d38"
      unitRef="usd">7088000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTgtMy0xLTEtMjExNjE_e05f961c-9ae6-4812-87cb-a9b7d10c8e53"
      unitRef="usd">8267000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTktMS0xLTEtMjExNjE_00180fd1-b91b-474e-8576-47a3bb00fba1"
      unitRef="usd">742731000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMTktMy0xLTEtMjExNjE_2b7ee856-d171-4798-ad7f-c1dc090c884f"
      unitRef="usd">793052000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjMtMS0xLTEtMjExNjE_b46c2a5c-253e-42ae-8dfd-3b2b214d25ed"
      unitRef="usd">10721000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjMtMy0xLTEtMjExNjE_64482a40-413a-419f-b56d-0b83c3a5f193"
      unitRef="usd">10395000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjQtMS0xLTEtMjExNjE_78fde84e-a017-4042-ab15-967d30646ff3"
      unitRef="usd">11079000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjQtMy0xLTEtMjExNjE_2750a442-eee3-4179-a59e-9e0c7285d7f2"
      unitRef="usd">13163000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjUtMS0xLTEtMjExNjE_fd814993-7143-406b-be04-f6efe54a6ff9"
      unitRef="usd">10088000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjUtMy0xLTEtMjExNjE_6df4ccfc-cf6e-4e9f-b891-82d18b2514a9"
      unitRef="usd">7687000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjYtMS0xLTEtMjExNjE_51ca954f-c7f1-43fb-8204-3bf78a610f95"
      unitRef="usd">5293000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjYtMy0xLTEtMjExNjE_9e311381-ae2c-4d49-877c-2fd9d632dfd2"
      unitRef="usd">3634000</us-gaap:TaxesPayableCurrent>
    <aort:AccruedProcurementFees
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjctMS0xLTEtMjExNjE_02c473d6-d63f-424c-9e81-e80434a00660"
      unitRef="usd">2302000</aort:AccruedProcurementFees>
    <aort:AccruedProcurementFees
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjctMy0xLTEtMjExNjE_5b41d22f-b3e1-467e-b970-4a20ca2f7bf0"
      unitRef="usd">3689000</aort:AccruedProcurementFees>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjgtMS0xLTEtMjExNjE_95d43722-a684-46ff-bc3e-37418e22ff93"
      unitRef="usd">3061000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjgtMy0xLTEtMjExNjE_2fabb848-d0e7-4808-a08f-2eda11a506c2"
      unitRef="usd">3149000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjktMS0xLTEtMjExNjE_2ae2a861-7009-4431-a319-863a788ae57e"
      unitRef="usd">1562000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMjktMy0xLTEtMjExNjE_95762b2c-6fee-4988-82b1-e1ccfe73c5bf"
      unitRef="usd">1630000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzAtMS0xLTEtMjExNjE_8bf7a364-6f0b-422e-add8-215d645f5d5f"
      unitRef="usd">1886000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzAtMy0xLTEtMjExNjE_c4496916-6f8a-4d60-9bb5-cc22ffca4c73"
      unitRef="usd">1606000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzEtMS0xLTEtMjExNjE_d5fb1641-d009-4a26-90e0-edb8ffda651d"
      unitRef="usd">45992000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzEtMy0xLTEtMjExNjE_b0d0093d-6682-4001-b194-9b73d4b5ea56"
      unitRef="usd">44953000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzMtMS0xLTEtMjExNjE_f96d07a5-27d4-4fe2-a157-a88c831abb74"
      unitRef="usd">306674000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzMtMy0xLTEtMjExNjE_023d9982-1bad-435e-8fa0-ba6acc123b1a"
      unitRef="usd">307493000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzQtMS0xLTEtMjExNjE_f5709bf0-66cd-4108-a955-7fd5df15b04c"
      unitRef="usd">44800000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzQtMy0xLTEtMjExNjE_a03721f2-15f9-4f8c-8156-8da1c35b4b27"
      unitRef="usd">49400000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzUtMS0xLTEtMjExNjE_6e16669b-ccd4-421f-a545-212008b24e3a"
      unitRef="usd">40915000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzUtMy0xLTEtMjExNjE_6d345779-d165-42f2-bddc-3a54f4930dcc"
      unitRef="usd">44869000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzYtMS0xLTEtMjExNjE_f1b9b011-72ff-45e3-a475-3802cd6bcbcf"
      unitRef="usd">3450000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzYtMy0xLTEtMjExNjE_91682428-89e5-47d7-8e08-ed5e92535ef2"
      unitRef="usd">4374000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzctMS0xLTEtMjExNjE_c53c244d-d70a-4adf-8596-d63e04ce4d1c"
      unitRef="usd">34058000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzctMy0xLTEtMjExNjE_1d59ca41-eb70-4e01-9ad7-cca6b3a776f3"
      unitRef="usd">28799000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzgtMS0xLTEtMjExNjE_6677fb93-85e8-47a1-bba9-d5459a14926a"
      unitRef="usd">5082000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzgtMy0xLTEtMjExNjE_60a6fa1c-0a34-4777-9186-c7b7cb1537d4"
      unitRef="usd">5952000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzktMS0xLTEtMjExNjE_28671504-3a61-410a-b665-f9a8051b1920"
      unitRef="usd">6652000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfMzktMy0xLTEtMjExNjE_846c0a29-32cd-4e69-86ef-dd57afb54e2c"
      unitRef="usd">6484000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDAtMS0xLTEtMjExNjE_6a7d92a5-733b-4865-923d-664dc1c068cb"
      unitRef="usd">487623000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDAtMy0xLTEtMjExNjE_73167ef4-5d8c-4d59-af5b-1677e5d92a02"
      unitRef="usd">492324000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDItMS0xLTEtMjExNjE_b5f4e67c-ed18-4295-b943-1c7021e85ef1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDItMy0xLTEtMjExNjE_af9abe2d-89cd-489a-aeb7-a33aa82c2f60"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDUtMS0xLTEtMjExNjE_0cd8eac5-29b7-4401-8e40-f3640383d0d5"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDUtMy0xLTEtMjExNjE_277fdf38-68d7-4919-aab0-666338fa595c"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesIssued
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDYtMC0xLTEtMjExNjEvdGV4dHJlZ2lvbjpmY2MzNjJkYzEwZTE0OGY0ODM3ZDc3YzVlMWY4MGQyN18xMDk5NTExNjI3ODUx_6882f1bb-9528-4717-bb43-d3bf87522926"
      unitRef="shares">41816000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDYtMC0xLTEtMjExNjEvdGV4dHJlZ2lvbjpmY2MzNjJkYzEwZTE0OGY0ODM3ZDc3YzVlMWY4MGQyN18xMDk5NTExNjI3ODYw_db104ff0-6165-4857-b4b1-87c5bec6f227"
      unitRef="shares">41397000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDYtMS0xLTEtMjExNjE_84285f69-b480-42f1-b78b-4b57cd7a4881"
      unitRef="usd">418000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDYtMy0xLTEtMjExNjE_ceff7806-7ad1-4f69-b9c5-b4359164ee07"
      unitRef="usd">414000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDctMS0xLTEtMjExNjE_c52136fb-3afa-4a00-a569-d94cbdb2bef3"
      unitRef="usd">334077000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDctMy0xLTEtMjExNjE_2a70fd3d-7d45-4a93-b420-1a9db5887d3c"
      unitRef="usd">322874000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDgtMS0xLTEtMjExNjE_71482eeb-53e6-4a3b-a94f-08f587883e0f"
      unitRef="usd">-19386000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDgtMy0xLTEtMjExNjE_14335dc6-785e-435d-bbd0-b91f40f09ac4"
      unitRef="usd">1975000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDktMS0xLTEtMjExNjE_fb3de999-ba28-4e54-b5e6-caa7d5869d00"
      unitRef="usd">-45353000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNDktMy0xLTEtMjExNjE_fe615ffb-e253-4b98-93c5-1533d0e31d92"
      unitRef="usd">-9887000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTAtMC0xLTEtMjExNjEvdGV4dHJlZ2lvbjpiOWYyMzkxNTBhNTQ0NWMzYWQ2YzQwN2EwZWVhMDVlZF8yOQ_4d859516-548c-4ae4-aa26-fe848ae32475"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTAtMC0xLTEtMjExNjEvdGV4dHJlZ2lvbjpiOWYyMzkxNTBhNTQ0NWMzYWQ2YzQwN2EwZWVhMDVlZF8yOQ_e716b0f6-85ac-48c1-9999-214ef1dc36dc"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTAtMS0xLTEtMjExNjE_b15ed6a8-a399-4bf8-ac26-6813d4281387"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTAtMy0xLTEtMjExNjE_f9c2c894-e065-4ecd-bb4c-f132253025c6"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTEtMS0xLTEtMjExNjE_a616f334-13ab-4b6d-915a-8fef83b53d66"
      unitRef="usd">255108000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTEtMy0xLTEtMjExNjE_6d468c9a-95f1-4dfe-865a-884a2616ad18"
      unitRef="usd">300728000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTMtMS0xLTEtMjExNjE_13dc3741-1083-4a98-a2d0-0e3dde96cc63"
      unitRef="usd">742731000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8xOS9mcmFnOjQxOGE3MjExMGJjODRhZDdhYjEwNzE3YWM5NjVlNGE5L3RhYmxlOjA2ZGM1ODVjNDg2NDQ3N2RhYjc0MTVmYjI3OTNlY2NmL3RhYmxlcmFuZ2U6MDZkYzU4NWM0ODY0NDc3ZGFiNzQxNWZiMjc5M2VjY2ZfNTMtMy0xLTEtMjExNjE_1987c53c-286c-4fea-b658-0b01379bdd63"
      unitRef="usd">793052000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMy0xLTEtMS0yMTE2MQ_426cb798-186c-41ce-aee2-4b0c4993b6d8"
      unitRef="usd">-21361000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMy0zLTEtMS0yMTE2MQ_0cc44ea8-c8ac-4928-b7f8-1f80d4e1dd09"
      unitRef="usd">5266000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfNi0xLTEtMS0yMTE2MQ_cfff51fa-bd8b-4bbb-9844-89f4bdedfeb9"
      unitRef="usd">17016000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfNi0zLTEtMS0yMTE2MQ_69faa21c-2119-473e-a685-8795b2886656"
      unitRef="usd">18008000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfNy0xLTEtMS0yMTE2MQ_006551df-247d-422a-9195-2d09731588e3"
      unitRef="usd">9189000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfNy0zLTEtMS0yMTE2MQ_a96abf1f-89d2-49e9-8c98-f1899cde44f9"
      unitRef="usd">7471000</us-gaap:ShareBasedCompensation>
    <aort:NoncashLeaseExpense
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfOC0xLTEtMS0yMTE2MQ_037371d9-009f-455d-b5a5-e03ea09e0d73"
      unitRef="usd">5656000</aort:NoncashLeaseExpense>
    <aort:NoncashLeaseExpense
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfOC0zLTEtMS0yMTE2MQ_beed1551-ba85-458b-8f39-bb9d642de64d"
      unitRef="usd">5566000</aort:NoncashLeaseExpense>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfOS0xLTEtMS0yOTAzNg_e9a94fcb-c5cf-4814-af36-be3267c04d0e"
      unitRef="usd">-5097000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfOS0zLTEtMS0yOTAzNg_f5d9507f-5d0a-465a-b17b-1e9c062a1753"
      unitRef="usd">8128000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <aort:WriteDownOfDeferredPreservationCostsAndInventories
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfOS0xLTEtMS0yMTE2MQ_6b1057a9-adb4-46b9-8353-5f7cd1c7aaf5"
      unitRef="usd">3116000</aort:WriteDownOfDeferredPreservationCostsAndInventories>
    <aort:WriteDownOfDeferredPreservationCostsAndInventories
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfOS0zLTEtMS0yMTE2MQ_a65cd2e2-1fc1-4947-b126-230458ca363b"
      unitRef="usd">3987000</aort:WriteDownOfDeferredPreservationCostsAndInventories>
    <aort:NoncashInterestExpense
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTAtMS0xLTEtMjgwMzI_944f5450-ebed-4602-93c1-23dd490cadfa"
      unitRef="usd">1372000</aort:NoncashInterestExpense>
    <aort:NoncashInterestExpense
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTAtMy0xLTEtMjgwNDE_85feb210-0aab-4a50-8755-6e0153431d72"
      unitRef="usd">2025000</aort:NoncashInterestExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTAtMS0xLTEtMjExNjE_d4a9ad6c-2f30-4fe9-91a1-e027aba3f93e"
      unitRef="usd">-4600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTAtMy0xLTEtMjExNjE_a9f9108f-522b-416a-a8ac-870da5151514"
      unitRef="usd">4970000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTMtMS0xLTEtMjE2MzI_48b297f8-af77-4884-a170-2812dce60dbb"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTMtMy0xLTEtMjE2MjQ_73dca91d-dc97-452e-8647-373ff067d6d0"
      unitRef="usd">15923000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OtherNoncashExpense
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTItMS0xLTEtMjExNjE_837e9dab-3855-440f-8be7-1b3b39829c20"
      unitRef="usd">151000</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTItMy0xLTEtMjExNjE_38a202be-5fac-450f-beca-3d395586f1b3"
      unitRef="usd">678000</us-gaap:OtherNoncashExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTQtMS0xLTEtMjExNjE_0f7f2a8c-dbae-4faa-b8cd-19478fd3b249"
      unitRef="usd">1788000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTQtMy0xLTEtMjExNjE_c41a45f4-bf21-43a7-822a-345f97b11ca3"
      unitRef="usd">2268000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTctMS0xLTEtMjkwNTU_59b57e2d-ab5f-484f-ac9e-40334c953031"
      unitRef="usd">-2103000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTctMy0xLTEtMjkwNTU_5b4dc128-655d-4b8d-87ef-944864572b47"
      unitRef="usd">65000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <aort:IncreaseDecreaseInDeferredPreservationCostsAndInventories
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTUtMS0xLTEtMjExNjE_6772b230-fdc3-4f39-957c-f4bf23a9b883"
      unitRef="usd">5781000</aort:IncreaseDecreaseInDeferredPreservationCostsAndInventories>
    <aort:IncreaseDecreaseInDeferredPreservationCostsAndInventories
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTUtMy0xLTEtMjExNjE_5ad461b9-35d7-4687-827c-137f339b11ac"
      unitRef="usd">16986000</aort:IncreaseDecreaseInDeferredPreservationCostsAndInventories>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTYtMS0xLTEtMjExNjE_e80a3882-6cc1-4b28-bf7f-c7d5b06fb5a0"
      unitRef="usd">10900000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTYtMy0xLTEtMjExNjE_d10d4895-8845-47ae-bb77-68fadd21b4d9"
      unitRef="usd">8032000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTgtMS0xLTEtMjExNjE_da065e41-57bc-4a76-8875-8979b48678ac"
      unitRef="usd">-4936000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMTgtMy0xLTEtMjExNjE_6c1621e0-5bee-4a48-be59-b781b8e11819"
      unitRef="usd">-3301000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjUtMS0xLTEtMjc5NDE_f84c6bdd-1786-4bac-9b1e-6308d170296f"
      unitRef="usd">1123000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjUtMy0xLTEtMjc5NTA_0552b200-7ecc-498b-aee0-9492e344a7ce"
      unitRef="usd">726000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjQtMS0xLTEtMzAwNTk_bbdabfb1-8314-4739-b551-446e9b0db663"
      unitRef="usd">6924000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjQtMy0xLTEtMzAwNTk_421c82a5-80ba-484d-8a97-c5716c719ca7"
      unitRef="usd">10524000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjUtMS0xLTEtMjkzMzA_8c5b3215-2842-47a4-a661-b5d5b5fbf0d5"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjUtMy0xLTEtMjkzMzA_2a88e5da-8850-41e4-a7c2-362abc1e1673"
      unitRef="usd">19000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjItMS0xLTEtMjExNjE_224fe417-0151-4a25-8c05-adb13d46b5de"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjItMy0xLTEtMjExNjE_026b2de7-f650-468f-ae6d-6153ec68d436"
      unitRef="usd">-722000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjMtMS0xLTEtMjExNjE_464d6f00-7e11-4d9b-91b8-0fb2f5fd30f7"
      unitRef="usd">-8047000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjMtMy0xLTEtMjExNjE_1b859dc2-6119-438d-b509-3194fbed46ac"
      unitRef="usd">8472000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjYtMS0xLTEtMjExNjE_b7212612-3c36-4972-bc17-d55a07aef8e0"
      unitRef="usd">3344000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjYtMy0xLTEtMjExNjE_2fd9ea6e-e72b-45d8-a612-00d0346a326c"
      unitRef="usd">3531000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzEtMS0xLTEtMzAwNzQ_a864e2f8-144e-4128-bb87-44f8f91303be"
      unitRef="usd">1791000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzEtMy0xLTEtMzAwNzQ_0c17f7e0-b2e4-4b05-9ac3-3ae9820ae9de"
      unitRef="usd">1898000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzEtMS0xLTEtMjgyMTY_da5cbc23-308e-4a4e-8a33-7af5fb815ff1"
      unitRef="usd">2033000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzEtMy0xLTEtMjgyMTY_060e8c33-1404-49ab-810c-ee72b58a7fc1"
      unitRef="usd">2397000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjctMS0xLTEtMjExNjE_a0fffd9f-e898-4868-aa03-161643c9e80f"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMjctMy0xLTEtMjExNjE_a0b5e97b-cb89-493f-bbd7-61028738e124"
      unitRef="usd">2219000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzAtMS0xLTEtMjExNjE_a19927e9-b532-48df-a991-b9d91f7b4ebe"
      unitRef="usd">-300000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzAtMy0xLTEtMjExNjE_53f4853a-c382-4c4b-be3d-99bbf6ac09d4"
      unitRef="usd">-439000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzEtMS0xLTEtMjExNjE_426a4def-ef6f-4377-9cde-ba21d8bc588c"
      unitRef="usd">-780000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzEtMy0xLTEtMjExNjE_7eeb8296-9b9d-45ff-8ee2-e5bb98de051e"
      unitRef="usd">-3422000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzMtMS0xLTEtMjExNjE_47d6fd35-6398-4324-8276-ae8340c26b88"
      unitRef="usd">-3675000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzMtMy0xLTEtMjExNjE_ba692f5c-81f5-4a6a-bc73-de55940e30bb"
      unitRef="usd">1418000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzQtMS0xLTEtMjExNjE_400f952e-b1a5-4dcc-b743-d5adfb08229c"
      unitRef="usd">-17438000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzQtMy0xLTEtMjExNjE_c7ca414a-272e-4bfd-b9c3-adcdec183afa"
      unitRef="usd">3167000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzYtMS0xLTEtMjExNjE_1a6d87fa-ba3c-42b0-930d-086066bef152"
      unitRef="usd">55010000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i02c95f38d9b543ae84f37d41d8baa157_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzYtMy0xLTEtMjExNjE_ddbdfca2-1d2b-49a7-98df-abc6674d6094"
      unitRef="usd">61958000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzctMS0xLTEtMjExNjE_48a018e2-b603-4103-98f5-8c44e146426a"
      unitRef="usd">37572000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idfb7570230e54f50941fc14b31243894_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yMi9mcmFnOmYxNTE3MjIzMzk4MjRjZmRhZTlkMTJmNDNiZDUxMDY3L3RhYmxlOmUzMWQ4YjIwNzM0ZDQ1ZWY5M2JjMGE3ZjA1Yzk5NWNhL3RhYmxlcmFuZ2U6ZTMxZDhiMjA3MzRkNDVlZjkzYmMwYTdmMDVjOTk1Y2FfMzctMy0xLTEtMjExNjE_649a5e60-467c-4676-abcc-cf67b17769ae"
      unitRef="usd">65125000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3f32d331c65a4d77abae1c29bfd76fad_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi0xLTEtMS0yMTE2MQ_a6b01f66-bd9a-4d39-b487-2184c9cf1a30"
      unitRef="shares">41744000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3f32d331c65a4d77abae1c29bfd76fad_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi0zLTEtMS0yMTE2MQ_4f54f0c6-4ba8-4929-8703-66662e265445"
      unitRef="usd">417000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i75cedf86a43b46479cf2b7e2e4ffa5b6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi01LTEtMS0yMTE2MQ_ad7959cb-da8d-48c8-b245-92008dbe07f6"
      unitRef="usd">329871000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2327fb17357843d49351125df49690ce_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi03LTEtMS0yMTE2MQ_3b57411f-5847-4d40-ad46-b2d340d3e486"
      unitRef="usd">-5673000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i500babc0c996435a9c7bf3de79597910_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi05LTEtMS0yMTE2MQ_1fa29faf-9917-4ced-a93f-5ab4d8024a49"
      unitRef="usd">-28458000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i5517182634564914ba321ae01406e558_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi0xMS0xLTEtMjExNjE_3809f1ce-ec0c-4951-8863-224f60f1e45d"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i5517182634564914ba321ae01406e558_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi0xMy0xLTEtMjExNjE_783102ae-dc8f-4ca7-abcc-6c6608328e91"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="ic0173bc1ef6e4cd89e057d607f1488e3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMi0xNS0xLTEtMjExNjE_83c14c3e-b867-474f-a37f-b9dbfcab4890"
      unitRef="usd">281509000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ie53b06b7fc644641930b5fae9767bb47_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMy03LTEtMS0yMTE2MQ_264811e6-335c-46a8-9fec-e7982c0b8a0e"
      unitRef="usd">-13713000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfMy0xNS0xLTEtMjExNjE_41e932c2-5c07-4a68-98ab-679df512a652"
      unitRef="usd">-13713000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i27b4dd9bf4a1461f8c3787382c8bdc2c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNC05LTEtMS0yMTE2MQ_3e57dab3-20a7-4f54-a785-d538b3b36634"
      unitRef="usd">-16895000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNC0xNS0xLTEtMjExNjE_805d4166-8036-4a7b-82af-f50261f173b5"
      unitRef="usd">-16895000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i4d654e08061c4d2eb225d927a13203b2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNS0xLTEtMS0yMTE2MQ_89dd115c-9db6-49ab-baba-4b1f2594431a"
      unitRef="shares">7000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib4351c2916a14e6583947067dccfd48f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNS01LTEtMS0yMTE2MQ_7bde48cd-373a-4db6-a198-651977886db3"
      unitRef="usd">3233000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNS0xNS0xLTEtMjExNjE_a734cb9b-039c-4552-9cf5-d7c7568ad22e"
      unitRef="usd">3233000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4d654e08061c4d2eb225d927a13203b2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNi0xLTEtMS0yMTE2MQ_87794f6f-d14b-4f78-802c-ee12ee1eebfb"
      unitRef="shares">9000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib4351c2916a14e6583947067dccfd48f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNi01LTEtMS0yMTE2MQ_51a76d9a-e430-4bb5-8682-73c0dd217ad8"
      unitRef="usd">85000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNi0xNS0xLTEtMjExNjE_2b26e93a-4c52-4c53-a596-8e1202a99365"
      unitRef="usd">85000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i4d654e08061c4d2eb225d927a13203b2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNy0xLTEtMS0yMTE2MQ_1c8d4bcb-2900-477a-ae00-959ab362f0c5"
      unitRef="shares">58000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4d654e08061c4d2eb225d927a13203b2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNy0zLTEtMS0yMTE2MQ_e53474da-523d-43c5-983b-7adb4b365c0e"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib4351c2916a14e6583947067dccfd48f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNy01LTEtMS0yMTE2MQ_77ac4b4e-f57e-497e-801f-6a1775a090a0"
      unitRef="usd">940000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfNy0xNS0xLTEtMjExNjE_657b1c7a-0986-4eb4-8e29-37c9dca016ef"
      unitRef="usd">941000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="i4d654e08061c4d2eb225d927a13203b2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOC0xLTEtMS0yMTE2MQ_f5ed024d-66a1-4b01-ad69-ebcce42fbb22"
      unitRef="shares">2000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="ib4351c2916a14e6583947067dccfd48f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOC01LTEtMS0yMTE2MQ_f25be2f1-a883-47a9-9bc2-b515a9f3e8cc"
      unitRef="usd">52000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOC0xNS0xLTEtMjExNjE_8770528f-7fb9-40dd-8630-0f07358dd7a2"
      unitRef="usd">52000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ifb24e4445f234f45bd7b3b6d182b317a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS0xLTEtMS0yMTE2MQ_f57636e9-8dfe-4869-a94d-faecb4e7a3db"
      unitRef="shares">41816000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ifb24e4445f234f45bd7b3b6d182b317a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS0zLTEtMS0yMTE2MQ_4493094e-05f4-4988-8e7e-5102151d3900"
      unitRef="usd">418000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0ebbddb2f6f04869aef50eed79a94a0a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS01LTEtMS0yMTE2MQ_87520455-544e-4e42-9112-2e33968a30a9"
      unitRef="usd">334077000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1c92a5fd903b49a588c3ceab6bf0fd71_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS03LTEtMS0yMTE2MQ_f3c9432f-4a77-4889-8adf-977374f2d82f"
      unitRef="usd">-19386000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idcf07ce8eeae433881f120218ee9a339_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS05LTEtMS0yMTE2MQ_435e8c31-3762-4b64-a9c1-3d1818db2cde"
      unitRef="usd">-45353000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i855b2caffaf74a64b3f2ef74285e23ad_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS0xMS0xLTEtMjExNjE_c74c2d71-ca96-44b2-984b-b32ded3f906c"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i855b2caffaf74a64b3f2ef74285e23ad_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS0xMy0xLTEtMjExNjE_71fed71c-df64-4141-a783-42f310a527dc"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjg4N2UyOWQ3OTk5MDRlOWE4NTQyZTFkOTdjNGFlMzJjL3RhYmxlcmFuZ2U6ODg3ZTI5ZDc5OTkwNGU5YTg1NDJlMWQ5N2M0YWUzMmNfOS0xNS0xLTEtMjExNjE_374890e6-210b-4657-aebf-522ce370d079"
      unitRef="usd">255108000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i707205b1c07e4c1988ca5ff5d74d4a17_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi0xLTEtMS0yMTE2MQ_1e0e6d7b-9e34-499a-871d-d2ef9ff31162"
      unitRef="shares">41397000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i707205b1c07e4c1988ca5ff5d74d4a17_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi0zLTEtMS0yMTE2MQ_bb3b280f-6ef3-4e6d-b80c-4e4ea9c2f182"
      unitRef="usd">414000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iee6c1445ceaf40bbb5e5f10623f14612_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi01LTEtMS0yMTE2MQ_868ba4e2-4bd1-44e6-a03f-2180f022312f"
      unitRef="usd">322874000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i017ca17a602e45219dab10ea1da5ec48_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi03LTEtMS0yMTE2MQ_bf839bc8-21cf-439e-84ee-cba7356a4294"
      unitRef="usd">1975000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2d546f3304f74a65ad65e63d5f35549c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi05LTEtMS0yMTE2MQ_1c9f1e41-ae10-47cf-b32a-4c6da051dabf"
      unitRef="usd">-9887000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i3556d5d3a27c416a831f28c2fa395382_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi0xMS0xLTEtMjExNjE_bbeedfe1-d85c-47f7-be26-d99df946168e"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i3556d5d3a27c416a831f28c2fa395382_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi0xMy0xLTEtMjExNjE_f760186f-73f5-4310-87f5-5a524aa189b1"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMi0xNS0xLTEtMjExNjE_9d875298-4b8e-427c-9678-170b49c0c630"
      unitRef="usd">300728000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i5632806a31294031ba676bcf8ede366e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMy03LTEtMS0yMTE2MQ_d05a5aff-79bb-4ed5-9ce5-72d6c3f3376c"
      unitRef="usd">-21361000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfMy0xNS0xLTEtMjExNjE_7d808437-c66e-4405-bf57-75f1128f4f12"
      unitRef="usd">-21361000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iebd5d3ab6b5148ef93bef9493a895975_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNC05LTEtMS0yMTE2MQ_f72b2452-b5b8-4118-855f-82c5a5c0010b"
      unitRef="usd">-35466000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNC0xNS0xLTEtMjExNjE_38e12143-40c9-44a0-83ae-cc2cfa5691fd"
      unitRef="usd">-35466000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNS0xLTEtMS0yMTE2MQ_d1bd1f38-5055-42ee-bb5e-d758de5b56ae"
      unitRef="shares">269000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNS0zLTEtMS0yMTE2MQ_074a4e65-2111-449a-9d86-6570e7f9bc12"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic31b11b9e24042e291cfae22df2c5210_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNS01LTEtMS0yMTE2MQ_537496a8-73c6-45db-9fde-223e333e8c69"
      unitRef="usd">9652000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNS0xNS0xLTEtMjExNjE_6da41176-475c-460a-9a5e-60c9ef22dd53"
      unitRef="usd">9654000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNi0xLTEtMS0yMTE2MQ_8df183e1-b549-4d91-aaa0-184738da6277"
      unitRef="shares">149000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNi0zLTEtMS0yMTE2MQ_09bc7473-4194-4146-94ee-a38fc931cdc8"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic31b11b9e24042e291cfae22df2c5210_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNi01LTEtMS0yMTE2MQ_d424646f-739e-4a28-8aa3-94d4ac43c4b9"
      unitRef="usd">1763000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNi0xNS0xLTEtMjExNjE_78f96dbf-79a5-4eb4-b805-efa13b5259bc"
      unitRef="usd">1765000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNy0xLTEtMS0yMTE2MQ_53647e8f-fdd5-48ec-a27e-8c1900316e1b"
      unitRef="shares">95000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNy0zLTEtMS0yMTE2MQ_809091f4-6faa-426b-8592-6c85115fa926"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ic31b11b9e24042e291cfae22df2c5210_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNy01LTEtMS0yMTE2MQ_00914fda-cabc-4a01-a6ea-a3fca7e9dc3d"
      unitRef="usd">1578000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfNy0xNS0xLTEtMjExNjE_625d0b87-bb00-4c0f-a376-b89b1e4eaa40"
      unitRef="usd">1579000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOC0xLTEtMS0yMTE2MQ_1da5cc79-073d-4662-9a0f-1aebdb076408"
      unitRef="shares">94000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="i28f78d09ab10498dabbd1641f39ceaea_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOC0zLTEtMS0yMTE2MQ_116ab782-6e81-4c3a-9e0c-44cab728bd20"
      unitRef="usd">1000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="ic31b11b9e24042e291cfae22df2c5210_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOC01LTEtMS0yMTE2MQ_c5734572-b720-4801-b63e-d71361630d94"
      unitRef="usd">1790000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOC0xNS0xLTEtMjExNjE_da94ba90-a646-44fe-886e-12e70af38729"
      unitRef="usd">1791000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ifb24e4445f234f45bd7b3b6d182b317a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS0xLTEtMS0yMTE2MQ_7d1c78e9-79e2-4697-8c1d-1f7ed61375f8"
      unitRef="shares">41816000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ifb24e4445f234f45bd7b3b6d182b317a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS0zLTEtMS0yMTE2MQ_d489aef7-832d-446a-99c8-5e4ab4e4ce2b"
      unitRef="usd">418000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0ebbddb2f6f04869aef50eed79a94a0a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS01LTEtMS0yMTE2MQ_ae53e06e-ce0e-47cf-8a9c-e6d07df98001"
      unitRef="usd">334077000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1c92a5fd903b49a588c3ceab6bf0fd71_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS03LTEtMS0yMTE2MQ_49c049a7-077a-4ff8-9757-a1f4fcc31221"
      unitRef="usd">-19386000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idcf07ce8eeae433881f120218ee9a339_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS05LTEtMS0yMTE2MQ_ebe0ef38-61a3-4037-bd13-108bbd8e113a"
      unitRef="usd">-45353000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i855b2caffaf74a64b3f2ef74285e23ad_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS0xMS0xLTEtMjExNjE_5dcfab43-46db-436e-94e5-ecb819f1ef03"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i855b2caffaf74a64b3f2ef74285e23ad_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS0xMy0xLTEtMjExNjE_845d1522-0f03-43fb-8ce0-70856956c777"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmQyY2Y2Nzc1NGZkMDQ2MzQ5MGM4MTQ0YzM0MTNkODAyL3RhYmxlcmFuZ2U6ZDJjZjY3NzU0ZmQwNDYzNDkwYzgxNDRjMzQxM2Q4MDJfOS0xNS0xLTEtMjExNjE_1b1c5331-4a45-4573-8514-cb54bb58d641"
      unitRef="usd">255108000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie9e49d8b70744e2291a48074042aac1d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi0xLTEtMS0yMTE2MQ_9ad0fa25-9a5f-434e-8987-fa4bf750361c"
      unitRef="shares">40742000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie9e49d8b70744e2291a48074042aac1d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi0zLTEtMS0yMTE2MQ_4698fa6a-f17d-4e48-b472-a64e524fb1c5"
      unitRef="usd">407000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibd29210f343141e18bac0fa033368edb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi01LTEtMS0yMTE2MQ_4f94a6f7-b487-44f6-a6a6-7e93c82a031f"
      unitRef="usd">305157000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib6cad2dbd6f2405aa20050ef52e24d72_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi03LTEtMS0yMTE2MQ_dbee0e7e-069d-4a7e-a3e6-04f98265697e"
      unitRef="usd">11493000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idc8bf90a94e84b16b4e0133d5e3511c8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi05LTEtMS0yMTE2MQ_e1464268-578b-46d5-98a3-193da30b0627"
      unitRef="usd">-574000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i382d3d021f0e4fc5926b820bd792e570_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi0xMS0xLTEtMjExNjE_cf1c6808-1771-45ec-b922-c29b7bb39ff1"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i382d3d021f0e4fc5926b820bd792e570_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi0xMy0xLTEtMjExNjE_35032822-15fb-46d1-8648-8691e47d79d5"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="ic8fc748ed8cc4d6197311f7f5b70f8b9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMi0xNS0xLTEtMjExNjE_548b3d31-885f-4108-9f4a-3ff65778db38"
      unitRef="usd">301835000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i3d640434e1ec4e1f8bc779369e3c30fc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMy03LTEtMS0yMTE2MQ_04be3321-6144-4b9c-aca9-cb61965762e8"
      unitRef="usd">10582000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfMy0xNS0xLTEtMjExNjE_37e3ba29-8276-4666-8e84-243c4e13dae7"
      unitRef="usd">10582000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i1171158da9d64ea3bb3f8187eeb9bb6a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNC05LTEtMS0yMTE2MQ_56e6cef8-8fd3-474b-8c4a-5e8949bc0ba1"
      unitRef="usd">-5010000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNC0xNS0xLTEtMjExNjE_4832c725-c04c-4068-ad68-effb8ddfbbf7"
      unitRef="usd">-5010000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i7c9e6fcb6b5041a28fcbb938004e223e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNS0xLTEtMS0yMTE2MQ_da14462d-ab8d-4a29-a655-54683fe75c0d"
      unitRef="shares">8000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7c9e6fcb6b5041a28fcbb938004e223e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNS0zLTEtMS0yMTE2MQ_fbc95b30-f152-4d81-8a1a-c59501cc6e37"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i37d952f703594debb99cbb034f182acc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNS01LTEtMS0yMTE2MQ_5d8cb327-6e46-4b22-afc4-1abb79e6ae23"
      unitRef="usd">2990000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNS0xNS0xLTEtMjExNjE_26f273b5-776d-48b4-b5d2-93add6d01fe7"
      unitRef="usd">2991000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7c9e6fcb6b5041a28fcbb938004e223e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNi0xLTEtMS0yMTE2MQ_dafe8861-adb8-4d76-aeab-5297945c636c"
      unitRef="shares">18000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i37d952f703594debb99cbb034f182acc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNi01LTEtMS0yMTE2MQ_8f0a2848-7da4-4cf1-a8f7-ca2e9c3fe69b"
      unitRef="usd">191000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNi0xNS0xLTEtMjExNjE_4b3f9932-cb8a-438d-a748-ecf401f39cfd"
      unitRef="usd">191000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i7c9e6fcb6b5041a28fcbb938004e223e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNy0xLTEtMS0yMTE2MQ_619fe65e-351b-4bc5-81ac-b965bb88d354"
      unitRef="shares">50000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i37d952f703594debb99cbb034f182acc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNy01LTEtMS0yMTE2MQ_7e8b6478-50fd-4b86-9d39-f583b1a94627"
      unitRef="usd">1019000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfNy0xNS0xLTEtMjExNjE_d04f347d-b512-45e5-8c75-fbeeecf2b933"
      unitRef="usd">1019000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="i7c9e6fcb6b5041a28fcbb938004e223e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOC0xLTEtMS0yMTE2MQ_198c6aa5-9cf7-4510-af51-dfa0dadfc845"
      unitRef="shares">2000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="i37d952f703594debb99cbb034f182acc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOC01LTEtMS0yMTE2MQ_559996f9-94f1-4fb6-a66b-50850777aa77"
      unitRef="usd">67000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOC0xNS0xLTEtMjExNjE_f9aea4fc-a26b-41ed-b939-6ef64a3ca07b"
      unitRef="usd">67000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i280bd3e07c864a7c9aaa759e2c9d499a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS0xLTEtMS0yMTE2MQ_81eb62bd-3fc7-40e4-834a-736e26bb02f9"
      unitRef="shares">40816000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i280bd3e07c864a7c9aaa759e2c9d499a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS0zLTEtMS0yMTE2MQ_68dfc2d1-c1ec-4b3c-bd26-067b2c804dc9"
      unitRef="usd">408000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0e85ab3998944bb3b78d14636d55e58c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS01LTEtMS0yMTE2MQ_81f92c72-1bd9-4a6c-8658-a8425d29902e"
      unitRef="usd">309290000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5a36f4d7f25b4eeaa95f908a94d5a7d0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS03LTEtMS0yMTE2MQ_d821360f-2d13-43c8-8ff8-9f23a6153b69"
      unitRef="usd">22075000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if5259bc5ea2d48cfb9c3d8a509a38485_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS05LTEtMS0yMTE2MQ_c0f077fa-5218-4356-9231-e7de4a5740f1"
      unitRef="usd">-5584000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i874eb09dd9e04c1193c970174fefa74c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS0xMS0xLTEtMjExNjE_e0975ac5-0321-4221-8c4e-c75f95421388"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i874eb09dd9e04c1193c970174fefa74c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS0xMy0xLTEtMjExNjE_178b56f9-911c-4652-b295-9b693ac3fcb3"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="idfb7570230e54f50941fc14b31243894_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOmEzNGMyMDkzN2RlYjQyY2U5ZjYzMWU0YzY4ZjM5MzhhL3RhYmxlcmFuZ2U6YTM0YzIwOTM3ZGViNDJjZTlmNjMxZTRjNjhmMzkzOGFfOS0xNS0xLTEtMjExNjE_73282e41-9d44-4a23-b8ee-e05d9a0a05ef"
      unitRef="usd">311541000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6421cdadddcd4de2b8a922abe34ec4d4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi0xLTEtMS0yMTE2MQ_ca4e1de8-197b-49d2-8e07-bfa6d635c6b6"
      unitRef="shares">40394000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i6421cdadddcd4de2b8a922abe34ec4d4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi0zLTEtMS0yMTE2MQ_7ae27756-f88f-4558-92ef-c3608fff86cc"
      unitRef="usd">404000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i34648a7bb99f40b581988c47181998e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi01LTEtMS0yMTE2MQ_108f5ec7-7dfe-42ec-9608-524a229e551e"
      unitRef="usd">316192000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie76736e9a34845c0be39eb23bee21d1d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi03LTEtMS0yMTE2MQ_cfaabf71-89e8-47ff-83d1-81f7149a69dc"
      unitRef="usd">20022000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib3ea81c295134d2a950a870df83c0fc8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi05LTEtMS0yMTE2MQ_1521ded9-0b2e-49d0-8c5a-f44acdcead3a"
      unitRef="usd">6743000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i39b0402fe99e4b81b9cc8baa58b16782_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi0xMS0xLTEtMjExNjE_5cde27e9-815e-4a69-9951-939dfaf1a98a"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i39b0402fe99e4b81b9cc8baa58b16782_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi0xMy0xLTEtMjExNjE_6af734f4-cc86-4f6e-8df1-ac49cfe2f757"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="i02c95f38d9b543ae84f37d41d8baa157_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMi0xNS0xLTEtMjExNjE_31eba2b4-34ac-4fa0-afdb-d796690a3642"
      unitRef="usd">328713000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ib830edf09033428cbcfce9cd0d56ccd3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMy03LTEtMS0yMTE2MQ_cbf4610a-a57e-409d-8cbb-d1bbd40e4706"
      unitRef="usd">5266000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMy0xNS0xLTEtMjExNjE_c0705aad-3307-46d5-92b7-337782098a72"
      unitRef="usd">5266000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="idfcc2e11a6ef41a4bf0b9fc74a0437c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNC05LTEtMS0yMTE2MQ_a476d7c7-785c-4db0-a81d-2e2680e534a7"
      unitRef="usd">-12327000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNC0xNS0xLTEtMjExNjE_6cc843b0-bc0b-4943-827e-eb3b808f7347"
      unitRef="usd">-12327000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i88ff77f1faa34bb5a9274393c266a3c5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNS01LTEtMS0yMTE2MQ_0ef14621-9f7a-4491-ba15-5f980b71c7d8"
      unitRef="usd">-16426000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0c206091bc204dc2a0b88d27cd64ac1c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNS03LTEtMS0yMTE2MQ_6be6cde8-8bcd-4e1b-8b96-a1ecc65b8853"
      unitRef="usd">-3213000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia34aaa5e1fdf43c6976074120b87cf65_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNS0xNS0xLTEtMjExNjE_8b5974b7-cc10-408b-b94b-61a2a3391f64"
      unitRef="usd">-19639000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNi0xLTEtMS0yMTE2MQ_ec534b3a-b164-4ecb-8e21-3d93ebe0ff34"
      unitRef="shares">252000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNi0zLTEtMS0yMTE2MQ_35f54bdf-183b-464a-be70-770cab9a4cc3"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4bb844b6a956440a8c40b76f8ef5e9ad_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNi01LTEtMS0yMTE2MQ_d46a097b-4415-4846-a1ae-d02322fca90e"
      unitRef="usd">7892000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNi0xNS0xLTEtMjExNjE_ec019366-9aa9-4a71-b0c8-1f7906f20cc2"
      unitRef="usd">7895000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNy0xLTEtMS0yMTE2MQ_6490c6b7-5477-4cf2-be29-27e260878f44"
      unitRef="shares">158000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNy0zLTEtMS0yMTE2MQ_89b1dacf-914b-46b9-a319-a576a98013bf"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4bb844b6a956440a8c40b76f8ef5e9ad_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNy01LTEtMS0yMTE2MQ_60be776b-ec42-473c-91fa-900f88d9fb4d"
      unitRef="usd">1921000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfNy0xNS0xLTEtMjExNjE_21afc4c3-6118-427b-a5c5-0dda1ba64870"
      unitRef="usd">1922000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOC0xLTEtMS0yMTE2MQ_ff67220c-4ffa-4b4a-b73b-f88fbb14ae87"
      unitRef="shares">87000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOC0zLTEtMS0yMTE2MQ_ccfc1ddf-9330-4f3d-b9f0-5bb67fdc9495"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4bb844b6a956440a8c40b76f8ef5e9ad_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOC01LTEtMS0yMTE2MQ_514e2b07-7b7a-4f50-b562-4101c3403cc4"
      unitRef="usd">1608000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOC0xNS0xLTEtMjExNjE_e622c485-551d-4311-921e-e8cdef1d31de"
      unitRef="usd">1609000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOS0xLTEtMS0yMTE2MQ_0b4e073a-8863-4295-8ba5-c65ba247d0c2"
      unitRef="shares">75000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="i53f2fb2d31264673a42ebfbefb9cb098_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOS0zLTEtMS0yMTE2MQ_a8400146-3c6b-4753-aac4-0b0a8239376d"
      unitRef="usd">1000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="i4bb844b6a956440a8c40b76f8ef5e9ad_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOS01LTEtMS0yMTE2MQ_f65ab4cf-450c-4463-a6ba-9dd36eafadc8"
      unitRef="usd">1897000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfOS0xNS0xLTEtMjExNjE_81c5710e-a558-46b2-b8c4-67e53b9915ed"
      unitRef="usd">1898000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i280bd3e07c864a7c9aaa759e2c9d499a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtMS0xLTEtMjExNjE_3e1b9951-72d8-4f1d-9118-aa7f36c6deda"
      unitRef="shares">40816000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i280bd3e07c864a7c9aaa759e2c9d499a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtMy0xLTEtMjExNjE_7060be81-28bc-4097-b9b9-21550691fd42"
      unitRef="usd">408000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0e85ab3998944bb3b78d14636d55e58c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtNS0xLTEtMjExNjE_d3405e2a-3cbb-4e92-b885-6123fe9a9d5f"
      unitRef="usd">309290000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5a36f4d7f25b4eeaa95f908a94d5a7d0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtNy0xLTEtMjExNjE_cc4a2d11-a450-464d-b1b1-a1f1a8b29722"
      unitRef="usd">22075000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if5259bc5ea2d48cfb9c3d8a509a38485_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtOS0xLTEtMjExNjE_cfe47f0b-9c04-48a5-8cbe-bb949063f236"
      unitRef="usd">-5584000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i874eb09dd9e04c1193c970174fefa74c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtMTEtMS0xLTIxMTYx_9c62ce4d-75d2-49a0-9b16-e81fea132472"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i874eb09dd9e04c1193c970174fefa74c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtMTMtMS0xLTIxMTYx_a714f82f-2505-40e9-9344-a1e553546a59"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="idfb7570230e54f50941fc14b31243894_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8yNS9mcmFnOjU1YTQ3YTcyNWZhMzQ3ZGFhM2Y5ZGFmNzQ2MDlhMDFlL3RhYmxlOjI5N2IwZTAxYTlhMjRjYTE4MjI5OTM1M2I0ODM5MDhkL3RhYmxlcmFuZ2U6Mjk3YjBlMDFhOWEyNGNhMTgyMjk5MzUzYjQ4MzkwOGRfMTAtMTUtMS0xLTIxMTYx_b5903e87-ef36-43a1-ab09-340a59625a90"
      unitRef="usd">311541000</us-gaap:StockholdersEquity>
    <us-gaap:BasisOfAccounting
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zMS9mcmFnOmMzNGY4MjI0NTI4NzRmYTBiNTI1MjVjMjhkODdmOTU0L3RleHRyZWdpb246YzM0ZjgyMjQ1Mjg3NGZhMGI1MjUyNWMyOGQ4N2Y5NTRfNDE5Nw_d4493cab-f5ff-4550-9d67-6c8e9e28fd51">Basis of Presentation and Summary of Significant Accounting Policies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements include the accounts of Artivion, Inc. and its subsidiaries (&#x201c;Artivion,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; or &#x201c;us&#x201d;). All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying Condensed Consolidated Balance Sheet as of December&#160;31, 2021 has been derived from audited financial statements. The accompanying unaudited Condensed Consolidated Financial Statements as of, and for the three and nine months ended, September&#160;30, 2022 and 2021 have been prepared in accordance with (i) accounting principles generally accepted in the US for interim financial information and (ii) the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the US Securities and Exchange Commission (the &#x201c;SEC&#x201d;). Accordingly, such statements do not include all the information and disclosures that are required by accounting principles generally accepted in the US for a complete presentation of financial statements. In the opinion of management, all adjustments (including those of a normal, recurring nature) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. These Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes included in Artivion&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 filed with the SEC on February&#160;22, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of our significant accounting policies is included in Note 1 of the &#x201c;Notes to Consolidated Financial Statements&#x201d; contained in our Form 10-K for the year ended December&#160;31, 2021. Management believes that the consistent application of these policies enables us to provide users of the financial statements with useful and reliable information about our operating results and financial condition. The Condensed Consolidated Financial Statements are prepared in accordance with accounting principles generally accepted in the US, which require us to make estimates and assumptions. We did not experience any significant changes during the three and nine months ended September&#160;30, 2022 in any of our Significant Accounting Policies from those contained in our Form 10-K for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020 the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standard Update (&#x201c;ASU&#x201d;) Update No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2020-06&#x201d;). The update simplifies the accounting for convertible instruments by eliminating two accounting models (i.e., the cash conversion model and beneficial conversion feature model) and reducing the number of embedded conversion features that could be recognized separately from the host contract. ASU 2020-06 also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. On January 1, 2021 we adopted ASU 2020-06 using the modified retrospective approach. See Note 9 for further discussion of convertible debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Not Yet Effective &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020 the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform Topic 848&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 848&#x201d;). The amendments in this ASU were put forth in response to the market transition from the LIBOR and other interbank offered rates to alternative reference rates. Accounting principles generally accepted in the United States of America require entities to evaluate whether a contract modification, such as the replacement or change of a reference rate, results in the establishment of a new contract or continuation of an existing contract. ASC 848 allows an entity to elect not to apply certain modification accounting requirements to contracts affected by reference rate reform. The standard provides this temporary election through December&#160;31, 2022 and cannot be applied to contract modifications that occur after December&#160;31, 2022. &lt;/span&gt;We are in the process of evaluating the effect that the adoption of this standard will have on our financial position and results of operations.</us-gaap:BasisOfAccounting>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zMS9mcmFnOmMzNGY4MjI0NTI4NzRmYTBiNTI1MjVjMjhkODdmOTU0L3RleHRyZWdpb246YzM0ZjgyMjQ1Mjg3NGZhMGI1MjUyNWMyOGQ4N2Y5NTRfNDE5Ng_393f4a9a-79f8-4877-95b0-ccf8e431b1ef">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020 the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standard Update (&#x201c;ASU&#x201d;) Update No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2020-06&#x201d;). The update simplifies the accounting for convertible instruments by eliminating two accounting models (i.e., the cash conversion model and beneficial conversion feature model) and reducing the number of embedded conversion features that could be recognized separately from the host contract. ASU 2020-06 also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. On January 1, 2021 we adopted ASU 2020-06 using the modified retrospective approach. See Note 9 for further discussion of convertible debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Not Yet Effective &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020 the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform Topic 848&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 848&#x201d;). The amendments in this ASU were put forth in response to the market transition from the LIBOR and other interbank offered rates to alternative reference rates. Accounting principles generally accepted in the United States of America require entities to evaluate whether a contract modification, such as the replacement or change of a reference rate, results in the establishment of a new contract or continuation of an existing contract. ASC 848 allows an entity to elect not to apply certain modification accounting requirements to contracts affected by reference rate reform. The standard provides this temporary election through December&#160;31, 2022 and cannot be applied to contract modifications that occur after December&#160;31, 2022. &lt;/span&gt;We are in the process of evaluating the effect that the adoption of this standard will have on our financial position and results of operations.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzEwOTk1MTE2MzI3NTY_1d1c9feb-9a72-4776-b76e-639dce424dcd">Sale of PerClot&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 28, 2021 we entered into an asset purchase agreement and other ancillary agreements related to the sale of PerClot&#xae;, a polysaccharide hemostatic agent used in surgery (&#x201c;PerClot&#x201d;), to a subsidiary of Baxter International, Inc. (&#x201c;Baxter&#x201d;) and an agreement to terminate all of our material agreements with Starch Medical, Inc. (&#x201c;SMI&#x201d;) related to PerClot (collectively the &#x201c;Baxter Transaction&#x201d;). Under the terms of the Baxter Transaction, Baxter will pay an aggregate of up to $60.8 million in consideration (we will receive up to $45.8 million and SMI will receive up to $15.0 million), consisting of (i) $25.0 million at closing, of which $6.0 million was paid to SMI; (ii) up to $25.0 million upon our receipt of Premarket Approval (&#x201c;PMA&#x201d;) approval from the US Food and Drug Administration (the &#x201c;FDA&#x201d;) for PerClot and our transfer of the PMA to Baxter, of which up to $6.0 million is payable to SMI, subject to certain reductions for delay in PMA approval; and (iii) up to $10.0 million upon Baxter&#x2019;s achievement of certain cumulative worldwide net sales of PerClot prior to December 31, 2026 and December 31, 2027, of which up to $3.0 million is payable to SMI. In addition, at the conclusion of our manufacturing and supply services for Baxter, Baxter will pay $780,000 upon transfer of our PerClot manufacturing equipment. Under the terms of the Baxter Transaction, we will continue to provide to Baxter certain transition and manufacturing and supply services relating to the sale of SMI PerClot outside of the US and manufacture and supply of PerClot to Baxter post PMA approval.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for the Transaction&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon closing of the Baxter Transaction, we received $25.0 million from Baxter and paid $6.0 million to SMI. We derecognized intangible assets with a carrying value of $1.6 million and wrote-off $1.5 million of prepaid royalties previously recorded on our Condensed Consolidated Balance Sheets related to PerClot. Under the terms of the agreement, Baxter acquired intellectual property related to our development efforts for PerClot. We recorded a pre-tax gain of $15.9 million, included as Gain from sale of non-financial assets within the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2021. The PerClot product line was included as part of our Medical Devices segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i93965fb5672a40aaa73943e5e32c7968_I20210728"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxNDY_5f88d329-c644-4d38-8d1a-86c7ac5c5a6f"
      unitRef="usd">60800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="if7419f77f0164d6e8bbfd14061a58dc8_I20210728"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxNTQ_7aa3ec57-d92e-4caf-8015-a8a299c18c13"
      unitRef="usd">45800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i6db073c52b794f6f9307cf9c09aa6840_I20210728"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxNjI_56095147-d787-40a6-a0f5-8eee4655c000"
      unitRef="usd">15000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i474797d7697b4b30bbed0e1b1e4c0c1f_D20210728-20210728"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxNzA_0574bdf1-7795-49f7-ac23-df66b89dfb5b"
      unitRef="usd">25000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="ic8c37cb40b344c3fba9bdc98b545a5de_D20210728-20210728"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxNzg_eb3270e4-8062-4d78-a16d-4edd823ba47f"
      unitRef="usd">6000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable
      contextRef="i1e2e38f130ed4105acb2e32af2c464db_I20210728"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxODY_69604dd6-5eaa-4220-afe3-3e286f693444"
      unitRef="usd">25000000</aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable>
    <aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable
      contextRef="ieec45bdddc8041219cabad03cec97440_I20210728"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAxOTQ_a9210058-27c9-4abd-bd64-82b73591e071"
      unitRef="usd">6000000</aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable>
    <aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable
      contextRef="i377d4fb97be743429e52f8c0cf18419e_I20210728"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyMDI_7331ec2e-44e5-47bb-8ad6-5c17cc649f50"
      unitRef="usd">10000000</aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable>
    <aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable
      contextRef="ic721009275b44299b76bee3aab313494_I20210728"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyMTA_d9e65a21-8d65-4f54-a798-a069319e22d4"
      unitRef="usd">3000000</aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable>
    <aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable
      contextRef="iea42e8fd134e416a8ca4bf1b048423f4_I20210728"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyMjA_ae2501ec-2c3e-4fdd-b2c6-5be9ba865ccb"
      unitRef="usd">780000</aort:DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i474797d7697b4b30bbed0e1b1e4c0c1f_D20210728-20210728"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyMzI_0574bdf1-7795-49f7-ac23-df66b89dfb5b"
      unitRef="usd">25000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="ic8c37cb40b344c3fba9bdc98b545a5de_D20210728-20210728"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyNDA_eb3270e4-8062-4d78-a16d-4edd823ba47f"
      unitRef="usd">6000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
      contextRef="if7419f77f0164d6e8bbfd14061a58dc8_I20210728"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyNDg_e0a8ef19-8699-4c26-b75c-2c73394051c7"
      unitRef="usd">1600000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i3c6ab9a4a9c64f29a055949f7555bfee_D20210728-20210728"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyNTY_7460abf8-ec61-448e-a433-bc4ebafa677e"
      unitRef="usd">1500000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i3c6ab9a4a9c64f29a055949f7555bfee_D20210728-20210728"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80NzYvZnJhZzoyYzVhNDA5OTJhODI0MWVhYWY4MWE4NDU0ZGJmOWQ3Yy90ZXh0cmVnaW9uOjJjNWE0MDk5MmE4MjQxZWFhZjgxYTg0NTRkYmY5ZDdjXzcxNDY4MjU1OTAyNjQ_03dcfed6-2332-4e4c-83ca-1d5d3583a6da"
      unitRef="usd">15900000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjkzMQ_35afa3ae-b11e-4680-99eb-6074c2802e65">Financial Instruments&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our financial instruments measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(44,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(44,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,015&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,015&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(49,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(49,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We used prices quoted from our investment advisors to determine the Level 1 valuation of our investments in money market funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;2, 2020 we entered into a Securities Purchase Agreement to acquire 100% of the outstanding equity interests of Ascyrus Medical LLC (&#x201c;Ascyrus&#x201d;). Ascyrus developed the AMDS, the world&#x2019;s first aortic arch remodeling device for use in the treatment of acute Type A aortic dissections. As part of the acquisition, we may be required to pay additional consideration in cash of up to $100.0 million to the former shareholders of Ascyrus upon the achievement of certain milestones and the sales-based additional earn-out. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent consideration represents the estimated fair value of future potential payments. The fair value of the contingent consideration liability was estimated by discounting to present value the contingent payments expected to be made based on a probability-weighted scenario approach. We applied a discount rate based on our unsecured credit spread and the term commensurate risk-free rate to the additional consideration to be paid, and then applied a risk-based estimate of the probability of achieving each scenario to calculate the fair value of the contingent consideration. This fair value measurement was based on unobservable inputs, including management estimates and assumptions about the future achievement of milestones and future estimate of revenues, and is, therefore, classified as Level 3 within the fair value hierarchy. We used a discount rate of approximately 13% and estimated future achievement of milestone dates between 2025 and 2026 to calculate the fair value of contingent consideration as of September&#160;30, 2022. We will remeasure this liability at each reporting date and will record changes in the fair value of the contingent consideration in General, administrative, and marketing expenses on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. Increases or decreases in the fair value of the contingent consideration liability can result from changes in passage of time, discount rates, the timing and amount of our revenue estimates, and the timing and expectation of regulatory approvals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We performed an assessment of the fair value of the contingent consideration and recorded expense of $400,000 and income of $4.6 million for the three and nine months ended September&#160;30, 2022, respectively, and expense of $700,000 and $5.0 million for the three and nine months ended September&#160;30, 2021, respectively, in General, administrative, and marketing expenses on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income, as a result of this assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the contingent consideration component of the Ascyrus acquisition was updated using Level 3 inputs. Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(44,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjkzMg_0b623d3b-54f0-4922-a3df-a216047533b1">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our financial instruments measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(44,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(44,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,015&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,015&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(49,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(49,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i950e76f991cb4fe09eff1721971650dd_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMi0yLTEtMS0yMTE2MQ_bf1f68fc-f8c8-401a-ada5-e126799d3fd4"
      unitRef="usd">10051000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iec9b82a7f6604a2bbbe148b7d4abe182_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMi00LTEtMS0yMTE2MQ_12517dc8-c756-49aa-b255-baa024d0c609"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6bf831653ca749c6acafb610a2e28758_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMi02LTEtMS0yMTE2MQ_d8dcc448-998e-4ae4-abb9-114e81e8b6b4"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7e42ab1c54464099a18768bdfff45114_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMi04LTEtMS0yMTE2MQ_e06582fa-245e-47c9-8b69-f5884e1f2392"
      unitRef="usd">10051000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8204321837cc4faeaa2f049f14c3892b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMy0yLTEtMS0yMTE2MQ_572dfeaa-669f-492c-affe-5e1b2dc6131a"
      unitRef="usd">10051000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6561a8259c80412f9d65d166fc210a1a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMy00LTEtMS0yMTE2MQ_a04590c9-34ae-4d39-b9f9-5e89b48e1d9b"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7196597c5deb49e1bb184bfb4947a913_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMy02LTEtMS0yMTE2MQ_1c152f17-8e65-4b79-abce-70a31b45dff0"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfMy04LTEtMS0yMTE2MQ_9579032c-ab45-4bef-b3a5-24b3c28e006f"
      unitRef="usd">10051000</us-gaap:AssetsFairValueDisclosure>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="i8204321837cc4faeaa2f049f14c3892b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNi0yLTEtMS0yMTE2MQ_89470468-221a-4eca-93b6-66909c8cd3c6"
      unitRef="usd">0</aort:ContingentConsiderationNoncurrentFairValue>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="i6561a8259c80412f9d65d166fc210a1a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNi00LTEtMS0yMTE2MQ_136825d6-a256-4082-a1ec-8fdbb0b078fd"
      unitRef="usd">0</aort:ContingentConsiderationNoncurrentFairValue>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="i7196597c5deb49e1bb184bfb4947a913_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNi02LTEtMS0yMTE2MQ_bbfb52dd-5d2a-44ec-851f-141cd07e434e"
      unitRef="usd">44800000</aort:ContingentConsiderationNoncurrentFairValue>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNi04LTEtMS0yMTE2MQ_278d4c3a-81a0-4a75-83c3-4baee1d93c0b"
      unitRef="usd">44800000</aort:ContingentConsiderationNoncurrentFairValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8204321837cc4faeaa2f049f14c3892b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNy0yLTEtMS0yMTE2MQ_c1884402-0ced-40e4-880b-89eb0c622409"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6561a8259c80412f9d65d166fc210a1a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNy00LTEtMS0yMTE2MQ_ba84e6a3-028b-44ad-b594-19a22d5ccd4d"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7196597c5deb49e1bb184bfb4947a913_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNy02LTEtMS0yMTE2MQ_57b1735d-7d31-4ac3-af7b-3204ed5a9ecd"
      unitRef="usd">44800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmE4YzVmNjVhNjFmMDRlNjNiMWQwYmZjOGUxMTZiOGMzL3RhYmxlcmFuZ2U6YThjNWY2NWE2MWYwNGU2M2IxZDBiZmM4ZTExNmI4YzNfNy04LTEtMS0yMTE2MQ_6d99e362-f78b-4991-84d6-675a6498c003"
      unitRef="usd">44800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i1dc99e11cae64b9ea4455cb43369f79c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMi0yLTEtMS0yMTE2MQ_ef81dc56-99e8-4daf-baeb-71631dffcc4c"
      unitRef="usd">10015000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iab3c1df5f3a046efb727e88f49e41f79_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMi00LTEtMS0yMTE2MQ_135b560a-b983-45e8-81d3-e077eb7cf325"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic70a37d9dc5d47ff92c7cf4a36a1f693_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMi02LTEtMS0yMTE2MQ_515b0ee9-7626-437a-8801-9dd485b16b01"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iedfc3424257043348e41663c5bdc6fd2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMi04LTEtMS0yMTE2MQ_47ca99a5-9da9-4633-960c-a99290138ee0"
      unitRef="usd">10015000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib7748b61019a4fd4a51f83204e8a357b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMy0yLTEtMS0yMTE2MQ_062fafe6-d529-4115-9da3-5524592ddfb9"
      unitRef="usd">10015000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1f304425672d48179954b9c1f45b94c7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMy00LTEtMS0yMTE2MQ_d5add3b3-bfcb-4a48-85d0-5e79ccde9c3f"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i81cb3cd3d95849408779cbf36a73bfc6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMy02LTEtMS0yMTE2MQ_de735c21-9278-4c54-9c3c-3c01b8b6ff17"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfMy04LTEtMS0yMTE2MQ_38c40c75-19d1-4b25-a313-f0cb1ef637ec"
      unitRef="usd">10015000</us-gaap:AssetsFairValueDisclosure>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="ib7748b61019a4fd4a51f83204e8a357b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNi0yLTEtMS0yMTE2MQ_fb359734-f02d-4bdb-8b00-1f33fb3cf36d"
      unitRef="usd">0</aort:ContingentConsiderationNoncurrentFairValue>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="i1f304425672d48179954b9c1f45b94c7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNi00LTEtMS0yMTE2MQ_39d88226-3121-4ae9-ad91-a29fecadf16c"
      unitRef="usd">0</aort:ContingentConsiderationNoncurrentFairValue>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="i81cb3cd3d95849408779cbf36a73bfc6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNi02LTEtMS0yMTE2MQ_28c486f3-3904-4ee6-8e69-dd8ae34e8e7f"
      unitRef="usd">49400000</aort:ContingentConsiderationNoncurrentFairValue>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNi04LTEtMS0yMTE2MQ_54bb6fbb-dd9d-4c15-887b-9434ff66844f"
      unitRef="usd">49400000</aort:ContingentConsiderationNoncurrentFairValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib7748b61019a4fd4a51f83204e8a357b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNy0yLTEtMS0yMTE2MQ_05ff1729-27e5-404e-a0e0-a8b7d2692c6c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1f304425672d48179954b9c1f45b94c7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNy00LTEtMS0yMTE2MQ_b1a94e7f-6c6c-432b-a1b5-2edae3cf8bb2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i81cb3cd3d95849408779cbf36a73bfc6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNy02LTEtMS0yMTE2MQ_b8a66f97-4e40-4ce8-a357-4e00c26dde7e"
      unitRef="usd">49400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmQwNzQ1MGMyMjE2NTQyYmRhYjA5OWUwYjdjOGZiZWJmL3RhYmxlcmFuZ2U6ZDA3NDUwYzIyMTY1NDJiZGFiMDk5ZTBiN2M4ZmJlYmZfNy04LTEtMS0yMTE2MQ_cf71d80b-272e-47cf-8ea9-af39003550f6"
      unitRef="usd">49400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i6525e7731ff74ad0828ab59973e96ed9_I20200902"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMzQz_2bae9dfd-1795-4964-a576-9ef1399d13fe"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i6525e7731ff74ad0828ab59973e96ed9_I20200902"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfNjUx_33f0e4af-fe88-405c-9b6d-c3f128352124"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i0da58d4628e84024a2ac81e40f54f818_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMTY2NQ_1b109f82-0016-42a8-a888-8efefb2568c9"
      unitRef="number">0.13</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id93794b724d14804926854714e119380_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjQyMA_62e07e4f-21d2-4c8b-8fb5-df52b46199bc"
      unitRef="usd">-400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i260c7a4a20d1487d8c43eb7ccdbcf577_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjQyNw_57e256d4-a255-4b63-a667-509096df4887"
      unitRef="usd">4600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4a6f190d5fa245329e12192250fb7f35_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjQ4Nw_3ae99122-7563-4ab8-8b03-e69c4f8ae8d1"
      unitRef="usd">-700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ie7832872936b4b9fb5d8ab87dfa734ae_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjQ5NA_d7b06d38-b367-4d31-b8db-7896aba64ef5"
      unitRef="usd">-5000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RleHRyZWdpb246N2VkMDdjYWFmNDM5NDRmNGIwMjIwN2I5NDY0ZjY4YjZfMjkzMw_898f87e8-6b92-479c-b7be-2a5b184ff35c">Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(44,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmI2YjY2MWI4ZDk1ZTRjZTk5Y2I0ZWZlZjFlYWUzZWUxL3RhYmxlcmFuZ2U6YjZiNjYxYjhkOTVlNGNlOTljYjRlZmVmMWVhZTNlZTFfMS0xLTEtMS0yMTE2MQ_91a4d4e5-b7ab-4e6c-a34a-c6a84f5b04e5"
      unitRef="usd">49400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmI2YjY2MWI4ZDk1ZTRjZTk5Y2I0ZWZlZjFlYWUzZWUxL3RhYmxlcmFuZ2U6YjZiNjYxYjhkOTVlNGNlOTljYjRlZmVmMWVhZTNlZTFfMi0xLTEtMS0yMTE2MQ_bed41ac4-cc1a-4ebd-bce6-9f1af50e55fb"
      unitRef="usd">-4600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNC9mcmFnOjdlZDA3Y2FhZjQzOTQ0ZjRiMDIyMDdiOTQ2NGY2OGI2L3RhYmxlOmI2YjY2MWI4ZDk1ZTRjZTk5Y2I0ZWZlZjFlYWUzZWUxL3RhYmxlcmFuZ2U6YjZiNjYxYjhkOTVlNGNlOTljYjRlZmVmMWVhZTNlZTFfMy0xLTEtMS0yMTE2MQ_d3840702-7708-4710-84cc-57212d7246ca"
      unitRef="usd">44800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RleHRyZWdpb246MjRjNGIxNmUwNzNiNDE4ZDg0ZmZkMmQ4OTEwYmFjMzRfMTkx_04e18fcb-d31c-472d-9dd9-78cf8ea43003">Cash Equivalents &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of cash equivalents (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost Basis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Holding&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost Basis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Holding&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,015&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,015&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;There were no gross realized gains or losses on cash equivalents for the three and nine months ended September&#160;30, 2022 and 2021.</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RleHRyZWdpb246MjRjNGIxNmUwNzNiNDE4ZDg0ZmZkMmQ4OTEwYmFjMzRfMTky_1ce62adf-cbbd-4773-8c71-e410f4f8705a">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of cash equivalents (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost Basis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Holding&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost Basis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Holding&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,015&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,015&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i8491b725aa2a46399318dc2aa090e37e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOmJhOGViYTJhODIyYjQzODRhNzdlYTIwMmRmOTgzYmEzL3RhYmxlcmFuZ2U6YmE4ZWJhMmE4MjJiNDM4NGE3N2VhMjAyZGY5ODNiYTNfMi0yLTEtMS0yMTE2MQ_f337dc80-6453-46a1-8726-94f25608fa69"
      unitRef="usd">10051000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="ie18a5ff4b2e4444f818e82a116bbe4cf_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOmJhOGViYTJhODIyYjQzODRhNzdlYTIwMmRmOTgzYmEzL3RhYmxlcmFuZ2U6YmE4ZWJhMmE4MjJiNDM4NGE3N2VhMjAyZGY5ODNiYTNfMi00LTEtMS0yMTE2MQ_5946cb7d-211c-4791-947a-9eb3c570f13b"
      unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i8491b725aa2a46399318dc2aa090e37e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOmJhOGViYTJhODIyYjQzODRhNzdlYTIwMmRmOTgzYmEzL3RhYmxlcmFuZ2U6YmE4ZWJhMmE4MjJiNDM4NGE3N2VhMjAyZGY5ODNiYTNfMi02LTEtMS0yMTE2MQ_709dacaf-7a66-44d0-a447-d64ed0e43cca"
      unitRef="usd">10051000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOmJhOGViYTJhODIyYjQzODRhNzdlYTIwMmRmOTgzYmEzL3RhYmxlcmFuZ2U6YmE4ZWJhMmE4MjJiNDM4NGE3N2VhMjAyZGY5ODNiYTNfMy0yLTEtMS0yMTE2MQ_b54c7d8e-f27b-41e5-9a10-58c9db893cb5"
      unitRef="usd">10051000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOmJhOGViYTJhODIyYjQzODRhNzdlYTIwMmRmOTgzYmEzL3RhYmxlcmFuZ2U6YmE4ZWJhMmE4MjJiNDM4NGE3N2VhMjAyZGY5ODNiYTNfMy00LTEtMS0yMTE2MQ_3b527a3e-ebae-4da6-b715-bc3b71a81bf4"
      unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOmJhOGViYTJhODIyYjQzODRhNzdlYTIwMmRmOTgzYmEzL3RhYmxlcmFuZ2U6YmE4ZWJhMmE4MjJiNDM4NGE3N2VhMjAyZGY5ODNiYTNfMy02LTEtMS0yMTE2MQ_652a9ba8-e4b6-4ad2-a0b2-45286669806c"
      unitRef="usd">10051000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i47ea06876fd54ecdab5ff8648c2c9200_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOjVmZjM5Nzg1NzJkMTQ5NmU5ODQ3NmQwMzMzZjU3YjYyL3RhYmxlcmFuZ2U6NWZmMzk3ODU3MmQxNDk2ZTk4NDc2ZDAzMzNmNTdiNjJfMi0yLTEtMS0yMTE2MQ_e662031e-5fe4-4165-83e6-7dc89303c919"
      unitRef="usd">10015000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="ic210a1a5c32344f8a0d5bb24192cd622_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOjVmZjM5Nzg1NzJkMTQ5NmU5ODQ3NmQwMzMzZjU3YjYyL3RhYmxlcmFuZ2U6NWZmMzk3ODU3MmQxNDk2ZTk4NDc2ZDAzMzNmNTdiNjJfMi00LTEtMS0yMTE2MQ_3e460ba6-92a9-4169-9b3c-47f913efed6f"
      unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i47ea06876fd54ecdab5ff8648c2c9200_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOjVmZjM5Nzg1NzJkMTQ5NmU5ODQ3NmQwMzMzZjU3YjYyL3RhYmxlcmFuZ2U6NWZmMzk3ODU3MmQxNDk2ZTk4NDc2ZDAzMzNmNTdiNjJfMi02LTEtMS0yMTE2MQ_d511eca0-5caa-47ab-b95d-4057d2150d95"
      unitRef="usd">10015000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOjVmZjM5Nzg1NzJkMTQ5NmU5ODQ3NmQwMzMzZjU3YjYyL3RhYmxlcmFuZ2U6NWZmMzk3ODU3MmQxNDk2ZTk4NDc2ZDAzMzNmNTdiNjJfMy0yLTEtMS0yMTE2MQ_2fd56ad4-0bdd-4229-ba1a-69dbf516ce52"
      unitRef="usd">10015000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i92f2162a5f2c42d99bb26f8349f42660_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOjVmZjM5Nzg1NzJkMTQ5NmU5ODQ3NmQwMzMzZjU3YjYyL3RhYmxlcmFuZ2U6NWZmMzk3ODU3MmQxNDk2ZTk4NDc2ZDAzMzNmNTdiNjJfMy00LTEtMS0yMTE2MQ_db7e9c8e-668e-4623-ae7d-31de1b21626c"
      unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RhYmxlOjVmZjM5Nzg1NzJkMTQ5NmU5ODQ3NmQwMzMzZjU3YjYyL3RhYmxlcmFuZ2U6NWZmMzk3ODU3MmQxNDk2ZTk4NDc2ZDAzMzNmNTdiNjJfMy02LTEtMS0yMTE2MQ_a9ae0e9e-87f3-46e0-b6ba-27d183a420c4"
      unitRef="usd">10015000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RleHRyZWdpb246MjRjNGIxNmUwNzNiNDE4ZDg0ZmZkMmQ4OTEwYmFjMzRfMTA0_35336718-a400-4a86-aa36-09c2982672ef"
      unitRef="usd">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RleHRyZWdpb246MjRjNGIxNmUwNzNiNDE4ZDg0ZmZkMmQ4OTEwYmFjMzRfMTA0_3f061c26-630d-4e07-84ed-12dea4b58ffb"
      unitRef="usd">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RleHRyZWdpb246MjRjNGIxNmUwNzNiNDE4ZDg0ZmZkMmQ4OTEwYmFjMzRfMTA0_7a111df5-7622-4727-bb35-477af1c66860"
      unitRef="usd">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV8zNy9mcmFnOjI0YzRiMTZlMDczYjQxOGQ4NGZmZDJkODkxMGJhYzM0L3RleHRyZWdpb246MjRjNGIxNmUwNzNiNDE4ZDg0ZmZkMmQ4OTEwYmFjMzRfMTA0_fa8e353c-c42a-4d61-85dc-db1acfc12ef3"
      unitRef="usd">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfOTI1_1ad61947-a517-4fe9-9e22-20f99460dc05">Inventories, net and Deferred Preservation Costs &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories at September&#160;30, 2022 and December&#160;31, 2021 were comprised of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.881%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total inventories, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;76,971&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To facilitate product usage, we maintain consignment inventory of our On-X heart valves at domestic hospital locations and On-X heart valves and aortic stent grafts at international hospital locations. We retain title and control over this consignment inventory until the device is implanted, at which time we invoice the hospital and recognize revenue. As of September&#160;30, 2022 we had $13.2 million in consignment inventory, with approximately 39% in domestic locations and 61% in international locations. As of December&#160;31, 2021 we had $12.9 million in consignment inventory, with approximately 43% in domestic locations and 57% in international locations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deferred preservation costs were $45.5 million and $42.9 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory and deferred preservation costs obsolescence reserves were $1.9 million and $3.2 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfOTI2_3118ce58-3a33-4d5b-87ec-9b36f666935c">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories at September&#160;30, 2022 and December&#160;31, 2021 were comprised of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.881%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total inventories, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;76,971&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfMS0xLTEtMS0yMTE2MQ_80bf16fe-5dff-4f3b-adc3-2bc4cb7cc85e"
      unitRef="usd">35206000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfMS0zLTEtMS0yMTE2MQ_e628c321-2b5c-43c2-8b95-4c09d610ccf5"
      unitRef="usd">35780000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfMi0xLTEtMS0yMTE2MQ_7e80d0aa-0d27-444c-ba29-510e40e2654f"
      unitRef="usd">11976000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfMi0zLTEtMS0yMTE2MQ_23860bb0-f0b8-4aac-b26e-298bf4270ed3"
      unitRef="usd">9712000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfMy0xLTEtMS0yMTE2MQ_51810796-7d44-4b1e-9f0c-2d3ed60b9fb4"
      unitRef="usd">25862000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfMy0zLTEtMS0yMTE2MQ_43e8bc18-7f35-4cec-a7a8-9654223a5be7"
      unitRef="usd">31479000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfNC0xLTEtMS0yMTE2MQ_416cb7b3-c7bb-4036-9690-f265d5407d7b"
      unitRef="usd">73044000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RhYmxlOjNjN2VmZDRlOGZmYTQ2MmRiYWVjNzM2Zjg5YzZmNDIwL3RhYmxlcmFuZ2U6M2M3ZWZkNGU4ZmZhNDYyZGJhZWM3MzZmODljNmY0MjBfNC0zLTEtMS0yMTE2MQ_7b9ef9ac-792d-4394-b2a7-59902ccc7b80"
      unitRef="usd">76971000</us-gaap:InventoryNet>
    <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNTA0_4b31f561-5808-4317-82ec-e0bf8a558688"
      unitRef="usd">13200000</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment>
    <aort:ConsignmentInventoryPercentage
      contextRef="ic5f9cb6f422b426ea46da0e9c04c8488_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNTUy_44779586-8077-4424-93ab-3c58c9e8fe53"
      unitRef="number">0.39</aort:ConsignmentInventoryPercentage>
    <aort:ConsignmentInventoryPercentage
      contextRef="i5bf438e13a654ecf8c83a67427ed9c00_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNTgx_24be7b66-e853-4240-8e3c-51dc0c9a3a20"
      unitRef="number">0.61</aort:ConsignmentInventoryPercentage>
    <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNjI4_df0b5e5e-7be9-4b17-923b-b96f5f77c8a5"
      unitRef="usd">12900000</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment>
    <aort:ConsignmentInventoryPercentage
      contextRef="iedf397d3ddca43f3bc7c0be07a26764c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNjc2_1ba39fa2-c242-4238-b297-3f14e1a5318e"
      unitRef="number">0.43</aort:ConsignmentInventoryPercentage>
    <aort:ConsignmentInventoryPercentage
      contextRef="i415a7398d0b44f30b0c2ac4c3cd52d77_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNzA1_32b9b8ff-8c6c-40fa-929e-ee1b138d449b"
      unitRef="number">0.57</aort:ConsignmentInventoryPercentage>
    <aort:DeferredPreservationCosts
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNzc1_0b7a0f4f-7508-4c1f-830c-349ede7ad220"
      unitRef="usd">45500000</aort:DeferredPreservationCosts>
    <aort:DeferredPreservationCosts
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfNzgy_527be094-4180-40e3-beb9-2820eb7842a1"
      unitRef="usd">42900000</aort:DeferredPreservationCosts>
    <us-gaap:InventoryValuationReserves
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfODg2_9438c8eb-c647-49cd-b095-ab5b5b8fb896"
      unitRef="usd">1900000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80MC9mcmFnOjUyNGUwZDcwNmExMDQxMTM4MGZkZTZiMzZhZGRlMzI1L3RleHRyZWdpb246NTI0ZTBkNzA2YTEwNDExMzgwZmRlNmIzNmFkZGUzMjVfODkz_8a51d873-669e-4072-a22b-51553ca6b800"
      unitRef="usd">3200000</us-gaap:InventoryValuationReserves>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RleHRyZWdpb246YzNmODdmM2ZiZGViNGIxZThmNDc4ZTdmNDRhMmE2ZThfMjkyNw_8769ad21-bf5a-4ea5-aee1-69ce0397850c">Goodwill and Other Intangible Assets &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indefinite Lived Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021 the carrying values of our indefinite lived intangible assets were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.172%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;234,773&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;In-process R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,901&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,208&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Procurement contracts and agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,013&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;247&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;66&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We monitor the phases of development of our acquired in-process research and development projects, including the risks associated with further development and the amount and timing of benefits expected to be derived from the completed projects. Incremental costs associated with development are charged to expense as incurred. Capitalized costs are amortized over the estimated useful life of the developed asset once completed. Our in-process research and development projects are reviewed for impairment annually, or more frequently, if events or changes in circumstances indicate that the asset might be impaired. We did not record any impairment of indefinite lived intangible assets during the three and nine months ended September&#160;30, 2022. In-process research and development, procurement contracts and agreements, and trademarks are included in Other intangibles, net on the Condensed Consolidated Balance Sheets as of September&#160;30, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on our experience with similar agreements, we believe that our acquired procurement contracts and agreements have indefinite useful lives, as we expect to continue to renew these contracts for the foreseeable future. We believe that our trademarks have indefinite useful lives as we currently anticipate that our trademarks will contribute to our cash flows indefinitely.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate our goodwill and non-amortizing intangible assets for impairment on an annual basis during the fourth quarter of the year, and, if necessary, during interim periods if factors indicate that an impairment review is warranted. As of September&#160;30, 2022 we concluded that our assessment of current factors did not indicate that goodwill or non-amortizing intangible assets are more likely than not to be impaired. We will continue to evaluate the recoverability of these non-amortizing intangible assets in future periods as necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021 the carrying value of goodwill, all of which is related to our Medical devices segment, is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Medical Devices Segment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(15,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;234,773&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Definite Lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The definite lived intangible assets balance includes balances related to acquired technology, customer relationships, distribution and manufacturing rights and know-how, patents, and other definite lived intangible assets. As of September&#160;30, 2022 and December&#160;31, 2021 the gross carrying values, accumulated amortization, and approximate amortization period of our definite lived intangible assets were as follows (in thousands, except weighted average useful life): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Gross Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted Average&lt;br/&gt;Useful Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Acquired technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;190,108&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;42,048&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;148,060&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;18.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Other intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Customer lists and relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;30,868&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,677&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20,191&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Distribution and manufacturing rights and know-how&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;8,476&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,900&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,576&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,171&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,168&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,325&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,144&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,181&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;47,840&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;20,889&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;26,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;10.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Gross Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted Average&lt;br/&gt;Useful Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Acquired technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;213,626&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;46,632&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;166,994&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Other intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Customer lists and relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;31,148&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;9,618&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;21,530&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Distribution and manufacturing rights and know-how&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;9,847&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,308&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,539&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,083&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,144&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;939&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,969&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,762&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,207&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;49,047&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;18,832&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;30,215&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amortization Expense &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of amortization expense as recorded in General, administrative, and marketing expenses on our Condensed Consolidated Statement of Operations and Comprehensive (Loss) Income (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 scheduled amortization of intangible assets for the next five years is as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Remainder&lt;br/&gt;of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RleHRyZWdpb246YzNmODdmM2ZiZGViNGIxZThmNDc4ZTdmNDRhMmE2ZThfMjkyOA_b3ba1264-dd41-413a-83cf-e987075775c0">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021 the carrying values of our indefinite lived intangible assets were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.172%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;234,773&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;In-process R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,901&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,208&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Procurement contracts and agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,013&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;247&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;66&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfMS0xLTEtMS0yMTE2MQ_3fca925e-9662-4133-bb22-dea755166f8e"
      unitRef="usd">234773000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfMS0zLTEtMS0yMTE2MQ_ba07bfcb-1085-4991-9d4f-3fa3c6b241e8"
      unitRef="usd">250000000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i5d1dafbd2f6f4fe292ea508a5b6aae73_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfMi0xLTEtMS0yMTE2MQ_5563735f-3429-4866-b996-22808a268240"
      unitRef="usd">1901000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9458b6ce90844216a730adfd5f9304f1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfMi0zLTEtMS0yMTE2MQ_dcec5a44-30eb-44a1-951b-3dfae1efee11"
      unitRef="usd">2208000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2bc1a93076b240cdb83aca83562c898c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfMy0xLTEtMS0yMTE2MQ_4996d8c3-03fe-40c4-acda-453a9a2eba1e"
      unitRef="usd">2013000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i33d83b59bd714eed96ac088c627a3bb4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfMy0zLTEtMS0yMTE2MQ_7768519f-ad7b-4911-bd32-6917b3b95037"
      unitRef="usd">2013000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2f7ee96a23d84973bb23f2b986cd0caa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfNC0xLTEtMS0yMTE2MQ_5d64529a-c990-4477-8849-e97f8dd93727"
      unitRef="usd">247000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ibc1a239494bc4d77b7d869dfb120b17b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjhjMzFlOTRiOWJmZTRmMDk4ZjJhNTkwMDE5MGY0ODg3L3RhYmxlcmFuZ2U6OGMzMWU5NGI5YmZlNGYwOThmMmE1OTAwMTkwZjQ4ODdfNC0zLTEtMS0yMTE2MQ_79a29f13-79d3-4ce8-ad87-a26eda88c590"
      unitRef="usd">66000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RleHRyZWdpb246YzNmODdmM2ZiZGViNGIxZThmNDc4ZTdmNDRhMmE2ZThfMjkyOQ_d7f7f3b6-204a-4cf5-bb25-872d399e65e1">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021 the carrying value of goodwill, all of which is related to our Medical devices segment, is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Medical Devices Segment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;250,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(15,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Balance as of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;234,773&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI4ZDNiNjAzNmQwNjQzZjY5Njg5NDFjYTc2MjA5NDE4L3RhYmxlcmFuZ2U6YjhkM2I2MDM2ZDA2NDNmNjk2ODk0MWNhNzYyMDk0MThfMS0xLTEtMS0yMTE2MQ_d90fd63a-db98-4ab4-bc5b-522b72fd7b4e"
      unitRef="usd">250000000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI4ZDNiNjAzNmQwNjQzZjY5Njg5NDFjYTc2MjA5NDE4L3RhYmxlcmFuZ2U6YjhkM2I2MDM2ZDA2NDNmNjk2ODk0MWNhNzYyMDk0MThfMi0xLTEtMS0yMTE2MQ_a603da48-7196-434e-b622-039e2f2b9760"
      unitRef="usd">-15227000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI4ZDNiNjAzNmQwNjQzZjY5Njg5NDFjYTc2MjA5NDE4L3RhYmxlcmFuZ2U6YjhkM2I2MDM2ZDA2NDNmNjk2ODk0MWNhNzYyMDk0MThfMy0xLTEtMS0yMTE2MQ_c58b0bbe-bd44-4340-b3ab-c9c7e0e69b62"
      unitRef="usd">234773000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RleHRyZWdpb246YzNmODdmM2ZiZGViNGIxZThmNDc4ZTdmNDRhMmE2ZThfMjkzMA_99feaaf2-16fd-4d1d-b9ce-9255139172ab">As of September&#160;30, 2022 and December&#160;31, 2021 the gross carrying values, accumulated amortization, and approximate amortization period of our definite lived intangible assets were as follows (in thousands, except weighted average useful life): &lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Gross Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted Average&lt;br/&gt;Useful Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Acquired technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;190,108&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;42,048&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;148,060&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;18.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Other intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Customer lists and relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;30,868&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,677&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20,191&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Distribution and manufacturing rights and know-how&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;8,476&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,900&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,576&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,171&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,168&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,325&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,144&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,181&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;47,840&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;20,889&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;26,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;10.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Gross Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted Average&lt;br/&gt;Useful Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Acquired technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;213,626&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;46,632&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;166,994&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Other intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Customer lists and relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;31,148&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;9,618&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;21,530&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Distribution and manufacturing rights and know-how&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;9,847&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,308&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,539&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,083&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,144&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;939&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,969&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,762&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,207&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;49,047&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;18,832&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;30,215&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;10.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3fb32fabff8742a98b5467dff62122bf_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMS0yLTEtMS0yMTE2MQ_7568f34a-b7b1-4492-bd7d-0209798619f5"
      unitRef="usd">190108000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3fb32fabff8742a98b5467dff62122bf_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMS00LTEtMS0yMTE2MQ_596aa571-4a1e-4c88-988f-3468f47e6fab"
      unitRef="usd">42048000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3fb32fabff8742a98b5467dff62122bf_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMS02LTEtMS0yMTE2MQ_34543463-948c-499e-bbe8-78b02015704a"
      unitRef="usd">148060000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ida30868564d148eca610e7d10cfd5e6f_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMS04LTEtMS0yMTE2MQ_859021cd-7a35-46c4-91b3-feb820883479">P18Y3M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ideb42e83c22b42c3bb0af7e0655023df_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMy0yLTEtMS0yMTE2MQ_0ca8ec64-c275-46fa-bd59-e8bfcb507cd2"
      unitRef="usd">30868000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ideb42e83c22b42c3bb0af7e0655023df_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMy00LTEtMS0yMTE2MQ_c5622a9c-4dc8-4ff8-9710-317d9dd1e942"
      unitRef="usd">10677000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ideb42e83c22b42c3bb0af7e0655023df_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMy02LTEtMS0yMTE2MQ_61396f78-980c-48a4-817d-b80ccecc10df"
      unitRef="usd">20191000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5927140a3ae44b469c4565ca6f2dc116_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfMy04LTEtMS0yMTE2MQ_71db0a49-f094-44be-9551-240c72416b06">P20Y7M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3d32d2810d144a3f896cf0d85612aeb7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNC0yLTEtMS0yMTE2MQ_2bbbfea0-f313-4933-b518-70042f08ae7b"
      unitRef="usd">8476000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3d32d2810d144a3f896cf0d85612aeb7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNC00LTEtMS0yMTE2MQ_3e0a7122-71ad-49ce-836f-7bae45f15dc9"
      unitRef="usd">4900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3d32d2810d144a3f896cf0d85612aeb7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNC02LTEtMS0yMTE2MQ_c2f3ee35-4a2e-4d30-afc0-e6491e20636f"
      unitRef="usd">3576000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i92c5d5cd7490482d80b5d6c02da7f08d_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNC04LTEtMS0yMTE2MQ_bc8ea700-f080-461a-b317-6f93d082fb45">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaf210313db394b1ba95827556680cf9d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNS0yLTEtMS0yMTE2MQ_dd8bee50-2d41-47c6-8c66-ec14eedf5111"
      unitRef="usd">4171000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaf210313db394b1ba95827556680cf9d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNS00LTEtMS0yMTE2MQ_cf697a82-c124-4b6c-8edd-41e9118f416d"
      unitRef="usd">3168000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iaf210313db394b1ba95827556680cf9d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNS02LTEtMS0yMTE2MQ_79ae8d5a-5c48-47e2-aa1f-dfe92689dbc2"
      unitRef="usd">1003000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ia1ef7a095c054e5bb5088a9e425e637d_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNS04LTEtMS0yMTE2MQ_fe2902d4-a8db-40cd-bfaa-fc7964e9c6df">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7d4aa5c197a74658b6b130f04486afd2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNi0yLTEtMS0yMTE2MQ_edb42971-7527-475f-9f34-ef0d3abfa3ae"
      unitRef="usd">4325000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7d4aa5c197a74658b6b130f04486afd2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNi00LTEtMS0yMTE2MQ_772934e3-9a1a-43c6-b669-d26c2d1b70d7"
      unitRef="usd">2144000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7d4aa5c197a74658b6b130f04486afd2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNi02LTEtMS0yMTE2MQ_8a91807d-ca98-444c-a214-6657d1a53df9"
      unitRef="usd">2181000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iffdb325d037c49f5ad546b5419a0a089_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNi04LTEtMS0yMTE2MQ_281950d2-28ac-44d0-b372-c1ae88927fc1">P4Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib74a27dcdc9b4dd6af46f79ebbdf834b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNy0yLTEtMS0yMTE2MQ_de7c4d2b-38d8-46d1-8e93-afdecfdea2da"
      unitRef="usd">47840000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib74a27dcdc9b4dd6af46f79ebbdf834b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNy00LTEtMS0yMTE2MQ_e40583a0-d8ea-4ea4-b05b-68d91923d631"
      unitRef="usd">20889000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib74a27dcdc9b4dd6af46f79ebbdf834b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNy02LTEtMS0yMTE2MQ_2e2d859b-6bf4-4422-be90-6b71b37d3a9e"
      unitRef="usd">26951000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i2d72e53f0f1a452eb2f9cac1876bdd95_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmI3ZDQyM2E5MzU0YzQwMGU4MWFhNDQ1OWQ2MzA1NmJhL3RhYmxlcmFuZ2U6YjdkNDIzYTkzNTRjNDAwZTgxYWE0NDU5ZDYzMDU2YmFfNy04LTEtMS0yMTE2MQ_96402881-ff2a-4978-b9ab-4320a11c4614">P10Y9M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5835fa7529b2441f8256f2039dcd4977_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMS0yLTEtMS0yMTE2MQ_4cccdc18-3a09-4499-b505-617190304799"
      unitRef="usd">213626000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5835fa7529b2441f8256f2039dcd4977_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMS00LTEtMS0yMTE2MQ_6e8778eb-d913-4d5e-97f2-064861985e53"
      unitRef="usd">46632000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5835fa7529b2441f8256f2039dcd4977_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMS02LTEtMS0yMTE2MQ_dcda0d87-ae53-408c-8099-9dd77849e0f4"
      unitRef="usd">166994000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4ec8b963122c48c1bc141284ae59b0cd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMS04LTEtMS0yMTE2MQ_f7ac3e41-15f7-4a10-96f7-6eb1f194b6c5">P17Y8M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1319adccede54d05b8a215934cf0b015_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMy0yLTEtMS0yMTE2MQ_e09095b3-aa98-4392-80a0-4aea07b95451"
      unitRef="usd">31148000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1319adccede54d05b8a215934cf0b015_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMy00LTEtMS0yMTE2MQ_85332d1a-b93a-45a8-a329-c040776a7c5d"
      unitRef="usd">9618000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1319adccede54d05b8a215934cf0b015_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMy02LTEtMS0yMTE2MQ_3e53ad53-f52e-472d-9474-e3da0577842d"
      unitRef="usd">21530000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3e3f166e92e3409b8d455325985327e8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfMy04LTEtMS0yMTE2MQ_7870b0c9-3a2d-4bcd-9d90-9d65fc6be083">P20Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2b943d5080d34bec84109493c800df5f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNC0yLTEtMS0yMTE2MQ_9f680324-8e2e-4afe-a286-c0eb4ceaf703"
      unitRef="usd">9847000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2b943d5080d34bec84109493c800df5f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNC00LTEtMS0yMTE2MQ_196ad97a-3e39-4d39-8023-f873e4e38e2e"
      unitRef="usd">4308000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2b943d5080d34bec84109493c800df5f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNC02LTEtMS0yMTE2MQ_64d536b1-a5cd-4305-9cc0-66d3ed0b41b5"
      unitRef="usd">5539000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ia15d0aa664ea4a7f97d1948f098fd347_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNC04LTEtMS0yMTE2MQ_4539fa18-933c-47a0-b3fc-74c20871ffaa">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i30ad3a0d685c4b1fa5f05ae3aeeb8d54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNS0yLTEtMS0yMTE2MQ_fa9dbe1b-6d49-4dad-852e-8def53963b33"
      unitRef="usd">4083000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i30ad3a0d685c4b1fa5f05ae3aeeb8d54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNS00LTEtMS0yMTE2MQ_c88f7333-d7dd-4663-b4a4-a0e13f35829d"
      unitRef="usd">3144000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i30ad3a0d685c4b1fa5f05ae3aeeb8d54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNS02LTEtMS0yMTE2MQ_efabf410-a853-4896-8321-59a2741aae99"
      unitRef="usd">939000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie597e010fff64cb687fea5326f697ce7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNS04LTEtMS0yMTE2MQ_3423bb56-58e8-48ad-94a6-6687975c4441">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i90c63eb879c049d8a922a2011f7756e8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNi0yLTEtMS0yMTE2MQ_872ae80a-05ce-456f-9b81-a8e51ceb8c83"
      unitRef="usd">3969000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i90c63eb879c049d8a922a2011f7756e8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNi00LTEtMS0yMTE2MQ_e88da0b1-5bf7-468a-81d4-9a54a5632ad8"
      unitRef="usd">1762000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i90c63eb879c049d8a922a2011f7756e8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNi02LTEtMS0yMTE2MQ_70a904c5-efba-416e-9218-f5d334110d09"
      unitRef="usd">2207000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8267638c5c76419694cfdd6148d710ec_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNi04LTEtMS0yMTE2MQ_2bf726a6-d498-48fd-a144-92a11e767a8e">P4Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0452204939dc44418b4b735573daceb1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNy0yLTEtMS0yMTE2MQ_30be6f81-1611-4807-9ab5-5a3802663fb3"
      unitRef="usd">49047000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0452204939dc44418b4b735573daceb1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNy00LTEtMS0yMTE2MQ_168a15c2-3627-4905-8e66-362c2591bdf4"
      unitRef="usd">18832000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0452204939dc44418b4b735573daceb1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNy02LTEtMS0yMTE2MQ_155eb785-3ca4-4337-a746-296f7e6b45f3"
      unitRef="usd">30215000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i1b5b7de541014928a789871dab61c5b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOmRiMmQwNDliYjY0NTQ2MmNiYjg2NDllNzk4NTA3OTIxL3RhYmxlcmFuZ2U6ZGIyZDA0OWJiNjQ1NDYyY2JiODY0OWU3OTg1MDc5MjFfNy04LTEtMS0yMTE2MQ_5e06b7c4-cee0-4eb2-a4e3-462c9344bd15">P10Y7M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RleHRyZWdpb246YzNmODdmM2ZiZGViNGIxZThmNDc4ZTdmNDRhMmE2ZThfMjkzMQ_29acec9c-da2b-4b7e-bfef-ae54678f63c3">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of amortization expense as recorded in General, administrative, and marketing expenses on our Condensed Consolidated Statement of Operations and Comprehensive (Loss) Income (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjQ4MzJiZDhkYzU2NzRjMGQ5OGI0Y2VmYWI3OTVmOTE4L3RhYmxlcmFuZ2U6NDgzMmJkOGRjNTY3NGMwZDk4YjRjZWZhYjc5NWY5MThfMi0xLTEtMS0yMTE2MQ_7d4992a0-fe93-468c-97b4-0068252fb41d"
      unitRef="usd">3686000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjQ4MzJiZDhkYzU2NzRjMGQ5OGI0Y2VmYWI3OTVmOTE4L3RhYmxlcmFuZ2U6NDgzMmJkOGRjNTY3NGMwZDk4YjRjZWZhYjc5NWY5MThfMi0zLTEtMS0yMTE2MQ_91445e98-86e8-4266-92ab-4abd3ab57c90"
      unitRef="usd">4203000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjQ4MzJiZDhkYzU2NzRjMGQ5OGI0Y2VmYWI3OTVmOTE4L3RhYmxlcmFuZ2U6NDgzMmJkOGRjNTY3NGMwZDk4YjRjZWZhYjc5NWY5MThfMi01LTEtMS0yMTE2MQ_5f17457a-5e02-4b04-ba7b-cda9431d2f64"
      unitRef="usd">11675000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjQ4MzJiZDhkYzU2NzRjMGQ5OGI0Y2VmYWI3OTVmOTE4L3RhYmxlcmFuZ2U6NDgzMmJkOGRjNTY3NGMwZDk4YjRjZWZhYjc5NWY5MThfMi03LTEtMS0yMTE2MQ_1092c0b6-d07a-46a5-b85b-997e540c20e4"
      unitRef="usd">12701000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RleHRyZWdpb246YzNmODdmM2ZiZGViNGIxZThmNDc4ZTdmNDRhMmE2ZThfMjkzMg_e1195a24-7dad-427b-a707-ce694128a882">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 scheduled amortization of intangible assets for the next five years is as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Remainder&lt;br/&gt;of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS0xLTEtMS0yMTE2MQ_e8667189-3360-44b1-9f54-990de78d00ff"
      unitRef="usd">3593000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS0zLTEtMS0yMTE2MQ_86a2f514-bce5-4ce1-8dbd-fd8c6898c58b"
      unitRef="usd">14174000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS01LTEtMS0yMTE2MQ_05562bfa-d4e7-4e39-858c-2708a88647ce"
      unitRef="usd">13822000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS03LTEtMS0yMTE2MQ_f7bf4e37-510e-4a93-a705-56f3451137dc"
      unitRef="usd">12070000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS05LTEtMS0yMTE2MQ_168d4352-9dcc-41da-848c-f7c610f8980f"
      unitRef="usd">11842000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS0xMS0xLTEtMjExNjE_4d176a39-b099-4540-a7c1-efc77a1486df"
      unitRef="usd">11748000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <aort:FiniteLivedIntangibleAssetsAmortizationExpenseEstimate
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80My9mcmFnOmMzZjg3ZjNmYmRlYjRiMWU4ZjQ3OGU3ZjQ0YTJhNmU4L3RhYmxlOjBkNjAxZDAyYmJkNDQwNDI5YzUwMjI0Y2Q4NTdkOWMwL3RhYmxlcmFuZ2U6MGQ2MDFkMDJiYmQ0NDA0MjljNTAyMjRjZDg1N2Q5YzBfMS0xMy0xLTEtMjExNjE_502aa335-8748-45d4-9a1d-b63890c869ac"
      unitRef="usd">67249000</aort:FiniteLivedIntangibleAssetsAmortizationExpenseEstimate>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTU4MQ_36813065-0289-4734-bfe7-eba9f0c3ffc6">Income Taxes &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Tax Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective income tax rate was an expense of 9% and 17% for the three and nine months ended September&#160;30, 2022, respectively, as compared to a benefit of 33% and 318% for the three and nine months ended September&#160;30, 2021, respectively. Our income tax rate for the three and nine months ended September&#160;30, 2022 was primarily impacted by changes in our valuation allowance against our net deferred tax assets, non-deductible executive compensation, the foreign derived intangible income deduction, the research and development tax credit, changes in our uncertain tax position liabilities, and tax shortfalls on stock compensation. Our income tax rate for the three and nine months ended September&#160;30, 2021 was primarily impacted by non-deductible executive compensation, changes in our valuation allowance against our net deferred tax assets, changes in our uncertain tax position liabilities, the research and development tax credit, and excess tax benefits on stock compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate deferred tax assets primarily as a result of finance leases, net operating losses, amortization of research and development expenses, excess interest carryforward, stock compensation, and accrued compensation. Our deferred tax liabilities are primarily made up of intangible assets acquired in previous years, finance leases, and unrealized gains and losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintained a net deferred tax liability of $28.0 million and $26.4 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively. Our valuation allowance against our deferred tax assets was $17.8 million and $13.3 million as of September&#160;30, 2022 and December&#160;31, 2021, respectively, primarily related to net operating loss carryforwards and disallowed excess interest carryforwards.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfODE_db8c2e8d-342f-4341-9e22-3c8f6225b24e"
      unitRef="number">0.09</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfODg_6850d5e0-6480-4ddb-92c0-e166987f8ea9"
      unitRef="number">0.17</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTYw_6f4782f8-638c-4ca1-91af-489c4929e708"
      unitRef="number">-0.33</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTY3_a8bbd752-07a6-4c65-b105-be2bc4c9a989"
      unitRef="number">-3.18</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxLiabilities
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTM0MQ_11bfcf4d-c8c8-4631-8954-75a93b81e824"
      unitRef="usd">28000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTM0OA_f0b17fd9-72c5-4cf2-b1e9-72ba14bb9be5"
      unitRef="usd">26400000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTQ0Mg_fd0ef1fb-ae0c-44d5-b93b-601a80efb7ae"
      unitRef="usd">17800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80Ni9mcmFnOjgwNGRmNjEzMGQ2ZTQ0NjM5MTdjMTAxNTgyZTg2MjQ2L3RleHRyZWdpb246ODA0ZGY2MTMwZDZlNDQ2MzkxN2MxMDE1ODJlODYyNDZfMTQ0OQ_d054b2a2-52d5-403d-9e03-a78f4c068048"
      unitRef="usd">13300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyMg_008a5e25-1b2f-4abc-b360-e453944cb855">Leases &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have operating and finance lease obligations resulting from the lease of land and buildings that comprise our corporate headquarters and various manufacturing facilities; leases related to additional manufacturing, office, and warehouse space; leases on company vehicles; and leases on a variety of office and other equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;6, 2021 we executed a modification to extend the lease of our headquarters located in Kennesaw, Georgia. This modification resulted in an increase in the present value of future lease obligations and corresponding right-of-use asset of $23.3 million, using a discount rate of 6.41%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;1, 2021 we began occupancy of the newly constructed addition to our leased international headquarters located in Hechingen, Germany. This lease resulted in an increase in the present value of future lease obligations and corresponding right-of-use asset of $9.8 million, using a discount rate of 5.46%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to leases included in the Condensed Consolidated Balance Sheets is as follows (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.172%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;55,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;58,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(14,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(12,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating lease right-of-use assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;41,320&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;45,714&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Current maturities of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Non-current maturities of operating leases &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;44,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;43,976&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;48,018&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Property and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(2,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(2,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,695&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,654&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Current maturities of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Non-current maturities of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,919&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,902&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;12.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;8.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current maturities of finance leases are included as a component of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyNA_232befca-efbd-4242-931d-c2e23c341abe"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyNA_bf517df5-2808-40a4-b74d-94a6a829e5d0"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt; on our Condensed Consolidated Balance Sheets. A summary of lease expenses for our finance and operating leases included in General, administrative, and marketing expenses on our Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income is as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Amortization of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;127&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;190&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;395&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Interest expense on finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;85&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total finance lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;149&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;217&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;464&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;585&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,853&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,989&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,656&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,566&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;1,910&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2,114&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;5,845&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;5,843&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of our cash flow information related to leases is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,939&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,536&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;346&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;446&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;62&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments and sublease rental income are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Sublease&lt;br/&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;120&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;660&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;549&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,624&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;545&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,252&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;525&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,173&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;508&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,719&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,986&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,247&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;63,414&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less amount representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(19,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Present value of net minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,919&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;43,976&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(3,061)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Lease liabilities, less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,450&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,915&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i1155d3f6605345d9bf6e5eff5b2ff517_D20210106-20210106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfNTgw_4a5ca26a-3ce2-4db7-961a-d6ad49b65dd6"
      unitRef="usd">23300000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i98cd2d841a0d40e39000ad02cbe23dfe_I20210106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfNTgw_abf5adc3-f765-41a0-bcef-dcad71f28a9e"
      unitRef="usd">23300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="i98cd2d841a0d40e39000ad02cbe23dfe_I20210106"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfNjA5_3a3b36dd-d323-41f2-957c-61eef7b26ad5"
      unitRef="number">0.0641</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i91ff9b76a1ca40d280c764ffb11b5962_D20210601-20210601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfODY4_4d0bd569-34cf-41fc-bcd3-45f7bce1f828"
      unitRef="usd">9800000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i704c126d4e494f8d8caab84f162c9d5f_I20210601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfODY4_b7d34cf4-3ef0-4a9c-a882-21ae7c8a36cc"
      unitRef="usd">9800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="i704c126d4e494f8d8caab84f162c9d5f_I20210601"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfODk3_040199d2-148d-422a-a45d-8085dd2a7991"
      unitRef="number">0.0546</us-gaap:LesseeOperatingLeaseDiscountRate>
    <aort:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyMw_beed89b0-56b4-4663-9f92-fdd8abc50cde">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to leases included in the Condensed Consolidated Balance Sheets is as follows (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.172%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;55,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;58,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(14,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(12,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating lease right-of-use assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;41,320&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;45,714&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Current maturities of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Non-current maturities of operating leases &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;44,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;43,976&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;48,018&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Property and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(2,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(2,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,695&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,654&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Current maturities of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Non-current maturities of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,919&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,902&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;12.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;8.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</aort:AssetsAndLiabilitiesLesseeTableTextBlock>
    <aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMS0xLTEtMS0yMTE2MQ_d6fddd26-5913-47f1-a678-4ee70ce05a9f"
      unitRef="usd">55405000</aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMS0zLTEtMS0yMTE2MQ_df596b2a-22f1-4571-9161-309097193721"
      unitRef="usd">58097000</aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMi0xLTEtMS0yMTE2MQ_27ec1913-278f-4ec8-b255-140bf472f11b"
      unitRef="usd">14085000</aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMi0zLTEtMS0yMTE2MQ_cbf75ecd-e96b-49c4-81bf-108eebe5a48c"
      unitRef="usd">12383000</aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMy0xLTEtMS0yMTE2MQ_36a807df-b870-4000-9a06-16193bcd9be6"
      unitRef="usd">41320000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMy0zLTEtMS0yMTE2MQ_53d4fa91-eea6-4a63-bb09-4dc5898abf9a"
      unitRef="usd">45714000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfNS0xLTEtMS0yMTE2MQ_6bb34a3c-5ff5-4add-a539-53d330421811"
      unitRef="usd">3061000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfNS0zLTEtMS0yMTE2MQ_b94506ba-c1c7-45f0-a7c0-ad065f17baf2"
      unitRef="usd">3149000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfNi0xLTEtMS0yMTE2MQ_becfcd81-7d5b-4526-86c4-462c8b1759d1"
      unitRef="usd">40915000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfNi0zLTEtMS0yMTE2MQ_3738ad64-1f10-4fde-ab8e-5478a84f3573"
      unitRef="usd">44869000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfNy0xLTEtMS0yMTE2MQ_0525b4e9-6d2a-4414-888e-07897e0b2a3b"
      unitRef="usd">43976000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfNy0zLTEtMS0yMTE2MQ_9ca33741-b8a6-4772-a6e6-520b29b2ff04"
      unitRef="usd">48018000</us-gaap:OperatingLeaseLiability>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTAtMS0xLTEtMjExNjE_2a8f8e1d-3f84-4131-8776-ebdbb48b9a96"
      unitRef="usd">5861000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTAtMy0xLTEtMjExNjE_38c1922d-a698-4fff-8e47-e194d0e7b945"
      unitRef="usd">6759000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTEtMS0xLTEtMjExNjE_dd2d14de-4675-40bf-8e30-15dc5b7a3bba"
      unitRef="usd">2166000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTEtMy0xLTEtMjExNjE_4cd9b62d-f339-4c6d-b63d-6b33c348e6de"
      unitRef="usd">2105000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTItMS0xLTEtMjExNjE_5e587483-9ac4-4eb1-a8a9-56a4867ea598"
      unitRef="usd">3695000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTItMy0xLTEtMjExNjE_dc3928de-4f9c-4e99-aa3d-899adccb9c47"
      unitRef="usd">4654000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTQtMS0xLTEtMjExNjE_d03fce1c-60ff-48ad-9552-8386b69ed79b"
      unitRef="usd">469000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTQtMy0xLTEtMjExNjE_10d123e4-5869-4ae9-961a-d77471bad4db"
      unitRef="usd">528000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTUtMS0xLTEtMjExNjE_6a34c30b-6a84-43fe-8066-9cc7ab683230"
      unitRef="usd">3450000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTUtMy0xLTEtMjExNjE_6be89756-214d-493f-b04b-44354332c895"
      unitRef="usd">4374000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTYtMS0xLTEtMjExNjE_0b18f93f-108e-4564-a9bd-8fcb94c2bd99"
      unitRef="usd">3919000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTYtMy0xLTEtMjExNjE_e85188d0-debb-45c1-b948-c960a29567e3"
      unitRef="usd">4902000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTktMS0xLTEtMjExNjE_0b6d93a8-43c2-4938-b6c5-923be737e781">P12Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMTktMy0xLTEtMjExNjE_780e72be-a65f-4c61-a80b-d371625acb47">P12Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMjAtMS0xLTEtMjExNjE_31a5489d-882b-485f-bf42-399d1d75298a">P8Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMjAtMy0xLTEtMjExNjE_be4aeeee-8d53-46f9-b0b5-5389a342a848">P8Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMjMtMS0xLTEtMjExNjE_efb9eecd-d1c0-4b1a-81d4-c6402b10c0f9"
      unitRef="number">0.059</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMjMtMy0xLTEtMjExNjE_4f79cfc7-6e8c-4a7f-b6eb-3e1e29b39080"
      unitRef="number">0.058</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMjQtMS0xLTEtMjExNjE_819fe2dc-663b-44ca-a301-f315288d0e9c"
      unitRef="number">0.021</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmEzMmIwODg3NTgwNzQxNmNiMDA5N2FlOTIxYmYyMWMxL3RhYmxlcmFuZ2U6YTMyYjA4ODc1ODA3NDE2Y2IwMDk3YWU5MjFiZjIxYzFfMjQtMy0xLTEtMjExNjE_a9c5ee38-a5ad-45a0-b6f9-312cb9d9c013"
      unitRef="number">0.020</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYxOQ_3aca6295-3471-41bc-8768-055118374bc4">A summary of lease expenses for our finance and operating leases included in General, administrative, and marketing expenses on our Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income is as follows (in thousands): &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Amortization of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;127&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;190&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;395&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Interest expense on finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;85&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total finance lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;149&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;217&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;464&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;585&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,853&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,989&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,656&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,566&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;1,910&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2,114&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;5,845&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;5,843&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of our cash flow information related to leases is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,939&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,536&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;346&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;446&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;62&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMi0xLTEtMS0yMTE2MQ_2f4de146-b692-4948-bd5a-5589d66140ac"
      unitRef="usd">127000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMi0zLTEtMS0yMTE2MQ_e1adaeae-50ad-4062-ade7-0d70e51a41af"
      unitRef="usd">190000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMi01LTEtMS0yMTE2MQ_599ae88a-55f0-442e-86d2-476bf7e9fc18"
      unitRef="usd">395000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMi03LTEtMS0yMTE2MQ_10a5976a-1ac2-49f4-9b73-40ee40e7a845"
      unitRef="usd">500000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMy0xLTEtMS0yMTE2MQ_69b496da-c194-453f-8cac-ecc1064b34dc"
      unitRef="usd">22000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMy0zLTEtMS0yMTE2MQ_8f2b0572-9755-4d4c-96b5-8f0a818a04c7"
      unitRef="usd">27000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMy01LTEtMS0yMTE2MQ_100b1c1c-5bee-494f-b5c9-e3d44907a0be"
      unitRef="usd">69000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfMy03LTEtMS0yMTE2MQ_99afd7ec-0c12-45b4-b998-83db24e58a95"
      unitRef="usd">85000</us-gaap:FinanceLeaseInterestExpense>
    <aort:FinanceLeaseCost
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNC0xLTEtMS0yMTE2MQ_d40854d4-8f7b-4338-bf2d-ce2a206c9b2f"
      unitRef="usd">149000</aort:FinanceLeaseCost>
    <aort:FinanceLeaseCost
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNC0zLTEtMS0yMTE2MQ_98ea3ca3-ca1f-484a-8086-4559494bafa8"
      unitRef="usd">217000</aort:FinanceLeaseCost>
    <aort:FinanceLeaseCost
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNC01LTEtMS0yMTE2MQ_bf1235fe-c858-4429-a896-f8bfa50102e2"
      unitRef="usd">464000</aort:FinanceLeaseCost>
    <aort:FinanceLeaseCost
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNC03LTEtMS0yMTE2MQ_0ff6bde9-5979-45ce-af12-1f16aa052aa1"
      unitRef="usd">585000</aort:FinanceLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNS0xLTEtMS0yMTE2MQ_91b56cc5-521b-4bc5-9b74-47afbec2d4dc"
      unitRef="usd">1853000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNS0zLTEtMS0yMTE2MQ_4059940c-ef0a-4176-bacb-6648852e398b"
      unitRef="usd">1989000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNS01LTEtMS0yMTE2MQ_4de08043-c67d-4020-b1f5-aad59a2e9181"
      unitRef="usd">5656000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNS03LTEtMS0yMTE2MQ_64b3f474-c4db-473d-b767-1104cf44adec"
      unitRef="usd">5566000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNi0xLTEtMS0yMTE2MQ_1ae02452-6d77-46c6-8884-9f770a0e2db7"
      unitRef="usd">92000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNi0zLTEtMS0yMTE2MQ_c1828a46-84a2-4a56-8272-259bd582b77b"
      unitRef="usd">92000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNi01LTEtMS0yMTE2MQ_3727249f-82e8-41f3-b752-6b9bad349597"
      unitRef="usd">275000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNi03LTEtMS0yMTE2MQ_1d21e853-5ef2-481e-8d11-c0aa7c818891"
      unitRef="usd">308000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNy0xLTEtMS0yMTE2MQ_8f4c8c5e-a553-4857-bae8-668a01b98b24"
      unitRef="usd">1910000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNy0zLTEtMS0yMTE2MQ_7ae83422-f4ab-4d51-ba86-05c2aada2c6d"
      unitRef="usd">2114000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNy01LTEtMS0yMTE2MQ_f3b2b5e5-a7dd-460c-a158-cd9d2eb86d0d"
      unitRef="usd">5845000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmY4MTBjYjk2MzRmMTQ3MDFiZDhhN2YyZjhhMzRhYzU3L3RhYmxlcmFuZ2U6ZjgxMGNiOTYzNGYxNDcwMWJkOGE3ZjJmOGEzNGFjNTdfNy03LTEtMS0yMTE2MQ_daa448f7-3f07-4cce-8c3e-9902667d92e7"
      unitRef="usd">5843000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOjM1NzM5YjA5OGRhYjQ0M2FiYzQ1MzA1YTY4Yjk5MTU0L3RhYmxlcmFuZ2U6MzU3MzliMDk4ZGFiNDQzYWJjNDUzMDVhNjhiOTkxNTRfMi0xLTEtMS0yMTE2MQ_b421aaff-34d0-405f-83a2-9d2fb2e95998"
      unitRef="usd">4939000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOjM1NzM5YjA5OGRhYjQ0M2FiYzQ1MzA1YTY4Yjk5MTU0L3RhYmxlcmFuZ2U6MzU3MzliMDk4ZGFiNDQzYWJjNDUzMDVhNjhiOTkxNTRfMi0zLTEtMS0yMTE2MQ_b27c9ac3-30cc-4a4c-a3af-7931ab3951c1"
      unitRef="usd">4536000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOjM1NzM5YjA5OGRhYjQ0M2FiYzQ1MzA1YTY4Yjk5MTU0L3RhYmxlcmFuZ2U6MzU3MzliMDk4ZGFiNDQzYWJjNDUzMDVhNjhiOTkxNTRfMy0xLTEtMS0yMTE2MQ_bf686fd2-6309-4f0d-b81c-bccb35446611"
      unitRef="usd">346000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOjM1NzM5YjA5OGRhYjQ0M2FiYzQ1MzA1YTY4Yjk5MTU0L3RhYmxlcmFuZ2U6MzU3MzliMDk4ZGFiNDQzYWJjNDUzMDVhNjhiOTkxNTRfMy0zLTEtMS0yMTE2MQ_90536f40-f77d-4e7c-9e54-abd7ce5d1834"
      unitRef="usd">446000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOjM1NzM5YjA5OGRhYjQ0M2FiYzQ1MzA1YTY4Yjk5MTU0L3RhYmxlcmFuZ2U6MzU3MzliMDk4ZGFiNDQzYWJjNDUzMDVhNjhiOTkxNTRfNC0xLTEtMS0yMTE2MQ_75a480bc-9033-4bad-822c-970ccfd3fb5c"
      unitRef="usd">62000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOjM1NzM5YjA5OGRhYjQ0M2FiYzQ1MzA1YTY4Yjk5MTU0L3RhYmxlcmFuZ2U6MzU3MzliMDk4ZGFiNDQzYWJjNDUzMDVhNjhiOTkxNTRfNC0zLTEtMS0yMTE2MQ_209b790b-b092-4ef5-8949-cb13f7dfe68e"
      unitRef="usd">82000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyMQ_e207bb54-320f-468a-97dd-1930e48ce2bb">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments and sublease rental income are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Sublease&lt;br/&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;120&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;660&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;549&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,624&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;545&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,252&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;525&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,173&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;508&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,719&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,986&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,247&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;63,414&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less amount representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(19,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Present value of net minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,919&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;43,976&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(3,061)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Lease liabilities, less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,450&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,915&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RleHRyZWdpb246N2Y3NTk4Mzg2NzJkNDY5YjkyZDVjYzUwYzg1MjJjYTVfMTYyMQ_e7de1887-fec3-4525-bbb0-f59caf36f6fb">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments and sublease rental income are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Sublease&lt;br/&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;120&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;660&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;549&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,624&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;545&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,252&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;525&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,173&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;508&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,719&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,986&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,247&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;63,414&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less amount representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(19,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Present value of net minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,919&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;43,976&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(3,061)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Lease liabilities, less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,450&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,915&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMS0xLTEtMS0yMTE2MQ_8216e124-b97b-42ec-b097-988911d66a6d"
      unitRef="usd">120000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMS0zLTEtMS0yMTE2MQ_51a039aa-7021-4fc8-98b8-ad8cb0371bd0"
      unitRef="usd">660000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMS01LTEtMS0yMTE2MQ_123e28bd-a58c-4497-9009-f97939ecac1b"
      unitRef="usd">31000</aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMi0xLTEtMS0yMTE2MQ_c908163c-e2ca-473c-8865-864986ae9065"
      unitRef="usd">549000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMi0zLTEtMS0yMTE2MQ_e70b1d86-20aa-4e28-bf27-6228fd9c24b6"
      unitRef="usd">5624000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMi01LTEtMS0yMTE2MQ_7e43c6d8-f000-4e0f-80a3-cf14020c0395"
      unitRef="usd">0</aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMy0xLTEtMS0yMTE2MQ_228f6d12-0ff8-4ebd-95d2-525f8d7484b6"
      unitRef="usd">545000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMy0zLTEtMS0yMTE2MQ_a534ed58-4b19-46cd-a205-14428f471a4f"
      unitRef="usd">6252000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMy01LTEtMS0yMTE2MQ_18d7f8f4-6f20-48af-b259-765b1686187d"
      unitRef="usd">0</aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNC0xLTEtMS0yMTE2MQ_b6c986a8-e021-46d9-9a09-540c7722cf1e"
      unitRef="usd">525000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNC0zLTEtMS0yMTE2MQ_bf2538a8-887a-4f02-89d8-08f93e298a5b"
      unitRef="usd">5173000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNC01LTEtMS0yMTE2MQ_6c690c9d-290f-429b-abb3-dc50bcc1e9c1"
      unitRef="usd">0</aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNS0xLTEtMS0yMTE2MQ_3d8f7d3a-06ad-4028-9175-8ccaa2e91005"
      unitRef="usd">508000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNS0zLTEtMS0yMTE2MQ_7abd643d-b952-4089-887c-86431cd4c318"
      unitRef="usd">4719000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNS01LTEtMS0yMTE2MQ_a33cd97c-7160-4417-a8a6-ded9680731dc"
      unitRef="usd">0</aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour>
    <aort:FinanceLeaseLiabilityToBePaidAfterYearFour
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNi0xLTEtMS0yMTE2MQ_079c8609-4a97-48c3-8f41-b2774ccacb9d"
      unitRef="usd">2000000</aort:FinanceLeaseLiabilityToBePaidAfterYearFour>
    <aort:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNi0zLTEtMS0yMTE2MQ_76ea031d-4191-4ef9-bad3-07751903ed8c"
      unitRef="usd">40986000</aort:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNi01LTEtMS0yMTE2MQ_dfa331d7-0ecf-41db-ab27-fabf207942cc"
      unitRef="usd">0</aort:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNy0xLTEtMS0yMTE2MQ_2e03b0fb-ef2b-49fb-a396-908999fab01b"
      unitRef="usd">4247000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNy0zLTEtMS0yMTE2MQ_e45ace64-15e1-44fd-89cd-25d5d3fd8725"
      unitRef="usd">63414000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfNy01LTEtMS0yMTE2MQ_46fe7588-cada-463a-a07b-fd57935282e2"
      unitRef="usd">31000</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNet>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfOC0xLTEtMS0yMTE2MQ_1a3fa6d8-f0f7-49ff-95c2-dd9aed8dff2e"
      unitRef="usd">328000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfOC0zLTEtMS0yMTE2MQ_9400e51a-6543-4674-9c33-d7b309603bef"
      unitRef="usd">19438000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfOS0xLTEtMS0yMTE2MQ_ae826f1d-2583-4547-8bb0-f768842f4ff2"
      unitRef="usd">3919000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfOS0zLTEtMS0yMTE2MQ_63ddb292-341c-4de3-a1f3-93bd6192e2de"
      unitRef="usd">43976000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMTAtMS0xLTEtMjExNjE_c4b85b1d-0ab3-47a0-a4a8-7395fe63a343"
      unitRef="usd">469000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMTAtMy0xLTEtMjExNjE_10012213-f615-4456-9207-559047170103"
      unitRef="usd">3061000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMTEtMS0xLTEtMjExNjE_100fbb9f-8ccc-48dd-9c3f-16ea03ec1b7f"
      unitRef="usd">3450000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV80OS9mcmFnOjdmNzU5ODM4NjcyZDQ2OWI5MmQ1Y2M1MGM4NTIyY2E1L3RhYmxlOmQ1MTgxMjgyYjA3YTRkMDc5NTE4ZWVkMDVkN2M3YmUxL3RhYmxlcmFuZ2U6ZDUxODEyODJiMDdhNGQwNzk1MThlZWQwNWQ3YzdiZTFfMTEtMy0xLTEtMjExNjE_e2a8dd86-a44d-4957-a818-2aae7d6ceb4a"
      unitRef="usd">40915000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfODIyMw_59fd09ae-aab8-41c3-ac15-a6fbacc3acc3">Debt&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;1, 2017 we entered into a credit and guaranty agreement for a $255.0 million senior secured credit facility, consisting of a $225.0 million secured term loan facility (the &#x201c;Term Loan Facility&#x201d;) and a $30.0 million secured revolving credit facility (the &#x201c;Revolving Credit Facility&#x201d; and, together with the Term Loan Facility, the &#x201c;Credit Agreement&#x201d;). We and each of our existing domestic subsidiaries (subject to certain exceptions and exclusions) guarantee the obligations under the Credit Agreement (the &#x201c;Guarantors&#x201d;). The Credit Agreement is secured by a security interest in substantially all existing and after-acquired real and personal property (subject to certain exceptions and exclusions) of us and the Guarantors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;2, 2021 we entered into an amendment to our Credit Agreement to extend the maturity dates of our Term Loan and Revolving Credit Facility. As part of the amendment, the maturity dates of both our Term Loan and Revolving Credit Facility were each extended by two and one-half years, until June 1, 2027 and June 1, 2025, respectively, subject to earlier springing maturities triggered if our 4.25% Convertible Senior Notes, described below, remain outstanding on April 1, 2025 and December 31, 2024, respectively. With respect to the Term Loan, if the Convertible Senior Notes remain outstanding on April 1, 2025, the Term Loan&#x2019;s maturity date will be April 1, 2025, or, if the Convertible Senior Notes&#x2019; own maturity date has been extended, the earlier of (i) 91 days prior to the Convertible Senior Notes&#x2019; new maturity date and (ii) June 1, 2027. In the case of the Revolving Credit Facility, if the Convertible Senior Notes are still outstanding on December 31, 2024, the Revolving Credit Facility&#x2019;s maturity date will be either December 31, 2024 or, if the Convertible Senior Notes&#x2019; own maturity date has been extended, the earlier of (i) 182 days prior to the Convertible Senior Notes&#x2019; new maturity date and (ii) June 1, 2025. Under the amendment, the Term Loan Facility bears interest, at our option, at a floating annual rate equal to either the base rate, plus a margin of 2.50%, or LIBOR, plus a margin of 3.50%. Prior to the amendment, the optional floating annual rate was equal to either the base rate plus a margin of 2.25%, or LIBOR, plus a margin of 3.25%. We paid debt issuance costs of $2.1 million, of which $1.8 million will be amortized over the life of the Term Loan Facility and included in current and long-term debt on the Condensed Consolidated Balance Sheets. The remaining $361,000 of debt issuance costs and $474,000 of non-cash debt extinguishment costs were recorded in Interest expense on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As discussed in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 the Credit Agreement contains certain customary affirmative and negative covenants, including covenants that limit our ability and the ability of our subsidiaries to, among other things, grant liens, incur debt, dispose of assets, make loans and investments, make acquisitions, make certain restricted payments (including cash dividends), merge or consolidate, change business or accounting or reporting practices, in each case subject to customary exceptions for a credit facility of this size and type. Beginning in 2021 if we repay borrowings under our Revolving Credit Facility to 25% or less, no financial maintenance covenants, including the minimum liquidity covenant and the maximum first lien net leverage ratio covenant, are applicable. We are in compliance with our debt covenants as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;18, 2020 we issued $100.0 million aggregate principal amount of 4.25% Convertible Senior Notes with a maturity date of July&#160;1, 2025 (the &#x201c;Convertible Senior Notes&#x201d;). The net proceeds from this offering, after deducting initial purchasers&#x2019; discounts and costs directly related to this offering, were approximately $96.5 million. On January 1, 2021 we adopted ASU 2020-06 and adjusted the carrying balance of the Convertible Senior Notes to notional. The Convertible Senior Notes balance was $100.0 million recorded in Long-term debt on the Condensed Consolidated Balance Sheets as of September&#160;30, 2022. The Convertible Senior Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. The initial conversion rate of the Convertible Senior Notes is 42.6203 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $23.46 per share, subject to adjustments. We use the if-converted method for assumed conversion of the Convertible Senior Notes for the diluted earnings per share calculation. The fair value and the effective interest rate of the Convertible Senior Notes as of September&#160;30, 2022 was approximately $92.3 million and 5.05%, respectively. The fair value was based on market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest expense recognized on the Convertible Senior Notes includes $1.2 million and $3.7 million for the &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three and nine months ended September&#160;30, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively, and $1.2 million and $3.7 million for the &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three and nine&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; months ended September&#160;30, 2021, respectively, related to the aggregate of the contractual coupon interest, and the amortization of the debt issuance costs&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Interest on the Convertible Senior Notes began accruing upon issuance and is payable semi-annually. As of September&#160;30, 2022 there were $2.0 million of unamortized debt issuance costs related to Convertible Senior Notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the Convertible Senior Notes may convert their notes at their option at any time prior to January 1, 2025, but only under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (iii) we give a notice of redemption with respect to any or all of the notes, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate events. On or after January 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their notes at any time, regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We cannot redeem the Convertible Senior Notes before July 5, 2023. We can redeem them on or after July 5, 2023, in whole or in part, at our option, if the last reported sale price per share of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption. We may redeem for cash all or part of the Convertible Senior Notes at a redemption price equal to 100% of the principal amount of the redeemable Convertible Senior Notes, plus accrued and unpaid interest to, but excluding, the redemption date. No principal payments are due on the Convertible Senior Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the Convertible Senior Notes do not contain any financial covenants and do not restrict us from conducting significant restructuring transactions or issuing or repurchasing any of its other securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loan Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The short-term and long-term balances of our term loan and other long-term borrowings were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Term loan balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;214,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;216,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.45% Sparkasse Zollernalb (KFW Loan 1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1.40% Sparkasse Zollernalb (KFW Loan 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total loan balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;315,369&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;317,627&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less unamortized loan origination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(7,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(8,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;308,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;309,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less short-term loan balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(1,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(1,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Long-term loan balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;306,674&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;307,493&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Expense&lt;/span&gt;&lt;/div&gt;Interest expense was $4.8 million and $12.9 million for the three and nine months ended September&#160;30, 2022, respectively, as compared to $4.1 million and $13.0 million for the three and nine months ended September&#160;30, 2021, respectively.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i48b9bbe85c68425d911ee0c362147e39_I20171201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfOTA_680fce03-9d85-4d9a-ab3b-1d95761ceea3"
      unitRef="usd">255000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if48526739d454c7aa0ead75443f922f1_I20171201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMTQx_d3183b5e-6a73-4951-b1da-f7700e6685b4"
      unitRef="usd">225000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib252a536e8c2403f88b1f7002f4ad93d_I20171201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjA0_b9c0aff8-4b6d-4afb-af62-78d2ec7680cb"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0a9e96716e2d43fc8cb58b6a571003ac_I20210602"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMTEwMw_f373b21f-cdee-493f-9f01-b1aa0cbb2314"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aort:DebtInstrumentExtensionCircumstancePeriod
      contextRef="ibd8fae709fff4c1da4933fc5331a3616_D20210602-20210602"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMTQ2OA_4f33015a-6040-4916-8453-713e9c22ef61">P91D</aort:DebtInstrumentExtensionCircumstancePeriod>
    <aort:DebtInstrumentExtensionCircumstancePeriod
      contextRef="i308d3c512f144d22ba8f06fad96609aa_D20210602-20210602"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMTg0NQ_95041a4a-0aa8-4005-92da-10fac1d2fef5">P182D</aort:DebtInstrumentExtensionCircumstancePeriod>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iaea6f089ed074e359ce7c3f017e6b10b_D20210602-20210602"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjA3Nw_d5c89334-d46a-4413-aad1-0d768d75027f"
      unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i3079296817f64fe0829aa2166586dc63_D20210602-20210602"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjEwOA_d23ceee1-daf4-4711-b099-12127f7b5b22"
      unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2c4d08f8fa5d4fa69f8b6d4049e4bb52_D20210601-20210601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjIyMQ_66aa3a3c-48aa-438d-9fdd-bbadd8100d1c"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7d9fad1b5e5f409ab72291a10865c569_D20210601-20210601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjI1Mg_9d27b698-c715-4464-8f84-2df73eed0c0c"
      unitRef="number">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i7ee1e8077bf9471fbd587c9b736b28e0_D20210602-20210602"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjI4Nw_6ed7d29f-364c-4cb4-a550-7451d7aadb89"
      unitRef="usd">2100000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i7ee1e8077bf9471fbd587c9b736b28e0_D20210602-20210602"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjMwMA_3853b618-b9ad-4c89-8c72-1e112e644ec3"
      unitRef="usd">1800000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ie5eabbbcdab349c69c7b71952f9f1c67_D20210602-20210602"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjQ2NA_2c8a4ba6-96c6-4440-b6da-c07e1fc7f1d9"
      unitRef="usd">361000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ie5eabbbcdab349c69c7b71952f9f1c67_D20210602-20210602"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMjQ5NA_6db054c5-fd61-41c7-bcfe-750d2bf3fc2d"
      unitRef="usd">474000</us-gaap:ExtinguishmentOfDebtAmount>
    <aort:RevolvingCreditFacilityPercentageRepaidForNoCovenants
      contextRef="i7ea6eb948294472ab4381af301387075_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMzMxMA_16db16bb-3866-437e-a7a2-4566df68f47d"
      unitRef="number">0.25</aort:RevolvingCreditFacilityPercentageRepaidForNoCovenants>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i18723f9aeb154e06b9755af8e0a35dc0_I20200618"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMzU2OA_3e58ec24-a08b-4f01-a370-1d524f98ec7e"
      unitRef="usd">100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i18723f9aeb154e06b9755af8e0a35dc0_I20200618"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMzYwMQ_da508608-c598-4a83-9868-bd843455db83"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i0f3ad67fb29042d3a507e43f558ecda8_D20200618-20200618"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfMzgzNw_9c765930-d69e-4aae-9d88-797802d6deb4"
      unitRef="usd">96500000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:LongTermDebt
      contextRef="i57c5164417a34d7cad7bfcdca48c018d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDAwMw_8be7ca79-02c0-419f-8577-94ff76fa9f9f"
      unitRef="usd">100000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i18723f9aeb154e06b9755af8e0a35dc0_I20200618"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDM1Nw_0fe49c63-ee12-41f6-bb21-976f85559641"
      unitRef="usdPerShare">23.46</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFairValue
      contextRef="icc66c0e69857453e9e2dfc50dbf9e1be_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDYzNQ_2ec84e04-0885-4f01-8f18-07b1a643f983"
      unitRef="usd">92300000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="icc66c0e69857453e9e2dfc50dbf9e1be_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDY0Mg_60376191-a68e-4923-821a-f7ccbf61ef43"
      unitRef="number">0.0505</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpenseDebt
      contextRef="i027b214348ca447cb2405a448216447e_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDg2Ng_0fe7e9b5-9928-4429-b7a0-5bec0f702d64"
      unitRef="usd">1200000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ibaad6e3991c64789be68b008759c87e6_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDg3NA_ae18bee1-d7b8-4e8e-a3d8-544ba15b1c4d"
      unitRef="usd">3700000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="icbe178457b16413291bbf12b116f4451_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDkyMw_821a000b-5494-4113-9395-9f7289f4efbe"
      unitRef="usd">1200000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ibaf43f6c29284708b18275267e3af457_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNDkzMA_a2ddf465-96b7-46e5-bdd4-ac863d79dade"
      unitRef="usd">3700000</us-gaap:InterestExpenseDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="icc66c0e69857453e9e2dfc50dbf9e1be_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNTIwNQ_527424cf-790b-48b6-83a9-83848ca1c757"
      unitRef="usd">2000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="idb55cd7b1c67424e83334b51ddeeed75_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNTY0OA_2716fc83-02ed-4b71-a716-68a5cce10d58"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="idb55cd7b1c67424e83334b51ddeeed75_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNTcxMg_e816bd60-d67b-4458-a908-10509ec9aecf"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="idb55cd7b1c67424e83334b51ddeeed75_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNTg2MQ_437ac25f-cc97-49c6-a86f-b0f205fa4359"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i3162fd9f3aad4da4b4a6c31ca14cc416_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNTkzNg_d942f530-565b-4189-990c-e8f4a874cf24"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i3162fd9f3aad4da4b4a6c31ca14cc416_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNTk2OQ_cc8bca95-2413-4b21-b4ee-ef52a4f8557c"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i3162fd9f3aad4da4b4a6c31ca14cc416_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNjEyNA_82ecabfb-2cb3-497f-9c8f-4d4785e2ce55"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="iee01dabe643e479586ec04799b683ba4_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNjk1Mg_6e54f696-869b-4eaa-bce4-abb657a18735"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="iee01dabe643e479586ec04799b683ba4_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNzAwNw_62b6f31b-9630-49cf-89de-4bca8afe3678"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="iee01dabe643e479586ec04799b683ba4_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNzA2Mw_efb6c633-221b-441d-951c-9dba986d019f"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <aort:DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount
      contextRef="iee01dabe643e479586ec04799b683ba4_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfNzM1OA_ccd04e71-d19a-4ed3-ad2f-abb95bedbd80"
      unitRef="number">1</aort:DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfODIyNA_9be787ee-d704-4ac4-95c7-6900a1dca259">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The short-term and long-term balances of our term loan and other long-term borrowings were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Term loan balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;214,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;216,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.45% Sparkasse Zollernalb (KFW Loan 1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1.40% Sparkasse Zollernalb (KFW Loan 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total loan balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;315,369&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;317,627&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less unamortized loan origination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(7,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(8,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;308,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;309,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less short-term loan balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(1,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(1,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Long-term loan balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;306,674&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;307,493&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i33db3b1cd5a744adaf668932b3d7a752_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMS0xLTEtMS0yMTE2MQ_f0880971-3c5c-4e02-894d-15b4167fc39e"
      unitRef="usd">214313000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifda76d72993449d1998f915ef6c42d12_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMS0zLTEtMS0yMTE2MQ_62ff535a-9fe9-436b-863f-309daff104f4"
      unitRef="usd">216000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iacc74ff3ae064710b11fbf91c5b4da32_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMi0xLTEtMS0yMTE2MQ_e3a32b03-8dd1-4719-b7f8-bdbfac50113e"
      unitRef="usd">100000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ieb17620c310648b8a165d09b227c1a9d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMi0zLTEtMS0yMTE2MQ_a1ec6c45-ac4f-4375-aeed-b64a20d0e6ca"
      unitRef="usd">100000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2917e811dec840bfa296f07c2b87727d_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMy0wLTEtMS0yMTE2MS90ZXh0cmVnaW9uOmUxOGI5ZGY5NjhjMTQ5M2ZhMDEyNTkyOTFlNGUxZjg0XzQ_b4234b10-b1f6-4f21-8731-2f9a92983680"
      unitRef="number">0.0245</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2917e811dec840bfa296f07c2b87727d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMy0xLTEtMS0yMTE2MQ_aa698a9f-95d1-48c0-918a-57ff15fac653"
      unitRef="usd">325000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib6c541e6344348c7932037179bc9a6a0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfMy0zLTEtMS0yMTE2MQ_536392df-62f3-4115-9d5e-0fa259d4bbbf"
      unitRef="usd">566000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7d9322af829e4028a7955119f8529d4f_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNC0wLTEtMS0yMTE2MS90ZXh0cmVnaW9uOjdmZTRjNWIxOTBkNjRhNzFiOGNlZDRhYmM3Y2ViOTYzXzQ_a8f3cdd3-2d68-4266-b6d8-94327d1a5524"
      unitRef="number">0.0140</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7d9322af829e4028a7955119f8529d4f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNC0xLTEtMS0yMTE2MQ_1a49e448-a06a-4987-a87a-5cf5c20b8db1"
      unitRef="usd">731000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id8d8863bba6645fab208cbec4e5af0c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNC0zLTEtMS0yMTE2MQ_c64f44c7-89c1-472a-a750-ee15ca802112"
      unitRef="usd">1061000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNS0xLTEtMS0yMTE2MQ_66389956-bda8-4593-8900-d7ba215c6033"
      unitRef="usd">315369000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNS0zLTEtMS0yMTE2MQ_779c4634-ad90-43c4-835f-b6a816246d4c"
      unitRef="usd">317627000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNi0xLTEtMS0yMTE2MQ_05e50421-cccf-4344-b228-200fb62d66c7"
      unitRef="usd">7133000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNi0zLTEtMS0yMTE2MQ_bf585f29-9bd9-4a37-9eb3-0a7f6a74e7c1"
      unitRef="usd">8504000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNy0xLTEtMS0yMTE2MQ_5d61ec09-efe8-43a7-8ed4-b91629cf3b48"
      unitRef="usd">308236000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfNy0zLTEtMS0yMTE2MQ_7adc88ba-2a39-422d-a64e-c1f1079429a1"
      unitRef="usd">309123000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfOC0xLTEtMS0yMTE2MQ_48e3e2f8-17a2-48f7-b4cd-09cf5c81bd1f"
      unitRef="usd">1562000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfOC0zLTEtMS0yMTE2MQ_c5c3bbc1-62d8-4028-9fa5-985ccc53f2fb"
      unitRef="usd">1630000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfOS0xLTEtMS0yMTE2MQ_fef5fa17-2ccf-4355-b981-29680d00d6ab"
      unitRef="usd">306674000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i92a6652f436d43be99bd75c32c0406d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RhYmxlOjcyY2YxMjgzNDcwYzQ5MDNiMjBiMDgwMGM0Njk0ZmU0L3RhYmxlcmFuZ2U6NzJjZjEyODM0NzBjNDkwM2IyMGIwODAwYzQ2OTRmZTRfOS0zLTEtMS0yMTE2MQ_2d0bde54-bd75-45ba-9f9a-cccc3a3252cd"
      unitRef="usd">307493000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:InterestExpenseDebt
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfODEwNQ_bccbdc51-c110-402f-8dc2-c845f8c7f826"
      unitRef="usd">4800000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfODExMg_3899681a-ea06-42fa-abce-ae3e7fb0b92a"
      unitRef="usd">12900000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfODE3Mg_d6c6a7b1-ff02-472e-aa1e-ffbcc960793e"
      unitRef="usd">4100000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81Mi9mcmFnOjRhOWRlMjRmOTU1ODQ5ZGI4MzA4NzFiMDk3MDNkYWZhL3RleHRyZWdpb246NGE5ZGUyNGY5NTU4NDlkYjgzMDg3MWIwOTcwM2RhZmFfODE3OQ_0c618c51-71c1-4d82-8b0a-6cf8534a09dc"
      unitRef="usd">13000000</us-gaap:InterestExpenseDebt>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81OC9mcmFnOmIwOTM0YzA4N2I2YjRlOGRiNDZjMWFhNTlkNDBjYTVkL3RleHRyZWdpb246YjA5MzRjMDg3YjZiNGU4ZGI0NmMxYWE1OWQ0MGNhNWRfOTI3_016b3242-694a-4aa2-a840-16322c91f902">Commitments and Contingencies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liability Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, we are made aware of adverse events involving our products and tissues. Future adverse events could ultimately give rise to a lawsuit against us, and liability claims may be asserted against us in the future based on past events that we are not aware of at the present time. We maintain claims-made insurance policies to mitigate our financial exposure to product and tissue processing liability claims. Claims-made insurance policies generally cover only those asserted claims and incidents that are reported to the insurance carrier while the policy is in effect. The amounts recorded in these Condensed Consolidated Financial Statements as of September&#160;30, 2022 represent our estimate of the probable losses and anticipated recoveries for incurred but not reported claims related to products sold and services performed prior to the balance sheet date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PROACT Xa Clinical Trial Termination&lt;/span&gt;&lt;/div&gt;On September 23, 2022 we announced that we were stopping the PROACT Xa clinical trial as recommended by the trial's independent Data and Safety Monitoring Board. The PROACT Xa clinical trial was a prospective, randomized, trial designed to determine if patients with  On-X mechanical aortic valves could be maintained safely and effectively on apixaban rather than on warfarin. As a result of PROACT Xa's early termination, we recorded $4.7 million of termination and wind-down expenses that are included in Research and development operating expenses on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income for the three and nine months ended September 30, 2022. The majority of these costs include future administrative costs that will be incurred during the fourth quarter of 2022 and the first quarter of 2023, as well as the estimated cost of clinical drugs purchased for patients participating in the study that are not expected to be recovered.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <aort:ResearchAndDevelopmentExpenseTerminationAndWindDownCosts
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81OC9mcmFnOmIwOTM0YzA4N2I2YjRlOGRiNDZjMWFhNTlkNDBjYTVkL3RleHRyZWdpb246YjA5MzRjMDg3YjZiNGU4ZGI0NmMxYWE1OWQ0MGNhNWRfNTQ5NzU1ODE1MjU3_83b44fdc-94ef-4190-87ef-40a98da3edfc"
      unitRef="usd">4700000</aort:ResearchAndDevelopmentExpenseTerminationAndWindDownCosts>
    <aort:ResearchAndDevelopmentExpenseTerminationAndWindDownCosts
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV81OC9mcmFnOmIwOTM0YzA4N2I2YjRlOGRiNDZjMWFhNTlkNDBjYTVkL3RleHRyZWdpb246YjA5MzRjMDg3YjZiNGU4ZGI0NmMxYWE1OWQ0MGNhNWRfNTQ5NzU1ODE1MjU3_c7d6b4e9-2b46-4f3a-9d6e-6dd451ed2318"
      unitRef="usd">4700000</aort:ResearchAndDevelopmentExpenseTerminationAndWindDownCosts>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RleHRyZWdpb246MGNjNjM2Y2RjY2YxNDMxM2JmYTRkYjk4NTUxYzUyZTZfMTcxNw_5f71a00e-5b48-4811-88f0-67818dc8be33">Revenue Recognition&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sources of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have identified the following revenues disaggregated by revenue source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Domestic hospitals &#x2013; direct sales of products and preservation services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;International hospitals &#x2013; direct sales of products and preservation services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;International distributors &#x2013; generally these contracts specify a geographic area that the distributor will service, terms and conditions of the relationship, and purchase targets for the next calendar year.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;CardioGenesis cardiac laser console trials and sales &#x2013; CardioGenesis cardiac trialed laser consoles are delivered under separate agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September&#160;30, 2022 and 2021 the sources of revenue were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Domestic hospitals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,842&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;36,129&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;117,343&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;111,291&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;International hospitals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;24,119&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;25,458&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;79,768&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;79,219&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;International distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11,469&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,544&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;34,685&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;28,694&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;CardioGenesis cardiac laser therapy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;408&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;76&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,595&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;238&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total sources of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;76,838&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;72,207&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;234,391&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;219,442&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also see segment disaggregation information in Note 14 below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may generate contract assets during the pre-delivery design and manufacturing stage of E-xtra Design Engineering product order fulfillment. We assess the balance related to any arrangements in process and determine if the enforceable right to payment creates a material contract asset requiring disclosure. No material arrangements in process existed as of September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also incur contract obligations on general customer purchase orders that have been accepted but unfulfilled. Due to the short duration of time between order acceptance and delivery of the related product or service, we have determined that the balance related to these contract obligations is generally immaterial at any point in time. We monitor the value of orders accepted but unfulfilled at the close of each reporting period to determine if disclosure is appropriate. The value of orders accepted but unfulfilled as of September&#160;30, 2022 and 2021 was not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RleHRyZWdpb246MGNjNjM2Y2RjY2YxNDMxM2JmYTRkYjk4NTUxYzUyZTZfMTcxOA_126add70-5d7d-4ea9-87b6-d00c3af53ed4">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September&#160;30, 2022 and 2021 the sources of revenue were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Domestic hospitals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,842&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;36,129&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;117,343&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;111,291&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;International hospitals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;24,119&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;25,458&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;79,768&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;79,219&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;International distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11,469&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,544&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;34,685&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;28,694&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;CardioGenesis cardiac laser therapy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;408&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;76&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,595&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;238&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total sources of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;76,838&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;72,207&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;234,391&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;219,442&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19857ac737a849ee839c3f22bc8089c2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMi0xLTEtMS0yMTE2MQ_2ba8ee51-a229-4ead-a477-9bda13b025fa"
      unitRef="usd">40842000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11915924fe704fb89347da42e1ef2eb2_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMi0zLTEtMS0yMTE2MQ_e956b928-ff4a-46fb-9029-6385e54a98b2"
      unitRef="usd">36129000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia809a613bd144fa0a274104dcd26acb1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMi01LTEtMS0yMTE2MQ_c210c98d-c188-43fc-b394-b7b1144d11fb"
      unitRef="usd">117343000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i899343d6cb944a4681fdbfcdbd5d1ca8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMi03LTEtMS0yMTE2MQ_1ade94a8-eada-4bb1-984a-ce15b7ff0d64"
      unitRef="usd">111291000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id714b6b2b6a64790a42d603abb8e18f3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMy0xLTEtMS0yMTE2MQ_4b1ab3b0-176c-4034-bd81-31146268df2f"
      unitRef="usd">24119000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68e49df3a3c64e688b8a31a561b96ed9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMy0zLTEtMS0yMTE2MQ_f916af3f-8dab-4534-af81-1dd9a5c56b32"
      unitRef="usd">25458000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa5de9333d824fe48fda6782f64fdc3c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMy01LTEtMS0yMTE2MQ_d8b61572-1e4f-408b-b7a9-6b8f1b93a0f0"
      unitRef="usd">79768000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4668dfae4f444b93ac2d0b184ad2f75e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfMy03LTEtMS0yMTE2MQ_e69ec47f-14c4-4099-948d-d1e556a8d7fb"
      unitRef="usd">79219000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45c79bfd4d6346bb876c81a81a51573a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNC0xLTEtMS0yMTE2MQ_a91d3173-a85b-4e31-a64b-f659b5cd1272"
      unitRef="usd">11469000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i281a6ea681e94b3b8da636232186b497_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNC0zLTEtMS0yMTE2MQ_2046faa3-90bf-41ae-9078-9ab1d65af3ec"
      unitRef="usd">10544000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48e4181561d94c5fbb84354840056db1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNC01LTEtMS0yMTE2MQ_21c7c121-0e82-4e56-b79a-dcf5c613cf04"
      unitRef="usd">34685000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1599f4e6f31b49738062fad1654aec04_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNC03LTEtMS0yMTE2MQ_b656ef86-1e32-4ea5-92af-c44b32620698"
      unitRef="usd">28694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9704cb4285d424bbc6f7b1dfef34dc5_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNS0xLTEtMS0yMTE2MQ_92d3ffbf-de27-461c-8298-242a57041981"
      unitRef="usd">408000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i342b33ea32d64961aa1bcb645535ae46_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNS0zLTEtMS0yMTE2MQ_6532b82d-7700-4a70-a736-c4f6469eaaba"
      unitRef="usd">76000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42999e55d750436abb4dc19f0fde883f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNS01LTEtMS0yMTE2MQ_6cca7ef9-3510-4877-81c6-5764723a3f7f"
      unitRef="usd">2595000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fdd33ca91264d388735248eee07f5b7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNS03LTEtMS0yMTE2MQ_9813d3c9-eb10-4bca-9a50-9188793d38b0"
      unitRef="usd">238000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNi0xLTEtMS0yMTE2MQ_7df14d68-e2c0-4f3d-bbe5-a8b72becb3dc"
      unitRef="usd">76838000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNi0zLTEtMS0yMTE2MQ_cd543aad-feb7-4793-97f5-15db4c261a6d"
      unitRef="usd">72207000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNi01LTEtMS0yMTE2MQ_1b37d4c7-449b-4ab3-86d6-43c2c03fe11d"
      unitRef="usd">234391000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82MS9mcmFnOjBjYzYzNmNkY2NmMTQzMTNiZmE0ZGI5ODU1MWM1MmU2L3RhYmxlOjg4MTVhYzk4ZGYyNzRiNTE4MGIxMjZkNTVmMTIyYzY0L3RhYmxlcmFuZ2U6ODgxNWFjOThkZjI3NGI1MTgwYjEyNmQ1NWYxMjJjNjRfNi03LTEtMS0yMTE2MQ_708c9b8e-d8d1-4060-8c0b-7b1ae7cb6d3f"
      unitRef="usd">219442000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjg2NQ_189d9b04-69f8-4aad-91cc-c3842c957b70">Stock Compensation &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock units (&#x201c;RSUs&#x201d;), performance stock units (&#x201c;PSUs&#x201d;), and options to purchase shares of our common stock at exercise prices generally equal to the fair value of such stock at the dates of grant. We also maintain a shareholder-approved Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) for the benefit of our employees. The ESPP allows eligible employees to purchase common stock on a regular basis at the lower of 85% of the market price at the beginning or end of each offering period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Grants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2022 the&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Compensation Committee of our Board of Directors (the &#x201c;Committee&#x201d;) authorized awards from approved stock incentive plans of RSAs to non-employee directors and RSUs and PSUs to certain employees and company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together totaled 520,000 shares and had an aggregate grant date fair value of $9.7 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021 the Committee authorized awards from approved stock incentive plans of RSAs to non-employee directors, RSUs to certain employees, and RSAs and PSUs to certain Company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together totaled 494,000 shares and had an aggregate grant date fair value of $12.5 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Committee authorized, from approved stock incentive plans, grants of stock options to purchase a total of 314,000 and 226,000 shares to certain Company officers during the nine months ended September&#160;30, 2022 and 2021, respectively. The exercise prices of the options were equal to the closing stock prices on their respective grant dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employees purchased common stock totaling 58,000 and 95,000 shares in the three and nine months ended September&#160;30, 2022, respectively, as compared to 51,000 and 87,000 shares in the three and nine months ended &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively, through the ESPP. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Compensation Expense &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used to determine the fair value of options and shares purchased under the ESPP: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Stock&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.5 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.0 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.5 Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.52%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1.89%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.22%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes total stock compensation expenses prior to the capitalization of amounts into Deferred preservation and Inventory costs (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;RSA, RSU, and PSU expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;7,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Stock option and ESPP expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,233&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2,990&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;9,654&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;7,895&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Included in the total stock compensation expense, as applicable in each period, were expenses related to RSAs, RSUs, PSUs, and stock options issued in each respective year, as well as those issued in prior periods that continue to vest during the period, and compensation related to the ESPP. These amounts were recorded as stock compensation expense and were subject to our normal allocation of expenses to inventory costs and deferred preservation costs. We capitalized $144,000 and $465,000 in the three and nine months ended September 30, 2022, respectively, and $115,000 and $424,000 in the three and nine months ended September 30, 2021, respectively, of the stock compensation expense into our inventory costs and deferred preservation costs.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="iee66ca91fc234b09b3c2d8a46621d0df_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfNjAy_82970806-b999-4e6b-bec7-293118e9e86c"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i15ccab14e00e482fa8cc9b73fec811d4_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTA0MQ_76bbfd37-161c-4985-b931-a7daeac03789"
      unitRef="shares">520000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <aort:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted
      contextRef="i15ccab14e00e482fa8cc9b73fec811d4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTA5Nw_5e36be95-6c44-4d62-bc29-ee4d87e29b9d"
      unitRef="usd">9700000</aort:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8cfd4278c4d54da3ad77a6c6aa2631c6_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTQxMg_a39d692a-26f2-45ba-a2bd-5c7852f9502b"
      unitRef="shares">494000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <aort:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted
      contextRef="i8cfd4278c4d54da3ad77a6c6aa2631c6_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTQ2OA_24e82834-c603-4671-945c-a43efe9588d5"
      unitRef="usd">12500000</aort:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i2743263dde35403486ed30d48ff92d6f_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTU4Mw_7cf17319-a5b3-458d-91e7-75368686a104"
      unitRef="shares">314000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i41e84a48d560438c8c1d2cd5b2e60304_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTU5MA_f5dd1704-4403-4bd5-b72a-4683a8d48d22"
      unitRef="shares">226000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i7fb88599f3ba47168b057695501cbbcf_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMTgyOQ_e11999d0-e419-4fd6-b96e-3a6b178c76aa"
      unitRef="shares">58000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="iee66ca91fc234b09b3c2d8a46621d0df_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfNDk0NzgwMjMyODA1Mw_3886090e-cad2-4369-97b0-59b4643da3d5"
      unitRef="shares">95000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i461739b4f0b94d58b483520fd7eacf68_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfNDk0NzgwMjMyODA1Nw_94d06333-5f68-41e0-9fb6-428f0c090c65"
      unitRef="shares">51000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i014313fc131f48999cd3c9dec9fb977c_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfNDk0NzgwMjMyODA2MQ_85885d6a-bcfb-42fd-b582-48a094086e60"
      unitRef="shares">87000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjg2Ng_cb827b1c-4259-4524-9bc5-26a4ae69bc75">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used to determine the fair value of options and shares purchased under the ESPP: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Stock&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.5 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.0 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.5 Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.52%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1.89%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.22%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i7fb88599f3ba47168b057695501cbbcf_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfMi0zLTEtMS0yMTE2MQ_7ff104af-657e-44ca-ae2f-aea34f60056a">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i42eac7fb937149b19cdc9f258f5ac32e_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfMi01LTEtMS0yMTE2MQ_baac7d95-3eb5-42d6-8216-4958b2e8eb4e">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="iee66ca91fc234b09b3c2d8a46621d0df_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfMi03LTEtMS0yMTE2MQ_0231c6c9-a662-4e41-9d07-4eb33de19f2a">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i7fb88599f3ba47168b057695501cbbcf_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfMy0zLTEtMS0yMTE2MQ_ba149bcf-eac7-495f-96e9-ff9ac4509fbb"
      unitRef="number">0.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i42eac7fb937149b19cdc9f258f5ac32e_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfMy01LTEtMS0yMTE2MQ_e2cbdcb8-5f8b-4aa3-b1ff-a2bc263c3291"
      unitRef="number">0.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="iee66ca91fc234b09b3c2d8a46621d0df_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfMy03LTEtMS0yMTE2MQ_546d15af-ae66-409c-83e4-700881fffafa"
      unitRef="number">0.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i7fb88599f3ba47168b057695501cbbcf_D20220701-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfNC0zLTEtMS0yMTE2MQ_61efe5c9-8619-4062-8459-d4936b205e7a"
      unitRef="number">0.0252</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i42eac7fb937149b19cdc9f258f5ac32e_D20220101-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfNC01LTEtMS0yMTE2MQ_e0db0db9-f245-49a8-b93d-655c0eb498c1"
      unitRef="number">0.0189</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="iee66ca91fc234b09b3c2d8a46621d0df_D20220101-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOjZjYzU0OWE3ZTJjMDRlNTdhNmVlODdhMzhlNmUyZTA2L3RhYmxlcmFuZ2U6NmNjNTQ5YTdlMmMwNGU1N2E2ZWU4N2EzOGU2ZTJlMDZfNC03LTEtMS0yMTE2MQ_21d0597b-df46-4e24-9d33-aefd9ec39ff2"
      unitRef="number">0.0022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjg2NA_3423c464-97ff-4a8a-b3c7-42a236ae23cf">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes total stock compensation expenses prior to the capitalization of amounts into Deferred preservation and Inventory costs (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;RSA, RSU, and PSU expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;7,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Stock option and ESPP expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,233&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2,990&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;9,654&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;7,895&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i7b553a2641f34d9fbc27aa2ae76e41e4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMi0xLTEtMS0yMTE2MQ_cbce07ae-02b2-414e-90f5-e37d6256ba90"
      unitRef="usd">2622000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i89e0d9a60d324513b3fdf16f71bc2d39_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMi0zLTEtMS0yMTE2MQ_602da83c-35af-459a-99ed-ee9b15a09cff"
      unitRef="usd">2465000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i381fc1148e2b43d8bbc80cf38962e6a1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMi01LTEtMS0yMTE2MQ_a2e8a68f-2741-4eb2-befa-dcfc82a41cf3"
      unitRef="usd">7860000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i298934a6b2a54c778e6398d092865235_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMi03LTEtMS0yMTE2MQ_b8e309f8-e15b-4755-8031-dbe88ea8a380"
      unitRef="usd">6211000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="ie9c2d41d46d24d208d34d8d8f2b436e1_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMy0xLTEtMS0yMTE2MQ_8eacb6a6-71ec-4898-b648-4bc4b4410efc"
      unitRef="usd">611000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i6984cade7c05443d9b12c962524d654d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMy0zLTEtMS0yMTE2MQ_b13b6c26-f1a6-4eb5-932f-71fbe2d60558"
      unitRef="usd">525000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i354fb63b18a2436c9633c0f1845308b2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMy01LTEtMS0yMTE2MQ_eea78d05-b4fd-4b86-90a5-cef21e3b80ff"
      unitRef="usd">1794000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="ib4a80aa36fc046ebb86b318c4afa0f59_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfMy03LTEtMS0yMTE2MQ_55a28ffb-c272-45a4-98dd-55d64a920e26"
      unitRef="usd">1684000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfNC0xLTEtMS0yMTE2MQ_7a4e7f91-88c6-4f2b-ba5c-689d415655d6"
      unitRef="usd">3233000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfNC0zLTEtMS0yMTE2MQ_d447c0ae-9dcd-40c2-a60e-214f0876d258"
      unitRef="usd">2990000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfNC01LTEtMS0yMTE2MQ_af965f13-49c3-4770-8c72-fc0b78efea90"
      unitRef="usd">9654000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RhYmxlOmFjNWU3YmQ2MWQ1ZjQ3OGE4M2NkOGI5ZjU2YmNkODJhL3RhYmxlcmFuZ2U6YWM1ZTdiZDYxZDVmNDc4YTgzY2Q4YjlmNTZiY2Q4MmFfNC03LTEtMS0yMTE2MQ_b47246a3-93f5-468b-bb87-bfc9517fe579"
      unitRef="usd">7895000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjY5OA_4c967e49-369a-40d4-99fe-522695ca7123"
      unitRef="usd">144000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjcwNQ_333ec157-7447-4cd3-bcfa-c33a8be7cff2"
      unitRef="usd">465000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjczNw_d01eda82-f131-4c1e-b06b-a04284ce7f5c"
      unitRef="usd">115000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82NC9mcmFnOmI5MjM5ZWE4NjljNDRjYjZhMDkwMGZiZDJmOTU0MWE5L3RleHRyZWdpb246YjkyMzllYTg2OWM0NGNiNmEwOTAwZmJkMmY5NTQxYTlfMjc0NA_56a1c72c-c99a-4dc9-847f-e097b2c05d9d"
      unitRef="usd">424000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RleHRyZWdpb246M2I0Y2ZhYTc4ZjJmNDhlMWJkNGJjYTdiMjIyODUwMmNfODAx_b3e5a239-5e26-4548-89df-24e4489241d5">(Loss) Earnings Per Common Share &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted (loss) income per common share (in thousands, except per share data): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Basic (loss) income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(13,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(21,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss (income) allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;109&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net (loss) income allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(13,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;10,519&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(21,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;5,232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,115&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;39,086&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;39,999&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;38,924&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Basic (loss) income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;0.27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;0.13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Diluted (loss) income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(13,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(21,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss (income) allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;109&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss attributable to convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net (loss) income allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(13,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;11,446&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(21,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;5,232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,115&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;39,086&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;39,999&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;38,924&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Effect of dilutive stock options and awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1.25pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;505&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;572&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Effect of convertible senior notes &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1.25pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,862&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,115&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;44,453&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;39,999&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;39,496&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Diluted (loss) income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;0.26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;0.13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares because the inclusion of these stock options would be antidilutive to loss per common share. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September&#160;30, 2022 all stock options and awards were excluded from the calculation of diluted weighted-average common shares outstanding as these would be antidilutive due to the net loss. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September&#160;30, 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 539,000 and 517,000 of potential common shares relating to stock options, respectively, were antidilutive and excluded from the calculation of diluted weighted-average common shares outstanding. We excluded 4,860,685 of potential common shares related to our Convertible Senior Notes calculated under the if-converted method, as these shares would be antidilutive for the nine months ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2021&lt;/span&gt;.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RleHRyZWdpb246M2I0Y2ZhYTc4ZjJmNDhlMWJkNGJjYTdiMjIyODUwMmNfODAy_ea2205ea-c2a7-4c4c-b31d-b9639e12661a">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted (loss) income per common share (in thousands, except per share data): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Basic (loss) income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(13,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(21,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss (income) allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;109&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net (loss) income allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(13,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;10,519&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(21,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;5,232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,115&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;39,086&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;39,999&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;38,924&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Basic (loss) income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;0.27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;0.13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.409%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Diluted (loss) income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(13,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(21,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss (income) allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;109&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss attributable to convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net (loss) income allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(13,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;11,446&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(21,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;5,232&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,115&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;39,086&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;39,999&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;38,924&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Effect of dilutive stock options and awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1.25pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;505&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;572&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Effect of convertible senior notes &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1.25pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,862&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,115&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;44,453&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;39,999&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;39,496&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Diluted (loss) income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;0.26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;0.13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMi0yLTEtMS0yMTE2MQ_9a7720e6-29c8-4297-91fc-7549a42ea72b"
      unitRef="usd">-13713000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMi00LTEtMS0yMTE2MQ_52d4fcd5-0f3d-4bba-af12-201fc85d3dbe"
      unitRef="usd">10582000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMi02LTEtMS0yMTE2MQ_42f8c92d-8c3c-42f1-ac99-e1e0c71da31e"
      unitRef="usd">-21361000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMi04LTEtMS0yMTE2MQ_d08cd39d-5550-4d94-855d-71b27ac97b80"
      unitRef="usd">5266000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMy0yLTEtMS0yMTE2MQ_bc63931e-ce06-4342-afc5-c87c41cc80c3"
      unitRef="usd">-70000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMy00LTEtMS0yMTE2MQ_ffeeb880-f992-4d30-8015-2ba1e136f730"
      unitRef="usd">63000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMy02LTEtMS0yMTE2MQ_d96f7764-2060-41c8-87e7-4e861ebafd41"
      unitRef="usd">-109000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfMy04LTEtMS0yMTE2MQ_6c2e1294-72ff-48c2-8953-cbed6ebe3275"
      unitRef="usd">34000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNC0yLTEtMS0yMTE2MQ_4c519e9e-233a-46e6-bd81-31e204ab471f"
      unitRef="usd">-13643000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNC00LTEtMS0yMTE2MQ_79d7554e-6cca-45bd-97af-e2f15d2fd57a"
      unitRef="usd">10519000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNC02LTEtMS0yMTE2MQ_6e12073b-671c-483e-b7cf-ffabf9330c04"
      unitRef="usd">-21252000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNC04LTEtMS0yMTE2MQ_345c5ebd-f508-4358-91ea-811bc2ae022c"
      unitRef="usd">5232000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNi0yLTEtMS0yMTE2MQ_485a300e-cfa6-407b-ae98-00451b5f75e4"
      unitRef="shares">40115000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNi00LTEtMS0yMTE2MQ_e7f9634e-894b-473e-916a-a4499bee03bd"
      unitRef="shares">39086000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNi02LTEtMS0yMTE2MQ_5d7a016a-1c4d-440e-89c3-fe4529c81c86"
      unitRef="shares">39999000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNi04LTEtMS0yMTE2MQ_56691b54-c8b3-48b0-98ab-f51746e6d8c1"
      unitRef="shares">38924000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNy0yLTEtMS0yMTE2MQ_26214ed2-1590-4c7e-b4a0-9ee8d87da872"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNy00LTEtMS0yMTE2MQ_68c7897b-57dc-44b5-97b8-d309d9d906fa"
      unitRef="usdPerShare">0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNy02LTEtMS0yMTE2MQ_0a3c78ef-6427-4e1a-8620-eb5df3347ab9"
      unitRef="usdPerShare">-0.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmMyNWQ0M2I5OTU3ZDQ5ZjM5MzNkNzdkMTY2NzMxY2IyL3RhYmxlcmFuZ2U6YzI1ZDQzYjk5NTdkNDlmMzkzM2Q3N2QxNjY3MzFjYjJfNy04LTEtMS0yMTE2MQ_c4b4c5ac-459d-4b61-b24b-796912c9b3dd"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMi0yLTEtMS0yMTE2MQ_bf65b2e0-b00f-4cb5-9d84-a6f7af99e2ee"
      unitRef="usd">-13713000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMi00LTEtMS0yMTE2MQ_3775cc7c-7cad-4ee8-ade3-532907477edb"
      unitRef="usd">10582000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMi02LTEtMS0yMTE2MQ_745b07ed-e51e-463f-b51a-db421a18e267"
      unitRef="usd">-21361000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMi04LTEtMS0yMTE2MQ_f72d3880-caf4-446c-b1f3-6ba9edc973ef"
      unitRef="usd">5266000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMy0yLTEtMS0yMTE2MQ_d63b8332-5135-4c30-b020-eaf3ae426135"
      unitRef="usd">-70000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMy00LTEtMS0yMTE2MQ_f869f8c5-4331-46f7-8899-04a642e4f64b"
      unitRef="usd">55000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMy02LTEtMS0yMTE2MQ_591b5cd3-ac2f-4c51-8644-34786b90d3ec"
      unitRef="usd">-109000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfMy04LTEtMS0yMTE2MQ_4ac65ff3-a825-416a-920f-b5307c263e49"
      unitRef="usd">34000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC0yLTEtMS0yMzgzOA_12fa691b-76bb-4ad6-89df-f06172bf1e03"
      unitRef="usd">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC00LTEtMS0yMzgzOA_b40208e4-40c0-4313-a88c-e01b3accfa61"
      unitRef="usd">919000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC02LTEtMS0yMzgzOA_35f0cdae-57d8-4c8c-957f-a2bb58180e19"
      unitRef="usd">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC04LTEtMS0yMzgzOA_6c928697-6ad1-4189-997b-90fb459ceafb"
      unitRef="usd">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC0yLTEtMS0yMTE2MQ_6f2c349e-a541-42cb-b096-804d8bd2a870"
      unitRef="usd">-13643000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC00LTEtMS0yMTE2MQ_35dcf56b-bfd9-40b7-a338-485068342d60"
      unitRef="usd">11446000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC02LTEtMS0yMTE2MQ_7d424174-933b-4b55-8172-b1cc0fa6c8b0"
      unitRef="usd">-21252000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNC04LTEtMS0yMTE2MQ_d13f3e48-043a-4b1b-93db-e08cbb9d0998"
      unitRef="usd">5232000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNi0yLTEtMS0yMTE2MQ_52af7fe9-783f-4d53-8d52-171c763488e1"
      unitRef="shares">40115000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNi00LTEtMS0yMTE2MQ_0485388d-b45f-430e-807f-9c1b6f150073"
      unitRef="shares">39086000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNi02LTEtMS0yMTE2MQ_e93182df-8c1a-48a3-9408-e88af208a1c4"
      unitRef="shares">39999000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNi04LTEtMS0yMTE2MQ_e055b82e-79bb-4600-9a32-c2fe1aaa98da"
      unitRef="shares">38924000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC0yLTEtMS0zMDE5MQ_1d677c72-6328-491a-921b-280f8258a559"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC00LTEtMS0zMDE5MQ_6865c4e1-8c7f-4c3a-9328-221775b38b9d"
      unitRef="shares">505000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC02LTEtMS0zMDE5MQ_45fb1e63-9d60-4e12-ad9b-de9efccb276c"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC04LTEtMS0zMDE5MQ_4f3a1f68-d933-4492-8fbc-12ca3ec088d5"
      unitRef="shares">572000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOS0yLTEtMS0zMDE5MQ_9824e7bd-4989-460d-ad0b-2e2841e51c01"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOS00LTEtMS0zMDE5MQ_89817233-4cce-4d25-826e-a79922835fb8"
      unitRef="shares">4862000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOS02LTEtMS0zMDE5MQ_9ceeedb5-91c9-4423-956c-555e2dec1575"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOS04LTEtMS0zMDE5MQ_a79a18ad-cfff-4c58-a894-68072f24a301"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNy0yLTEtMS0yMTE2MQ_04fcee66-4e1e-40f6-b126-04f5013016cd"
      unitRef="shares">40115000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNy00LTEtMS0yMTE2MQ_7b81b47b-9d4f-4326-885c-e2249b422147"
      unitRef="shares">44453000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNy02LTEtMS0yMTE2MQ_5cc6bd29-d450-48f3-9f05-cdb1f2e5eaa6"
      unitRef="shares">39999000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfNy04LTEtMS0yMTE2MQ_76c3dd35-4564-4205-aa6c-051c25429fa4"
      unitRef="shares">39496000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC0yLTEtMS0yMTE2MQ_d91959de-053c-44b8-ba5e-b09ed2ab5940"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC00LTEtMS0yMTE2MQ_2a5ab59c-e603-4f39-8566-109b903dd18c"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC02LTEtMS0yMTE2MQ_b27cc972-6a13-43ae-9dc5-f616672ab4c8"
      unitRef="usdPerShare">-0.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RhYmxlOmQ0YWU3YWJmZDQyZjQyMzk4ZTg4MWE4NDQ4MmU0MzBlL3RhYmxlcmFuZ2U6ZDRhZTdhYmZkNDJmNDIzOThlODgxYTg0NDgyZTQzMGVfOC04LTEtMS0yMTE2MQ_fe1e66fb-049f-4d45-bd41-aceb8add176a"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if109928fc6f647eab134f6bf056db23a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RleHRyZWdpb246M2I0Y2ZhYTc4ZjJmNDhlMWJkNGJjYTdiMjIyODUwMmNfNzE0NjgyNTU4MTgzMA_0e2cf8ef-2877-4d0a-9b9b-5f8955366c34"
      unitRef="shares">539000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idb0051e154454d23a5b025f8cdd2f9a0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RleHRyZWdpb246M2I0Y2ZhYTc4ZjJmNDhlMWJkNGJjYTdiMjIyODUwMmNfNzE0NjgyNTU4MTg0MA_5a5e7ca7-94ed-4f19-a031-7d15bdccd461"
      unitRef="shares">517000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibba44be2c273425fa97ea9bf1feae546_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV82Ny9mcmFnOjNiNGNmYWE3OGYyZjQ4ZTFiZDRiY2E3YjIyMjg1MDJjL3RleHRyZWdpb246M2I0Y2ZhYTc4ZjJmNDhlMWJkNGJjYTdiMjIyODUwMmNfNTQ5NzU1ODE1NDI0_faab1cb8-18b7-479f-ab7f-74ea7c4488af"
      unitRef="shares">4860685</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RleHRyZWdpb246NjM3YmQwNzRhOGEzNDk0OWE0YjNkYWFjMjBjMGE2YmRfMTM4Mg_39cdbe61-32fa-4d16-b652-e19bbea2fe55">Segment Information  &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have two reportable segments organized according to our products and services: Medical devices and Preservation services. The Medical devices segment includes external revenues from product sales of aortic stent grafts, surgical sealants, On-X, and other product revenues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Aortic arch stent grafts include our E-vita Open NEO, E-vita Open Plus, AMDS, NEXUS, E-vita Thoracic 3G, and E-nya products. Abdominal stent grafts include our E-xtra Design Engineering, E-nside, E-tegra, E-ventus BX, and E-liac products. Surgical sealants include BioGlue Surgical Adhesive products. The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues. There are no intersegment revenues. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary measure of segment performance, as viewed by our management, is segment gross margin or net external revenues less cost of products and preservation services. We do not segregate assets by segment, therefore, asset information is excluded from the segment disclosures below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Medical devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;55,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;53,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;171,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;162,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;21,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;62,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;56,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;76,838&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;72,207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;234,391&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;219,442&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Cost of products and preservation services:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Medical devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;15,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;53,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;46,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;8,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;29,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;26,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total cost of products and preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;28,094&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;24,418&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;82,756&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;73,302&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Gross margin:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Medical devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;37,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;37,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;118,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;115,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;33,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;30,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total gross margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;48,744&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;47,789&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;151,635&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;146,140&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes net revenues by product and service (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Products:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Aortic stent grafts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,674&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20,896&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;69,013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;62,165&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Surgical sealants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17,374&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;16,544&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;49,022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;52,236&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;On-X&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;16,456&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;14,022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;47,082&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;41,843&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,744&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,645&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,609&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,284&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;55,248&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;53,107&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;171,726&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;162,528&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;21,590&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;62,665&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;56,914&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;76,838&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;72,207&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;234,391&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;219,442&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RleHRyZWdpb246NjM3YmQwNzRhOGEzNDk0OWE0YjNkYWFjMjBjMGE2YmRfMjI_a349f839-dd57-40fd-b865-19cb1e609d62"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:Revenues
      contextRef="i9cc67891184f42aca2e8fcb53d876e27_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RleHRyZWdpb246NjM3YmQwNzRhOGEzNDk0OWE0YjNkYWFjMjBjMGE2YmRfODM0_65d3b6bc-be8f-47b5-b8f8-ec7acfe22076"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RleHRyZWdpb246NjM3YmQwNzRhOGEzNDk0OWE0YjNkYWFjMjBjMGE2YmRfMTM4Mw_b09e80d5-ffe8-4de9-8b61-982534b11193">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Medical devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;55,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;53,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;171,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;162,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;21,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;62,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;56,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;76,838&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;72,207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;234,391&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;219,442&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Cost of products and preservation services:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Medical devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;15,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;53,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;46,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;8,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;29,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;26,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total cost of products and preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;28,094&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;24,418&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;82,756&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;73,302&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Gross margin:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Medical devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;37,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;37,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;118,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;115,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;33,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;30,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total gross margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;48,744&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;47,789&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;151,635&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;146,140&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ed6e56bac6643c2b13e09943b8594b7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMy0xLTEtMS0yMTE2MQ_a4b52f87-002f-4a72-b42c-5f95ee9cb3d2"
      unitRef="usd">55248000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b620f0bebe540458a2e554bbc88fa32_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMy0zLTEtMS0yMTE2MQ_a70c48dd-a433-40d9-b305-3ef82e67497b"
      unitRef="usd">53107000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7ee257b1f5e474fa73da9aed693faf2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMy01LTEtMS0yMTE2MQ_dc907863-fa03-45d4-8823-8338e51acf7e"
      unitRef="usd">171726000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7dd6b35f20045999c192f8de847c482_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMy03LTEtMS0yMTE2MQ_86df50a9-c58f-4518-a4f2-12d874bdba45"
      unitRef="usd">162528000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1220aed07ca14aa8abe0c90027bf1bd1_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNC0xLTEtMS0yMTE2MQ_a762a41b-2aab-4345-98d6-dd1d66c5693f"
      unitRef="usd">21590000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc4c0fa38f304458a49eead228b1f066_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNC0zLTEtMS0yMTE2MQ_50f6eefe-9cdb-4c59-ab36-3b8743cbd5ac"
      unitRef="usd">19100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9732a2ada58456da4367d2ad51237e4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNC01LTEtMS0yMTE2MQ_8776e974-b0e1-4eb4-a971-d407488955c8"
      unitRef="usd">62665000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae2dfd5024fd4d04a7f0acbdbbea5062_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNC03LTEtMS0yMTE2MQ_4f11526d-2c4e-4536-a432-f5a94a9a3764"
      unitRef="usd">56914000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNS0xLTEtMS0yMTE2MQ_a0023f8b-9f2b-492e-8bd3-b7889d8d8b1b"
      unitRef="usd">76838000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNS0zLTEtMS0yMTE2MQ_a90bd242-2790-46fe-b736-aaa87e90d27f"
      unitRef="usd">72207000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNS01LTEtMS0yMTE2MQ_eaefb9c5-d569-40e0-a4e1-1264871058ab"
      unitRef="usd">234391000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfNS03LTEtMS0yMTE2MQ_d2b87e53-f1af-4a3e-8d89-32b8bc077d91"
      unitRef="usd">219442000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4ed6e56bac6643c2b13e09943b8594b7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOC0xLTEtMS0yMTE2MQ_ba3e799c-6a14-4c81-b9e5-7437530c0560"
      unitRef="usd">17743000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9b620f0bebe540458a2e554bbc88fa32_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOC0zLTEtMS0yMTE2MQ_bc422665-7870-4953-abe1-57c2c4f0565e"
      unitRef="usd">15503000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if7ee257b1f5e474fa73da9aed693faf2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOC01LTEtMS0yMTE2MQ_0d7d78e0-596e-48f4-934f-0d411e7ac0a6"
      unitRef="usd">53381000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id7dd6b35f20045999c192f8de847c482_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOC03LTEtMS0yMTE2MQ_fce35df8-5eaf-482b-937a-464283d23b19"
      unitRef="usd">46592000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1220aed07ca14aa8abe0c90027bf1bd1_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOS0xLTEtMS0yMTE2MQ_baa975cc-517d-4677-91e9-11a20cdca7e0"
      unitRef="usd">10351000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ifc4c0fa38f304458a49eead228b1f066_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOS0zLTEtMS0yMTE2MQ_e5c26ee3-4a7c-4b5f-9b93-30f7043884f9"
      unitRef="usd">8915000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id9732a2ada58456da4367d2ad51237e4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOS01LTEtMS0yMTE2MQ_db0726f1-d725-432e-b7fb-bbd5ab60486d"
      unitRef="usd">29375000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iae2dfd5024fd4d04a7f0acbdbbea5062_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfOS03LTEtMS0yMTE2MQ_73ccb653-9a7e-4965-8809-dab8b3ba9fa9"
      unitRef="usd">26710000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTAtMS0xLTEtMjExNjE_5270f308-1f82-4882-8590-ebc9b9f699e7"
      unitRef="usd">28094000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTAtMy0xLTEtMjExNjE_7e744054-522e-4f87-9a59-3957ff0f8f69"
      unitRef="usd">24418000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTAtNS0xLTEtMjExNjE_cf2eb229-aab1-4f89-adb8-2bef5649c61e"
      unitRef="usd">82756000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTAtNy0xLTEtMjExNjE_8a55297b-c160-42c5-bc94-551018c049a2"
      unitRef="usd">73302000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i4ed6e56bac6643c2b13e09943b8594b7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTMtMS0xLTEtMjExNjE_f5fcb216-9396-4ba6-9762-805f555cd01d"
      unitRef="usd">37505000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i9b620f0bebe540458a2e554bbc88fa32_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTMtMy0xLTEtMjExNjE_444cb510-6548-47a1-a3e6-f6fae556ef36"
      unitRef="usd">37604000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="if7ee257b1f5e474fa73da9aed693faf2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTMtNS0xLTEtMjExNjE_d7054824-0c5b-4581-b9ba-f8b35d88a18a"
      unitRef="usd">118345000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="id7dd6b35f20045999c192f8de847c482_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTMtNy0xLTEtMjExNjE_3aa10cac-c966-43a6-8878-5768763fa12c"
      unitRef="usd">115936000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i1220aed07ca14aa8abe0c90027bf1bd1_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTQtMS0xLTEtMjExNjE_f1171f35-5d6f-46ad-bb7e-4953eba20e75"
      unitRef="usd">11239000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ifc4c0fa38f304458a49eead228b1f066_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTQtMy0xLTEtMjExNjE_7bf5ddaf-2c8a-49e7-99af-ed3ffc504151"
      unitRef="usd">10185000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="id9732a2ada58456da4367d2ad51237e4_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTQtNS0xLTEtMjExNjE_f09af5c1-c6d2-4ac2-b858-b303df44758d"
      unitRef="usd">33290000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iae2dfd5024fd4d04a7f0acbdbbea5062_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTQtNy0xLTEtMjExNjE_c156a2e6-d88b-4c28-9208-77ee5e3bdfe4"
      unitRef="usd">30204000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTUtMS0xLTEtMjExNjE_f43e0f85-3c9d-4643-892d-93f436741228"
      unitRef="usd">48744000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTUtMy0xLTEtMjExNjE_405cd7f3-0377-423a-b9de-6fb6579845ef"
      unitRef="usd">47789000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTUtNS0xLTEtMjExNjE_ab048001-b1da-469b-ac89-f37661e5f347"
      unitRef="usd">151635000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmE2OGM5ODJiZWEyYzQzNjFiYmE0NmZiOGJjMzFlOGQ1L3RhYmxlcmFuZ2U6YTY4Yzk4MmJlYTJjNDM2MWJiYTQ2ZmI4YmMzMWU4ZDVfMTUtNy0xLTEtMjExNjE_0f7cd3d0-f407-4e61-ae13-08290a9ecc30"
      unitRef="usd">146140000</us-gaap:GrossProfit>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RleHRyZWdpb246NjM3YmQwNzRhOGEzNDk0OWE0YjNkYWFjMjBjMGE2YmRfMTM4NA_8181da81-8567-41b4-9bae-1d9fa8bc39c5">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes net revenues by product and service (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Products:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Aortic stent grafts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,674&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20,896&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;69,013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;62,165&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Surgical sealants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17,374&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;16,544&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;49,022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;52,236&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;On-X&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;16,456&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;14,022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;47,082&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;41,843&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,744&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,645&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,609&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,284&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;55,248&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;53,107&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;171,726&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;162,528&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;21,590&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;62,665&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;56,914&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;76,838&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;72,207&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;234,391&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;219,442&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie06e2f5450764fcd97b8a391bba3cd2d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMy0xLTEtMS0yMTE2MQ_a22fa86e-5f01-482c-8a24-efa9d4bb93aa"
      unitRef="usd">19674000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c63bff320e64af081a5cce353c3a62f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMy0zLTEtMS0yMTE2MQ_ff87fa30-0857-4e85-8ea9-917401f12140"
      unitRef="usd">20896000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifae4dce6ca1b41baa6d2d313ffead3fa_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMy01LTEtMS0yMTE2MQ_bb0207bf-9fe6-414f-bbb1-e40d6b40bd3a"
      unitRef="usd">69013000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie049d9169eb74ff0b2390aefc7f182e5_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMy03LTEtMS0yMTE2MQ_9b6d4728-481d-4eea-be62-73b3504793f8"
      unitRef="usd">62165000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if3c197a3565b4c02b9d51132c7d4c1b9_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNC0xLTEtMS0yMTE2MQ_479de71a-64b4-4065-a1a6-d90e065c1a0f"
      unitRef="usd">17374000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82adeb266a2341f1901704b9be13d09a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNC0zLTEtMS0yMTE2MQ_1c14ed2f-36c5-4a8b-88e0-caedac8ac1bd"
      unitRef="usd">16544000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7616c3cb7c904ae6b62508a5b0cc36f6_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNC01LTEtMS0yMTE2MQ_aa224a9f-7358-4f2e-8d63-50a5fdad1c32"
      unitRef="usd">49022000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i487be8addd144d008e7c5a14b09cc518_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNC03LTEtMS0yMTE2MQ_c5fbf10c-d412-4762-bdb2-8e786403d22b"
      unitRef="usd">52236000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3211f9da72d54b2cab2ccedbc087d2ba_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNS0xLTEtMS0yMTE2MQ_624fb0e5-9a31-4c8f-8534-6d3ec5ce4ff8"
      unitRef="usd">16456000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96b0754bb93c43ceb3c6ef24d7d19ba5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNS0zLTEtMS0yMTE2MQ_7a32a01b-f275-403a-b3b4-965df26b61b4"
      unitRef="usd">14022000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if29b95e231c94833a32e361d0662e465_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNS01LTEtMS0yMTE2MQ_dae82f44-8798-4f3f-9ec2-01a27b827501"
      unitRef="usd">47082000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a377880ef554ca480923257a9fe5357_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNS03LTEtMS0yMTE2MQ_492ee37b-d5a9-4963-b82d-f1da0139efde"
      unitRef="usd">41843000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib053fe4e77a849b7bafcb527494112c2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNi0xLTEtMS0yMTE2MQ_6f1bf3bb-b4c1-4be9-8d83-803f26f84dae"
      unitRef="usd">1744000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4b2d900fb184620875c7570364d036e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNi0zLTEtMS0yMTE2MQ_fe982409-b240-44e3-a506-25c9b631fd30"
      unitRef="usd">1645000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf398fc9c82649119889d264cbda9dbf_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNi01LTEtMS0yMTE2MQ_e7680465-6d3e-4dcc-a84a-99d7e6f1b976"
      unitRef="usd">6609000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7aeb442b84a4ce49062b5e2c520b373_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNi03LTEtMS0yMTE2MQ_ede0a6ec-184b-4eb4-86a0-4ac0b32334fa"
      unitRef="usd">6284000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc916650fa81469598a7b03003c27168_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNy0xLTEtMS0yMTE2MQ_2d8137a8-fb29-4584-82b0-80831ff40a73"
      unitRef="usd">55248000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f5bc0203be146e5bb0bd8b45cbdb2b7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNy0zLTEtMS0yMTE2MQ_1c17c5ad-8d4f-43fc-9b28-8328c0b8f268"
      unitRef="usd">53107000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e5a4f6af84f4ddeae300f7b08e9e59d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNy01LTEtMS0yMTE2MQ_c5b10574-3273-48af-a2c1-0fa39f4b8659"
      unitRef="usd">171726000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd7debfcacac4069a398cab44625bd73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfNy03LTEtMS0yMTE2MQ_3914514c-951c-415e-9863-18c81df973fa"
      unitRef="usd">162528000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i640c303a0a1c4e72a4879aa8b98e0402_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfOS0xLTEtMS0yMTE2MQ_f02f7632-2469-4baf-886f-76f795789749"
      unitRef="usd">21590000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i377e56bf409a455ba20de5d37520ea48_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfOS0zLTEtMS0yMTE2MQ_f5036458-dcc7-4fe2-9c99-ece55f1849b2"
      unitRef="usd">19100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84212de5e3c34a078a34d879bfeeb394_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfOS01LTEtMS0yMTE2MQ_1d691d51-4c00-4b65-96d9-6fd582821cb8"
      unitRef="usd">62665000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8faff0cacc944396b07783c2a5b064e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfOS03LTEtMS0yMTE2MQ_385d1515-ca5d-427b-b712-fdb73f511c00"
      unitRef="usd">56914000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMTAtMS0xLTEtMjExNjE_f1bec906-77af-48cb-83f3-d98c6acc8fc5"
      unitRef="usd">76838000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86c51ac8a3744aeeb62b440a452e3c7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMTAtMy0xLTEtMjExNjE_6e49f410-a2cd-4afa-b6df-128f9db5f110"
      unitRef="usd">72207000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMTAtNS0xLTEtMjExNjE_0ce58f4c-9ddb-4f11-a404-26ed36c29191"
      unitRef="usd">234391000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fa3612dc95b4b1db76ab1c6b961c9c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE2N2I3ODI1YzE1ZTQ4MGViYTYxZjc3ZTAwOGMzMmRlL3NlYzoxNjdiNzgyNWMxNWU0ODBlYmE2MWY3N2UwMDhjMzJkZV83MC9mcmFnOjYzN2JkMDc0YThhMzQ5NDlhNGIzZGFhYzIwYzBhNmJkL3RhYmxlOmU5ZWVkZGE2NWI5NDQ0YzU5NzliY2NjODVhYzZjNDVkL3RhYmxlcmFuZ2U6ZTllZWRkYTY1Yjk0NDRjNTk3OWJjY2M4NWFjNmM0NWRfMTAtNy0xLTEtMjExNjE_65325cb1-a13f-46d1-8542-25b64898bab8"
      unitRef="usd">219442000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>77
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M,."I?*,T/]%RG>TUSJ76,LH.5X+[0ID;X/N%E'I_8GZ@V*X>_ M02P,$%
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M[8?\UM+BS5%PR18[94M<L8VC,!0ES%Z4O'[4S\P=9LZIIX]\",:(<=@/P$A
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MB6IG0L\$GBT4^JH&7%&X[,)&YQ2_D!G%OF*&C(0CEP@WR#R4,Z!$@%B1&X&
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M&GZ6,)QHN>UW]A^EUK+I#S>"&]G6P'R_DE(?3NR/!8X_#EG^'U!+ P04
M"  ,=V15>WWY;F8"  #K!0  &    'AL+W=O<FMS:&5E=',O<VAE970T+GAM
M;*U4RV[;,!#\%4(%B@1(HV<2-Y4%) Z"]E# B/LX%#W0TMHB0I$JN;:3O^^2
MD@4;<9P>>I&XY,YPAN1NOM'FT=8 R)X:J>PXJ!';ZS"T90T-M^>Z!44K"VT:
MCA2:96A; [SRH$:&211=A@T7*BAR/S<U1:Y7*(6"J6%VU33</-^"U)MQ$ ?;
MB0>QK-%-A$7>\B7, +^W4T-1.+!4H@%EA5;,P&(<W,37D\SE^X0? C9V9\R<
MD[G6CR[X4HV#R D""24Z!DZ_-4Q 2D=$,O[TG,&PI0/NCK?L]]X[>9ES"Q,M
M?XH*ZW$P"E@%"[Z2^* WGZ'W<^'X2BVM_[)-EWN9!JQ<6=1-#R8%C5#=GS_U
MY[ #B+-7 $D/2/X5D/: U!OME'E;=QQYD1N]8<9E$YL;^+/Q:'(CE+O%&1I:
M%83#8J)517<"%:.1U5)4'"FXY9*K$MC,$5MV,N4&%-: HN3RE'U@MJ89FX=(
M&AQ36/;[W7;[):_L-X/VG*71&4NB)#D GQR'WT%)\-C#XWUX2,X'^\E@/_%\
MZ6MRD.S2HT2F%^Q>*#(MN&13;85_9;]NYA8-O;7?AZQVW-EA;E=_U[;E)8P#
M*C +9@U!\?Y=?!E].F3\/Y'M'4,Z'$-ZC)U>0=.06WIMY>-9?[=,6+NBIW B
M5#]S>N@,.N(+3^Q:QKK(XA')BJ(\7._Z.Y28?KS:3=S3G@W:LZ/:OU'SLBOS
MW*EG'%FI+0XNWI"?O5 59Z.KE^K?SNO$ASNEZ-K@5VZ60EDF84'(Z/R**$S7
M6KH =>NK<ZZ1:MT/:^K&8%P"K2^TQFW@"G[H[\5?4$L#!!0    (  QW9%4Y
M\]$ %0<  (D>   8    >&PO=V]R:W-H965T<R]S:&5E=#4N>&ULK5E;<]LV
M%OXK'#6SD\Q$$0'PZK4UXRA-MP_=>N)F^PR3D(6&)%0"DIW]]7L RJ)$7&+/
M^L4FJ8/#[UR_ ^+R0?3?Y(8Q%3VV32>O9ANEMA>+A:PVK*7R@]BR#GY9B[ZE
M"F[[^X7<]HS69E';+' <9XN6\FZVO#3/;OKEI=BIAG?LIH_DKFUI__TC:\3#
MU0S-GAY\X?<;I1\LEI=;>L]NF?JZO>GA;G'44O.6=9*++NK9^FIVC2Y6)-<+
MC,1_.'N0)]>1-N5.B&_ZYM?Z:A9K1*QAE=(J*/S;LQ5K&JT)</Q]4#H[OE,O
M/+U^TO[9& _&W%')5J+YD]=J<S4K9E'-UG37J"_BX5_L8%"J]56BD>9O]'"0
MC6=1M9-*M(?%@*#EW?"?/AX<<;( ]+@7X,,"/%V0>!:0PP)B#!V0&;,^4467
ME[UXB'HM#=KTA?&-60W6\$Z'\5;U\"N'=6JY$ET-06%U!%=2-+RF"FYN%?R#
M:"D9B76THG(3?8:(RV@>?;W]%+U]\RYZ$_$N^F,C=I)VM;Q<*$"C=2ZJPYL_
M#F_&GC>7T6^B4QL9_0P(ZO/U"[#B: I^,N4C#BJ\9=L/$8G?1SC&V(%G]?SE
M* "''#U+C#[BT?=OJ,%*.VYM'+?N11M!]?54\>Y^2%^N.),7+M<-JA.W:EW:
M%W)+*W8U@]J5K-^SV?(?/Z$L_J?+[E=2=N:%Y.B%)*3=>.%M(Z1\!^E2B9:Y
MK!U49$:%[CO[Y1PCDD$4]J=VV&(ISK*CT!F^](@O#4;INOX+BFS(="6@,56B
MJWC#HFX*7/_<'6/ZHFBFKQG-5U)VYJWLZ*TL&,U/#)16G X=N*LCVHI>\?^:
M!R[+!W7I2<A0'J-L$EB'5!''A3NR^1%K'LX\T<U-K"!X0'K2BS&WWEZBHIQ
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M='^_;9KVZX.+CO_0[#X>:ES]'U!+ P04    "  ,=V15;(M!970(  !;%@
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M]"F75G Z.!)90EC+C1.:/EA3Y([^FLZ=M\B4OY\"HM1S_+0>9L][EXM87G1
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MR/$!O%]9#'#MA@7T'^<N_@=02P,$%     @ #'=D556X6'B# @  , 8  !D
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M;]RE8.SYQO^2@CT\<),)91J-\/OMVEA->^:/4Q&WA.EI0G>.;DS-,EP&=9M
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MV)T5=4YV)0Y:&G"'W50FN06QK;1KMJRU<_60 E&D$[Q4=?=7ED0'\BQ$!:=
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M;005NI.F=6P%)L#[,! !3:NQ_2CY'1JQ2N)A%Y-A"'E8A4(9X)[_7#QKD*L
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M3>=E281KGN6H@C1)<4W2E#UVLVKHZP!-L(L\O!PNX91Z2>1GEX,%NQ+/2%I
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MZ;@I-!'@_5PINWH@!>L_2F[_!E!+ P04    "  ,=V15O=N-T> -  "0)P
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M=!(<)% .O06YI,U&6QAH:,T/W7 T83(J=B28+%707S3]FNML+-Z+05%M]LI
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M GLQP/[&N7B82(#IS\?J;U!+ P04    "  ,=V15GJ J'H(%   8#0  &0
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M275J7Q(/Q^U[[ ,56X;97$*.HMYD%CM$V#>.G2C>F'?%ABM\I9AA@<]"$/H
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MCD?1@'3SV="\6+6JK^I397'QKX<+?&E)[02P/E/*=B_.0?_M=OX_4$L#!!0
M   (  QW9%4F'%JJ=P4  !,,   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q
M+GAM;(U7[V_;-A#]5PXN4+1 XE]QV[1)#-CIBG98FR!N-@S#/M#2V2)*D2I)
MQ4W_^KVC9%79W&!?8E'B'=^]>W>\G.^<_Q(*YDC?2F/#Q:"(L7HS&H6LX%*%
MH:O8XLO&^5)%+/UV%"K/*D]&I1E-Q^.7HU)I.YB?IW?7?G[NZFBTY6M/H2Y+
MY>^7;-SN8C 9[%_<Z&T1Y<5H?EZI+:\XWE;7'JM1YR77)=N@G27/FXO!8O)F
M.9/]:</OFG>A]TP2R=JY+[+XD%\,Q@*(#6=1/"C\W/$E&R.. .-KZW/0'2F&
M_>>]]W<I=L2R5H$OG?E#Y[&X&)P.*.>-JDV\<;OWW,;S0OQESH3TEW;MWO&
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M9C6A'9+35D,?6AWVG( KR:,P%;T+%:<[C50%<"HKAK1BD2YR_CJ!V]0^25-
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M]RP[=,S=\1/X(JH/Z8^)^K:5. 'XOA6'"3P(@LS6(BAR-LN+5@>:YEE)%-(
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MXPB/;[+]AM$^:%&;[P8SH;4HS7#!&:*%%N#[N1!Z^4 ;]!^2IO\!4$L#!!0
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M(C#CG!L73O=AMFRTH\L3S(8^#6A\ +W?:NT."Y_@^+%9_0!02P,$%     @
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M&O6O2"^J?>W:B9&U>V'6TM![Y88%_2"@L@;T/9?2["=V@^Z78_X_4$L#!!0
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MTLL8>TOW=Y9^857;W1/6RN*MHYL6>,V3VAW _:U2=ERX -/%<?D?4$L#!!0
M   (  QW9%7Q:^KVU08  ,U#   9    >&PO=V]R:W-H965T<R]S:&5E=#,R
M+GAM;-6<76_;-A2&_PKA%4,+M+$^;.=CB8'$(KL."QHT[7HQ[(*1:%NH++H4
M[;3 ?OPH6;',2E&M[,V%;QJ+T7F.J/?PPV\CG=]+]26;"Z')MT629A>]N=;+
MLWX_"^=BP;,CN12I^<U4J@77YE#-^ME2"1X508ND[SG.J+_@<=H;GQ=M-VI\
M+E<ZB5-QHTBV6BRX^GXE$GE_T7-[#PT?XME<YPW]\?F2S\2MT)^6-\H<];>4
M*%Z(-(ME2I287O0NW3/F#_* XHR_8G&?[7PF>5?NI/R2'[R++GI.?D4B$:'.
M$=S\6(N)2)*<9*[C:PGM;7/F@;N?'^BLZ+SIS!W/Q$0FG^-(SR]Z)ST2B2E?
M)?J#O/]=E!T:YKQ0)EGQ+[DOSW5Z)%QE6B[*8',%BSC=_.3?RANQ$^ .'@GP
MR@#OQX#A(P%^&>#OFV%0!@SVS3 L X;[9AB5 :/BWF]N5G&G Z[Y^%S)>Z+R
MLPTM_U#(542;&QRG>67=:F5^&YLX/;[EB2!R2FZ$FB12DY>!T#Q.LE?D#?ET
M&Y"7+UZ1%R1.R<>Y7&4\C;+SOC9Y\^A^6.:8;')XC^3PR;5,]3PC-(U$U!!/
MV^-/6^+[IK_;3GL/G;[R6H%_K)(CXIV\)I[CN4W]:0^_%<LCXCM%N-<0'NP?
MWI2=_K_L[,G9K7OI;PO(+WC^([QW:2@7@MQJKH69<?1K<L43GH:FJ9@93<F0
MRRB*\WF$)R2(LS"1V4J)C-Q]SP^7,C/M;Y5<+;/7Q."2512GL^),(WN<KD1$
MWB^%XCDB(W__::Z O#/9LG\:NG^UN=Q!\^7F$_59MN2AN.B9F3@3:BUZXU]_
M<4?.;TV%@(0%2!A%PA@(9A708%M @S;Z^$;)4(@H(U,E%R0KYR.>94(WS357
MK;2N^B)A 1)&-[!1 <NW!^NQ<]Y?[XI6/\,]=9SJ+$N-X5:-8:L:;\UFQ%8B
ME>F;:9R:(1V;<?JX+JW<KKH,?];[H'Z&.SSU?/LL^E,.^QG'NHNC[5T<M=>T
M4"1?3ION4VMDU_N$A 5(&$7"& AF:7F\U?+XL!:X8V0!(6$!$D:1, :"605T
MLBV@D];)8&)$C:-27F*^#.ZQR)W49J7!\,3Y8>Z:M.;M*AX21I$P!H)9XIUN
MQ3MM%2\02H1REA;#.]<L3C5/9_&=4?!Q^3;,X>ZB,JJIUYJXJWI(&$7"& AF
MJ><ZU==;IU6_SRK6^5B;[JU=";3$&];$:T_;53THC4)I#$6S!=SQ)]QGVI"6
M8%O(T[J2K?D[*XFD42B-H6BVDEZEI+?7IIC\2SXJGF93<_R^<)["O/6:IZLI
M#_5*Y9LC^G45+_/M5J.RK8FZ;H&@M !*HU :0]'L JB<(O? K"(7ZA5!:0&4
M1J$TAJ+9=5091FZ[8S0IM)Z9"B*AM;<V6S41K[E9WQO5'M36@^.3VFH =82@
M- JE,13-%K'RF=QVHVEG-;A4.E[G^ID1?40NS2Q@I@@5SLFUB.+0C/B\O5%1
MJ.<$I050&H72&(IF2U^98^[HP-8!J"<'I050&H72&(IFUU%ES+FMMLV3C)42
MN;L(C)RZL]*>N;.&4&,,2F,HFJUAY8VY[>98U__]*7&[^GE#IZX?U!J#TBB4
MQE T6[_*'G/;_;&NR[@Y[V;!R>5RJ>2:)XT2(^VG"9060&D42F,HFOTG%973
MYCF'M:I[2!ML J4%4!J%TAB*9M=19?AY[8;?$[_=>76WKVEA:$_>64:HVP>E
M,13-EK%R^[R]W;Y]%X8K_DV;J,MP'HMU,8?D_N!GJ9+HWI0!R?]6K7%3T'XI
MG4<ZU ^$TBB4QE TNT0J/] [,#_0@_J!4%H I5$HC:%H=AU5?J#W+'Z@5_<#
M7:=AQ8 Z@E :A=(8BF;+6#F"WMZ.X)[^7SNP\WB%^G]0&H72&(IF"UWY?]Z!
M^7\>U/^#T@(HC4)I#$6SZZCR_SR\_^?5_3^WZ6L"U/^#TBB4QE T6\/*__.P
M_I]7]_]&#?)![3\HC4)I#$6SY:OL/V]O^^]I9E\[O_/4"S7[H#0*I3$4S7[F
MIS+[_ ,S^WRHV0>E!5 :A=(8BF;7467V^<]B]OEULZ]A%6C/W5E%J-<'I3$4
MS5:Q\OK\O;T^L+/7GKCSL(8Z>U :A=(8BF87Q,XSH0?F[/G8IT*QCX5BGPO%
M/ACZ',Z>7SE[_K,X>R5U]_$9OV%Y@!I[4!J%TAB*ME&QO_.V@850L^*]$)D1
M:)7JS7/CV];MNR<NBS<N_- ^<<\"MZ&=NF=L\V:)"K]YT<4U5[/8#/=$3$TJ
MY^C8[ #4YMT1FP,ME\6[#NZDUG)1?)P+;LHF/\'\?BJE?CC($VS?X#'^#U!+
M P04    "  ,=V15;<7KP+\$  !&'@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970S,RYX;6S%65UOXC@4_2M6=K1JI4[S!12Z@#2EZFREJ;8:YN-AM0\NF&(U
MB1G;@1EI?_S:21K'$^,DFJQX@23<>W+N];7/Q9X>"'UA6X0X^!Y'"9LY6\YW
MUZ[+5EL40W9)=B@1OVP(C2$7M_3993N*X#ISBB,W\+R1&T.<./-I]NR1SJ<D
MY1%.T",%+(UC2'_<H(@<9H[OO#[XB)^W7#YPY],=?$9+Q#_O'JFX<TN4-8Y1
MPC!) $6;F?/.OUZ$H73(++Y@=&"5:R!#>2+D1=[<KV>.)QFA"*VXA(#B:X\6
M*(HDDN#QK0!URG=*Q^KU*_I=%KP(Y@DRM"#15[SFVYDS=L :;6 :\8_D\"<J
M AI*O!6)6/8)#H6MYX!5RCB)"V?!(,9)_@V_%XFH./B#(PY!X1"T=0@+ARQS
M;LXL"^L6<CB?4G( 5%H+-'F1Y2;S%M'@1 [CDE/Q*Q9^?'Z'$YBL,(S ?<(X
M3<4(<0;.EOFH@K\VP&SQ@"!+*5J#=QS<04S!%QBEZ!R<W2(.<<3.P5OP>7D+
MSMZ<@S< )^#3EJ0,)FLV=;G@+=_NK@J.-SG'X C')=I=@M"[ ($7! ;WA=W]
M%JV$NY^Y^[J[*[)5IBPH4Q9D>.&QE)7A7H ;&(GD(+#,IMQ[2M(=3IXO*DE;
M<LB1S!E8P)VL7 ;^_B 0P;UXS/XQ92-__<#\>CFOK]D.KM#,$1.7(;I'SOSW
MW_R1]X<I-SV!:9D*RTR%-O3Y K(M0-]2O(>1K)IK4[0YQ"B#D(O.?NY[WE ,
MU+X:AM'*'Y96&K]!R6]@Y?>)<#%"D#'$C669>P\;J!FMCE$;EM2&]M21A(M*
MDG6S$C6#UXA"63TFFL,:@;>#P=CS?N)I,IL,*F8:T5%)=-0BAQ&&3SC"'"-C
M(D?M&)K,CC.\*AE>61D^D 3]$&LF?1%3=),>68*L&%TG74]@6KCC,MSQ:9>G
M<9^9Z@E,R]2DS-3DUY>G2:LUP&AU; WP/27.GI7A![1'$?"-DFGU[#H,?:'I
M<5::$/^T-5N\OZ]L]82F9TOU'[Y5M!MEJW!OJEFSV=&B5:+O-ZA^!^DJH*H<
M?A8%JXE.4>F^WT;X&T3+KPM[C9O-1.>FA-^W*W\QY\&_H)UPV>$ZEW9/:'KP
MJIGP1R=>"*S=3.=L]82F9TLU-KZ]LVDE8 5&XVI@-#NZ&JANQ+=*>%'.IK]M
M-W;/SF/Q?[02ONHE_,F)*]?:S'3.5D]H^C]HU=@$]L:F2<(*=]O::S71::D^
M)+ J=R?I*J"L%&TF.L7*YD,;\6^0KJ N[35N-A.=FU+^P*[\Q5QO+5UVN,X[
M'3VAZ<&KGB(8G'A;R-K3=,Y63VAZME27$S3L;[21KJ"^95$K8YN)SDTU(8%]
M2R,OX]#(J-?VH2\T/4[5/@17)Z[87C=5^D+3LZ4:F<#>R#1*UKBY6&TF.BW5
M=P0-FQA=)*N^36'<AS/:'=^("Y7LAVUDOT&\PKJP&UD:[2PL51<0VKN 8OZW
MEC$[7-<R[PM-#U[U%^&)3S?"7H\W^D+3LU4YX.CCA*-^>%&K99M)SLVM'/+)
M$]8'2)^QR'>$-L+'N[P2$X'FAY;Y#2>[[-SOB7!.XNQRBZ!8'Z2!^'U#"'^]
MD4>)Y='Q_#]02P,$%     @ #'=D54/E.N=4!   8Q@  !D   !X;"]W;W)K
M<VAE971S+W-H965T,S0N>&ULS9G;;N,V$(9?A5 710*DT<%GUS806Q(V0+((
MDN[VHN@%(XUM8B522U)V O3A2TJR8CN*8!=$L;F(*(KS\? /AP=/MHQ_%VL
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M.TRP?P5I G!](H1>3LP+JHXX_ 502P,$%     @ #'=D54PL[3J+ @  T0<
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MS_<\]^+SW:#BXD'F  IM"LKDT,F5*ONN*],<"BS/>0E,GRRX*+#26[%T92D
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M<FMS:&5E=',O<VAE970T-"YX;6R-E5MOTS 4Q[^*%2:T26A)<^]((W6KQO8
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M6ZMHNM&EVGDK<:32B[*47,T2Y2?3#XSE+:$4X2I'GV4!'-U6$E<;LJ* YD*
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M?*ZJU2G)HE.2Q:<D&YZ(;*_&S;+&S3KV,)Y.P9S^ZAPPU9:JVAQ+0+!1MYL
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MA94[AHX$U.UD;N";DM1MU\BR[0.K%@&O(>!I"<P+2OF&Q;=&5M"(17Q/(VM
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MZ6+B'#LD@YPV3-^*]2?H_(P-7RJ8LD^R[F(]AZ2-TJ+JP*B@*GG[IH]='K8
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MCGK%T;_E^<^*HV<)C/P=P<]#COT=O>Y6/ZI +FV;5B05#=?M6>U7^YO@S#;
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M:.W5NOAR3]3W4P750E03J!:AFD2U&-44JFE*LQNGR:['ISG5>HQFVJ@6HII
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MK'I ^?N;M%R%U=]4$WQ+L]^W+^?R_P!02P,$%     @ #'=D5;V=(O6K!
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M _5\S9A\'I03M/^(6/X+4$L#!!0    (  QW9%4+M1@;AP0  (T8   9
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MWK6KZ]P#?'%1_Q73*!9L)+ 6IJSKH5@L+>Z^BP=.<G6Y^T X)ZD:;@"'0*6
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M9:@^9X#K '5_SIC<#?0#\@^DX1]02P,$%     @ #'=D51^FL'R* P  RA
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M+#?%!4!^OF*R3M8WQ0#->?[R/U!+ P04    "  ,=V155XH)0'<"  "I!@
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M8*J?!0840;VSH(]"'O*PGO\,,!<[V#=G! 0/G[SPS4^#9HJN!H\2S1\FF.-
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M^[S>=&7Q+A;UKD$/*_2[VJM/[(7E.R;0[7?T6/#E+I;H)E^B!2M>DIA=HHN
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MJLT.U"8Y&GGN3H.$!9"P$ C66W[:+C\%-P *619(6  )"X%@O;),VK),WFD
M=;Q[\#2Z+G&&!J!1V?C( (Y5>((GA X,0".CQ"6>W@"\-E5O--4;7L@D1D*6
M7U_61;32>\$HY-Q-!PD+(&$A$*Q7";^MA _N!3YD62!A 20L!(+URH*M[KN]
M]4XW: "]9].G$V=@!QH9L3Q_\* '&AGU+6P/_$ G(YBZ>C_ !ZT,'DUWL2O6
M2:PR%BQ*HUSO!^.,<W<>*"T I850M'XU2%<- NX*#1*J.)"T )060M'ZQ>G:
M-SS:AISB#+;FP]T^=@:-C+J.,W2&8YGC5YULWQF.92XA-GW#&;JV"(_W10_Y
MQ[^T28Z&G;W?(&D!*"V$HO4+T#5KV(4W ] V#I06@-)"*%J_.%TKAT=;DE/,
M@&J><L>E0S/0R)RCISS0R)R)Y1V9@4:&/<=^PPRZ%@F/]T@/<L,*;9:C<6=O
M.$A: $H+H6C]"G2=&_;@W0"TD0.E!:"T$(K6+T[7S.'1IN04-_ U7PV&'_EW
M.I7RC*$7'*LHM?RA%6A4Q'/T3D"Z_HB,]T>/]?K5&U#4IQG:C,<YYVX^4%H
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MMZAW^YUZE^GSD,NUYVN-S_].JJ?SO?GZ^,ORZ^3LO5QP3K<5Y?DO4$L#!!0
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MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ #'=D59E<G",0!@
MG"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    "  ,=V15RLRPU,8%  "Z'@  &               @($-"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ #'=D558P5X!!"
M63$  !@              ("!"0X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    (  QW9%4E!EKAJP<  "@B   8              " @8 6
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    "  ,=V15>WWY
M;F8"  #K!0  &               @(%A'@  >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L! A0#%     @ #'=D53GST0 5!P  B1X  !@
M ("!_2   'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (  QW
M9%7&#%AOMA   "WA   8              " @4@H  !X;"]W;W)K<VAE971S
M+W-H965T-BYX;6Q02P$"% ,4    "  ,=V15;(M!970(  !;%@  &
M        @($T.0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%
M  @ #'=D52(I_J[Y!0  -@X  !@              ("!WD$  'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    (  QW9%6MS)D80@<  *@3   8
M              " @0U(  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"
M% ,4    "  ,=V155;A8>(,"   P!@  &0              @(&%3P  >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (  QW9%5$J,V\Y@,
M ,D)   9              " @3]2  !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&UL4$L! A0#%     @ #'=D57H;">]-"   /18  !D              ("!
M7%8  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  ,=V15
M]6:1M2,$  "2"P  &0              @('@7@  >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;%!+ 0(4 Q0    (  QW9%58_<U_S@8  #01   9
M      " @3IC  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%
M  @ #'=D5;W;C='@#0  D"<  !D              ("!/VH  'AL+W=O<FMS
M:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  ,=V15X#4V]LH#  "("
M&0              @(%6>   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+
M 0(4 Q0    (  QW9%6>H"H>@@4  !@-   9              " @5=\  !X
M;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ #'=D5?/_L$LB
M!@  0Q   !D              ("!$((  'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6Q02P$"% ,4    "  ,=V15OZN6FNX$  !T#@  &0
M@(%IB   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (  QW
M9%78' '9@P4  ,<-   9              " @8Z-  !X;"]W;W)K<VAE971S
M+W-H965T,C N>&UL4$L! A0#%     @ #'=D528<6JIW!0  $PP  !D
M         ("!2),  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M    "  ,=V15\(JB96\#  !3"0  &0              @('VF   >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (  QW9%6]CD=;F0(  $T&
M   9              " @9R<  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M4$L! A0#%     @ #'=D5='UZGJZ @  Y04  !D              ("!;)\
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    "  ,=V15 :\&
MJ1P&  "4$   &0              @(%=H@  >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+ 0(4 Q0    (  QW9%4Q/Q%F)P8  %02   9
M  " @;"H  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @
M#'=D5<VH(<$N P  V 8  !D              ("!#J\  'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"% ,4    "  ,=V15Z]"H#@X#  !X!@  &0
M            @(%SL@  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4
M Q0    (  QW9%61?(XRJP,  'X(   9              " @;BU  !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ #'=D56J/-5&W P
M, H  !D              ("!FKD  'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6Q02P$"% ,4    "  ,=V15HB$VXQX$  !$"@  &0              @(&(
MO0  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (  QW9%7Q
M:^KVU08  ,U#   9              " @=W!  !X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL4$L! A0#%     @ #'=D56W%Z\"_!   1AX  !D
M     ("!Z<@  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  QW9%4P?HXAMP(  !X'   9              "
M@6;;  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ #'=D
M51.]'!0( P  D@L  !D              ("!5-X  'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q02P$"% ,4    "  ,=V15P>\EK3T#  "!#0  &0
M        @(&3X0  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0
M   (  QW9%6TY$0_BP(  -L%   9              " @0?E  !X;"]W;W)K
M<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ #'=D52?6U:1+!@  UR,
M !D              ("!R><  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q0
M2P$"% ,4    "  ,=V1530F=7+0"   *"   &0              @(%+[@
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (  QW9%4-]&P+
MI (  ! '   9              " @3;Q  !X;"]W;W)K<VAE971S+W-H965T
M-#0N>&UL4$L! A0#%     @ #'=D57;P%:DO P  YPL  !D
M ("!$?0  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  ,
M=V154C'*[40#  !9"P  &0              @(%W]P  >&PO=V]R:W-H965T
M<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    (  QW9%4*DTHJ004  "@=   9
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M970U,2YX;6Q02P$"% ,4    "  ,=V15O9TB]:L$  !@&@  &0
M    @($U'0$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (
M  QW9%7*<%%-70(  /<%   9              " @1<B 0!X;"]W;W)K<VAE
M971S+W-H965T-3,N>&UL4$L! A0#%     @ #'=D5<ERNE(_!   E!@  !D
M             ("!JR0! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"
M% ,4    "  ,=V15"[48&X<$  "-&   &0              @($A*0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    (  QW9%7*NA0^4P,
M "P-   9              " @=\M 0!X;"]W;W)K<VAE971S+W-H965T-38N
M>&UL4$L! A0#%     @ #'=D51^FL'R* P  RA   !D              ("!
M:3$! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    "  ,=V15
M&.UH5+(%  #;'P  &0              @($J-0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4X+GAM;%!+ 0(4 Q0    (  QW9%57B@E =P(  *D&   9
M      " @1,[ 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%
M  @ #'=D5=B/_>Z'!   718  !D              ("!P3T! 'AL+W=O<FMS
M:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    "  ,=V15L-->8-\$  !3(
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M+G)E;'-02P$"% ,4    "  ,=V15U7(SD.@$  #\*   #P
M@ $%3@$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ #'=D57=+<84& @
M\20  !H              ( !&E,! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ #'=D5?\GIW7C 0  ;"0  !,              ( !
M6%4! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $8 1@ A$P  ;%<!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>237</ContextCount>
  <ElementCount>291</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>67</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Sale of PerClot</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SaleofPerClot</Role>
      <ShortName>Sale of PerClot</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Cash Equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CashEquivalents</Role>
      <ShortName>Cash Equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Inventories, net and Deferred Preservation Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts</Role>
      <ShortName>Inventories, net and Deferred Preservation Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Stock Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/StockCompensation</Role>
      <ShortName>Stock Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - (Loss) Earnings Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LossEarningsPerCommonShare</Role>
      <ShortName>(Loss) Earnings Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/FinancialInstruments</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Cash Equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CashEquivalentsTables</Role>
      <ShortName>Cash Equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/CashEquivalents</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Inventories, Net And Deferred Preservation Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/InventoriesNetAndDeferredPreservationCostsTables</Role>
      <ShortName>Inventories, Net And Deferred Preservation Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/Leases</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/Debt</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/RevenueRecognition</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Stock Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/StockCompensationTables</Role>
      <ShortName>Stock Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/StockCompensation</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - (Loss) Earnings Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LossEarningsPerCommonShareTables</Role>
      <ShortName>(Loss) Earnings Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LossEarningsPerCommonShare</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/SegmentInformation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Sale of PerClot (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SaleofPerClotDetails</Role>
      <ShortName>Sale of PerClot (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/SaleofPerClot</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails</Role>
      <ShortName>Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Financial Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails</Role>
      <ShortName>Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Cash Equivalents (Summary Of Cash Equivalents And Restricted Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails</Role>
      <ShortName>Cash Equivalents (Summary Of Cash Equivalents And Restricted Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/CashEquivalentsTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Cash Equivalents (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CashEquivalentsNarrativeDetails</Role>
      <ShortName>Cash Equivalents (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/CashEquivalentsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Inventories, net and Deferred Preservation Costs (Schedule Of Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails</Role>
      <ShortName>Inventories, net and Deferred Preservation Costs (Schedule Of Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Inventories, net and Deferred Preservation Costs (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails</Role>
      <ShortName>Inventories, net and Deferred Preservation Costs (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Carrying Values of Indefinite Lived Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Carrying Values of Indefinite Lived Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Goodwill and Other Intangible Assets (Summary of Amortization Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Summary of Amortization Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Goodwill and Other Intangible Assets (Scheduled Amortization of Intangible Assets for Next Five Years) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Scheduled Amortization of Intangible Assets for Next Five Years) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/IncomeTaxes</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Leases (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LeasesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails</Role>
      <ShortName>Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LeasesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Leases (Summary Of Lease Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails</Role>
      <ShortName>Leases (Summary Of Lease Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LeasesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails</Role>
      <ShortName>Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LeasesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Leases (Schedule Of Minimum Lease Payments For Finance, Operating, And Sublease Income Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails</Role>
      <ShortName>Leases (Schedule Of Minimum Lease Payments For Finance, Operating, And Sublease Income Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LeasesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Debt (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/DebtTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Debt (Schedule Of Short-Term And Long-Term Balances Of Term Loan) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails</Role>
      <ShortName>Debt (Schedule Of Short-Term And Long-Term Balances Of Term Loan) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/DebtTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/CommitmentsandContingencies</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Revenue Recognition (Disaggregation Of Revenue) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails</Role>
      <ShortName>Revenue Recognition (Disaggregation Of Revenue) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/RevenueRecognitionTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Stock Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/StockCompensationNarrativeDetails</Role>
      <ShortName>Stock Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/StockCompensationTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails</Role>
      <ShortName>Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/StockCompensationTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Stock Compensation (Summary Of Total Stock Compensation Expenses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails</Role>
      <ShortName>Stock Compensation (Summary Of Total Stock Compensation Expenses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/StockCompensationTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - (Loss) Earnings Per Common Share (Computation Of Basic And Diluted (Loss) Income Per Common Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails</Role>
      <ShortName>(Loss) Earnings Per Common Share (Computation Of Basic And Diluted (Loss) Income Per Common Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LossEarningsPerCommonShareTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Segment Information (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/SegmentInformationTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Segment Information (Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails</Role>
      <ShortName>Segment Information (Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/SegmentInformationTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Segment Information (Summary Of Net Revenues By Product And Service) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails</Role>
      <ShortName>Segment Information (Summary Of Net Revenues By Product And Service) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/SegmentInformationTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="aort-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - aort-20220930.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - aort-20220930.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: aort:DebtInstrumentExtensionPeriod, us-gaap:DebtInstrumentConvertibleConversionRatio1 -  aort-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="aort-20220930.htm">aort-20220930.htm</File>
    <File>a101-form10xqexxformofinde.htm</File>
    <File>a102-redactedxdavisxchange.htm</File>
    <File>a103-redactedxhollowayxcha.htm</File>
    <File>a104-redactedxleexchangeof.htm</File>
    <File>aort-20220930.xsd</File>
    <File>aort-20220930_cal.xml</File>
    <File>aort-20220930_def.xml</File>
    <File>aort-20220930_lab.xml</File>
    <File>aort-20220930_pre.xml</File>
    <File>aort-20220930xex311.htm</File>
    <File>aort-20220930xex312.htm</File>
    <File>aort-20220930xex32.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="879">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>83
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "aort-20220930.htm": {
   "axisCustom": 1,
   "axisStandard": 25,
   "contextCount": 237,
   "dts": {
    "calculationLink": {
     "local": [
      "aort-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "aort-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "aort-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aort-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aort-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "aort-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 480,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 4,
    "http://www.cryolife.com/20220930": 1,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 10
   },
   "keyCustom": 28,
   "keyStandard": 263,
   "memberCustom": 29,
   "memberStandard": 34,
   "nsprefix": "aort",
   "nsuri": "http://www.cryolife.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "role": "http://www.cryolife.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Cash Equivalents",
     "role": "http://www.cryolife.com/role/CashEquivalents",
     "shortName": "Cash Equivalents",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Inventories, net and Deferred Preservation Costs",
     "role": "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts",
     "shortName": "Inventories, net and Deferred Preservation Costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Income Taxes",
     "role": "http://www.cryolife.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Leases",
     "role": "http://www.cryolife.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Debt",
     "role": "http://www.cryolife.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Commitments and Contingencies",
     "role": "http://www.cryolife.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Revenue Recognition",
     "role": "http://www.cryolife.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Stock Compensation",
     "role": "http://www.cryolife.com/role/StockCompensation",
     "shortName": "Stock Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - (Loss) Earnings Per Common Share",
     "role": "http://www.cryolife.com/role/LossEarningsPerCommonShare",
     "shortName": "(Loss) Earnings Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income",
     "role": "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Segment Information",
     "role": "http://www.cryolife.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.cryolife.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Cash Equivalents (Tables)",
     "role": "http://www.cryolife.com/role/CashEquivalentsTables",
     "shortName": "Cash Equivalents (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Inventories, Net And Deferred Preservation Costs (Tables)",
     "role": "http://www.cryolife.com/role/InventoriesNetAndDeferredPreservationCostsTables",
     "shortName": "Inventories, Net And Deferred Preservation Costs (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aort:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Leases (Tables)",
     "role": "http://www.cryolife.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aort:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Debt (Tables)",
     "role": "http://www.cryolife.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Revenue Recognition (Tables)",
     "role": "http://www.cryolife.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Stock Compensation (Tables)",
     "role": "http://www.cryolife.com/role/StockCompensationTables",
     "shortName": "Stock Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - (Loss) Earnings Per Common Share (Tables)",
     "role": "http://www.cryolife.com/role/LossEarningsPerCommonShareTables",
     "shortName": "(Loss) Earnings Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Segment Information (Tables)",
     "role": "http://www.cryolife.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfProductiveAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Sale of PerClot (Details)",
     "role": "http://www.cryolife.com/role/SaleofPerClotDetails",
     "shortName": "Sale of PerClot (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "if7419f77f0164d6e8bbfd14061a58dc8_I20210728",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details)",
     "role": "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails",
     "shortName": "Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Financial Instruments (Narrative) (Details)",
     "role": "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails",
     "shortName": "Financial Instruments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i6525e7731ff74ad0828ab59973e96ed9_I20200902",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i92a6652f436d43be99bd75c32c0406d7_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details)",
     "role": "http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails",
     "shortName": "Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i92a6652f436d43be99bd75c32c0406d7_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Cash Equivalents (Summary Of Cash Equivalents And Restricted Securities) (Details)",
     "role": "http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails",
     "shortName": "Cash Equivalents (Summary Of Cash Equivalents And Restricted Securities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RealizedInvestmentGainsLosses",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RealizedInvestmentGainsLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Cash Equivalents (Narrative) (Details)",
     "role": "http://www.cryolife.com/role/CashEquivalentsNarrativeDetails",
     "shortName": "Cash Equivalents (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RealizedInvestmentGainsLosses",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RealizedInvestmentGainsLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Inventories, net and Deferred Preservation Costs (Schedule Of Inventories) (Details)",
     "role": "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails",
     "shortName": "Inventories, net and Deferred Preservation Costs (Schedule Of Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Inventories, net and Deferred Preservation Costs (Narrative) (Details)",
     "role": "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails",
     "shortName": "Inventories, net and Deferred Preservation Costs (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Carrying Values of Indefinite Lived Intangible Assets) (Details)",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Carrying Values of Indefinite Lived Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i5d1dafbd2f6f4fe292ea508a5b6aae73_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i92a6652f436d43be99bd75c32c0406d7_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets) (Details)",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i3fb32fabff8742a98b5467dff62122bf_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Goodwill and Other Intangible Assets (Summary of Amortization Expense) (Details)",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails",
     "shortName": "Goodwill and Other Intangible Assets (Summary of Amortization Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Goodwill and Other Intangible Assets (Scheduled Amortization of Intangible Assets for Next Five Years) (Details)",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Scheduled Amortization of Intangible Assets for Next Five Years) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Income Taxes (Details)",
     "role": "http://www.cryolife.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncreaseDecreaseInOperatingLeaseLiability",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i704c126d4e494f8d8caab84f162c9d5f_I20210601",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Leases (Narrative) (Details)",
     "role": "http://www.cryolife.com/role/LeasesNarrativeDetails",
     "shortName": "Leases (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i91ff9b76a1ca40d280c764ffb11b5962_D20210601-20210601",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncreaseDecreaseInOperatingLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "aort:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details)",
     "role": "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails",
     "shortName": "Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "aort:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Leases (Summary Of Lease Costs) (Details)",
     "role": "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails",
     "shortName": "Leases (Summary Of Lease Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details)",
     "role": "http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails",
     "shortName": "Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Leases (Schedule Of Minimum Lease Payments For Finance, Operating, And Sublease Income Leases) (Details)",
     "role": "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
     "shortName": "Leases (Schedule Of Minimum Lease Payments For Finance, Operating, And Sublease Income Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Debt (Narrative) (Details)",
     "role": "http://www.cryolife.com/role/DebtNarrativeDetails",
     "shortName": "Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Debt (Schedule Of Short-Term And Long-Term Balances Of Term Loan) (Details)",
     "role": "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails",
     "shortName": "Debt (Schedule Of Short-Term And Long-Term Balances Of Term Loan) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "idd9590ccbffc4f6b912ae40ff2eacdfa_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "aort:ResearchAndDevelopmentExpenseTerminationAndWindDownCosts",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "aort:ResearchAndDevelopmentExpenseTerminationAndWindDownCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.cryolife.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "aort:ResearchAndDevelopmentExpenseTerminationAndWindDownCosts",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "aort:ResearchAndDevelopmentExpenseTerminationAndWindDownCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Revenue Recognition (Disaggregation Of Revenue) (Details)",
     "role": "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
     "shortName": "Revenue Recognition (Disaggregation Of Revenue) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i19857ac737a849ee839c3f22bc8089c2_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Stock Compensation (Narrative) (Details)",
     "role": "http://www.cryolife.com/role/StockCompensationNarrativeDetails",
     "shortName": "Stock Compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i42eac7fb937149b19cdc9f258f5ac32e_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details)",
     "role": "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails",
     "shortName": "Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i42eac7fb937149b19cdc9f258f5ac32e_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Stock Compensation (Summary Of Total Stock Compensation Expenses) (Details)",
     "role": "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails",
     "shortName": "Stock Compensation (Summary Of Total Stock Compensation Expenses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - (Loss) Earnings Per Common Share (Computation Of Basic And Diluted (Loss) Income Per Common Share) (Details)",
     "role": "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails",
     "shortName": "(Loss) Earnings Per Common Share (Computation Of Basic And Diluted (Loss) Income Per Common Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Segment Information (Narrative) (Details)",
     "role": "http://www.cryolife.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i6421cdadddcd4de2b8a922abe34ec4d4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Shareholders' Equity",
     "role": "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i6421cdadddcd4de2b8a922abe34ec4d4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Segment Information (Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments) (Details)",
     "role": "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails",
     "shortName": "Segment Information (Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i4ed6e56bac6643c2b13e09943b8594b7_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "i2bfb03a8b6f541a5ab1ca525825733f2_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Segment Information (Summary Of Net Revenues By Product And Service) (Details)",
     "role": "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails",
     "shortName": "Segment Information (Summary Of Net Revenues By Product And Service) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "ie06e2f5450764fcd97b8a391bba3cd2d_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Sale of PerClot",
     "role": "http://www.cryolife.com/role/SaleofPerClot",
     "shortName": "Sale of PerClot",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Financial Instruments",
     "role": "http://www.cryolife.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20220930.htm",
      "contextRef": "id4a4cbbef73e4f5295c9e1fcce2d85a3_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": null,
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - aort-20220930.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - aort-20220930.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 67,
   "tag": {
    "aort_AccruedProcurementFees": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Donated tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. The Company accrues estimated procurement fees due at the time tissues are received based on contractual agreements between the Company and the tissue banks and organ procurement organizations.",
        "label": "Accrued Procurement Fees",
        "terseLabel": "Accrued procurement fees"
       }
      }
     },
     "localname": "AccruedProcurementFees",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_AorticStentGraftsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aortic Stent Grafts [Member]",
        "label": "Aortic Stent Grafts [Member]",
        "terseLabel": "Aortic stent grafts"
       }
      }
     },
     "localname": "AorticStentGraftsMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_ArtivionInc.AndStarchMedicalInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Artivion, Inc. And Starch Medical, Inc. [Member]",
        "label": "Artivion Inc. And Starch Medical Inc. [Member]",
        "terseLabel": "Artivion Inc. And Starch Medical Inc."
       }
      }
     },
     "localname": "ArtivionInc.AndStarchMedicalInc.Member",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_AscyrusMedicalLlcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ascyrus Medical LLC [Member]",
        "label": "Ascyrus Medical Llc [Member]",
        "terseLabel": "Ascyrus Medical LLC"
       }
      }
     },
     "localname": "AscyrusMedicalLlcMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Supplemental Balance Sheet Information Related To Leases [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Balance Sheet Information Related to Leases"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aort_BaxterAchievementOfWorldwideSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Baxter Achievement Of Worldwide Sales [Member]",
        "label": "Baxter Achievement Of Worldwide Sales [Member]",
        "terseLabel": "Baxter Achievement Of Worldwide Sales"
       }
      }
     },
     "localname": "BaxterAchievementOfWorldwideSalesMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_CardiogenesisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiogenesis [Member]",
        "label": "Cardiogenesis [Member]",
        "terseLabel": "CardioGenesis cardiac laser therapy"
       }
      }
     },
     "localname": "CardiogenesisMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_CircumstanceAfterJuly52023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Circumstance After July 5, 2023 [Member]",
        "label": "Circumstance After July52023 [Member]",
        "terseLabel": "Circumstance After July 5, 2023"
       }
      }
     },
     "localname": "CircumstanceAfterJuly52023Member",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_CircumstanceIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Circumstance I [Member]",
        "label": "Circumstance I [Member]",
        "terseLabel": "Circumstance I"
       }
      }
     },
     "localname": "CircumstanceIMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_CircumstanceIiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Circumstance II [Member]",
        "label": "Circumstance Ii [Member]",
        "terseLabel": "Circumstance II"
       }
      }
     },
     "localname": "CircumstanceIiMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_ConsignmentInventoryPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consignment inventory percentage.",
        "label": "Consignment Inventory Percentage",
        "terseLabel": "Consignment inventory percentage"
       }
      }
     },
     "localname": "ConsignmentInventoryPercentage",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aort_ContingentConsiderationNoncurrentFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Noncurrent, Fair Value",
        "label": "Contingent Consideration, Noncurrent, Fair Value",
        "negatedLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationNoncurrentFairValue",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Redemption Percentage Of Principal Amount",
        "label": "Debt Instrument, Convertible, Redemption Percentage Of Principal Amount",
        "terseLabel": "Conversion percentage of principal amount"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aort_DebtInstrumentExtensionCircumstancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, extension circumstance period.",
        "label": "Debt instrument, extension circumstance period",
        "terseLabel": "Debt instrument, extension circumstance period"
       }
      }
     },
     "localname": "DebtInstrumentExtensionCircumstancePeriod",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aort_DebtInstrumentExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, extension period",
        "label": "Debt instrument, extension period",
        "terseLabel": "Debt instrument, extension period"
       }
      }
     },
     "localname": "DebtInstrumentExtensionPeriod",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aort_DebtPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Period",
        "label": "Debt Period [Axis]",
        "terseLabel": "Debt Period [Axis]"
       }
      }
     },
     "localname": "DebtPeriodAxis",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aort_DebtPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Period [Domain]",
        "label": "Debt Period [Domain]",
        "terseLabel": "Debt Period [Domain]"
       }
      }
     },
     "localname": "DebtPeriodDomain",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_DeferredPreservationCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Donated human tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. By federal law, human tissues cannot be bought or sold, so the preservation process is a manufacturing process that is accounted for using the same principles as inventory costing. Preservation costs consist primarily of direct labor and materials and indirect costs which are stated at the lower of cost or market value on a first in, first out basis and are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.",
        "label": "Deferred Preservation Costs",
        "terseLabel": "Deferred preservation costs, net"
       }
      }
     },
     "localname": "DeferredPreservationCosts",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Contingent Consideration Receivable",
        "label": "Disposal Group Including Discontinued Operation, Contingent Consideration Receivable",
        "terseLabel": "Contingent consideration receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationContingentConsiderationReceivable",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_DomesticHospitalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Domestic Hospitals [Member]",
        "label": "Domestic Hospitals [Member]",
        "terseLabel": "Domestic hospitals"
       }
      }
     },
     "localname": "DomesticHospitalsMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of finance lease cost recognized by lessee for lease contract.",
        "label": "Finance Lease, Cost",
        "totalLabel": "Total finance lease expense"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_FinanceLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, to be Paid, after Year Four",
        "label": "Finance Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the first five fiscal years following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Estimate",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_GovernmentSponsoredDebtKfwLoan1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Sponsored Debt (KFW Loan 1) [Member]",
        "label": "Government Sponsored Debt Kfw Loan1 [Member]",
        "terseLabel": "2.45% Sparkasse Zollernalb (KFW Loan 1)"
       }
      }
     },
     "localname": "GovernmentSponsoredDebtKfwLoan1Member",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_GovernmentSponsoredDebtKfwLoan2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Sponsored Debt (KFW Loan 2) [Member]",
        "label": "Government Sponsored Debt Kfw Loan2 [Member]",
        "terseLabel": "1.40% Sparkasse Zollernalb (KFW Loan 2)"
       }
      }
     },
     "localname": "GovernmentSponsoredDebtKfwLoan2Member",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in deferred preservation costs and inventories, associated with underlying transactions that are classified as operating activities. Preservation costs consists primarily of direct labor and materials and indirect costs which are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.",
        "label": "Increase (Decrease) in Deferred Preservation Costs and Inventories",
        "negatedLabel": "Inventories and deferred preservation costs"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredPreservationCostsAndInventories",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_IntangibleAssetsOtherThanAcquiredTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets Other Than Acquired Technology [Member]",
        "label": "Intangible Assets Other Than Acquired Technology [Member]",
        "terseLabel": "Other intangibles:"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanAcquiredTechnologyMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_InternationalDistributorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Distributor [Member]",
        "label": "International Distributor [Member]",
        "terseLabel": "International distributors"
       }
      }
     },
     "localname": "InternationalDistributorMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_InternationalHospitalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Hospitals [Member]",
        "label": "International Hospitals [Member]",
        "terseLabel": "International hospitals"
       }
      }
     },
     "localname": "InternationalHospitalsMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_MedicalDevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Devices [Member]",
        "label": "Medical Devices [Member]",
        "terseLabel": "Medical devices"
       }
      }
     },
     "localname": "MedicalDevicesMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_NoncashInterestExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Interest Expense",
        "label": "Noncash Interest Expense",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "NoncashInterestExpense",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_NoncashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Lease Expense",
        "label": "Noncash Lease Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "NoncashLeaseExpense",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_OnXMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "On-X [Member]",
        "label": "On X [Member]",
        "terseLabel": "On-X"
       }
      }
     },
     "localname": "OnXMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals After Year Four",
        "label": "Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals After Year Four",
        "terseLabel": "Sublease Income, Thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsAfterYearFour",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractually required future rental payments receivable on noncancelable subleasing arrangements, having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.",
        "label": "Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Remainder of Fiscal Year",
        "terseLabel": "Sublease Income, Remainder of 2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Four",
        "label": "Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Four",
        "terseLabel": "Sublease Income, 2026"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearFour",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year One",
        "label": "Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year One",
        "terseLabel": "Sublease Income, 2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearOne",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Three",
        "label": "Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Three",
        "terseLabel": "Sublease Income, 2025"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearThree",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Two",
        "label": "Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Year Two",
        "terseLabel": "Sublease Income, 2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsYearTwo",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_OtherProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Products [Member]",
        "label": "Other Products [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherProductsMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_PerClotMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PerClot [Member]",
        "label": "Per Clot [Member]",
        "terseLabel": "Per Clot"
       }
      }
     },
     "localname": "PerClotMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_PmaApprovalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PMA Approval [Member]",
        "label": "Pma Approval [Member]",
        "terseLabel": "Pma Approval"
       }
      }
     },
     "localname": "PmaApprovalMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_PreservationServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preservation Services [Member]",
        "label": "Preservation Services [Member]",
        "terseLabel": "Preservation services"
       }
      }
     },
     "localname": "PreservationServicesMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails",
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_ProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products [Member]",
        "label": "Products [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductsMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from operating lease.",
        "label": "Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and operating lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_ResearchAndDevelopmentExpenseTerminationAndWindDownCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Expense, Termination and Wind-down Costs",
        "label": "Research And Development Expense, Termination and Wind-down Costs",
        "terseLabel": "Termination and wind-down expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseTerminationAndWindDownCosts",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Awards Restricted Stock Units Performance Stock Awards Performance Stock Units [Member]",
        "label": "Restricted Stock Awards Restricted Stock Units Performance Stock Awards Performance Stock Units [Member]",
        "terseLabel": "RSA, RSU, and PSU expense"
       }
      }
     },
     "localname": "RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Awards, Restricted Stock Units, Preferred Stock Units",
        "label": "Restricted Stock Awards Restricted Stock Units Preferred Stock Units [Member]",
        "terseLabel": "RSAs, RSUs, And PSUs"
       }
      }
     },
     "localname": "RestrictedStockAwardsRestrictedStockUnitsPreferredStockUnitsMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_RevolvingCreditFacilityAndTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility And Term Loan [Member]",
        "label": "Revolving Credit Facility And Term Loan [Member]",
        "terseLabel": "Revolving Credit Facility And Term Loan"
       }
      }
     },
     "localname": "RevolvingCreditFacilityAndTermLoanMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Percentage Repaid for No Covenants",
        "label": "Revolving Credit Facility, Percentage Repaid for No Covenants",
        "terseLabel": "Revolving credit facility, percentage repaid for no covenants"
       }
      }
     },
     "localname": "RevolvingCreditFacilityPercentageRepaidForNoCovenants",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market value of share based compensation arrangement by share based payment award other than options granted during the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Market Value Of Shares Granted",
        "terseLabel": "Aggregate grant date market value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_StarchMedicalInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Starch Medical, Inc. [Member]",
        "label": "Starch Medical Inc. [Member]",
        "terseLabel": "Starch Medical Inc."
       }
      }
     },
     "localname": "StarchMedicalInc.Member",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option And Employee Stock Purchase Plan Option Expense [Member]",
        "label": "Stock Option And Employee Stock Purchase Plan Option Expense [Member]",
        "terseLabel": "Stock option and ESPP expense"
       }
      }
     },
     "localname": "StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_SurgicalSealantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Sealants [Member]",
        "label": "Surgical Sealants [Member]",
        "terseLabel": "Surgical sealants"
       }
      }
     },
     "localname": "SurgicalSealantsMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_TransferOfPerclotManufacturingEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer Of PerClot Manufacturing Equipment [Member]",
        "label": "Transfer Of Perclot Manufacturing Equipment [Member]",
        "terseLabel": "Transfer Of Perclot Manufacturing Equipment"
       }
      }
     },
     "localname": "TransferOfPerclotManufacturingEquipmentMember",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_WriteDownOfDeferredPreservationCostsAndInventories": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts of the current period expense charged to cost of products and preservation services for the purpose of reducing deferred preservation costs and inventory, respectively, to amounts that approximate their net realizable value.",
        "label": "Write-Down of Deferred Preservation Costs and Inventories",
        "terseLabel": "Write-down of inventories and deferred preservation costs"
       }
      }
     },
     "localname": "WriteDownOfDeferredPreservationCostsAndInventories",
     "nsuri": "http://www.cryolife.com/20220930",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r119",
      "r172",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r192",
      "r196",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r269",
      "r271",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r119",
      "r172",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r192",
      "r196",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r269",
      "r271",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r124",
      "r131",
      "r137",
      "r215",
      "r370",
      "r371",
      "r372",
      "r388",
      "r389",
      "r419",
      "r422",
      "r424",
      "r425",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r124",
      "r131",
      "r137",
      "r215",
      "r370",
      "r371",
      "r372",
      "r388",
      "r389",
      "r419",
      "r422",
      "r424",
      "r425",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r124",
      "r131",
      "r137",
      "r215",
      "r370",
      "r371",
      "r372",
      "r388",
      "r389",
      "r419",
      "r422",
      "r424",
      "r425",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OfficerMember": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Officer [Member]",
        "terseLabel": "Officers"
       }
      }
     },
     "localname": "OfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r198",
      "r331",
      "r333",
      "r489",
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r198",
      "r331",
      "r333",
      "r489",
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Products and Services [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r199",
      "r200",
      "r331",
      "r334",
      "r526",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r199",
      "r200",
      "r331",
      "r334",
      "r526",
      "r539",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r204",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r125",
      "r126",
      "r127",
      "r128",
      "r208",
      "r209",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r258",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r388",
      "r389",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r480",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible Enumeration]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r53",
      "r484"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r22",
      "r35",
      "r205",
      "r206"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r38",
      "r71",
      "r72",
      "r73",
      "r513",
      "r534",
      "r538"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r70",
      "r73",
      "r79",
      "r80",
      "r81",
      "r121",
      "r122",
      "r123",
      "r411",
      "r529",
      "r530",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r370",
      "r371",
      "r372",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r125",
      "r126",
      "r127",
      "r128",
      "r137",
      "r208",
      "r209",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r258",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r386",
      "r387",
      "r388",
      "r389",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r480",
      "r491",
      "r492",
      "r493",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net (loss) income to net cash from operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r89",
      "r110",
      "r298",
      "r457"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of the debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r110",
      "r226",
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive shares (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Effect of convertible senior notes"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r116",
      "r180",
      "r187",
      "r194",
      "r211",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r270",
      "r272",
      "r273",
      "r409",
      "r413",
      "r438",
      "r482",
      "r484",
      "r497",
      "r511"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r23",
      "r24",
      "r67",
      "r116",
      "r211",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r270",
      "r272",
      "r273",
      "r409",
      "r413",
      "r438",
      "r482",
      "r484"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r353",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails",
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails",
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccounting": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfAccounting",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r349",
      "r350",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "verboseLabel": "Percentage of outstanding equity acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r109",
      "r408"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedLabel": "Change in valuation",
        "terseLabel": "Change in fair value of contingent consideration",
        "verboseLabel": "Increase (decrease) in fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Maximum amount of future consideration payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Contingent consideration, measurement input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r405",
      "r406"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "netLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]",
        "terseLabel": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r20",
      "r51",
      "r112"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents:",
        "verboseLabel": "Estimated Market Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails",
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Cash and Cash Equivalents [Line Items]",
        "terseLabel": "Cash and Cash Equivalents [Line Items]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CashEquivalents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r107",
      "r112",
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents end of period",
        "periodStartLabel": "Cash and cash equivalents beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r107",
      "r447"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "(Decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cost Basis"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r63",
      "r255",
      "r501",
      "r517"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r252",
      "r253",
      "r254",
      "r256",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r121",
      "r122",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r34",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r34",
      "r484"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock (issued shares of 41,816 in 2022 and 41,397 in 2021)"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r75",
      "r77",
      "r78",
      "r86",
      "r504",
      "r519"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive (loss) income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Procurement contracts and agreements"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r278",
      "r288",
      "r289",
      "r290",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r308",
      "r309",
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Effect of convertible senior notes"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r91",
      "r489"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Total cost of products and preservation services"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "verboseLabel": "Cost of products and preservation services:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerListsMember": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.",
        "label": "Customer Lists [Member]",
        "terseLabel": "Customer lists and relationships"
       }
      }
     },
     "localname": "CustomerListsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r114",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r292",
      "r299",
      "r300",
      "r302",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r115",
      "r119",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r308",
      "r309",
      "r310",
      "r311",
      "r458",
      "r498",
      "r499",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Credit facility margin"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r32",
      "r303",
      "r499",
      "r510"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Secured term loan facility",
        "verboseLabel": "Total loan balance"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r277",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r60",
      "r277",
      "r314",
      "r315",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Conversion consecutive trading day threshold"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Conversion percentage of stock price threshold"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Conversion trading day threshold"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r275",
      "r308",
      "r309",
      "r456",
      "r458",
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Face value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r290",
      "r308",
      "r309",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r59",
      "r306",
      "r456",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r59",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on amounts borrowed"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r61",
      "r115",
      "r119",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r308",
      "r309",
      "r310",
      "r311",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r61",
      "r115",
      "r119",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r301",
      "r308",
      "r309",
      "r310",
      "r311",
      "r314",
      "r316",
      "r317",
      "r318",
      "r455",
      "r456",
      "r458",
      "r459",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r288",
      "r455",
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Less unamortized loan origination costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liability"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r377",
      "r378"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r377",
      "r378"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "verboseLabel": "Valuation allowances against deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r378",
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "terseLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r110",
      "r175"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Consideration for sale of assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r14",
      "r239",
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent",
        "terseLabel": "Derecognition of intangible assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r19",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Sale of PerClot"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClot"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DistributionRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal rights, generally of a limited duration, to distribute a product or products, often within specific geographic areas or supply channels.",
        "label": "Distribution Rights [Member]",
        "terseLabel": "Distribution and manufacturing rights and know-how"
       }
      }
     },
     "localname": "DistributionRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r87",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r138",
      "r141",
      "r155",
      "r158",
      "r159",
      "r163",
      "r164",
      "r425",
      "r426",
      "r505",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "(Loss) income per share, basic (in usd per share)",
        "verboseLabel": "Basic (loss) income per common share (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "verboseLabel": "(Loss) income per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "verboseLabel": "Weighted-average common shares outstanding:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r87",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r141",
      "r155",
      "r158",
      "r159",
      "r163",
      "r164",
      "r425",
      "r426",
      "r505",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "(Loss) income per share, diluted (in usd per share)",
        "verboseLabel": "Diluted (loss) income per common share (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r160",
      "r161",
      "r162",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "(Loss) Earnings Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r447"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "verboseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate expense (benefit)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Amount Capitalized",
        "terseLabel": "Capitalized stock compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails",
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options",
        "verboseLabel": "Effect of dilutive stock options and awards"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails",
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r79",
      "r80",
      "r81",
      "r121",
      "r122",
      "r123",
      "r126",
      "r134",
      "r136",
      "r166",
      "r215",
      "r313",
      "r319",
      "r370",
      "r371",
      "r372",
      "r388",
      "r389",
      "r424",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r529",
      "r530",
      "r531",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Debt extinguishment costs"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r427",
      "r428",
      "r429",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Fair Value by Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r427",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r427",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r427",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "verboseLabel": "Summary of Financial Instruments Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r290",
      "r308",
      "r309",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r428",
      "r485",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r290",
      "r341",
      "r342",
      "r347",
      "r348",
      "r428",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r290",
      "r308",
      "r309",
      "r341",
      "r342",
      "r347",
      "r348",
      "r428",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r290",
      "r308",
      "r309",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r428",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r432",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Changes in Fair Value of Level 3 Liabilities"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "negatedPeriodEndLabel": "Ending balance",
        "negatedPeriodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r290",
      "r308",
      "r309",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r485",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r464",
      "r469",
      "r477"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "aort_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest expense on finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r466",
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows for finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r462",
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of net minimum lease payments",
        "totalLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease Liability [Abstract]",
        "terseLabel": "Finance leases:"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r462"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "negatedLabel": "Less current maturities",
        "terseLabel": "Current maturities of finance leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Finance Lease, Liability, Fiscal Year Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r462"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "netLabel": "Lease liabilities, less current maturities",
        "terseLabel": "Non-current maturities of finance leases",
        "verboseLabel": "Non-current finance lease obligation"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r476"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less amount representing interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r465",
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows for finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r464",
      "r469",
      "r477"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "aort_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of property and equipment"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r474",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "netLabel": "Weighted average discount rate: Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r473",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Weighted average remaining lease term (in years): Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted Average Useful Life (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "verboseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": 5.0,
       "parentTag": "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": 3.0,
       "parentTag": "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "verboseLabel": "Remainder of 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]",
        "verboseLabel": "Summary of Amortization Expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": 1.0,
       "parentTag": "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": 6.0,
       "parentTag": "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": 4.0,
       "parentTag": "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": 2.0,
       "parentTag": "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r227",
      "r229",
      "r231",
      "r235",
      "r490",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r231",
      "r494"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r227",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r231",
      "r490"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Acquired technology, net",
        "totalLabel": "Net Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r110",
      "r412"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain from sale of non-financial assets",
        "terseLabel": "Gain from sale of non-financial assets"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r221",
      "r222",
      "r484",
      "r496"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails",
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r90",
      "r116",
      "r180",
      "r186",
      "r190",
      "r193",
      "r196",
      "r211",
      "r259",
      "r260",
      "r261",
      "r264",
      "r265",
      "r266",
      "r268",
      "r270",
      "r272",
      "r273",
      "r438"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin",
        "verboseLabel": "Total gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r110",
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Write off of intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process R&amp;D"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r84",
      "r180",
      "r186",
      "r190",
      "r193",
      "r196",
      "r495",
      "r502",
      "r507",
      "r521"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "(Loss) income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r6",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r15",
      "r16",
      "r17",
      "r18",
      "r246",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r243",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r117",
      "r381",
      "r382",
      "r385",
      "r390",
      "r392",
      "r394",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r118",
      "r135",
      "r136",
      "r178",
      "r379",
      "r391",
      "r393",
      "r522"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued expenses, and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r109",
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Increase in operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r149",
      "r150",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "terseLabel": "Effect of convertible senior notes (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Effect of dilutive stock options and awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r228",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "verboseLabel": "Total indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r228",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r82",
      "r174",
      "r454",
      "r457",
      "r506"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r94",
      "r296",
      "r307",
      "r310",
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestOnConvertibleDebtNetOfTax": {
     "auth_ref": [
      "r140",
      "r146",
      "r159"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.",
        "label": "Interest on Convertible Debt, Net of Tax",
        "terseLabel": "Net loss attributable to convertible senior notes"
       }
      }
     },
     "localname": "InterestOnConvertibleDebtNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r172",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r192",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]",
        "terseLabel": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories, net and Deferred Preservation Costs"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r42",
      "r219"
     ],
     "calculation": {
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r21",
      "r66",
      "r484"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r44",
      "r45",
      "r219"
     ],
     "calculation": {
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw materials and supplies"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r66",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory valuation reserve"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r43",
      "r219"
     ],
     "calculation": {
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r93",
      "r173"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "negatedLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r475",
      "r477"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease expense"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOperatingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases, Operating [Abstract]",
        "terseLabel": "Operating leases:"
       }
      }
     },
     "localname": "LeasesOperatingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments.",
        "label": "Lessee, Operating Lease, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r476"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less amount representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r56",
      "r116",
      "r188",
      "r211",
      "r259",
      "r260",
      "r261",
      "r264",
      "r265",
      "r266",
      "r268",
      "r270",
      "r272",
      "r273",
      "r410",
      "r413",
      "r414",
      "r438",
      "r482",
      "r483"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r41",
      "r116",
      "r211",
      "r438",
      "r484",
      "r500",
      "r515"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r58",
      "r116",
      "r211",
      "r259",
      "r260",
      "r261",
      "r264",
      "r265",
      "r266",
      "r268",
      "r270",
      "r272",
      "r273",
      "r410",
      "r413",
      "r414",
      "r438",
      "r482",
      "r483",
      "r484"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "negatedTotalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility aggregate commitments"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r54",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term loan balance"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r32",
      "r289",
      "r304",
      "r308",
      "r309",
      "r499",
      "r512"
     ],
     "calculation": {
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Net borrowings",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedLabel": "Less short-term loan balance",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Long-term loan balance"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r61",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Marketable Securities, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized Holding Gains"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails",
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash flows used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Net cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash flows (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Net cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r107",
      "r108",
      "r111"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash flows used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Net cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r18",
      "r74",
      "r76",
      "r81",
      "r85",
      "r111",
      "r116",
      "r125",
      "r129",
      "r130",
      "r131",
      "r132",
      "r135",
      "r136",
      "r152",
      "r180",
      "r186",
      "r190",
      "r193",
      "r196",
      "r211",
      "r259",
      "r260",
      "r261",
      "r264",
      "r265",
      "r266",
      "r268",
      "r270",
      "r272",
      "r273",
      "r426",
      "r438",
      "r503",
      "r518"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net (loss) income",
        "totalLabel": "Net (loss) income",
        "verboseLabel": "Net (loss) income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132",
      "r138",
      "r139",
      "r154",
      "r159",
      "r180",
      "r186",
      "r190",
      "r193",
      "r196"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net (loss) income allocated to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Basic (loss) income per common share"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r140",
      "r145",
      "r146",
      "r147",
      "r148",
      "r154",
      "r159"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net (loss) income allocated to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Diluted (loss) income per common share"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r180",
      "r186",
      "r190",
      "r193",
      "r196"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating (loss) income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r470",
      "r477"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r462"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of net minimum lease payments",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r462"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Less current maturities",
        "terseLabel": "Current maturities of operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r462"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "netLabel": "Non-current maturities of operating leases",
        "terseLabel": "Non-current maturities of operating leases",
        "verboseLabel": "Lease liabilities, less current maturities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r467",
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r461"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Increase in the present value of future lease obligations and corresponding right-of-use asset",
        "totalLabel": "Operating lease right-of-use assets, net",
        "verboseLabel": "Operating lease right-of-use assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/LeasesNarrativeDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r474",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "netLabel": "Weighted average discount rate: Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r473",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Weighted average remaining lease term (in years): Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "netLabel": "Foreign currency translation adjustments",
        "terseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Other Intangible Assets, Net",
        "terseLabel": "Other intangibles, net"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.",
        "label": "Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross",
        "terseLabel": "Consignment inventory"
       }
      }
     },
     "localname": "OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r25",
      "r26",
      "r57",
      "r484"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashExpense": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.",
        "label": "Other Noncash Expense",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r97",
      "r99"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payment of debt issuance costs",
        "verboseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Redemption and repurchase of stock to cover tax withholdings"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Acquisition of intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r33",
      "r484"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r23",
      "r49",
      "r50"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible debt"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from exercise of stock options and issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r102",
      "r106"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Proceeds from Sale of Productive Assets",
        "terseLabel": "Proceeds from sale of non-financial assets, net",
        "verboseLabel": "Proceeds from sale of assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.cryolife.com/role/SaleofPerClotDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]",
        "terseLabel": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r241",
      "r464",
      "r469"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedLabel": "Finance leases, Accumulated amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r68",
      "r242",
      "r469"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "totalLabel": "Finance leases, property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r28",
      "r240",
      "r461"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Finance leases, Property and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r28",
      "r29",
      "r242",
      "r484",
      "r508",
      "r516"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet": {
     "auth_ref": [
      "r242",
      "r460",
      "r479"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.",
        "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease, after Accumulated Depreciation",
        "totalLabel": "Sublease Income"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "verboseLabel": "Gross realized gains or losses on cash equivalents"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CashEquivalentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Repayment of term loan"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r376",
      "r488",
      "r550"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r37",
      "r319",
      "r373",
      "r484",
      "r514",
      "r533",
      "r538"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained (deficit) earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r121",
      "r122",
      "r123",
      "r126",
      "r134",
      "r136",
      "r215",
      "r370",
      "r371",
      "r372",
      "r388",
      "r389",
      "r424",
      "r529",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r171",
      "r172",
      "r185",
      "r191",
      "r192",
      "r198",
      "r199",
      "r202",
      "r330",
      "r331",
      "r489"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total sources of revenue",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails",
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r332",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r83",
      "r116",
      "r171",
      "r172",
      "r185",
      "r191",
      "r192",
      "r198",
      "r199",
      "r202",
      "r211",
      "r259",
      "r260",
      "r261",
      "r264",
      "r265",
      "r266",
      "r268",
      "r270",
      "r272",
      "r273",
      "r438",
      "r507"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Intersegment revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances.",
        "label": "Schedule of Cash and Cash Equivalents [Table]",
        "terseLabel": "Schedule of Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CashEquivalentsSummaryOfCashEquivalentsAndRestrictedSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments.",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "terseLabel": "Summary of Cash Equivalents and Restricted Securities"
       }
      }
     },
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CashEquivalentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Summary of Total Stock Compensation Expenses"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Schedule of Short-Term and Long-Term Balances of Term Loan"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Computation of Basic and Diluted (Loss) Income Per Common Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "verboseLabel": "Summary of Net Revenues by Product and Service"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r227",
      "r230",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r227",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r224",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r234",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values of Indefinite Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r27",
      "r46",
      "r47",
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesNetAndDeferredPreservationCostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r180",
      "r183",
      "r189",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails",
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r180",
      "r183",
      "r189",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Revenues, Cost of Products and Services, and Gross Margins for Operating Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r353",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails",
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails",
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Weighted-Average Assumptions Used to Determine the Fair Value of Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "verboseLabel": "Scheduled Amortization of Intangible Assets for Next Five Years"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r167",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r202",
      "r250",
      "r251",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r167",
      "r169",
      "r170",
      "r180",
      "r184",
      "r190",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r201",
      "r202",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails",
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "General, administrative, and marketing"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Non-cash compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Authorized awards from approved stock incentive plans (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock price volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails",
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails",
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Grants of stock options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r351",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails",
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails",
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "auth_ref": [
      "r363"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount",
        "terseLabel": "Total stock compensation expense"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r359",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "ESPP, percentage of market price for eligible employees"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r7",
      "r167",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r202",
      "r224",
      "r245",
      "r250",
      "r251",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r64",
      "r79",
      "r80",
      "r81",
      "r121",
      "r122",
      "r123",
      "r126",
      "r134",
      "r136",
      "r166",
      "r215",
      "r313",
      "r319",
      "r370",
      "r371",
      "r372",
      "r388",
      "r389",
      "r424",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r529",
      "r530",
      "r531",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Other Comprehensive Income [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "StatementOfOtherComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r166",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r33",
      "r34",
      "r313",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r33",
      "r34",
      "r313",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Equity compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r33",
      "r34",
      "r313",
      "r319",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r33",
      "r34",
      "r313",
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r33",
      "r34",
      "r319",
      "r352",
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r64",
      "r313",
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodShares": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.",
        "label": "Stock Redeemed or Called During Period, Shares",
        "negatedTerseLabel": "Redemption and repurchase of stock to cover tax withholdings (in shares)"
       }
      }
     },
     "localname": "StockRedeemedOrCalledDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodValue": {
     "auth_ref": [
      "r313"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.",
        "label": "Stock Redeemed or Called During Period, Value",
        "negatedTerseLabel": "Redemption and repurchase of stock to cover tax withholdings"
       }
      }
     },
     "localname": "StockRedeemedOrCalledDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r34",
      "r39",
      "r40",
      "r116",
      "r207",
      "r211",
      "r438",
      "r484"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r471",
      "r477"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Acquired technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "negatedPeriodEndLabel": "Ending balance, treasury stock (in shares)",
        "negatedPeriodStartLabel": "Beginning balance, treasury stock (in shares)",
        "verboseLabel": "Treasury stock at cost, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r65",
      "r320",
      "r321"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedLabel": "Treasury stock, at cost, 1,487 shares as of September\u00a030, 2022 and December\u00a031, 2021",
        "negatedPeriodEndLabel": "Ending balance, treasury stock",
        "negatedPeriodStartLabel": "Beginning balance, treasury stock"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r125",
      "r126",
      "r127",
      "r128",
      "r137",
      "r208",
      "r209",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r258",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r386",
      "r387",
      "r388",
      "r389",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r480",
      "r491",
      "r492",
      "r493",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r153",
      "r156",
      "r157"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
        "negatedLabel": "Net loss (income) allocated to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": {
     "auth_ref": [
      "r151",
      "r153",
      "r156",
      "r157"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted",
        "negatedLabel": "Net loss (income) allocated to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r140",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted weighted-average common shares outstanding (in shares)",
        "verboseLabel": "Weighted-average common shares outstanding, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r138",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average common shares outstanding, basic (in shares)",
        "verboseLabel": "Basic weighted-average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossIncome",
      "http://www.cryolife.com/role/LossEarningsPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2029-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2740-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "65",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2793-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "66",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2814-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2510-110228"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919398-209981"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r551": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r552": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r553": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r554": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r555": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r556": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>84
<FILENAME>0000784199-22-000189-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000784199-22-000189-xbrl.zip
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M20$;OT1S3V8999==2[QL].1YHT5;/%B5&5KPXQ8.&:PV7#M/5KAO\&>3KNW
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M0-3OC:]T K'3#24F7"T/TC*@-(YO^-Y,CPQ2@,NC)QT&6:<URLI$H]A6-IV
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MQ&.*HTTP+]_8G#F1&UP;/3/>E\>X8,/,7I,'1L@M6BRJPW]C_IR""@C06'.
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MMM)_!\=9F1$>?\VIN_'<><4SH38>:Z:J/Z]FOO+V\^>IC%1.B":LB?;PO-6
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M-K];8!Q8FH2SZ\ZT&4Y#@RBKX-QK4*DMR+>L+991J[\$?3[#\P-U>,,<Y:#
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M+P(98WIK46:)J>.&OCN!2#J?6FUB?N\2&XAAV5M8%94.>ET=^V^;.?,SW/P
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M\*,63$-$0I#*TN!* 35ZW?W*8+&8N-61QQB<X(G[H'-I?Z(=4UJ)!<["F;=
M3,\^"RIS!383B4?SS(DGZ*D$$7B(DD6]P(MH"R,0TR.&C#2ZY"-+:"42,,O
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M#B))9F6P0!.">!:-='P5XZF88KH=XS$F&<<$+00%4PB(MO VI<)28R./AD2
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M<#?@RQ=P/SBXY_U^'SD7"DGPDB2_/Y$V:,D4V!B%I\)R(_S.KKRQG6P!]\:
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MFIY?:H/6UDON*'$H.=M>5O2$,:&XT%.[Z.GS'#TIK[+1'%AJ)3 1#5@?%="
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M/@KI'3Y,NTZ[X7BR@';8!N=E4>U@AJ/)XZO5_^/:XC_):U_8J"DV.JYG?(2
M0MH<9'J$$@<QSR3HK"(P=QY)K2SC244PWF6J/JRPA!\V!<&+JHB"X)4A>%Y/
M$&FD8!X#IQ6"102;?@)8:FRD<R8XF1!,NDJT"<%;$'M(.#@W/=\)G\YS&=NX
MRI$=Y@!=B4(L.0HQ6_JGTY7?&_@J+KI7Y9J7>&C3I%3/CT 1\Y >*I HBD1*
M^7A#&0.("Z-)Y 1K-AT[P=ODY)3@1+MD18'SP\"YIC&RD4RD";_>  L1@\8Y
M35PBQ#3STI$\TIQU):MW"EW[F,6##\^Z6T75R7!B^K/)65=U58N$+!;HSO2
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M1<3BA;8M' )Z\S+<?0CH_>Z])2S<LGXOA7:;H]WW-=V$$%8H>IS<-)S'=;$
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MM[-?PH,&-/\PEU7WEY-A9951./ABC9+(VK 6>'?]/-7QW PO*I:DG?> I1+
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M\T>S8SL>4*WQ?@ ?M#-YKH>H99G5+Q\Z=AB:,(%?KQCL[8"#D;4K9MBVO<\
M"Y7.H1F(:TV#LHG\@NC+=O/QL#]HIK/+U9#REQYI6<A&K89G_XZ,Q]UA&^[L
MIZQ%;KEW+B;%(EB+U AO(AB,/M*@A675F2\Z/O-%:[/QLJ'XRO:;_;VTY3TH
M^4%U#N(Q#<#O.V,#L+WS???M03;>\.[^-M_]_JY]L/^J":_)SO$_QSO'1U_V
MWH3VWOX'#,9<*_[WN[/#C^'$42X/ON_@P^-LO/T-W_W,=M^" ?DV_^Y#'L/9
MWMN_^2X8DKO[[]+NF]_%[NFGP+EAWCJ41,HG_ 5&)DB%I-?11*I3$*0VU9N=
M80Q;V8PV-$E"$O?:4\ZQ=T0FB9W%@=. K5IK1+"J3[+P]88QGQN"I<Y@^E<O
M]H'A['F=J_?#-G#O6;[V'KBSF<#TZ0P:%T1I_ 5B[RO4NL0.4U@,UT9#K.]=
M4?+'P[P\+44<M\(E(:GF4G"M WPU89U() S[M9ND[O[$I[KCB^8 Y-??0J#V
MP(+\VHRGUP+B-%S,@L/#VU;5R/>/8L,"Y=OP[+-,^WGPO]GQK6&(C<'H)L/\
M(;#5%<JP"5?Z$PJQ\4L^%4SQR_/O5N_)R^IFHVNOZV&=7QI]?!K//^GVQA\.
M^Z//?MUH;+5:U9[OF+6;606-YG@QT#RL00_6KG:+^HTC^S4V7(R=1FPUP>BK
M)M[L9(X=+01\;:-QVR4;G]Q[?Q3CH&&KE7D3?76"KT9;1NIC?/#D?OU@L)O
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M\RIOI^73#9-3KJ*@X UEAWHGYAR)Z:>]W]D^?]3$ HWFTO@%"-^JPR= E8F
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M!+@O/V)KY\W[]>K5:;?7"E5$3KWL-U*SUP=MU\VZOV&!)QN]V.Z&V,IC@5N
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M_/)GM]__M;'=R=;:1OX/X%T]H9>%:O1F_CE=+)^W6:?VAZU!'8*:6*<3@!L
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M2!*2(*&Q!A F"FD:/8K8)6V%T%+KE37"5J>MF#6@\$Z5]W(-P0%-M@]W:_8
M*/5GU0VG<W)]HCIL"YRXR8KB(AGO9.*4.DYEM%P&BZ,!GNXUUWKV\:%GIR?3
MY[M+!^'\ /T'#@N\ N"XR("D;V[_OYW\X%PI [N,-%;90TXY,LPZQ'SN5AYU
MBH*MK+%IF]??\[:?H^95L+S;'@L',IN.A%F9RS$G[36\5)RJ&&"C<=GCA^SQ
MSL\?E+NHG)0H:L$0;#%&.C*/! D>>V.9I2!HR6DAJ]KCJ\SL$@\;\8IK,XSN
MS"KN*< 75O$$QVCO$_\1$G8BBH@4[$UV>2ED*,O5MF4222D/_ )8!5V=!HNG
M8!4Q)&948"%XRUEBSBN/7<3*4JDD][./3X&1^?;?TQ_$66:2I<A33@%&F 9]
MS2C$$N&16,&(CBMKG#TBJ^!$6,6,#MAQGAAVV%/KN6<^"!K4-1!1]GBN/3Y=
M)S\8=<;IE)#VTB.0TRW0N(DH1N((TX%SXU;6A+H;JY@W?729-,VL)(6SU/"#
MRZGAODH-KU)HGU(3J@[O6;+ZY5SU*E6]\*W99]J3']@IBQ-/2(FLXG@"IYMA
MCQ@W,41E \WB#Q>KTX4'S_E6AJJGE&7*9M]GLW=.?@@*T@DVN:F:Q@!@D2$7
MG4%44QR=TIQ: IM]HY!B;S2"7)]67Z_!1AU$G^LD=DY6Y\Z:7Q[8.V>(U2QO
M@K]^+NX8A\ U?38?C2)4GAX4IXSVN:9K-<Z[1<V\-5K9:.S0'P;4;J^C0UYR
MT/V-#\AA(Y!U O[7R6DC0:"_D52>&!?+?M]WO_=/?X!^1H)6#$D)(AW'BB)+
MJ4."",&\E4YC8(0WFOH6!(T3A3IG5J.=LR05>W4EJ>1SE:3*(8?'L-'KO? )
ME*'>3MMUXGK5LFD)BU2=U8OKYIK5.VP[NQKA7EM[7]O-[]_X]MX7MO'Q&[S_
M!6]M?MYM=;_Q20K: AK9:(1NDVZWMV%LN7;<]N9NM]7P?'LSP.^ONTUX/KR7
MFGO[)ZWC'UI) Q(C02X)BWBT )>@'"%I?,3,*"VPGRQ3Q2UC0D;IA)$\<N4"
M=98Z'4&/)<9-51PZVX>1XRE;LVH7^U$;;<A]2E/=/HZ)\EI4P&R93@ 7H&U+
M@UDR,B-(B!(H\IEJ(U5W?)>]6&T_!SE] HI.;6!)L?8[H$^8N983:_=$Y;FN
MTAB0W=G.+U>EKF>@M(WU'XXY2ZCD* 1.0)QG%M0VGU T6F$E%(@-^ ZUNI9'
MR+[9QWI#U:[LP/7C+F+9"WT4AV<^[?;%(>]4A[Q]<<A'3?=&LKD=CJM\#5].
MC2^"\2H>10/=H\@74?11BGPQ\RA%ON1C#!9KML@B7\L53#>[IO_L&)T777Q+
MEW)D,U:DE"/+JW F.+S5XF-Z5OSL7;+4YHR_6S7J[B%XS[$8SY#D<'8&7TC0
M[/VDVG'0;+[/A\[&YM?VQO?/W>W-K]UF8Q^N@>]M[L-SWHOFQRUX_@Z;#)JM
MQOS]FP )6&QUMSNMCUO'&R )@_1+-F!.3;@>GLE!6IY5;HPE;PT5$1DI:9:*
M&7*.4EA>JX0@4J;LA*6,UY6:]L0^8^?E C%O&&(6%9M?(.81(&8R+M]9K%SR
M#L$V"\2-(<@$GE#N1.(E:/,DZIS:CNMPOFZ&F-=>5$M7]J6S>EJUK_]CNP?_
M:MP+96?-_ (*ECIE_HY@( ()-KE DTP\16I SA!86^&DM5&Q^9,JSVP>E5UO
MTISV_J?O'.6U+*"Q<-"8KK0EA&2*"4 )3@WB6DKDC)&(4@U;2Z6FN7D(J1M\
M?2[/H]2^*C17,6 NM),^&JPYIT1:Q; -*8@$9,83F3\YKM#<L]'<)*,./GIA
M.4<,1X<XM\"H!7&(@=(624PQ$@*,NDZQ7C";?H$6DERK[6@0J[#C*M,*%F*<
MQ+4SB-7[UY>MNNM:O$X0H<X3"WBALA"(?7":66\U$Y)Z;;0OC'OI062ZD!7(
M]S)HSQ!F*0>%>(ZL#Q9QP:RQ-#I+LD&ACLG3F!,*S5UM_\B"9DYD?9GP&(.1
MUF.MO:3*,N=X8=PO@.:F,M^5U(*8A&Q0P+@-(<@%1I$T1#GFC,!,S45S;T&_
MWAS8$+MVL'\_]OQV9'R:5(R #Q0@@QL%Z$!9HLYHZ0/V]@[%BNX*%04-YD:#
M&36+1)!<4&.1-P:CG)"+-&P@BD8E'8)ABF8TX--)-T5Q?G2BRB(O988;[CP/
M2CD5M#0A.4*Q [1^//Y;B.HN1#7%8D%V-8DPI$Q@N9ZC!F:K%;)4QF!!@!(F
MYSQ/5WV?YJ\OOV[*]ZIE</MPW$WX8-<.1Z%C(?X5._V#2BD>1Y)9_]^C]J"*
M(#NW:^?\#COPN^.LD(MKX M[$?3H.GQ[?("K)PS:P_UA#CSK^[8]A)M5V;WI
M:% %LUZ^0[YCOL)V 5_&?[:[^3XP'A=[0#2@IL>?.78<[G/8AS?A!H,JR"T-
M^MU15%R_>]")AU6JRFA$J[5//3]2]VUGG+,R.9XKX\@-,7=A T</R0_L#:MX
M.9A9;I\:5FN_V:IV2M6]>7S'035R0+;\WKAP2ZSE1-=N]9RC84Q'G5JGG>)9
ME\WQ4^'#*C"OUL\9-.<36*UM5.%\\Z]]-8A!_*L=C_.2P!ZWNP>V/1@O;^_(
M=CHG]=QH&@8:8<WB?X_@H_Q>.]5RX9?#J@UUSHC?B<,J1;L]\$?=(4"4K]X(
M -R'N8",/1QM5C7P;CYA>3M&S\MCAX,6VJ'6ZQ]6Q64&,,?>R>7QP!K,$:H8
MC@9G)^D>G:_SUM^Z?/6\?K<:A.JC WDN@59K/3KJU<#'T=D7,Q@7).WWJL'_
MUL_9!+G#:DXZSO[>ZE#\:CMY96M_[,98'<O[Q8.^P+3:7VW5;K97(4VFL4&[
M2B"KR'$(=-^Q@RO+?QSA@'7:L&^CTW<%H>;9P=JN_2M>/G/G%/E7WBR;XV+'
M\)+I_BP /K\> /H<YWT<QDNW/VO)#K_A@UA%PJ:C0QA'=?RG1GOI\-PTE/%(
M_*A3<R<GX(&XU#XXI[N)>U7Y =6HVN[HL!IO_D;503Y5\;T7#YHSX69\%L8;
MQG-L[D%_V,Y?>#>('9MS=RY"<O]^-=IZ'-"++RZQ.4,0AG;M)5-QA<\D#1(R
ML3J7?NX.+J(B=R)R@VCWD4TPV'>V<VQ/ABN_7*4\(+O+"S@Y]VMGF-*CS7!$
M_B'C<;7;[XYRS9/\+1B379JQU #I0>+^V^TY7Z -50D2&39_R\)Z9;JW:[.V
M<7:/]ML26R8288@3FE+!(W>,:Q^<8[GH1*34,6FY>B&)!P!/\:\J7S)68+%S
M.<\(9%HT%F4R[YUFRA.2197\.98O:LX.VU?8=NIG6:_VWR,[ %HY$WU.@!57
M++42/7HQ<VB;B[^,KZSJ1[2[M<P7^F&8OY0 =/N#22$$GGQI*"/A)Y?!.[:#
M054&;XY*=K#%8SY^P5E@IL/AF: RQN+S(9Q)-E>'<KZ(L#RWKF$6'RHIK-/>
MSQ5NX Z]ZIXCN?:*('6.\&?\Z'SO*@D;2 C$3>MR-<23\0(#H[IU"""TC-C5
M^2H#YSG?BM7G284ZSWMZRRE/7WX$E51B3L**<0M*:Q(YN%,@K6A@QD0I(GGK
M*4_Y1F<T!UB2"2^-"UZVL[C?L6,],1-T,V92[8P+90YKP[@S$O[;PQM2H5YC
M)I06JXKHQTDNFB_!:L[DHE>7H')V!AOC,_C'Z R^N0",,ZW77BD;6#LC]9*Y
M4L+*2UCYHUODNY_X=J/5;NVM@WCRY;BU]P7NL25:>SNBU?BPM[7I:7-O'5Z_
MYY,6^:V]W?TF_42;#1!I&NNTU6AU6WO[=*.QCYO?6[NMTZV39GZ=!9KIS)5@
M< J2612<R;T;'4?."X<$:%&*IJ <CR6L_)P,/H": (,8:R'^)!M_>L-.I<6^
MH<;->2G^<9=DMONH)5>Q(5>'A%?7@<1X8WX;[\OFQ;9\M.W>[_WA2VG4]A)@
M9#K0W$K,@N4:*6(DXHQ'Y"2E"#,3:0YW4#('FHLZI=,.\W^^X/:OU;/%4K=H
MFQ;SKN2KUV;EJL\IWKSR_C^+D@(?UEUDE8IEDQ%G+U7);GX-X#X=C.R%=ABX
M-W)55UW&,7*Y&X$W7D4<I0&HGS.[^4&A&TM3O*IQ2^FJE^<"WJQ"(&X) '!C
M)C)VM9^_<<7 =^X'/HQ^MP?#WSFI@[@\!%@"?C/R6/9[P]WVP;!>"^WAR%5Z
M5K42)G*4+?LCST,%<2/?\7ZO?XQV^\?U6G:^G@<!],>A*S>/?+7V9#;S#]='
MD[WU\F&GS?4?QJ1H;:*(R!00#R0@9WQ$A@I!F"&*6C?IY_-)R,BY!N54<JRU
MII(+XS&SP$)2$I.V]P>9M8&-#X>3];S@K'E_U#T:'?*Q(Z<ZQZ-3>*E!PI5/
MQ\Z<LR"NAQ4#J]?B3P^3JHT(.0\DNYIVXN5PIJIBV)U+$-ZZPJ_%WL[Y*M;7
M?_R0$F&/4L\,W_.V9;"O;+#S%:![D97BYBBI-E-%?4O>JH\55_IMS)6J@FJY
MQ'9\RVNR?L&2JP59O\1XW_*ZM.+A^4FIE:.BJQ"KL<2T/I*8JE7Y-I*:?@>I
MJ?K['UO1#H;_7(@'>.Z^L4N"P;,M_.O3JEPI559\RL^2<)T<H\FZE+3BU!KM
M!)<JI"0IH=2E>>V%-ZCG%8]]$W9$MMWX<M*D[T7S]!O>.OURW/SXC3>_?]AM
M-;Z0C>]?:/-TG;2ZGW>G[8AAO]7X=+JUN7_:VORZUVJL'V]O[OS<^OX>MQK?
MQ'9CZ[39^$:WNA^RK_ED,OM+2)T8M\@I1Q#GAB(75$ 8-DX9+8G)JB8QN$YN
MJXU2H*= S^N!GDNB[&4IMH#1 L$(3^9W&VFM4(!#ED3$O=;(:)TKI0%(<14E
M;'EN25;'O&!1P:(W@T6@/A;<62#NT,E2T5QPP!B&#-<^UW&-R+FHD=(.Y" B
M%.86A""NZUC>$G#W#+6=[DQ[2Q_&=J-GT#*LI1:2!]B0Z*TD.*I L$]! (>8
MPS-X/:6-[ _9_'"%WF >_ETX&N2LK$)A\U 8GZ P+0RFQ >D+!.(2\^1(8ZA
M%)VF6&O&E0$*TZOL6E?9$X:S BD]DU5L*DO^W;)4KBGW> 'W>*T!E+/9Q&]G
M$2R=]G <DG(EEN6Y&?,+9[]SQ0Q&QVG4S(.DRZEGSF&;5,12"$Q9*#; Y6/.
M)U,V0.PM"%*2(T]59L[)(A>$05'GY@8"*Q_HRAK#=9"[ED[Z+416K%TO@^PF
MK5U>2$JM 84S>(UX2AH913!B1 43 HF& ]D17)=J004-"]DM&=D5P\YB26S2
ML",),S*I;$;&0&?:<J2!NI"#/WWTGN"05M8HKA.SH&8;A<1NM-X(0Q7AV#(;
M.7=<&L^%%-[*1(,G1!;KS3*0T:3U1I$ V,<-2MAP!!L7D1$"MHACKR@GTF&9
MR6A5/H7UYH5HIXT[YU$LBZGGA0+.7,Z:P&B@&G"?<&Y9TD;ZA(,6,B>[.57T
MU66#H]9O4_HJ=<ZE:#%*C##$3>[L*8A&"F-.$]8V*K>RINM<W5*TN-#8"Z6Q
MHJX^/M5-JJLL8JL(I4@1&X#J?$2:R824 UE.)"*"-RMKO&YNJTE2J.Z%4EW1
M5A=+89/:JJ>)Q9C]HY9&Q /#R":/493<D$BQ!');66-U4?C:DRBKAGH1A ^*
M&\PU#1H[$:3'-%@%8D8HRNHR4-&DLNJ\CA9$05!6-49<$HL<(PK)9%C FB;'
MQ<J:6,6+U55?M"?U/_9P45T=W[#%:QXV;1,E&-26X)CACCAKA*9*""DU]LF$
MHH N'<1,)TV$H%V, B,:.$%<>8FTEQ)%7W4>3(+D=K*\3E2Q*K].&BL*Z.-3
MW92_-$FCK*;($\H1=](C'0.HHB0:0G3B1(8L'I,2I?!*J:XHH(NEL$D%5!D;
M=1 6"<\U\+5(D;4DH9"BH5*;X'R.2*AC7#H</X4":DE,RF(C/!8\"N<$UMJ:
MR*F(DJFB@"X%%4TJH"E2@T$R1%8'E_N$!^22M2AY922/QLL<=$#4HC70%^TM
MK0+?BQ'KT;FT"MQ:X0E(4HI+H9UTA.&$.=?2ID"+_KET"-.>TC]C<)P:19 2
M5 &?%@F9Q#B*"0=F 6R8C5G_9%040_&KI+&B?SX^U4WJGTI1PWADR%AB$6=>
M(B>E08%*3P-Q"H?<?;Q.."]4]RJIKNB?BZ6P2?T3=!NBL8+#:W/C$\X]LI1P
M)*50@5C!0C(5A>D%V54+A=VH?Z84',@0 3/EN4G"!L&E$YP8BRW6INB?RT!%
MD_HGU<0('"BBVGJ@HI!+PZML-K51:T-5\MD[L2J>S %:'<6ES;G>[.?&]_W)
MS.MGK"=36G@\_C(M8RV:![?P<(I;JH(/WC@> L@]7"9EHG,A:<9=T>Z7#K^G
MTW%#!&X;J$-,!Y""9"!(1\,0"+'1PS]+@P7\5G7-GZ8834&M@EHO'+6*O>3Q
M<6S27A(Y%II9C(*.%O%H.7)8."1U,,10%B0C5?(E"*4%QPJ.%1PK%JBGQJQ)
M"Q2M^DL9 "F7<J8KI<A%@^%/14")#LR:W'I7UHU8OM"^!1/F$IFN;B3-F:8K
M&A2-@B6<B.6"1D>3\=83K:3+C0Z+Z6H9R&_2=&4DQU1K@E*B(#(8I9$SUB'.
M*+:$>"X)SR515O7MMJNK'0U+KZS2T:D,MO3*>BK>=-;.L';6R? M]_HIK;)*
MJZS2*JNTRGI:SW9IE55Z1"Q);)+03"2K!#6.<DZ2ID(FBID)/H"6,RK.0 AE
MI/CE;E-.X3O=+\>M1J>]M;>%6YN@C'9;\'J'PGN=UND^;VVNLXW-3S\GE=/M
MCY].MAOK>./[YW9K[PMI-;9.MNCG]D9C"][[!M?LD&;#B^;>S%99W'L?/-&(
M66QRJRR#G, "2:*(P0QS97)T$F%U21=4H*% 3X&>Y8>>-^Q<>S(PFG2NR:B5
MTM&A8'(-M" B,BI1A"7/3?NTB(*MK'%9EXP6+"I8]%:PZ(TXR)X,=R8=9+!3
M%@>MD 6 01QKCS0&2<B$ 'C$3<0I6^BEK!NSH#2(TBKKGN';/'KMC&2$4L^U
M)\X33JCFL'7&83]*'R9G/K QW14?V!-3V%3ZL+*>14X0$4GE3I@8Y1KF2$9'
M$C&Y[H6HTH=5:9556F65>Y166:55UG.SWWF$7\*(L0'F&Z+@ 0NG+27",.X3
M=IB(8@-<.N8\'9L?L<%&.(9LE:'(# 7QUV)@T]%BY8S@@JRL,5(G3]2ANA#9
M4Q-9L78]/ME-6KNT8(R&7,G5,(NXL!I91@WRF&.EI%5>A)4U4Y>D4-WKI+IB
MUUDLA4VU0(^"V2 82B+7'E<T(,,51Y$%BT4V[="0G5MUP9:O _H+)[&9QAL6
M62)21D,CX]@X';@0C H#6$A5U,5XLPQD--4I2RM /&\0LT!!W'D@HV P_) B
M>>DBUJSJE+7@Y/L77?NM=,I:0IY.G>$L"*QQ8-Q%KSG!AAOF-<8AB534U66#
MHQF=LDR2&C/*D8Z9J]L4D:5:@MP<'??1)H59EILU7U"'V4)C2T9C15M]?*J;
MU%:)D38891'(<";W\3%(8PJBM58L\L@R,5;E&?&"M-5"=4M&=45;72R%3?5U
MYJ"J2D>0%2!A<X8%,MYC)&5@,6#'B<L]?D!975!E@4)AMQ0J%P%;*V6N\F!5
M,BH0PW7"1B<@,E64U66@HDEEE0-Y)$LT,HQYQ)7-A>*21XI[BK4B*5E;.F65
M3EG/U- 2V\ L#E(+SQU)5B0L;&0V1J>#X$4!73J(F<Z92-8$%XE#,O L"MN
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MB%K5S"S<PV]6C;S^T^6*1BAC+6,M8WV\L3Y-H,_T5U^&$_AK[-IV#G"N EB
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M<B,!.<DT;+B6QH*R)%6=\NDVBLN(?G.$ML\N>CJJ!WE;Q4DN5VX/#3Z;",I
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MA-T]A2LJRJS>'*W)<A[^V\Y(#N_/6)'+"$PCS-FJ5ATK_L_C6\G%I,QS1HQ
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M-I,XS":;+,)7#TQ5V<D9QS/O#)RPS(7[O7P$:U4\$NHG=#0<&U?N:C(@1(C
MDI18,"Z"<4E&$5,2 &-)D N_B41G+VZ6\#Z-IP<R1/7[4^\JHSC3,$]>AISW
MU.P$Y,7C']P*;ZFTB %71CPXA8PD%@5I S=.BA#DG<(GC?8!V#LG%@.P1V:
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M:@%$-:D*&ATM\Y8A;TGNZLHMTEA+8,+"@$#K;+(:5$'R-($JA:B>6DLL1+4
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M4\0%O+(F9<&<@CFO W.JYG!7H68X,ODU1Q:_,[QI',4K[Y]I*%\KHU^!HT7
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MLME7W/;?'0-:'")[&@RHQ,K\J)][X+6.JRZ(G6OZ+=W":VY<XV_G,R^JE6A
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M_.U[!\+5BSI]7IFQ^5 O<YG\9&WO#(<QC@'SCQY 0OYE8N5^R2]>8^[%]1?
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M@O0)<E?XA EGA"5/&$E< S3Z7(@%%@:>:I3RW^#M-1)R;Q*2S\5H 30C2(N
M4SB0BQ20$[E8LK;8<*PEN.EKS[7Z7GQ:R;2%*S9Z%HWUH88T"]@PI[W1P6&9
MWYQHMJ(AS25S=Q9DS+[\DG^.K;E,V7O,J/[;'\8PZHXC[W,1HS+,.FR40_15
MI"GOIE5_*Q[33YU@?;#OG:;*Y20%*H ""\J1<5X@*BVW4<+/2LPF3*^*U-X8
MB$^]G-:9O;?JTAB0_1S[^225G8A!%5 :#>+,48[Y9-9Q!*JD"5?8.7$;)YNQ
M6=&?W5K187[*8<1)V*@<XX5YZMK307PV_N'WT!F<=NWYL\Y)>=ORI=_KF]6Q
MIAQ?F3G"6Q:D^G@2>MG 5?BEKH]6/[G^>*-\-'-TN_J,\PTF^)4?XPURY6?7
MW9;0#:RO_NIUM[W^,XYE,]BG-5AQJ]O>4-WOQG*99N[2!<4#JA#L2IV)WRT<
M;;NB9B\S-?N7Z_\V84*ML>=XBRH./^PDM3-Z+SM'WRM14]4Q;E>'8:6G<<+R
M:OYTFZH@-[[W3S1YF0/<A0[^6#.CQV)5-+(1K6^:P#G1>J ^H8]6!+KHTY?L
M50/-[G;27%7;95[ZFZ1@]8IBMW_;?.P.5S_(3%X7I/BF;;P[.H/W"ES/DE@X
M%;$8:\$NN*CD4I 4WMX_"Z/^>;3]IQG)J$L,?3S:^PKW__ 2QO'GT?;6NVY[
M-QRVC__3W=D*A]M?#[OMX_?G,$8Z6V*H?=P^:N^^%7N[H;M]O'W6?OV>M.E+
M^O'#>P[_^W7G]7L*]^QN;WU,V_-U(%5*!'.;D!0J(LZ]13;2!/]8QE/>W)9V
M[3F>Y"N.#X>W]F#.[Z1=<:.-UVHCI]%Z4$G#%.'&$>.#-XD*G83UC,;;A P;
M;5Q-;9RM8>@L+'4P K'H!.(T2*0ID8@;H1V-.CH>UYZ+#=QHXR-IXS<E,S3:
M^"2T<;;\'J;YC(4WR,+J(AXY029@!3\YQD(D@,*WMHT/U IR-;R5J8S4UN=>
M3ACM=H9WUP9RU?'C6[V4INO1U=5/%]8.^<Y\0WIG6?K7(?-_+A3@G1W&IY[&
M\;"8?#[GKSB;2;!/*)/BS(L2,C(:E)*QG@MLDG,9D[EI.I$]BDY^D[O2Z.13
MTLE9KR52[X)W&HFD<^5URY C*>6CM)Y*!JMN2-')^62L1B<?0B>_,P.[T<G5
MU\E9WT5P&8BP.9 G)>+8>*19Y$AAK#4H9[*I^"[LAE8(/\,NR[O.X!-*.<6@
MD[>]XF#8RN6K[R*:\M1P904V6)[JU#VHZ\+O%9*S0KP"?7A3J\,E0'ZJM0\?
M%)';+^8[F).8HO &:9F/76%)D>;"H, -DXYB$14@,MT0\YT<_MGHY!-P71J=
M7'F=G/-<<'#P_P8ER@7BQNI<L2X@*83'T7&C/7@N9$//1Q,:G7P*KDNCDRNO
MD[.>2UY7891#(7'P7&(^FQ$8 T<F!1,],RG1[+G0F^SD+5H>/=1)G6E9RRT/
M7O7Z\U(VU?IEL]OM^7+U]"F?V;L,_CC/YP:; SV;^XQ3YKGDN8EI0MQJBP I
M%.+44B9MA$_3$@=Z5N+T3GT^9G0,@X.;#.H"6-7FFI\^AA:K8VB#O.66J[_7
M]6'L:3G;]O6BKXT]!CM2&@O!)5M 1_O]TK,FYEXU]J(7P)N3SR"$O?XY/&60
MR^F7HY*]$;Q:&/S:G/'YH4^B-(-MSOBLZAF?YGC/[:>G.=DS.X.W/"#6G+JX
M/&>D.=#32-,]2=./OKN47_K=WYNE//KZN/[YF*[/2L_=9->N6D/PQ9,RUQ#\
MCE[^B8:^YBM_*R<$LU1RDA@/)CE/E;741B4C)Y'?L#\TW]O[F[..9Z,.Y&FT
M_/ZNZ-?QJR.X/]L[?@OW?DL^'KUE.Z]?\FW:_K3S^HWX>/2>[AW#SUM_'LY&
MO_8^;,.[!+@OO,?6?X[;6Y[O[1Y\W:-O^=Y1][B]^[&3?]X^?I5SCK_,1+^\
M\Q$K&Q&FCB).>$0&)X$B4T%2(9TU&(!T72X(?]4-/>]%LT@=7EY"P^XR,-Y@
M8X.-DZX()N)@K,2!42X(<RR%1&12!% R,'-#2;\&&Y\(-L[MH&,:K&8>L9S8
MQ(6QR)@84(S&$6&Q\2EE;.1ROKM"@XT--OX,V,@T29X0KB-UG 7MG-?8)Z:-
MI%%:<E./LP8;GP8VSF8R6!JUE3HAJCC))]0H<C%9%'SRFEI.0 ;6GJMU+>>3
ML!ML;+#Q9\!&:K1AW$I'K>!>*1TE,SI@0[44E(F;NFDUV/@TL'$VH\3IR+!)
M&D4B'.)*"*0Q(RBXJ'6TVC(-/K5<IV0^&7X5L?%'/TM\42^K+CU: J>E8?T5
MD=.+2:#+3<)"7'_2$!<->,"<!"X#Y8%BG5N;Z*!39H,RDD<-&S8H=GL4.Y^+
M# )2>2>M1(I$C[@V&CG)->+.<\<YP3%Y0+'OQ[#%:'&O+.ZV)_I^>OV61G-O
M0U0>"P[^G7&$>G#M!&B[%#P\:NBKT>]E]'ON9#MA3GHJ42(VY[TZ@0RC"=0]
MN4B#Q$+HW#W]NV-;C7ZOKGXSP9.3S!%M*1AL4&W&/$Y$<\&P=K0)W_P8RC]W
M$"5:!9ZH0(ZG "9=2V2P%<C'1$ED3N,<VB;KRO!&_7]<]7?<:FPMD\EC+J,#
M.7",:,]MLC@)TT0H?@SUGSNM+RS5*3GDJ<I]Z"U'1H> A B26T-QI#*KO]2K
MI/YWE+U5GLTW"%N9D,05&<HW'+_XQB!1?< !WKX5>J-\7*($BIYF9'KQS'UK
M9/K[IF95K,+B.5DF;NV2P\QJ)Y/@Q KKB+?@"&@J%&.)-KE@/X!5:+^8B_@H
MRZ-*AB"M/7B$B3KDK/!(:A,X$3);A[7G;)TR=F41E\<@/-\5,_\NG7\:NXT-
MXC>(?T.&F_2"6*\M4YS;&)VDCG-LN:"1>?6X8;X&\>\,\6=C@(%SY;&-R 0?
M$,>>(BMQ1)3PA+62@>88(%TWYNI2>@WB-XC?(/Y*S,D2B/]-Y28:Q']RB#^7
MMY>,%(DPQ(V'?Y3"2'M%4?+8*1U3+.<]S+H4\Y&?!O$;Q&\0?Z7F9)FMOF29
M)#1X(QQW)#@E<V!'.B.)-UXUL?X? _'GLA&YHEQ:A@Q+ G&I'7).*^022 )1
M*0IE2J:VF=_I;Q!_Z?V)ZPN Y=^S5G9.1K::X:?0Y?U?,Z.N]%!$3S 57DGB
M>/):4YW[MQ$<F9:!@./XYL1W1R&&5BGH%&\L*+7>LH.6/3WMPA3G-8.O1>L/
M6Z<P[%Y8KUK(7Q2?ZL>N'5;MY-_]O3DHA][AW[_*OZ5Y_%1.YZ#5&0Q&U5#*
M/?MQD.N =S['5NY85!Y]%KO=_+_#P]X@3GVA*G-5C2)_:H>M>CKR.[4^YPK.
M8=0O1;3@-<?#S6.X])I3(QYWL-]H[1Y&>-BX5%9YQ7[T65!#'LO5LU7N7ZX?
MC-P1O$N^;V_4;YUD,(47N2CJEFMQ74P;7-29*;B5;Q06EN<JGV^T/DQ5]X)+
M_O&8FPDOCT^[O?,8_X9!=GR\HL#B5$&[=S";!R=YX'^5A2FE[%Y,7F>S3/WM
M;- 3K0[_'>7N]L3.YC[W1JK(#6+26,1QX,B8%)&@5(+G:!6A;.TYX7P=@&C.
MBA3Y6D9F[MPY;63F067&G[7?[C/&P$ (A13G"G$?&'(^6>191H.H?*FKR:58
M+#-CDU'*=&4!.LD%J8ZK@E0Q%Z1JS?>:7Y^"]>[Y^M*"=^=Q\$;P'E;POK;/
M]@,F,5A-42*,@."1B!R6#EG,J>8^JB0\@!6Y0O"6E9D[]ZL:F7E8F<'MS7TA
M+?&*>N1--G AE\WG*J&(C7+48Q%, +"B5QBX;P$K,@M60-+R3:XA?*6.:F9X
MRQ*X>;]C05'5LNY$*J> FP%R1ZXQ..^2)*4BQMHS&N*^5&LW5V(=NU,H!Y&>
M$;W0F:G^U('9.1D^0_FBAP^B%/>&L(W*V9S_]YXK-K^T?9"4@P'H;5'SE:FJ
M?%YKX1%HSNOV\=Z'EVSG]=[YQZ.W_./N*]"^=YT]^I+M';TYWSXZ(-M;?Q[-
M:N$V?8/WZ,?#O5W//Q[]>=S>.NQN?_CS4_OUGT=[NZ&S#=_=V8+G'K?3SM;F
MEWW'HK"4&20BE8@+KI$V(2'*(^?:4$Z"6+MPO,)F1C*3N)39-)-D>;38RH@5
MCY+(1*V6<S68?_EW;S#XM36>]Q9,? M@%32U51:@->^Q3ZO)0C_XYC%<'C.U
MU ?PD(TR-B?=FJ0X,"--);4N>7=]0^ [K1,^*W]@9CI^\R1L=;JCW.1WI2I]
M/[Q,GN]'2W.G%&"MU&82RSURC 0$QIW!M%,IB9U=W^2H=)(0'RW( _.6&2N]
M4]Y39XT02]0%7YT0T,)2X1%,#Y"*X6%5_QM,UFAX$7!P698JRU1)4^N7;E&^
MS@E<6:(D^2M9]09%]2Z5_5X'H^?!9);+JL^#'=I5K@9NS 8S[)N*@:L-J:_^
M^'MJ2YN[KRT-'YK;U99N!ON##_9VM[V[TM _;+7MIAKYHU0C?PK;WH63W6 [
MFY+93<GLI@![(TTK.&=W4X#]FR9DY8H,M>/P,I#?1T^_I@3=CUZ"[I>'W7X?
MP O#3[-1)!#F-T6(<TCMB61P?5L(J<[@VH9GO,7;](W8V7W//FZ]%1^/ML7V
MU_:G]M?P:7MWC[:_;G_9HV_.YS*XOKXA</W7O:-/HKT;/K6WNL?;7S]]W:9O
M88QOX1U@%KZ^.MH[^C/7DSN?R> R5BF*HT34>(TX-0KE!I5("6YL;B*KJ,M1
M['5%Y@_F_;I:M>0:D&M [L[KL]_UKGT#;?<%;7BV$ 4-//D@$$XLUZ%Q%ME$
M**P3 )P6@047 =KP.ABL)U$KL\&W!M_NG,3=03Y<0^(>&.GH#-)QFK0W-"#M
MF0<2EPBRWA@42<1>D6 9 :2C9)W)^8J:#8EK0.XI@MQCIM$UT'9?T,9GJPA@
M[0,SN7R8P(@'PY$6(B!%'%4 <LKE>N=BG4KY)#C<'=4[+\\6&V+%D2D')7-,
M,N=?9'7Y=7QPI#JH<FKS4#NG=I@3/P;1C_J=82<.OBET>=O"C,M.]H91]7S_
M2-49[R]V]_XD= ;#?L?EO)QQ$EC&R<WQTN_V_II>^+\OUKUL1S:(N0QBGL]%
M])R7S #A0SYBB3CC%-Q>+Y#7RG/B<PNEW#WGZJ(KC=;=G[=UY^&D1ML>5MMF
M@TPIP2)JC5$RA@(_81AI3 2BSI)(F 2W.O=CN47LO%&W.S=R]Q?;:-3N8=5N
M-N(1#&B6DAS638);0+Q&6D6%>-221&=3X"3'=DUCY1[!RMVYO]VHV\.JVZP7
M+CV-A(+OK6A*B&M/D3:"(>]BD-%%1I58>\[FRSK]>B<9.JN9AW-%-NEL'LYE
MEW<ZL_*PUPVQ_VW>[D\9_KS;VDU/)?RY^*U7,%%G\[/M=,NQKEYU[JTTOJNE
MO,;A)E1Z-R#=?C'G^'-P+4TT$5'&+.(R2N2")HB12#&WCBN22BJ/Y$TJ3P.#
M/P8,KDPJ3P-^#PI^LW$898(2@D<DO0?P$RX@HVQ"D28B DU!*%LE^Y"K?<(G
M5XJN0=]5P:&?$WU7,-&HP>$'Q>'9P)R,!!P)YI!4)'?V91$YY1-*R;ID&,,>
M\Y**1,5\TF5#0AL8?(HPN#*I2 WX/2CXS89)&1=>1*">26"-.!,:&1(MTH0X
M3VT$L^9+LA*;Q[Z&@RY,E!J/8CQ>415?>;Q]F^^YQ]2,S5:/;H;X,P_Q9]@8
MJ6I-5)?$@"R,S1[$2QLB@U9O-!P,[4E^J?O8%OGFN=V@8O4V:I<D(]44WW<)
M[0_U F]6Z]L>Y1HJ.ZF4@!OL3):W82-WRT;FC_;R[%5C')%/5B*.E4,V&HTP
MYH(XD92(X(IQO$[(U=T9&NV[3^V[\Y!THWV/I7VS >G<[58R'I$VW"&N6 1?
M0%ID.3?&Q8B9"VO/F5G'>O[D0J-]#Z%]=]X*H-&^Q]*^V3"D",KBK&[$\X
M4K,>>H92!&@U7A.O9=$^8^XH1;#1OB6U[\XC88WV/9;VS<;!A)0&&"9'7CN&
MN'88&6T=2H*HG)<2M">@?7K=T*L[0?[0Q^7NM1SCTJ&-6X8S;FY\=E6PXT?<
MP+C3N5EM8+]VFW=<W_UN POTRMW>A77E5Z?'R%- [/E#@U12PF.@B B#$??_
M/WMOVMPVCBT,_Q669WF[JT@W%W!+YKK*G3BYZ>?:3B?IR:2_=($$:#&11 TI
MV5%^_7L. "ZB)*^R+=F8);8E$LO!V3>$W$H(!;;-><2BD-$H=/<.[/TK4[P?
MBF+N.Z:K.:;FF/<4$5[#,._H"W(UG[P'/MGWZ@11&D9QF%A^R%*P*Q/?PA84
M%O/LF,%_[2"CR"?=<)<#O)I1:T;]3!CU;53;._H-M6I[KRR[[PJT*4C/B&=6
M0%PL$':H%06N;?'$9YGGD9 F,;)L_RY%,9IC:H[Y3#CF+1CF'5V]6K6]#S[9
M=]JF)"&I3T&K]6-LEQLX5N*2Q KC(';<-$X\QI!/KN@#KE7;FZ<V_B+N@CM0
M5\TMW0S9OU.U>QF=VC]!=_:DJ')\X$7)AQ1O>U47QCFVN%ZK\Y;:J]V^0I.J
MP-OSUKZR= '((_6>P)(M=;X26IU_!TV*Z(2><2LI.?UFT0P6^X(.+^B\VOME
M\2:_?&QU =C?^]H=9MF][5#B#S"\HA2G_0(0EI?X%*R);LU:C$&)[/QO5U_D
M&^X=B/L]\:[&5R@)QM/J7[_0@U7'>.DMBRLO1;WRDM/^I:BIS5U. IH2'\1/
M2#T29X03/Z(<5,!XW3Q77K9YH&^!U'<5ZL7J6R!WX+HL?0NDO@5RS=9?7^L.
M97USG[ZY3]\#J;%I"V&F[X&\I/^<;B^G;]>XWW:?^A[(C7E_?[>_?/[#^_+Y
MM]&?KW_'=^;'/[[!>V?D^/,1.7D-:QW]81__^'78]_["N(,_/S'X[,]O)Z]_
M&YV\?O?C]--@>/KZ[/N73V?VR>NS.>SU!^QUU3V021;XB<MM*['MS"(I)C:P
MB%@TR$*:Q3%W.=?W0&HF]Z28W-8TC].L;8.LK9^SY86AGZ9A:H4I91;A/+(H
MXY[E>VYLAR0,.4OT/9":OST]_K:%[=DTI]L@I^NG.H7$3VQ@9Q;W'6Z1P,NL
M!*26Q1+B.M2)N!N$^AY(S>2>%)/;FN9KFK5MD+7ULY.RT&4>WK.4THQ8A 2I
ME3B99P4)C3D<*$BM3-\#N:V<2=\#N:TL<2OO@50!2<TS;\(SEXLZ6> ED>>Y
MEN]XOD52#[U[F/E.,X]RX@;PL;X)4M\$J>GM=O2V=!=D%,19E *I>9X#YE<6
M6E$4QY9-:$!<L*H#DH".LMQL3=\%^4SO@M2$=RO"6^KVA-UF4N99-'4Q>.4[
M5A008GDDC,"XLYG'4WT;I+X-4A/<+0FN;XT3F@9^!N8W!3O!(MAH+79M]#9Z
M=IBZ ;#8^.'N@]PU(YA.)?**V@%Q)^18K%.4$O!Q7I3&N)C>TOR];A\Z]V9@
M7ND!W:WBQ/ON?/P.4^-X-3T=OVH/]#5/IG#PI]DG^GW109CEWSFS?O"RT-SH
M!MQHX>+#'V<_3@__<MR,8L,Y*PR2Q"*4!584L\S*[, )X9@=;GM8*!BYCOMR
MEXL7+V%_CQ1>>3+L9/L21*[!3C3;N G;L'ML(R&V:T><6,1.;;#9'51GHM3B
MMI-X-,6NZ<[>0;SBOD!-MMM"MG?6 C;> UIK 0]$SFZ/G#T_LU-&.;;FBBR2
M B7'?IA9U$T2/W(BFSNQU@(T.[E7=K)Q7X=F)P_$3DB/G01I[$9!'%H!98Y%
MG"BV8FS\%]M90OPXY31+-#NYEZ2&+?'BK*D3[M=7+:8R="MFU;V+C]BQ>\?2
MVC;;A6M7TMKN?K7R Q5@77J[:.-9UTEP]^#H4MUG,S?U2,PM"L=L$3=-K,2.
M RNR"8L2YM(HM$615D VU\SPD?-[-2-\YHQP:XJT-/M[-(>=*N3R69KY 3"]
MC,46L9/0HIX'MG[DVT'D$9<%R/X<DY#U5ZKM@$:N^:_FO]NSZRTL(M.<^-%\
MK:K0C!&7."&Q8L]++)+XOA4YH6N!W9':&0W2*+%%H9GK+Y?4:D54,\)=9(1;
M4VBFV=^C^895887C92#@(LLF'@7VYR3 "%EB<3L"Z1<S.XXC48SF+7,_K8>N
M]!G7JZC7ZPOF^HB7K]YEC&OT#]=+?(Y+?%H!DM5,1EYB>J$NX[6HO(UW(3!2
M&45[':].P=]P;MK*VY8WGNVJ;UM^'&UDN76;[](LS'ALA9&7683YGA4QW[6<
MT$G#P"-1Q)V] V*;CK-<>J:I[R&H;^..:4U]CT5]?:>T32+?BR)F)<0'ZO-L
M;D5VF%EQZ@"O=7S;#KV] R\V[6B]4UI3WWU2W\9S/#7U/1;U]1V1//:<R&69
M%:4.6.+ 8*V8V)'%HXAFKAU1)R6"^N)8%W\^#O5MW!>FJ>^QJ*_O!^.V[R>1
MRZTPQL*KP+:MF'JNE;H9=RBE<<0H4%]DQNYR*>@SK@0]RC*>3O%R+(;>VOP<
MKY JTF]&,4'05 8@L$$O:,DV50.Z[P),C$VX2R2S$L,]069U#T6A:<E'?#RE
M0^6K%],>=DJ /Q7U)9:<O:=S?/BP+.GX3+Q7Z03O#3"OTS:9[L?QZR,?F)?#
M@C!,0]<*/#>R2.Q@#;N36&YD9W#<$?7]:]2+/);G\7F0XST45=Z='#79W83L
M[![9!5'@IX0[H+&'V*O% [)# G1=)PS]Q(N2F.T=^/:&7%6:Y![;6-82<%M(
MT>V1(O&SQ.$!F,PLL"V@2=>B+$[ .HHY''CBAD&J)> 3LYZU!'QHLB-]LLL\
MZF1!9+'8\RQ"8M>*LB2U'#>E'D_M*&(^2,!P?>[(,^P@W)K,Z[HE&1MRY]W!
M5%[IUWNJG.EQ3&59!5W!\DXS+(-N6[MI+6$3[.KCDIT<1R[A8<+ 1(YB=/(Q
MT!)LL).Y&Q&'^TYJ.QO6$N[-Q_Y4:?%Q[.3KTJ+VNM^)(/L6=!1CKCVJ#J )
M6X2YOA6Y ;=H&,>N&WF@U4=[!\2,@BLT"$V.3\J&UJ+QOBFQ;T#'8(ERAE=E
M@BT&FKP+IK0?I);O^W#2/'7\T->B\3D:T)H6[YL6^U8U2#_J1!20'' ;>X!'
M%HUB8@61';J92ZAW;35U0\'H+;&G5Q<SJ3*A^\[3?E;^OAN6C3UJGK8Z_Z6D
M&:VY;RQ?9OE"'IMD@,M!@+YVT-SM++ 2QPTL^-RW'6!00<HVFZFMZ>^Q+6E-
M?X]'?_U<[3")G(1@$S]&,%<;2"^*_-3BKDOBA+BN0T*@/V(2?[E_DJ:_AZ"_
MA\K5UO3W /2W=$]/"G87<V.+$=^V2)2!O9S9OI6RQ,E<[G-*@\UF:VOZ>VQS
M6=/?X]%?/U\[#%*/,;P+T@^(15P@/:"XU+)])W5]XL89E=42)+ZB5NFI!I\O
M-Y87^[Y.>+E@+3]BGU<)G:4:]&N4IS_]IC-WA,UV,_=+FW.]YZ7@KYMU,;AK
M>W355['5\_8O6[,UU[Y)HGK3;29V8C]F'-BTEUJ$))&54)]CZU?.7)KX,;'W
M#NS]*Z];>RB:V8U.7)IG/E.>>0N6>4>OD*LYY;W6%M2<TD5AYL>IQ0/;LTCF
MQ5;D!X$%!Y+$-JB^3I0BIW2?4'M8S:HUJWZRK/HVZNT=/8A:O7V@*I2::2=N
MF*8QUF%2!YBV1[D5L]2WLL )@A#T6Y)&R+17N.2U>JMYIN:9=U=O[^CTU>KM
M_18.U9PRXPX/@BRQ;!)CHS?B6PDCCD53GD2 H X<&W)*9WWP4JNWUV]*^XO(
MY3L0L$1RR<<SJH"Y_ G+SP_^!?_4^QK1\BP?RZ:Y[B(;_3JKIGDVEY3:'482
MA9O:W.4DH"GQ@1A#ZL%I$T[\B'(&)HVD77B'LT,,D_@>6#WP)*%V2@(24R!F
MUR4D"6-XP_$>/DO3M>'4/W.#?T^',\99K[E)5A8C8SK@!D _G0WEUNM>*#=*
M23/R3 R$GGCQK7%.AS-NHH<>9L8G\.MJ-L+Q?\I_%G_R[[Q,\PI>*_.4XS?X
M:;?URD^Y>I2. #.G]2.PC@D?5W+!:5%-#:J2/N7=;]EL.BNQ**T\AX'E4.-B
M:LSYU"AY6IR- 7[,-"YH99R5G$YAV=,!'(V82FT6$.<;/+^P-K7SA*=T!NO&
MC\0.*P4Y^*#JMY"Y*&9#!J_ *J9YTV8&5HDQC*78Q;ZQBD.L)<Z'0J(W12EV
M.QV4G$MXPC,&+'LZJ P^1N3ZR"=3CD%%R6<\VS10K\=K^=9VU0$<*SOXN4&,
MA*.5I[$:_FPFS@#G&L,IXUFL!OWV0]C92HPQ;A;NSD"9B=TH2X,L("$'K<<C
M69!DMA^PQ/7HC=.]#CNGW29]'RE,>P.(]@JXR&PJ<.PTZVM*AX+A7"\(OJ-:
MU)#_[X?YGY_9)'%)<.R^L[^X?PZ^?$K)GU]1(QH,CS__]NWD[6]?OWQB^3&\
M>_H:YAV=9"<_CNR3K["V3W^0XT]G/XX/_P))F681SRPW"D/0B&QJQ4F<6'X6
MQ;[O!4'JD;T#'[MOVO:24B30_8;I28EM^PYW? +"F0&"^(GMPFPI8VX64_O&
MZ1$:7QX*7VS %U"4>)C2T(H)<'.2.;%%;<^Q0N;X"4M31@('\,4)5^,+B(1)
M,>5P9'38DP$E1[&!"D>Q*'5,^*J:\!0/>#@WI>19D F(A?<@BO:-K@IV,S1/
M$@H*)!"7&WH$\)O&P!OC)',R3KE/@BO0W-98_G!8_NEW_^3''\[IZR,'[$G[
MKXRB[9Y$EA,EP!-#,!5I$F962#@-4T*P,ZHL#[7-(%K.,[\2RZ6R6\Q*HW,E
M.2@)HA7#B6C%4",O/ JJ )<J1IY9JG<#?#SBTT$!NG"C+ZD95JM-F=)2EG63
MQ]2=KM"+EJW$K=*45EN?5UN3^\L;:UMO-&:P&,P)PB2,7#]U?$XBFR<T<+(P
MY+8=I9[+^%]X7>W5MK.RZ"WT/[YPHI76M/PH!YP83U]8^-##N]\$6!VR+]%A
M^5_%@T]F(Q@ZW4#48I')?N1G6);X@4^*$D71Z[Q*P<  D_033//K$(32X_)&
M[_A5S1N__#AQ?_MV_#JUOWP:#(Y_  ][/1R<O'WWX\^W;P9??KR[^/+CU\')
MZ+=O?=YX\O78^S+Z_>+DQX?!Z=NC'R>OO]FGGX_L+U]/OGWY_.;K\==?OQZ_
M/7*_C#YDQY^.R?'97UZ<LH0'CN6Y&04MT0FL)/!=BSLQ0)RZ&??]OE?%SC+N
M)CR*PS FH/#%,?<2Y@5VE 5VG,9[!@>!,P'P3\L91UX@@&^\&TLAA015LU9U
MX/?MA!,COLBG0!?I-1!U-?U?O>]%.(%60%W?\>TD!&[A^#0* DH]4*CB-(47
MT");X2[KLHN5Z[ARW-XZN!\X7I:"SA_9)'4<2A(G<.TH\$(29SS9N[EW[I&\
M9@/0["Y1UR2>;3;F^>[DS=*%<RI/6W(3=(0J#%\L8(9]IJB*710EJ_AX6[2P
MA^<T7]_])1RUD1=;C/DA5O<Q*XD"WP*,Q39[=LP"=^]@>E$LJUQE V5#'3"H
M\N49%0Y#@Z8I@%<9%ZAW3<J"S=*I]&C5[L87QC%GZ-&&@VW]C^]!J8(')&75
MC^X;GT"9ZC^N9E;.4_@ T(N78WBBY.<<*$VY;M7L1@4G7:&V2%'>I$ J^/99
M2;,I6#T@=\[$\!6G0U#FX*/3L?4?4ZRJ &6NV48S_+YQN#Q2O9QZ%EJF@]Y4
M-&'%*,>%]CY'Z,Q!6>3XXCFM4"<MU=?-9$L#-C,BJ(^L<^"HQNF$CXV3HU-S
MX8/WPQE,<WC\^J,)7_[GCX_-UY\&!1PNC.Z]E>LXLL9SVAP<3+YRS;VIOT]+
M:KSFF(]@'(V!8W'@*N,SG&5<Y8SC+U,.KXIY89A99?SZGWK"84[3SHP?^P?2
M3/9K7KP=SGC[Q"$#E1SU[O9M1)@%7/I8>[G7HTWC"%_$'^&Q[PZ%3=TH(#@L
M%U?>'-0TKZJ9PE8TFLM+^.+R'9P@)X(PBATG(AEQ:4I='F5IXGLL"@/NAC?G
MB1_4-JYLX?#<N-_IZV/[K\!G7A(DJ07:0P9V9^(#^\LBBZ<A34&I<.TPV#L8
MK^!^.9Q:6:-1RPR6C8IME]Z?!&8# I5S,' IJMZ(W/76)KP4B#-.N3!\SW-^
M >P]F0MRA\^I[+!I&GE+5F C5I4AMVQ@KT,^7<&8@1-7,B2%UGM7/$Q6"P!0
M-%@AHE,P4<G/P%:')54<WH+UJ,E-I-62PZ+%@N%;.*M6O\VK%7ZK>MVLL3XP
M<#4L+OH'NJP5=HY8@95@9="DJ')\X(7TL9WSEQ<YFP[@4(0:VWE+!8OM]A6:
M5 4ZSM:^TL&=E",>/E)3&]?N0:?S[Z"Y'74"&&(E):??+! 7O'Q!AQ=T7NW]
MLD@?0!Q= /;WOG:'679O.Y1$"NP5Y*(X&>$7PJ=@371KUF(,2A0>?[N&ZP+(
M72AL0'"O4.Z 1/W7+_1@U3&NM'"N8;'<L[\@'7 V&_+3K.\YZ!BQO\[5E\_:
MAW#Q%Q;;1#;S+;"/(XLP'EM1$CA6##CBP<DY3NSU?0([([.R8@@,6A@8T@:9
MC6"],$BKNIDWD"Y2 >T*KDIX<%'*%2 $9:"D,71^RC$#HIC!+ECU\XMKRWV\
M'UHNM^;^(B<( #>DDXJ_J']Y":)H,J3S%_E8;%^\]%(-ID0&LLE>1I X(?EU
MRT'W;<E%5>FKFEE]O2^^ZB4XR>\(V?=\LO9K>]]9^]UEPSKNOAVM?_6R82__
MCMB!7NQN+=:_UK!7%&Y?V2@A7GIT1:*PU*2V*BOVD\AO.9:AHR,,'?TK*7]I
M0SB&9YO7*.!^LO YP<C:#<!S5SSJ),"WJ9R8K@GZ>LY69G)N.011S;I."X K
MM_N\8.9L@NJ>)&0T-MT5FYY6(\_5CH/:*?GB+OV1-H-&]]E]2:_PP5>XR1X_
M IFWF8QZP;";5JML<^W<Z@W?N'9N*TO@;M@A?#E*1#@+N!_ KH. >*F;.!ZW
MXYAX2>3') EOW&]7\6.9TSB>XA(^Y]/!JUD%\."ES'D$.!Y6%8?_L4_T^T[T
M/+NMXTT5S1VY,+=_^OJW_,_/1_,O/W[_<?+U30YSV2>C/_/3M[_!/&^&IV]_
M=_I%<[!^\N7'-W(\^FWXY=-O7T]>'\/Z?H-]_>[^.7I'OHQ@3Y__('^^_G=V
M/+>_]XKF*$E\-XM"R[;=S"(T=*V$N*GE9['/>9PF'G/W#GS?=$FT%)JZ7>G:
M#A4+:[ZU37N[270["5P[LQ.><)_86!SH<M\G29)&$:9LWKAP1?.MQ^5;/_I\
M*[13$C%F48)7_=@LMA+/]BV/9Y'+@Y#$88*E+28<LN9;FF_M"-_*0LY=/TR<
MS.<D)!D-/49C"EI8[&6T:3YX_?[.FF\]+M]R^MT*T]@.H\ #3,,>7#XC5A2Y
MGA5Y7L2QB1I@P-Z!$SIFN*(-EV9<FG%M)^-B(6-!XOF9:X.Z%<=QZL1@5S >
MD1 $M7OCRD_-N!Z7<7D]QA4%+/-M&ENIC_F+OA.!ZI6YEN.R*"0)2RCQ@7$%
MKNF[VV0I;LC)O1MNNI7I[&L]W^[-H+"2'^\TTW) @P+=R@Y3ZA!*(YIP&^2S
M[89)YB3,T=ZM76):)Z^6O5MAX%+B))9+:6(1C_A6'+' 8LQA09#ZJ%7O';B.
MZ<?+]>PWY%F7\(W[4K:N&_QX]H2>I22U,^I%F6<3] :1F'/*7#<"2\L. NT.
MVC%"[[N#?#L+ (^YA;6L>+UE;-'$"RPO >7$2Q/FTQ2TD]AT5C2NT(3^9 B=
MQ:'G4I<RZD?$#Q@E7A R^-MW7"_D1/M/=HS0^_Z3* P#'H?$2FSN6(0GQ*)Q
MZ%B,V"&)L*T1ML,%*R0(EGMW:$)_,H1.N<LRYMLNR1AA-J%A9E/@\]BQP+<#
M[6_8-4+O^QM(YCB^&S#+30FWB _"')BY:V4^C0F-J1<&V+LL,&-G^6*7QR/T
M368%N=[67_WUJ9AVZBQOY6E8;&A[19;EUC&RFS>9ON\;K34C>TQ&]G'9!V';
MKI=%B15G+I@FL<NM*&&>E82@KK"(@0F:[!V$@1EYRW[3G6U,?76V]&.&H31C
MNIHQ;?RJ;\V8'I<Q+:70Q';"7.):;AC;%@DR#CP)U2Q*HY#'-G/##!B3:[HK
M4F@T8]*,Z9$8T\;O0->,Z7$94]_'PRG/DCCU+>8'L45L;H/IQQW+<0,2A8[M
M1Q0T)M<CIA<[FC-ISK0MG&GCM\-KSO2XG*GOE&)N JJ1[UF90[%:P@-;CD6Q
MY<'G26J'(8L=C"?')B&NYDS7\Y7UFEHYONQ=\O %@'J,'1IC0X[6+?&NKB;:
M5]?N*72[\N;KBGP]QO:,\:SR&:\H.];AT'NKTT76<YJ]+0I6'8Y9W<WV8S%D
M6L'<E()YNIRPF(!*&<9QBK?]$HNDD6,E,?>MD'BA[]FI[0<VEH>8\,$613UU
M>L.VUZ]J>GX0>N[[V).4N&X0  %'H6V1&$Q'FG#'\L/430G>H^=CN9=O^K:F
MYR=,SQNOZ]3T_"#TW'=-VRQD8<1MRX\#;I$H(U;LD<RR&7$<'M+4IH$H._>B
M9<^TIN<G0\\;+W?4]/P@]-QWZ&8I]WR619;/T:$;N0G0<T@M$A W\ICK)4Z\
M=T "TX^7_;E/(\MPZYT FRMJO&Z1^4ZSIHT7-6K6] "L:3EO,*$T#OTTM7PG
M9,"0PM"*'1Y;CD-=.V4I#3FZ FS3\^^L:FQ?HPA-S_=6NZCI^4'HN>\*X'[J
M!IQ[V&0OM4CB9W@9NV=Y=A;:Q(LBDH&J$9FQ<^?")4W.VTO.&Z]0U.3\(.2\
MU,@IL4,WR!R+A:YO$<_%[-DLL1*L-4X"FT0!VSMP8],+-3T_87K>>"&BIN<'
MH>>^)R#TTC0)?,^*0;&V2!SX5A39L<5H$B5>0N.,@GAV S-T[MQ!8$O;&UVO
MWG"4,S;DCUIO>/V[MNZ2,?!<LU@W7I&H.=H#=&S[=(C<3#H1OA[!_H[^\MW0
M!J,QLIPL<BT2P3^1']L63U*P/+(@CGD(+"TR[7BYA'J'DE5O1*\[%$)YK@QH
MXY6'F@$]$ .:+S*@D,,!VCZQ?!?,(X+7#,34CRTO]L,LL[,(>! P(&(29Z=+
MGS4#>EH,:.,5AIH!/0P#.NEI0&GF\L1U8XN"$HL,"'YC262Y<+9^0.(T<,"2
MB5PS])>;;6L&I!G04RDDU SH@1A03P.*J _B(TRL%.C9(F[J6V!\@4+DP]E%
MJ4UBZNX=A)[IV3M=+_@@#&@C]8*[4..CQ]C:NJFMSI1Z6Q9598QH>9:/[W3A
MZ597?NHQ]$6D=ZH(?!9QR8U7! KF\KXLLGRJ=<;-Z8S'2V[[S,_2Q'4"*_;B
MP"()A=_"P+4BV\]\WT^9[;"] R\T?5MG%CQA"MYX#:"FX/NBX)[51PA)$[#P
MK, GD45"ZEC4XX&5!1F%(PQXY@6"@@/[SKV+-05O+P5OO.I/4_ ]47#?<<Q"
M&TC7)9:=^HD%O!?K\!-J95'B^2R*J!/1O0/'B4R/:"'\A$EXXX5^FH3OBX1[
M0MBCU+%3FEII'( :[8$:'45A9/EA$(4!\%_'Q2N!'-^,O6VZ:?59-?C1%Q8^
M;FV?YD;WPHU^7S;J'2=T,L^W?!9D%@DHLY)$)!K['D^H:_,0KT]U3->+MZC0
M6#<.V/9J/DW!]T7!_62V)/,9HYGEIA$%NN6A%<?P)V=>EJ6^31S?$?6X3J1O
M'GO"%+SQ CY-P?=$P7VC/K.!7OW4L=* N1:AJ6LED1]9B6=[+",D]"-TK'NF
MJV\#?LH4O/&2/4W!]T7!/1F<.GY 71Y8+(KPFE\WLF+7CJPPY-SG7L(R3H""
M;=.]NV-]2]OU[,RE@&>=9)1;]IV7NWCAP=99,4N&7.:2W2$K=.M@]?=' <VV
ML/+MJU74K/Q>6/D?RPX1XG$[BWS+2V-L;T0\*XI=9L5>A@HU<< DWCL@D1F2
MG2Y.W"#9/G)02#-MS;2WL[Y3,^W[8MK]Q!;;3UF8>9;MA:%%7(]:2<RX%61)
MX(=Q1'R> =,.S3!:]F)KIJV9MF;:6P63QZR)U4S[GIAVW^U)$YM$-IQ+XC#L
M;!PG%@C?V,J\, @<[F<>"?$. L<,O.7(A>;:FFMKKKU5,'G,0F+-M>^+:_=4
M;3L+4^8QV\J(#:HV#QR+<@<T[\B-;1KS-/6P_3,)3(<L1ZLTU[ZQ?_Z7*87I
MX"?+SP]J@)[,1@"$M"8Y]><&-*-%JOJ8#CB;#?EI=C2>YM/YYYSQ=V-)7G"<
MG6N C[Y/>3FFP_H*X.K7^7O5!:]3V/\)%O?KL$B_[2;Q#?G_?IC_^9E-$I<$
M)U^/O2^CWR].?GP8G+X]^G'R^IM]^OG(_O+UY-N7SV^^'G_]]>OQVR/WR^@#
MYH&2D\._(B<"52=RK,@/@':<A%AQ0KGEL#BC49)Z<>KO&1PXU 0.85K.L)TA
M''N-I#)H(;'-71207P'N>39_^""G:V-D9<"!Z0Z'Q06@O"$0UJAF(U@O#%(9
M8SXU2HDKE9',Z_Z(HCVB2JXT?LK'QG10S& 9K/KYA='0J4#[]4# $GLYGR)D
M29&P\R&=5/Q%_<M+EE>3(9V_R,=B_>*EEVHP1=T8P.H1I "Q_/KE1<ZF P")
MO0_01'FG0F=J9O7UOOBJQU[D=X3L>SY9^[6][ZS][K)A'7??CM:_>MFPEW]'
M[$ O=K<6ZU]KV"L"OU>F:L1+CZ[0V5,.PJC<*@WUTZ#DW#B&YP:5<31FG/TK
M*7\Y^,@G4SY*>&EXMGF-_@1/%CXG\,E-P'-7/.J8HM=5I+8<@JA)7:?#Q97;
M?5XP<S9!=4\2,AJ;[HI-SZ'#3FUKW:F[SF;0Z#[[S.@5/O@*GU47G\,"UP*S
M ELSSDJ:39>*_NY<=KQUFUYR9=^VRMK9C\.;>[JV/"F;VP%W,Y_X=AB0+&5Q
MF$34BYTDH5[*7';C3+Z.T^P53(1+^)Q/![7C[.A[.IPA2 ^KBL/_V"?Z_3EX
MM/_P__S\[V]_OH4U?GX'S_]N?_GQAW_R8YA_<4^^GK[^-[SWY]>3U__^UO=H
M__EI./SS\X=OL _GR]=O]LGK#U]//GWS3C__]O6+>TQ./K_Y>C(ZMD\^?\B:
MQ)'V@A7JNAF- F[Y&9PAB=S4BJA++)[1F)$DB3V*+15B,PC7)_P]9)!-<YBG
MQ6'\-/"2+/-<FP>$9G;D4#_%^W^]U*.!F]TX[4QSF,?E,/T;%K,L"C/JV98=
M^1@RBWPKXC2V8B<DMI,YKD-LM%O,*%[?[5MS&,UA;EW<33EA*0]2ZB3$22@-
M0''Q'"_+.&5>1F^<(Z4YS.-RF/ZECTEB@PJ:9%:<\< B#LFL)$D<BQ.;!0FQ
M$^:!#A/$INUXFL-H#G,/5A*)6>P$,4]"DF5VXGJQ37F6AID3N=R_<3Z/YC"/
MRV'ZUU#&2<!(Z$9@(#D,=!A.K80'KA5ZB>?;)(R]+ (.XYI.L#Y7\_GUD?HX
M*\]$7^B*TR$=+[N3;@V!EHL\I1+XS$N=.*2>'_@)26TWB9GO.)Z;AHRD3A)K
M;\LN\9&35TO>%N 4C(<.M0*2$(O8@6]1AP86BVT.?Z0.M;.] R<TO4UY6^ZA
MS?T3)L#(I8PG;A!0UR-@F\:V$]HDB1/N>,R.J79&[!@!]IT13NH0SMS,\H+4
MMPB-$BN*N&VEE#.L?00NRX   ]._I+Y9$^"]$6 8.$'JI4F8QC:A/$@"U[<C
MZB=VFGI!%FA;?<<(L&^K4^JZA,89J,X^J-.9RZV(!9[EV]3/&&5.ZKE[!P1L
M=7?]U5N: ._O@I(H3'@$^V0.(<RV(QZF/G5(8L=IZCN1-F5WC #[IFSJ9TGF
MV*G%B.-:!*\P25CB6G#044!LC[ENLG?@NZ:[HO_RW4S97<Z-.!U;_]F$J_ )
MLP[/=9PL9C1TF4\2-Z7P_Y2S)+6CD+D)U=;K3K&.CTO6:^"2++&Y;\74<RR2
M1ID5^1ZQ N;QU$\YR= +!LHSN>3>WL>^?O )$V <)';HBZ2-E'@I3[PTX)E+
M6,B<.*&^MEYWC #[UFM(/9?:3F)E;@C6JXV-7CPLHPM\EKE@+#D)P>K3S2G/
MF@!OY+]UXR3VN>LY:4PBSX/CXE[@,#L(7$X"7UNO.T: ?>N541ZY&2%6%,9H
MO7J9%?/4M6R'NF$2 57:CNBT9$>: !^! %WJA6$4V3SS?9)2$MFQZ[E^2..,
M^YY_\\8*F@ ?EP#[UBN)7<Z],+&83V.+Q(%G =DQ*W,8"$8OYAGC0(".&9$K
M4CV>52#V=#K@I0Z^7LH[$MOW,DYX&-*(Q$F8T"Q-?#<D,7$<-[UYTUK-.QZ3
M=^3+YFOF))F7)%9"4C!?$QY;$8L\*[(]4)ZSB(!T!^WYTM:VVO-\;_27DL1E
ML6UGB1.1P+6CT$]#/[2]@##XAVOK=<?H;RD1G,>12^S82N!?BQ#N67BQ@^7Z
M:9P$GI,QT3O)#%;<W:GI[_[E7^;%49;&:>0&)':<.(IB!K^F":,Q2S)MO.X8
M_?6-5QX&D4T"7_AK+<+2U )-AUIQS$*.PC$.@[V#P SL]5V"-?W=XYVVE">$
MN$F$G<LXB>W 37SNIKYK)U[H:=MUQ^BO;[MRQFT:\-0"_2:Q"!RV%074QBNO
MX(!=SR,9EBF8;G2%_OGP%]>,<L:&_%$OKE%=TVZ70KS8S?"J)A_[KK]]_.7N
MK:+3V D"W\YHY) @]N.(AHGMV;:7NJ$31-J^W2G^LES*[;+(\4(:65GBQA;Q
M(^ O;F*#?1N!<IT1FX;>WH'OFRZ)MLXY_:Q),\[\)+5=VTLXD";WD\1.6)00
M'Z^_<Y-0F[X[1IHKTHXQC8Y9$2.91;PLM>+$C:S(<R,0_E'F!A&0IF?"(6O2
MW";2]+E/21;0+"(988Q3#A(S \$9\9C[,=-6\8Z19M\J3OW$L?V06)X;>A:)
M:&91-W4LO X\SD@2!7Z,)3F.&;K;E]7TK&F3L9#Q)$LI_)?800P'%J44;.C
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M^[O7VT/V9VFSH2_IU%(WT4  G>=<>KU@ ?1,9DC1)@V@/D9TV"]V>BG*'."
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M')IU=Z4/XMDW$AOJ'DMBMH568P+!AA6_0)6TCN#*])D<Z0M+<-9.+I0EB77
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M'YBQ<R]WC#X'Z#G:GWWK4("^I45W&-,=QG1+IX<&E>L1TXNO4WVH6XQI?'P
M?'1BDY!'3]E\;MV7;JE^:(CK'F.[#//+>XSU6C%U]_9U5DWS;/[P*J]K=QM<
MY..TY+3BS C^8= Q,\)_U.TLX/\EY^+#,3:U&!6BJ07'IA;&0D,+ XO>3:/D
MU82GV#YM.#>Q=49:C":TA*>GQ<T'=/:-3_!.O4#X!298;+BA!KQB8<8%+(7-
M.*X"(+UZ0.Q_,EGE C(-S EM HFF4?7+(DRQHP)3:CJ/P<:G.1T.YT:1916?
M&LG<H ;CZR:GRU6BUP# =0[FVOM?L03SFD#9! 26 +MO''U/AS-D%&*SP'
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MM=H%?&O;X%K>DJ=KS%X);Q,5:&50@KYA=O""/"!>?!KD+4H*QTR'1EM_=&W
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M@,I@_%3-0)'"K!<1I*GJ/)L)X-K/0K-CF)H#Y)5SN0[ID&Q"LB6?T+S$\8<
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M(OVU. *0%SST'C9@O'MG&N_@:\,Y- V5T?DAK[X9;V#"HJSP(\=]^6[,@%\
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M+-XA/F7US.KK??%5?2G[PG>$['L^6?NUO>^L_>ZR81UWWX[6OWK9L)=_1^Q
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M.WDN;XDX^6!JDU3C&2W"2V^U%&.R]2SW#&3RZ/SQ#P^%& 9[/X,]/GS\Y&0
MF0P@DP%D,L "]FO-!I#)($T#R.0^@FN!I=WGYP^PDB&Y)LFU^/'3(5\[B-37
M6XRG\=/'6UU@@T0-$K5EU6]\/K3)&$3J:W9>>10?/7DT8$JV-QD'%$D_J=P
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M_S;2IP;_6L_ .9G A*F5QZJ27M6,.\>]N4Z:CD^^NC1U70=?FK:4@EL*7:_
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M@NYL\QD,K*R_X]BN2Z)GG]CEH1F680?Q<&7P-_0/7,BK))<.[G!434$AHI8
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M.)PKQP&$8I:!:9757A*#RPN]]\*W>$,[PG-R>GCVB!Y/;PI,*18."=W\RQ#
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M*6*3!3]]35&&1 X5Q1-XP)V( B?(!3U@>:WJ: K&(+T6;GUQ.U<6FUBBM(G
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MC+$M>UAQ\O/PI=T@LC\H@U&$45GIZ>9"'0+BRV+9D(5_4$!/I,@@D8U:KC^
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M^;@"58C"A\X$2EQ)*1BHG3[^:Y/<TB(@\NN]Y@O3<$<MGAJX[E.I*241L9_
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M\ RJB!T:BM^<4?&/ZVEAFAE>9#AL7A&T&:\0?<V564R,AED:[9M'"H7'J"%
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M $ZP):[*BG*LA/NEZA*Z;E D.H8+H5S1/&)/MO%(OH=M_!-C#R%+[ 9^_OY
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M='G%,8B%L44S[*P[)(*_:71^8&14^08#I\X"W&PWRI$D3I;5%F_Y-E+= Q&
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M7*KFHG:OO934^7L1_6#L@\O[+57%KQ3UF!H?&=N)IQ"^27K24-'[@5!1!.%
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M_2UUR!<O=N]:^T8+-:7WUVC_=,[F3K<@W[\AY,#17!"#P352&,.Y91Y>I;3
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M1M2VU.^&9D!8L:M57+%6G:;T790!>UMT"<1><<?%<70!6FN53HQ'I:Z-$,;
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ML:=;^% >_;V%<WEZ1'[ *4T=S$GT@&,"+.C)MD?=/89>I=<\_&P)#&$Q$%>
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M7P>)", F42YQI05SXF:'*'4K<1@)" ;>,=JN;7>_$C,<QO9,P#SO9\(L2CD
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M=UW2>/II$F=$(&D3[.395A P?*FZ6JW%6G76M2<JS,3$2 Q!3HC-FPF-'R>
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M@AO6<(0'/JQ^-^#A?X4URS$E'WBIYOMDM]4HZ',JZ&>$1=/H'SH_4!65CD)
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MNL#(&=(=TR"ZV!A,!,8>"A293+5JIT4HFYCZ2=S=CE9)7[?$QR'_-4!R!8.
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MF<T<3#.C5]);(3#2"269G"XB8F1FF@%216[%PT@IF.F=+L)1G:5I.!#8^-@
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M[0BS^HNYC\/(.^>&".,E9C4S^213X,5#-A@;;&RLJ!KY'!/5CH\(]?<<X^U
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M 1_-[=U^4TYM,,!C+$8X4WMDV*ZLN%<5_ZY54:<XI3-F$_KAA_\#4$L#!!0
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M10@(A0@U&]/P8$IV\@H];@BP;_CR(9V5=)9UD_EM(^7?YS03+V=?IT?EQH,
M4ECG1SYUQ%9%B8$+2"9S4-P*B('7JYHL,*%C,4%L18+[/WM(QR^'X$AGZ3S
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M:T9:(9/8" /.89;>>:GP8?7=H*Y>#I=Q]Q;F@W!N=;?)8U8ET5) AN34"4L
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MQ&6C(?+D#*M\^-UU" =/4#PZR8^C_<>2TKC!]V@#EP X[W0NJ0.B=(;6AEC
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MWM9#,+6OL:Y%4*/0#'2B,00K=<[!2:9<D&B^6YNU&G1X;[=E8?7B[U=NADC
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MVE6F6Z=EK_'JGR>3].=P-/+CM PES?SX;(AFR>+*SNHH?))OI.DUD_Q^O$0
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MZ3)#7T,K+XCT'-V9[!EA%#@3BE*QOB$?57-;]M2ZBMM'1KW[V-<Z);Y?U<L
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M[:D]>+A6F'X08DDI=)%HFBR1$!SQ5'("B@L42K(T'"*%YRZ,SX,IE712X5K
M3:2+(PV6E><Q9F(DBSAR7-(<!T&"D8$S'4&(.MVW-H Y5 7W^BS87[:/I6K[
MAIHX@4DCE*.$4E=.O0PN=\8[8J-W,6<%:/S421%_-#7#.FOW_FIA^TCY4"6B
M=L'T<JN%[:6Q76I%/43<AZ("CUEE-'*)$!&(U+A .BDE*BSYX"133KV\:F&]
M,V ?*5>)'MPJ;L2B$S3CGBAB+,V,$I 0=23,&.9"Q/VQ4JCQT5:/VDM']U>/
MVD? -6J$;KRLY!2W.O)$&%44B:TB"=+@D%,0PD5MM:VC]4=R*ZQWQ7<7\Z&N
MBAO%&,@4"35<$QF"1S[R0*)":N8@@V'U@H:/Y:IXW_9>9TE7"B-NN/FX"ZJ7
M?4E\+[WM=C7X(4(_W"5QJYD.)CO"F,M$\ERZT5-%$DN4(UBG7:T*DH_[DG@%
M)NPCZ[Y39GZ>X!XU+BO>IR^3<3-95C;]__*?Q6YARTU+.VN\$:(4-,1M4)6$
M+!\=,8EZ ]XJNW[&N"5O9J?7/9H;X7LI9E)5JGVGN=V-D"\1)ANBDA9(UJ:T
M!E>(-4 D&3Q(,%+XH'O0.W\9>G^(5+?.]UY3J#["5QC/\0_BY&SQM+?#QI^=
M3>&LO=%PFI>?Z) WM?<[>DB6ZC:NM0PI1H7BWCGF@4M@.$<%KOSE1@ O54/2
M8.^W=0SM;W[X56S;9A%#*40=0BS6:S+$,P,$:!0I)R1AKA._N0]9#^6/R_-^
MPOF,3M9LZN/L7\/9^9MY,YM<P/3=MSB:E_[@)TT#^-_TV7\;,"F#8Q+]KM*2
M7EH/Q!KK$+T0*"=!M:MSZ/$ L$<X).N32QO*)E=55XVTJ\WR6'B%Z/33(+4C
M2DF%^W8JC8ABV2,8BY3YZ%.=PY&[4!WL(*TF4WH3^[&/UDKKH _329K'V>GT
M$TR_#N/"?;#4>N:")EF"(]*;1)P 0WCR/ODH\"?]=?O:A.!HX97>5#OI4<0]
MNE/7\#0GX[1$U*Q,RAU ]=X@<"N<P_<$[*ZIVVKO2<P'XP!$8=!:9,AMCRNC
M=X$$")98YB35"-/RG?HR/$;=W]'<[T"JWT>ZO5_/1#NFF0WC_YDT7X8S/VI6
M;4(\3RZ(XNF5JM.1<F(MKFM!!>]U=A%_N9/_O.4%AVVUUY/L)ST+KN_02)O.
M-6ZW*3]:!Y:$48(K1[3BZ+L[&Q"8D"1':H/D+HIU-V*+1N]ZRY-7:V\B['NB
MW@"&)LEL.@QS_/SJ<$X$H(H[8I@.1/(2W+4T$$A:B^25EWZW..?=[WE>^NTF
MQAY/N187&/TT#2=G,(9FN&(<MS8E4\JW:X:KB4R26.\#20*]26_!6J9V4NN&
MAS]Y7785V-:D]UXCE)]FD_C'F\E%*8?2\NXW/YVV?5D[A"3O?V@/,<@]D:\%
M':,"XZ-A7@HJ<4K9&!A#)XGZZ+0$/[C_\1V["9[[*93&".GZ2T[P'>.SUE=^
M_?WJ(Q_\][9LXI_(J:N(@/$2"6,"H:Y4R--)$\>15SQ#9)(:*:Y*J/3;?K S
M]LZ]&,OCP_T(PCJ"#_-I/,<??ICB'#_-^-<7DW&KZV5N^2 *2E-6C%@9+9&4
MH\\<HB3>QAP\<"MM1:E6&=/AXYX'9O>M7I*/@QX5 J@/%NR[_YX/9]^O$G&:
MT]DY3#^?^_%IVW"[^1D?,6O>CQ?U#@:<.7Q[=@0'C+8&"ZVGD$G4RCI@6M-*
MAQR'&N'+G!2/C3I].R(/'N3ZF'[UTS]@]D\_FK=5&?!/%L.$-,A4)!DB,M>(
M4HK%<^($&H?!Z8S&A-%FO=OS%K/W &!?#,L?I?8KI!H^?(B;YNK/TTG3#!)S
M3"<CB**0B(Q.$!NU0T<'J+ &'1W[R-;Z[8-Y,81_+(2H<#F[-;C>-\T<TMOY
M=#@^6V!;S,-WZ(%.O@,LK+*5O3;RXV8@0>7 O2*T^-B2V42<488 5S$FQZQ<
MCT?TQ>.' 7YY7#V 8BM<%;]$M@@-;1'B:+2L4UL.8=M4I?]I;RSC -],FEGS
MQK?AVO+390T<P9/77BH2?8XXS40B7@A'+/H1SG*&/ZYS/Z#2@%X<GQ\#,2I<
M;K]>CNP>^3;;!+RL\LNBM48)XA+@Q-5@B5>,HF?@@K+>91<J!5/Z&L*A\G^.
MO3(?1>6/(9WH\W!6AOU^G(9?AVGN1^TY>I3:.8B22)?0RD^:$1<8TDQ(Y7E*
M"M9/K#KD%&R$<*R$HB,Q8=*G1GI./;D%J*19?H11*X_F?/CE\^3=>'9UNW$7
MJ+TG)>T)\O"I2CVH]2Z25-#)D6FDE8RTY/)(%CF12DGB/.7$**J=#S[*9)X7
M?>[(=CHN>_911<^L.<T93<M5"D#B$'!W;WNGE^/HC&MJV>,IMP$RL$A%?[EN
M-UY]V /YJ@J:]"'="H<[B[US=2.2*^:CRKA]&@HE5TL2RVDF)ON@90J:QCHW
M*V[ >)EF2'>-'"/TNU405\,8IQ)1N=:U;Y<Q5;VC7F-4Q[GAWH$L^\9T#Z7I
M"A?CJXP-M_NDG:8DE]L.DB5/',V10!"&A>ADV"T%_!FS]YY+^8^<O/LHN )I
M;\2FE\8"=4)R8P)A#,U.2:DC(8 C5BI-%6@=*W%N YA'&'FMKN5ML=@'JJCO
M=/>/4-)WXPQ2BZ@==;/VP]]12\T'Y 9,I]=_M*IGI9/+/%)B:?%N@HO$VQ"1
M#]1Y8#8ZLU9W=DNB07<L+YA@Q]#F8<H3W,IQO3*Z_P7#LW,<V,E7F/HS.&F:
M^<7BO/CW<I-X\A9*?8?A&#Z?PT]^.%VF2BS/E/O,'>X;4XW4XZIR6V\HPT $
M"=8%(:17-GCA($1I@K 0=+R=N=PWNJ,G/GNA7>2VM(H/N*RGK'!9%Y%PH='7
MRXXF6Z>(TA-.?+Y4YS6EERZH9?4JQ=G9@&<K@D+OG&5<%B4U0(+BDBB5@L_
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MT^^G^?-DYD>W?EWB7>,&^CW(V^^55<[I.HQZO6IYDHHJP0(ZKS+'[*R7'K=
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M<KUX5:S6>DG4"Y_^J<J%+&OV?E^L^*8L]:]_H7GY-[K<R$7,PS!% H&0<;U
MR9@#EF50TW)$J8A3BCE?[ _$0J[ ;Y\[N>K.!_7\)QLD+GYJI:R*3<EWJ^'#
M\M02IU<WLQ[BGU;T05:/M'U!BV\,AT:C?]O)'O!]X?_EIYVJ_H!?3@YF]UE-
MAN*!U#?!3NZ;P$@>U**/@ZYH#;_Z@9= ^4" ?P*T"WX@X](8?$7Y'+."#\6L
MX57S,C"F-20QK%G3M;F?CKZ1V[(3G9;\PM"T3_RDYS>7CVMP,!?,AN J'=?%
M59]5@[P6\4]!4>KG]0;GA+K;*;&IP!VECZ8CO2-:YVPI7TNV_E4^,%DN.(X5
MY+$ 3#%JMB )(%(PP"1$,(H93)A8K+<FS-DITMN+RX18G['*/,^&3LB@DJN\
M*(-5L9:5'<?T ]K/U]Y@&I^=MP@9 8,_&A'__^N)P0J"G7E5:>EK_16M6*U
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M,<)QA@3%MC:117]S8\1&Y.! YIOFHEG#'+22!T9T>[O)!O?+9I1G-$>F.A]
M.IE:#O ,MKQL^IC,$'-0>-\N<WEMH)DFV?KMJEJ7]1YZ+^J^^=$D#_Q8YER&
M"T)"AB%A ,7F["=,$D A#379\(PE29*)S,TNL^UY;K2SDR]X- (&/^2K0!3+
M)2VK0"\#075/2_EG1WO,>APL#; QT)WB%'PG=&U0=6)W_ZAAKR7W:&"Y8N77
MHK+N?5H3RA64(YO)N8%A#/9)/DEM@?VB-3!YA$K*U[_GZ_M7FVI=/,CREE7U
M[Q9099S&,@&2128V!J6 I)R"#"*.HXQF:>+D&&W9[]S8JQ6[2>G:"=[D>NU$
M#_[HA'=T:;0="CL*&P'@D0G,$[;.!.:(E%?ZLNU[4O)R!.0Y=;F^/HRX;H7(
MC45'EQ]I+MZN7M''?$V7KXJ'!V/F%?SOBY@*(=($ 99)#!##7&_U% :"(,%A
MRE%*G=R$+G<Y-[K:21P\:I&!-K5X([0;-5F ;<=*?B$<F9#VT#/2FLC(5EYC
M3QF)@UID?U1D#X]7%K+H=E("LH?A.?<XO.DC;/MW:>+3I+C5)AF]DY^D<1CH
M_OA%E@_A E))!$LX4,*DO>64 )H@!9(T3!2/<(25N":2^[((+C-J&M_L3N:
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M72Q4T"G@<Q,P #?/FP$7"2;>% P YWAS,*21H9EG?LF7\OVF.<5.L2 J8H#
M*#6I]S!@"H6 2DH2#!$.0ZN2+Z<:GQLUM:E0C(!!(Z%KZI@]X/H9YUHX1B84
M!R0&Y'XY5OG*1"][#4Z<U>58E>,4+B>>&7A7?<E_Z)S[T+:$^&U5;1X>Z\*7
M;[X]2F-)_:U8ZF:66DYC'6FQB=Z48P:T;1(!1"4'VC[1/Z4)Y%F4:#9(G6Z\
MQY=Y=C322AE4)F*SS1/SM!79\1Y]@C&WO(V?UTB.?:=OX?_9Z_YY$QB]@UKQ
M8$_SFV#[?>R4K_?='OT&IALJO]X'$\@]K0_#= -QY DQ8=<#_"GJ5(EW*]/K
MUK;5NWANKFWOY$+%F$ <"Q"E4NC%AT2 )2$&$"<JXBDC66(?==G?U]R6CSUI
M@[P3U^06:^5UN,*_ +*%DX0_Z,8^,-U#;2MI\'$$U!R\'/RA-Y%+PZ5O[T=/
MK@MVP/3Z*5QH8CJG!#M=#CP0+%_QD'R[ZD]86YG?+HMJ4\HO\MOZYZ7)A4.R
M-)24IR#+. $HEM+$A4H09Y"F1,"$LV1P$NX! LV-H#^WJ;?;D@=7Y-X>,CIV
MQOJ4F(_,[(>YN*O+R;CU(SN-@C^,3D&ME$>W!U_XCI>?>XA0+Y>G^PH(>_-U
M7]/NP+INN[R7;[ZMM=UM\H+GI5Z^JS75P#1750L1HS##$3>E#8R[EW&-B"0$
ML5(X52Q5J0R="KY9=3LW*JVSON9[65]E)WO ]X0W%HB6WK$JFMU 6!C!H\ [
M-FN^/+*.A>B\(SQEA3IKI'U9T,Z(7:QJ9]?:M.7NG#0\JH/G]O:0 GEMK%H=
MP'B[$MOH1?WS8:#:)Y.WZH/ZK6I\CO<B%O<#%O5KA[714ZA7"6;RK&=ZD0@9
M B2% A L"64B10RKQ4K>F78LEHF1Q;6:FZ29F_M"CS<U]P-#J7,5]4F&V&+Y
MF<.PS2$DN/[7LQ#@H%89% IHI9LPC)NS\<!U U85W:?_#ERJ)<[G>YAHB=7B
M;5:U[PK=&UKQ?&CWIWB3A_NQ^8P>M]^5>4P>?%!E]P%M] =4)X=J7BT.<W;Z
M6K<G&KS^*I(CRS!A7<IIT#RL=#E1GP/SO95W=-4V98X9BV4NNFX^ZCG93=8/
MZI=\I:V@G"ZW,;/5KEZ"B"56*0%AF"8 J5@ )LSNE,<0IS!6<:R<\L/YD&IN
MF]=]I9H"<%NU:F;95\QPUU:U8*?;X'(+?L;9[C!Q\M$;V<R8:N#<,^7Y!-IO
M9CTODDV;B<\GF$>9^[PV/K"&Q-ZJ\4$]CVI=T"B3C),()%PA@(A @&E2!XAB
M3#"+N2*96^KV_@Y=)O@TB=KWY0WD-^,$X9BUZ0+$=O3I#[:1>?$ +\U[1P'N
M'DM%6&'BMTQ$?Y?3EHBP4O^H/(3=6T-#6GA9T].VWH3Q#JINU^LR9YNU2;_T
MI=B5[_J@S E;6SLZE]6"901!F,0 -R2#4D 502#$:9QB&&*&G1Q'KY1G;L9B
M$W9D9A7?54,+]#J1%V6P*M:RJBM&U.4#*\?Z@=<.G1V-33@@(_/<GB;;2CBU
M+L&^,L&Z"%[GR\TZ?^I"(LWP[94BU/^J#_]W2OH,J?&"MN<@F^MDFCCLQ@N
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MN7Y:O>>S^<Q3 Z_!\U6^UI3P9$Z*UWH<3>K<YL[]G;9OWJ[E0[5 *<\2#!-
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M%+=/LJ1WTC@JFX0RG^A:MNDR%SQ"0JD$ DA@!I!@":"1-D\4RB2+0TH$-\[
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MI/B[U/G+Y/NSA.1L\C_;]P=4=.H2V^WGM:O3VBT(Y"@SI=RYTE2&)$> R4@
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M+\8#L7**N+% 8G#035_;D\7=6"BX'WIC\_CUOK#/$R3N)T?E,0Q3*0E(%>(
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MRV. $UW;2.:96BG($B2%)!#%%%.963:FOB1G:E^(1LUH?ZC@>B33AZL9MWM
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MT8 1D3VI/S"FY!NWRS[LX[(=UVO?Q*_-*P7[/V:(2,PX3$%9DA1 *3C O*1
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M<;+.0)V'S;H_*FRQE(_BU^;;3['X(?Y8+3??JUD<QY2BG -4:B\J35* *,%
ME'E)<4Y@7!@M/6]59&ILJ=[B+$S1E+,A,./%,8 -3(YV157N(MV#/?JT]$B&
MMX+X(N56SI299/F5/LA<R['T/L^-(#]MOHNU)MRU^*XX=_Y#-#UO=?BL^NR*
M^<.R"3-@S]_4=[DBK,YQ6/+Z7XN:H^_Y?VZ;EBL?Q>:3_$9^S41*..,$@@P2
M"2"C&:"H$(!(D60\EXE@W#RJ-8R2=N%'H<-=6SO:HI;L.=KL=8_(3GG+??]
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M7>JHY&(,PBG7F-_H'-VDOZ-U5<[.7WG^@VRV:_7?DQ 9 4F2XI("2'/U/XF
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MWV>WU^E])F342=UGXNE4[KW.;@)S,9^]:;W*S]VNRANR$;-<I$DA"P@8E!+
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M2J\9?5:R].H-KBMKQ3[;]7/=XKSI=OZ_R&(K9F6:$<9X M*T$ "2+ >(9"6
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MMGQHDC>V>=QU0]MS<(=-^@Y![)D&=C0M/_:[+6B[IX9 7+IN\M H<^@6#R$
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MG F5(V$@13R'Q&0<\EQ)AU1N&.<(9TD:7 (H2.38IBOZ&Z'_[MQ[L?C+!["
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M0JAZWQVM42K5Z^'8ML'\3B?Y,3F#SO0&0U].]Z9+6P9KE$>_GCR^&?6T* O
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M^-Z_(B;[=2S#]Z5.5?71$LK1&45((RDJNN<%QU<)G2#  D"%6+]^S"_ #21
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MVP107L2((EBL_WHWGB8ZHIXJ1K.#)(T"P6D$+R,#;HSEB3C"=.X))$^\?B^
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MKVDRN:'>46,96M) 9$0[.J2 6!<$DB56$4J)YWT9%O??NQ\B&HY-GLC*)H"
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MR11X0%0%71*E@A!E,"+NZ*2XY)$K(NO$U/<B[_0A8^N7?.XBU=DPJY@5D%Q
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ME;[%9TZ_E%J\%XM%.DXW/?O,7C32893WI(=N7HHGV.;[GD">]9%)3SP>FUR
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M]9R!__BQ@]LS]:4XZX6E X(AIO'H7?KB)BOOM]L[C 43?""@9-!HV76M*5F
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M+MUXO@I /6H9WG43GY1NXJ,@8E+11."R]#H+ 6TU7"E$QY-RBDEOZHPJVI/
M87N]_R@0KR'M!D#\#S>>EK8 [Z<KF^WEU0+9M5B,J.?<2D=P"Y;>$BY$M-4(
M \*B#49EDDFET6-;*-H+INK_[S#M19ZM=MY8]8\=ERR*Q7)^U74C^71U<>'F
MU]V4G4<_O)FX_6)Y-^C[^-*X/E_?2T5=-7[T5(BW<[JZM9E*/-_!<F/+V(YR
M[J-&,$P*KH-7M9HT[J+JY-;3-\]^>7U?170* '?^.KBJ9$XZ)<@L2Q#44G#>
M:I#>)^-SXHJPNBO?0=VP@;O>$/.H]73?@FG@[+ZWIMLO_Z\QGB?S\/7Z7?J6
M)EVVAC*$.:=1U:<@0)#$4/-K U(JEC-S9?)B;;CMH*\1P/6&B^W ZTM(+4%O
M?:)TI\OC]:UO9K.E&:T. VB_%,<NER&?OM@W4GKE'16Q3J;5060V \3><+(-
MBKT+K25$OIU>7BT7'<?HS94]*W-DM05NR\'AT#MS/"#3B$K!.S2G19T>]#N(
M:@1M_4-A&^A.E$NC$&/KI?BLA+*" Y*./IN)$IPP$CQ-1HN<)/-U^O7N(&K8
M>ZMA(7:,7!J%&%\OA27/5& "E",!A&2E#;DE):DM9XN,8J%.1&8'4</>( T+
ML6/DTA+$7EYWT<M7$[=8U6)K&DP27@)5:%:(['$-(2906LH<K/"9UQD8L)6D
M1C38&7R#$T31$J96\?";,-/[<OEY-2]9E*6-YN+WZ<POTKR[#.TV4AD;,@WC
MR7A=87#'A9L]RY)&'CJ@E&00VF9 LR! HC%)3XPQK++GT/.*&C'[3@/<-A@/
M*?T&=L&OLVFZ_M7-_YF6;ZZF\38/G>@D)5,(-8,FB%<2C$^X%)ER-C9E$NNT
M\7F:GD80."A69KT+K@'XW6WN)PZKV]N VRNL5^YRX][)FD0B'F>@B;6%A11,
MX!RL5J:[OHR;W45Z/_^/H[P1*[2^F7 &P38 Y%=N\?7%-):_2O'%-S=Y8-??
M70V,I.&1N3)$()0FML9S<(8P4-[3S"UEGM29(+LWB8UHV[,@9[/2LXH8&\#G
M.NGCB84H(H4+M%RRAUAZ+5*P*@<(P<BDN6-4U-&@6TEJQ8,: '_]B.EXO,V6
M;G)Z%O*6K-*[M+G;!8Y$I#GZ;" HK4 D@=LH\01:(*L4(<JJ_7*,]W]G*R?O
M&>%54RJ'@\VNP#8M4P;7GSUYE/MZ,O,X/;EY-/5$,)_+Z*PR#%PH,)P&8%*C
MJ6V)BJ%.E&@W7<,FZ@ZJZ'H4V*D _+RA],Z0 /:;FY?-]ZWOS*Y'SZV6LK5[
M!>?(Q0JLZT54BCS+@:@\ Z.=!^X#29HY86F=%.6SY&*M# $T1>]ME"<"#_@!
MU-_S!W&(E?-&O'1H$G@@P3EDCPW@(K%@LU8IL&AUI1GFO2VA$3?D5.P]$WD\
MDX@;<$%NTGI?!/2L%EWN<1?&34E1IG*Y4>=H;$2EP20;@1OGHM"")%7'(=Y"
M4".X.R\\9OW+JE'(E2_GZ:8!1RIC7+AU("73Z,8CIWPDKM@P4L>49-9U<B">
M)6U8&/8"@#U =;PTAFY_\V(1KN=7BW6/Q'>3<-.<.5(2N-:04D"K.&F)OE/4
M$'7TG#%JI-JOM>26%[2'BQ-D..N9H0WHG'MY'=TMT&T'NNRR(3Y(\#IX$,X[
M<,9J]+%33))$$BKUP]A&42-QMD$/NEZDU2CJUAN2V.!IJ>Z3Y6Y1D&S06%4&
M.#,L9R-$5G6*F;?3-*P.ZT?F>P#I" $T"*6N].]JNOSHEFFMDGGBJ-R- IV*
M_R/0$S*Y&XX=2XLZJU2JE![P+&WM0>L8%#P#KA-%T@#(^M#^=Y%(H[W3G@I@
MM)@(DA#P03G(7%@CH@M!5LX"Z&,9C5Q,#'H>#X>+!C;%$\9UZ>Y84/ EO<__
M,5N-R,47IL5RL;:[XTAEY85"LYB4D)20MHPH#0(L3]9JSZ0.=0[XX^C]\>,K
M1P+L>7>X;VDW,03Y9IVO9A=^/-W5=NC%?.[PN]T%P\?RU?O\_FI9FA@LUMGQ
M7[Z.F&(BI'(W:;N+<'0,O541DLB!<<FYSG7B_OVNX\=WOOK=!0.@HR&-__SJ
M;^1SO6D+CG#/!YJE :NY+EX+*?$1#IHG:I),-IDZI?D]$/_CFSSGW@7]X."'
M@O[]C?_J:_GR[?3%1?%_WN?GN$1'W$HKLB5 I$6-8&-QZB-**1BB%&62R+K7
M2Y47V$@2R0^TA<Z'IQ[MKS-DI3RL5T!>=+Q9O)W>"OE]7E41WI-QSQDL)]%0
M+=NE/\Z<(S,F!1NES1$1FAGZW['80)* $BXR(X2@MG(TI&9FS&]I^3K-Q]_<
M;9/>S2/QT,J<C[/)Y,UL_J>;QQ$).?-<TFRMD2"XR6!B&3]/6);>"L4JM70^
MS_H:\;U/1>W6J%$[X&C PGJJU/R/\?+KHQ5OZ+?%QXWC><W!56YPN0=QS"F(
M-"E N03PS@K(+F6?C&6ZTL",*LMI9$,TA-L]&O"<%T2GYO=^0,;.NFFFRQ_*
M<2$R.4X-ZD(3\ \4$UB.JE$'+84SW;RQO[SC4C\"UN[6:Q%H351[U-%)0GGB
M U%@LA/%^90H):/ )^*M-YZ:VF;SV0^V^I&U=G?7\"#JYV#[91KKA0DV"F%O
M&_5N?/_%-'Y,:,>/ Y+UJ?#GU-A /R_N)2!0@0<]10&>KE:^]:AH#-[:7/H[
M"<2B0T :$A,X%;)&,TN(2E,L=M-UJO;_%+ZF>%4:A3_]GE42@E/H3%).(29?
MFA<D5U0#4AMI)@0W(X]U%K\7>0//Q>T/-YM:M7_A-.!(;^%721D4/$H1+ /G
MB@%5^K@8S9!7(N1 2;29U3'2M],T++8J &"O'@T'2Z,!7-V=%T^OZ>GOKA/^
MK'?(,:I =9-GD&FXUNQ 9F*)25997L=</87J)O7>P<B9#23&!B"[I>V4$RYF
M82E87[JA"#PRO, 3Q-B$9PB1WN<Z!?8M]@L['Q[VZPEVB' :@-C3[+F[)$9_
M3PD:(VCGBHVB [B4*00I38Y:6!;K#.%XAK!AXUE#G;O'R:41F-T_!9:OW'Q^
MC6[]RI'/5IJ0$0=,\8A&L"5@5="@?7!42V:TKE.MM9NN%@_0(R'P!+QZDD<#
MZ%IIX;+G[D(!OT_GR4W&_Y7BS<2KD1(\2^4)>&,,B%BZB,62^A)(8@+U<_*^
MSKFY%WW#JK2::*L@GP90MW_[.A6L(2%:H-;[DL44P):B71=\*=)EB<4ZC=G[
M[4)8+8!=6]/U+Z5V<\TV%MI'\Z/G'EDC\'N6ED?/A.8R\9IXQ:$4TZ-W8#C@
M^9<@9QWQY8[(4"?7NVY(]^-:[[Z=?D/?J=S$% V\*"HX+496$5E$#S005,(9
M]YH-!/_P*B3<!5+*.@W5=Y+5HB5V%$X>AS/Z$D:[*JFL;8J8Q%-_BKMY&E^O
MR?M07C#_MKYL7RP7=W[5O=\Y07/U].9>%%P-+O2D!V]><WUW&MZ"6T5G S4.
M>&0$A)<,?/$,>-:<T,#1':@TG'H[42</YKYY]$?WYZ\.+<*QFY0KQ4]7EY<3
MY/5O:?D^?^RD@IM0BVB%#F@(J%Q*/61$NR ZD)8Z1[0AQ-:IOS^(S&$U9%\(
M>C14NYJD&G @;A?WQVS^S[?3#_-92(N-)3%CM##"0C!!@>#:@XG(2\.U2#HP
MGRI-IMN#N&$=UNJ0ZTDJ+0&MS*%?X.'RC]DL;BR)AL1I=@R=*K0RA"M-I"+N
M'?2MD&,A>OQ.7:!M)VY8[[0ZT'J22DM PU6,;&0L4(V;1-J,QBM/8#PA@)Y[
MELG8C$YU740A%<,6[%6'SJ%\[JU9_6 N0A\!C1/>=F97X"QAD%TH#5ZPS+2"
M7-H*"HTFE2/*0Q39*2:])$K^L.;_JU4K_O4 GAP,9269U%%4M39[<#0;R*ZH
M6I=IJE1J\R0Y[9KSAR!BJ]XZFO,#'G*+^7)TVZ#_'VGV9>XNOY;NF5U.B]5:
M$U'TMS2IY+2@29A3!M3-QB9KB-D//OB6>]!9K%37?=CL)*,1V!POWEG?O!X:
M,.G+YA+6+>J8-10]4H&V7*8@6,R M#-T)+1&;O&@U5YAA?T LXV,80#3HWAG
M??-Z0,!T;0;GUZ/?/XU,S-H)%\!97[2L2,7#),#0V8PT6;3W=H7=%BG\_<OL
MV\_K)ZX LOY'AX\.&7?O&Q &_0AM=A('&W"=?IM-?[_)(3,QH+7J"2B-ZT5Z
M+5B/GH*DUD>AH^.A3CK,/2*&">[TCXA3^=L -&Z/U7>W-^(\)FI*VU$>/9ZI
M@9:1/8X!,UYJX;RVI+)9_JZ-3+S^3(Z>N-T 7MXOOZ;Y[3)NP^8W,?,7T_AK
MFH>OZ'>.%^EW="#G7;'JEVG9=B.NI+0>)6\<_B&L+_-L@P+I$XV<(,&B3@NG
MD\ANQ/ ]$C.SH00X]%R'>W3?KO>N+^<H$J*U+'FS:!+B&1Y+7UL$3]02OR[I
M8F:_\0Z[W].("CL-/'WS<VAH;(V)C:1UA/LRE")&Y X:<^!M\D (ZGCNG4?<
M[X6*K:]HY,*A!T#TP\4&#K5;II2TO55M^LTEB5'<V10\)!+1TA<Q@@M!@]?<
M>943T97&DF^GJ9%KAWZ.HYY8WQN(>KY[*-=N?XXG$SQ.UP?OTDV_C-&.7+59
MO$G'F>4'2?*+67Z+1V\>3\?+]&[\K>1P/?S%$VXHJM/4RSW&>3G7TVW'#=%H
M13UZ[>-H=Q8N>F$%)$M+)01B&\]."LYI(XP-W(HZ.: 'D=E?E?\S@EFY5PQW
MMC8Z0U94H(4ID2E">E V1^91D[A<IRCL,#J']0GJX6Q[&X#>I=?$P;]S32_1
M/_K?L_FKB5NLBHMS3B)S(D IXD%P%_"D(Q%"",1JHU0VM3*F#B*TE<X!_6/F
MD?E03X#MX_-N<;^YB]OQ1-227.)3(9)<.G]XL,12R)XFH:(42M1*C3F8V*$C
M*Q7!<QA03Y9D$V!=YS,6"QXI*64-KTLOY=EEB1FLX^-,::JC+[E(C.-NUUU)
M7H+ @B7,<,MIK52(/<AK&I"G@^01*/N66 ,P+&T2B]ESY28?QU^^WO9CB$9+
MFZT&R9-%=S+EU3'#+0W,1QU=K*,7MQ T=&#PO%#K0RH-@.OS'.FY</-_WM#O
MK2>*1@HL:PE"$P?>.0M)RT"H2)+;.N[*)B5#AQ7/"Z>3Y-  C@XP/>[B;,QF
M7$B(0+N;QV0E..((4&--#-I*3^KT&#B&VE::J+3D@APGR@;@>A-O&%%/&'&.
M@LX9U;4Q"JSW$K(D249OK0YUZM5N*&C:0.M!UK,>&-\ 8)YAU"_?P^0JCJ=?
M;M>G),/#O@QY2P+UM],1K!0.B+%">Z4%KS3[[%!*FS;;^@=@54&V6U:^_^W#
MS2?]]<=T.9NO.]%T669GN:/9X_UGOH\YE".#W+V83#6GU  )P8!@NM2]^0Q<
M&U].?!]5G;8Y9[U[N7G9_5;K/#MK2!+@HT5;![D 920;H+GMLTR1!5WW"/_8
MRA2C>HC9=HP?*X<&3O1;!<^HR81; D;1DOOL(KCLT(%CR0D3E?2N3H?0-DS
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MN8>L672!1^IUI;%S/UYB6+\XV1P(5TEH;>/QR3M6%A7CD0=<GD,V4A7 <6?
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M@\TV@I Q9DN%4*Y.KM[AM#8;T*@.QSZ$USI NUD V2BE<3V6: 5"$='-)(&
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M_OD_KJ;K:9_T^4G'Z272RL5;EUU_0F* MOBU(F=W[[X:$82)R=1F<9&D;$C
M(5J03HE06.V4Z+ZWPYV/W!X >B*JYEVK^-F"?D]9V!0XBBB Y1QJHS$!7E@+
M.<H<>(B9V?WZ"#8FM <'O >@-U#KX1#W&XC/\$.E8YAF34]&OA23T6#D$ LM
M6Z4Y T\&/Q2TP3+E0E*AT[!C8\=]&$P.KX4.;NP_$MC:>GR3V@NY:)20@R9N
M5!(0T1!SUEF.7@?DY\#4?;IZ<+=;@NHD/700%'J$F]_FL[1EB*R*E"L'0M2*
MK'HCU\GD@=9+SKF4D'B;T3[?)6W<@N S8NM(;9QP$@XSE.RQ6'PU5X/4$HS5
MZZ)/0]+1# R/R097F,,V?45.28<TJ]$](Y .DGP'9][.&.<W 2%ZJZ,6X-RZ
MA1[25AN0O!^O\GI(I$K-&A$^3E8/IOT@09;AA-_!.?>4AW*;T5,<\<1$E,PP
M"+J0(YY,@$#KJHYWIL_,AHQMJ@G.P-SH30Z'@N+]EL"=X>+Y+I5]HU6D#):<
M@,+KA8^Z&<68$3@Y7($45DQH4QS1E*W1FR[VM3P:8*&+L,ZQXBBT.O>42=0F
MI9P5Z" 3G=A1TV:A%3#&K/=96]4HO=Z>M]$;1':V2!JAHE>[_3I"DI0*%HL#
M.A5U;5IHR!P5$B+S-J1D=,QM6L4]1=7HW20;87,P371@F.SDY59LQ J1O/8&
M0K0,E \%(IE8D(.U)NK">+L^#$\1-FZ<ZLS8.E(?O<)KDJV7W!D!QA9B C,#
MQY6$8I++A(=L7+,>N _)&3=2=68H'23[#DZ]NT&WOV,][C&_^$)?_;!M4G;]
MS?>X^,0GJ6#,C M00M6TIE/@C#6 T7-G465OVVQ8AU+:0VIPD)A64Q7UTE7C
MVTK:@S]'2\CQ5  Q.% R9HA61"@!LT^HG%#MC;&! 'BVJMV!@JH#JZ<+^#VY
MP&Y7S[_!15H;"=FP:+(D8=;+JI;7T8":@;8Z2UIY)I0V]Q@.I;2';&/[/?!4
M%8V><WQB@>WBC3&!+"=BAGGB31<-4; "7DJ/EAG/<IL)?(?1V4.&LO7^=ZIZ
M!H)>F[L)FR;^%V7]SU?SY6J *P>//W/(FP1[4M[F@H!P3J0:(:[-?,D&(S_2
M!^[ ^J"+BL%XHYLLSV$O"#P5!;P3YA.<,5:(7<(U[;29X*Y*AE*+B3S/Q3=J
M>+ G@3W49Q^%C:>VH:$4TED(X_6,GHO+U;;C50TABU(4AZ(UN>>T6=.N'2/]
M@8YV[""3;-,A_@FBNJJ5& I/IPA^[/K\VWS4O7["LK6*102IRMH)5A!4'<]A
MF4^>?..DV/>.JYU/[BJD<(SJ3Y=7=R&K-0<E!)ZBMB#IA:"4D!""5(!!LR"*
MT5JV2= _I*4KK_^4[>%$,7=PLKR[BI>;S:TV'IHX%,@#!F#>\]H#"(&(]I ,
M$MU:Q.C;V&5WZ>C*)S\%(">(MXO"B!M<>^2:.4S@/9.$:VLA9MH%I4+F2N+"
MVC9%<(?M&N?RE4\!Q7%"[;5+Z5,7TU^%Y<=?+N=_G/V"_OXO;GXY_T@9M/&[
MBW1>>>LA\U![O"F$*$,]IW1P,3MG0YM+'\/ZW7?/W3?A:Q7U<L)DD=I*"=J[
M.DQ%Y]IT&D$H(ZQ@= *G-BW$=]/3E5=]B.:?-G..$G<'ILYMF_[-8CI+T\_A
M\ALSB>5BF:8=/$4%"H,E9I2FDSJES)- 8JVY&_V K*X<Z5,@-)SP.T/2=51@
MR\O%[*;,@3-?!#,)G,JB]CSWX# R($L-=7*^9'^^R,Q#^KKRU(?"UD#J>"X=
MD?XZG4T_77VZLR__,E]L)7)S]VR6[WHB@QM?PQ#2Q!AK(*,VQEDBGR$XPX&V
M0ET;9S((5B7@,FEO35(>V]1LM$N*W&ID?2WZGZYN6AH7%+QX88$S<HJ5BAF"
M"QDR60_6Y!#3&6_Z[::Q*R/N$(3L4XHW@%HZ.XZ_;??7?.T>(IHP9KMN"E%R
M(?<]!SH+B&%FR0+QP@?5Z/+[X;3V=T-O"-3L4R<ZG I[!RF)\<%D4.:9*0$5
M:*P-)U $\%*YVM6$Y9Q2,+Y-P.U02ON[(W=N@)ZJOF< S^OAG]K5/)BR$)%9
M4+5F,="I!")R;77T2O/V/LT3!/9W%VT$,!ZCK.>"P?4D3\:<I,V>0=:1%I>7
M%@(90B"S<LYD&UH-$-F;Q/[NG8V%PX,5]DR0N![.J8U%6;O/\ZC4YAJ!5\)
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MJ7>(G.T*BS[7;JB)7$-1DR5!@U/% "TLBR6S;#2>!3L]V#RGZ_D[P#E"Z!U
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MVHG];OSL];J^4'*,4N=-)=PW9L26H^QBTLHA%&-KJET3;Q$3% RHT"H9HAD
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M(@>2/VX@H8OLP/EAT.O%[W?XH5I#KV?K1CSU:;\%,N6K8$YI5_K]IP[3D?1
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MN^K"0]BV=)M=GOR<X\&U^HC&?\YS_E]02P,$%     @ #'=D50:O. FH!P
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MN@D6+3;=\%P@./CG0%"R1.4(,N%E'=0F\ =Q--N-=I4GH ].90A^Q[H4&!/
MV8A@$Z!31#D%XDZ0)2AKO<9D#0?W8&K 7H3ZIDD2I88 @&B EC"="_K$W*4L
MT6;NEBBU<JJ<1W'D&:>'E=[0LKD!-K=49DO;YX*WX=[A[>9><%X<'*/>&[L:
M475-0!1ADD3A-H3MBG$K T 0<!5I28%D$JB,M'(IB9-8!GHDBJ1[H5RLC2O1
MCXC3&ETAI; FE@*/'7L)8 @)I%71G]S%*<^GDIV#D]Z7&A*] 6_UCE[*P]"U
M=R2JN^H6<TF;5PBE\1D1UP9P*R"1+CM-1)[HGHPQ0;*:;O/98;#Y(;0A1_G]
M$^JGP:L]@BL_W".X]H?DATOI4'(C<B&[_36LFI1X8UZZW;M0!HPD(%+/5.54
M4UH, **:*1?H#U(R#^-0R;PFSDWRM5+S@+DZJ:ZQTJR)F1H52!2Z.*.5"#L]
M5T9."<6M(@-4E?I#.LAII-)1.@Y+U(7<'<@26TDHA#U>Z%2@I%1QJ3EQ/,P*
M2JS3.GI41<)F;8-?D21!T##Z2_$)M+M7.([V!L<G[5>OMV&\,W=MH7EWUML9
MU%@(V!L25KDS.2=ZYPXXIP*3 ,RM6(()\%8\4EKY!27ZQZ:EI15P%R!5K8I[
MHAL%:L@B=[5!16D+0-J%PB2.C15!@5"J3F6.>D,#V6B1!2T9$D$97J$72TL5
M(/+G@M]X;_"[XN')C.LRD!5%5R8):D4U0US<(S7?JJS8@7RKV\?+P(!7= 1Q
MNJK8C$SIG]9@E_3 5]*2*NGDKS<_+%K6Z&$)RLH3T"? C29X!I 3>P.Y%656
MP=P&!>W ZQ(NM#R*O(\@2LKF)HY+2Z'?2)V/C)H9Y_$\I@U4 OTP4'V8PUX^
MT24!AD%A#Z1KQ;%QDN'P@,X5\G*EUV&E5<K=JLX@\@N8ER)DA>"/FK$73*M;
MJ>N3A ?RS4]VT2?B?*]V9$?/9$<6CA7%<HDTUQQ%E+D)TS5=$= ^HO+8*F%7
MJG&4L=Y8MTKVX0&&S#+EO91_DA B@W*"VH6"?F&0EP S^-<1O^,O%=/+%2A_
M*Q74#ZNMS.-PX'#X_\W6WY;DSS7J,]2+"DBC_2WMFF,E 8TZ4:\V/7/);RGS
M5O5:R+VAT@S'GLO#H8\"7+T_J4X:'N$U+M#1R16M/0G.NCY%%R ,962S2O\.
MN=^5&? !+P5CZG3RZ#':<TKM^[<;.D<&3RQ8HXFHRT!TP$TXI*X!UJP2H,IG
M1L\D9<&<3^NS=EMSH\P*;182K?/45(3([\$7</LL)4)[9Q!LO"3\;^F(N;]0
MS"_AQT"4["VLRB)I7QST7G7'PV9X;_P1+RQ]V!'6S1'6D[0M6*%YX>1H^6.,
M3%1HOABI/.@2.HWKP2+CO<E&]+IX1ND,=5#MH^"NJGG])KG=K=XF>XO_8CES
MW=P.31TOMMN&Q^V3[M/-W7;OR;;/-&PGJ%RI#<^X@N=O&H/&LD.]%$9=U@N>
M78[W)Z+]XHZ$-W%%"VG+CZ;X0CA[<3#$4@I7=MEFYS]]=SWYE5U/)BN$?5['
MU  ,^"Q@+1VA,3)S_(]QV>1.QB7M7-DOJ.?8.^Q*%>6(\(J$OB:X2)5,V+<K
M'OJA*ORV/=H)R^R15;SYA49AJN]31M79Y$P^^<U&O4Z[ZRX\@H-+O]WER6\?
M[EVK+T["MR]G?P!02P,$%     @ #'=D50U5?1I"!0  5!<  !8   !A;W)T
M+3(P,C(P.3,P>&5X,S(N:'1MY5AM3]M($/Y^OV(:=)1*\6L")$Z*E#I!34L3
MFKC7ZZ?3QE[C%8[776\(Z:^_V;4#H9 >5UT+]!"*"//^S,S.[':?]<=^\.ET
M (F<IW#ZX=7)T(>:85D?&[YE]8,^O [>G4#3M!T(!,D*)AG/2&I9@U$-:HF4
MN6=9R^727#9,+LZL8&(I54TKY;R@9B2CVE%7_0<_*8F.?NL^,PSH\W QIYF$
M4% B:02+@F5G\#&BQ3D81L7E\WPEV%DBP;5=%SYR<<XN2$F73*;T:*VG:Y7?
MNY8VTIWQ:'74C=@%L.AEC34;D=-N4*?EDG:3'#KMV7[#;CBQ2Z+6['"_^9>#
M3EK(7LH4<I72E[4YRXR$*OM><S^7G26+9.(YMOU[[28?$6?(*GGN.2[R27HI
M#9*RL\S3WB-WS#'6BCWD*1?>CJU_.HIBQ&3.TI7W/&!S6L"(+F'"YR1[7B\0
M<:.@@L4E8\&^4/0 C>BOR]*[0]23LHRNO75<Y>+@,F$S)J'A=BW%?=.+_\)N
M\TZ[:VLEGK=1O1]:F$/QE:K[*0FQ'*CXX9C?';L_F 3#XZ'?"X;C$;;39/JA
M-PH@&&^-Y+%X[K3@@SDU?1.F U][[S3V[?JC][LWA5Y_?!H,^D\*[C7(;?L
MQL<0O![ M#=YU1L-IL;XSY/!)^CY@:*XMNW>MPT>*)9A!B'/,AJJT0!+)A.0
M"87W"R(0X'0%$YIS(8''T!.272!7'899:,*>XMO=:;FNW?'Y/"?92G]S.B\
M51US,0?'-MY#S(76^;G4"32+U+R8TES2^8R*W1WGP.XT[+J>%'4@!<0LQ;ER
MY<V4A@N!PPO#)ED$@\LP(=D9Q1DSG[.B4)[CK^*,<"!!0@5%?S<=+*-8^U<'
M2L)$Q?2&*"Q/B10L/(=W)#QG&)\2]!/"!,);AU-!"Q9AP=6U=3]A-$8?T"?$
M@\(XCEF(8:$V+5="4?+VR06+H%<D*5W!":6EZFO9/U#R;OW'+"-9R$BZ5;^*
M<K8")$D6(S1UR!>B6!"L(<FU)@4\_B_'65XH\8UCHLJW/B84X"3BN1KEFRK6
M3*K,*^-3(F8DHX4QOE01]4)=&*K,560$(V 9)*R D.0D9'*E=6-V[HQ!.XF&
ME,!YQI>8\S.ZN[/?ZMQ[=N0D4L5DI#267N-@/4U8IO#T#*?U8(VUY[RX:W3_
M'/,W<3DP&TV%0X#05^T<+U+L[1#SD*JNNNHT03\OF*!J+=,E<UTH>P3;6H"S
MOQ>]N"J'Z[Z\ZLFJ)G!E:V(JVQV5Y%\AG>ZC3"?+L,GG1.<(SW%)4#)232@W
M<HT'&28[QV-&I57W*$E30#%T!D\8).28YZ(\G>*KDP<51OK*H!L5N19I614\
MIT+;++[J:/-?3#M)9BE=DV=<1%08"&=*\H)ZZS\Z$2ORE*P\EFE0M%"G4C;C
M4O*YI];["W4*AB2MU@-=-27Y>O,W[7+[E[B;RFAMN2*;Y?8KH]NTYJ'9:K2W
MDFW3^2Z:8[;=[Y7\MK/-[>1-M98&H@0#\2XP@2]KC=I:H*HYS\TOP;FYIJLR
MO 4YSW]^:^J$[NXT#SN%_H0W)ISV@LG0?POO>O[;X>BJ("LTOA&HK<*LW8OU
M26'2-Z$W?:W6TI/!X 8>_U !55/JGLTQ!)[B,J-\[SP9''YP/?P""'UW=3R%
M",M[_99-7CU2;%GF_W^G1O7J](V+R35<M^XF/[QL]#;Q$-TQXA<;=]1F>47]
MZI'LX6KDT<.B:\'22]L=.^'F^RQ>4O6JZ0F:$E6"6U]LJZW/OA8A,SQX%_*V
MR-;7R!N?Y7NS?OD^^AM02P$"% ,4    "  ,=V15R[!""DD[  "EA $ '@
M            @ $     83$P,2UF;W)M,3!X<65X>&9O<FUO9FEN9&4N:'1M
M4$L! A0#%     @ #'=D56Y0DZ<B+0  V30! !X              ( !A3L
M &$Q,#(M<F5D86-T961X9&%V:7-X8VAA;F=E+FAT;5!+ 0(4 Q0    (  QW
M9%5,Y?3R["P  '$L 0 >              "  >-H  !A,3 S+7)E9&%C=&5D
M>&AO;&QO=V%Y>&-H82YH=&U02P$"% ,4    "  ,=V15^WQ 5KPL  #O*0$
M'@              @ $+E@  83$P-"UR961A8W1E9'AL965X8VAA;F=E;V8N
M:'1M4$L! A0#%     @ #'=D58>_'E@A= ( C"H; !$              ( !
M \,  &%O<G0M,C R,C Y,S N:'1M4$L! A0#%     @ #'=D5>8 540[$0
MI[0  !$              ( !4S<# &%O<G0M,C R,C Y,S N>'-D4$L! A0#
M%     @ #'=D5957X8<^(P  F6$! !4              ( !O4@# &%O<G0M
M,C R,C Y,S!?8V%L+GAM;%!+ 0(4 Q0    (  QW9%7"^BCK*$D  (H1 P 5
M              "  2YL P!A;W)T+3(P,C(P.3,P7V1E9BYX;6Q02P$"% ,4
M    "  ,=V15OE=7,^3B  "80 D %0              @ &)M0, 86]R="TR
M,#(R,#DS,%]L86(N>&UL4$L! A0#%     @ #'=D5739P52,@@  <\T% !4
M             ( !H)@$ &%O<G0M,C R,C Y,S!?<')E+GAM;%!+ 0(4 Q0
M   (  QW9%4':65FX@<  "DD   7              "  5\;!0!A;W)T+3(P
M,C(P.3,P>&5X,S$Q+FAT;5!+ 0(4 Q0    (  QW9%4&KS@)J <  %8C   7
M              "  78C!0!A;W)T+3(P,C(P.3,P>&5X,S$R+FAT;5!+ 0(4
M Q0    (  QW9%4-57T:0@4  %07   6              "  5,K!0!A;W)T
H+3(P,C(P.3,P>&5X,S(N:'1M4$L%!@     -  T B ,  ,DP!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
